Citrus Sinensis ID: 013504

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-
Protein Sequence
MSSEAIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWLTWRPKLVKTS
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHHccccccccccccccEEEEEEEccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHcHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccEEEEEEEccccccccHHHHHHHHHHHHHccccHEEEEEEEccccccccEEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEcccccccccccccccEEEEEEEcccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHccccccccccccccccccccEEccc
Coil and Loop (DISEMBL)
msseaigfqedmkclyasnkdkneeqktaksisvrssasntsmstdrdvrksgsefnsqnasdfssesssrnTFAVLSQRQSNLRVFTFSELKTATKNFSRSlmigeggfggvYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLgvvehpnlVKLIGYCAEDDERGIQRLLIYEympnrsvqdHLTSRfqatlpwntRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWnaklsdfglarlgpsdglshvsTAVVGTigyaapeyiqtgrltyksDIWSFGVFLYELitgrrpldrnrpksEQKLLEWVRphltdakkftmildpklegkYSIKLAQKLAAVANKCLArqakgrpkMSEVVEVLNKIVDaaetgtpqtplknlslkddFETSKKERLkrrfvdpirgekgclawltwrpklvkts
Flexible Loop (DISEMBL)
msseaigfqedmkclyasnkdkneeqktaksisvrssasntsmstdrdvrksgsefnsqnasdfssesssrNTFAVLSQRQSNLRVFTFSELKtatknfsrslmigeGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELItgrrpldrnrpksEQKLlewvrphltdakkFTMILDPKLEGKYSIKLAQKLAAVANKCLArqakgrpkmsEVVEVLNKIVDaaetgtpqtplknlslkddfetskkerlkrrfvdpirgekgclawltwrpklvkts
Low Complexity Region (SEG)
MSSEAIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIgeggfggvyrgVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWLTWRPKLVKTS
Disordered region (IsUnstruct)
**********************************************************************************NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR***********KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQA*******EVVEVLNKIVD******************************RFVDPIRGEKGCLAWLTWRPKL****
Disordered Region (DISOPRED)
******G***DMK***********************************************************************RVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK**************************************************W*PK*****
Disordered Region (DISEMBL)
MSSEAIGFQEDMKCLYASNKD****************************************************FAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWLTWRPKLVKTS
Disordered Region (DISPRO)
MSSEAIGFQEDMKCLYAS***************************************************************SNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD**********************************************T*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSEAIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWLTWRPKLVKTS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	441	2.2.26 [Sep-21-2011]
Q9LTC0	410	Probable receptor-like pr	no	no	0.873	0.939	0.479	1e-105
Q9LFP7	493	Probable receptor-like pr	no	no	0.820	0.734	0.494	8e-99
Q9SRH7	490	Receptor-like serine/thre	no	no	0.854	0.769	0.481	2e-98
P43293	389	Probable serine/threonine	no	no	0.768	0.871	0.475	5e-90
O49839	426	Protein kinase 2A, chloro	no	no	0.705	0.730	0.521	4e-89
Q8GXZ3	410	Serine/threonine-protein	no	no	0.725	0.780	0.498	4e-89
P46573	412	Protein kinase APK1B, chl	no	no	0.684	0.733	0.520	1e-87
O49840	426	Protein kinase 2B, chloro	no	no	0.696	0.720	0.509	5e-87
Q06548	410	Protein kinase APK1A, chl	no	no	0.775	0.834	0.476	7e-86
O48814	395	Serine/threonine-protein	no	no	0.743	0.830	0.470	1e-85

>sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1

 Score =  382 bits (980), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 196/409 (47%), Positives = 270/409 (66%), Gaps = 24/409 (5%)

Query: 12  MKCLY--------ASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASD 63
           M CL+           KD N+ ++  K +   S+   T+       R   S FN Q    
Sbjct: 1   MNCLFLFKSKKPRKQQKDNNKNKRKGKELLQNSAPELTN-------RSETSSFNLQTPRS 53

Query: 64  FSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTED 123
             S  S ++ +   ++R+ NLRVF++ EL  AT  FSR L+IGEGGFG VY+G I S  D
Sbjct: 54  LPSPRSIKDLY---TEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKILSNGD 110

Query: 124 S-HKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S    + +A+K+L+R+GLQGHK+W+ EV  LGVV HPN+VKLIGYC+ED E GI+RLL+Y
Sbjct: 111 SSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVY 170

Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM NRS++DHL  R   TLPW  RL+I   AA GL YLH   D ++I+RDFKSSN+LLD
Sbjct: 171 EYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH---DLKVIYRDFKSSNVLLD 227

Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +Q+  KLSDFGLAR GP    +HV+TA VGT GYAAPEY+QTG L  KSD++SFGV LYE
Sbjct: 228 DQFCPKLSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYE 287

Query: 303 LITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKC 362
           +ITGRR ++RN+P +E++LL+WV+ +  D+++F+MI+DP+L   Y    A+ LA +A+ C
Sbjct: 288 IITGRRTIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLC 347

Query: 363 LARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKE 411
           L +  K RP M  VVE L KI++  E+ +   P+   + K+  +  +++
Sbjct: 348 LKKNDKERPTMEIVVERLKKIIE--ESDSEDYPMATTTTKESSQVRRRQ 394

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  361 bits (926), Expect = 8e-99,   Method: Compositional matrix adjust.
 Identities = 194/392 (49%), Positives = 260/392 (66%), Gaps = 30/392 (7%)

Query: 31  SISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQR---QSNLRVF 87
           +++   S S    S D+ V +  S   + NA     ESSS  +  V+S+     S+LR F
Sbjct: 78  TVTTMESKSANEKSNDQPVGQVSSTTTTSNA-----ESSS--STPVISEELNISSHLRKF 130

Query: 88  TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRRGLQGH 143
           TF++LK +T+NF    ++GEGGFG V++G I     +  K    + +AVK L+  GLQGH
Sbjct: 131 TFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGH 190

Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           KEW+ E+N LG + HPNLVKL+GYC EDD    QRLL+YE+MP  S+++HL  R    LP
Sbjct: 191 KEWLAEINFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLP 245

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
           W+ R+KIA  AA+GL++LHE     +I+RDFK+SNILLD  +NAKLSDFGLA+  P +G 
Sbjct: 246 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGK 305

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
           +HVST V+GT GYAAPEY+ TG LT KSD++SFGV L E++TGRR +D+NRP  E  L+E
Sbjct: 306 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 365

Query: 324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           W RPHL D ++F  +LDP+LEG +SIK AQK+  +A +CL+R  K RPKMS+VVE L   
Sbjct: 366 WARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALK-- 423

Query: 384 VDAAETGTPQTPLKNL-SLKDDFETSKKERLK 414
                   P   LK++ S    F+T + ERLK
Sbjct: 424 --------PLPHLKDMASSSYYFQTMQAERLK 447

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  359 bits (922), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 197/409 (48%), Positives = 264/409 (64%), Gaps = 32/409 (7%)

Query: 14  CLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNT 73
           C  +S  D   E     S S   S S    S D+ V    S   + NA       SS +T
Sbjct: 57  CCASSTSDV--ETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAE------SSLST 108

Query: 74  FAVLSQR---QSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK--- 127
             ++S+     S+L+ F+F +LK AT+NF    ++GEGGFG V++G +     +  K   
Sbjct: 109 -PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167

Query: 128 -IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
            + +AVK L+  GLQGHKEW+ E+N LG + HPNLVKL+GYC EDD    QRLL+YE+MP
Sbjct: 168 GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMP 223

Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
             S+++HL  R    LPW+ R+KIA  AA+GL++LHE     +I+RDFK+SNILLD ++N
Sbjct: 224 RGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYN 282

Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG 306
           AKLSDFGLA+  P +G +HVST V+GT GYAAPEY+ TG LT KSD++SFGV L E++TG
Sbjct: 283 AKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342

Query: 307 RRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQ 366
           RR +D+NRP  E  L+EW RPHL D ++F  +LDP+LEG +S+K AQK+  +A +CL+R 
Sbjct: 343 RRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRD 402

Query: 367 AKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNL-SLKDDFETSKKERLK 414
           +K RPKMSEVVEVL           P   LK++ S    F+T + ERLK
Sbjct: 403 SKIRPKMSEVVEVLK----------PLPHLKDMASASYYFQTMQAERLK 441

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  332 bits (850), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 171/360 (47%), Positives = 246/360 (68%), Gaps = 21/360 (5%)

Query: 54  SEFNSQNASDFSSESS----SRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGG 109
           S+F S++ S  SS +S     R    +L  + +NL+ F+ SELK+AT+NF    ++GEGG
Sbjct: 21  SKFLSRDGSKGSSTASFSYMPRTEGEIL--QNANLKNFSLSELKSATRNFRPDSVVGEGG 78

Query: 110 FGGVYRGVIRSTEDSHKK----IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLI 165
           FG V++G I  +  +  K    I IAVK+L++ G QGH+EW+ E+N LG ++HPNLVKLI
Sbjct: 79  FGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLI 138

Query: 166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHE 223
           GYC E++     RLL+YE+M   S+++HL  R  F   L WNTR+++A  AARGLA+LH 
Sbjct: 139 GYCLEEE----HRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN 194

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
               Q+I+RDFK+SNILLD  +NAKLSDFGLAR GP    SHVST V+GT GYAAPEY+ 
Sbjct: 195 AQP-QVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLA 253

Query: 284 TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
           TG L+ KSD++SFGV L EL++GRR +D+N+P  E  L++W RP+LT+ ++   ++DP+L
Sbjct: 254 TGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRL 313

Query: 344 EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI----VDAAETGTPQTPLKNL 399
           +G+YS+  A K+A +A  C++  AK RP M+E+V+ + ++      + E   PQ  + N+
Sbjct: 314 QGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDNI 373

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  328 bits (842), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 167/320 (52%), Positives = 220/320 (68%), Gaps = 9/320 (2%)

Query: 83  NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRR 138
           NL+ FTF+ELK ATKNF +  ++GEGGFG V++G I  T  +  +    I +AVKQL   
Sbjct: 70  NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129

Query: 139 GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF 198
           G QGHKEW+TEVN LG + HPNLV L+GYCAE    G  RLL+YE+MP  S+++HL  R 
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPKGSLENHLFRRG 185

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
              L W  R+K+A  AA+GL +LHE    Q+I+RDFK++NILLD  +NAKLSDFGLA+ G
Sbjct: 186 AQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNAKLSDFGLAKAG 244

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE 318
           P+   +HVST V+GT GYAAPEY+ TGRLT KSD++SFGV L ELI+GRR +D +   +E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304

Query: 319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
             L++W  P+L D +K   I+D KL G+Y  K A   A +A +CL   AK RPKMSEV+ 
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364

Query: 379 VLNKIVDAAETGTPQTPLKN 398
            L ++   A+ GT  T +++
Sbjct: 365 TLEQLESVAKPGTKHTQMES 384

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  328 bits (842), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 165/331 (49%), Positives = 226/331 (68%), Gaps = 11/331 (3%)

Query: 57  NSQNASDFSSESSSR---NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGV 113
           +S++ SD S  S+ R   ++   +S  Q  +  FT  EL+T TK+F    ++GEGGFG V
Sbjct: 26  HSRSVSDLSDPSTPRFRDDSRTPISYAQ--VIPFTLFELETITKSFRPDYILGEGGFGTV 83

Query: 114 YRGVIRST-EDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD 172
           Y+G I        K + +AVK L++ GLQGH+EW+TEVN LG + HPNLVKLIGYC EDD
Sbjct: 84  YKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD 143

Query: 173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR 232
                RLL+YE+M   S+++HL  +  A L W+ R+ IA  AA+GLA+LH   +  +I+R
Sbjct: 144 ----HRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNA-ERPVIYR 198

Query: 233 DFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSD 292
           DFK+SNILLD  + AKLSDFGLA+ GP    +HVST V+GT GYAAPEY+ TG LT +SD
Sbjct: 199 DFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSD 258

Query: 293 IWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLA 352
           ++SFGV L E++TGR+ +D+ RP  EQ L++W RP L D +K   I+DP+LE +YS++ A
Sbjct: 259 VYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAA 318

Query: 353 QKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           QK  ++A  CL++  K RP MS+VVE L  +
Sbjct: 319 QKACSLAYYCLSQNPKARPLMSDVVETLEPL 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  323 bits (829), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 164/315 (52%), Positives = 221/315 (70%), Gaps = 13/315 (4%)

Query: 83  NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRR 138
           NL+ FTF+ELK AT+NF    ++GEGGFG V++G I     +  K    + IAVK+L++ 
Sbjct: 53  NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQD 112

Query: 139 GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR- 197
           G QGH+EW+ EVN LG   HPNLVKLIGYC ED+     RLL+YE+MP  S+++HL  R 
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRG 168

Query: 198 --FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA 255
             FQ  L W  RLK+A  AA+GLA+LH   +  +I+RDFK+SNILLD ++NAKLSDFGLA
Sbjct: 169 SYFQP-LSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLA 226

Query: 256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           + GP+   SHVST ++GT GYAAPEY+ TG LT KSD++S+GV L E+++GRR +D+NRP
Sbjct: 227 KDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRP 286

Query: 316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
             EQKL+EW RP L + +K   ++D +L+ +YS++ A K+A +A +CL  + K RP M+E
Sbjct: 287 PGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNE 346

Query: 376 VVEVLNKIVDAAETG 390
           VV  L  I    E G
Sbjct: 347 VVSHLEHIQTLNEAG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  322 bits (824), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 163/320 (50%), Positives = 222/320 (69%), Gaps = 13/320 (4%)

Query: 83  NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRR 138
           NL+ FTF+ELK AT+NF    ++GEGGFG V++G I  T  +  K    I +AVK+L   
Sbjct: 67  NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTE 126

Query: 139 GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF 198
           G QGHKEW+TEVN LG + HPNLVKL+GYC E    G  RLL+YE+MP  S+++HL  R 
Sbjct: 127 GYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVE----GENRLLVYEFMPKGSLENHLFRRG 182

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
              L W  R+K+A  AA+GL +LH+    Q+I+RDFK++NILLD ++N+KLSDFGLA+ G
Sbjct: 183 AQPLTWAIRMKVAIGAAKGLTFLHDAKS-QVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE 318
           P+   +HVST V+GT GYAAPEY+ TGRLT KSD++SFGV L EL++GRR +D+++   E
Sbjct: 242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301

Query: 319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
           Q L++W  P+L D +K   I+D +L G+Y  K A   A++A +CL   AK RPKMSEV+ 
Sbjct: 302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361

Query: 379 VLNKIVDAAETGTPQTPLKN 398
            L+++    E+  P T + N
Sbjct: 362 KLDQL----ESTKPGTGVGN 377

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  318 bits (814), Expect = 7e-86,   Method: Compositional matrix adjust.
 Identities = 171/359 (47%), Positives = 239/359 (66%), Gaps = 17/359 (4%)

Query: 32  ISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSE 91
           +S +  A ++  ST  D +  GS      AS  S   S R    +L  +  NL+ F+F+E
Sbjct: 5   LSAQVKAESSGASTKYDAKDIGSL--GSKASSVSVRPSPRTEGEIL--QSPNLKSFSFAE 60

Query: 92  LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRRGLQGHKEWV 147
           LK+AT+NF    ++GEGGFG V++G I     +  +    + IAVK+L++ G QGH+EW+
Sbjct: 61  LKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWL 120

Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR---FQATLPW 204
            EVN LG   H +LVKLIGYC ED+     RLL+YE+MP  S+++HL  R   FQ  L W
Sbjct: 121 AEVNYLGQFSHRHLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRGLYFQP-LSW 175

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
             RLK+A  AA+GLA+LH   + ++I+RDFK+SNILLD ++NAKLSDFGLA+ GP    S
Sbjct: 176 KLRLKVALGAAKGLAFLHSS-ETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKS 234

Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
           HVST V+GT GYAAPEY+ TG LT KSD++SFGV L EL++GRR +D+NRP  E+ L+EW
Sbjct: 235 HVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEW 294

Query: 325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +P+L + +K   ++D +L+ +YS++ A K+A ++ +CL  + K RP MSEVV  L  I
Sbjct: 295 AKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHI 353

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  317 bits (812), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 160/340 (47%), Positives = 233/340 (68%), Gaps = 12/340 (3%)

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK----IDIAVKQLSRRG 139
           ++ FTF+ELK AT+NF    +IGEGGFG V++G +  +  +  K    + IAVK+L++ G
Sbjct: 52  VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEG 111

Query: 140 LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-- 197
            QGH+EW+TE+N LG + HPNLVKLIGYC ED+     RLL+YE+M   S+++HL  R  
Sbjct: 112 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQKGSLENHLFRRGA 167

Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
           +   LPW  R+ +A DAA+GLA+LH     ++I+RD K+SNILLD  +NAKLSDFGLAR 
Sbjct: 168 YFKPLPWFLRVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
           GP   LS+VST V+GT GYAAPEY+ +G L  +SD++SFGV L E+++G+R LD NRP  
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
           E+ L++W RP+LT  +K  +I+D +L+ +Y  + A ++A+VA +CL+ + K RP M +VV
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 378 EVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRF 417
             L ++ D     +   P+K+ + K  F+T   +  ++RF
Sbjct: 347 RALQQLQDNLGKPSQTNPVKD-TKKLGFKTGTTKSSEKRF 385

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
359486879	2201	PREDICTED: uncharacterized protein LOC10	0.963	0.193	0.795	0.0
255580209	457	Protein kinase APK1B, chloroplast precur	0.997	0.962	0.751	0.0
224109804	431	predicted protein [Populus trichocarpa]	0.965	0.988	0.771	0.0
224100757	403	predicted protein [Populus trichocarpa]	0.911	0.997	0.757	0.0
449464368	430	PREDICTED: probable receptor-like protei	0.968	0.993	0.723	0.0
449520643	430	PREDICTED: probable receptor-like protei	0.968	0.993	0.721	0.0
297741627	460	unnamed protein product [Vitis vinifera]	0.936	0.897	0.689	1e-166
356505240	428	PREDICTED: probable receptor-like protei	0.959	0.988	0.669	1e-165
357440361	427	Protein kinase 2A [Medicago truncatula]	0.961	0.992	0.661	1e-165
359481541	437	PREDICTED: probable receptor-like protei	0.956	0.965	0.663	1e-165

>gi|359486879|ref|XP_002273591.2| PREDICTED: uncharacterized protein LOC100254784 [Vitis vinifera]

 Score =  704 bits (1817), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/426 (79%), Positives = 378/426 (88%), Gaps = 1/426 (0%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSR 71
           M C      +KN+E K  KS SVRSS S  SMSTD +VR+SGSEFNSQNASD S+ESS++
Sbjct: 1   MTCFPFHKGEKNDEPKATKSTSVRSSTS-ISMSTDHEVRRSGSEFNSQNASDISTESSAK 59

Query: 72  NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIA 131
            +F  L QR SNL+VFTFSELK+ATKNFSRSLMIGEGGFGGVYRGVIRSTED HKKIDIA
Sbjct: 60  TSFTSLQQRPSNLKVFTFSELKSATKNFSRSLMIGEGGFGGVYRGVIRSTEDPHKKIDIA 119

Query: 132 VKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ 191
           VKQLSRRGLQGHKEWVTEVNVLGVVEH NLVKL+GYCAEDDERGIQRLLIYEYMPNRSVQ
Sbjct: 120 VKQLSRRGLQGHKEWVTEVNVLGVVEHENLVKLVGYCAEDDERGIQRLLIYEYMPNRSVQ 179

Query: 192 DHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD 251
           DHLT+RF+  L W+TRL+IAQDAARGLAYLHEGM+FQIIFRDFKSSNILLDEQWNAKLSD
Sbjct: 180 DHLTNRFETPLSWSTRLRIAQDAARGLAYLHEGMEFQIIFRDFKSSNILLDEQWNAKLSD 239

Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT KSD+WS+GVFLYELITGRRPLD
Sbjct: 240 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTAKSDVWSYGVFLYELITGRRPLD 299

Query: 312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           RNRPK+EQKLLEW+RPHL+D KKF +ILDP+LEGKY++K AQKLAAVANKCL RQ K RP
Sbjct: 300 RNRPKNEQKLLEWIRPHLSDVKKFQLILDPRLEGKYTLKSAQKLAAVANKCLVRQIKTRP 359

Query: 372 KMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWL 431
           KMSE+++++N+IV+AAETG+PQ P+K+ + +D  E SK++RLK  FVDPI GE   L W 
Sbjct: 360 KMSEILDMVNRIVEAAETGSPQPPIKSSTPRDAPEESKRKRLKTMFVDPIIGENRRLVWQ 419

Query: 432 TWRPKL 437
            WRPKL
Sbjct: 420 KWRPKL 425

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255580209|ref|XP_002530935.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223529494|gb|EEF31450.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/450 (75%), Positives = 385/450 (85%), Gaps = 10/450 (2%)

Query: 1   MSSEAIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMST-DRDVRKSGSEFNSQ 59
           + SE IG    MKC Y SN++KNEE KT KS S RS+AS +   + DRD+++SGSEFNSQ
Sbjct: 7   VCSEGIGPLGAMKCFYFSNREKNEEPKTTKSASGRSTASTSMSMSTDRDLKRSGSEFNSQ 66

Query: 60  NASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIR 119
           N SDFS+ESS++N+FA LS RQSNLRVFTFSELK+ATKNFSRSLM+GEGGFG VYRGVIR
Sbjct: 67  NVSDFSTESSTKNSFAALSLRQSNLRVFTFSELKSATKNFSRSLMVGEGGFGSVYRGVIR 126

Query: 120 STEDSHKKIDIAVKQLSRRGLQ---------GHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           STED +KKID+AVKQLSRRGLQ         GHKEWVTEV VLGVVEHPNLVKL+GYCAE
Sbjct: 127 STEDPNKKIDVAVKQLSRRGLQAGILLLHHHGHKEWVTEVKVLGVVEHPNLVKLVGYCAE 186

Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
           DDERGIQRLL+YEYMPNRSVQDHL+SRFQ  LPW  R+K+AQDAA+GLAYLHE MDFQII
Sbjct: 187 DDERGIQRLLVYEYMPNRSVQDHLSSRFQTPLPWAARVKVAQDAAQGLAYLHEEMDFQII 246

Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK 290
           FRDFKSSNILLD+QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT K
Sbjct: 247 FRDFKSSNILLDDQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTSK 306

Query: 291 SDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIK 350
           SD+W +GVFLYELITGRRPLDRNRPK EQKLLEWVRPHL+D KKF +ILDP+LEGKY++K
Sbjct: 307 SDVWGYGVFLYELITGRRPLDRNRPKEEQKLLEWVRPHLSDLKKFKLILDPRLEGKYNLK 366

Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKK 410
            AQKLAAVAN+CL RQAK RPKMSEV+ +++KIVD  + G+P  P+K+L+ KD  E S++
Sbjct: 367 SAQKLAAVANRCLIRQAKSRPKMSEVLAMVSKIVDTTDLGSPLLPMKSLAPKDASEMSRR 426

Query: 411 ERLKRRFVDPIRGEKGCLAWLTWRPKLVKT 440
           ERLKR+ ++   GEK  LAW  W PKLV+ 
Sbjct: 427 ERLKRKLLNQEIGEKVWLAWRRWTPKLVRA 456

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224109804|ref|XP_002315317.1| predicted protein [Populus trichocarpa] gi|222864357|gb|EEF01488.1| predicted protein [Populus trichocarpa]

 Score =  683 bits (1762), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/433 (77%), Positives = 381/433 (87%), Gaps = 7/433 (1%)

Query: 12  MKCLYASNKDKNEEQKTA--KSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESS 69
           MKC + S+++KNEE KT         +S+++ SMSTDRD+RKSGSE NSQN SDFS+ESS
Sbjct: 1   MKCFHFSSREKNEEPKTVTKSVSVQSTSSTSMSMSTDRDLRKSGSELNSQNVSDFSTESS 60

Query: 70  SRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKID 129
           ++N+FA   QRQSNL+ FTFSELKTATKNFSRS+MIGEGGFGGVYRGVIRS EDS KKID
Sbjct: 61  TKNSFA---QRQSNLKAFTFSELKTATKNFSRSVMIGEGGFGGVYRGVIRSMEDSSKKID 117

Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           IAVKQLSRRGLQGHKEWVTEVNVLG+VEHPNLVKL+GYCAEDDERGIQRLL+YE+MPNRS
Sbjct: 118 IAVKQLSRRGLQGHKEWVTEVNVLGIVEHPNLVKLVGYCAEDDERGIQRLLVYEFMPNRS 177

Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           VQDHL+S+FQ  LPW TR+KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD+QWNAKL
Sbjct: 178 VQDHLSSKFQKALPWATRVKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDDQWNAKL 237

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT KSD+WSFGVFLYELITGRRP
Sbjct: 238 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTSKSDVWSFGVFLYELITGRRP 297

Query: 310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
           LDRNRPK+EQ LLEWVR HL+D +KF +I+DPKLEGKY+IK AQKLA+VAN+CL RQAK 
Sbjct: 298 LDRNRPKNEQNLLEWVRSHLSDVRKFRLIMDPKLEGKYNIKAAQKLASVANRCLVRQAKS 357

Query: 370 RPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRG-EKGCL 428
           RPKMS++++++NKIVD  + G+P    K+L+ KD  E   +ER+KRRF+D I G +KGC 
Sbjct: 358 RPKMSDILDMINKIVDTTDNGSPLPCTKSLAPKDAPEGPGRERMKRRFLDSIIGDQKGCW 417

Query: 429 -AWLTWRPKLVKT 440
            AW TWR KLV+T
Sbjct: 418 SAWRTWRTKLVRT 430

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100757|ref|XP_002312001.1| predicted protein [Populus trichocarpa] gi|222851821|gb|EEE89368.1| predicted protein [Populus trichocarpa]

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/425 (75%), Positives = 362/425 (85%), Gaps = 23/425 (5%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSR 71
           MKC + SNK+KNEE KT   I    SA +TS        KSGSEFNSQN SDFS++SS++
Sbjct: 1   MKCFHFSNKEKNEEPKTCNQIC---SARSTS--------KSGSEFNSQNVSDFSTDSSTK 49

Query: 72  NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIA 131
           N+FA LSQRQSNLRVFTFSELKTATKNFSRS+MIGEGGFGGVYRGVIRS EDS KKIDIA
Sbjct: 50  NSFAALSQRQSNLRVFTFSELKTATKNFSRSVMIGEGGFGGVYRGVIRSMEDSSKKIDIA 109

Query: 132 VKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ 191
                     GHKEWVTEVN LG+ EHPN+VKL+GYCAEDDERG+QRLL+YE+MPN+SVQ
Sbjct: 110 ----------GHKEWVTEVNFLGIAEHPNIVKLVGYCAEDDERGVQRLLVYEFMPNKSVQ 159

Query: 192 DHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD 251
           DHL+S+FQ  LPW TR+KIAQDAARGLAYLHEGMDFQIIFRD KSSNILLD+QWNAKLSD
Sbjct: 160 DHLSSKFQKVLPWATRVKIAQDAARGLAYLHEGMDFQIIFRDVKSSNILLDDQWNAKLSD 219

Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           FGLARLGPSDGLSHVSTAVVGTIGYAAPEYI+TGRLT KSD+WSFGVFLYELITGRRPLD
Sbjct: 220 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIRTGRLTSKSDVWSFGVFLYELITGRRPLD 279

Query: 312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           RNRPK+EQKLLEWVRPHL+ A+KF +ILDP+LEGKY+IK AQKLAAVAN CL RQAK RP
Sbjct: 280 RNRPKNEQKLLEWVRPHLSGARKFRLILDPRLEGKYNIKTAQKLAAVANCCLVRQAKTRP 339

Query: 372 KMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAWL 431
           KMSE++E++NKIVD  + G+P  P+K+L+ KD  E SK+ER+K RFVDPI GE GC  W 
Sbjct: 340 KMSEILEMINKIVDTTDNGSPLLPMKSLAPKDAPERSKRERIKMRFVDPIIGESGC--WS 397

Query: 432 TWRPK 436
            WR +
Sbjct: 398 AWRTR 402

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449464368|ref|XP_004149901.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/431 (72%), Positives = 358/431 (83%), Gaps = 4/431 (0%)

Query: 12  MKCLYASNKDKN-EEQKTAKSISVRSSASN-TSMSTDRDVRKSGSEFNSQNASDFSSESS 69
           MKC Y  N ++    + T KS S  S  SN TSM+ D  +  S ++ NSQN S+ S  SS
Sbjct: 1   MKCFYFFNNERTVGTRTTTKSNSFLSCTSNSTSMNQDFKMFDS-ADLNSQNVSEISVASS 59

Query: 70  SRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKID 129
           +  +FA LSQRQSNLR FTFSELK ATKNFSRSLM+GEGGFG VYRG IR++ED HK+ID
Sbjct: 60  AV-SFAALSQRQSNLREFTFSELKAATKNFSRSLMVGEGGFGSVYRGAIRNSEDPHKRID 118

Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           IAVKQLSRRGLQGHKEWVTEVN LGVVEHPNLVKL+GYCAEDDERGIQRLL+YEYMPNRS
Sbjct: 119 IAVKQLSRRGLQGHKEWVTEVNFLGVVEHPNLVKLLGYCAEDDERGIQRLLVYEYMPNRS 178

Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           VQDHL+SRF ++LPW  R+KIAQD ARGLAYLHEGMDFQIIFRDFKSSNILLD+QWNAKL
Sbjct: 179 VQDHLSSRFNSSLPWAIRMKIAQDTARGLAYLHEGMDFQIIFRDFKSSNILLDDQWNAKL 238

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           SDFGLARLGPSDGLSHVSTA+VGTIGYAAPEY+QTGRLT K D+WS+GVFLYELITGRRP
Sbjct: 239 SDFGLARLGPSDGLSHVSTAIVGTIGYAAPEYLQTGRLTAKIDVWSYGVFLYELITGRRP 298

Query: 310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
           LDRNRPK EQKLLEWVRPHL+D KKF +ILDP+L GKYSIK A KLAAVA++CL R+A  
Sbjct: 299 LDRNRPKGEQKLLEWVRPHLSDLKKFELILDPRLGGKYSIKAAYKLAAVASRCLVRKAAA 358

Query: 370 RPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLA 429
           RPKMSEV+E++N+I+D     +P  P K+ +   D E SK E L++R ++P  GE GCL 
Sbjct: 359 RPKMSEVLEMVNRIMDGFNLESPLIPEKSSTSNSDSEGSKSESLRKRILNPFIGENGCLI 418

Query: 430 WLTWRPKLVKT 440
            L+WRPK+V+T
Sbjct: 419 CLSWRPKVVRT 429

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449520643|ref|XP_004167343.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/431 (72%), Positives = 357/431 (82%), Gaps = 4/431 (0%)

Query: 12  MKCLYASNKDKN-EEQKTAKSISVRSSASN-TSMSTDRDVRKSGSEFNSQNASDFSSESS 69
           MKC Y  N ++    + T KS S  S  SN TSM+ D  +  S ++ NSQN S+ S  SS
Sbjct: 1   MKCFYFFNNERTVGTRTTTKSNSFLSCTSNSTSMNQDFKMFDS-ADLNSQNVSEISVASS 59

Query: 70  SRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKID 129
           +  +FA LSQRQSNLR FTFSELK ATKNFSRSLM+GEGGFG VYRG IR++ED HK+ID
Sbjct: 60  AV-SFAALSQRQSNLREFTFSELKAATKNFSRSLMVGEGGFGSVYRGAIRNSEDPHKRID 118

Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           IAVKQLSRRGLQGHKEWVTEVN LGVV HPNLVKL+GYCAEDDERGIQRLL+YEYMPNRS
Sbjct: 119 IAVKQLSRRGLQGHKEWVTEVNFLGVVGHPNLVKLLGYCAEDDERGIQRLLVYEYMPNRS 178

Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           VQDHL+SRF ++LPW  R+KIAQD ARGLAYLHEGMDFQIIFRDFKSSNILLD+QWNAKL
Sbjct: 179 VQDHLSSRFNSSLPWAIRMKIAQDTARGLAYLHEGMDFQIIFRDFKSSNILLDDQWNAKL 238

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           SDFGLARLGPSDGLSHVSTA+VGTIGYAAPEY+QTGRLT K D+WS+GVFLYELITGRRP
Sbjct: 239 SDFGLARLGPSDGLSHVSTAIVGTIGYAAPEYLQTGRLTAKIDVWSYGVFLYELITGRRP 298

Query: 310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
           LDRNRPK EQKLLEWVRPHL+D KKF +ILDP+L GKYSIK A KLAAVA++CL R+A  
Sbjct: 299 LDRNRPKGEQKLLEWVRPHLSDLKKFELILDPRLGGKYSIKAAYKLAAVASRCLVRKAAA 358

Query: 370 RPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLA 429
           RPKMSEV+E++N+I+D     +P  P K+ +   D E SK E L++R ++P  GE GCL 
Sbjct: 359 RPKMSEVLEMVNRIMDGFNLESPLIPEKSSTSNSDSEGSKSESLRKRILNPFIGENGCLI 418

Query: 430 WLTWRPKLVKT 440
            L+WRPK+V+T
Sbjct: 419 CLSWRPKVVRT 429

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297741627|emb|CBI32759.3| unnamed protein product [Vitis vinifera]

 Score =  591 bits (1524), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 291/422 (68%), Positives = 343/422 (81%), Gaps = 9/422 (2%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSR 71
           MKC      DK EE KT+K  SV+S   N S  T++++++  SE +SQN S+ S+ES +R
Sbjct: 1   MKCFTFYYGDKKEEPKTSKWTSVQS---NNSTLTEQEMKRFASELSSQNVSNVSTESLAR 57

Query: 72  NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIA 131
            TF  LSQR SNLRVFTFSELK+ TKNFSRS MIGEGGFG VY+G+I+S++D   K+D+A
Sbjct: 58  PTFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVA 117

Query: 132 VKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ 191
           VKQL +RG+QGHKEWVTEV VLGVVEHPNLVKL+GYCAEDDERGIQRLLIYEYMPN SV+
Sbjct: 118 VKQLGKRGMQGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLLIYEYMPNGSVE 177

Query: 192 DHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD 251
            HL+S+ Q  L W  RLKIAQDAA+GLAYLHE MDFQIIFRDFKSSNILLDE+WNAKLSD
Sbjct: 178 SHLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNILLDEEWNAKLSD 237

Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           FGLARLGPS+GL+HVSTAVVGT+GYAAPEY+QTGRLT KSD+WS+GVF+YELITGRRP D
Sbjct: 238 FGLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFIYELITGRRPFD 297

Query: 312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           RNRPKSEQKLL WV+P L+D KKF +ILDP+LEG Y +K  Q+LA VAN+CL R  K RP
Sbjct: 298 RNRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVANRCLVRNPKSRP 357

Query: 372 KMSEVVEVLNKIVDAA-ETGTPQTPLKNLSLKDDFETSKKERL-KRRFVDPIR-GEKGCL 428
           KMSEV+E++N+IVDA  ETG+PQ P+K L      ETS+   L K+R +  +R GE G L
Sbjct: 358 KMSEVLEMVNRIVDAPRETGSPQPPVKRLL---SIETSQITELKKKRNIKDLRIGEGGWL 414

Query: 429 AW 430
            W
Sbjct: 415 PW 416

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356505240|ref|XP_003521400.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max]

 Score =  588 bits (1516), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 290/433 (66%), Positives = 348/433 (80%), Gaps = 10/433 (2%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDF-SSESSS 70
           MKC   S  +K +E K  +  S  S  S+ SM  + +VR+SGSE NSQ+ SD  SSES  
Sbjct: 1   MKCFPFSYGEKKDEPKGLQLQST-SGRSDNSMCVEAEVRRSGSELNSQDVSDNGSSESQR 59

Query: 71  RNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDI 130
           RN    LSQR SNLRVFT SELK+ATKNFSRS+MIGEGGFG VY G+IRS EDS ++I++
Sbjct: 60  RNAIPSLSQRPSNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYLGLIRSAEDSSRRIEV 119

Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           AVKQLS+RG+QGH+EWVTEVNVLG+VEHPNLVKL+GYCA+DDERGIQRLLIYEYMPNRSV
Sbjct: 120 AVKQLSKRGMQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSV 179

Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
           + HL+ R +  LPW  RLKIA+DAARGL YLHE MDFQIIFRDFKSSNILLDEQWNAKLS
Sbjct: 180 EHHLSHRSETPLPWTRRLKIARDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLS 239

Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           DFGLARLGPSDGL+HVSTAVVGT+GYAAPEY+QTGRLT K+D+WS+GVFLYELITGRRPL
Sbjct: 240 DFGLARLGPSDGLTHVSTAVVGTMGYAAPEYVQTGRLTSKNDVWSYGVFLYELITGRRPL 299

Query: 311 DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR 370
           DRNRP+ EQKLLEW+RP+L+D KKF +ILDP+L+ K   K AQ+LA +AN+CLA+  K R
Sbjct: 300 DRNRPRREQKLLEWIRPYLSDGKKFQLILDPRLDKKQVFKSAQRLAMIANQCLAKNPKNR 359

Query: 371 PKMSEVVEVLNKIVDAAETGTPQTPLKN---LSLKDDFETSKKERLKRRFVDPIRGEKGC 427
           PKMSEV+E++N +V+++ + +PQ PL++   L    D ET+     K+R +D   GE   
Sbjct: 360 PKMSEVLEMVNGMVESSSSSSPQLPLRSVVTLEASQDTETNN----KKRTMDQKLGESNW 415

Query: 428 LAWLTWRPKLVKT 440
              + WRPKLV+T
Sbjct: 416 FVRM-WRPKLVRT 427

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357440361|ref|XP_003590458.1| Protein kinase 2A [Medicago truncatula] gi|355479506|gb|AES60709.1| Protein kinase 2A [Medicago truncatula] gi|388509014|gb|AFK42573.1| unknown [Medicago truncatula]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 285/431 (66%), Positives = 348/431 (80%), Gaps = 7/431 (1%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRS--SASNTSMSTDRDVRKSGSEFNSQNASDFSSESS 69
           M C +  N    E++  AK + ++S    SN S     DVR++GSE NS +ASD SS+S 
Sbjct: 1   MNC-FPFNIYYGEKKGDAKGLQMQSLSGLSNNSTYGGSDVRRTGSELNSLDASDNSSDSL 59

Query: 70  SRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKID 129
            RN F  LSQR SNLRVFT SELK+ATKNF RS+M+GEGGFG VY+G+I+S +D  KKI+
Sbjct: 60  RRNAFPNLSQRPSNLRVFTVSELKSATKNFGRSVMLGEGGFGCVYKGLIKSVDDPAKKIE 119

Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           IAVKQL +RG+QGHKEWVTEVNVLG+VEHPNLVKL+GYCA+DDERGIQRLL+YEYMPNRS
Sbjct: 120 IAVKQLGKRGIQGHKEWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLVYEYMPNRS 179

Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++ HL+ R +  LPW+ RLKIAQDAARGL YLHE MDFQIIFRDFKSSNILLDEQWNAKL
Sbjct: 180 LEHHLSPRSETPLPWSRRLKIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKL 239

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           SDFGLARLGPSDGL+HVSTAVVGT+GYAAPEYIQTGRLT K D+WS+GVFLYELITGRRP
Sbjct: 240 SDFGLARLGPSDGLTHVSTAVVGTMGYAAPEYIQTGRLTSKIDVWSYGVFLYELITGRRP 299

Query: 310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
           LDRNRPK EQ+LLEW+RP+L+D KKF +ILDP+LE K+ +K AQKLA VAN+CL R  K 
Sbjct: 300 LDRNRPKGEQQLLEWIRPYLSDVKKFQIILDPRLERKHLLKSAQKLAIVANRCLVRNPKN 359

Query: 370 RPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLA 429
           RPKMSEV+E++++IV+++ +   Q PL +++  DD + ++    K+R +DP   +  C  
Sbjct: 360 RPKMSEVLEMVDRIVESSVSTNQQPPLNSVASADDSQDTEINN-KKRIMDP---KPDCNW 415

Query: 430 WLTWRPKLVKT 440
           +  WRPKL++T
Sbjct: 416 FRLWRPKLLRT 426

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481541|ref|XP_002276673.2| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 294/443 (66%), Positives = 349/443 (78%), Gaps = 21/443 (4%)

Query: 12  MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSR 71
           MKC      DK EE KT+K  SV+S   N S  T++++++  SE +SQN S+ S+ES +R
Sbjct: 1   MKCFTFYYGDKKEEPKTSKWTSVQS---NNSTLTEQEMKRFASELSSQNVSNVSTESLAR 57

Query: 72  NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIA 131
            TF  LSQR SNLRVFTFSELK+ TKNFSRS MIGEGGFG VY+G+I+S++D   K+D+A
Sbjct: 58  PTFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVA 117

Query: 132 VKQLSRRGLQ-----------GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           VKQL +RG+Q           GHKEWVTEV VLGVVEHPNLVKL+GYCAEDDERGIQRLL
Sbjct: 118 VKQLGKRGMQARFLHDVFLVMGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLL 177

Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           IYEYMPN SV+ HL+S+ Q  L W  RLKIAQDAA+GLAYLHE MDFQIIFRDFKSSNIL
Sbjct: 178 IYEYMPNGSVESHLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNIL 237

Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           LDE+WNAKLSDFGLARLGPS+GL+HVSTAVVGT+GYAAPEY+QTGRLT KSD+WS+GVF+
Sbjct: 238 LDEEWNAKLSDFGLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFI 297

Query: 301 YELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVAN 360
           YELITGRRP DRNRPKSEQKLL WV+P L+D KKF +ILDP+LEG Y +K  Q+LA VAN
Sbjct: 298 YELITGRRPFDRNRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVAN 357

Query: 361 KCLARQAKGRPKMSEVVEVLNKIVDAA-ETGTPQTPLKNLSLKDDFETSKKERL-KRRFV 418
           +CL R  K RPKMSEV+E++N+IVDA  ETG+PQ P+K L      ETS+   L K+R +
Sbjct: 358 RCLVRNPKSRPKMSEVLEMVNRIVDAPRETGSPQPPVKRLL---SIETSQITELKKKRNI 414

Query: 419 DPIR-GEKGCLAWLTWRPKLVKT 440
             +R GE G L W  W  ++V+T
Sbjct: 415 KDLRIGEGGWLPW-KWTSRVVRT 436

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
TAIR|locus:2064920	435	AT2G39110 [Arabidopsis thalian	0.936	0.949	0.670	5.9e-144
TAIR|locus:2085069	418	AT3G09830 [Arabidopsis thalian	0.934	0.985	0.627	2e-136
TAIR|locus:2142639	420	AT5G03320 [Arabidopsis thalian	0.941	0.988	0.612	3.9e-131
TAIR|locus:2053250	462	AT2G28940 [Arabidopsis thalian	0.920	0.878	0.552	1.8e-112
TAIR|locus:2151992	410	AT5G47070 [Arabidopsis thalian	0.895	0.963	0.459	2.2e-89
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.895	0.801	0.445	7.2e-84
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.854	0.769	0.462	2.4e-83
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.673	0.655	0.542	5e-83
TAIR|locus:2129326	388	AT4G17660 [Arabidopsis thalian	0.841	0.956	0.455	5.2e-81
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.850	0.880	0.460	6.8e-79

TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1407 (500.3 bits), Expect = 5.9e-144, P = 5.9e-144
 Identities = 289/431 (67%), Positives = 339/431 (78%)

Query:    12 MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSR 71
             MKC Y S KDK ++ + AK+   R   S T M+       SGSEFNS    D S+ +S  
Sbjct:    16 MKCFYFS-KDKTQDDE-AKT---RKFGSAT-MARGG----SGSEFNS----DTSTATSIT 61

Query:    72 NTFAVLSQRQSN-LRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDI 130
             ++  VLS+  SN L+VF   +LKTATKNFSRSLMI           VI++ +DS KKIDI
Sbjct:    62 SSLHVLSETHSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQDSRKKIDI 121

Query:   131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
             AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL+YEY+ NRSV
Sbjct:   122 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSV 181

Query:   191 QDHLTSRFQAT-LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
             QDHL++RF  T LPW+TRLKIAQD ARGLAYLH+GM+FQIIFRDFKSSNILLDE WNAKL
Sbjct:   182 QDHLSNRFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKL 241

Query:   250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             SDFGLAR+GPSDG++HVSTAVVGTIGYAAPEYIQTG LT KSD+WS+G+FLYELITGRRP
Sbjct:   242 SDFGLARMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRP 301

Query:   310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
              DRNRP++EQ +LEW+RPHL+D KKF MI+DP+LEG Y +K A KLAAVAN+CL  +AK 
Sbjct:   302 FDRNRPRNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKA 361

Query:   370 RPKMSEVVEVLNKIVDAAETGTPQ-TPL-KNLSLKDDFETSKKERLKRRFVDPIRGEKGC 427
             RP MS+V E+L +IV+ +  G P   PL K+L+ KD FE S++ER+KRRFV+ + GE GC
Sbjct:   362 RPTMSQVSEMLERIVETSSDGAPSGLPLMKSLTPKDAFEASRRERVKRRFVELLIGENGC 421

Query:   428 LAWLTWRPKLV 438
                 TW  KLV
Sbjct:   422 PNLPTWSHKLV 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)]

 Score = 1336 (475.4 bits), Expect = 2.0e-136, P = 2.0e-136
 Identities = 271/432 (62%), Positives = 328/432 (75%)

Query:    12 MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSS- 70
             MKC   S  DK  EQKT  S+S+      TS+ +DR++ +SGSEFNS++ S  S+ESS  
Sbjct:     1 MKCFLFSGGDKRGEQKTPISVSL------TSIFSDREINRSGSEFNSRDVSGTSTESSMG 54

Query:    71 -RNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKID 129
              +N++  +S R SNLR F+ ++LK+ATKNFSRS+MI            +R+ EDS  KI+
Sbjct:    55 RKNSYPPVSTRASNLREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDSSVKIE 114

Query:   130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
             +AVKQL +RGLQGHKEWVTEVN LG+VEH NLVKL+GYCAEDDERGIQRLL+YEYMPNRS
Sbjct:   115 VAVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVYEYMPNRS 174

Query:   190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
             V+ HL+ R    L W+ RL+IAQDAARGL YLHE M+FQIIFRDFKSSNILLDE W AKL
Sbjct:   175 VEFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKL 234

Query:   250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             SDFGLARLGPS+GL+HVST VVGT+GYAAPEYIQTGRLT KSD+W +GVFLYELITGRRP
Sbjct:   235 SDFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRP 294

Query:   310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
             +DRNRPK EQKLLEWVRP+L+D +KF +ILDP+LEGKY IK  QKLA VAN+CL R +K 
Sbjct:   295 VDRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKA 354

Query:   370 RPKMSEVVEVLNKIVDAAE-TGTPQ-TPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGC 427
             RPKMSEV+E++NKIV+A+   G+PQ  PL ++      + S+  R K        GE G 
Sbjct:   355 RPKMSEVLEMVNKIVEASSGNGSPQLVPLNSV------KASRDARGKNNGGG---GEGGW 405

Query:   428 LAWLTWRPKLVK 439
                L W PK ++
Sbjct:   406 FGKL-WNPKTIR 416

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 264/431 (61%), Positives = 319/431 (74%)

Query:    12 MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSS- 70
             MKC      DK +EQ++ K +S  S+ S        DV KSGS+F+ ++ S  S+ SS+ 
Sbjct:     1 MKCFLFPLGDKKDEQRSPKPVSPTSNFS--------DVNKSGSDFSPRDVSGTSTVSSTG 52

Query:    71 RNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDI 130
             RN+   +S R++NLR FT  +LK+AT+NFSRS MI            I++ ED  KKI++
Sbjct:    53 RNSNTSMSARENNLREFTIGDLKSATRNFSRSGMIGEGGFGCVFWGTIKNLEDPSKKIEV 112

Query:   131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
             AVKQL +RGLQGHKEWVTEVN LGVVEH NLVKL+G+CAEDDERGIQRLL+YEYMPN+SV
Sbjct:   113 AVKQLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGHCAEDDERGIQRLLVYEYMPNQSV 172

Query:   191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
             + HL+ R    L W+ RL+IAQDAARGL YLHE MDFQIIFRDFKSSNILLDE W AKLS
Sbjct:   173 EFHLSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDENWTAKLS 232

Query:   251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
             DFGLARLGPS G SHVST VVGT+GYAAPEYIQTGRLT KSD+W +GVF+YELITGRRPL
Sbjct:   233 DFGLARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFIYELITGRRPL 292

Query:   311 DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR 370
             DRN+PK EQKLLEWVRP+L+D ++F +I+DP+LEGKY IK  QKLA VAN CL R AK R
Sbjct:   293 DRNKPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKYMIKSVQKLAVVANLCLTRNAKAR 352

Query:   371 PKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAW 430
             PKMSEV+E++ KIV+A+  G      + + LK   ETS+ E  K + V  + G +G   W
Sbjct:   353 PKMSEVLEMVTKIVEASSPGNGGKKPQLVPLKSQ-ETSRVEEGKNKKV--LDGAEG--GW 407

Query:   431 LT--WRPKLVK 439
             L   W PK V+
Sbjct:   408 LEKLWNPKNVR 418

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)]

 Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
 Identities = 242/438 (55%), Positives = 307/438 (70%)

Query:    33 SVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSE---SSSRNTFAV-LSQR-------Q 81
             SV S AS  S +    V  S +  +    S+F S+   S  R TF   LSQR       +
Sbjct:    26 SVVSRASRLSWARSLSVASSTTS-DPTRRSEFDSDWSFSPERLTFPKPLSQRWIGGLVPE 84

Query:    82 SNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSH---KKIDIAVKQLSRR 138
             ++L+VFTF ELK ATK F+R L+I           V+    DS+    KI++AVKQL+R+
Sbjct:    85 NDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGVV-DVSDSNGFDSKINVAVKQLNRQ 143

Query:   139 GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF 198
             GLQGHKEW+ EVN LGVV HPNLVKL+GYCA+DDERG+QRLL+YE M N+S++DHL  R 
Sbjct:   144 GLQGHKEWINEVNFLGVVNHPNLVKLVGYCADDDERGMQRLLVYELMCNKSLEDHLVGRV 203

Query:   199 -QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
                +LPW  RLKIAQDAA+GLAYLHE MDFQ+IFRDFKSSNILLDE++ AKLSDFGLAR 
Sbjct:   204 VSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKSSNILLDERFGAKLSDFGLARQ 263

Query:   258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
             GP +GL HVST+VVGT+GYAAPEY+QTG+LT KSD+WSFGV LYELITGRR +DRNRP+ 
Sbjct:   264 GPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSFGVVLYELITGRRAVDRNRPRG 323

Query:   318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKY-SIKLAQKLAAVANKCLARQAKGRPKMSEV 376
             EQKLLEWV+P+++D+KKF +I+DP+LEG+Y  +K  Q++AA+ANKCL +Q K RPKMSEV
Sbjct:   324 EQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRVAALANKCLMKQPKSRPKMSEV 383

Query:   377 VEVLNKIVDA-AETGTP----QTP--LK-NLSLKDDFETSKKERLKRRFVDPIRGEKGC- 427
             V +L +I+D  AE   P    +T   +K  L+ + + E  K+    R+ V  +R +    
Sbjct:   384 VSLLGRIIDEEAENVPPPVADETEEIIKAELNGESEPELKKQGSSYRKKVLDLRDKMNLN 443

Query:   428 -----LAWLTWRPKLVKT 440
                  L W  W P LV+T
Sbjct:   444 KSLSKLDWRNWTPGLVRT 461

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)]

 Score = 892 (319.1 bits), Expect = 2.2e-89, P = 2.2e-89
 Identities = 186/405 (45%), Positives = 258/405 (63%)

Query:    12 MKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSG-SEFNSQNASDFSSESSS 70
             M CL+     K  +Q+   + + R        S      +S  S FN Q      S  S 
Sbjct:     1 MNCLFLFKSKKPRKQQKDNNKNKRKGKELLQNSAPELTNRSETSSFNLQTPRSLPSPRSI 60

Query:    71 RNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKK-ID 129
             ++ +   ++R+ NLRVF++ EL  AT  FSR L+I            I S  DS    + 
Sbjct:    61 KDLY---TEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKILSNGDSSDPPLV 117

Query:   130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
             +A+K+L+R+GLQGHK+W+ EV  LGVV HPN+VKLIGYC+ED E GI+RLL+YEYM NRS
Sbjct:   118 VAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRS 177

Query:   190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
             ++DHL  R   TLPW  RL+I   AA GL YLH   D ++I+RDFKSSN+LLD+Q+  KL
Sbjct:   178 LEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH---DLKVIYRDFKSSNVLLDDQFCPKL 234

Query:   250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             SDFGLAR GP    +HV+TA VGT GYAAPEY+QTG L  KSD++SFGV LYE+ITGRR 
Sbjct:   235 SDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRT 294

Query:   310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
             ++RN+P +E++LL+WV+ +  D+++F+MI+DP+L   Y    A+ LA +A+ CL +  K 
Sbjct:   295 IERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKE 354

Query:   370 RPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLK 414
             RP M  VVE L KI++  E+ +   P+   + K+  +  +++  K
Sbjct:   355 RPTMEIVVERLKKIIE--ESDSEDYPMATTTTKESSQVRRRQVAK 397

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 840 (300.8 bits), Expect = 7.2e-84, P = 7.2e-84
 Identities = 187/420 (44%), Positives = 263/420 (62%)

Query:     4 EAIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQ-NAS 62
             EA G     + +      K++   ++ SI   S+ + T+M +     KS  +   Q +++
Sbjct:    44 EASGCWVKFRFMIGCIPSKSDLDASSSSI-YGSNCTVTTMESKSANEKSNDQPVGQVSST 102

Query:    63 DFSSESSSRNTFAVLSQR---QSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIR 119
               +S + S ++  V+S+     S+LR FTF++LK +T+NF    ++            I 
Sbjct:   103 TTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIE 162

Query:   120 STEDSHKK----IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
                 +  K    + +AVK L+  GLQGHKEW+ E+N LG + HPNLVKL+GYC EDD   
Sbjct:   163 ENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDD--- 219

Query:   176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
              QRLL+YE+MP  S+++HL  R    LPW+ R+KIA  AA+GL++LHE     +I+RDFK
Sbjct:   220 -QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFK 277

Query:   236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWS 295
             +SNILLD  +NAKLSDFGLA+  P +G +HVST V+GT GYAAPEY+ TG LT KSD++S
Sbjct:   278 TSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 337

Query:   296 FGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKL 355
             FGV L E++TGRR +D+NRP  E  L+EW RPHL D ++F  +LDP+LEG +SIK AQK+
Sbjct:   338 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKV 397

Query:   356 AAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDD-FETSKKERLK 414
               +A +CL+R  K RPKMS+VVE L           P   LK+++     F+T + ERLK
Sbjct:   398 TQLAAQCLSRDPKIRPKMSDVVEALK----------PLPHLKDMASSSYYFQTMQAERLK 447

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
 Identities = 189/409 (46%), Positives = 254/409 (62%)

Query:    14 CLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNT 73
             C  +S  D   E     S S   S S    S D+ V    S   + NA       SS +T
Sbjct:    57 CCASSTSDV--ETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAE------SSLST 108

Query:    74 FAVLSQR---QSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKK--- 127
               ++S+     S+L+ F+F +LK AT+NF    ++            +     +  K   
Sbjct:   109 -PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167

Query:   128 -IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
              + +AVK L+  GLQGHKEW+ E+N LG + HPNLVKL+GYC EDD    QRLL+YE+MP
Sbjct:   168 GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMP 223

Query:   187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
               S+++HL  R    LPW+ R+KIA  AA+GL++LHE     +I+RDFK+SNILLD ++N
Sbjct:   224 RGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYN 282

Query:   247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG 306
             AKLSDFGLA+  P +G +HVST V+GT GYAAPEY+ TG LT KSD++SFGV L E++TG
Sbjct:   283 AKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342

Query:   307 RRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQ 366
             RR +D+NRP  E  L+EW RPHL D ++F  +LDP+LEG +S+K AQK+  +A +CL+R 
Sbjct:   343 RRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRD 402

Query:   367 AKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNL-SLKDDFETSKKERLK 414
             +K RPKMSEVVEVL           P   LK++ S    F+T + ERLK
Sbjct:   403 SKIRPKMSEVVEVLK----------PLPHLKDMASASYYFQTMQAERLK 441

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
 Identities = 166/306 (54%), Positives = 215/306 (70%)

Query:    82 SNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKK----IDIAVKQLSR 137
             S LR+F F++LK AT+NF    ++            I     +  K    + +AVK L+ 
Sbjct:    86 SKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNP 145

Query:   138 RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR 197
              GLQGHKEW+ E+N LG + HP+LVKL+GYC E+D    QRLL+YE+MP  S+++HL  R
Sbjct:   146 DGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEED----QRLLVYEFMPRGSLENHLFRR 201

Query:   198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
                 LPW+ R+KIA  AA+GLA+LHE  +  +I+RDFK+SNILLD ++NAKLSDFGLA+ 
Sbjct:   202 -TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 260

Query:   258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
              P +  SHVST V+GT GYAAPEY+ TG LT KSD++SFGV L E++TGRR +D++RP  
Sbjct:   261 APDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNG 320

Query:   318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
             EQ L+EWVRPHL D K+F  +LDP+LEG YSIK AQK   VA +CL R +K RPKMSEVV
Sbjct:   321 EQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVV 380

Query:   378 EVLNKI 383
             E L  +
Sbjct:   381 EALKPL 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2129326 AT4G17660 [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 5.2e-81, P = 5.2e-81
 Identities = 175/384 (45%), Positives = 243/384 (63%)

Query:    12 MKCLYA--SNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESS 69
             M CL+   S K K+      +  ++R        + +   RK+   FN        S +S
Sbjct:     1 MNCLFLFMSKKPKSRGNMEKEKKNIRGREFLQKSAPELTTRKTTLSFNLPTPRSLPSPTS 60

Query:    70 SRNTFAVLSQRQS-NLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTE--DSHK 126
              ++ +    Q Q+ NLRVF+F EL  AT  FSR L I            I +    DSH 
Sbjct:    61 IKDLYTDREQNQNQNLRVFSFKELSDATCEFSRKLKIGEGGFGSVYKATINNPTVGDSHS 120

Query:   127 K-IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
               + +AVK+L+R+ LQGHK+W+ EV+ LGVV HPN+V+L+GYC+ED ER    LL+YE M
Sbjct:   121 SPLTVAVKKLNRQSLQGHKQWLAEVHFLGVVNHPNVVRLLGYCSEDRER----LLVYELM 176

Query:   186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
              NRS++DHL +    TL W  RL+I   AA+GLAYLHE    Q+I+RDFKSSN+LL+E++
Sbjct:   177 SNRSLEDHLFTLRTLTLSWKQRLEIMLGAAQGLAYLHE---IQVIYRDFKSSNVLLNEEF 233

Query:   246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             + KLSDFGLAR GP    +HV+TA VGT GYAAPEY+ TG L    D++SFGV LYE+IT
Sbjct:   234 HPKLSDFGLAREGPEGDNTHVTTARVGTDGYAAPEYVITGHLKTHCDVYSFGVVLYEIIT 293

Query:   306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR 365
             GRR L+R +P +EQKLLEWV+ +  ++K+F MI+D KL  KY I + +++A +A+ C+ +
Sbjct:   294 GRRTLERMKPLAEQKLLEWVKKYPINSKRFKMIVDSKLCNKYPIAMVRRVAKLADHCVNK 353

Query:   366 QAKGRPKMSEVVEVLNKIVDAAET 389
               K RP M+ VVE L  I++ + +
Sbjct:   354 IDKERPTMAFVVESLTNIIEESNS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
 Identities = 180/391 (46%), Positives = 236/391 (60%)

Query:    14 CLYASNK-DKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNA-SDFSSESSSR 71
             CL +S K D +     A S S   S S  S  T R    SG    S +  S F    + R
Sbjct:     4 CLDSSAKVDNSNHSPHANSAS---SGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60

Query:    72 NTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKK---- 127
                 +LS    NL+ FTF+ELK ATKNF +  ++            I  T  +  +    
Sbjct:    61 TEGEILSS--PNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSG 118

Query:   128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
             I +AVKQL   G QGHKEW+TEVN LG + HPNLV L+GYCAE    G  RLL+YE+MP 
Sbjct:   119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPK 174

Query:   188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
              S+++HL  R    L W  R+K+A  AA+GL +LHE    Q+I+RDFK++NILLD  +NA
Sbjct:   175 GSLENHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNA 233

Query:   248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
             KLSDFGLA+ GP+   +HVST V+GT GYAAPEY+ TGRLT KSD++SFGV L ELI+GR
Sbjct:   234 KLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGR 293

Query:   308 RPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQA 367
             R +D +   +E  L++W  P+L D +K   I+D KL G+Y  K A   A +A +CL   A
Sbjct:   294 RAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDA 353

Query:   368 KGRPKMSEVVEVLNKIVDAAETGTPQTPLKN 398
             K RPKMSEV+  L ++   A+ GT  T +++
Sbjct:   354 KLRPKMSEVLVTLEQLESVAKPGTKHTQMES 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00018160001 SubName- Full=Chromosome chr13 scaffold_17, whole genome shotgun sequence; (429 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	441
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-41
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-32
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-26
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  177 bits (452), Expect = 5e-53
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 29/279 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
            +GEG FG VY+G ++      KK+++AVK L      Q  +E++ E  ++  ++HPN+V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGG-KKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KL+G C E++       ++ EYM    +  +L    +  L  +  L  A   ARG+ YL 
Sbjct: 65  KLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLE 119

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                  I RD  + N L+ E    K+SDFGL+R    D         +  I + APE +
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESL 175

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           + G+ T KSD+WSFGV L+E+ T G +P       S +++LE+++        + +   P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLK------NGYRL---P 223

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           +           +L  +  +C A   + RP  SE+VE+L
Sbjct: 224 QPPNC-----PPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (449), Expect = 1e-52
 Identities = 89/279 (31%), Positives = 140/279 (50%), Gaps = 28/279 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
            +GEG FG VY+G ++      K++++AVK L      Q  +E++ E  ++  ++HPN+V
Sbjct: 6   KLGEGAFGEVYKGTLKGK-GDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KL+G C E++      +++ EYMP   + D+L       L  +  L  A   ARG+ YL 
Sbjct: 65  KLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                  I RD  + N L+ E    K+SDFGL+R    D    V    +  I + APE +
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESL 176

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           + G+ T KSD+WSFGV L+E+ T G  P       S  ++LE+++      K + +   P
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYLK------KGYRL---P 224

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           K           +L  +  +C A   + RP  SE+VE+L
Sbjct: 225 KPPNC-----PPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (426), Expect = 9e-50
 Identities = 71/202 (35%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVK 163
           +GEGGFG VY        D      +A+K + +       E  + E+ +L  + HPN+VK
Sbjct: 1   LGEGGFGTVYLA-----RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK 55

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L G   +++   +    + EY    S++D L       L  +  L+I      GL YLH 
Sbjct: 56  LYGVFEDENHLYL----VMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHS 110

Query: 224 GMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                II RD K  NILLD      KL+DFGL++L        +   +VGT  Y APE +
Sbjct: 111 ---NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVL 165

Query: 283 -QTGRLTYKSDIWSFGVFLYEL 303
              G  + KSDIWS GV LYEL
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (425), Expect = 5e-49
 Identities = 88/279 (31%), Positives = 124/279 (44%), Gaps = 34/279 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           +G G FG VY+   + T        +AVK L +R    +  +    E+ +L  + HPN+V
Sbjct: 7   LGSGSFGTVYKAKHKGTGKI-----VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +LI    + D       L+ EY     + D+L+      L  +   KIA    RGL YLH
Sbjct: 62  RLIDAFEDKDHL----YLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH 115

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 II RD K  NILLDE    K++DFGLA+       S   T  VGT  Y APE +
Sbjct: 116 S---NGIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVL 170

Query: 283 QTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
             G     K D+WS GV LYEL+TG+ P        + +L+               IL P
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------------RILGP 217

Query: 342 KLEG--KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            LE         +++   +  KCL +    RP   E+++
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  167 bits (425), Expect = 6e-49
 Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 42/285 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG VY+G ++   +  +   +AVK L      +  +E++ E +++  + HPN+V+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTE-TKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L+G C + +       ++ EYMP   + D L       L     L++A   A+G+ YL  
Sbjct: 66  LLGVCTQGE----PLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLES 120

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
                 + RD  + N L+ E    K+SDFGL+R    D            I + APE ++
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 284 TGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV-------RPHLTDAKKF 335
            G+ T KSD+WSFGV L+E+ T G +P       S +++LE +       RP        
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG---MSNEEVLELLEDGYRLPRPENCP---- 230

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                             +L  +  +C A   + RP  SE+VE L
Sbjct: 231 -----------------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  164 bits (418), Expect = 7e-48
 Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 35/285 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG VY+G ++  +   K  ++AVK L      +  K+++ E  V+  + HPN+V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDG--KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-------FQATLPWNTRLKIAQDAAR 216
           L+G C E++       L+ EYM    + D+L           ++TL     L  A   A+
Sbjct: 61  LLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           G+ YL      + + RD  + N L+ E    K+SDFGL+R    D      T     I +
Sbjct: 117 GMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
            APE ++ G  T KSD+WSFGV L+E+ T G  P        E      V  +L    + 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEE------VLEYLRKGYR- 225

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
             +  P+           +L  +   C     + RP  SE+VE L
Sbjct: 226 --LPKPEYCP-------DELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  159 bits (405), Expect = 4e-46
 Identities = 69/208 (33%), Positives = 100/208 (48%), Gaps = 18/208 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVK 163
           +GEG FG VY    + T     K+ +A+K + ++ ++  +E  + E+ +L  ++HPN+V+
Sbjct: 7   LGEGSFGKVYLARDKKT----GKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L     ++D+      L+ EY     + D L  R    L  +      +     L YLH 
Sbjct: 62  LYDVFEDEDKL----YLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLH- 114

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
                I+ RD K  NILLDE  + KL+DFGLAR              VGT  Y APE + 
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLL 169

Query: 284 TGRLTYKSDIWSFGVFLYELITGRRPLD 311
                   DIWS GV LYEL+TG+ P  
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFP 197

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  146 bits (371), Expect = 5e-41
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 29/280 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWVTEVNVLGV 155
            ++R  ++G G FG VY  + + T     ++ +AVK   LS    +  +    E+ +L  
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDT----GEL-MAVKSVELSGDSEEELEALEREIRILSS 55

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           ++HPN+V+  G   ++++  +   +  EY+   S+   L  +F   LP     K  +   
Sbjct: 56  LQHPNIVRYYGSERDEEKNTL--NIFLEYVSGGSLSSLL-KKFGK-LPEPVIRKYTRQIL 111

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            GLAYLH      I+ RD K +NIL+D     KL+DFG A+          + +V GT  
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           + APE I+       +DIWS G  + E+ TG+ P       SE          +  + + 
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW------SELGNPMAALYKIGSSGEP 222

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
             I            L+++      KCL R  K RP   E
Sbjct: 223 PEI---------PEHLSEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (328), Expect = 1e-34
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 9/215 (4%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGV 155
           ++      +GEG FG V         D+  +  +AVK L+  G + H  ++  E+ +L  
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRT 62

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           ++H N+VK  G C +   R ++  LI EY+P+ S++D+L  R +  +     L  +    
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLR--LIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQIC 119

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVSTAVVGTI 274
           +G+ YL      + I RD  + NIL++ +   K+SDFGLA++ P D    +V       I
Sbjct: 120 KGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            + APE ++T + +  SD+WSFGV LYEL T   P
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 1e-34
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 18/218 (8%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH 158
           F     IG+GGFG VY+   + T       ++A+K +     +  ++ + E+ +L   +H
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRT-----GKEVAIKVIKLESKEKKEKIINEIQILKKCKH 56

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           PN+VK  G   + DE  I    + E+    S++D L S  Q TL  +    + ++  +GL
Sbjct: 57  PNIVKYYGSYLKKDELWI----VMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGL 111

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYA 277
            YLH      II RD K++NILL      KL DFGL+ +L  SD  +  +   VGT  + 
Sbjct: 112 EYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTM--VGTPYWM 164

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           APE I      YK+DIWS G+   EL  G+ P     P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 41/230 (17%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGV 155
           N+    +IG G FG VY+G+   T D      +A+KQ+S   +  +  K  + E+++L  
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDF-----VAIKQISLEKIKEEALKSIMQEIDLLKN 55

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD----------HLTSRFQATLPWN 205
           ++HPN+VK IG   E  +      +I EY  N S++            L + +       
Sbjct: 56  LKHPNIVKYIG-SIETSD---SLYIILEYAENGSLRQIIKKFGPFPESLVAVY------- 104

Query: 206 TRLKIAQDAARGLAYLHEGMDFQ-IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               + Q   +GLAYLHE    Q +I RD K++NIL  +    KL+DFG+A     + +S
Sbjct: 105 ----VYQ-VLQGLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVS 153

Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRN 313
               +VVGT  + APE I+    +  SDIWS G  + EL+TG  P  D N
Sbjct: 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 49/284 (17%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWVTEVNVLGVVEHPNL 161
            IG+G FG VY   +R   D        +K+  LS    +  ++ + EV +L  + HPN+
Sbjct: 7   QIGKGSFGKVYL--VRRKSDGKLY---VLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 162 VKLIGYCAEDDERGIQRLLI-YEYMPNRSVQDHLTSRFQA--TLPWNTRLKIAQDAARGL 218
           +K      E       +L I  EY     +   +  + +     P    L         L
Sbjct: 62  IKYYESFEEKG-----KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH---VSTAVVGTIG 275
            YLH     +I+ RD K  NI L      KL DFG++++     LS    ++  VVGT  
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVDLAKTVVGTPY 168

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           Y +PE  Q     YKSDIWS G  LYEL T + P +     +  +L              
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLEL-------------A 212

Query: 336 TMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
             IL    P +  +YS     +L  + +  L +  + RP ++++
Sbjct: 213 LKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 2e-33
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V  G  R      +K+  AVK L +      + ++ E +V+  + HPNLV+L
Sbjct: 14  IGKGEFGDVMLGDYRG-----QKV--AVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQL 65

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G   + +   +   ++ EYM   S+ D+L SR +A +    +L  A D   G+ YL E 
Sbjct: 66  LGVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                + RD  + N+L+ E   AK+SDFGLA+          S  +   + + APE ++ 
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALRE 173

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
            + + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  124 bits (315), Expect = 4e-33
 Identities = 78/226 (34%), Positives = 112/226 (49%), Gaps = 24/226 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV---TEVNVLGVVEHPNL 161
           +G+G FG V     + T     K+  A+K L ++ +   KE     TE N+L  + HP +
Sbjct: 1   LGKGSFGKVLLVRKKDTG----KL-YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 162 VKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           VKL  + A   E    +L L+ EY P   +  HL+   + +     R   A+     L Y
Sbjct: 56  VKL--HYAFQTEE---KLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAE-IVLALEY 108

Query: 221 LHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           LH  G    II+RD K  NILLD   + KL+DFGLA+   S+G S  +T   GT  Y AP
Sbjct: 109 LHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT-FCGTPEYLAP 162

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEW 324
           E +         D WS GV LYE++TG+ P    +R +  +K+L+ 
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 2e-32
 Identities = 85/310 (27%), Positives = 141/310 (45%), Gaps = 54/310 (17%)

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQG 142
           LR+   +EL+       +  ++G G FG VY+GV    E    KI +A+K L      + 
Sbjct: 1   LRILKETELE-------KIKVLGSGAFGTVYKGVWI-PEGEKVKIPVAIKVLREETSPKA 52

Query: 143 HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-----TSR 197
           +KE + E  V+  V+HP++V+L+G C        Q  LI + MP   + D++        
Sbjct: 53  NKEILDEAYVMASVDHPHVVRLLGICL-----SSQVQLITQLMPLGCLLDYVRNHKDNIG 107

Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
            Q  L W  ++      A+G++YL E    +++ RD  + N+L+    + K++DFGLA+L
Sbjct: 108 SQYLLNWCVQI------AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK 316
              D   + +      I + A E I     T+KSD+WS+GV ++EL+T G +P +     
Sbjct: 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218

Query: 317 SEQKLLE----WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK 372
               LLE      +P +     + M+L                     KC    A+ RP 
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVY-MVLV--------------------KCWMIDAESRPT 257

Query: 373 MSEVVEVLNK 382
             E++   +K
Sbjct: 258 FKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 2e-32
 Identities = 74/209 (35%), Positives = 104/209 (49%), Gaps = 22/209 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G    T        +AVK L + G    + ++ E  ++  + H  LV+L
Sbjct: 14  LGAGQFGEVWMGTWNGT------TKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
              C+E++   I    + EYM   S+ D L S     L     + +A   A G+AYL E 
Sbjct: 67  YAVCSEEEPIYI----VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ES 121

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            ++  I RD  + NIL+ E    K++DFGLARL   D      TA  G    I + APE 
Sbjct: 122 RNY--IHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEA 175

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              GR T KSD+WSFG+ L E++T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  116 bits (293), Expect = 7e-30
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 13/281 (4%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVK 163
           +GEG FG V         D   ++ +AVK L R   Q +   W  E+N+L  + H N+VK
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G C+E   +G+Q  LI EY+P  S++D+L    +  L     L  AQ    G+AYLH 
Sbjct: 71  YKGCCSEQGGKGLQ--LIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEYI 282
                 I RD  + N+LLD     K+ DFGLA+  P     + V       + + A E +
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
           +  + +Y SD+WSFGV LYEL+T          K E+ ++   +       +   +L+  
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIG-PKQGQMTVVRLIELLERG 240

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           +         Q++  +   C   +AK RP    ++ +L ++
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 67/297 (22%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVK--------QLSRRGLQGHKEWVTEVNVLGVV 156
           IG+G FG VY+GV++         ++AVK         L R+ LQ       E  +L   
Sbjct: 3   IGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPPDLKRKFLQ-------EAEILKQY 49

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HPN+VKLIG C +         ++ E +P  S+   L  + +  L     L+++ DAA 
Sbjct: 50  DHPNIVKLIGVCVQKQPI----YIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAA 104

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR------LGPSDGLSHVSTAV 270
           G+ YL        I RD  + N L+ E    K+SDFG++R         SDGL  +    
Sbjct: 105 GMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP--- 158

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL 329
              I + APE +  GR T +SD+WS+G+ L+E  + G  P                 P +
Sbjct: 159 ---IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY----------------PGM 199

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQ----KLAAVANKCLARQAKGRPKMSEVVEVLNK 382
           ++ +    I     E  Y +   Q    ++  +  +C A   + RP  SE+   L  
Sbjct: 200 SNQQTRERI-----ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 7e-29
 Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 54/287 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G  R       KID+A+K + R G     +++ E  V+  + HPNLV+L
Sbjct: 12  LGSGQFGVVHLGKWRG------KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQL 64

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C +  +R I   ++ EYM N  + ++L  R +  L     L +  D    + YL   
Sbjct: 65  YGVCTK--QRPI--FIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
                I RD  + N L+ E    K+SDFGLAR    D      T+  GT   + +A PE 
Sbjct: 120 ---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVKWAPPEV 172

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV-------RPHLTDAK 333
               R + KSD+WSFGV ++E+ + G+ P +R    S  +++E V       RP L    
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER---FSNSEVVESVSAGYRLYRPKLA--- 226

Query: 334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                               ++  +   C   + + RP   +++  L
Sbjct: 227 ------------------PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 4e-28
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 22/209 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G+  +T        +AVK L + G    K+++ E  ++  + HP L++L
Sbjct: 14  LGAGQFGEVWEGLWNNT------TPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
              C  ++   I    + E M   S+ ++L       L     + +A   A G+AYL E 
Sbjct: 67  YAVCTLEEPIYI----VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EA 121

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            ++  I RD  + N+L+ E    K++DFGLAR+   D    +  A  G    I + APE 
Sbjct: 122 QNY--IHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKWTAPEA 175

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
               R + KSD+WSFG+ L E++T GR P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 35/288 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---EVNVLGVV-EHPN 160
           +GEG FG VY            +  +A+K L+++     KE      E+ +L  +   PN
Sbjct: 8   LGEGSFGEVYLA--------RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ-ATLPWNTRLKIAQDAARGLA 219
           +VKL  +  ++        L+ EY+   S++D L    +   L  +  L I       L 
Sbjct: 60  IVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDFGLARLGPSDGLS----HVSTAVVGTI 274
           YLH      II RD K  NILLD      KL DFGLA+L P  G +     + +  VGT 
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 275 GYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDR-NRPKSEQKLLEWVRPHLT 330
           GY APE +        +  SDIWS G+ LYEL+TG  P +      +  + L+ +    T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            +    +          +         +  K LA+  K R   S  + 
Sbjct: 233 PSLASPLSPSNPELISKAAS------DLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  110 bits (278), Expect = 8e-28
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G+ ++       + +A+K L    L   +++  EV  L  + H +L+ L
Sbjct: 14  LGSGYFGEVWEGLWKNR------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
              C+  +   I    I E M   S+   L S     LP  + + +A   A G+AYL E 
Sbjct: 68  FAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD  + NIL+ E    K++DFGLARL   D        +     + APE    
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASH 178

Query: 285 GRLTYKSDIWSFGVFLYELIT 305
           G  + KSD+WSFG+ LYE+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  110 bits (277), Expect = 9e-28
 Identities = 72/268 (26%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V++ V ++ +  +    I + +++RR     +E + E  VL  ++   +++ 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE---REEAIDEARVLAKLDSSYIIRY 64

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                +  +  I    + EY  N  +   L  +    LP +   +       GLA+LH  
Sbjct: 65  YESFLDKGKLNI----VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
              +I+ RD KS N+ LD   N K+ D G+A+ L  +   ++ +  +VGT  Y +PE  +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCE 174

Query: 284 TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 KSD+W+ GV LYE  TG+ P D N   ++  L+           K    + P +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKIIRGVFPPV 221

Query: 344 EGKYSIKLAQKLAAVANKCLARQAKGRP 371
              YS    Q+LA + ++CL +  + RP
Sbjct: 222 SQMYS----QQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 20/211 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW--VTEVNVLGVVEHPNLV 162
           IG G FG V RG ++      K+ID+A+K L + G    +    +TE +++G  +HPN++
Sbjct: 12  IGGGEFGEVCRGRLKLP--GKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L G       +    ++I EYM N S+ D               + + +  A G+ YL 
Sbjct: 69  RLEGVVT----KSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIG--YAAP 279
           E M++  + RD  + NIL++     K+SDFGL+R L  S+      T   G I   + AP
Sbjct: 124 E-MNY--VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA---TYTTKGGKIPIRWTAP 177

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   + T  SD+WSFG+ ++E+++ G RP
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 5e-27
 Identities = 71/208 (34%), Positives = 114/208 (54%), Gaps = 15/208 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVK 163
           +G G FG V +GV      S K++++AVK L +  +  G KE++ E +V+  ++HP +V+
Sbjct: 3   LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           LIG C  +       +L+ E  P   +  +L  R    +P +   ++A   A G+AYL E
Sbjct: 61  LIGVCKGE-----PLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYL-E 112

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI 282
              F  + RD  + N+LL  +  AK+SDFG++R LG        +TA    + + APE I
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             G+ + KSD+WS+GV L+E  + G +P
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (272), Expect = 8e-27
 Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 44/231 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVT-EVNVLGVVE-HPN 160
           IGEG F  V     + T       + A+K L +R L   K  ++V  E  VL  +  HP 
Sbjct: 9   IGEGSFSTVVLAKEKET-----NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 161 LVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWN-TRLKIAQ--DAAR 216
           ++KL  Y  +D+E     L  + EY PN  +  ++  R   +L    TR   A+   A  
Sbjct: 64  IIKLY-YTFQDEEN----LYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA-- 114

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV------ 270
            L YLH      II RD K  NILLD+  + K++DFG A++   +     +         
Sbjct: 115 -LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 271 ------------VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
                       VGT  Y +PE +        SD+W+ G  +Y+++TG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (269), Expect = 9e-27
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 18/220 (8%)

Query: 100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP 159
           +    IG G FG V+ G         +K  +A+K + R G    ++++ E  V+  + HP
Sbjct: 7   TLVQEIGSGQFGLVWLGYWL------EKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            LV+L G C E         L++E+M +  + D+L ++ +      T L +  D   G+A
Sbjct: 60  KLVQLYGVCTERSPI----CLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMA 114

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           YL       +I RD  + N L+ E    K+SDFG+ R    D  +  ST     + +++P
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE 318
           E     + + KSD+WSFGV ++E+ + G+ P + NR  SE
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (270), Expect = 1e-26
 Identities = 76/277 (27%), Positives = 120/277 (43%), Gaps = 39/277 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH--KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+G  G VY+   + T   +  KKI +   +  R+ L      + E+  L   E P +V
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL------LRELKTLRSCESPYVV 62

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL--KIAQDAARGLAY 220
           K   Y A   E  I   ++ EYM   S+ D L    +        +   IA+   +GL Y
Sbjct: 63  KC--YGAFYKEGEIS--IVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDY 114

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAP 279
           LH      II RD K SN+L++ +   K++DFG+++ L  +    +     VGT+ Y +P
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSP 169

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
           E IQ    +Y +DIWS G+ L E   G+ P       S  +L++                
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----------AICDGP 219

Query: 340 DPKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
            P L   ++S     +     + CL +  K RP  +E
Sbjct: 220 PPSLPAEEFS----PEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 4e-26
 Identities = 87/280 (31%), Positives = 125/280 (44%), Gaps = 38/280 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G  G V + + R T     KI +AVK +         K+ + E+++L     P +V 
Sbjct: 9   LGAGNSGVVSKVLHRPTG----KI-MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G    + +  I      EYM   S+ D +    Q  +P     KIA    +GL YLHE
Sbjct: 64  FYGAFYNNGDISI----CMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYI 282
               +II RD K SNIL++ +   KL DFG++ +L  S     ++   VGT  Y APE I
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAPERI 171

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD-- 340
           Q    + KSDIWS G+ L EL TGR P                 P     +    I++  
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIVNEP 220

Query: 341 -PKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            P+L  GK+S      +    N CL +  + RP   E++E
Sbjct: 221 PPRLPSGKFSPDFQDFV----NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  105 bits (263), Expect = 8e-26
 Identities = 72/209 (34%), Positives = 110/209 (52%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G        H K+  A+K L ++G    + ++ E N++  ++HP LV+L
Sbjct: 14  LGAGQFGEVWMGYYNG----HTKV--AIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                ++        +I EYM N S+ D L +     L  N  + +A   A G+A++ E 
Sbjct: 67  YAVVTQE-----PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ER 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            ++  I RD +++NIL+ E    K++DFGLARL   +      TA  G    I + APE 
Sbjct: 121 KNY--IHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEA 174

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           I  G  T KSD+WSFG+ L E++T GR P
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/241 (29%), Positives = 118/241 (48%), Gaps = 19/241 (7%)

Query: 85  RVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGH 143
           R+   +EL+       +  ++G G FG V++G+     DS  KI +A+K +  R G Q  
Sbjct: 2   RILKETELR-------KLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDRSGRQTF 53

Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           +E    +  +G ++H  +V+L+G C      G    L+ +  P  S+ DH+     +  P
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSLDP 108

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
               L      A+G+ YL E    +++ R+  + NILL      +++DFG+A L   D  
Sbjct: 109 -QRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL 322
            +  +     I + A E I  GR T++SD+WS+GV ++E+++ G  P    RP     LL
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Query: 323 E 323
           E
Sbjct: 225 E 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (260), Expect = 2e-25
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY GV +     +    +AVK L    ++   E++ E  V+  ++HPNLV+L
Sbjct: 14  LGGGQYGEVYEGVWKK----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 67

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G C  +    I    I E+M   ++ D+L    +  +     L +A   +  + YL E 
Sbjct: 68  LGVCTREPPFYI----ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EK 122

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            +F  I RD  + N L+ E    K++DFGL+RL   D      TA  G    I + APE 
Sbjct: 123 KNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPES 176

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT 305
           +   + + KSD+W+FGV L+E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 4e-25
 Identities = 80/285 (28%), Positives = 120/285 (42%), Gaps = 49/285 (17%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
            + +     IGEG  G VY+       D     ++A+K++  R  Q  +  + E+ ++  
Sbjct: 18  RELYKNLEKIGEGASGEVYKAT-----DRATGKEVAIKKMRLRK-QNKELIINEILIMKD 71

Query: 156 VEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
            +HPN+V         DE     L ++ EYM   S+ D +T  F        R+   Q A
Sbjct: 72  CKHPNIVDYYDSYLVGDE-----LWVVMEYMDGGSLTDIITQNF-------VRMNEPQIA 119

Query: 215 A------RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
                  +GL YLH      +I RD KS NILL +  + KL+DFG A     +     S 
Sbjct: 120 YVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS- 175

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL--EWVR 326
            VVGT  + APE I+      K DIWS G+   E+  G  P  R  P     L+  + + 
Sbjct: 176 -VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI- 233

Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           P L + +K++                 +     NKCL +  + RP
Sbjct: 234 PPLKNPEKWS----------------PEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  103 bits (259), Expect = 5e-25
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 41/299 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG  G V +  +++T      I  A+K ++        K+ + E+ +    + P +VK
Sbjct: 9   LGEGAGGSVTKCRLKNT----GMI-FALKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR------LKIAQDAARG 217
             G   ++    I   +  EY    S    L S ++       R       KIA+   +G
Sbjct: 64  YYGAFLDESSSSIG--IAMEYCEGGS----LDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L+YLH     +II RD K SNILL  +   KL DFG++     + ++ ++    GT  Y 
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYM 170

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPL--DRNRPKSEQKLLEWVRPHLTDAKKF 335
           APE IQ    +  SD+WS G+ L E+   R P   +   P    +LL ++     +    
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNP 226

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS------EVVEVLNKIVDAAE 388
            +  +P    K+S +    +     +CL +    RP          +   + K V+ A+
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIK----QCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  103 bits (258), Expect = 6e-25
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 21/219 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG V+ G     E  + K  +AVK L         K++  E  +L   +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-----RFQATLPWNTR-------LKIA 211
             G C E D      ++++EYM +  +   L S      F  +             L+IA
Sbjct: 73  FYGVCTEGD----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
              A G+ YL     F  + RD  + N L+      K+ DFG++R   +     V    +
Sbjct: 129 VQIASGMVYL-ASQHF--VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             I +  PE I   + T +SD+WSFGV L+E+ T G++P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 32/221 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWV--------TEVNVL 153
           +IG+G +G VY  +  +T +      +AVKQ  L       H            +E+  L
Sbjct: 8   LIGKGTYGRVYLALNVTTGEM-----MAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTS--RFQATLPWNTRLKI 210
             ++H N+V+ +G+     E   + L I+ EY+P  S+   L +  RF+  L    R   
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-F 113

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
            +    GLAYLH      I+ RD K+ N+L+D     K+SDFG+++       +  + ++
Sbjct: 114 TEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 271 VGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRP 309
            G++ + APE I +    Y  K DIWS G  + E+  GRRP
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (252), Expect = 2e-24
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 37/283 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVK 163
           +G+G FG V RG    +    K I +AVK L    L     +++ E  ++  ++H NL++
Sbjct: 3   LGDGSFGVVRRGE--WSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L G            +++ E  P  S+ D L          +T    A   A G+ YL  
Sbjct: 61  LYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYI 282
               + I RD  + NILL      K+ DFGL R  P +   +V    +     + APE +
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           +T   ++ SD+W FGV L+E+ T G  P              W    L+ ++    I D 
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP--------------WA--GLSGSQILKKI-DK 215

Query: 342 KLE----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           + E     +      Q +  V  +C A     RP  + + E L
Sbjct: 216 EGERLERPEAC---PQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 4e-24
 Identities = 71/220 (32%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           IG G FG VY  V   T +      +AVK+  +     +  KE   E+ VL +++HPNLV
Sbjct: 8   IGGGTFGKVYTAVNLDTGEL-----MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 163 KLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWN-TRLKIAQDAARGLAY 220
           K  G     ++     + I+ EY    ++++ L       L  +  R+   Q    GLAY
Sbjct: 63  KYYGVEVHREK-----VYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQ-LLEGLAY 114

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAV-------VG 272
           LH      I+ RD K +NI LD     KL DFG A +L  +      +T +        G
Sbjct: 115 LHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN------TTTMGEEVQSLAG 165

Query: 273 TIGYAAPEYIQTGRLTYK---SDIWSFGVFLYELITGRRP 309
           T  Y APE I  G+       +DIWS G  + E+ TG+RP
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  100 bits (251), Expect = 4e-24
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLV 162
           IG+G FG V + V R    S  KI +  K++    +   +  + V+EVN+L  ++HPN+V
Sbjct: 8   IGKGSFGTVRK-VRRK---SDGKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 163 KLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQAT---LPWNTRLKIAQDAARGL 218
           +   Y     +R  Q L I  EY     +   L  + +     +      +I       L
Sbjct: 63  R---YYDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 219 AYLHEGMDF--QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
              H   D    ++ RD K +NI LD   N KL DFGLA++   D  S  +   VGT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYY 176

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            +PE +       KSDIWS G  +YEL     P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  100 bits (252), Expect = 4e-24
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 24/228 (10%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTE 149
           E+  +   F   L  GEG FG VY+G +    +      +A+K L      +  +E+  E
Sbjct: 1   EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 150 VNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR------------ 197
             ++  ++HPN+V L+G C ++        +++EY+ +  + + L               
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT----CMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114

Query: 198 --FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA 255
              +++L  +  L IA   A G+ YL        + RD  + N L+ E    K+SDFGL+
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
           R   S     V +  +  + +  PE I  G+ T +SDIWSFGV L+E+
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 33/229 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW--VT---EVNVLGVVEHP 159
           IGEG +G VY+   + T +      +A+K++    ++  KE   +T   E+ +L  + HP
Sbjct: 7   IGEGTYGQVYKARNKKTGEL-----VALKKIR---MENEKEGFPITAIREIKLLQKLRHP 58

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLPWNTRLK-IAQDAAR 216
           N+V+L        +  I   +++EYM +    + D    +F  T     ++K   +    
Sbjct: 59  NIVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKF--TES---QIKCYMKQLLE 111

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL YLH      I+ RD K SNIL++     KL+DFGLAR       +  +  V+ T+ Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167

Query: 277 AAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
             PE +  G  R   + D+WS G  L EL  G+      +  +E + LE
Sbjct: 168 RPPE-LLLGATRYGPEVDMWSVGCILAELFLGKPIF---QGSTELEQLE 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 99.8 bits (248), Expect = 2e-23
 Identities = 75/246 (30%), Positives = 130/246 (52%), Gaps = 27/246 (10%)

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQG 142
           LR+   +ELK       R  ++G G FG VY+G I   E    KI +A+K L+   G + 
Sbjct: 1   LRILKETELK-------RVKVLGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKA 52

Query: 143 HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMPNRSVQDHLTSRF 198
           + E++ E  ++  ++HP+LV+L+G C     + + +L+    + +Y+     +D++ S  
Sbjct: 53  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEH--KDNIGS-- 108

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
           Q  L W  ++      A+G+ YL E    +++ RD  + N+L+    + K++DFGLARL 
Sbjct: 109 QLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS 317
             D   + +      I + A E I   + T++SD+WS+GV ++EL+T G +P D    + 
Sbjct: 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219

Query: 318 EQKLLE 323
              LLE
Sbjct: 220 IPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 97.6 bits (243), Expect = 4e-23
 Identities = 74/242 (30%), Positives = 126/242 (52%), Gaps = 27/242 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V  G  R       + D+A+K + + G     E++ E  V+  + H  LV+L
Sbjct: 12  LGTGQFGVVKYGKWRG------QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C +  +R I   ++ EYM N  + ++L    +   P +  L++ +D   G+AYL   
Sbjct: 65  YGVCTK--QRPI--YIVTEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLESK 119

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
              Q I RD  + N L+D+Q   K+SDFGL+R    D      T+ VG+   + ++ PE 
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEV 172

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR-NRPKSEQKL---LEWVRPHLTDAKKFT 336
           +   + + KSD+W+FGV ++E+ + G+ P +R N  ++ +K+   L   RPHL   K + 
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA 232

Query: 337 MI 338
           ++
Sbjct: 233 IM 234

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG +G VY+ + + T        +A+K +        +E + E+++L   + P +VK 
Sbjct: 11  LGEGSYGSVYKAIHKET-----GQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKY 63

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G   ++        ++ EY    SV D +      TL       I     +GL YLH  
Sbjct: 64  YGSYFKNT----DLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH-- 116

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
              + I RD K+ NILL+E+  AKL+DFG++ +L  +D ++  +T V+GT  + APE IQ
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNT-VIGTPFWMAPEVIQ 172

Query: 284 TGRLTYKSDIWSFGVFLYELITGRRPL 310
                 K+DIWS G+   E+  G+ P 
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 26/217 (11%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVLG 154
           F+    IG+G FG VY+ + + T     ++ +A+K +    L+  ++ +     E+  L 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRT----NQV-VAIKVID---LEEAEDEIEDIQQEIQFLS 54

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
               P + K  G   +  +  I    I EY    S  D L       L       I ++ 
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWI----IMEYCGGGSCLDLLKPG---KLDETYIAFILREV 107

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGT 273
             GL YLHE      I RD K++NILL E+ + KL+DFG++ +L  +  +S  +T  VGT
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNT-FVGT 161

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
             + APE I+      K+DIWS G+   EL  G  PL
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 6e-23
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 24/223 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR---GLQGHKEWVTEVNVLGVVEHPNL 161
           IG+G FG V        +    K   A+K ++++        +  + E  +L  + HP L
Sbjct: 8   IGKGAFGKV-----CIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAARGLA 219
           V L  Y  +D+E      L+ + +    ++ HL+   +F        +  I +     L 
Sbjct: 63  VNLW-YSFQDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWICE-IVLALE 114

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           YLH      II RD K  NILLDEQ +  ++DF +A     D L+   T+  GT GY AP
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
           E +     +   D WS GV  YE + G+RP   +      ++ 
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 40/280 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G  R+       I +A+K +   G    ++++ E  V+  + HP LV+L
Sbjct: 12  LGSGQFGVVHLGKWRAQ------IKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 165 IGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
            G C        Q+  +Y   E+M N  + ++L  R Q  L  +  L + QD   G+ YL
Sbjct: 65  YGVC-------TQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYL 116

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
                   I RD  + N L+      K+SDFG+ R    D  +  S A    + ++ PE 
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEV 172

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD 340
               + + KSD+WSFGV ++E+ T G+ P ++   KS  +++E +        +   +  
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEVVEMI-------SRGFRLYR 222

Query: 341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           PKL      +       V   C   + +GRP  +E++  +
Sbjct: 223 PKLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 9e-23
 Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 46/281 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLV 162
           ++G+G FG V++G ++       K  +AVK       Q  K ++++E  +L   +HPN+V
Sbjct: 2   LLGKGNFGEVFKGTLK------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAARGLAY 220
           KLIG C        QR  IY  M      D L+   + +  L     +K A DAA G+AY
Sbjct: 56  KLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           L        I RD  + N L+ E    K+SDFG++R    DG+   S      I + APE
Sbjct: 109 LESK---NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPE 164

Query: 281 YIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            +  GR + +SD+WS+G+ L+E  + G  P                 P +T+ +      
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPY----------------PGMTNQQA----- 203

Query: 340 DPKLEGKYSIKLAQK----LAAVANKCLARQAKGRPKMSEV 376
             ++E  Y +   QK    +  V  +C   + + RPK SE+
Sbjct: 204 REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 24/220 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKI---DIAVKQLSRRGLQGHKEWVTEVNVLG 154
            + +  ++G G FG V+   +   +   K +    I V+Q+++      +    E  VL 
Sbjct: 1   KYEKIRVVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLK 54

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
           ++ HPN+++      ED    I    + EY P  ++ +++  R  + L  +T L      
Sbjct: 55  LLSHPNIIEYYENFLEDKALMI----VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDGLSHVSTA--VV 271
              L ++H      I+ RD K+ NILLD+     K+ DFG++++     LS  S A  VV
Sbjct: 111 LLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVV 162

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           GT  Y +PE  +      KSDIW+ G  LYEL + +R  +
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 69/211 (32%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-----GLQGHKEWVTEVNVLGVVEHP 159
           +G GGFG V    ++S   +      A+K + +R     G Q H    +E  +L    HP
Sbjct: 1   LGVGGFGRVELVKVKSKNRTF-----ALKCVKKRHIVETGQQEHI--FSEKEILEECNHP 53

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP-WNTRLKIAQDAARGL 218
            +VKL  Y    D++ I  L+  EY     +   L  R       +  R  IA       
Sbjct: 54  FIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILRDR--GLFDEYTARFYIAC-VVLAF 106

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            YLH      II+RD K  N+LLD     KL DFG A+   S   +       GT  Y A
Sbjct: 107 EYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVA 160

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           PE I      +  D WS G+ LYEL+TGR P
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 21/209 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V  G        ++   +AVK +        + ++ E +V+  + H NLV+L
Sbjct: 14  IGKGEFGDVMLG-------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 64

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G   E+        ++ EYM   S+ D+L SR ++ L  +  LK + D    + YL E 
Sbjct: 65  LGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EA 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
            +F  + RD  + N+L+ E   AK+SDFGL +    +  S   T  +  + + APE ++ 
Sbjct: 121 NNF--VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALRE 173

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
            + + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 18/233 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH--KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+GGFG V    +++T   +  KK+D   K+L +R  +G +  + E  +L  V    +V
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLD--KKRLKKR--KGEQMALNEKKILEKVSSRFIV 56

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            L  Y  E  +      L+   M    ++ H+ +  +   P    +  A     GL +LH
Sbjct: 57  SL-AYAFETKD---DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           +    +I++RD K  N+LLD+  N ++SD GLA                GT GY APE +
Sbjct: 113 Q---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVL 166

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           Q     +  D ++ G  LYE+I GR P  + + K E++ L+  R  L  A ++
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEMAVEY 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 6e-22
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 25/222 (11%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL---SRRGLQGHKEWVT---EVNV 152
           +++  ++G+G +G VY G+    +       IAVKQ+   +   L   KE+     EV++
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQL------IAVKQVELDTSNVLAAEKEYEKLQEEVDL 55

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L  ++H N+V+ +G C +D+   I      E++P  S+   L +RF   LP     K  +
Sbjct: 56  LKSLKHVNIVQYLGTCLDDNTISI----FMEFVPGGSISSIL-NRFGP-LPEPVFCKYTK 109

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR----LGPSDGLSHVST 268
               G+AYLH      ++ RD K +N++L      KL DFG AR    +G     S++  
Sbjct: 110 QILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           ++ GT  + APE I       KSDIWS G  ++E+ TG+ PL
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G        +    +AVK L + G    + ++ E N++  ++H  LV+L
Sbjct: 14  LGAGQFGEVWMGYY------NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
             Y     E  I   +I EYM   S+ D L S     +     +  +   A G+AY+   
Sbjct: 67  --YAVVTKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD +++N+L+ E    K++DFGLAR+   +  +    A    I + APE I  
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 178

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
           G  T KSD+WSFG+ LYE++T G+ P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 57/293 (19%)

Query: 105 IGEGGFGGVYRG--VIRSTEDSHKKID-----IAVKQLSRRGLQGHKEWVTEVNVLGVVE 157
           IG G    VY    +  + + + K+ID      +V +L +           EV  +    
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-----------EVQAMSQCN 57

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAAR 216
           HPN+VK        DE  +    +  Y+   S+ D + S + +  L       + ++  +
Sbjct: 58  HPNVVKYYTSFVVGDELWL----VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPSDGLSHVSTAVVGTI 274
           GL YLH       I RD K+ NILL E  + K++DFG++       D    V    VGT 
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 275 GYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK 333
            + APE ++      +K+DIWSFG+   EL TG  P  +  P                 K
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----------------MK 214

Query: 334 KFTMILD---PKLE-----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              + L    P LE      KYS K  +K+ +    CL +    RP   E+++
Sbjct: 215 VLMLTLQNDPPSLETGADYKKYS-KSFRKMIS---LCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 94.2 bits (234), Expect = 7e-22
 Identities = 70/221 (31%), Positives = 104/221 (47%), Gaps = 22/221 (9%)

Query: 103 LMIGEGGFGGVYRGVIRST-EDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHP 159
             +G G FG VY G            I +AVK L R+G   Q  KE++ E +++    HP
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-----TSRFQATLPWNTRLKIAQDA 214
           N+VKL+G C  ++ +     +I E M    +  +L            L     L I  D 
Sbjct: 60  NIVKLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-----KLSDFGLARLGPSDGLSHVSTA 269
           A+G  YL E M F  I RD  + N L+ E+        K+ DFGLAR             
Sbjct: 116 AKGCVYL-EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            +  + + APE +  G+ T +SD+WSFGV ++E++T G++P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 41/287 (14%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNVL 153
           ++    ++G+G FG     + R TED      K+++     L+R   +  ++ + E+ +L
Sbjct: 1   HYIPIRVLGKGAFGEAT--LYRRTEDDSLVVWKEVN-----LTRLSEKERRDALNEIVIL 53

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLI-YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
            +++HPN++    +  +D       LLI  EY    ++ D +  +          L    
Sbjct: 54  SLLQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
                ++Y+H+     I+ RD K+ NI L +    KL DFG++++  S+  S   T VVG
Sbjct: 109 QIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-VVG 163

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD-RNRPKSEQKLLEWVRPHLTD 331
           T  Y +PE  Q  +  +KSDIW+ G  LYEL+T +R  D  N      K++         
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--------- 214

Query: 332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              +T ++       YS +L      + +  L +  + RP   EV++
Sbjct: 215 QGNYTPVVSV-----YSSELIS----LVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 68/226 (30%), Positives = 123/226 (54%), Gaps = 21/226 (9%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVE 157
           F +  ++G G FG VY+G +   E    KI +A+K+L      + +KE + E  V+  V+
Sbjct: 9   FKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIY----EYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
           +P++ +L+G C     + I +L+ +    +Y+  R  +D++ S++   L W  ++     
Sbjct: 68  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQY--LLNWCVQI----- 118

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
            A+G+ YL E    +++ RD  + N+L+    + K++DFGLA+L  +D   + +      
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE 318
           I + A E I     T++SD+WS+GV ++EL+T G +P D   P SE
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 35/218 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS-----RRGLQGHKEWVTEVNVLGVVEH 158
           ++G G FG VY G+     D       AVK++S     + G +  K+   E+ +L  ++H
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDF-----FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 159 PNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
           PN+V+ +G   E+D      L I+ E +P  S+   L  ++ +      RL   Q    G
Sbjct: 62  PNIVQYLGTEREED-----NLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILL-G 114

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST-----AVVG 272
           L YLH   D   + RD K +NIL+D     KL+DFG+A+         V       +  G
Sbjct: 115 LEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKG 163

Query: 273 TIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRP 309
           +  + APE I Q G     +DIWS G  + E+ TG+ P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWV-TEVNVLGVVEHPNL 161
           I +G +G V+    +ST D +     A+K + +  +      + V TE ++L   + P +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIY-----AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPN---RSVQDHLTSRFQATLPWN-TRLKIAQDAARG 217
           VKL  Y +   ++ +   L+ EY+P     S+ +++ S     L  +  R+ IA+     
Sbjct: 56  VKL--YYSFQGKKNL--YLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVL-A 105

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG---PSDGLSHVSTA---VV 271
           L YLH      II RD K  NIL+D   + KL+DFGL+++G       L+        +V
Sbjct: 106 LEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           GT  Y APE I     +   D WS G  LYE + G  P     P
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 8/203 (3%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
            +G+G FG V        +D+  ++ +AVK+L     +  +++  E+ +L  ++H N+VK
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEV-VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G C     R ++  L+ EY+P  S++D+L  + +  L     L  A    +G+ YL  
Sbjct: 70  YKGVCYSAGRRNLR--LVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEYI 282
               + + RD  + NIL++ +   K+ DFGL ++ P D   + V       I + APE +
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 283 QTGRLTYKSDIWSFGVFLYELIT 305
              + +  SD+WSFGV LYEL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 23/206 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IGEG FG V +G     + + K I   V           + ++ E  V+  + H NLV+L
Sbjct: 14  IGEGEFGAVLQGEYTGQKVAVKNIKCDVTA---------QAFLEETAVMTKLHHKNLVRL 64

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G    +   G+   ++ E M   ++ + L +R +A +     L+ + D A G+ YL   
Sbjct: 65  LGVILHN---GLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
              +++ RD  + NIL+ E   AK+SDFGLAR+G   G+ +    V  T    APE ++ 
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPVKWT----APEALKH 171

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
            + + KSD+WS+GV L+E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 72/244 (29%), Positives = 125/244 (51%), Gaps = 23/244 (9%)

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQG 142
           +R+   +ELK       +  ++G G FG VY+G I   +  + KI +A+K L      + 
Sbjct: 1   MRILKETELK-------KVKVLGSGAFGTVYKG-IWIPDGENVKIPVAIKVLRENTSPKA 52

Query: 143 HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQA 200
           +KE + E  V+  V  P + +L+G C     + + +L+ Y  + +  R  +D + S+   
Sbjct: 53  NKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQD-- 110

Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
            L W  ++      A+G++YL E    +++ RD  + N+L+    + K++DFGLARL   
Sbjct: 111 LLNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQ 319
           D   + +      I + A E I   R T++SD+WS+GV ++EL+T G +P D    +   
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP 221

Query: 320 KLLE 323
            LLE
Sbjct: 222 DLLE 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 69/227 (30%), Positives = 114/227 (50%), Gaps = 31/227 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE--- 157
           IGEG +G VY+   R          KK+ +    LS  G+      + E+ +L  +E   
Sbjct: 7   IGEGAYGTVYKA--RDLNTGRFVALKKVRV---PLSEEGIP--LSTLREIALLKQLESFE 59

Query: 158 HPNLVKLIGYCA-EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           HPN+V+L+  C     +R ++  L++E++ ++ +  +L+   +  LP  T   + +   R
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS--TAVVGTI 274
           G+ +LH     +I+ RD K  NIL+      K++DFGLAR+      S     T+VV T+
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI-----YSFEMALTSVVVTL 170

Query: 275 GYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
            Y APE +   + +Y +  D+WS G    EL   RRPL R   +++Q
Sbjct: 171 WYRAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 14/208 (6%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLV 162
            IGEG FG VY+GV  S E+  +KI +AVK          +E ++ E  ++   +HP++V
Sbjct: 13  CIGEGQFGDVYQGVYMSPEN--EKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KLIG   E+        ++ E  P   ++ +L    + +L   + +  +   +  LAYL 
Sbjct: 71  KLIGVITEN-----PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYL- 123

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           E   F  + RD  + N+L+      KL DFGL+R    +     S   +  I + APE I
Sbjct: 124 ESKRF--VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESI 180

Query: 283 QTGRLTYKSDIWSFGVFLYE-LITGRRP 309
              R T  SD+W FGV ++E L+ G +P
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.0 bits (228), Expect = 4e-21
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V+ G    T        +A+K L + G    + ++ E  V+  + H  LV+L
Sbjct: 14  LGQGCFGEVWMGTWNGT------TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ EYM   S+ D L       L     + +A   A G+AY+ E 
Sbjct: 67  YAVVSEE-----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ER 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
           M++  + RD +++NIL+ E    K++DFGLARL   +  +    A    I + APE    
Sbjct: 121 MNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 177

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
           GR T KSD+WSFG+ L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 92.1 bits (228), Expect = 5e-21
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 33/220 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNL 161
           +IGEG FG V +  I+       ++D A+K++     +  H+++  E+ VL  +  HPN+
Sbjct: 2   VIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR------------- 207
           + L+G C   + RG   L I EY P+ ++ D L  SR   T P                 
Sbjct: 59  INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           L  A D ARG+ YL +    Q I RD  + NIL+ E + AK++DFGL+R     G     
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166

Query: 268 TAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
              +G   + + A E +     T  SD+WS+GV L+E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 22/219 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-----KEWVTEVNV 152
           N+ R  ++G+G FG VY        D     ++AVKQ+                  E+ +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-----DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L  ++H  +V+  G C  DDE     L I+ EYMP  SV+D L  +    L      K  
Sbjct: 58  LKNLQHERIVQYYG-CLRDDET----LSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT 110

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAV 270
           +    G+ YLH  M   I+ RD K +NIL D   N KL DFG + RL           +V
Sbjct: 111 RQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            GT  + +PE I       K+D+WS G  + E++T + P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 73/289 (25%), Positives = 125/289 (43%), Gaps = 40/289 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +G+G FG VY G+ +       +  +A+K ++       + E++ E +V+      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-----FQATLPWNTRLKIAQDA---A 215
           L+G  +     G   L++ E M    ++ +L SR         L   T  K  Q A   A
Sbjct: 74  LLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTI 274
            G+AYL      + + RD  + N ++ E    K+ DFG+ R +  +D        ++  +
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PV 185

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV--RPHLTD 331
            + APE ++ G  T KSD+WSFGV L+E+ T   +P    +  S +++L++V    HL  
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY---QGLSNEEVLKFVIDGGHL-- 240

Query: 332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                                 KL  +   C     K RP   E+V  L
Sbjct: 241 --------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 92.2 bits (229), Expect = 6e-21
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 37/231 (16%)

Query: 105 IGEGGFGGVYR----GVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHP 159
           IG+G FG V++    G++     +     +AVK L          ++  E  ++   +HP
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTM----VAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR------------------FQAT 201
           N+VKL+G CA     G    L++EYM    + + L  R                      
Sbjct: 69  NIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 202 LPWNT--RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP 259
           LP +   +L IA+  A G+AYL E    + + RD  + N L+ E    K++DFGL+R   
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           S      S      I +  PE I   R T +SD+W++GV L+E+ + G +P
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 39/293 (13%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEH 158
           ++GEG FG V  G +   + S  K+  AVK +     +   ++   E+++E   +   +H
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKV--AVKTMKLDIHTYSEIE---EFLSEAACMKDFDH 60

Query: 159 PNLVKLIGYC--AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN----TRLKIAQ 212
           PN++KLIG C  A   ++  + ++I  +M +  +   L       LP      T LK   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
           D A G+ YL    +   I RD  + N +L E     ++DFGL++   S            
Sbjct: 121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE-QKLLEWVRPHLT 330
            + + A E +     T KSD+W+FGV ++E+ T G+ P     P  E  ++ +++R H  
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY----PGVENHEIYDYLR-HGN 232

Query: 331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
             K+    LD             +L  +   C     K RP  +++ EVL  I
Sbjct: 233 RLKQPEDCLD-------------ELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +IG+G FG VY G +  ++   +KI  AVK L+R   L+  ++++ E  ++    HPN++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDG--QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 163 KLIGYCAEDD----------ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
            L+G C   +          + G  R  I     N +V+D +    Q             
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------------ 107

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS------HV 266
             A+G+ YL      + + RD  + N +LDE +  K++DFGLAR    D         H 
Sbjct: 108 --AKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHN 158

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            T     + + A E +QT + T KSD+WSFGV L+EL+T
Sbjct: 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 86/277 (31%), Positives = 118/277 (42%), Gaps = 79/277 (28%)

Query: 60  NASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIR 119
            +S  SS SSS  + +  S  +S       SEL+       R   IG G  G VY+ + R
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKS------LSELE-------RVNRIGSGAGGTVYKVIHR 96

Query: 120 STEDSH--KKI-----DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD 172
            T   +  K I     D   +Q+ R           E+ +L  V HPN+VK    C +  
Sbjct: 97  PTGRLYALKVIYGNHEDTVRRQICR-----------EIEILRDVNHPNVVK----CHDMF 141

Query: 173 ERG--IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ-----DAAR----GLAYL 221
           +    IQ LL  E+M   S++                  IA      D AR    G+AYL
Sbjct: 142 DHNGEIQVLL--EFMDGGSLEGT---------------HIADEQFLADVARQILSGIAYL 184

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV---STAVVGTIGYAA 278
           H      I+ RD K SN+L++   N K++DFG++R+     L+       + VGTI Y +
Sbjct: 185 HRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI-----LAQTMDPCNSSVGTIAYMS 236

Query: 279 PEYIQT----GRLT-YKSDIWSFGVFLYELITGRRPL 310
           PE I T    G    Y  DIWS GV + E   GR P 
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 1e-20
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 32/215 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           +GEG +G VY+       D      +A+K++  R     +E +      E+++L  ++HP
Sbjct: 7   LGEGTYGVVYKAR-----DKKTGEIVALKKI--RLDNE-EEGIPSTALREISLLKELKHP 58

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD--HLTSRFQATLPWNTRLKIAQDAARG 217
           N+VKL+     +     +  L++EY       D      +    L  N    I     RG
Sbjct: 59  NIVKLLDVIHTER----KLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           LAY H     +I+ RD K  NIL++     KL+DFGLAR       ++  T  V T+ Y 
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYR 165

Query: 278 APEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           APE I  G   Y +  DIWS G    E+ITG +PL
Sbjct: 166 APE-ILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 54/291 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW----------VTEVNVLG 154
           +G G FG VY+  +R   +    +  A+K+++       K+           V+EV ++ 
Sbjct: 8   LGSGAFGCVYK--VRKKNNGQNLL--ALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63

Query: 155 -VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS------RFQATLPWNTR 207
             + HPN+V+      E+D   I    + + +    + +H  S      RF     WN  
Sbjct: 64  EQLRHPNIVRYYKTFLENDRLYI----VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL-GPSDGLSHV 266
           +++       L YLH+  + +I+ RD   +NI+L E     ++DFGLA+   P   L   
Sbjct: 120 VQMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            T+VVGTI Y+ PE ++      K+D+W+FG  LY++ T + P                 
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------------ 217

Query: 327 PHLTDAKKFT-MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
             L+ A K    + +P  EG YS    + +  V   CL   A+ RP + +V
Sbjct: 218 -MLSLATKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 16/227 (7%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH 158
           F +  ++G+GGFG V    +R+T   +     A K+L ++ ++  K     +N   ++E 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMY-----ACKKLEKKRIKKRKGESMALNEKQILEK 56

Query: 159 PN--LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            N   V  + Y  E  +      L+   M    ++ H+    +A       +  A +   
Sbjct: 57  VNSRFVVSLAYAYETKD---ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL  LH+    +I++RD K  NILLD+  + ++SD GLA   P           VGT+GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGY 167

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            APE ++  R T+  D W+ G  LYE+I G+ P  + + K +++ +E
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 33/220 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNL 161
           +IGEG FG V R +I+       K++ A+K L     +  H+++  E+ VL  +  HPN+
Sbjct: 9   VIGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR------------- 207
           + L+G C   + RG   + I EY P  ++ D L  SR   T P   +             
Sbjct: 66  INLLGAC---ENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           L+ A D A G+ YL E    Q I RD  + N+L+ E   +K++DFGL+R     G     
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYV 173

Query: 268 TAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
              +G   + + A E +     T KSD+WSFGV L+E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G             +AVK L + G    + ++ E  ++  + H  LV+L
Sbjct: 14  LGNGQFGEVWMGTWNGN------TKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ EYM   S+ D L       L     + +A   A G+AY+ E 
Sbjct: 67  YAVVSEE-----PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ER 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
           M++  I RD +S+NIL+ +    K++DFGLARL   +  +    A    I + APE    
Sbjct: 121 MNY--IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 177

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRPLD--RNRPKSEQ 319
           GR T KSD+WSFG+ L EL+T GR P     NR   EQ
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 25/221 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V+     +      K+ +AVK L        +++  E  +L V++H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 165 IGYCAEDDERGIQRLLIYEYMP----NRSVQDH-----------LTSRFQATLPWNTRLK 209
            G C E    G   L+++EYM     NR ++ H             +  Q TL     L 
Sbjct: 73  YGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG--QMLA 126

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           IA   A G+ YL   + F  + RD  + N L+ +    K+ DFG++R   S     V   
Sbjct: 127 IASQIASGMVYL-ASLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            +  I +  PE I   + T +SDIWSFGV L+E+ T G++P
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 33/220 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVV-EHPNL 161
           +IGEG FG V +  I+       ++D A+K++     +  H+++  E+ VL  +  HPN+
Sbjct: 14  VIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--------------TSRFQATLPWNTR 207
           + L+G C   + RG   L I EY P+ ++ D L               +   +TL     
Sbjct: 71  INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           L  A D ARG+ YL +    Q I RD  + NIL+ E + AK++DFGL+R     G     
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178

Query: 268 TAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
              +G   + + A E +     T  SD+WS+GV L+E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.4 bits (219), Expect = 9e-20
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 38/223 (17%)

Query: 101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN 160
             +++G+G +G VY        D   ++ IA+K++  R  +  +    E+ +   ++H N
Sbjct: 12  ERVVLGKGTYGIVYAA-----RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 161 LVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRF------QATLPWNTRLKIAQD 213
           +V+ +G  +E+         I+ E +P  S+   L S++      + T+ + T+ +I + 
Sbjct: 67  IVQYLGSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE- 119

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFG----LARLGPSDGLSHVST 268
              GL YLH+    QI+ RD K  N+L++      K+SDFG    LA + P       + 
Sbjct: 120 ---GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTE 167

Query: 269 AVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRP 309
              GT+ Y APE I  G   Y   +DIWS G  + E+ TG+ P
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 34/216 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IGEG +G VY+   R          +A+K++  R      E +      E+ +L  + HP
Sbjct: 7   IGEGTYGVVYKA--RDKLT---GEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHP 58

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD--HLTSRFQATLPWNTRLK-IAQDAA 215
           N++KL+     D  R    L L++E+M      D   L    Q  LP  + +K       
Sbjct: 59  NIIKLL-----DVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLP-ESLIKSYLYQLL 108

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GLA+ H      I+ RD K  N+L++ +   KL+DFGLAR   S    +  T  V T  
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRW 163

Query: 276 YAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPL 310
           Y APE +   +  +   DIWS G    EL++ RRPL
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 80/294 (27%), Positives = 114/294 (38%), Gaps = 50/294 (17%)

Query: 104 MIGEGGFGGVYRGVIRSTED--SHKKI-----DIAVKQLSRRGLQGHKEWVTEVNVLGVV 156
           ++GEG +G V +   ++T +  + KK      D  VK+ + R          EV VL  +
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----------EVKVLRQL 57

Query: 157 EHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
            H N+V L             RL L++EY+  R++ + L       LP +          
Sbjct: 58  RHENIVNLKEAFRRKG-----RLYLVFEYVE-RTLLELL-EASPGGLPPDAVRSYIWQLL 110

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           + +AY H      II RD K  NIL+ E    KL DFG AR   +   S + T  V T  
Sbjct: 111 QAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRW 166

Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL-------DR---------NRPKS 317
           Y APE +  G   Y    D+W+ G  + EL+ G  PL       D+           P S
Sbjct: 167 YRAPELL-VGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPS 224

Query: 318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
            Q+L     P               LE +Y  K++         CL    K R 
Sbjct: 225 HQELFS-SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 58/208 (27%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVK 163
           +G G FG V +GV +  +   K+ID+A+K L     +    E + E  ++  +++P +V+
Sbjct: 3   LGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           +IG C  +       +L+ E      +   L+ + +  +  +  +++    + G+ YL E
Sbjct: 60  MIGVCEAEA-----LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYL-E 112

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI 282
           G +F  + RD  + N+LL  Q  AK+SDFGL++ LG  D      +A    + + APE I
Sbjct: 113 GKNF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              + + +SD+WS+G+ ++E  + G++P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNL 161
           +IG G FG V RG  R      ++I +A+K L + G      +++++E +++G  +HPN+
Sbjct: 11  VIGAGEFGEVCRG--RLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           + L G       +    ++I E+M N ++ D    +          + + +  A G+ YL
Sbjct: 68  IHLEGVVT----KSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG---TIGYAA 278
            E M++  + RD  + NIL++     K+SDFGL+R    D      T+ +G    I + A
Sbjct: 123 SE-MNY--VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           PE I   + T  SD+WS+G+ ++E+++ G RP
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 85/290 (29%), Positives = 120/290 (41%), Gaps = 51/290 (17%)

Query: 105 IGEGGFGGVYRGVIR--STEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           IG G FG V + + +   T  + K+I   V +  ++ L    + V   +     + P +V
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIV 66

Query: 163 KLIG---------YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
           K  G          C E  +  + +   Y Y   +S            +P     KIA  
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS-----------VIPEEILGKIAVA 115

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL--SHVSTAVV 271
             + L YL E  + +II RD K SNILLD   N KL DFG+     S  L  S   T   
Sbjct: 116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI-----SGQLVDSIAKTRDA 168

Query: 272 GTIGYAAPEYIQT-GRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
           G   Y APE I    R  Y  +SD+WS G+ LYE+ TG+ P  +     +Q L + V+  
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVK-- 225

Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
             D      IL    E ++S           N CL +    RPK  E++E
Sbjct: 226 -GDPP----ILSNSEEREFSPSFVN----FINLCLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 19/217 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V+     +      KI +AVK L        K++  E  +L  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF-----------QATLPWNTRLKIAQD 213
            G C E D      ++++EYM +  +   L +              A L  +  L IAQ 
Sbjct: 73  YGVCVEGDP----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
            A G+ YL        + RD  + N L+ E    K+ DFG++R   S     V    +  
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           I +  PE I   + T +SD+WS GV L+E+ T G++P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 32/247 (12%)

Query: 101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-----SRRGLQGHKEWVT----EVN 151
           +  +IG G FG VY G+  S+ +      +AVKQ+     S       +  +     E+ 
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGEL-----MAVKQVELPSVSASSKDRKRSMLDALAREIA 58

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLK 209
           +L  ++H N+V+ +G   + D   I      EY+P  SV   L +   F+ TL  N   +
Sbjct: 59  LLKELQHENIVQYLGSSLDADHLNI----FLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST- 268
           I +    GL YLH   +  II RD K +NIL+D +   K+SDFG+++   ++ LS  +  
Sbjct: 115 ILK----GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 269 ---AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEW 324
              ++ G++ + APE ++    T K+DIWS G  + E++TG+ P  D  + ++  K+ E 
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227

Query: 325 VRPHLTD 331
             P +  
Sbjct: 228 ASPEIPS 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 105 IGEGGFGGVY----RGVIR-----STEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLG 154
           +GEG FG V+     G+       + E   + + +AVK L +        +++ E+ ++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-------FQATLPWNTR 207
            +++PN+++L+G C  DD       +I EYM N  +   L+ R           +P  + 
Sbjct: 73  RLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 208 ---LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              L +A   A G+ YL        + RD  + N L+   +  K++DFG++R   S    
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +    V  I + A E I  G+ T  SD+W+FGV L+E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V+     +   +  K+ +AVK L    L   K++  E  +L  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--------------RFQATLPWNTRLKI 210
            G C + D      ++++EYM +  +   L +              + +  L  +  L I
Sbjct: 73  YGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A   A G+ YL        + RD  + N L+      K+ DFG++R   S     V    
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +  I +  PE I   + T +SD+WSFGV L+E+ T G++P
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVE 157
           F++   IG+G FG VY+G+     D+  K  +A+K +     +   E +  E+ VL   +
Sbjct: 6   FTKLERIGKGSFGEVYKGI-----DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
            P + +  G       +G +  +I EY+   S  D L       L       I ++  +G
Sbjct: 61  SPYITRYYGSYL----KGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKG 113

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L YLH     + I RD K++N+LL EQ + KL+DFG+A  G            VGT  + 
Sbjct: 114 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM 337
           APE I+     +K+DIWS G+   EL  G  P     P     L+    P          
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---------- 218

Query: 338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              P LEG+YS    + + A    CL +  + RP   E+++
Sbjct: 219 ---PTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 33/233 (14%)

Query: 95  ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL---SRRGLQGHKEWVTEVN 151
              + +    +G G FG VY G+ R  +    ++ +AVK L        Q   +++ E  
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEAL 61

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP----------NRSVQDHLTSRFQAT 201
           ++    H N+V+LIG   E     + R ++ E M           NR   +  +S     
Sbjct: 62  IMSKFNHQNIVRLIGVSFER----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKLSDFGLAR-L 257
           L     L  A+D A+G  YL E      I RD  + N LL        AK++DFG+AR +
Sbjct: 118 L-----LFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +        A++  I +  PE    G  T K+D+WSFGV L+E+ + G  P
Sbjct: 170 YRASYYRKGGRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G +G VY+    +T +      +A+K +        +    E+++L    HPN+V  
Sbjct: 11  IGSGTYGDVYKARDIATGEL-----VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 165 IGYCAEDDERGIQRLLI-YEYMPNRSVQD--HLTSRFQATLPWNTRLKIA---QDAARGL 218
            G           +L I  EY    S+QD   +T      L     L+IA   ++  +GL
Sbjct: 66  FG-----SYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLS---ELQIAYVCRETLKGL 114

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS---TAVVGTIG 275
           AYLHE      I RD K +NILL E  + KL+DFG++       L+       + +GT  
Sbjct: 115 AYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFIGTPY 166

Query: 276 YAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPL 310
           + APE       G    K DIW+ G+   EL   + P+
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 40/221 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVE 157
           +G+G +G VY+  ++   D+     K++D+        G    KE    V E+ +L  V 
Sbjct: 8   LGKGSYGSVYK--VKRLSDNQFYALKEVDL--------GSMSQKEREDAVNEIRILASVN 57

Query: 158 HPNLVKLIGYCAEDDERGIQRLLI-YEYMPNRSVQDHLTSRFQATLP------WNTRLKI 210
           HPN++       ++      +L I  EY P   +   ++ R +          W   +++
Sbjct: 58  HPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
                RGL  LHE    +I+ RD KS+NILL      K+ D G++++   +    ++   
Sbjct: 113 L----RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQ 161

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           +GT  Y APE  +    +YKSDIWS G  LYE+ T   P +
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.1 bits (213), Expect = 7e-19
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL--SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +GEG FG V         D+  +  +AVK L     G         E+ +L  + H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLK-KEIEILRNLYHENIV 69

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           K  G C ED   GI+  LI E++P+ S++++L  R +  +    +LK A    +G+ YL 
Sbjct: 70  KYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVSTAVVGTIGYAAPEY 281
                Q + RD  + N+L++ +   K+ DFGL +   +D     V   +   + + APE 
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT 305
           +   +    SD+WSFGV LYEL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V+ G    T        +A+K L + G    + ++ E  ++  + H  LV L
Sbjct: 14  LGQGCFGEVWMGTWNGT------TKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ E+M   S+ D L       L     + +A   A G+AY+ E 
Sbjct: 67  YAVVSEE-----PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ER 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
           M++  I RD +++NIL+ +    K++DFGLARL   +  +    A    I + APE    
Sbjct: 121 MNY--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 177

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
           GR T KSD+WSFG+ L EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVT-----EVN 151
            + +   +G G F   Y        D      +AVKQ++  R     +E V      E+ 
Sbjct: 1   EWLKGQQLGTGAFSSCY-----QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR 55

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           ++  + HP++++++G   ED    +      E+M   SV  HL S++ A       +   
Sbjct: 56  LMARLNHPHIIRMLGATCEDSHFNL----FVEWMAGGSVS-HLLSKYGA-FKEAVIINYT 109

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDFGLARLGPSD--GLSHVST 268
           +   RGL+YLHE    QII RD K +N+L+D      +++DFG A    +   G      
Sbjct: 110 EQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            ++GTI + APE ++  +     D+WS G  + E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 58/213 (27%), Positives = 112/213 (52%), Gaps = 13/213 (6%)

Query: 100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEH 158
           ++  +IG G FG V+RG+++      K++ +A+K L     +  + ++++E +++G   H
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMP--GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            N+++L G   +        ++I EYM N ++  +L         +   + + +  A G+
Sbjct: 66  HNIIRLEGVVTKFKPA----MIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGM 120

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVSTAVVGTIGYA 277
            YL    D   + RD  + NIL++     K+SDFGL+R+   D   ++ ++     I + 
Sbjct: 121 KYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           APE I   + T  SD+WSFG+ ++E+++ G RP
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 18/233 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH--KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+GGFG V    +++T   +  KK+D   K+L ++   G K  + E  +L  V  P +V
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLD--KKRLKKKS--GEKMALLEKEILEKVNSPFIV 56

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            L    A   E      L+   M    ++ H+ +  +  L     +  +     G+ +LH
Sbjct: 57  NL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 I++RD K  N+LLD+Q N +LSD GLA     DG +   T   GT GY APE +
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEIL 166

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           +    +Y  D ++ G  +YE++ GR P   ++ K  ++  E  R  L D  KF
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 72/292 (24%), Positives = 132/292 (45%), Gaps = 46/292 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-----WVTEVNVLGVVEH 158
           +IG G FG V  G  R      ++I +A+K L      G+ E     +++E +++G  +H
Sbjct: 11  VIGAGEFGEVCSG--RLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEASIMGQFDH 64

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           PN++ L G       +    +++ EYM N S+ D    +          + + +  A G+
Sbjct: 65  PNIIHLEGVVT----KSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVSTAVVGTIGYA 277
            YL    D   + RD  + NIL++     K+SDFGL+R+   D   ++ +      I + 
Sbjct: 120 KYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDA 332
           APE I   + T  SD+WS+G+ ++E+++ G RP     +++  K+ ++      P    A
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA 236

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
               ++LD                     C  +    RPK  ++V +L+K++
Sbjct: 237 ALHQLMLD---------------------CWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 33/192 (17%)

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           KIA     GL YL+     +I+ RD K SNIL++ +   KL DFG++     + ++ ++ 
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIAD 160

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  Y +PE IQ G+ T KSD+WS G+ + EL  G+ P   +               
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS-------------NI 207

Query: 329 LTDAKKFTM-ILD----------PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
             D +   M ILD          P+L    S    + L    + CL +    RP   ++ 
Sbjct: 208 DDDGQDDPMGILDLLQQIVQEPPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLC 264

Query: 378 EVLNKIVDAAET 389
            +   I     +
Sbjct: 265 AMPPFIQALRAS 276

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 87/287 (30%), Positives = 124/287 (43%), Gaps = 50/287 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV-LGVV----EHP 159
           IG G  G VY+   + T   H    +AVKQ+ R    G+KE    + + L VV    + P
Sbjct: 23  IGSGTCGQVYKMRFKKT--GHV---MAVKQMRR---TGNKEENKRILMDLDVVLKSHDCP 74

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            +VK  GY   D +  I      E M   +  D L  R Q  +P +   K+     + L 
Sbjct: 75  YIVKCYGYFITDSDVFI----CMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAA 278
           YL E     +I RD K SNILLD   N KL DFG++ RL   D  +   +A  G   Y A
Sbjct: 129 YLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSA--GCAAYMA 182

Query: 279 PEYI--QTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
           PE I        Y  ++D+WS G+ L EL TG+ P    +               T+ + 
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---------------TEFEV 227

Query: 335 FTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            T IL    P L    +   +    +  + CL +  + RPK  E+++
Sbjct: 228 LTKILQEEPPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 69/230 (30%), Positives = 101/230 (43%), Gaps = 48/230 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL----SRRGLQGHKEWVT---EVNVLGVVE 157
           +GEG FG VY+     T        +A+K++     + G       +T   E+ +L  ++
Sbjct: 16  LGEGTFGEVYKARQIKT-----GRVVALKKILMHNEKDGFP-----ITALREIKILKKLK 65

Query: 158 HPNLVKLIGYCAE-DDERGIQRLLIYEYMPNRSVQDH-LTSRFQATLPWNTRLKIAQDAA 215
           HPN+V LI    E  D+   +R  +Y   P     DH L     + L  N  +K+ +   
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTP---YMDHDL-----SGLLENPSVKLTESQI 117

Query: 216 R--------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL---------G 258
           +        G+ YLHE     I+ RD K++NIL+D Q   K++DFGLAR          G
Sbjct: 118 KCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGR 307
              G +   T +V T  Y  PE +    R T   DIW  G    E+ T R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 26/258 (10%)

Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           +E+  +G ++HPN+VKLIG C  +        LI+EY+  +++ + L +     L W  R
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWERR 782

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
            KIA   A+ L +LH      ++  +     I++D +    L    L  L  +D    +S
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEWV 325
           +A      Y APE  +T  +T KSDI+ FG+ L EL+TG+ P D    +      ++EW 
Sbjct: 842 SA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWA 892

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA--VANKCLARQAKGRPKMSEVVEVLNKI 383
           R   +D     M +DP + G  S+   + +    +A  C A     RP  ++V++ L   
Sbjct: 893 RYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951

Query: 384 VDAAETGTPQTPLKNLSL 401
             ++ +    T LK  SL
Sbjct: 952 SRSSSSCV--TGLKFSSL 967

Length = 968

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 27/232 (11%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR---GLQGHKEWVTEVNVLG 154
           +  R   +G G FG V+    R +E  +     A+K ++      L+  +    E  VL 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYY-----ALKVMAIPEVIRLKQEQHVHNEKRVLK 56

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQ 212
            V HP +++L  +  E D+R +   ++ EY+P   +  +L +  RF  +    T L  A 
Sbjct: 57  EVSHPFIIRL--FWTEHDQRFL--YMLMEYVPGGELFSYLRNSGRFSNS----TGLFYAS 108

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
           +    L YLH     +I++RD K  NILLD++ + KL+DFG A+      L   +  + G
Sbjct: 109 EIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCG 160

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLE 323
           T  Y APE IQ+       D W+ G+ +YE++ G  P  D N     +K+L 
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 77/295 (26%), Positives = 121/295 (41%), Gaps = 60/295 (20%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE 157
                + IGEG       G++    D      +AVK++  R  Q  +    EV ++   +
Sbjct: 20  YLDNFVKIGEGS-----TGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA-- 215
           HPN+V++       DE      ++ E++   ++ D +T         +TR+   Q A   
Sbjct: 75  HPNIVEMYSSYLVGDEL----WVVMEFLEGGALTDIVT---------HTRMNEEQIATVC 121

Query: 216 ----RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV- 270
               + L++LH      +I RD KS +ILL      KLSDFG          + VS  V 
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVP 170

Query: 271 -----VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
                VGT  + APE I   RL Y +  DIWS G+ + E++ G  P     P    K + 
Sbjct: 171 RRKSLVGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228

Query: 324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              P             PKL  K   K++ +L +  ++ L R    R   +E++ 
Sbjct: 229 DNLP-------------PKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 67/302 (22%), Positives = 122/302 (40%), Gaps = 46/302 (15%)

Query: 99  FSRS-----LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNV 152
           F RS       +G G FG V+    +  E+   +  + VK L +   +    E+  E+++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 153 LGVVEHPNLVKLIGYCAEDDERGI-----------QRLLIYEYMPNRSVQDHLTSRFQAT 201
              + H N+V+L+G C E +   +           Q L   +    +     L+++    
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK---- 117

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
                ++ +    A G+ +L      + + RD  + N L+  Q   K+S   L++   + 
Sbjct: 118 ----QKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQK 320
               +  A++  + + APE +Q    + KSD+WSFGV ++E+ T G  P           
Sbjct: 171 EYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF---------- 219

Query: 321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                   L+D +    +   KLE         +L  +  +C A   K RP  SE+V  L
Sbjct: 220 ------YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Query: 381 NK 382
            +
Sbjct: 274 GE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 22/203 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G FG V+ G +R+         +AVK   R  L      +++ E  +L    HPN+V
Sbjct: 3   IGRGNFGEVFSGRLRADNTP-----VAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAARGLAY 220
           +LIG C        Q+  IY  M      D LT        L     +++ ++AA G+ Y
Sbjct: 57  RLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEY 109

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAP 279
           L        I RD  + N L+ E+   K+SDFG++R    DG+   +  +    + + AP
Sbjct: 110 LESK---HCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAP 165

Query: 280 EYIQTGRLTYKSDIWSFGVFLYE 302
           E +  GR + +SD+WSFG+ L+E
Sbjct: 166 EALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 28/239 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GE  FG +Y+G +      H ++ +A+K L      Q   E+  E +++  + HPN+V 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQL-VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR---------------FQATLPWNTRL 208
           L+G   ++        +++EY+    + + L  R                +++L     L
Sbjct: 72  LLGVVTQEQPV----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            IA   A G+ YL        + +D  + NIL+ EQ + K+SD GL+R   S     V  
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVR 326
             +  I +  PE I  G+ +  SDIWSFGV L+E+ + G +P       S Q+++E VR
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY---YGFSNQEVIEMVR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 27/220 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVV-EHPNL 161
            +GEG FG V +      ++ ++   +AVK L      +   + V+E+ ++ ++ +H N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR------FQATLPWNTRLKIAQDAA 215
           + L+G C ++        ++ EY  + +++D L +R           P      + Q   
Sbjct: 79  INLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 216 RGLAY-LHEGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
              AY +  GM+F    + I RD  + N+L+ E    K++DFGLAR      + H+    
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYR 189

Query: 271 VGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             T G     + APE +     T++SD+WSFGV L+E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+     +T + H K+  AVK + + G    + ++ E NV+  ++H  LVKL
Sbjct: 14  LGAGQFGEVWM----ATYNKHTKV--AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                ++        +I E+M   S+ D L S   +  P    +  +   A G+A++ + 
Sbjct: 67  HAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD +++NIL+      K++DFGLAR+   D            I + APE I  
Sbjct: 122 ---NYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINF 177

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
           G  T KSD+WSFG+ L E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.7 bits (208), Expect = 5e-18
 Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 35/229 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPNL 161
           +G G FG V     + +   +     A+K LS+  +   K+    + E  +L  + HP L
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYY-----ALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 162 VKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGL 218
           V L G   +DD      L L+ EY+P   +  HL  + RF    P   R   AQ     L
Sbjct: 64  VNLYG-SFQDD----SNLYLVMEYVPGGELFSHLRKSGRF--PEPV-ARFYAAQVVL-AL 114

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST---AVVGTIG 275
            YLH      I++RD K  N+LLD     K++DFG A+         V      + GT  
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPE 163

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLE 323
           Y APE I +       D W+ G+ +YE++ G  P  D N  +  +K+LE
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 69/222 (31%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKID--IAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNL 161
           IGEG +G VY+         HKK    +A+K +        +E   E N+L     HPN+
Sbjct: 14  IGEGTYGKVYKAR-------HKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNI 65

Query: 162 VKLIG-YCAEDDE-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK------IAQD 213
               G +  ++      Q  L+ E     SV D +    +       RLK      I ++
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLKEEWIAYILRE 121

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
             RGLAYLHE    ++I RD K  NILL +    KL DFG++     D         +GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGT 176

Query: 274 IGYAAPEYI---QTGRLTY--KSDIWSFGVFLYELITGRRPL 310
             + APE I   +    +Y  +SD+WS G+   EL  G+ PL
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 32/225 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVK 163
           +GEG FG V +      +       +AVK L         ++ ++E N+L  V HP+++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--------------TSRFQATL------P 203
           L G C++D       LLI EY    S++  L               +R  + L       
Sbjct: 68  LYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 204 WNTR--LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPS 260
                 +  A   +RG+ YL E    +++ RD  + N+L+ E    K+SDFGL+R +   
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           D     S   +  + + A E +     T +SD+WSFGV L+E++T
Sbjct: 181 DSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 81/281 (28%), Positives = 121/281 (43%), Gaps = 35/281 (12%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVE 157
           F++   IG+G FG V++G+     D+  +  +A+K +     +   E +  E+ VL   +
Sbjct: 6   FTKLEKIGKGSFGEVFKGI-----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
            P + K  G   +D +  I    I EY+   S  D L       L       I ++  +G
Sbjct: 61  SPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEP---GPLDETQIATILREILKG 113

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L YLH     + I RD K++N+LL E    KL+DFG+A  G            VGT  + 
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM 337
           APE I+      K+DIWS G+   EL  G  P     P     L+    P          
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---------- 218

Query: 338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              P LEG YS  L + + A    CL ++   RP   E+++
Sbjct: 219 ---PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.4 bits (203), Expect = 9e-18
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 14/216 (6%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLG 154
           N+    ++G+G FG VY   +    D+ +++ +   Q      +  KE      E+ +L 
Sbjct: 3   NWRLGKLLGQGAFGRVY---LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK 59

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
            + H  +V+  G   +  ER +   +  E+MP  S++D L S     L  N   K  +  
Sbjct: 60  NLLHERIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQI 115

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS-TAVVGT 273
             G++YLH  M   I+ RD K +NIL D   N KL DFG ++   +  LS     +V GT
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             + +PE I       K+DIWS G  + E++T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLV 162
           IGEG  G V++   R T ++     +A+K+++ R L+G    + + E+  L   +HP +V
Sbjct: 8   IGEGAHGIVFKAKDRETGET-----VALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KL+         G   +L+ EYMP   + + L    +  LP        +   +G+AY+H
Sbjct: 63  KLLDVFPH----GSGFVLVMEYMP-SDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 I+ RD K +N+L+      K++DFGLARL   +    + +  V T  Y APE +
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELL 172

Query: 283 QTGRLTYKS--DIWSFGVFLYELITGRRPL 310
             G   Y    D+W+ G    EL+ G  PL
Sbjct: 173 -YGARKYDPGVDLWAVGCIFAELLNG-SPL 200

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 72/212 (33%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNL 161
           IG G FG VY        +SH    +AVK++S  G Q +++W   + EV  L  ++HPN 
Sbjct: 29  IGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT 83

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           ++  G C   +       L+ EY    S  D L    +  L       I   A +GLAYL
Sbjct: 84  IEYKG-CYLKEHTA---WLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYL 137

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      +I RD K+ NILL E    KL+DFG      S   S  + + VGT  + APE 
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEV 188

Query: 282 I---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           I     G+   K D+WS G+   EL   + PL
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 63/199 (31%), Positives = 86/199 (43%), Gaps = 36/199 (18%)

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
           +P N   KI+    RGL YL E    +I+ RD K SNIL++ +   KL DFG++      
Sbjct: 96  IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 147

Query: 262 GLSHVSTA--VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL--------- 310
           G    S A   VGT  Y +PE +Q    T +SDIWS G+ L E+  GR P+         
Sbjct: 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207

Query: 311 ---DRNRPKSEQKL-LEWVRPHLTDAKKFTMI---LD-------PKLEGKYSIKLAQKLA 356
               R   + E K     V  H  D+ +   I   LD       PKL        + +  
Sbjct: 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA---FSDEFQ 264

Query: 357 AVANKCLARQAKGRPKMSE 375
              +KCL +  K R  + E
Sbjct: 265 DFVDKCLKKNPKERADLKE 283

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 16/217 (7%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---EVNVLG 154
           N+ R  ++G+G FG VY   +    D+ +++     Q      +  KE      E+ +L 
Sbjct: 3   NWRRGKLLGQGAFGRVY---LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK 59

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
            ++H  +V+  G C  D  R  + L I+ EYMP  SV+D L + + A     TR K  + 
Sbjct: 60  NLQHERIVQYYG-CLRD--RAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTR-KYTRQ 114

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST-AVVG 272
              G++YLH  M   I+ RD K +NIL D   N KL DFG ++   +  +S     +V G
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           T  + +PE I       K+D+WS G  + E++T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 22/241 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR----RGLQGHKEWVTEVNVLGVVEHP 159
           ++G+GG+G V++  +R    +      A+K L +    R  +       E N+L  V+HP
Sbjct: 3   VLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            +V LI Y  +   +     LI EY+    +  HL    +     +T      + +  L 
Sbjct: 61  FIVDLI-YAFQTGGK---LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALE 114

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +LH+     II+RD K  NILLD Q + KL+DFGL +    +G   V+    GTI Y AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAP 169

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLD-RNRPKSEQKLLEW---VRPHLT-DAKK 334
           E +         D WS G  +Y+++TG  P    NR K+  K+L+    + P+LT +A+ 
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229

Query: 335 F 335
            
Sbjct: 230 L 230

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 70/248 (28%), Positives = 115/248 (46%), Gaps = 39/248 (15%)

Query: 98  NFSRSLM-----IGEGGFGGVY----RGVIRSTEDSHKKID-------IAVKQLSRRGLQ 141
            F R  +     +GEG FG V+     G+   +E +  + D       +AVK L R    
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDAS 59

Query: 142 GH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-- 197
            +  ++++ EV +L  +  PN+ +L+G C  D    +    I EYM N  +   L     
Sbjct: 60  DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVA 115

Query: 198 -------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
                     +L ++T L +A   A G+ YL E ++F  + RD  + N L+ + +  K++
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNF--VHRDLATRNCLVGKNYTIKIA 172

Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           DFG++R   S     V       I + A E +  G+ T KSD+W+FGV L+E++T    L
Sbjct: 173 DFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----L 228

Query: 311 DRNRPKSE 318
            R +P   
Sbjct: 229 CREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 30/274 (10%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH 158
           F +  ++G+GGFG V    +R+T   +     A K+L ++ ++  K     +N   ++E 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMY-----ACKRLEKKRIKKRKGESMALNEKQILEK 56

Query: 159 PN--LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            N   V  + Y  E  +      L+   M    ++ H+ +           L  A +   
Sbjct: 57  VNSQFVVNLAYAYETKD---ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC 113

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL  LH       ++RD K  NILLD+  + ++SD GLA   P           VGT+GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GRVGTVGY 167

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE +   R T   D W  G  +YE+I G+ P    R + E+   E V   + +     
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEKVKREEVDRRVLET---- 220

Query: 337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR 370
                  E  YS K +++  ++    L +  K R
Sbjct: 221 -------EEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVK----QLSRRGLQGHKEWVTEVNVLGVVE--- 157
           IG G +G VY+       D H    +A+K    Q +  GL      V EV +L  +E   
Sbjct: 8   IGVGAYGTVYKA-----RDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFD 60

Query: 158 HPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           HPN+V+L+  CA    +R  +  L++E++ ++ ++ +L       LP  T   + +   R
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +LH      I+ RD K  NIL+      KL+DFGLAR+          T VV T+ Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            APE +         D+WS G    E+   R+PL
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 75/306 (24%), Positives = 138/306 (45%), Gaps = 54/306 (17%)

Query: 105 IGEGGFGGVYRGVIRSTED-----------SHKKIDIAVKQLSRRGLQGHK-EWVTEVNV 152
           +GEG FG V+   + + +D             + + +AVK L     +  + +++ EV +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF-------------- 198
           L  ++ PN+++L+G C ++D       +I EYM N  +   L+S                
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 199 QATLP---WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA 255
              LP   +++ L +A   A G+ YL   ++F  + RD  + N L+ E    K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL-SSLNF--VHRDLATRNCLVGENLTIKIADFGMS 185

Query: 256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           R   +     +    V  I + A E I  G+ T  SD+W+FGV L+E++     L + +P
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241

Query: 316 KSE---QKLLEWVRPHLTDAKKFTMILDPKL--EGKYSIKLAQKLAAVANKCLARQAKGR 370
             E   ++++E       D  +   +  P    +G Y + L         +C +R  + R
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELML---------QCWSRDCRER 292

Query: 371 PKMSEV 376
           P  S++
Sbjct: 293 PSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 71/237 (29%), Positives = 107/237 (45%), Gaps = 58/237 (24%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL----SRRGLQGHKEWVTEVNV 152
             F +   IGEG +G VYR       D+     +A+K++     R G+      + E+ +
Sbjct: 7   TEFEKLNRIGEGTYGIVYRA-----RDTTSGEIVALKKVRMDNERDGIPISS--LREITL 59

Query: 153 LGVVEHPNLVKL---------------IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR 197
           L  + HPN+V+L               + YC +D    +  LL           D++ + 
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD----LASLL-----------DNMPTP 104

Query: 198 FQATLPWNTRLK-IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
           F       +++K +     RGL YLHE     II RD K SN+LL ++   K++DFGLAR
Sbjct: 105 FS-----ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Query: 257 L-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
             G         T  V T+ Y APE +  G  TY +  D+W+ G  L EL+   +PL
Sbjct: 157 TYGLPA---KPMTPKVVTLWYRAPE-LLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 72/265 (27%), Positives = 111/265 (41%), Gaps = 55/265 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNL 161
           +G+GG+G V+    + T +      +A+K++ +  L    E    +TE ++L   +   L
Sbjct: 9   VGQGGYGQVFLAKKKDTGEI-----VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMP---------NRSVQDHLTSRFQATLPWNTRLKIAQ 212
           VKL+ Y  +DDE      L  EY+P         N  V     +RF         +  A 
Sbjct: 64  VKLL-YAFQDDE---YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-----EMFEAV 114

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
           DA   L Y+H         RD K  N L+D   + KL+DFGL+       +++ ++ VVG
Sbjct: 115 DALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLS----KGIVTYANS-VVG 160

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWV----RP 327
           +  Y APE ++     +  D WS G  LYE + G  P   + P    + L  W     RP
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP 220

Query: 328 HLTDAKKF----------TMILDPK 342
              D +             +I DP 
Sbjct: 221 VYDDPRFNLSDEAWDLITKLINDPS 245

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 24/221 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVN------ 151
           N+    ++G G FG VY        D+    ++AVKQ+        +E   EVN      
Sbjct: 3   NWRLGKLLGRGAFGEVYL-----CYDADTGRELAVKQVPFD--PDSQETSKEVNALECEI 55

Query: 152 -VLGVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLK 209
            +L  + H  +V+  G C  D E   ++L I+ EYMP  S++D L +     L  N   +
Sbjct: 56  QLLKNLRHDRIVQYYG-CLRDPEE--KKLSIFVEYMPGGSIKDQLKA--YGALTENVTRR 110

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS-T 268
             +   +G++YLH  M   I+ RD K +NIL D   N KL DFG ++   +  +S     
Sbjct: 111 YTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +V GT  + +PE I       K+D+WS    + E++T + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 68/230 (29%), Positives = 118/230 (51%), Gaps = 23/230 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-VTEVNVLGVV 156
           NF +   +GEG +  VY+G  R+T +      +A+K++     +G     + E++++  +
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEI-----VALKEIHLDAEEGTPSTAIREISLMKEL 55

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +H N+V+L      ++    + +L++EYM     +   T   +  L  NT         +
Sbjct: 56  KHENIVRLHDVIHTEN----KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL--SHVSTAVVGTI 274
           G+A+ HE    +++ RD K  N+L++++   KL+DFGLAR   + G+  +  S  VV T+
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR---AFGIPVNTFSNEVV-TL 164

Query: 275 GYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
            Y AP+ +   R TY +  DIWS G  + E+ITG RPL       +Q L 
Sbjct: 165 WYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLK 212

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSH---KKIDI--AVKQLSRRGLQGHKEWVTEV 150
             NF     IG+G F  VY+  I   +      KK+ I   +   +R      ++ + E+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA-ICLLDGRVVALKKVQIFEMMDAKAR------QDCLKEI 53

Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQA---TLPWNTR 207
           ++L  ++HPN++K +    E++E     L I   + +      +   F+     +P  T 
Sbjct: 54  DLLKQLDHPNVIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
            K        L ++H     +I+ RD K +N+ +      KL D GL R   S   +  S
Sbjct: 109 WKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             +VGT  Y +PE I      +KSDIWS G  LYE+   + P
Sbjct: 166 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 63/203 (31%), Positives = 85/203 (41%), Gaps = 36/203 (17%)

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
             T+P +   KIA    + L YLH  +   +I RD K SN+L++     KL DFG+    
Sbjct: 97  GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI---- 150

Query: 259 PSDGL--SHVSTAVVGTIGYAAPEYI--QTGRLTY--KSDIWSFGVFLYELITGRRPLDR 312
            S  L  S   T   G   Y APE I  +  +  Y  KSD+WS G+ + EL TGR P D 
Sbjct: 151 -SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKL-EGKYSIKLAQKLAAVANKCLARQAKGRP 371
            +   +Q         L    +      P+L   K+S +         NKCL +  K RP
Sbjct: 210 WKTPFQQ---------LKQVVEEP---SPQLPAEKFSPEFQD----FVNKCLKKNYKERP 253

Query: 372 KMSE------VVEVLNKIVDAAE 388
              E          L+K  D A 
Sbjct: 254 NYPELLQHPFFELHLSKNTDVAS 276

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 76/309 (24%), Positives = 135/309 (43%), Gaps = 51/309 (16%)

Query: 99  FSRSLM-----IGEGGFGGVYRGVIRSTEDSHKK-----------IDIAVKQL-SRRGLQ 141
           F R  +     +GEG FG V+       E    K           + +AVK L       
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 142 GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-RFQ- 199
              +++ E+ ++  ++ PN+++L+  C   D       +I EYM N  +   L+    Q 
Sbjct: 62  ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDLNQFLSRHEPQE 117

Query: 200 -------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
                   T+ ++T + +A   A G+ YL   ++F  + RD  + N L+ + +  K++DF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYL-SSLNF--VHRDLATRNCLVGKNYTIKIADF 174

Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDR 312
           G++R   S     +    V  I + + E I  G+ T  SD+W+FGV L+E++T    L +
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCK 230

Query: 313 NRPKSE---QKLLEWVRPHLTDAKKFTMILDPKL--EGKYSIKLAQKLAAVANKCLARQA 367
            +P S+   ++++E       D  +   +  P L  +  Y + L+         C  R A
Sbjct: 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS---------CWRRNA 281

Query: 368 KGRPKMSEV 376
           K RP   E+
Sbjct: 282 KERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 11/212 (5%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V  G + + +DS  K+ +   +++       +++++E   +   +HPN+++L
Sbjct: 7   LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65

Query: 165 IGYCAEDDERG--IQRLLIYEYMPNRSVQDHLT-SRFQAT---LPWNTRLKIAQDAARGL 218
           IG C +  E       ++I  +M +  +   L  SR       LP    +K   D A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            YL        I RD  + N +L+E  N  ++DFGL++   +             + + A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            E +     T KSD+WSFGV ++E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGV 155
           K ++R   IG+G  G VY  +  +T       ++A+KQ++ +  Q  KE +  E+ V+  
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQ-----EVAIKQMNLQQ-QPKKELIINEILVMRE 72

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
            +HPN+V  +      DE  +    + EY+   S+ D +T          T +   Q AA
Sbjct: 73  NKHPNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVVTE---------TCMDEGQIAA 119

Query: 216 ------RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVST 268
                 + L +LH     Q+I RD KS NILL    + KL+DFG  A++ P        +
Sbjct: 120 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRS 173

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
            +VGT  + APE +       K DIWS G+   E++ G  P     P
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH---KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL 161
           IGEG FG +Y    +S +  H   K+ID     L++  ++  +    EV +L  ++HPN+
Sbjct: 8   IGEGSFGKIYLAKAKS-DSEHCVIKEID-----LTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 162 VKLIGYCAEDDERGIQRLLIYEY------MPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V       E+     +  ++ EY      M   + Q  +       L W  ++ +     
Sbjct: 62  VTFFASFQENG----RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----- 112

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGLAR-LGPSDGLSHVSTAVVGT 273
            GL ++H   D +I+ RD KS NI L +    AKL DFG+AR L  S  L++     VGT
Sbjct: 113 -GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY---TCVGT 165

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
             Y +PE  Q      K+DIWS G  LYEL T + P + N
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 74/215 (34%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNL 161
           IG G FG VY        D      +A+K++S  G Q +++W   + EV  L  + HPN 
Sbjct: 23  IGHGSFGAVYFA-----RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT 77

Query: 162 VKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           ++  G Y  E         L+ EY    S  D L    +  L       I   A +GLAY
Sbjct: 78  IEYKGCYLREHTA-----WLVMEYCLG-SASDILEVH-KKPLQEVEIAAICHGALQGLAY 130

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA--VVGTIGYAA 278
           LH     + I RD K+ NILL E    KL+DFG A L        VS A   VGT  + A
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL--------VSPANSFVGTPYWMA 179

Query: 279 PEYI---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           PE I     G+   K D+WS G+   EL   + PL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 21/224 (9%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE--WVT 148
           EL   +    R   +G G FG + RG ++    S +++ +A+  L R G    +   ++ 
Sbjct: 1   ELDNKSIKIERI--LGTGRFGELCRGCLKLP--SKRELPVAIHTL-RAGCSDKQRRGFLA 55

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E   LG  +H N+V+L G       RG   +++ EYM N    D    + +  L     +
Sbjct: 56  EALTLGQFDHSNIVRLEGVIT----RGNTMMIVTEYMSN-GALDSFLRKHEGQLVAGQLM 110

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +    A G+ YL E M +  + +   +  +L++     K+S F   R    D    + T
Sbjct: 111 GMLPGLASGMKYLSE-MGY--VHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYT 164

Query: 269 AVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            + G   + +AAPE IQ    +  SD+WSFG+ ++E+++ G RP
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 56/223 (25%), Positives = 110/223 (49%), Gaps = 18/223 (8%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVN 151
           + A +  + S  +G+G FG VY G+ +       +  +A+K ++    ++   E++ E +
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--------RFQATLP 203
           V+      ++V+L+G  ++    G   L+I E M    ++ +L S          QA   
Sbjct: 62  VMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDG 262
               +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R +  +D 
Sbjct: 118 LKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
                  ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 175 YRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 35/232 (15%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE----W 146
           +L+   ++F    +IG G FG V   ++R    S K++  A+K LS+  +    +    W
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQ--LVRHK--SSKQV-YAMKLLSKFEMIKRSDSAFFW 91

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
             E +++       +V+L  + A  D++ +   ++ EYMP   + + L S +     W  
Sbjct: 92  -EERDIMAHANSEWIVQL--HYAFQDDKYL--YMVMEYMPGGDLVN-LMSNYDIPEKW-A 144

Query: 207 RLKIAQ-----DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
           R   A+     DA   + ++H         RD K  N+LLD+  + KL+DFG      ++
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195

Query: 262 GLSHVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRP 309
           G+    TA VGT  Y +PE +++    G    + D WS GVFLYE++ G  P
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWV-TEVNVLGVV-EH 158
           ++G+G FG V    ++ T++ +     AVK L ++ +       E   TE  VL +  +H
Sbjct: 2   VLGKGSFGKVLLAELKGTDELY-----AVKVL-KKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           P L +L   C +  +R      + EY+    +  H+                A +   GL
Sbjct: 56  PFLTQLHS-CFQTKDR---LFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGL 109

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            +LHE     II+RD K  N+LLD + + K++DFG+ + G   G++  ++   GT  Y A
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIA 164

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           PE +         D W+ GV LYE++ G+ P +
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 12/225 (5%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH 158
           F    ++G+GGFG V    +R+T   +    +  K++ +R  +G    + E  +L  V  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNS 59

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
             +V L  Y  E  +      L+   M    ++ H+ +           +  A +   GL
Sbjct: 60  RFVVSL-AYAYETKD---ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
             LH     +I++RD K  NILLD+  + ++SD GLA   P           VGT+GY A
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR---GRVGTVGYMA 169

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
           PE ++  R T+  D W  G  +YE+I G+ P  + + K +++ +E
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 75/245 (30%), Positives = 111/245 (45%), Gaps = 36/245 (14%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYR------GVIRSTEDSHKKIDIAVKQLSRRGLQGHK 144
           ELK    +F R   +G G  G V +      G+I + +  H +I  A++           
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN---------- 48

Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKE--AKRIPE 102

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    RGLAYL E    QI+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 103 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 156

Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L EL  GR P+    P  + K LE 
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI----PPPDAKELEA 212

Query: 325 V--RP 327
           +  RP
Sbjct: 213 IFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV-----NVLGVVEHP 159
           I +G FG VY    RST D       A+K L +  +    + VT V      ++   E P
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY-----FAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESP 57

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            + KL  Y +   +  +   L+ EY+        +  +    LP +   +   +   G+ 
Sbjct: 58  YVAKL--YYSFQSKDYL--YLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVE 111

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
            LH      II RD K  N+L+D+  + KL+DFGL+R G        +   VGT  Y AP
Sbjct: 112 DLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAP 162

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK 316
           E I        SD WS G  ++E + G  P     P 
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 18/222 (8%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVV 156
           F+   M+G+G FG V    ++S + S +K+  AVK L          +E++ E   +   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKV--AVKMLKADIFSSSDIEEFLREAACMKEF 58

Query: 157 EHPNLVKLIGYCAEDDERGIQRL----LIYEYMPNRSVQDHL-TSRFQA---TLPWNTRL 208
           +HPN++KLIG       R   RL    +I  +M +  +   L  SR      TLP  T +
Sbjct: 59  DHPNVIKLIGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           +   D A G+ YL        I RD  + N +L+E     ++DFGL++   S        
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           A    + + A E +     T  SD+W+FGV ++E++T G+ P
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 11/209 (5%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVV- 156
           F ++L  G G FG V          S   + +AVK L        +E  ++E+ ++  + 
Sbjct: 39  FGKTL--GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            H N+V L+G C      G   L+I EY     + + L  + ++ L     L  +   A+
Sbjct: 97  NHENIVNLLGACT----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           G+A+L        I RD  + N+LL      K+ DFGLAR   +D    V       + +
Sbjct: 153 GMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            APE I     T++SD+WS+G+ L+E+ +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 47/224 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN 160
           +GEG +  VY+   R  E       KKI +  ++ ++ G+  +   + E+ +L  ++HPN
Sbjct: 8   LGEGTYAVVYKA--RDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHPN 63

Query: 161 LVKLIG-YCAEDDERGIQRLLIYEYMP--------NRSV---QDHLTSRFQATLPWNTRL 208
           ++ L+  +  + +   I   L++E+M         ++S+      + S    TL      
Sbjct: 64  IIGLLDVFGHKSN---IN--LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL------ 112

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
                  RGL YLH      I+ RD K +N+L+      KL+DFGLAR   S     ++ 
Sbjct: 113 -------RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTH 161

Query: 269 AVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            VV T  Y APE +  G   Y    D+WS G    EL+  R P 
Sbjct: 162 QVV-TRWYRAPELL-FGARHYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 28/221 (12%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVL 153
           K F+    IG G FG VY        D      +A+K++S  G Q +++W   + EV  L
Sbjct: 25  KLFTDLREIGHGSFGAVY-----FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79

Query: 154 GVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
             ++HPN ++  G Y  E         L+ EY    S  D L    +  L       I  
Sbjct: 80  QRIKHPNSIEYKGCYLREHTA-----WLVMEYCLG-SASD-LLEVHKKPLQEVEIAAITH 132

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
            A +GLAYLH      +I RD K+ NILL E    KL+DFG      S  ++  + + VG
Sbjct: 133 GALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFG------SASIASPANSFVG 183

Query: 273 TIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           T  + APE I     G+   K D+WS G+   EL   + PL
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 78/292 (26%), Positives = 115/292 (39%), Gaps = 43/292 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           IG G FG V  G          K  + VK+L +         ++ EV     + HPN+++
Sbjct: 3   IGNGWFGKVLLGEAHR---GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 164 LIGYCAEDDERGIQRLLIYEYMPN-------RSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            +G C E     I  LL+ E+ P        RS +  +    Q     +   ++A + A 
Sbjct: 60  CLGQCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVAS 111

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +LH+  DF  I  D    N  L    + K+ D+GLA     +            + +
Sbjct: 112 GLLWLHQ-ADF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 277 AAPEY-------IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPH 328
            APE        +     T KS+IWS GV ++EL T   +P        EQ L + VR  
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL--SDEQVLKQVVREQ 226

Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                K      P+L+ KYS     +   V   C     + RP   EV E+L
Sbjct: 227 DIKLPK------PQLDLKYS----DRWYEVMQFCWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 69/248 (27%), Positives = 105/248 (42%), Gaps = 30/248 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPNL 161
           +G G FG V     + T + +     A+K L +R +   K+      E ++L  + HP +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYY-----AIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           V +   C+  DE  +  LL  E++    +  HL  R     P +       +      YL
Sbjct: 81  VNM--MCSFQDENRVYFLL--EFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II+RD K  N+LLD + + K++DFG A+  P    +     + GT  Y APE 
Sbjct: 135 HS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEV 186

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQKLLE-------WVRPHLTDAK 333
           IQ+       D W+ GV LYE I G  P   + P +  +K+L        W      D  
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246

Query: 334 KFTMILDP 341
           K  +  D 
Sbjct: 247 KGLLQTDH 254

Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVE 157
           F++   IG+G FG V++G+     D+  +  +A+K +     +   E +  E+ VL   +
Sbjct: 6   FTKLERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
            P + K  G       +G +  +I EY+   S  D L +         T LK   +  +G
Sbjct: 61  SPYVTKYYGSYL----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKG 113

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L YLH     + I RD K++N+LL EQ + KL+DFG+A  G            VGT  + 
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           APE IQ      K+DIWS G+   EL  G  P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 16/220 (7%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH 158
           F    ++G+GGFG V    +R+T   +     A K+L ++ ++  K     +N   ++E 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKRILEK 56

Query: 159 PN--LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            N   V  + Y  E  +      L+   M    ++ H+ +           +  A +   
Sbjct: 57  VNSRFVVSLAYAYETKD---ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC 113

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL  L      +I++RD K  NILLD++ + ++SD GLA   P           VGT+GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGY 167

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK 316
            APE I   + T+  D W  G  +YE+I G+ P  + + +
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 67/247 (27%), Positives = 95/247 (38%), Gaps = 66/247 (26%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS-----RRGLQGHKEWVTEVNVLGVVEHP 159
           IG G FG V+  ++R   D       A+K L      +R    H     E ++L   + P
Sbjct: 9   IGRGAFGEVW--LVR---DKDTGQVYAMKVLRKSDMIKRNQIAHVR--AERDILADADSP 61

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMP---------NRSVQDHLTSRFQATLPWNTRLKI 210
            +VKL  Y +  DE  +   L+ EYMP          + V    T+RF         L +
Sbjct: 62  WIVKL--YYSFQDEEHL--YLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-----ELVL 112

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA--------------- 255
           A D+   L ++H         RD K  NIL+D   + KL+DFGL                
Sbjct: 113 ALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 256 ------------RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
                       R          + + VGT  Y APE ++      + D WS GV LYE+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 224 LYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 29/230 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVV-EHP 159
           M+G+G FG V+   ++ T         A+K L +  +    +    + E  VL +  EHP
Sbjct: 2   MLGKGSFGKVFLAELKGTNQF-----FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 56

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            L  L  YC    +  +    + EY+    +  H+ S  +  LP  T    A +   GL 
Sbjct: 57  FLTHL--YCTFQTKENL--FFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQ 110

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDGLSHVSTAVVGTIGY 276
           +LH      I++RD K  NILLD   + K++DFG+ +   LG +      +    GT  Y
Sbjct: 111 FLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGTPDY 162

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            APE +   +     D WSFGV LYE++ G+ P        E++L + +R
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 9e-16
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 20/257 (7%)

Query: 85  RVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK 144
           ++ T   +    K ++R   IG+G  G V+     +  D     ++A+KQ++ +     +
Sbjct: 7   KLRTIVSIGDPKKKYTRYEKIGQGASGTVF-----TAIDVATGQEVAIKQINLQKQPKKE 61

Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
             + E+ V+  +++PN+V  +      DE      ++ EY+   S+ D +T   +  +  
Sbjct: 62  LIINEILVMKELKNPNIVNFLDSFLVGDEL----FVVMEYLAGGSLTDVVT---ETCMDE 114

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGL 263
                + ++  + L +LH     Q+I RD KS N+LL    + KL+DFG  A++ P    
Sbjct: 115 AQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLL 322
           S  ST +VGT  + APE +       K DIWS G+   E++ G  P L+ N  ++   + 
Sbjct: 170 SKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 323 EWVRPHLTDAKKFTMIL 339
               P L + +K + I 
Sbjct: 229 TNGTPELQNPEKLSPIF 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 105 IGEGGFGGVYRGVIRSTE--DSHKKIDI-AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL 161
           +G+G FG VY+   + T    + K I I + ++L         +++ E+++L   +HPN+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE--------DFMVEIDILSECKHPNI 64

Query: 162 VKLI-GYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           V L   Y  E+       L I  E+    ++ D +    +  L       + +     L 
Sbjct: 65  VGLYEAYFYENK------LWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALN 117

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +LH     ++I RD K+ NILL    + KL+DFG++    S      +   +GT  + AP
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAP 172

Query: 280 EYI--QTGRLT---YKSDIWSFGVFLYELITGRRP 309
           E +  +T +     YK+DIWS G+ L EL     P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 29/217 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT--------EVNVLGVV 156
           IG G +G VY+      ++     + A+K+      +G KE  T        E+ +L  +
Sbjct: 8   IGRGTYGRVYKAK---RKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLREL 59

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           +H N+V L+    E  ++ +  L  Y E+   + ++ H  ++ + ++P +    +     
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQIL 118

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLARL--GPSDGLSHVSTA 269
            G+ YLH      ++ RD K +NIL+     E+   K+ D GLARL   P   L+ +   
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 270 VVGTIGYAAPEYIQTGRLTYKS-DIWSFGVFLYELIT 305
           VV TI Y APE +   R   K+ DIW+ G    EL+T
Sbjct: 176 VV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-----WVTEVNVL---GVV 156
           IGEG +G V++   R  ++  + +      L R  +Q  +E      + EV VL      
Sbjct: 9   IGEGAYGKVFKA--RDLKNGGRFV-----ALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 157 EHPNLVKLIGYCA-EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           EHPN+V+L   C     +R  +  L++E++ ++ +  +L    +  +P  T   +     
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL +LH     +++ RD K  NIL+      KL+DFGLAR+          T+VV T+ 
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
           Y APE +         D+WS G    E+   R+PL R     +Q
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 19/216 (8%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKI---DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN 160
           ++GEG FG   R ++    +S +K    +I + + S       KE V    +L  ++HPN
Sbjct: 7   VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV----LLAKMKHPN 59

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           +V       E  E      ++ EY     +   +  +     P +T L+       G+ +
Sbjct: 60  IVAF----KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           +HE    +++ RD KS NI L +    KL DFG ARL  S G ++  T  VGT  Y  PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACT-YVGTPYYVPPE 170

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK 316
             +      KSDIWS G  LYEL T + P   N  K
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT--EVNVLGVVEHPNL 161
           ++G+G FG V+  ++R           A+K L +  L+      T  E ++L  V HP +
Sbjct: 3   VLGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           VKL  + A   E  +   LI +++    +   L+     T   + +  +A+  A  L +L
Sbjct: 61  VKL--HYAFQTEGKL--YLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLAE-LALALDHL 114

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA--VVGTIGYAAP 279
           H      II+RD K  NILLDE+ + KL+DFGL++    + + H   A    GT+ Y AP
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAP 167

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPL---DRN 313
           E +     T  +D WSFGV ++E++TG  P    DR 
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 13/215 (6%)

Query: 98  NFSRSLMIGEGGFGGVYRG--VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           NF     IG G F  VYR   ++     + KK+ I          +   + + E+++L  
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI----FDLMDAKARADCIKEIDLLKQ 58

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HPN++K      ED+E  I   L      +R ++ H   + +  +P  T  K      
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQ-KRLIPEKTVWKYFVQLC 116

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
             L ++H     +++ RD K +N+ +      KL D GL R   S   +  + ++VGT  
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPY 171

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           Y +PE I      +KSDIWS G  LYE+   + P 
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 75/302 (24%), Positives = 135/302 (44%), Gaps = 38/302 (12%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV 156
           K ++R   IG+G  G VY  +  +T       ++A++Q++ +     +  + E+ V+   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMREN 74

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           ++PN+V  +      DE  +    + EY+   S+ D +T   +  +       + ++  +
Sbjct: 75  KNPNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQ 127

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIG 275
            L +LH     Q+I RD KS NILL    + KL+DFG  A++ P        + +VGT  
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPY 181

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWVRPHLTDAKK 334
           + APE +       K DIWS G+   E+I G  P L+ N  ++   +     P L + +K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQT 394
            + I    L                N+CL    + R    E+++  ++ +  A+  +  T
Sbjct: 242 LSAIFRDFL----------------NRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLT 283

Query: 395 PL 396
           PL
Sbjct: 284 PL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 74/223 (33%), Positives = 102/223 (45%), Gaps = 32/223 (14%)

Query: 97  KNFSRSLMIGEGGFGGVYRGV-IRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNV 152
           K FS    IG G FG VY    +R++E       +A+K++S  G Q +++W   + EV  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 153 LGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L  + HPN ++  G Y  E         L+ EY    S  D L    +  L       + 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTA-----WLVMEYCLG-SASD-LLEVHKKPLQEVEIAAVT 121

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAV 270
             A +GLAYLH      +I RD K+ NILL E    KL DFG A +  P++         
Sbjct: 122 HGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XF 171

Query: 271 VGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           VGT  + APE I     G+   K D+WS G+   EL   + PL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 42/221 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IGEG +G VY+G  + T        +A+K++    L+  +E V      E+++L  ++HP
Sbjct: 8   IGEGTYGVVYKGRNKKTGQI-----VAMKKIR---LESEEEGVPSTAIREISLLKELQHP 59

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           N+V L     ++      RL LI+E++           ++  +LP    +    DA    
Sbjct: 60  NIVCLQDVLMQES-----RLYLIFEFL------SMDLKKYLDSLPKGQYM----DAELVK 104

Query: 219 AYLH---EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-HVSTAV 270
           +YL+   +G+ F    +++ RD K  N+L+D +   KL+DFGLAR   + G+   V T  
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVYTHE 161

Query: 271 VGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPL 310
           V T+ Y APE +    R +   DIWS G    E+ T ++PL
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKI--DIAVKQLSRRGLQGHKEWVTEVNVLGVV 156
           + +   IGEG FG     +++S ED  + +  +I + ++S +  +   E   EV VL  +
Sbjct: 2   YVKVKKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNM 56

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HPN+V+   Y    +E G    ++ +Y     +   + ++     P +  L        
Sbjct: 57  KHPNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L ++H   D +I+ RD KS NI L +    KL DFG+AR+  S     ++   +GT  Y
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTCIGTPYY 167

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +PE  +      KSDIW+ G  LYE+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 53/226 (23%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IGEG +G VY+   + T +      +A+K++    L+   E V      E+++L  + HP
Sbjct: 7   IGEGTYGVVYKARDKLTGE-----IVALKKIR---LETEDEGVPSTAIREISLLKELNHP 58

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA--- 215
           N+V+L+     +      +L L++E++      D    ++  + P         D     
Sbjct: 59  NIVRLLDVVHSE-----NKLYLVFEFL------DLDLKKYMDSSP-----LTGLDPPLIK 102

Query: 216 -------RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSDGLSHV 266
                  +G+AY H     +++ RD K  N+L+D +   KL+DFGLAR  G P    +H 
Sbjct: 103 SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH- 158

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
              VV T+ Y APE I  G   Y +  DIWS G    E++  RRPL
Sbjct: 159 --EVV-TLWYRAPE-ILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 19/220 (8%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV 156
           K ++R   IG+G  G VY  +  +T       ++A+KQ++ +     +  + E+ V+   
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQ-----EVAIKQMNLQQQPKKELIINEILVMREN 73

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           ++PN+V  +      DE  +    + EY+   S+ D +T   +  +       + ++  +
Sbjct: 74  KNPNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQ 126

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIG 275
            L +LH     Q+I RD KS NILL    + KL+DFG  A++ P    S  ST +VGT  
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST-MVGTPY 180

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           + APE +       K DIWS G+   E++ G  P     P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 44/228 (19%)

Query: 99  FSRSLMIGEGGFGGVYRGV-IRSTEDSHKKI------DIAVKQLSRRGLQGHKEWVTEVN 151
           + R  +IG G +G VYRG  + +      KI      D  V  + R           EV 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-----------EVA 51

Query: 152 VLGVVEH---PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD-----HLTSRFQATLP 203
           +L  +     PN+ K  G   +     I    I EY    SV+       +  ++ +   
Sbjct: 52  LLSQLRQSQPPNITKYYGSYLKGPRLWI----IMEYAEGGSVRTLMKAGPIAEKYISV-- 105

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
                 I ++    L Y+H+     +I RD K++NIL+    N KL DFG+A L   +  
Sbjct: 106 ------IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-- 154

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPL 310
           S   +  VGT  + APE I  G+    K+DIWS G+ +YE+ TG  P 
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 39/226 (17%)

Query: 105 IGEGGFGGVYR----GVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EH 158
           +GEG FG V R    G+ +S  D  + + +AVK L      +   + ++E+ ++ ++ +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD--QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------FQAT------LPW 204
            N++ L+G C ++        +I EY    ++++ L +R        F  T      L +
Sbjct: 78  KNIINLLGVCTQEGPL----YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              +  A   ARG+ YL      + I RD  + N+L+ E    K++DFGLAR     G+ 
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVH 185

Query: 265 HVSTAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +      + G     + APE +     T++SD+WSFG+ ++E+ T
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVV-EHP 159
           ++G+G FG V    ++ +   +     AVK L +  +    +    +TE  +L +   HP
Sbjct: 2   VLGKGSFGKVMLARLKESGRLY-----AVKVLKKDVILQDDDVECTMTEKRILSLARNHP 56

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKI-AQDAAR 216
            L +L   C +  +R      + E++    +  H+  + RF        R +  A +   
Sbjct: 57  FLTQLY-CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEITS 107

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L +LH   D  II+RD K  N+LLD + + KL+DFG+ + G  +G +  ++   GT  Y
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDY 162

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            APE +Q        D W+ GV LYE++ G  P +    ++E  L E
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 28/252 (11%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTE 149
           E+  +T  F   L  GE  FG VY+G +  T    +   +A+K L  +      +E+  E
Sbjct: 1   EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 150 VNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR------------ 197
             +   ++HPN+V L+G   ++        +I+ Y  +  + + L  R            
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLS----MIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114

Query: 198 --FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA 255
              ++TL     + I    A G+ +L       ++ +D  + N+L+ ++ N K+SD GL 
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNR 314
           R   +     +    +  I + +PE I  G+ +  SDIWS+GV L+E+ + G +P     
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY---C 228

Query: 315 PKSEQKLLEWVR 326
             S Q ++E +R
Sbjct: 229 GYSNQDVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 42/107 (39%), Positives = 56/107 (52%), Gaps = 6/107 (5%)

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  LH+   F +I+RD K  NILLD Q +  L DFGL +L   D     +    GT  Y 
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYL 160

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLE 323
           APE +     T   D W+ GV LYE++TG  P  D N  +  +K+L+
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 8/143 (5%)

Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           LI +Y+    +  HL  R   T     R+ IA+     L +LH+     II+RD K  NI
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES-EVRVYIAE-IVLALDHLHQ---LGIIYRDIKLENI 136

Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
           LLD + +  L+DFGL++   ++     + +  GTI Y APE I+ G   +    D WS G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195

Query: 298 VFLYELITGRRPLDRNRPKSEQK 320
           V  +EL+TG  P   +  ++ Q 
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 35/260 (13%)

Query: 63  DFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTE 122
           DF +   ++N    L++ +  +R     +L+   +++    +IG G FG V   ++R   
Sbjct: 11  DFPALRKNKNIDNFLNRYEKIVR--KIRKLQMKAEDYDVVKVIGRGAFGEVQ--LVR--H 64

Query: 123 DSHKKIDIAVKQLSRRGLQGHKE----WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR 178
            S +K+  A+K LS+  +    +    W  E +++     P +V+L  +CA  D++ +  
Sbjct: 65  KSSQKV-YAMKLLSKFEMIKRSDSAFFW-EERDIMAFANSPWVVQL--FCAFQDDKYL-- 118

Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPW----NTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
            ++ EYMP   + + L S +     W       + +A DA   +  +H         RD 
Sbjct: 119 YMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH---------RDV 168

Query: 235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT----GRLTYK 290
           K  N+LLD+  + KL+DFG        G+    TA VGT  Y +PE +++    G    +
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRE 227

Query: 291 SDIWSFGVFLYELITGRRPL 310
            D WS GVFL+E++ G  P 
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 30/222 (13%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW--VT---EVNV 152
            + +   I EG +G VYR   + T     +I +A+K+L    ++  KE   +T   E+N+
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTG----EI-VALKKLK---MEKEKEGFPITSLREINI 57

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLPWNTRLK- 209
           L  ++HPN+V +       +   I   ++ EY+ +  +S+ + +   F  +      +K 
Sbjct: 58  LLKLQHPNIVTVKEVVVGSNLDKI--YMVMEYVEHDLKSLMETMKQPFLQS-----EVKC 110

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           +      G+A+LH   D  I+ RD K+SN+LL+ +   K+ DFGLAR   S  L   +  
Sbjct: 111 LMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQL 166

Query: 270 VVGTIGYAAPE-YIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           VV T+ Y APE  +     +   D+WS G    EL+T ++PL
Sbjct: 167 VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 145 EWV-TEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + E++    +  H+    Q  L
Sbjct: 40  DWVQTEKHVFETASNHPFLVGLHS-CFQTESR---LFFVIEFVSGGDLMFHMQR--QRKL 93

Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
           P       + + +  L +LHE     II+RD K  N+LLD + + KL+D+G+ + G   G
Sbjct: 94  PEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
               ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 44/221 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-----VTEVNVL-GVVEH 158
           +G+G FG VY    + T     ++ +A+K++ ++       W     + EV  L  + EH
Sbjct: 7   LGDGTFGSVYLARNKET----GEL-VAIKKMKKK----FYSWEECMNLREVKSLRKLNEH 57

Query: 159 PNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
           PN+VKL     E+DE     L  ++EYM   ++   +  R       +    I     +G
Sbjct: 58  PNIVKLKEVFRENDE-----LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS-----TAVVG 272
           LA++H+   F    RD K  N+L+      K++DFGLAR         +      T  V 
Sbjct: 112 LAHIHKHGFFH---RDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVS 160

Query: 273 TIGYAAPEYIQTGRLTYKS---DIWSFGVFLYELITGRRPL 310
           T  Y APE +   R T  S   DIW+ G  + EL T  RPL
Sbjct: 161 TRWYRAPEILL--RSTSYSSPVDIWALGCIMAELYTL-RPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 31/222 (13%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNV 152
           NF +   IGEG +G VY+   + T +      +A+K++    L    E V      E+++
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEV-----VALKKIR---LDTETEGVPSTAIREISL 52

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +   + +P         
Sbjct: 53  LKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSDGLSHVSTAV 270
              +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P    +H    V
Sbjct: 108 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EV 161

Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           V T+ Y APE I  G   Y +  DIWS G    E++T RR L
Sbjct: 162 V-TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 71/241 (29%), Positives = 111/241 (46%), Gaps = 28/241 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVL-GVVEHP 159
           +IG+G FG V     ++ E  +     AVK L ++ +   KE    ++E NVL   V+HP
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFY-----AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            LV L  +  +  ++      + +Y+    +  HL  R +  L    R   A + A  L 
Sbjct: 57  FLVGL-HFSFQTADK---LYFVLDYINGGELFYHL-QRERCFLEPRARF-YAAEIASALG 110

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST--AVVGTIGYA 277
           YLH      I++RD K  NILLD Q +  L+DFGL +    + + H  T     GT  Y 
Sbjct: 111 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYL 163

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLE---WVRPHLTDAK 333
           APE +         D W  G  LYE++ G  P   RN  +    +L     ++P++T++ 
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 223

Query: 334 K 334
           +
Sbjct: 224 R 224

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 49/229 (21%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-----VTEVNVLGVVEHP 159
           IGEG +G VY+   + T +        +  L +  L   KE      + E+ +L  + H 
Sbjct: 15  IGEGTYGQVYKARDKDTGE--------LVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 160 NLVKLIGYCAED----DERGIQR--LLIYEYMPNRSV-----------QDHLTSRFQATL 202
           N+V L     +     D +  +    L++EYM +  +           +DH+ S  +  L
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
                         GL Y H       + RD K SNILL+ +   KL+DFGLARL  S+ 
Sbjct: 127 -------------EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 263 LSHVSTAVVGTIGYAAPE-YIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            S   T  V T+ Y  PE  +   R     D+WS G  L EL T ++P+
Sbjct: 171 -SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V +G+ +  + S K + + + +          E + E NV+  +++P +V++
Sbjct: 3   LGSGNFGTVKKGMYK-MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 165 IGYCAEDDERGIQRLL----IYEYM-PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           IG C  +    +  L     + +++  N+ V +                ++    + G+ 
Sbjct: 62  IGICEAESWMLVMELAELGPLNKFLQKNKHVTEK------------NITELVHQVSMGMK 109

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAA 278
           YL E      + RD  + N+LL  Q  AK+SDFGL++ LG  +      T     + + A
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           PE +   + + KSD+WSFGV ++E  + G++P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 67/288 (23%), Positives = 119/288 (41%), Gaps = 27/288 (9%)

Query: 98  NFSRSLMIGEGGFGGVYRGV--IRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           NF     IG G F  VYR    +     + KK+ I          +  ++ V E+++L  
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI----FEMMDAKARQDCVKEIDLLKQ 58

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HPN++K +    ED+E  I  +L      + S       + +  +P  T  K      
Sbjct: 59  LNHPNVIKYLDSFIEDNELNI--VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
             + ++H     +++ RD K +N+ +      KL D GL R   S   +  + ++VGT  
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPY 171

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           Y +PE I      +KSDIWS G  LYE+   + P   ++               +  +K 
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----------FSLCQKI 220

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                P L  ++    ++KL  + + C+      RP +  V ++  ++
Sbjct: 221 EQCDYPPLPTEH---YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 145 EWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + EY+    +  H+    Q  L
Sbjct: 40  DWVQTEKHVFEQASNHPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQR--QRKL 93

Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
           P       + + +  L YLHE     II+RD K  N+LLD + + KL+D+G+ + G   G
Sbjct: 94  PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
               ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 15/234 (6%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+GGFG V    +R+T   +    +  K+L +R  +G++  + E  +L  V    +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLH 222
               A   +      L+   M    ++ H+          P             GL +LH
Sbjct: 59  ----AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           +    +II+RD K  N+LLD   N ++SD GLA +   DG S  +    GT G+ APE +
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK-TKGYAGTPGFMAPELL 169

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
           Q     +  D ++ GV LYE+I  R P      K E K  E  +  L D+  + 
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILNDSVTYP 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL--SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           IGEG +G V++   R T        +A+K+   S       K  + E+ +L  ++HPNLV
Sbjct: 9   IGEGSYGVVFKCRNRETGQI-----VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            LI    E   R  +  L++EY  + +V + L  +    +P +   KI     + + + H
Sbjct: 64  NLI----EVFRRKRKLHLVFEYC-DHTVLNEL-EKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGYAAPE 280
           +      I RD K  NIL+ +Q   KL DFG AR+  GP D      T  V T  Y APE
Sbjct: 118 K---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPE 170

Query: 281 YIQTGRLTYKS--DIWSFGVFLYELITG 306
            +  G   Y    D+W+ G    EL+TG
Sbjct: 171 LL-VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 73/219 (33%), Positives = 112/219 (51%), Gaps = 38/219 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IGEG +G VY+   R T ++     IA+K++    L+   E V      E+++L  ++H 
Sbjct: 10  IGEGTYGVVYKARDRVTNET-----IALKKIR---LEQEDEGVPSTAIREISLLKEMQHG 61

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRL--KIAQDAAR 216
           N+V+L     +D     +RL L++EY+ +  ++ H+ S        N RL         R
Sbjct: 62  NIVRL-----QDVVHSEKRLYLVFEYL-DLDLKKHMDS--SPDFAKNPRLIKTYLYQILR 113

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLAR-LG-PSDGLSHVSTAVVGT 273
           G+AY H     +++ RD K  N+L+D + NA KL+DFGLAR  G P    +H     V T
Sbjct: 114 GIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH----EVVT 166

Query: 274 IGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           + Y APE I  G   Y +  DIWS G    E++  ++PL
Sbjct: 167 LWYRAPE-ILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 21/147 (14%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A VGT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 161

Query: 277 AAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            APE +Q G + Y S  D +S G  L++L+ G  P  +++ K + ++            +
Sbjct: 162 MAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DR 209

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANK 361
            T+ +  +L   +S +L   L  +  +
Sbjct: 210 MTLTMAVELPDSFSPELRSLLEGLLQR 236

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 32/234 (13%)

Query: 98  NFSRSLMIGEGGFGGVYR------GVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVN 151
           +F +   +G G  G V++      G+I + +  H +I  A++           + + E+ 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN----------QIIRELQ 55

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           VL     P +V   G    D E  I      E+M   S+   L       +P     K++
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPEQILGKVS 109

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
               +GL YL E    +I+ RD K SNIL++ +   KL DFG++       +  ++ + V
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV 325
           GT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE +
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 21/234 (8%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLG 154
           +F+  +++G+G FG V     + T++ +     A+K L +  +    +    + E  VL 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELY-----AIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
           + + P  +  +  C +  +R      + EY+    +  H+    +   P    +  A + 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDR---LYFVMEYVNGGDLMYHIQQVGKFKEP--QAVFYAAEI 110

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
           + GL +LH      II+RD K  N++LD + + K++DFG+ +    DG++  +    GT 
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTP 165

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            Y APE I         D W++GV LYE++ G+ P D    + E +L + +  H
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 11/115 (9%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +LH      II+RD K  N++LD   + K++DFG+ +     G +  ST   GT  Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST-FCGTPDY 162

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR---PH 328
            APE +Q  + T+  D WSFGV LYE++ G+ P   +    E +L E +R   PH
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRVDTPH 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 30/230 (13%)

Query: 99  FSRSLM-----IGEGGFGGVY--RGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEV 150
            SR+ +     +GEG FG V     +    +  +K + +AVK L      +   + V+E+
Sbjct: 9   LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM 68

Query: 151 NVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------FQA- 200
            ++ ++ +H N++ L+G C +D   G   +L+ EY    +++++L +R        F   
Sbjct: 69  EMMKMIGKHKNIINLLGACTQD---GPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 201 -----TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA 255
                 L +   +  A   ARG+ YL      + I RD  + N+L+ E    K++DFGLA
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           R   +      +T     + + APE +     T++SD+WSFGV L+E+ T
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 35/260 (13%)

Query: 63  DFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTE 122
           DF +   ++N    L++ +  +      +L+   +++    +IG G FG V     +ST 
Sbjct: 11  DFPALRKNKNIDNFLNRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 68

Query: 123 DSHKKIDIAVKQLSRRGLQGHKE----WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR 178
             +     A+K LS+  +    +    W  E +++     P +V+L  Y  +DD      
Sbjct: 69  KVY-----AMKLLSKFEMIKRSDSAFFW-EERDIMAFANSPWVVQLF-YAFQDDR---YL 118

Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPW----NTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
            ++ EYMP   + + L S +     W       + +A DA   + ++H         RD 
Sbjct: 119 YMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDV 168

Query: 235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT----GRLTYK 290
           K  N+LLD+  + KL+DFG       +G+    TA VGT  Y +PE +++    G    +
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRE 227

Query: 291 SDIWSFGVFLYELITGRRPL 310
            D WS GVFLYE++ G  P 
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 46/252 (18%)

Query: 103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           + IGEG       G++    + H    +AVK++  R  Q  +    EV ++    H N+V
Sbjct: 28  IKIGEGS-----TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA------R 216
            +       DE  +    + E++   ++ D +T         +TR+   Q A       R
Sbjct: 83  DMYNSYLVGDELWV----VMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLR 129

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV------ 270
            L+YLH      +I RD KS +ILL      KLSDFG          + VS  V      
Sbjct: 130 ALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSL 178

Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRP 327
           VGT  + APE I   RL Y +  DIWS G+ + E+I G  P     P ++ +++ + + P
Sbjct: 179 VGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236

Query: 328 HLTDAKKFTMIL 339
            + D+ K + +L
Sbjct: 237 RVKDSHKVSSVL 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKID---IAVKQLSRRGLQGHKEW---VTEVNVL-GVV 156
           +IG+G FG V          + +K+D    AVK L ++ +   KE    + E NVL   V
Sbjct: 2   VIGKGSFGKVLL--------AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP LV L  Y  +  E+      + +++    +  HL    + + P       A + A 
Sbjct: 54  KHPFLVGL-HYSFQTTEK---LYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIAS 107

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH      I++RD K  NILLD Q +  L+DFGL + G +   S  +T   GT  Y
Sbjct: 108 ALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEY 162

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            APE I+        D W  G  LYE++ G  P 
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 58/295 (19%)

Query: 107 EGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKL 164
           EG FG ++ G++   E   K+ ++ VK +      +Q     + E  +L  + H N++ +
Sbjct: 16  EGTFGRIFYGILID-EKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPI 73

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLT----SRFQATLPWNTR--LKIAQDAARGL 218
           +  C ED E      ++Y YM   +++  L              +T+  + +A   A G+
Sbjct: 74  LHVCIEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGT---- 273
           +YLH+     +I +D  + N ++DE+   K++D  L+R L P D   H     +G     
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHC----LGDNENR 181

Query: 274 -IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD 331
            + + A E +     +  SD+WSFGV L+EL+T G+ P     P       E        
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMA------ 229

Query: 332 AKKFTMILDPKLEGKYSIKLAQ------KLAAVANKCLARQAKGRPKMSEVVEVL 380
                 + D         +LAQ      +L AV   C A   + RP  S++V+ L
Sbjct: 230 ----AYLKDGY-------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 69/211 (32%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVL-GVVEHPN 160
           IG+G FG V   + +   D   K   AVK L ++ +   KE    + E NVL   V+HP 
Sbjct: 3   IGKGSFGKVL--LAKHKAD--GKF-YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           LV L  Y  +  ++      + +Y+    +  HL  R ++      R   A + A  L Y
Sbjct: 58  LVGL-HYSFQTADK---LYFVLDYVNGGELFFHL-QRERSFPEPRARF-YAAEIASALGY 111

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV--GTIGYAA 278
           LH      II+RD K  NILLD Q +  L+DFGL +    +G+ H  T     GT  Y A
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLA 164

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           PE ++        D W  G  LYE++ G  P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 72/264 (27%), Positives = 117/264 (44%), Gaps = 51/264 (19%)

Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           +E++ L   +H  +VK       DD    + LLI EY     +   +  R +  LP+   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDD----KLLLIMEYGSGGDLNKQIKQRLKEHLPF--- 166

Query: 208 LKIAQDAARGLAY------LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
               Q+   GL +      L E    +++ RD KS+NI L      KL DFG ++   SD
Sbjct: 167 ----QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSD 221

Query: 262 GLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK 320
            +S  V+++  GT  Y APE  +  R + K+D+WS GV LYEL+T  RP    +  S+++
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQRE 278

Query: 321 LLEWVRPHLTDAKKFTMILDPKLEGKYS---IKLAQKLAAVANKCLARQAKGRPK----- 372
           +++ V                 L GKY      ++  + A+ +  L++    RP      
Sbjct: 279 IMQQV-----------------LYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Query: 373 ----MSEVVEVLNKIVDAAETGTP 392
               +  V  +   IV  +ET +P
Sbjct: 322 HTEFLKYVANLFQDIVRHSETISP 345

Length = 478

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 11/135 (8%)

Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            L+ EY+    +  H+    Q  LP       A +    L +LHE     II+RD K  N
Sbjct: 72  FLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDN 126

Query: 239 ILLDEQWNAKLSDFGLAR--LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           +LLD   + KL+D+G+ +  LGP D     ++   GT  Y APE ++     +  D W+ 
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182

Query: 297 GVFLYELITGRRPLD 311
           GV ++E++ GR P D
Sbjct: 183 GVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +LH+     II+RD K  N+LLD+  + K++DFG+ +   +      ++   GT  Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDY 162

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            APE ++  +     D WSFGV LYE++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 69/291 (23%), Positives = 129/291 (44%), Gaps = 44/291 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVK 163
           +G+G FG VY G  R       +  +AVK ++    L+   E++ E +V+      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS----------RFQATLPWNTRLKIAQD 213
           L+G  +    +G   L++ E M +  ++ +L S          R   TL     +++A +
Sbjct: 74  LLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAE 127

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVG 272
            A G+AYL+     + + RD  + N ++   +  K+ DFG+ R +  +D        ++ 
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL- 183

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA 332
            + + APE ++ G  T  SD+WSFGV L+E+ +               L E     L++ 
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228

Query: 333 KKFTMILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           +    ++D    G Y        +++  +   C     K RP   E+V +L
Sbjct: 229 QVLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 32/284 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +GEG +  VY+G  + T++      +A+K++     +G     + EV++L  ++H N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-----VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L  +     E+ +   L++EY+ ++ ++ +L     +    N +L + Q   RGL Y H 
Sbjct: 69  L--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYCHR 122

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
               +++ RD K  N+L++E+   KL+DFGLAR   S      S  VV T+ Y  P+ I 
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPD-IL 176

Query: 284 TGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ-----KLL----EWVRPHLTDA 332
            G   Y +  D+W  G   YE+ TG RPL       EQ     ++L    E   P +   
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR--QAKGRPKMS 374
           ++F     PK         A +L +   + L++  Q +GR ++S
Sbjct: 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 36/214 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-----VTEVNVLGVVEHP 159
           +GEG +  VY+G  + T        +A+K++    L+ H+E      + E ++L  ++H 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-----VALKEIR---LE-HEEGAPFTAIREASLLKDLKHA 63

Query: 160 NLVKLIGYCAEDDERGIQRLL--IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
           N+V L       D    ++ L  ++EY+ +  ++ ++          N RL + Q   RG
Sbjct: 64  NIVTL------HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ-LLRG 115

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIG 275
           LAY H     +++ RD K  N+L+ E+   KL+DFGLAR    PS   S+    VV T+ 
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLW 168

Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y  P+ +  G   Y +  D+W  G   YE+ TGR
Sbjct: 169 YRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 41/286 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKID--IAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPN 160
           ++G G +G VY+G        H K     A+K +   G +  +E   E+N+L     H N
Sbjct: 13  LVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRN 64

Query: 161 LVKLIGYCAEDDERGI--QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           +    G   + +  G+  Q  L+ E+    SV D + +    TL       I ++  RGL
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYA 277
           ++LH+    ++I RD K  N+LL E    KL DFG+ A+L  + G  +     +GT  + 
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---TFIGTPYWM 178

Query: 278 APEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA 332
           APE I           +KSD+WS G+   E+  G  PL    P     L+    P     
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPA---- 233

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                   P+L+ K   K ++K  +    CL +    RP   ++++
Sbjct: 234 --------PRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 48/169 (28%), Positives = 84/169 (49%), Gaps = 18/169 (10%)

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL-IYEYMPNRSVQDHLTSRFQATLPWNTR 207
           E  +   + HPN+V L+    +  E     L  ++EY+P R++++ L +     LP    
Sbjct: 28  ETALCARLYHPNIVALL----DSGEAPPGLLFAVFEYVPGRTLREVLAA--DGALPAGET 81

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLS 264
            ++       LA  H   +  I+ RD K  NI++     + +AK+ DFG+  L P    +
Sbjct: 82  GRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 265 HVSTA-----VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR 308
            V+T      V+GT  Y APE ++   +T  SD++++G+   E +TG+R
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 35/224 (15%)

Query: 105 IGEGGFGGVY--RGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPN 160
           +GEG FG V     +    E  ++   +AVK L     +    + ++E+ ++ ++ +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR------------- 207
           ++ L+G C +D        +I EY    +++++L +R    + +                
Sbjct: 86  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 208 -LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +  A   ARG+ YL      + I RD  + N+L+ E    K++DFGLAR      + H+
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHI 193

Query: 267 STAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
                 T G     + APE +     T++SD+WSFGV L+E+ T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG VY+   + T         A K +  +  +  ++++ E+ +L    HP +VKL
Sbjct: 20  LGDGAFGKVYKAKNKET-----GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G    D +  I    + E+ P  +V D +       L       I +     L YLH  
Sbjct: 75  LGAFYWDGKLWI----MIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHS- 128

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST-----AVVGTIGYAAP 279
              +II RD K+ N+LL    + KL+DFG++         +V T     + +GT  + AP
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSA-------KNVKTLQRRDSFIGTPYWMAP 179

Query: 280 EYIQTGRLT-----YKSDIWSFGVFLYEL 303
           E +    +      YK+DIWS G+ L E+
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 45/219 (20%)

Query: 104 MIGEGGFGGVYR-------------GVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV 150
           ++GEG +G V +               + S +D        VK+++ R          E+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM------VKKIAMR----------EI 51

Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
            +L  + H NLV LI        R  +RL L++E++ + +V D L  ++   L  +   K
Sbjct: 52  RMLKQLRHENLVNLIEVF-----RRKKRLYLVFEFV-DHTVLDDL-EKYPNGLDESRVRK 104

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
                 RG+ + H      II RD K  NIL+ +    KL DFG AR   + G   V T 
Sbjct: 105 YLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTD 159

Query: 270 VVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
            V T  Y APE +  G   Y    DIW+ G  + E++TG
Sbjct: 160 YVATRWYRAPELL-VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 79/310 (25%), Positives = 121/310 (39%), Gaps = 59/310 (19%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRG------------VIRSTEDSHKKIDIAVKQLS 136
            S L+     F    ++G G +G VY+G            V+  TED  ++I + +  L 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 137 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI--QRLLIYEYMPNRSVQDHL 194
           +                    H N+    G   +    G   Q  L+ E+    SV D +
Sbjct: 68  KYS-----------------HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV 110

Query: 195 TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
            +     L  +    I ++  RGLA+LH     ++I RD K  N+LL E    KL DFG+
Sbjct: 111 KNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGV 167

Query: 255 -ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRR 308
            A+L  + G  +     +GT  + APE I           Y+SDIWS G+   E+  G  
Sbjct: 168 SAQLDRTVGRRN---TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           PL    P     L+    P             PKL+ K   K ++K       CL +   
Sbjct: 225 PLCDMHPMRALFLIPRNPP-------------PKLKSK---KWSKKFIDFIEGCLVKNYL 268

Query: 369 GRPKMSEVVE 378
            RP   ++++
Sbjct: 269 SRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 42/97 (43%), Positives = 53/97 (54%), Gaps = 6/97 (6%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTI 274
           RGL YLH      +I RD K SNIL++   + K+ DFGLAR + P +      T  V T 
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 275 GYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
            Y APE +  + R T   DIWS G    EL+T R+PL
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG VY+      ++    +  A K +  +  +  ++++ E+++L   +HPN+VKL
Sbjct: 13  LGDGAFGKVYKA-----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +     ++   I    + E+    +V D +    +  L       + +     L YLHE 
Sbjct: 68  LDAFYYENNLWI----LIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI-- 282
              +II RD K+ NIL     + KL+DFG++    +        + +GT  + APE +  
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 283 QTGR---LTYKSDIWSFGVFLYEL 303
           +T +     YK+D+WS G+ L E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 22/225 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPN 160
           ++G+G FG V    I   E +  K   A+K L +  +    E    +TE  VL    HP 
Sbjct: 2   LLGKGTFGKV----ILVREKASGKY-YAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           L  L  Y  +  +R      + EY+    +  HL SR +      TR   A+  +  L Y
Sbjct: 57  LTSL-KYSFQTKDR---LCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVS-ALDY 110

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           LH G   +I++RD K  N++LD+  + K++DFGL + G +D  +       GT  Y APE
Sbjct: 111 LHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTFCGTPEYLAPE 165

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV 325
            ++        D W  GV +YE++ GR P      +  +KL E +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 67/235 (28%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--------RRGLQGHKEWVTEVNVLGVV 156
           IGEG +G     ++ S       + +A+K++S        +R L+       E+ +L   
Sbjct: 13  IGEGAYG-----MVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-------EIKILRRF 60

Query: 157 EHPNLVKLIGYCAEDDERGIQR----------LLIYEYMPN------RSVQ---DHLTSR 197
           +H N++ +           I R           ++ E M        ++     DH+   
Sbjct: 61  KHENIIGI---------LDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF 111

Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
               L             RGL Y+H      ++ RD K SN+LL+   + K+ DFGLAR+
Sbjct: 112 LYQIL-------------RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Query: 258 G-PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPL 310
             P    +   T  V T  Y APE +   +   K+ DIWS G  L E+++  RPL
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 50/258 (19%)

Query: 103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           + IGEG  G V    ++S+        +AVK++  R  Q  +    EV ++   +H N+V
Sbjct: 26  IKIGEGSTGIVCIATVKSSGKL-----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA------R 216
           ++       DE  +    + E++   ++ D +T         +TR+   Q AA      +
Sbjct: 81  EMYNSYLVGDELWV----VMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLK 127

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV------ 270
            L+ LH      +I RD KS +ILL      KLSDFG          + VS  V      
Sbjct: 128 ALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKSL 176

Query: 271 VGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRP 327
           VGT  + APE I   RL Y  + DIWS G+ + E++ G  P     P    K++ + + P
Sbjct: 177 VGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234

Query: 328 HLTDAKKFTMILDPKLEG 345
            L +  K    + P L+G
Sbjct: 235 KLKNLHK----VSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +GEG +  V++G  + TE+      +A+K++     +G     + EV++L  ++H N+V 
Sbjct: 13  LGEGTYATVFKGRSKLTENL-----VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L  +     ER +   L++EY+ +  ++ +L +        N ++ + Q   RGL+Y H+
Sbjct: 68  L--HDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCHK 121

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
               +I+ RD K  N+L++E+   KL+DFGLAR   S      S  VV T+ Y  P+ + 
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPD-VL 175

Query: 284 TGRLTYKS--DIWSFGVFLYELITGR 307
            G   Y +  D+W  G  LYE+ TGR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 7/101 (6%)

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           +IA    +GL YL      +I+ RD K SN+L++ +   KL DFG++       ++ ++ 
Sbjct: 99  RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAK 151

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             VGT  Y APE I   +    SD+WS G+   EL  GR P
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 24/213 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVL-GVVEHP 159
           +IG+G FG V     +S    +     AVK L ++ +   KE    + E NVL   ++HP
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFY-----AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP 56

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            LV L  Y  +  E+      + +Y+    +  HL  R +  L    R   A + A  + 
Sbjct: 57  FLVGL-HYSFQTAEK---LYFVLDYVNGGELFFHL-QRERCFLEPRARF-YAAEVASAIG 110

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIGYA 277
           YLH      II+RD K  NILLD Q +  L+DFGL + G  P +     ++   GT  Y 
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEYL 163

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           APE ++        D W  G  LYE++ G  P 
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 40/118 (33%), Positives = 63/118 (53%), Gaps = 8/118 (6%)

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A + A GL +LH      II+RD K  N++LD + + K++DFG+ +    DG++  +   
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            GT  Y APE I         D W+FGV LYE++ G+ P +    + E +L + +  H
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.1 bits (170), Expect = 7e-13
 Identities = 60/166 (36%), Positives = 83/166 (50%), Gaps = 30/166 (18%)

Query: 157 EHPNLVKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK------ 209
           +HPN+VKL+    AE+D + I   L++EYM     +  L +  +A +     L+      
Sbjct: 65  DHPNIVKLLNVIKAEND-KDI--YLVFEYM-----ETDLHAVIRANI-----LEDVHKRY 111

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL---GPSDGLSHV 266
           I     + L Y+H G    +I RD K SNILL+     KL+DFGLAR       +  + V
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 267 STAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPL 310
            T  V T  Y APE I  G  R T   D+WS G  L E++ G +PL
Sbjct: 169 LTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 18/156 (11%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A VGT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 161

Query: 277 AAPEYIQTGRLTYKSDIW-SFGVFLYELITGRRPLDRNRPKSEQ---KLLEWVRPHLTDA 332
            APE +Q G     S  W S G  L++L+ G  P  +++ K +    ++   V   L D+
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
             F+  L   LEG     ++++L      CL R A+
Sbjct: 222 --FSPELKSLLEGLLQRDVSKRLG-----CLGRGAQ 250

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 18/241 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IGEG       G++    + H    +AVK +  R  Q  +    EV ++   +H N+V++
Sbjct: 29  IGEGS-----TGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                  +E  +    + E++   ++ D ++   Q  L       + +   + L YLH  
Sbjct: 84  YKSYLVGEELWV----LMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ 136

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
               +I RD KS +ILL      KLSDFG       D     S  +VGT  + APE I  
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISR 191

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTDAKKFTMILDPKL 343
                + DIWS G+ + E++ G  P   + P    K L +   P L +A K + +L   L
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251

Query: 344 E 344
           E
Sbjct: 252 E 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLV 162
           +G+G FG VY  V      + +++ + +K++    L  ++  +   E  +L  ++HP +V
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQA--TLPWNTRLKIAQDAARGLAY 220
           K      E D   I    I EY   R +   L        TL  N   +       G+ Y
Sbjct: 66  KFHASFLERDAFCI----ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGYAA 278
           +H+    +I+ RD K+ NI L      K+ DFG++RL  G  D    ++T   GT  Y +
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD----LATTFTGTPYYMS 173

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYEL 303
           PE ++      KSDIWS G  LYE+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 5/101 (4%)

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A + A GL +LH      II+RD K  N++LD + + K++DFG+ +     G +  +   
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            GT  Y APE I         D W+FGV LYE++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 27/215 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLV 162
           +G+G +G VY+ + R T      + +A+K++ R  L   K  + + E+++L     P +V
Sbjct: 9   LGKGNYGSVYKVLHRPT-----GVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQAT--LPWNTRLKIAQDAARGLAY 220
               Y A   E  +   +  EYM   S+ D L +   AT  +P +   +I     +GL +
Sbjct: 63  DF--YGAFFIEGAV--YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           L E  +  II RD K +N+L++     KL DFG++     + ++ ++   +G   Y APE
Sbjct: 118 LKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPE 171

Query: 281 YIQ----TGRLTY--KSDIWSFGVFLYELITGRRP 309
            I+        TY  +SD+WS G+ + E+  GR P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A +    L +LH      +I+RD K  NILLD + + KL+DFG+ + G  +G+   +T  
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTF 156

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            GT  Y APE +Q        D W+ GV +YE++ G+ P + +   +E  L E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)

Query: 105 IGEGGFGGVYRGVIRSTED--SHKKIDIA--VKQLSRRGLQGHKEWVTEVNVLGVVEHPN 160
           IG G +G V   +   +    + KKI  A  V  L++R L+       E+ +L   +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-------ELKILRHFKHDN 65

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPN------RSVQDHLTSRFQATLPWNTRLKIAQDA 214
           ++ +               ++ + M +       S Q       +  L            
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL---------YQL 116

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH--VSTAVVG 272
            RGL Y+H      +I RD K SN+L++E    ++ DFG+AR   S    H    T  V 
Sbjct: 117 LRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 273 TIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPL 310
           T  Y APE + +    T   D+WS G    E++ GRR L
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 25/219 (11%)

Query: 105 IGEGGFGGVY--RGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPN 160
           +GEG FG V     +    +   + + +AVK L     +    + V+E+ ++ ++ +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA------ 214
           ++ L+G C +D        +I EY    +++++L +R    + ++  +    D       
Sbjct: 83  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 215 --------ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                   ARG+ YL      + I RD  + N+L+ E    K++DFGLAR   +      
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +T     + + APE +     T++SD+WSFGV ++E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 40/260 (15%)

Query: 55  EFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVY 114
           + +  +      ES +  + A+ ++ ++ +    FS L+T T         G  GF    
Sbjct: 60  DIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFTP--------GAEGFA--- 108

Query: 115 RGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER 174
                +  D+     + +K   R G        TE ++L  + HP++++L G    +   
Sbjct: 109 ----FACIDNKTCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFT 158

Query: 175 GI----QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            +     +  +Y Y+  +             +     L I +   R + YLHE    +II
Sbjct: 159 CLILPRYKTDLYCYLAAKR-----------NIAICDILAIERSVLRAIQYLHEN---RII 204

Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK 290
            RD K+ NI ++   +  L DFG A   P D  ++      GTI   APE +        
Sbjct: 205 HRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPA 263

Query: 291 SDIWSFGVFLYELITGRRPL 310
            DIWS G+ L+E+ T    L
Sbjct: 264 VDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPN 160
           ++G+G FG V    I   E +  K   A+K L +  +    E    +TE  VL    HP 
Sbjct: 2   LLGKGTFGKV----ILVREKATGKY-YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           L  L  Y  +  +R      + EY     +  HL SR +       R   A+     L Y
Sbjct: 57  LTAL-KYSFQTHDR---LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAE-IVSALGY 110

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           LH      +++RD K  N++LD+  + K++DFGL + G SDG +       GT  Y APE
Sbjct: 111 LHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 165

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            ++        D W  GV +YE++ GR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 40/99 (40%), Positives = 47/99 (47%), Gaps = 21/99 (21%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SNI ++E    K+ DFGLAR           T  V T  
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRW 180

Query: 276 YAAPE-------YIQTGRLTYKSDIWSFGVFLYELITGR 307
           Y APE       Y QT       DIWS G  + EL+TG+
Sbjct: 181 YRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPSDGLSHVSTAVVGTI 274
           GL YLHE    +I++RD K  N+LLD +   K++DFGL +  +G  D  S       GT 
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS----TFCGTP 165

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            + APE +     T   D W  GV +YE++ G  P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 37/229 (16%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNV 152
           K+F    ++G G FG V     ++T D +     A+K + +  L   +E V+    E ++
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIY-----AMKVMKKSVL-LAQETVSFFEEERDI 54

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN------T 206
           L +   P + +L  Y  +D +      L+ EY P   +   L +R++     +       
Sbjct: 55  LSISNSPWIPQLQ-YAFQDKD---NLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA 109

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            L +A  +   + Y+H         RD K  N+L+D   + KL+DFG A    ++ +   
Sbjct: 110 ELVLAIHSVHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159

Query: 267 STAVVGTIGYAAPEYIQT----GRLTY--KSDIWSFGVFLYELITGRRP 309
           S   VGT  Y APE + T    G+ TY  + D WS GV  YE+I GR P
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 38/96 (39%), Positives = 51/96 (53%), Gaps = 10/96 (10%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      ++ RD K SNIL++E  + K+ DFGLAR    D      T  V T  
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR--IQD---PQMTGYVSTRY 170

Query: 276 YAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPL 310
           Y APE + T  +   + DIWS G    E++ G +PL
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 56/231 (24%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSH-----------KKIDIAVKQLSRRGL-QGHKEWVTEVN 151
           +IG G FG V    +++T   +           K+ + A  +  R  L  G + W+T ++
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLP------ 203
                          Y  +D+        +Y  M      D LT  S+F+  LP      
Sbjct: 68  ---------------YAFQDENN------LYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
           +   + +A D+   L Y+H         RD K  N+LLD+  + +L+DFG      +DG 
Sbjct: 107 YLAEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157

Query: 264 SHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRP 309
              + A VGT  Y +PE +Q      GR   + D WS GV +YE++ G  P
Sbjct: 158 VQSNVA-VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 40/94 (42%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL YLH      I+ RD K  N+L++     K+ DFGLAR+   D   H++  VV T  
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169

Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I  G   Y S  DIWS G    EL+  R
Sbjct: 170 YRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 73/224 (32%), Positives = 99/224 (44%), Gaps = 28/224 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNLVK 163
           IG+G +G VY+  + + +D       AVK L        +E   E N+L  +  HPN+VK
Sbjct: 30  IGKGTYGKVYK--VTNKKDGSLA---AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVK 83

Query: 164 LIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK------IAQDAAR 216
             G +   D   G Q  L+ E     SV    T   +  L    RL       I   A  
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSV----TELVKGLLICGQRLDEAMISYILYGALL 139

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +LH     +II RD K +NILL  +   KL DFG++    S  L   ++  VGT  +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194

Query: 277 AAPEYI---QTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRP 315
            APE I   Q    +Y  + D+WS G+   EL  G  PL    P
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 22/154 (14%)

Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +Y Y+  RS            LP +  L I +    GL YLH     +II RD K+ NI 
Sbjct: 143 LYTYLTKRS----------RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIF 189

Query: 241 LDEQWNAKLSDFGLARL---GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +++     + D G A+     P+         + GT+   APE +   +   K+DIWS G
Sbjct: 190 INDVDQVCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAG 243

Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD 331
           + L+E++     +  + P + ++ ++    HL  
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Length = 357

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 30/225 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNLVK 163
           IG+G +G V++  + + ++  K    AVK L        +E   E N+L  + +HPN+VK
Sbjct: 26  IGKGTYGKVFK--VLNKKNGSKA---AVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79

Query: 164 LIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK------IAQDAAR 216
             G Y  +D + G Q  L+ E     SV D +    +  L    R++      I  +A  
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALM 135

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIG 275
           GL +LH     + I RD K +NILL  +   KL DFG+ A+L  +          VGT  
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST---RLRRNTSVGTPF 189

Query: 276 YAAPEYI---QTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRP 315
           + APE I   Q    TY  + D+WS G+   EL  G  PL    P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +GEG +  V++G  + TE+      +A+K++     +G     + EV++L  ++H N+V 
Sbjct: 14  LGEGTYATVFKGRSKLTENL-----VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L      D        L++EY+ ++ ++ ++          N ++ + Q   RGLAY H 
Sbjct: 69  LHDIVHTDK----SLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAYCHR 122

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE-YI 282
               +++ RD K  N+L++E+   KL+DFGLAR   S      S  VV T+ Y  P+  +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLL 177

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPL 310
            +   + + D+W  G   +E+ +G RPL
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 109 GFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL---I 165
           G G    G++ S  DS     +AVK++     Q  K  + E+ ++  ++H N+VK+   +
Sbjct: 14  GCGS--NGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71

Query: 166 GYCAEDDERGIQRL-------LIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           G    D    +  L       ++ EYM     +V +      Q  L             R
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE------QGPLSEEHARLFMYQLLR 125

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSH---VSTAVVG 272
           GL Y+H      ++ RD K +N+ ++ E    K+ DFGLAR+      SH   +S  +V 
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH-YSHKGYLSEGLV- 180

Query: 273 TIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGR 307
           T  Y +P  +      T   D+W+ G    E++TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 59/183 (32%), Positives = 84/183 (45%), Gaps = 15/183 (8%)

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 43  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 97

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+  +  L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 98  RFYGAEIVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL---DRNRPKSEQKLLE 323
                GT  Y APE ++        D W  GV +YE++ GR P    D  R   E  L+E
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME 210

Query: 324 WVR 326
            +R
Sbjct: 211 EIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 24/242 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPN 160
           ++G+G FG V   +++           A+K L +  +    E    +TE  VL    HP 
Sbjct: 2   LLGKGTFGKVI--LVKEKATGRY---YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           L  L  Y  +  +R      + EY     +  HL SR +       R   A+  +  L Y
Sbjct: 57  LTAL-KYSFQTHDR---LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS-ALDY 110

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           LH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y APE
Sbjct: 111 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE 166

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD 340
            ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F   L 
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFPRTLS 220

Query: 341 PK 342
           P+
Sbjct: 221 PE 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 15/227 (6%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAV--KQLSRRGLQGHKEWVTEVNVLGV 155
           NF    ++G G +G V+     S  DS K   + V  K    +  +  +   TE  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI-AQDA 214
           +     +  + Y  + D +     LI +Y+    +  HL+ R +        ++I + + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTK---LHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEI 114

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
              L +LH+     II+RD K  NILLD   +  L+DFGL++    D +   + +  GTI
Sbjct: 115 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTI 170

Query: 275 GYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
            Y AP+ ++ G   +    D WS GV +YEL+TG  P   +  K+ Q
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 39/110 (35%), Positives = 51/110 (46%), Gaps = 5/110 (4%)

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPS 260
           LP    + I +     LAYLH      II RD K+ NI LDE  NA L DFG A +L   
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
              +       GT+   +PE +       K+DIWS G+ L+E+      L
Sbjct: 239 PD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 85/338 (25%), Positives = 138/338 (40%), Gaps = 54/338 (15%)

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW--- 146
           +++K    NF R+L  G G FG V    I +T  +     +A+K+  +  +   K+    
Sbjct: 25  NKMKYEDFNFIRTL--GTGSFGRV----ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
            +E  +L  + HP  V L G   ++        L+ E++        L  R     P + 
Sbjct: 79  FSERKILNYINHPFCVNLYGSFKDES----YLYLVLEFVIGGEFFTFL--RRNKRFPNDV 132

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
               A        YL       I++RD K  N+LLD+    K++DFG A++     +   
Sbjct: 133 GCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTR 184

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWV 325
           +  + GT  Y APE +        +D W+ G+F+YE++ G  P   N P    QK+LE +
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA------VAN-KCLARQAKGRPKMSEV-- 376
                       I  PK        L +KL +        N K  A+  K  P    +  
Sbjct: 245 ------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292

Query: 377 VEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLK 414
           V +L+K V+      P  P      K+ F++S  ER++
Sbjct: 293 VSLLHKNVE-----VPYKP----KYKNVFDSSNFERVQ 321

Length = 340

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 74/296 (25%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKI--DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+G +G V   ++R   D  + +   + ++  SRR  +  ++   E  +L  ++HPN+V
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62

Query: 163 K--------------LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
                          ++G+C   D     +    + +P   V +           W  ++
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE-----------WFVQI 111

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +A      L YLHE     I+ RD K+ N+ L      K+ D G+AR+  +     +++
Sbjct: 112 AMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMAS 160

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            ++GT  Y +PE        YKSD+W+ G  +YE+ T +                    H
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK--------------------H 200

Query: 329 LTDAKKFTMILDPKLEGK-------YSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
             +AK    ++   +EGK       YS +L + +A +    L+++ + RP +  ++
Sbjct: 201 AFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM----LSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 50/94 (53%)

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      +I RD KS+NILL      KL DFG +++  +     V     GT  Y 
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           APE  +    + K+D++S GV LYEL+T +RP D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 25/233 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           IG G FG V  G + S     +   + VK+L     +Q   +++ E      ++H NL++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL--PWNTRL-KIAQDAARGLAY 220
            +G C E        LL+ E+ P   ++ +L S  +A L  P  T L ++A + A GL +
Sbjct: 60  CLGQCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           LH+      I  D    N LL      K+ D+GL+     +        +   + + APE
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Query: 281 YIQT--GRL-----TYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV 325
            +    G L     T +S++WS GV ++EL   G +P    R  S++++L + 
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYT 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IGEG +G V++   R T +        +  L R  L    E V      E+ +L  ++H 
Sbjct: 8   IGEGTYGTVFKAKNRETHE--------IVALKRVRLDDDDEGVPSSALREICLLKELKHK 59

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF---QATLPWNTRLKIAQDAAR 216
           N+V+L      D +      L++EY      QD L   F      +             +
Sbjct: 60  NIVRLYDVLHSDKK----LTLVFEYCD----QD-LKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS-TAVVGTIG 275
           GLA+ H      ++ RD K  N+L+++    KL+DFGLAR   + G+     +A V T+ 
Sbjct: 111 GLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLW 164

Query: 276 YAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPL 310
           Y  P+ +   +L   S D+WS G    EL    RPL
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 30/225 (13%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV 152
           ++  K++    +IG G FG VY  +   T +      +A+K++    LQ  +    E+ +
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEK-----VAIKKV----LQDPQYKNRELLI 112

Query: 153 LGVVEHPNLVKLIGY----CAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNT 206
           +  + H N++ L  Y    C + +E+ I   ++ E++P ++V  ++   +R    LP   
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFL 171

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLAR--LGPSDGL 263
               +    R LAY+H      I  RD K  N+L+D   +  KL DFG A+  L     +
Sbjct: 172 VKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
           S++ +       Y APE +  G   Y +  D+WS G  + E+I G
Sbjct: 229 SYICSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 34/236 (14%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV----TEVNVL 153
           NF    ++G G +G V+  ++R           A+K L +  L    + V    TE NVL
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 154 GVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
             V + P LV L  Y  + + +     LI +Y+    +  HL   +Q       R   ++
Sbjct: 59  EHVRQSPFLVTL-HYAFQTEAK---LHLILDYVSGGEMFTHL---YQ-------RDNFSE 104

Query: 213 DAAR--------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           D  R         L +LH+     I++RD K  NILLD + +  L+DFGL++   S+   
Sbjct: 105 DEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-K 160

Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
             + +  GTI Y APE I+      K+ D WS G+ ++EL+TG  P      ++ Q
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 37/96 (38%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      ++ RD K SN+LL+   + K+ DFGLAR   +       T  V T  
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173

Query: 276 YAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           Y APE +      T   D+WS G    EL+ GR+PL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 34/224 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEHP 159
           +I  G +G VY  ++R  E   +    A+K+++++ L    Q  + +V E ++L   E+P
Sbjct: 8   LISNGAYGAVY--LVRHKETRQR---FAMKKINKQNLILRNQIQQVFV-ERDILTFAENP 61

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT-RLKIAQDAARGL 218
            +V +  +C+ + +R +   ++ EY+        L +     LP +  R+  A+     L
Sbjct: 62  FVVSM--FCSFETKRHL--CMVMEYVEGGDCATLLKN--IGALPVDMARMYFAE-TVLAL 114

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-------------PSDGLSH 265
            YLH   ++ I+ RD K  N+L+    + KL+DFGL+++G               D    
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +   V GT  Y APE I         D W+ G+ LYE + G  P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 43/128 (33%), Positives = 60/128 (46%), Gaps = 21/128 (16%)

Query: 194 LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
           L S+F+  LP      +   + IA D+   L Y+H         RD K  NIL+D   + 
Sbjct: 91  LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHI 141

Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYE 302
           +L+DFG       DG    S A VGT  Y +PE +Q      G+   + D WS GV +YE
Sbjct: 142 RLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200

Query: 303 LITGRRPL 310
           ++ G  P 
Sbjct: 201 MLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 50/222 (22%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V      +  D+   + +AVK+LSR  + +   K    E+ +L  ++H N++
Sbjct: 25  VGSGAYGSVC-----AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQD--------HLTS-------RFQATLPWNTR 207
            L+                  + P RS+++        HL         + Q     + +
Sbjct: 80  GLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
             I Q   RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      
Sbjct: 124 FLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----M 174

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           T  V T  Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 175 TGYVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVL---GVVEH 158
           IG+G FG VY+   + T   +     A+K LS++ +   KE    + E N+L    + E 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIY-----AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAAR 216
           P +V L      D +      L+ +YM    +  HL    RF        +  IA+    
Sbjct: 56  PFIVGLKFSFQTDSDL----YLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAE-LVL 107

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L +LH+   + I++RD K  NILLD   +  L DFGL++   +D  +  +    GT  Y
Sbjct: 108 ALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEY 162

Query: 277 AAPE-YIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            APE  +     T   D WS GV ++E+  G  P 
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +GEG +  VY+G+ R          +A+K +S +  +G     + E ++L  ++H N+V 
Sbjct: 13  LGEGSYATVYKGISRINGQL-----VALKVISMKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           L      D     + L  ++EYM     Q ++        P+N RL + Q   RGLAY+H
Sbjct: 68  L-----HDIIHTKETLTFVFEYMHTDLAQ-YMIQHPGGLHPYNVRLFMFQ-LLRGLAYIH 120

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIGYAAPE 280
                 I+ RD K  N+L+      KL+DFGLAR    PS   S    + V T+ Y  P+
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS----SEVVTLWYRPPD 173

Query: 281 YIQTGRLTYKS--DIWSFGVFLYELITGR 307
            +  G   Y S  DIW  G    E++ G+
Sbjct: 174 VL-LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY+   +  +D     D A+KQ+   G+        E+ +L  ++HPN++ L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDR---DYALKQIEGTGIS--MSACREIALLRELKHPNVISL 63

Query: 165 IGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQ---ATLPWNTRLKIAQDAARGLAY 220
                   +R +  L  Y E+     ++ H  S+       LP      +      G+ Y
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 221 LHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTI 274
           LH      ++ RD K +NIL+     E+   K++D G ARL   P   L+ +   VV T 
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELIT 305
            Y APE +   R   K+ DIW+ G    EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 94  TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGH-KEWVTEVN 151
           T  K + +   IG G      +G++ +  D+   I++AVK+LSR    Q H K    E+ 
Sbjct: 18  TVLKRYQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV 72

Query: 152 VLGVVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
           +L  V H N++ L+  +  +      Q + L+ E M       +L       L       
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSY 127

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           +      G+ +LH      II RD K SNI++      K+ DFGLAR   ++    + T 
Sbjct: 128 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTP 181

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG 306
            V T  Y APE I         DIWS G  + EL+ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 64/256 (25%), Positives = 96/256 (37%), Gaps = 68/256 (26%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV---TEVNVL 153
           K+F +  ++G+G  G V+   ++ T         A+K L ++ +    +     TE  +L
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLF-----ALKVLDKKEMIKRNKVKRVLTEQEIL 55

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP----NRSVQDHLTSRFQATLPWNTRLK 209
             ++HP L  L  Y +   E  +   L+ +Y P     R +Q                  
Sbjct: 56  ATLDHPFLPTL--YASFQTETYL--CLVMDYCPGGELFRLLQRQPGKCLS---------- 101

Query: 210 IAQDAAR--------GLAYLH-EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL------ 254
             ++ AR         L YLH  G    I++RD K  NILL E  +  LSDF L      
Sbjct: 102 --EEVARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155

Query: 255 --------ARLGPSDGLSHV-------------STAVVGTIGYAAPEYIQTGRLTYKSDI 293
                    R G      +              S + VGT  Y APE I         D 
Sbjct: 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW 215

Query: 294 WSFGVFLYELITGRRP 309
           W+ G+ LYE++ G  P
Sbjct: 216 WTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 75/270 (27%), Positives = 112/270 (41%), Gaps = 72/270 (26%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS-----RRGLQGHKEWVTEVNVLGVVEH 158
           +IG G FG V     + T   +     A+K+L       +    H     E ++L   ++
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIY-----AMKKLRKSEMLEKEQVAHVR--AERDILAEADN 60

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN-TRLKIAQ----- 212
           P +VKL  Y +  DE  +   LI EY+P   +   L  +   T     TR  IA+     
Sbjct: 61  PWVVKL--YYSFQDENYL--YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAI 114

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL----------------AR 256
           D+   L Y+H         RD K  N+LLD + + KLSDFGL                + 
Sbjct: 115 DSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 257 LGPSDGLSHVST--------------------AVVGTIGYAAPE-YIQTGRLTYKSDIWS 295
             PS+ L  +S                     + VGT  Y APE ++QTG    + D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWS 224

Query: 296 FGVFLYELITGRRPLDRNRPKSE-QKLLEW 324
            GV +YE++ G  P   + P+   +K++ W
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKIINW 254

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 40/244 (16%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-----VTEVN 151
             + +   IG+G FG V++   + T    K+I +A+K++    ++  KE      + E+ 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKT----KQI-VALKKVL---MENEKEGFPITALREIK 63

Query: 152 VLGVVEHPNLVKLIGYC-----AEDDERGIQRLLIYEYMPNRSVQDH----LTSRFQATL 202
           +L +++H N+V LI  C       +  +G    L++E+       +H    L S      
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEFC------EHDLAGLLSNKNVKF 116

Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPS 260
             +   K+ +    GL Y+H     +I+ RD K++NIL+ +    KL+DFGLAR      
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSK 173

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSE 318
           +   +  T  V T+ Y  PE +  G   Y    D+W  G  + E+ T R P+ +    +E
Sbjct: 174 NSKPNRYTNRVVTLWYRPPE-LLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG--NTE 229

Query: 319 QKLL 322
           Q  L
Sbjct: 230 QHQL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNL 161
           +IG+G +G     V+ S  D+H    +A+K+++     +      + E+ +L ++ HP++
Sbjct: 7   VIGKGSYG-----VVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 162 VKLIGYCAEDDERGIQRL-LIYEYMPNRSVQ-----DHLTSRFQATLPWNTRLKIAQDAA 215
           V++         R  + + +++E M +   Q     D LT        +           
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL--------L 113

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS-TAVVGTI 274
           R L Y+H    F    RD K  NIL +     K+ DFGLAR+  +D  + +  T  V T 
Sbjct: 114 RALKYIHTANVFH---RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 275 GYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPL 310
            Y APE   +   + T   DIWS G    E++TG +PL
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 19/234 (8%)

Query: 78  SQRQSNLRVFTFSELK-TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS 136
           S+R +N       +   T  K +     IG G      +G++ +  D+  + ++A+K+LS
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLS 58

Query: 137 R--RGLQGHKEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDH 193
           R  +     K    E+ ++  V H N++ L+  +  +      Q +    Y+    +  +
Sbjct: 59  RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV----YIVMELMDAN 114

Query: 194 LTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG 253
           L    Q  L       +      G+ +LH      II RD K SNI++      K+ DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171

Query: 254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           LAR   + G S + T  V T  Y APE I         DIWS G  + E+I G 
Sbjct: 172 LAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 43/216 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE------- 157
           IGEG F  V +   R T   +     A+K + +     H + + +VN L  ++       
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYY-----AIKCMKK-----HFKSLEQVNNLREIQALRRLSP 56

Query: 158 HPNLVKLIGYCAEDDERG----IQRLL---IYEYMPNRSVQDHLTSRFQATLPWNTRLKI 210
           HPN+++LI     D + G    +  L+   +YE +  R          +  LP       
Sbjct: 57  HPNILRLIE-VLFDRKTGRLALVFELMDMNLYELIKGR----------KRPLPEKRVKSY 105

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
                + L ++H    F    RD K  NIL+      KL+DFG  R G      +  T  
Sbjct: 106 MYQLLKSLDHMHRNGIFH---RDIKPENILIK-DDILKLADFGSCR-GIYSKPPY--TEY 158

Query: 271 VGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELIT 305
           + T  Y APE + T G    K DIW+ G   +E+++
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHK-KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +IG G FG V    ++ TE  +  KI    + L R      +E   E NVL V      +
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE---ERNVL-VNGDCQWI 63

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLP------WNTRLKIAQDA 214
             + Y  +D+        +Y  M      D LT  S+F+  LP      +   + +A  +
Sbjct: 64  TTLHYAFQDENY------LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
              L Y+H         RD K  N+LLD   + +L+DFG       DG    S A VGT 
Sbjct: 118 IHQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGTP 167

Query: 275 GYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPL 310
            Y +PE +Q      G+   + D WS GV +YE++ G  P 
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 11/139 (7%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GL Y+H      II RD K  N+ ++E    K+ DFGLAR   S+      T  V T  
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRW 180

Query: 276 YAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
           Y APE I      T   DIWS G  + E++TG +PL +     +Q L+E ++   T +K+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQ-LMEIMKVTGTPSKE 238

Query: 335 FTMILDPKLEGKYSIKLAQ 353
           F   L  +    Y  KL +
Sbjct: 239 FVQKLQSEDAKNYVKKLPR 257

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 67/269 (24%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS-----RRGLQGHKEWVTEVNVLGVVEHP 159
           IG G FG V   ++R  + +      A+K L       R    H +   E ++L   ++ 
Sbjct: 9   IGIGAFGEVC--LVRKVDTNAL---YAMKTLRKADVLMRNQAAHVK--AERDILAEADNE 61

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARG 217
            +VKL  Y  +D +       + +Y+P   +   L     F+  L    R  IA+     
Sbjct: 62  WVVKLY-YSFQDKD---NLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCA 113

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---------------------R 256
           +  +H+ M F  I RD K  NIL+D   + KL+DFGL                       
Sbjct: 114 IESVHK-MGF--IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 257 LGPSDGLSHVSTA--------------------VVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           + PS+  S +                       +VGT  Y APE +     T   D WS 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 297 GVFLYELITGRRPLDRNRP-KSEQKLLEW 324
           GV LYE++ G+ P   + P +++ K++ W
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)

Query: 94  TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVN 151
           T  K +     IG G      +G++ +  D+    ++A+K+LSR  +     K    E+ 
Sbjct: 14  TVLKRYQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 152 VLGVVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
           ++  V H N++ L+  +  +      Q + L+ E M       +L    Q  L       
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 123

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           +      G+ +LH      II RD K SNI++      K+ DFGLAR   + G S + T 
Sbjct: 124 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 177

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI------TGRRPLDR-NR-------- 314
            V T  Y APE I         DIWS G  + E++       GR  +D+ N+        
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 315 -PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
            P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY+      +D   + + A+KQ+   G+        E+ +L  ++HPN++ L
Sbjct: 9   VGRGTYGHVYKA---KRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIAL 63

Query: 165 IGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQAT---LPWNTRLKIAQDAARGLAY 220
                   +R +  L  Y E+     ++ H  S+       LP +    +      G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 221 LHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTI 274
           LH      ++ RD K +NIL+     E+   K++D G ARL   P   L+ +   VV T 
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELIT 305
            Y APE +   R   K+ DIW+ G    EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 60/288 (20%), Positives = 120/288 (41%), Gaps = 51/288 (17%)

Query: 102 SLMIGEGGFGGVYRG-------VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG 154
           S++I E     +Y+G       +IR+ +  HK   + +                E+  L 
Sbjct: 25  SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITEN-----------EIKNLR 73

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
            ++  N++K+ G+   D    + RL LI EY     +++ L    +  L + T+L +A D
Sbjct: 74  RIDSNNILKIYGFII-DIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAID 130

Query: 214 AARGLAYLHE--GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
             +GL  L++     ++ +     S + L+ E +  K+   GL ++     LS      V
Sbjct: 131 CCKGLYNLYKYTNKPYKNL----TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNV 181

Query: 272 GTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL 329
             + Y + + +       T K DI+S GV L+E+ TG+ P +                +L
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE----------------NL 225

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
           T  + + +I++     K  +    ++  +   C +  +  RP + E++
Sbjct: 226 TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 9/99 (9%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDGLSHVSTAVVG 272
            GL Y+H      ++ RD K  N+L++     K+ DFGLAR     P +    + T  V 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171

Query: 273 TIGYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPL 310
           T  Y APE + + +   K+ D+WS G  L EL+ GR+P+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V      S  D+  +  +AVK+LSR  + L   +    E+ +L  ++H N++
Sbjct: 23  VGSGAYGSVC-----SAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77

Query: 163 KLIGYC--AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
            L+     A   E   +  L+   M       +   + Q     + +  I Q   RGL Y
Sbjct: 78  GLLDVFTPATSIENFNEVYLVTNLM---GADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKY 133

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           +H      II RD K SN+ ++E    ++ DFGLAR    +      T  V T  Y APE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPE 185

Query: 281 YIQTGRLTYKS--DIWSFGVFLYELITGR 307
            I    + Y    DIWS G  + EL+ G+
Sbjct: 186 -IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 49/236 (20%)

Query: 105 IGEGGFGGVYRGV--IRSTEDSHKK---IDIAVKQLSRRGLQG----HKEWVTEVNVLGV 155
           +GEG +G V +    +     + KK   I+I+      R L G    H   + E+ ++  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 156 VEHPNLVKLIG-YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ-- 212
           ++H N++ L+  Y   D    I   L+ + M          S  +  +    RL  +Q  
Sbjct: 77  IKHENIMGLVDVYVEGD---FIN--LVMDIM---------ASDLKKVVDRKIRLTESQVK 122

Query: 213 ----DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-------LGPSD 261
                   GL  LH+   +  + RD   +NI ++ +   K++DFGLAR            
Sbjct: 123 CILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 262 GLSHVS-----TAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
               +      T+ V T+ Y APE +  G   Y    D+WS G    EL+TG +PL
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELL-MGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)

Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM F      I RD  + NILL      K+ DFGLAR   +D    V       + + A
Sbjct: 225 KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMA 284

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           PE I     T++SD+WS+G+ L+E+ + G  P
Sbjct: 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 44/243 (18%)

Query: 104 MIGEGGFGGVYRG--VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL 161
           +IG+GG G VY     + S   + KKI    + LS   L   K ++ E  +   + HP +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIR---EDLSENPLL-KKRFLREAKIAADLIHPGI 64

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPN----------RSV--QDHLTSRFQATLPWNTRLK 209
           V +   C++ D        +Y  MP           +SV  ++ L+            L 
Sbjct: 65  VPVYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-------------R 256
           I       + Y+H      ++ RD K  NILL       + D+G A              
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 257 LGPSDGLSHVST---AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
           +   +      T    +VGT  Y APE +     +  +DI++ GV LY+++T   P  R 
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 314 RPK 316
           + +
Sbjct: 235 KGR 237

Length = 932

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--RRGL-QGHK---EWVTEVNVLGVVEH 158
           +G+G F  +Y+GV+R    S   I    +++S   + L   H+    +    +++  + H
Sbjct: 3   LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-RFQATLPWNTRLKIAQDAARG 217
            +LVKL G C  D     + +++ EY+    +   L   +   +L W  +L +A+  A  
Sbjct: 61  KHLVKLYGVCVRD-----ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASA 113

Query: 218 LAYLHEGMDFQIIFRDFKSSNILL----DEQWN---AKLSDFGLAR-LGPSDGLSHVSTA 269
           L YL +    +++  +    NIL+      +      KLSD G+   +   +        
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------ 164

Query: 270 VVGTIGYAAPEYIQTGR--LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP 327
            V  I + APE I+ G+  LT  +D WSFG  L E I        +   S +K   +   
Sbjct: 165 -VERIPWIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFYQDQ 222

Query: 328 H 328
           H
Sbjct: 223 H 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVK 163
           +GEG +  VY+G    ++ + K + + V +L     +G     + E ++L  ++H N+V 
Sbjct: 13  LGEGSYATVYKG---KSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVL 67

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           L      D     + L L++EY+     Q ++        P N +L + Q   RGL+Y+H
Sbjct: 68  L-----HDIIHTKETLTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQ-LLRGLSYIH 120

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           +     I+ RD K  N+L+ +    KL+DFGLAR       SH  +  V T+ Y  P+ +
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPD-V 174

Query: 283 QTGRLTYKS--DIWSFGVFLYELITG 306
             G   Y +  D+W  G    E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 33/233 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLV 162
           IG G FG V+    + T++         K +S RGL+  +  + V EVNV+  ++H N+V
Sbjct: 21  IGNGRFGEVFLVKHKRTQEF-----FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           + I        + +  L+ +    + S       +    +  +  + I +     LAY H
Sbjct: 76  RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 223 EGMDF----QIIFRDFKSSNILLDE----------QWN-------AKLSDFGLARLGPSD 261
              D     +++ RD K  NI L            Q N       AK+ DFGL++   + 
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NI 192

Query: 262 GLSHVSTAVVGTIGYAAPEYI--QTGRLTYKSDIWSFGVFLYELITGRRPLDR 312
           G+  ++ + VGT  Y +PE +  +T     KSD+W+ G  +YEL +G+ P  +
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Length = 1021

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 65/287 (22%), Positives = 128/287 (44%), Gaps = 41/287 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHK--KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+G F  +++G+ R   D  +  K ++ +K L +      + +    +++  + H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
              G C   DE     +++ EY+   S+  +L    +  +  + +L++A+  A  L +L 
Sbjct: 63  LNYGVCVCGDES----IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE 117

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV------VGTIGY 276
              D  +   +  + N+LL  + + K  +    +L  SD    +S  V      +  I +
Sbjct: 118 ---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL--SD--PGISITVLPKEILLERIPW 170

Query: 277 AAPEYIQTGR-LTYKSDIWSFGVFLYELITG-RRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
             PE I+  + L+  +D WSFG  L+E+ +G  +PL  +   S++KL  +   H   A K
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL--SALDSQKKLQFYEDRHQLPAPK 228

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN 381
           +T                 +LA + N+C+  +   RP    ++  LN
Sbjct: 229 WT-----------------ELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 67/272 (24%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVL 153
           +F    +IG G FG V   +++  +  H    I   ++ R+     KE V     E ++L
Sbjct: 2   DFESLKVIGRGAFGEVR--LVQKKDTGH----IYAMKILRKADMLEKEQVAHIRAERDIL 55

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV------QDHLTSRFQATLPWNTR 207
              +   +VK+  + +  D+R +   LI E++P   +      +D L+   +AT  +   
Sbjct: 56  VEADGAWVVKM--FYSFQDKRNL--YLIMEFLPGGDMMTLLMKKDTLSE--EATQFYIAE 109

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL------------- 254
             +A DA   L ++H         RD K  N+LLD + + KLSDFGL             
Sbjct: 110 TVLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 255 ---ARLGPSD-----------------GLSHVSTAVVGTIGYAAPE-YIQTGRLTYKSDI 293
                  PSD                     ++ + VGT  Y APE ++QTG      D 
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDW 219

Query: 294 WSFGVFLYELITGRRPLDRNRPK-SEQKLLEW 324
           WS GV +YE++ G  P     P+ + +K++ W
Sbjct: 220 WSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 69/266 (25%), Positives = 106/266 (39%), Gaps = 75/266 (28%)

Query: 64  FSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTED 123
           F S     +TF VL  R  NL+                   IG G      +G++ +  D
Sbjct: 2   FYSVEVGDSTFTVLK-RYQNLKP------------------IGSGA-----QGIVCAAYD 37

Query: 124 SHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI 181
           +    ++A+K+LSR  + +   K    E+ ++ +V H N++ L+                
Sbjct: 38  TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV-------------- 83

Query: 182 YEYMPNRSVQDHLTSRFQ----------ATLPWNTRLKIAQDAAR----------GLAYL 221
             + P +S+++     FQ          A L    ++ +  D  R          G+ +L
Sbjct: 84  --FTPQKSLEE-----FQDVYLVMELMDANLCQVIQMDL--DHERMSYLLYQMLCGIKHL 134

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II RD K SNI++      K+ DFGLAR   + G S + T  V T  Y APE 
Sbjct: 135 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 188

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGR 307
           I         DIWS G  + E+I G 
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNV 152
            + +   IGEG +G VY+   ++T        +A+K+     L+  +E +      E+++
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKL-----VALKKTR---LEMDEEGIPPTALREISL 53

Query: 153 LGVVEH-PNLVKLIGYCAEDDERG-IQRLLIYEYMPN--RSVQDHLTSRFQATLPWNTRL 208
           L ++     +V+L+     +++ G     L++EY+ +  +   D         LP  T  
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLG--PSDGLSH 265
                  +G+A+ H+     ++ RD K  N+L+D+Q    K++D GL R    P    +H
Sbjct: 114 SFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
               +V T+ Y APE +  G   Y +  DIWS G    E+   
Sbjct: 171 ---EIV-TLWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 82/347 (23%), Positives = 125/347 (36%), Gaps = 90/347 (25%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLV 162
           +G G FG V +      E S     +AVK L        +K  +TE+ +L  +  H N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 163 KLIG--------------YCAEDDERGIQRLLIYEYMPNR-------------------- 188
            L+G              YC   +     R     + P R                    
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 189 ---SVQDHLTSRFQATLPWNTRLKIAQDAARG-------------LAY---LHEGMDF-- 227
              S Q   +S F      +  L   ++   G             ++Y   +  GM+F  
Sbjct: 135 SVSSSQSSASSGFIE----DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190

Query: 228 --QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
             + I RD  + NILL E    K+ DFGLAR    D            + + APE I   
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 286 RLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMIL 339
             T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P     + ++++L
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           D                     C     + RP  SE+VE+L  ++  
Sbjct: 311 D---------------------CWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 80/346 (23%), Positives = 125/346 (36%), Gaps = 89/346 (25%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNL 161
           ++G G FG V        +       +AVK L        HK  ++E+ +L  +  H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 162 VKLIGYCAEDD-----------------------------------ERGIQRLLIYEYMP 186
           V L+G C + +                                   +RG  R ++ +   
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133

Query: 187 NR----SVQDHLTSRFQATLP------------WNTRLKIAQ------DAARGLAYLHEG 224
           +R         L SRFQ +              W + L +          ARG+ +L   
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--- 190

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
              + I RD  + NILL E    K+ DFGLAR    D       +    + + APE I  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMI 338
              T +SD+WSFGV L+E+ + G  P    +   E  Q+L +  R   P     + + ++
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIM 310

Query: 339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
           L                      C     K RP  S +VE+L  ++
Sbjct: 311 LA---------------------CWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 25/217 (11%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH---KEWVTEVNVL 153
           + ++    +G G +G V   +     D      +A+K+LSR   Q     K    E+ +L
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAI-----DKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLL 68

Query: 154 GVVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
             ++H N++ L+  + +       Q   L+  YM     Q  L       L  +    + 
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLV 123

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
                GL Y+H      II RD K  N+ ++E    K+ DFGLAR   ++      T  V
Sbjct: 124 YQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYV 175

Query: 272 GTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGR 307
            T  Y APE I          DIWS G  + E++TG+
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 52/174 (29%), Positives = 74/174 (42%), Gaps = 31/174 (17%)

Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM+F    + I RD  + NILL E    K+ DFGLAR    D            + + A
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDA 332
           PE I     T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 309

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           + +  +LD                     C   +   RP  SE+VE L  ++ A
Sbjct: 310 EMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQA 342

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT----I 274
           +GMDF      I RD  + N+LL +   AK+ DFGLAR    D ++  +  V G     +
Sbjct: 223 QGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----DIMNDSNYVVKGNARLPV 278

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            + APE I     T +SD+WS+G+ L+E+ + G+ P
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 67/273 (24%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV----TEVNV 152
           ++F    +IG G FG V   +++  +  H    +   ++ R+     KE V     E ++
Sbjct: 1   EDFESLKVIGRGAFGEVR--LVQKKDTGH----VYAMKILRKADMLEKEQVGHIRAERDI 54

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV------QDHLTSRFQATLPWNT 206
           L   +   +VK+  Y  +D    +   LI E++P   +      +D LT   + T  +  
Sbjct: 55  LVEADSLWVVKMF-YSFQDK---LNLYLIMEFLPGGDMMTLLMKKDTLTE--EETQFYIA 108

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA----------- 255
              +A D+   L ++H         RD K  N+LLD + + KLSDFGL            
Sbjct: 109 ETVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159

Query: 256 -----RLGPSD-----------------GLSHVSTAVVGTIGYAAPE-YIQTGRLTYKSD 292
                   PSD                     ++ + VGT  Y APE ++QTG      D
Sbjct: 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCD 218

Query: 293 IWSFGVFLYELITGRRPLDRNRPK-SEQKLLEW 324
            WS GV +YE++ G  P     P+ + +K++ W
Sbjct: 219 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL--SRRGLQGHKEWVTEVNVLGVVEHPNL 161
           ++GEG +G V +   + T++      +A+K+   S    +  +  + E+ +L  ++  N+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEI-----VAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           V+L     E   R  +  L++EY+  +++ + L        P   R  I Q   + + + 
Sbjct: 63  VEL----KEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQ-LIKAIHWC 116

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H+     I+ RD K  N+L+      KL DFG AR   S+G +   T  V T  Y +PE 
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPEL 172

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           +         D+WS G  L EL  G +PL
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG-QPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 7/126 (5%)

Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL 241
           Y+   +  V++ L+      L     L      ARG+ +L        + RD  + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270

Query: 242 DEQWNAKLSDFGLAR--LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
            +    K+ DFGLAR  +  S+ +S  ST +   + + APE I     T  SD+WS+G+ 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGIL 328

Query: 300 LYELIT 305
           L+E+ +
Sbjct: 329 LWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 217 GLAY-LHEGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPSDGLSHVSTA 269
           G +Y +  GM+F      + RD  + N+L+ E    K+ DFGLAR  +  S+ +S  ST 
Sbjct: 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF 302

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +   + + APE I     T  SD+WSFG+ L+E+ T
Sbjct: 303 L--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 30/157 (19%)

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP------WNTRLKIAQ 212
           PN+V L  Y   +D       L+ ++     +  H++      +P      W   + +A 
Sbjct: 45  PNMVCLHKYIVSED----SVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVAL 98

Query: 213 DAARGLAYLH-EGMDFQIIFRDFKSSNILLDEQWNAKLSDFG-LARLGPSDGLSHVSTAV 270
           DA      LH EG    I+ RD   +NILLD++ + +L+ F   + +  S     V    
Sbjct: 99  DA------LHREG----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM- 147

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
                Y APE       T   D WS G  L+EL+TG+
Sbjct: 148 -----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 37/259 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           IG G FG V    I +     + +   VK+L +    +   E++ + +   +++HPN+++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVV---VKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL----KIAQDAARGLA 219
            +G C E     I  LL++EY     ++ +L+   +     N++L    ++A + A G+ 
Sbjct: 60  CLGQCVE----AIPYLLVFEYCELGDLKSYLSQ--EQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVST--AVVGTIGY 276
           ++H+      +  D    N  L      K+ D+G   +GPS     ++ T       + +
Sbjct: 114 HMHK---HNFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRW 167

Query: 277 AAPEYIQT--GRL-----TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL 329
            APE +    G L     T  S++W+ GV L+EL       +  +P S     E V  H+
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDRE-VLNHV 221

Query: 330 TDAKKFTMILDPKLEGKYS 348
              ++   +  P+LE  YS
Sbjct: 222 IKDQQ-VKLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 61/255 (23%), Positives = 91/255 (35%), Gaps = 40/255 (15%)

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+     ++HPN++         D    +  ++   M   S +D L + F   LP     
Sbjct: 49  EIITSRQLQHPNILP-YVTSFIVDS---ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA 104

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA--------RLGPS 260
            I +D    L Y+H    F  I R  K+S+ILL       LS    +        R    
Sbjct: 105 FILKDVLNALDYIHS-KGF--IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSE 318
                 S      + + +PE +Q     Y  KSDI+S G+   EL  G  P         
Sbjct: 162 HDFPKSSVKN---LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-- 216

Query: 319 QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK-------------- 361
           Q LLE VR   P L D   + +  D   + + S +      +V +               
Sbjct: 217 QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276

Query: 362 -CLARQAKGRPKMSE 375
            CL R  + RP  S+
Sbjct: 277 LCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 41/146 (28%), Positives = 58/146 (39%), Gaps = 48/146 (32%)

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLA----------------------------- 255
           M F  I RD K  NIL+D   + KL+DFGL                              
Sbjct: 120 MGF--IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 256 ----------RLGPSD---GLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
                     RL P +      H   ++ ++VGT  Y APE +     T   D WS GV 
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 300 LYELITGRRPLDRNRP-KSEQKLLEW 324
           LYE++ G+ P     P +++ K++ W
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 40/141 (28%), Positives = 53/141 (37%), Gaps = 46/141 (32%)

Query: 230 IFRDFKSSNILLDEQWNAKLSDFGLA---------------------RLGPSDGLSHVST 268
           I RD K  NIL+D   + KL+DFGL                       + PSD    VS 
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 269 ------------------------AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
                                   ++VGT  Y APE +     T   D WS GV L+E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 305 TGRRPLDRNRPKSEQ-KLLEW 324
            G+ P     P   Q K++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 44/261 (16%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV 152
           +   ++F     IG G +G VY+    +T +       A+K +     +       E+ +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL-----AAIKVIKLEPGEDFAVVQQEIIM 59

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD--HLTSRFQATLPWNTRLKI 210
           +   +H N+V   G     D+  I      E+    S+QD  H+T          +  +I
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWIC----MEFCGGGSLQDIYHVTGPL-------SESQI 108

Query: 211 A---QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           A   ++  +GL YLH       + RD K +NILL +  + KL+DFG++        + ++
Sbjct: 109 AYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--------AQIT 157

Query: 268 TAV------VGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE 318
             +      +GT  + APE     + G      DIW+ G+   EL   + P+    P   
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217

Query: 319 QKLL---EWVRPHLTDAKKFT 336
             L+    +  P L D  K++
Sbjct: 218 LFLMTKSNFQPPKLKDKMKWS 238

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 69/317 (21%), Positives = 118/317 (37%), Gaps = 52/317 (16%)

Query: 35  RSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKT 94
           RS+A   + + D     SG+E +  +  DF            L+Q          ++LK 
Sbjct: 96  RSNADLFASAGDG---PSGAEDSDASHLDFDEAPPDAAGPVPLAQ----------AKLKH 142

Query: 95  ATKNFSRSLMIG---EGGFGGVY-------------RGVIRSTEDSHKKIDIAVKQLSRR 138
             +  +   +I     G FG ++             R  + ST     K +  + +  + 
Sbjct: 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA 202

Query: 139 GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-- 196
           G +   +   E+  LG + H N++K+           I R     YM  +     L S  
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKI---------EEILRSEANTYMITQKYDFDLYSFM 253

Query: 197 ---RFQ---ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
               F      L   TR  I +     + Y+H   D ++I RD K  NI L+      L 
Sbjct: 254 YDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLG 309

Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR-P 309
           DFG A     +  +      VGT+   +PE +        +DIWS G+ L ++++    P
Sbjct: 310 DFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368

Query: 310 LDRNRPKSEQKLLEWVR 326
           +     K  ++LL+ + 
Sbjct: 369 IGDGGGKPGKQLLKIID 385

Length = 501

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE--HPNLV 162
           +G G +G VY+     T +       AVK +      G    + +  +  V E  H N+V
Sbjct: 17  VGSGTYGDVYKARNLHTGEL-----AAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIV 69

Query: 163 KLIG-YCAEDDERGIQRLLIYEYMPNRSVQD--HLTSRFQATLPWNTRLKIA---QDAAR 216
              G Y + +     +  +  EY    S+QD  H+T          + L+IA   ++  +
Sbjct: 70  AYFGSYLSRE-----KLWICMEYCGGGSLQDIYHVTGPL-------SELQIAYVCRETLQ 117

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GLAYLH         RD K +NILL +  + KL+DFG+A             + +GT  +
Sbjct: 118 GLAYLHSKGKMH---RDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYW 172

Query: 277 AAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
            APE     + G      DIW+ G+   EL   + P+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 5/84 (5%)

Query: 220 YLH-EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           Y+H EG    II RD K+ N+L++   +  L DFG A        +     + GT+   A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYE 302
           PE +     T   DIWS G+ ++E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 31/100 (31%), Positives = 44/100 (44%), Gaps = 14/100 (14%)

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLARLGPSDGLSHVSTAVV--GT 273
            L  LH+     II  D K  N+L D  +    L D+GL +         + T     GT
Sbjct: 121 ALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGT 169

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
           + Y +PE I+        D W+ GV  YEL+TG+ P   +
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Length = 267

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 56/232 (24%)

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V H +L  + G C     RG + +++ E++ +  + D    + +  +P   ++ +AQ  A
Sbjct: 73  VSHIHLAFVHGVCV----RGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLA 127

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS--------HVS 267
             L+YL    D  ++  +  + NILL             ARLG ++G S         VS
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILL-------------ARLGLAEGTSPFIKLSDPGVS 171

Query: 268 TAV------VGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYEL-ITGRRPLDRNRPKSEQ 319
                    V  I + APE +  G  L+  +D WSFG  L E+   G  PL    P  ++
Sbjct: 172 FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231

Query: 320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           +  E  + H         + +P           ++LA + ++CL  +   RP
Sbjct: 232 RFYE--KKH--------RLPEPS---------CKELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 69/323 (21%), Positives = 125/323 (38%), Gaps = 53/323 (16%)

Query: 18  SNKDKNEEQKTAK-SISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSS------ 70
           + +  +    +A+ S S R   + TS  + R     G+    Q  +  ++          
Sbjct: 40  TGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKK 99

Query: 71  -RNTFAVLSQ--RQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK 127
            + T+A+ +Q   + +  V    ++  +T+ F    ++GEG FG V         D  +K
Sbjct: 100 KKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVE-----AWDRKRK 154

Query: 128 IDIAVKQLSR-----RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
              AVK +       R  +   +++ +V      +   L+K+  Y    +E G   +++ 
Sbjct: 155 EYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF--QNETGHMCIVMP 212

Query: 183 EYMPNRSVQDHLTSRFQATLPWNTR--LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +Y P       L        P++ R   +I       L Y H   +  ++  D K  NIL
Sbjct: 213 KYGPC------LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENIL 264

Query: 241 LD----------------EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
           ++                +    ++ D G    G  D   H  TA+V T  Y +PE +  
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLG----GCCDE-RHSRTAIVSTRHYRSPEVVLG 319

Query: 285 GRLTYKSDIWSFGVFLYELITGR 307
               Y +D+WS G  +YEL TG+
Sbjct: 320 LGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 41/237 (17%)

Query: 105 IGEGGFGGVYRGVIRSTED-------SHKKIDIAVKQLSRRGLQGHKE----WVTEVNVL 153
           +G G    +Y G++   +D         K+I + +K L       H++    +    +++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD----PSHRDISLAFFETASMM 58

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQA-TLPWNTRLKIAQ 212
             V H ++V L G C  D E     +++ E++    +   +  +    T PW  + K+A+
Sbjct: 59  RQVSHKHIVLLYGVCVRDVEN----IMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAK 112

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILL-----DEQWNA--KLSDFGLARLGPSDGLSH 265
             A  L+YL    D  ++  +  + NILL     D +     KLSD G+    P   LS 
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSR 165

Query: 266 VSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYEL-ITGRRPL-DRNRPKSEQ 319
                V  I + APE ++  + L+  +D WSFG  L+E+   G  PL D+   + E+
Sbjct: 166 --QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 75/282 (26%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV---TEVNVLG 154
           +F    +IG+G FG V   +++  +    KI  A+K L +  +    +      E +VL 
Sbjct: 2   DFHTVKVIGKGAFGEVR--LVQKKDTG--KI-YAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ-- 212
             + P +V L  Y +  D + +   LI E++P   +   L  ++       TR  +A+  
Sbjct: 57  ESDSPWVVSL--YYSFQDAQYL--YLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECV 111

Query: 213 ---DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-------------R 256
              +A   L ++H         RD K  NIL+D   + KLSDFGL+             +
Sbjct: 112 LAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 257 L-------GPSDGLSHVST-------------------------AVVGTIGYAAPE-YIQ 283
           L          D  + V+                          + VGT  Y APE ++Q
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 284 TGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEW 324
            G    + D WS G  ++E + G  P    N  ++ +K++ W
Sbjct: 223 QG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 24/157 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLV- 162
           +  G    VY   + + ++     D  +K    R     +E   EV +L ++      V 
Sbjct: 6   LKGGLTNRVYL--LGTKDE-----DYVLKINPSREKGADRE--REVAILQLLARKGLPVP 56

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           K++       E      L+ E++   +    L    +          IA+  A  LA LH
Sbjct: 57  KVLAS----GESDGWSYLLMEWIEGET----LDEVSEEEKE-----DIAEQLAELLAKLH 103

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP 259
           +     +   D    NIL+D+     + D+  A  GP
Sbjct: 104 QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 3/52 (5%)

Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
             +K   + A  L YLH      II RD K  N+L+  + + KL+DFGL+++
Sbjct: 105 MAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 16/183 (8%)

Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
            E++V  +  HPN+V        D+E  +    +  +M   S +D + + F   +     
Sbjct: 48  GELHVSKLFNHPNIVPYRATFIADNELWV----VTSFMAYGSAKDLICTHFMDGMSELAI 103

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS----DFGLARLGPSDGL 263
             I Q   + L Y+H  M +  + R  K+S+IL+       LS    +  +   G    +
Sbjct: 104 AYILQGVLKALDYIHH-MGY--VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160

Query: 264 SH-VSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQK 320
            H      V  + + +PE +Q     Y  KSDI+S G+   EL  G  P  ++ P + Q 
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF-KDMP-ATQM 218

Query: 321 LLE 323
           LLE
Sbjct: 219 LLE 221

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	441
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.34
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.09
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.97
PRK09902	216	hypothetical protein; Provisional	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.84
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.24
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.2
PLN02876	822	acyl-CoA dehydrogenase	98.18
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
PRK10593	297	hypothetical protein; Provisional	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.78
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.63
PRK05231	319	homoserine kinase; Provisional	97.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.57
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.35
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.21
PLN02236	344	choline kinase	97.05
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.96
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.92
PLN02756	418	S-methyl-5-thioribose kinase	96.79
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.75
KOG2270	520	consensus Serine/threonine protein kinase involved	96.74
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.65
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.35
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.29
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.94
COG2334	331	Putative homoserine kinase type II (protein kinase	95.68
PRK12396	409	5-methylribose kinase; Reviewed	95.57
PTZ00384	383	choline kinase; Provisional	95.37
PRK06148	1013	hypothetical protein; Provisional	95.17
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.1
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.26
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.0
PTZ00296	442	choline kinase; Provisional	93.78
PRK10271	188	thiK thiamine kinase; Provisional	93.42

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-55  Score=430.93  Aligned_cols=291  Identities=57%  Similarity=0.939  Sum_probs=252.9

Q ss_pred             CccccchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCee
Q 013504           83 NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV  162 (441)
Q Consensus        83 ~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv  162 (441)
                      ..+.|++.+++.+|++|...++||+|+||.||+|...++.      .||||++........++|.+|+.+|.+++|||+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~------~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv  134 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT------VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLV  134 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC------EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcc
Confidence            6788999999999999999999999999999999987752      3999988765533146699999999999999999


Q ss_pred             eEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       163 ~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                      +|+|||.+.+.   +++||+||+++|+|.++|.......++|..+++|+.++|.||.|||..+.+.||||||||+|||||
T Consensus       135 ~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  135 KLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             cEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            99999998774   349999999999999999875433899999999999999999999998878899999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      +++++||+|||+|+..+.. .........||.+|+|||++..+..+.++|||||||+++||+||+.|.+...+.....++
T Consensus       212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~  290 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV  290 (361)
T ss_pred             CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence            9999999999999876541 111111118999999999999999999999999999999999999999877666666688


Q ss_pred             HhhhhhcccccchhhhcCCCCC-CcchH-HHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLE-GKYSI-KLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      .|..+.+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.+|+++|+.+.
T Consensus       291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9988777766 88899999987 56554 57778999999999999999999999999996654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-52  Score=384.76  Aligned_cols=251  Identities=29%  Similarity=0.440  Sum_probs=211.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.+....||+|..|+||++.++.++..     +|+|.+..... ...+++.+|+++++.++||+||.+||.|.....   
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i-----~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---  151 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKI-----YALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---  151 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeE-----EEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---
Confidence            445556799999999999999988765     99999954332 345789999999999999999999999998774   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..+|+||||++|+|.+++..  .+.+++....+|+.+|++||.|||..  .+||||||||+|||++..|+|||||||.++
T Consensus       152 ~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence            24899999999999999976  47899999999999999999999963  399999999999999999999999999999


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC--chhHHHHHHhhhhhcccccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR--PKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~  334 (441)
                      .+...    ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....  ......++.++         
T Consensus       228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------  294 (364)
T KOG0581|consen  228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------  294 (364)
T ss_pred             Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------
Confidence            76554    5678999999999999999999999999999999999999999997541  22223333332         


Q ss_pred             hhhhcCCCCCCcchH-HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSI-KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          ++.. ....+. .+++++..++..||++||.+||++.++++
T Consensus       295 ----v~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  295 ----VDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----hcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                2211 122333 48899999999999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-51  Score=396.53  Aligned_cols=264  Identities=33%  Similarity=0.560  Sum_probs=217.5

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.+.+.||+|+||+||+|.++++..      ||||.+.......  .+.|.+|+.+|.+++|||||+++|+|.....   
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~------vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---  113 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDV------VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---  113 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCcee------EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            3444459999999999999988753      8999998755433  4589999999999999999999999987652   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEecccCCCcEEEcCCC-cEEEeecCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ-IIFRDFKSSNILLDEQW-NAKLSDFGL  254 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-iiHrDlKp~NILl~~~~-~~kl~DFGl  254 (441)
                      .++|||||+++|+|.+++..+....+++..++.++.||+.||.|||++   + ||||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            248999999999999999875467999999999999999999999998   7 99999999999999998 999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQ--TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++......  ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||....+......+          
T Consensus       191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v----------  258 (362)
T KOG0192|consen  191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV----------  258 (362)
T ss_pred             ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----------
Confidence            98754422  2234478999999999999  568999999999999999999999999876542211111          


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccCCC
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTP  392 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p  392 (441)
                            +....+...+..+++.+..++.+||..||..||++.+++..|+.+........+
T Consensus       259 ------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~  312 (362)
T KOG0192|consen  259 ------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP  312 (362)
T ss_pred             ------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence                  111122233344778899999999999999999999999999999876554443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-51  Score=383.00  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=209.9

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-------hHHHHHHHHHhccCCCCCeeeEEe
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-------HKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      ...+.|.+.+.||+|+||.|-+|..+.+++.     ||||++.++....       .....+|++||++|+|||||++++
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~-----vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQ-----VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcE-----EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence            3456788999999999999999999888764     9999998764432       123569999999999999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC--
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ--  244 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~--  244 (441)
                      +|...+..    ||||||++||+|.+++..  .+.+.+.....+++|++.||.|||++   ||+||||||+|||+..+  
T Consensus       244 ~f~~~ds~----YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e  314 (475)
T KOG0615|consen  244 FFEVPDSS----YMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE  314 (475)
T ss_pred             eeecCCce----EEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence            99988865    999999999999999987  46788888999999999999999998   99999999999999765  


Q ss_pred             -CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCC---CccccchhHHHHHHHHHhCCCCCCCCCchh-HH
Q 013504          245 -WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL---TYKSDIWSFGVFLYELITGRRPLDRNRPKS-EQ  319 (441)
Q Consensus       245 -~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlG~il~elltG~~P~~~~~~~~-~~  319 (441)
                       ..+||+|||+|+....   .....+.||||.|.|||++.+..+   ..++|+||+||+||-+|+|.+||....... ..
T Consensus       315 ~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~  391 (475)
T KOG0615|consen  315 DCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK  391 (475)
T ss_pred             ceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence             7799999999998653   335678999999999999987653   347899999999999999999997544332 11


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +.+...+-              .+.......++++..+||.+||..||++||++.|+|+
T Consensus       392 eQI~~G~y--------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  392 EQILKGRY--------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHhcCcc--------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            11111100              0112334578889999999999999999999999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=379.38  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=206.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..+|...+.||+|+||+||+|+++.++.     .||||.+....  ....+.+..|+.+|+.++|||||.+++++..++ 
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~-----~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGT-----EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCc-----eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence            3578888999999999999999988775     49999998763  334566789999999999999999999999887 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC------CcE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ------WNA  247 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~------~~~  247 (441)
                         .+|||||||+||+|.+||+.+  +.+++..+..++.||+.||++||++   +||||||||+||||+.+      -.+
T Consensus        83 ---~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L  154 (429)
T KOG0595|consen   83 ---FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL  154 (429)
T ss_pred             ---eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence               459999999999999999874  6899999999999999999999998   99999999999999764      458


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+|||+|+.+...   ....+.+|+|.|||||++....|+.|+|+||+|+|+|+|++|+.||+.....+....++..  
T Consensus       155 KIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~--  229 (429)
T KOG0595|consen  155 KIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG--  229 (429)
T ss_pred             EecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc--
Confidence            99999999987754   3456789999999999999999999999999999999999999999866554433222111  


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                   ..+....+...+..+.+++...+..+|.+|-+..+.+.
T Consensus       230 -------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  230 -------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             -------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence                         11112233344555667888888888888877655443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-50  Score=396.52  Aligned_cols=248  Identities=27%  Similarity=0.496  Sum_probs=214.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..|...++||+|||+.||.+++..+++.     ||+|++.+....   ..+.+.+||+|.+.|+|||||+++++|++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~-----~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEV-----VAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcE-----EEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            5799999999999999999999777765     999998874432   34678899999999999999999999998875


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .    |||.|+|.+++|..+++.  .+.+++.+++.+++||+.||.|||+.   +|||||||..|+||+++.+|||+|||
T Consensus        93 V----YivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 V----YIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             e----EEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            4    999999999999999985  57999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ||..+..++  ....+.+|||.|+|||++....++..+||||+||++|-||+|++||+...-.+....+...        
T Consensus       164 LAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--------  233 (592)
T KOG0575|consen  164 LATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--------  233 (592)
T ss_pred             eeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------
Confidence            999876543  3466799999999999999999999999999999999999999999865433322222111        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ....|..++....+||..+|+.||.+||++++|+.
T Consensus       234 ----------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ----------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      11233466788999999999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-50  Score=372.86  Aligned_cols=243  Identities=29%  Similarity=0.439  Sum_probs=206.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.++||+|+||+||.++.++++..     +|+|++++.....   .+....|..||..++||+||+++-.|++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~ki-----YAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKI-----YAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCce-----eehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence            46899999999999999999999887765     9999998865433   356778999999999999999999998877


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    +|||+||+.||.|..+|++  .+.+++..+..++.+|+.||.|||++   +||||||||+|||||.+|.++|+||
T Consensus        99 k----LylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   99 K----LYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             e----EEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            4    5999999999999999986  57899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++.....+  ....+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.....+.+...+      
T Consensus       170 gL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------  241 (357)
T KOG0598|consen  170 GLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------  241 (357)
T ss_pred             ccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------
Confidence            9999654432  24556899999999999999999999999999999999999999997654332222211110      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP  371 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  371 (441)
                                 ....+.-++.+..+++.++|..||++|.
T Consensus       242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                       0112223567889999999999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-51  Score=363.21  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=208.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeE-Eecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGY-CAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~-~~~~~~  173 (441)
                      .+|++.++||+|.||+||++....++..     +|.|.+.-...  +.......|+.+|++|+|||||+++++ |.++..
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l-----~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKL-----VALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcch-----hhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            4688888999999999999998887765     88888874333  234567899999999999999999984 443333


Q ss_pred             CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEcCCCcEEE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~~~~~~kl  249 (441)
                         -++||||||++|+|...++.  ..+..+++..+|+++.|++.||..+|++ .+.  |+||||||.||+|+.+|.+||
T Consensus        94 ---vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   94 ---VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ---hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceee
Confidence               25899999999999999863  3457899999999999999999999984 234  999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||++++.....  ....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-..   +...+..  
T Consensus       170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L~~KI~q--  242 (375)
T KOG0591|consen  170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---LCKKIEQ--  242 (375)
T ss_pred             ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---HHHHHHc--
Confidence            9999999876542  34567899999999999999999999999999999999999999997653222   2111110  


Q ss_pred             ccccchhhhcCCCCCCcch-HHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYS-IKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                                  .-....+ ..++..+.+||..|+..||+.||+...++..+..
T Consensus       243 ------------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 ------------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ------------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                        0111223 5688999999999999999999997555555444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=378.43  Aligned_cols=258  Identities=31%  Similarity=0.506  Sum_probs=218.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.+..++.||+|-||+||.|.+++..+      ||+|.++... .....|.+|+.+|++|+|+|||+++|+|...+.   
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~------vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p---  275 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTK------VAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP---  275 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCc------ccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCc---
Confidence            345566779999999999999998754      8999887643 335778899999999999999999999988764   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       +|||||||+.|+|.+||....+..+...+.+.++.|||+|++||+++   ++|||||...||||++++.+||+|||+|+
T Consensus       276 -iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  276 -IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             -eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence             49999999999999999987788999999999999999999999998   99999999999999999999999999999


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....+ .........-..-|+|||.+..+.++.+||||||||+||||+| |+.|+......+....++            
T Consensus       352 ~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------------  418 (468)
T KOG0197|consen  352 LIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------------  418 (468)
T ss_pred             ccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh------------
Confidence            54433 2333334445668999999999999999999999999999999 999997765443333222            


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                           ...+-..|..||+.+.+++..||..+|++|||++.+...|+++...
T Consensus       419 -----~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  419 -----RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -----ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                 2223345567899999999999999999999999999999988654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-48  Score=372.64  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=214.7

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccC-CCCCeeeEEeEE
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVV-EHPNLVKLIGYC  168 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~  168 (441)
                      +...++|..++.||.|+|++|++|+.+.++.     .+|||++.+.....   .+.+.+|-.+|.+| .||.|++|+..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~k-----eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGK-----EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCc-----eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            4556899999999999999999999887765     49999998765432   24567899999999 899999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                      ++...    +|+|+||+++|+|.++|++  .+.|++..+..++.+|+.||+|||++   |||||||||+|||||.++.+|
T Consensus       144 QD~~s----LYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  144 QDEES----LYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ecccc----eEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            88774    5999999999999999987  48999999999999999999999998   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCc---------ce--eeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          249 LSDFGLARLGPSDGLS---------HV--STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       249 l~DFGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      |+|||.|+.+......         ..  ...++||..|.+||++..+..+..+|+|+||||||+|+.|.+||...++-.
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            9999999976543211         11  256999999999999999999999999999999999999999996554322


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..+.+..                  +.-.+++.+++.+.+|+.++|..||.+|++.++|-+.
T Consensus       295 iFqkI~~------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 IFQKIQA------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHH------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1111111                  1223455677889999999999999999999888873

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4e-48  Score=348.41  Aligned_cols=266  Identities=25%  Similarity=0.346  Sum_probs=210.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-h-hHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-G-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +.|+...++|+|+||+||+|+++.+++.     ||||++...... . .+-.++|+++|++++|||+|.++.+|....  
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqI-----VAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr--   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQI-----VAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR--   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccE-----EEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--
Confidence            4678888999999999999999999876     999998765542 2 245689999999999999999999998766  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        .++||+|||+. ++.+-|... ...++...+..+++|++.|+.|+|++   +||||||||+||||+.+|.+||||||+
T Consensus        75 --klhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   75 --KLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             --eeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence              45999999966 555555543 56789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  331 (441)
                      |+.+...+  ...+.++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+....+....+......+..  
T Consensus       148 AR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  148 ARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence            99876433  34567899999999999987 68999999999999999999999999877655544333322211111  


Q ss_pred             ------ccchhhhcCCCCCCc-----chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ------AKKFTMILDPKLEGK-----YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ------~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ...+..+.-|.....     --+..+.-+.+++..||..||.+|++.++++.
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                  111111111221111     11245567889999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=360.64  Aligned_cols=258  Identities=30%  Similarity=0.462  Sum_probs=206.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|...+.||+|+||.||++.+..++..     .|||.+........+.+.+|+.+|.+++|||||+++|.......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~-----~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGEL-----MAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--D   89 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcc-----eeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--e
Confidence            4577788999999999999998876544     89999877644445678899999999999999999997544443  2


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEEeecCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLA  255 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla  255 (441)
                      .++++|||+++|+|.+++....+ .+++..+..+.+||+.||.|||++   |||||||||+||||+. ++.+||+|||++
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence            46899999999999999987544 899999999999999999999998   9999999999999999 799999999999


Q ss_pred             CCCCC-CCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPS-DGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +.... ...........||+.|||||++..+. ...++|||||||++.||+||+.||... ......+...         
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~i---------  235 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLI---------  235 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHH---------
Confidence            87553 11122334589999999999998633 345999999999999999999999753 1111111111         


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                          .... ....++..++.+..+++.+|+..+|++|||+.++|+..
T Consensus       236 ----g~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  236 ----GRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----hccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                0111 11245556888999999999999999999999999853

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=339.82  Aligned_cols=237  Identities=29%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh---HHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH---KEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|+..+.||.|+||.|.+++.+.++..     +|+|++.+......   +...+|..+|+.+.||+++++++.|.+.+ 
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~y-----YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNY-----YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCce-----eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-
Confidence            5789999999999999999999888765     99999988765444   34568999999999999999999988766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ++||||||++||.|..++++  .+++++..+..++.||+.||.|||+.   +|++|||||+|||||.+|.+||+|||
T Consensus       118 ---~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  118 ---NLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             ---eEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence               45999999999999999976  57899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+....     ...+.||||.|+|||+++..+|+.++|+|||||++|||+.|.+||...++.   .+.+.+        
T Consensus       190 FAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~iY~KI--------  253 (355)
T KOG0616|consen  190 FAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---QIYEKI--------  253 (355)
T ss_pred             ceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---HHHHHH--------
Confidence            9997643     366799999999999999999999999999999999999999999776652   222211        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCC
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR  370 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  370 (441)
                           +...  -.+|.-++..+.+|+..+|+.|-.+|
T Consensus       254 -----~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 -----LEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----HhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 1111  23555677889999999999999988

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-46  Score=366.88  Aligned_cols=268  Identities=26%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+...........||||++..... .....+.+|+.+|..+ +||||++++++|...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999875443333445699999875432 2345688999999999 89999999998875443


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-------------------------------------------------------  198 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  198 (441)
                         ..++||||+++|+|.+++....                                                       
T Consensus        86 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          86 ---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence               3589999999999999986421                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecc
Q 013504          199 -----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT  273 (441)
Q Consensus       199 -----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  273 (441)
                           ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...............++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 13477888999999999999999998   9999999999999999999999999999865432222222334567


Q ss_pred             cCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHH
Q 013504          274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLA  352 (441)
Q Consensus       274 ~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (441)
                      +.|+|||++.+..++.++|||||||++|||++ |..||........  .....    ....          ....+..++
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~----~~~~----------~~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRL----KDGT----------RMRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHH----hcCC----------CCCCCCCCC
Confidence            89999999999999999999999999999997 9999975432211  11111    0000          001122455


Q ss_pred             HHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          353 QKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       353 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      ..+.+++.+||+.||.+||++.+|++.|++++.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            679999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=359.25  Aligned_cols=270  Identities=25%  Similarity=0.348  Sum_probs=213.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .+.|+.++.||+|+||.||+|++..+++.     ||+|++......  ...-..+||.||++|+||||++|.+...+...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgki-----vALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKI-----VALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcE-----EEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            45688888999999999999999888765     999999876532  23456799999999999999999999988743


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .  .+|||+|||+. +|.-++.. .+-.|++.++..++.|++.||.|||++   +|+|||||.+|||||.+|.+||+|||
T Consensus       191 ~--siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  191 G--SIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             c--eEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            3  46999999965 88888764 356899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ||+++.... ....+..+-|.+|.|||++.+. .|+.++|+||.||||.||+.|++.|.+....+....+-.+.....+.
T Consensus       264 LAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  264 LARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             ceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence            999876554 2335677889999999998874 69999999999999999999999998877665555443332211110


Q ss_pred             -cc---hh--hhcCCCCC--Ccc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -KK---FT--MILDPKLE--GKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -~~---~~--~~~~~~~~--~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       +.   +.  ..+.+...  ..+   -..++....+|+..+|+.||.+|.|+.++|+
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             00   00  00101000  001   1235567889999999999999999999987

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=367.91  Aligned_cols=244  Identities=25%  Similarity=0.465  Sum_probs=208.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccC-CCCCeeeEEeEEec
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVV-EHPNLVKLIGYCAE  170 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  170 (441)
                      ..++|...++||+|.||+|+++..+.+++.     +|||.+++...-   +.+..+.|.+|+... +||.+++++..|++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~-----yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEY-----YAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcE-----EEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence            447899999999999999999999998875     999999986543   346678899998887 59999999999998


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .+.    +|+||||+.||++..+.+   ...|++..+..|+..|+.||+|||++   +|||||||.+|||||.+|.+||+
T Consensus       441 ~~~----l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  441 KEH----LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             CCe----EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence            884    599999999999554443   36899999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++.....+  ..+++++|||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+..+.-+.+-       
T Consensus       511 DFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-------  581 (694)
T KOG0694|consen  511 DFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-------  581 (694)
T ss_pred             ccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------
Confidence            999999765333  35778999999999999999999999999999999999999999998665433222211       


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                               .  .+..++..++.+...+++++|.++|++|.-+
T Consensus       582 ---------~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 ---------N--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------c--CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                     1  1234666788899999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=364.63  Aligned_cols=250  Identities=29%  Similarity=0.450  Sum_probs=216.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ..|.....||+|+.|.||.+....++..     ||||++........+-+++|+.+|+..+|+|||++++.|...+.   
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~-----VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de---  344 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQE-----VAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE---  344 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCce-----EEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce---
Confidence            4688888999999999999998877664     99999988876666778899999999999999999998877754   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       +++||||++||+|.+.+..   ..+++.++..|+++++.||+|||.+   +|+|||||.+|||++.+|.+||+|||+|.
T Consensus       345 -LWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  345 -LWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             -eEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence             5999999999999999976   4699999999999999999999998   99999999999999999999999999999


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      .+.....  ...+.+|||.|||||++....|++++||||||++++||+-|++||-...+.....++..            
T Consensus       418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------------  483 (550)
T KOG0578|consen  418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------  483 (550)
T ss_pred             ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------------
Confidence            8765533  45678999999999999999999999999999999999999999976554433332211            


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .....-..+..++..+.+++.+||+.|+++||++.|+|+
T Consensus       484 ---ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  484 ---NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               111222345578899999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=362.62  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=207.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc----Cc-hhhHHHHHHHHHhccCC-CCCeeeEEeEE
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR----GL-QGHKEWVTEVNVLGVVE-HPNLVKLIGYC  168 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~  168 (441)
                      ....|.+.+.||+|+||.|+.|.+..++.     .||+|++.+.    .. ...+.+.+|+.++++++ ||||++++.++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~-----~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGE-----KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCC-----eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            45689999999999999999999987764     3999977664    11 22345668999999998 99999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcE
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNA  247 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~  247 (441)
                      .....    .|+|||||.||+|.+++..  .+++.+..+..+++|++.|+.|||++   ||+||||||+|||++.+ +++
T Consensus        90 ~t~~~----~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   90 ATPTK----IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             ecCCe----EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence            88774    4999999999999999987  57899999999999999999999998   99999999999999999 999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LT-YKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      ||+|||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.....   .+...+
T Consensus       161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~ki  235 (370)
T KOG0583|consen  161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRKI  235 (370)
T ss_pred             EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHHH
Confidence            999999999763  1223466789999999999999877 86 6799999999999999999999863321   111111


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHH-HHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKL-AQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..   .            .-.++..+ +.++..|+.+||..||.+|+++.+|+.
T Consensus       236 ~~---~------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  236 RK---G------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             hc---C------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11   0            01122233 788999999999999999999999994

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.8e-46  Score=360.19  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=209.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ..++|+.+..||+|+||.||+|+-+.+++.     +|+|++++.....   .+.++.|-.+|....+|+||+||-.|++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~i-----yAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEI-----YAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcE-----EeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            347899999999999999999999999886     9999999876543   34567899999999999999999999987


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +.    +||||||++||++..+|..  ...|++..+..++.+++.||..||+.   |+|||||||+|+|||..|++||+|
T Consensus       214 ~~----LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  214 EY----LYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             Ce----eEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence            74    5999999999999999976  47999999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCC----------------------CCCc------c-----------------eeeceecccCcCCccccccCC
Q 013504          252 FGLARLGPS----------------------DGLS------H-----------------VSTAVVGTIGYAAPEYIQTGR  286 (441)
Q Consensus       252 FGla~~~~~----------------------~~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~  286 (441)
                      |||+.-...                      ....      .                 .....+|||.|||||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999853211                      0000      0                 012368999999999999999


Q ss_pred             CCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcc
Q 013504          287 LTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR  365 (441)
Q Consensus       287 ~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  365 (441)
                      |+..+|+||||||+||||.|.+||....+... .+++.|-.....               +....++.+..+||.+||+ 
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~~~~s~eA~DLI~rll~-  428 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEEVDLSDEAKDLITRLLC-  428 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCcCcccHHHHHHHHHHhc-
Confidence            99999999999999999999999987776544 344555422111               1112345789999999999 


Q ss_pred             cCCCCCC---HHHHHH
Q 013504          366 QAKGRPK---MSEVVE  378 (441)
Q Consensus       366 dP~~RPs---~~evl~  378 (441)
                      ||++|..   ++||-+
T Consensus       429 d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  429 DPENRLGSKGAEEIKK  444 (550)
T ss_pred             CHHHhcCcccHHHHhc
Confidence            9999976   555544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-47  Score=359.50  Aligned_cols=270  Identities=23%  Similarity=0.338  Sum_probs=215.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHH-HHHHHHHhccCC-CCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVE-HPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~E~~il~~l~-hpnIv~l~~~~~~~  171 (441)
                      ...++|.+++.||.|+||.||+|+...+++.     ||||.+++.-....+. =+||+..|++|+ ||||+++.+++.+.
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~-----VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGEL-----VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCce-----eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            4557899999999999999999998887765     9999998765543222 258999999998 99999999999887


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +.   .+|+||||| ..+|++.++.+ +..|++..+..|++||++||+|+|.+   |+.|||+||+|||+..+..+||+|
T Consensus        82 ~~---~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   82 DR---ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             Cc---eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecc
Confidence            64   469999999 56999999988 78999999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh--
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH--  328 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~--  328 (441)
                      ||+||.....   ...+.++.|.+|.|||++ +.+-|+.+.||||+|||++|+.+-++-|.+....+....+..+...  
T Consensus       154 FGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~  230 (538)
T KOG0661|consen  154 FGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD  230 (538)
T ss_pred             cccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence            9999976543   345678999999999976 4577999999999999999999999999876654443322221111  


Q ss_pred             ---cccccchhhhcCCCCC-------CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          329 ---LTDAKKFTMILDPKLE-------GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       329 ---~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                         +..+......+.-.+.       ...-..++.+..++|.+|+..||.+|||+.++++.
T Consensus       231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               1111111111111111       11112367889999999999999999999999984

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-46  Score=328.94  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=215.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++++.||+|.||.||.|..+.+...     ||+|++.+....   ..+++.+|++|-+.|+||||+++|++|.+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~I-----valKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFI-----VALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcE-----EEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            36799999999999999999998877664     999999876532   2467889999999999999999999999877


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    .||++||.++|+|+..|.......+++.....++.|++.||.|+|.+   +||||||||+|+|++..+.+||+||
T Consensus        96 r----iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   96 R----IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             e----eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence            5    49999999999999999976678899999999999999999999988   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |.+...+..    ...+.+||..|.|||+..+..++..+|+|++|++.||++.|.+||......   +....++.     
T Consensus       169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k-----  236 (281)
T KOG0580|consen  169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRK-----  236 (281)
T ss_pred             CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHH-----
Confidence            999865422    456789999999999999999999999999999999999999999755422   22222211     


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                .+-.++..++....++|.+|+..+|.+|.+..++++.
T Consensus       237 ----------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 ----------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                      1123345677889999999999999999999999873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=344.62  Aligned_cols=267  Identities=25%  Similarity=0.417  Sum_probs=216.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|+....||.|..++||+|....++..     ||||++....... ...+.+|+..|+.++||||++++..|..+..  
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~-----VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~--   98 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEV-----VAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE--   98 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCE-----EEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce--
Confidence            6799999999999999999999888765     9999998766554 4788899999999999999999999988774  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        +++||.||.+|++.+.+.......+++..+..|++++++||.|||++   |.||||||+.||||+.+|.|||+|||.+
T Consensus        99 --LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   99 --LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             --eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceee
Confidence              59999999999999999988888899999999999999999999998   9999999999999999999999999988


Q ss_pred             CCCCCCCCcc-ee-eceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          256 RLGPSDGLSH-VS-TAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       256 ~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ..+...+... .. .+++||++|||||++..  ..|+.|+||||||++..||.+|..||....+....  ...+.    +
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLq----n  247 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQ----N  247 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhc----C
Confidence            7654443221 12 67899999999999543  57999999999999999999999999766543221  11111    1


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      ......  -..+.......++..+.+++..||.+||++|||+++++.  ++...
T Consensus       248 ~pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  248 DPPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             CCCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            100000  001111222345668999999999999999999999998  45443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-45  Score=342.69  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=210.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +.|+..+.||+|.-|+||++..+++...     +|+|++.+.....   ..+...|-+||..+.||.++.||+.|..+.-
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~-----fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCL-----FAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCce-----EEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            5688888999999999999999988644     9999998866543   3456789999999999999999999988774


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .|||||||+||+|...++.+.++.+++..+..++.+|+.||+|||..   |||+|||||+||||.++|.+.|+||.
T Consensus       152 ----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  152 ----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             ----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence                49999999999999999998899999999999999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCC---------------------------------C-C--------------------CcceeeceecccCcCCc
Q 013504          254 LARLGPS---------------------------------D-G--------------------LSHVSTAVVGTIGYAAP  279 (441)
Q Consensus       254 la~~~~~---------------------------------~-~--------------------~~~~~~~~~gt~~y~aP  279 (441)
                      |+.....                                 . .                    ....+..++||-.|+||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8753211                                 0 0                    00123467899999999


Q ss_pred             cccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHH
Q 013504          280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVA  359 (441)
Q Consensus       280 E~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  359 (441)
                      |++.+...+.++|||+|||++||||.|..||.+......                +..++-..+.-......+..+.+||
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLI  368 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHH
Confidence            999999999999999999999999999999976543322                1222222222222236778899999


Q ss_pred             HHhhcccCCCCCC----HHHHHH
Q 013504          360 NKCLARQAKGRPK----MSEVVE  378 (441)
Q Consensus       360 ~~cl~~dP~~RPs----~~evl~  378 (441)
                      +++|.+||++|..    +.||-+
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHHhccChhhhhccccchHHhhc
Confidence            9999999999998    666655

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=360.54  Aligned_cols=264  Identities=28%  Similarity=0.477  Sum_probs=212.3

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEec
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAE  170 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~  170 (441)
                      ....+++.+...||+|.||+||+|.|.++        ||||++......  ..+.|..|+.++++-+|.||+-+.|||..
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd--------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD--------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccccc--------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            34456677788899999999999999876        999999876543  35789999999999999999999999987


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      +..     .||+-+|+|.+|+.+|+.. ...|+..+.+.|++||++|+.|||.+   +|||||||..||||.+++.|||+
T Consensus       460 p~~-----AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  460 PPL-----AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             Cce-----eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence            652     7899999999999999864 36799999999999999999999999   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||||+..-.............|...|||||+++.   .+|+..+||||||+++|||++|..||......  +-+....+.
T Consensus       531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVGrG  608 (678)
T KOG0193|consen  531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVGRG  608 (678)
T ss_pred             cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEeccc
Confidence            9999875332222222334568889999999864   56899999999999999999999999733221  111110111


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ++.          +. ......++++++.+|+..||..++++||.+.+|+..|+.++..
T Consensus       609 ~l~----------pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  609 YLM----------PD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ccC----------cc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            100          00 1123346788999999999999999999999999999988763

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.7e-46  Score=376.41  Aligned_cols=267  Identities=27%  Similarity=0.465  Sum_probs=227.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+....+.||+|+||+||+|...+.........||||.++..... ...+|.+|+++|..++|||||+|+|+|.+.+.. 
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~-  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL-  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee-
Confidence            455566779999999999999887766667778999999987765 568899999999999999999999999998875 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC--------CCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF--------QAT----LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                         |+|+|||..|+|.+||..+.        +..    ++..+.+.|+.|||.|+.||-++   .+|||||..+|+||.+
T Consensus       565 ---~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  565 ---CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             ---EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence               99999999999999997431        223    88899999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~  322 (441)
                      +..|||+|||++|.....+.........-..+|||||.+..++|+.+||||||||+|||+++ |+.||.+....+..+.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            99999999999998776665555545566789999999999999999999999999999999 99999765544333322


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .   .             ..+ -..+.++|.++.+|+..||+.+|.+||+++||-..|+......
T Consensus       719 ~---~-------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  719 R---A-------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             H---c-------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            2   1             112 3456689999999999999999999999999999999987653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.8e-46  Score=357.42  Aligned_cols=247  Identities=31%  Similarity=0.497  Sum_probs=212.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||||+.+.+.+.     ||+|.+.+...  +..+.+.+|++|++.++||||+.++++|....+ 
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~-----vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~-   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQV-----VAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH-   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeE-----EEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-
Confidence            5788899999999999999998887765     99999987654  345678899999999999999999999988774 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         +++|.|||.| +|..+|..  .+.++++.+..++.+++.||.|||++   +|+|||+||.||||+.++.+|+||||+
T Consensus        76 ---~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   76 ---LWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             ---EEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence               5999999966 99999977  68999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      |+.....  ....+.+.|||.|||||++.+.+|+..+|+||+|||+||+++|++||-..   ....++..+   +.+   
T Consensus       147 Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I---~~d---  215 (808)
T KOG0597|consen  147 ARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSI---LKD---  215 (808)
T ss_pred             hhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHH---hcC---
Confidence            9976543  45667789999999999999999999999999999999999999999532   122222221   111   


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +   ..++...+..+..++...|.+||..|.+-.+++.
T Consensus       216 ------~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 ------P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ------C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                  1   2344577889999999999999999999999987

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.1e-45  Score=360.13  Aligned_cols=266  Identities=24%  Similarity=0.410  Sum_probs=209.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|++...+.......||+|.+...... ....+.+|+.+++.+ +||||++++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            3579999999999999999999876555445556999999764432 345678999999999 89999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-------------------------------------------------------  198 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  198 (441)
                          .++||||+++|+|.+++....                                                       
T Consensus       117 ----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         117 ----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             ----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence                499999999999999985421                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcc
Q 013504          199 -------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH  265 (441)
Q Consensus       199 -------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  265 (441)
                                   ..++++..++.++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         12478889999999999999999998   99999999999999999999999999998654332222


Q ss_pred             eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCC
Q 013504          266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLE  344 (441)
Q Consensus       266 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (441)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||........  .......              ...
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~~--------------~~~  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVKR--------------GYQ  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHHc--------------ccC
Confidence            2223345678999999988899999999999999999997 9999965432211  1111100              001


Q ss_pred             CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       345 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ...+...+.++.+++.+||+.||++||++.+|++.|++++
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            1111124578999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-44  Score=359.13  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=207.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|++...........||||++..... ...+.+.+|+.+|..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            357899999999999999999875443334455699999875432 2345688999999999 89999999999987764


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-------------------------------------------------------  198 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  198 (441)
                          .++|||||++|+|.+++..+.                                                       
T Consensus       114 ----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         114 ----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             ----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence                499999999999999986432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          199 ------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       199 ------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                                        ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              12478889999999999999999998   999999999999999999999999999986544


Q ss_pred             CCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||.......  .....+....          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~----------  334 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGY----------  334 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCc----------
Confidence            322222223445678999999999999999999999999999998 889986543221  1111111110          


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                          ....+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus       335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                0001112356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-45  Score=344.40  Aligned_cols=265  Identities=27%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             chHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------------hhHHHHHHHHHh
Q 013504           88 TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------------GHKEWVTEVNVL  153 (441)
Q Consensus        88 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~il  153 (441)
                      .-.+-+...++|+++..||+|.||.|-+|+...++..     ||||++.+....              ..+...+|+.||
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l-----~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKL-----YAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcE-----EEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            3344456678999999999999999999998777654     999999864321              124678999999


Q ss_pred             ccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 013504          154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQAT-LPWNTRLKIAQDAARGLAYLHEGMDFQIIFR  232 (441)
Q Consensus       154 ~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  232 (441)
                      ++++|||||+|+.+..+....  .+|||+|||..|.+...=.   .+. +.+.++++|+++++.||.|||.+   |||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHR  234 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHR  234 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccC--ceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---Ceecc
Confidence            999999999999998776654  6799999999988754432   344 89999999999999999999999   99999


Q ss_pred             ccCCCcEEEcCCCcEEEeecCCCCCCCCC---CCcceeeceecccCcCCccccccCC----CCccccchhHHHHHHHHHh
Q 013504          233 DFKSSNILLDEQWNAKLSDFGLARLGPSD---GLSHVSTAVVGTIGYAAPEYIQTGR----LTYKSDIWSFGVFLYELIT  305 (441)
Q Consensus       233 DlKp~NILl~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~ellt  305 (441)
                      ||||+|+||+++|.+||+|||.+......   +........+|||.|+|||...++.    .+.+.||||+||+||.|+.
T Consensus       235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf  314 (576)
T KOG0585|consen  235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF  314 (576)
T ss_pred             ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence            99999999999999999999999865322   1112223479999999999887633    3567899999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       306 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      |+.||.+....   .+             +..+++..+.-...+++...+.+||.++|++||+.|.+..+|.....
T Consensus       315 G~~PF~~~~~~---~l-------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  315 GQLPFFDDFEL---EL-------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ccCCcccchHH---HH-------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            99999754322   12             12233333433344467788999999999999999999999877543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.3e-44  Score=341.20  Aligned_cols=250  Identities=20%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      ..||+|++|.||+|.+.+.       .||||.+.......   .+.+.+|+.+|.+++||||+++++++.+........+
T Consensus        26 ~~i~~g~~~~v~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNK-------EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEECCE-------EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            5799999999999998432       49999987654332   3567799999999999999999999876222222468


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+++|+|.+++..  ...+++...+.++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||+++...
T Consensus        99 lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         99 LILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999999999976  35789999999999999999999973  278899999999999999999999999998643


Q ss_pred             CCCCcceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      ..     .....||..|+|||++.+  ..++.++|||||||++|||++|..||.........   ..+..   .      
T Consensus       175 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~i~~---~------  237 (283)
T PHA02988        175 SP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DLIIN---K------  237 (283)
T ss_pred             cc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh---c------
Confidence            32     123568999999999976  68999999999999999999999999765432211   11100   0      


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                          ......+..++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       238 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 ----NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ----CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                0011122346778999999999999999999999999998764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-45  Score=356.95  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=210.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-c--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-L--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .-|+.++.||.|+.|.|-+|++..|++.     +|||++.+.. .  .....+.+|+.||+.+.||||+++|+++.+...
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGql-----aaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQL-----AAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccce-----eEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            4578888999999999999999998876     8999988752 1  123457799999999999999999999988764


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          +|+|.||++||.|+++|..  .+++++.++.++++||+.|+.|||..   +|+||||||+|+|||..+++||+|||
T Consensus        87 ----lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   87 ----LYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             ----EEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence                5999999999999999987  47999999999999999999999988   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +|..-...   ....+.||.|.|.+||++.+.+|+ .++||||.|||||.||||+.||++.+-.   .++..+....   
T Consensus       158 MAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~~G~---  228 (786)
T KOG0588|consen  158 MASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQRGV---  228 (786)
T ss_pred             eeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHHcCc---
Confidence            99875443   245668999999999999999985 6899999999999999999999855422   2222222211   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                  -..+..++.+..+|+.+||..||++|.|+++|++.
T Consensus       229 ------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                        12344678899999999999999999999999984

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-44  Score=319.41  Aligned_cols=266  Identities=23%  Similarity=0.362  Sum_probs=210.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .+|...+.||+|.||.||+|++..+++.     ||||+++..+..+  .....+|+..|+.++|+||+.++++|...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~-----VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKR-----VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcE-----EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce
Confidence            3577888999999999999998887765     9999998765432  35678999999999999999999999887754


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                          .||+||++ .+|+..++.+ ...+....+..++.++++||+|||.+   .|+||||||.|+|++.+|.+||+|||+
T Consensus        77 ----~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 ----SLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             ----EEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence                89999995 5999999865 46889999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh--------
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV--------  325 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~--------  325 (441)
                      |+........  ....+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.+....+....+-.+        
T Consensus       148 Ar~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  148 ARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             hhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence            9987765433  233478999999998877 46999999999999999999988878766554443332111        


Q ss_pred             hhhcccccchhhhc---CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          326 RPHLTDAKKFTMIL---DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       326 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ++.+..-..+..+.   .+.+. ..-..++.++.+|+..+|..||.+|+++.+++++
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111111111111   11111 1333456677999999999999999999999984

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.7e-44  Score=340.83  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=202.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .|+..+.||+|+||.||+|.+..++..     ||+|.+......   ....+.+|+.++..++|+||+++++++.+.+  
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--   73 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKM-----YACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--   73 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCce-----EEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence            377889999999999999998876654     999988654322   2345778999999999999999999987765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.++|+|||+
T Consensus        74 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          74 --ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             --eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence              359999999999999888654445789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..   ....   
T Consensus       149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~---  219 (285)
T cd05631         149 AVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKE---  219 (285)
T ss_pred             cEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhc---
Confidence            98653321   22345799999999999999999999999999999999999999976543221111110   0000   


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                              ....++..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       220 --------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 --------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                    011223345678999999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=333.00  Aligned_cols=282  Identities=24%  Similarity=0.315  Sum_probs=218.2

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcc--ccCchhhHHHHHHHHHhccCCCCCeeeEEeEEec
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAE  170 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  170 (441)
                      ......|...+.||+|+||.|+.+.+..++..     ||||++.  -......++..+|+.+|+.++|+||+.+++++..
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~-----VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p   92 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEK-----VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP   92 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCE-----eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence            34456677788999999999999999888754     9999998  3444556888999999999999999999999877


Q ss_pred             c-ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          171 D-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       171 ~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      + .......|+|+|+| +.+|...++.  +..++...+..+++|++.||.|+|+.   +|+||||||.|+|++.+..+||
T Consensus        93 ~~~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             ccccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEe
Confidence            2 22233569999999 7799999976  45699999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +|||+|+...........+.++-|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+........++....+.
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            9999999875432233446789999999999764 567999999999999999999999999877655544443322221


Q ss_pred             cccc----------cchhhhcCCCCCCcch---HHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          329 LTDA----------KKFTMILDPKLEGKYS---IKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       329 ~~~~----------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      ..+.          ..+...+.......+.   ++..+...+|+.+||..||.+|+|++|+++  .|....+
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence            1110          0000001111111111   145577889999999999999999999998  3555443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=347.82  Aligned_cols=249  Identities=28%  Similarity=0.440  Sum_probs=210.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ..|...++||+|.||.||+|.+..+.+.     ||+|++...... ....+.+|+.+|..++++||.++|+.+.....  
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~-----vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKV-----VAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--   85 (467)
T ss_pred             cccccchhccccccceeeeeeeccccce-----EEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc--
Confidence            4567778899999999999998887765     999999876543 35678899999999999999999999887664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        ++++||||.||++.+.|..  +..+++..+..++++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||++
T Consensus        86 --LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   86 --LWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             --HHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence              4899999999999999976  45668889999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  ....+++|||.|||||++.+..|+.++||||||++.+||++|.+|+....+....                
T Consensus       159 ~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------  220 (467)
T KOG0201|consen  159 GQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------  220 (467)
T ss_pred             eeeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------
Confidence            8765543  2347899999999999999889999999999999999999999999765442111                


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       -++.......+...+++.+++++..||.+||+.||++.++++
T Consensus       221 -flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  221 -FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence             111111222333467888999999999999999999999998

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-43  Score=342.31  Aligned_cols=268  Identities=26%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCC-----------cccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeE
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTED-----------SHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l  164 (441)
                      ++|.+.+.||+|+||.||+|.+.....           ......||+|.+...... ....+.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999998755331           123346999998764332 34578899999999999999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF-----------------QATLPWNTRLKIAQDAARGLAYLHEGMDF  227 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  227 (441)
                      ++++...+.    .++||||+++|+|.+++....                 ...+++..++.++.||+.||.|||+.   
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          85 LGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             EEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            999987654    499999999999999986421                 12467888999999999999999998   


Q ss_pred             CeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh--
Q 013504          228 QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT--  305 (441)
Q Consensus       228 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--  305 (441)
                      +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999999999999999999999986543322222334456889999999988899999999999999999987  


Q ss_pred             CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       306 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      |..||.......   ...............       .....+..++..+.+++.+||+.+|++||++.+|.+.|+
T Consensus       238 ~~~p~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTDEQ---VIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCHHH---HHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            567776543222   222111111110000       000112235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-43  Score=337.53  Aligned_cols=262  Identities=26%  Similarity=0.481  Sum_probs=211.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+...........|++|.+...... ....+.+|+.++..++||||+++++++.....  
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP--   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc--
Confidence            468888999999999999999876654445567999998754432 24568899999999999999999999876553  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQ--------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                        .+++|||+++|+|.+++.....              ..+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus        83 --~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~  157 (283)
T cd05048          83 --TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLV  157 (283)
T ss_pred             --eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEE
Confidence              4899999999999999975321              4578899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQK  320 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~  320 (441)
                      ++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986543332223344567889999999988899999999999999999998 999997654332   


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                      ....+...              .....+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       235 ~~~~i~~~--------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSR--------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcC--------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            22211110              0112234567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-44  Score=347.85  Aligned_cols=245  Identities=25%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||+|.+.....   .....+.+|+.+++.++||||+++++++...+ 
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEY-----YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCE-----EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-
Confidence            5799999999999999999998876653     99999875432   23456789999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        92 ---~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         92 ---RVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             ---EEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence               35999999999999999976  46789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+..      
T Consensus       164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~------  229 (329)
T PTZ00263        164 FAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---EKILA------  229 (329)
T ss_pred             CceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH---HHHhc------
Confidence            99865432     22467999999999999999999999999999999999999999754432211   11110      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                             ..  ..++..++..+.+++.+||+.||.+||+     +.+++.
T Consensus       230 -------~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 -------GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -------CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   00  0111224567889999999999999997     677775

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.4e-44  Score=346.26  Aligned_cols=242  Identities=27%  Similarity=0.433  Sum_probs=197.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      ++||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+++.++||||+++++++...+    ..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKY-----YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEE
Confidence            3699999999999998776653     99999875432   22356778999999999999999999988765    459


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          72 FVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            99999999999999976  46789999999999999999999998   99999999999999999999999999998543


Q ss_pred             CCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+..   .        
T Consensus       147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~~---~--------  210 (323)
T cd05571         147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILM---E--------  210 (323)
T ss_pred             cCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHHc---C--------
Confidence            221  12345689999999999999999999999999999999999999996543221   1111110   0        


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                          ...++..++..+.+++.+||+.||++||     ++.++++
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                0112234567889999999999999999     7888886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-43  Score=352.84  Aligned_cols=267  Identities=23%  Similarity=0.379  Sum_probs=210.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCC-CCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.++||+|+||.||+|++...........||||++...... ....+.+|+.+|.++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4688999999999999999999866554444556999999754432 2456889999999995 9999999999977653


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-------------------------------------------------------  198 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  198 (441)
                          .|||||||++|+|.+++....                                                       
T Consensus       116 ----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         116 ----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             ----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence                599999999999999886421                                                       


Q ss_pred             ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcE
Q 013504          199 ---------------------------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI  239 (441)
Q Consensus       199 ---------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NI  239 (441)
                                                             ...+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence                                                   12477888899999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhH
Q 013504          240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE  318 (441)
Q Consensus       240 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~  318 (441)
                      |++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986543322222233457788999999998899999999999999999997 9999965422111


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                        ....+..    .          .....+..++..+.+++.+||..+|++||++.+|.+.|+.++.
T Consensus       349 --~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 --FYNKIKS----G----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHhc----C----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              1111110    0          0111223456789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-44  Score=342.94  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+++.++||||+++++++.+.. 
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHY-----YALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCE-----EEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence            3688999999999999999998766553     99999865432   23456788999999999999999998887655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          75 ---FLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             ---eEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence               45999999999999999976  35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...        
T Consensus       147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------  213 (291)
T cd05612         147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--------  213 (291)
T ss_pred             cchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence            99865332     23457999999999999989999999999999999999999999765432211111100        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                              .  ..++..++..+.+++.+||+.||.+||+     ++++++
T Consensus       214 --------~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         214 --------K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             --------C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                    0  0122234567899999999999999995     777776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=348.00  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=216.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|..++.+|+|+||.++.+.++....     .+++|.+.......  .....+|+.++++++|||||.+.+.|.+++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~-----~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~-   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDK-----LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ-   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCc-----eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-
Confidence            578899999999999999998877655     38999887655332  3467899999999999999999999988774 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        .++|||+||+||+|.+.|....+..++++.+..++.|++.|+.|||++   +|+|||||+.|||++.++.|||+|||+
T Consensus        78 --~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   78 --LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             --eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence              259999999999999999887778999999999999999999999988   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      |+......  ....+.+||+.||.||++.+.+|+.++|||||||++|||++-+++|...+..   .++..+.+.      
T Consensus       153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~------  221 (426)
T KOG0589|consen  153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRG------  221 (426)
T ss_pred             hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhc------
Confidence            99876653  2456789999999999999999999999999999999999999999765432   222222111      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                              .....+..++.++..++..||..+|+.||++.++|..
T Consensus       222 --------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 --------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                    1223455788899999999999999999999999985

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-43  Score=335.63  Aligned_cols=266  Identities=26%  Similarity=0.452  Sum_probs=214.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|.+.+.||+|+||.||+|.+...........+++|.+........+.+.+|+.++++++||||+++++++...+.   
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP---   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc---
Confidence            46888899999999999999876654444555689999876665555778899999999999999999999987653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                       .++||||+++++|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+|||++
T Consensus        82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          82 -LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             -eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence             499999999999999996532              23488999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKL  321 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~  321 (441)
                      .++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986544322222334567889999999998899999999999999999999 999996554322   1


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      .+......              ....+..++..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus       235 ~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11111100              0011123456789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=345.78  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=205.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.++..++||||+++++++...+ 
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEI-----VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCE-----EEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence            3689999999999999999998876553     99999875432   23456788999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          75 ---YLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             ---EEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence               45999999999999999975  45789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++....     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+.   
T Consensus       147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (333)
T cd05600         147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---  218 (333)
T ss_pred             CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---
Confidence            9986433     23456899999999999999999999999999999999999999976544332221111000000   


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                            .+. .......++..+.+++.+||..+|.+||++.+++..
T Consensus       219 ------~~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 ------RPV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------CCC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  000 000012456788999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-44  Score=332.40  Aligned_cols=274  Identities=25%  Similarity=0.375  Sum_probs=211.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC-C
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER-G  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~  175 (441)
                      -.|...+++|+|+||.||+|+...+++.     ||||++.....    .--+|+.+|+.+.|||||++.-+|...... .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~-----vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEE-----VAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCce-----eEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            4577788999999999999999888554     99998865432    223799999999999999999988776554 3


Q ss_pred             eeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEeec
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDF  252 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DF  252 (441)
                      ....|||||++. +|.+.++..  .+..++.-.+.-+.+||.+||.|||+.   +|+||||||+|+|+|.+ |.+|||||
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence            456789999965 999998742  356788888999999999999999997   99999999999999876 89999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |.|+.....+   ...++..|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+....+....+-.+......
T Consensus       171 GSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  171 GSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             CcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            9999876543   2356788999999998877 56999999999999999999999999876655444333222111111


Q ss_pred             cc------chhhhcCCCCC-----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHhh
Q 013504          332 AK------KFTMILDPKLE-----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVDA  386 (441)
Q Consensus       332 ~~------~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~  386 (441)
                      ..      .......|.+.     ..+....++++.+|+.++|..+|.+|.++.+++.  .++.+.+.
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            00      00011112221     1234456788999999999999999999999987  56666554

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-43  Score=343.72  Aligned_cols=264  Identities=26%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||++.+..++..     +|+|.+..... .....+.+|+.+|+.++||||+++++++...+  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   76 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLI-----MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--   76 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcE-----EEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence            36899999999999999999998876643     88998875432 23467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||++  .+|+||||||+|||++.++.+||+|||+
T Consensus        77 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          77 --EISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             --EEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence              35999999999999999976  35789999999999999999999975  2699999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc-c
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA-K  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~  333 (441)
                      ++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............   ....+. .
T Consensus       151 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~  223 (331)
T cd06649         151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG---RPVVDGEE  223 (331)
T ss_pred             ccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc---cccccccc
Confidence            9765332    2234679999999999999999999999999999999999999996543322211111   000000 0


Q ss_pred             --------------------------------chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          334 --------------------------------KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       334 --------------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                                      ....+............++.++.+|+.+||+.||++||++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                            0000000000011112356789999999999999999999999984

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-43  Score=345.56  Aligned_cols=267  Identities=27%  Similarity=0.409  Sum_probs=210.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|...+++.......||+|++..... ...+.+.+|+.++.++ +||||++++++|...+. 
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~-   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG-   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC-
Confidence            57999999999999999999876655444556799999875432 2345678899999999 89999999998875543 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------------------------------------------------
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------------------------------------------------  198 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------  198 (441)
                        ..+++|||+++++|.+++....                                                        
T Consensus        86 --~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          86 --PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             --CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence              3589999999999999986422                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccC
Q 013504          199 ---QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG  275 (441)
Q Consensus       199 ---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  275 (441)
                         ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+++...............++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12688999999999999999999998   999999999999999999999999999987543322222334556788


Q ss_pred             cCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHH
Q 013504          276 YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQK  354 (441)
Q Consensus       276 y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (441)
                      |+|||++.+..++.++|||||||++|||++ |..||........  ....+    ....          ....+...+..
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~----~~~~----------~~~~~~~~~~~  304 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRL----KEGT----------RMRAPEYATPE  304 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHH----hccC----------CCCCCccCCHH
Confidence            999999999999999999999999999998 9999965432211  11111    0000          00111234567


Q ss_pred             HHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          355 LAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       355 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      +.+++.+||+.+|++||++.+|++.|+.++.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.4e-43  Score=338.55  Aligned_cols=264  Identities=27%  Similarity=0.459  Sum_probs=209.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|+..+.||+|+||.||+|.+..++.. ....||+|.+..... ....++.+|+.+++.++||||+++++++....   
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~---   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCc-cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC---
Confidence            5799999999999999999998665432 234589999875432 33467889999999999999999999997643   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++|+||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        83 --~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          83 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             --ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence              37999999999999999764 34688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||.............   .    .. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---~----~~-  228 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K----GE-  228 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---C----CC-
Confidence            87654332222223345678999999999999999999999999999998 999997543322111111   0    00 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                               ....+..++..+.+++.+||..+|.+||++.+++..|..+....
T Consensus       229 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                     00111234467889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-43  Score=336.93  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++..     +|+|++.....  ...+.+.+|+.+++.++||||+++++++...+  
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEI-----VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcE-----EEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--
Confidence            4689999999999999999998876653     89998875432  22456788999999999999999999997765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||++++.|..+...  ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        74 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          74 --KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             --EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence              35999999998777655433  45789999999999999999999988   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc---
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD---  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---  331 (441)
                      ++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+..   
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         147 ARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             cccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence            98654322 11223467899999999999889999999999999999999999999765433322211111110000   


Q ss_pred             -----ccchhhhcCCCC------CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 -----AKKFTMILDPKL------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 -----~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           .........+..      .......++..+.+++.+||+.||++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 000000000000      01112235678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=323.34  Aligned_cols=269  Identities=24%  Similarity=0.326  Sum_probs=210.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|+..+.|++|+||.||+|++..++..     ||+|+++......  .-..++|+.+|.+++|||||.+-.+....+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eI-----VALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEI-----VALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCccee-----EEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            45688888999999999999999888775     9999998654221  1235799999999999999999999887765


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .  ..|||||||+ .+|...+... ..+|...++.-++.|++.||+|||.+   .|+||||||+|+|++..|.+||+|||
T Consensus       150 d--~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  150 D--KIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             c--eeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence            5  3599999995 4888888765 46899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh-------
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV-------  325 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~-------  325 (441)
                      +||.+....  ...+..+-|.+|.|||++.+. .|+..+|+||+|||+.||+++++-|.+....+..+.+-..       
T Consensus       223 LAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  223 LAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             hhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            999876652  235567889999999998874 5999999999999999999999999876654443332211       


Q ss_pred             -hhhcccccchh-----hhcCCCCCCcchHH-HHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 -RPHLTDAKKFT-----MILDPKLEGKYSIK-LAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 -~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ++.+.......     ......++..+... .++.-.+|+..+|..||.+|.|+++.|+
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             11111111000     00001111122212 5577889999999999999999999987

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=347.94  Aligned_cols=241  Identities=25%  Similarity=0.436  Sum_probs=203.2

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      ..+-||+|+.|.||+|++++..       ||||+++...       ..+|.-|++|+||||+.+.|+|....    .+||
T Consensus       128 ELeWlGSGaQGAVF~Grl~net-------VAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP----cyCI  189 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLHNET-------VAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP----CYCI  189 (904)
T ss_pred             hhhhhccCcccceeeeeccCce-------ehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc----eeEE
Confidence            3456999999999999987654       9999875322       26888999999999999999998655    4599


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      |||||..|-|++.|+.  +..+.......+..+||.|+.|||.+   .|||||||.-||||..+..|||+|||.++....
T Consensus       190 iMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             eeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            9999999999999976  57888899999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcC
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD  340 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (441)
                      .   .....++||..|||||++...+.+.|+|||||||+|||||||..||.+....                ..+..+-.
T Consensus       265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwGVGs  325 (904)
T KOG4721|consen  265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWGVGS  325 (904)
T ss_pred             h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEeccC
Confidence            2   2345689999999999999999999999999999999999999999543211                01111122


Q ss_pred             CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       341 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ..+.-..+..+++.+.-|+++||...|.+||++.+|+..|+-.
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            3344456678899999999999999999999999999988643

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=359.90  Aligned_cols=265  Identities=25%  Similarity=0.342  Sum_probs=216.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeE-Eecc-c
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGY-CAED-D  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~~-~  172 (441)
                      ..++.+.+.|.+|||+.||+|.....+     ..+|+|++-..+....+.+.+||.+|++|+ |+|||.|++. .... .
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            357888899999999999999987764     349999998877777888999999999995 9999999993 3322 2


Q ss_pred             cC-CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          173 ER-GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       173 ~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .. ....+|+||||.||.|-+++..+.+..|++.++++|++++++|+.+||.. .++|||||||-+||||+.+|..||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence            22 35678999999999999999988888899999999999999999999986 67899999999999999999999999


Q ss_pred             cCCCCCCCCCC-Ccce------eeceecccCcCCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          252 FGLARLGPSDG-LSHV------STAVVGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       252 FGla~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      ||.+......- ....      .-...-|+.|++||++   .+.+.+.|+|||+|||+||-|+....||+....      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            99987432211 0000      0123468999999987   467889999999999999999999999975421      


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                    ..+++....-...+.++..+.+||..||+.||.+||++-+|+..+..+...
T Consensus       264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                          112333333333357899999999999999999999999999999887643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=334.91  Aligned_cols=248  Identities=20%  Similarity=0.419  Sum_probs=208.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..+|++.+.||+|+||.|-+|.....+.     .||||.+++....+   .-.+.+|++||..|+||||+.+|.+|...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR-----~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGR-----EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCc-----EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            3578888899999999999998765554     49999998766544   345779999999999999999999999877


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    .+|||||..+|.|++|+..  .+.+++.++..+++||..|+.|+|++   +++|||||.+|||||.|+++||+||
T Consensus       127 K----IvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  127 K----IVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             e----EEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence            5    4999999999999999987  47899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |++.++...   ...++++|+|.|.+||++.+.+|. +.+|-|||||+||-|+.|..||++...   ..++..+..    
T Consensus       198 GLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~----  267 (668)
T KOG0611|consen  198 GLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISR----  267 (668)
T ss_pred             chhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhc----
Confidence            999876554   346789999999999999999884 789999999999999999999986543   222222211    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      + .+           ..+..+....-||++||..+|++|.|+.+|...
T Consensus       268 G-aY-----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  268 G-AY-----------REPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             c-cc-----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            0 00           011233456789999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-42  Score=333.11  Aligned_cols=266  Identities=27%  Similarity=0.445  Sum_probs=211.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||++.............+|+|.+..........+.+|+.++.+++||||+++++++...+.   
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP---   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc---
Confidence            57889999999999999999865533333445689999876654556678999999999999999999999987653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRF-----------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                       .++||||+++++|.+++....           ...+++..++.++.|++.||.|||+.   +++||||||+|||+++++
T Consensus        82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          82 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             -cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence             499999999999999986431           13589999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~  324 (441)
                      .++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~  234 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC  234 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999986543322222233456788999999998899999999999999999998 899996554322   1111


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      +....    .      .    ..+..++..+.+++.+||+.+|.+||++.+++..|+++...
T Consensus       235 i~~~~----~------~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGR----V------L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCC----c------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11100    0      0    01112456799999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-43  Score=329.69  Aligned_cols=259  Identities=22%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+....  .....||+|.+...... ....+.+|+.++.+++||||+++++++...+.  
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT--   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC--
Confidence            57899999999999999999875432  13346999998765332 23568899999999999999999999987654  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.++++|||.+
T Consensus        81 --~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          81 --MMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             --cEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence              49999999999999999754 35789999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||........   ...+..    .. 
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~----~~-  225 (266)
T cd05064         155 QEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAVED----GF-  225 (266)
T ss_pred             ccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHC----CC-
Confidence            6542221 111122345678999999999999999999999999999875 9999976543322   111110    00 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                               ....+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       226 ---------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 ---------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     0112234667899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.3e-43  Score=333.15  Aligned_cols=261  Identities=27%  Similarity=0.446  Sum_probs=209.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+...........||+|.+...... ..+.+.+|+.+|+.++||||+++++++.....  
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP--   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC--
Confidence            568888899999999999998866533344556999998765444 34678899999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                        .++||||+++++|.+++....            ...+++..+..++.|++.||.|||++   +++||||||+||+++.
T Consensus        83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~  157 (280)
T cd05049          83 --PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY  157 (280)
T ss_pred             --eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence              599999999999999997532            24578899999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~  322 (441)
                      ++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........   .
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~  234 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---I  234 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H
Confidence            99999999999986433322222334456789999999999999999999999999999998 9999965443222   2


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      ..+...     .         ....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       235 ~~~~~~-----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQG-----R---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcC-----C---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            211100     0         00112245678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=348.81  Aligned_cols=265  Identities=29%  Similarity=0.498  Sum_probs=214.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++-...++||+|+||.||+|.+......... .||||......   .....++++|.++|+.++|||||++||++.....
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~-~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVV-PVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceee-eeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            4455567999999999999999876542222 28999988522   3456789999999999999999999999988876


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .    +||||+|+||+|.++|... ...++..+.+.++.+.+.||+|||++   ++|||||..+|+|++.++.+||+|||
T Consensus       236 l----~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  236 L----MLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             c----EEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence            5    9999999999999999875 34799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++.......  ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.  .      
T Consensus       308 Ls~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~--~------  377 (474)
T KOG0194|consen  308 LSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV--K------  377 (474)
T ss_pred             cccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH--h------
Confidence            9987542111  1112235678999999999999999999999999999999 888997765443222210  0      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                              .......+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       378 --------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  378 --------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                    011112223556788899999999999999999999999999886654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-43  Score=340.35  Aligned_cols=240  Identities=26%  Similarity=0.384  Sum_probs=193.7

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||+|+||.||+|.+..++.     .||+|.+....   ......+.+|+.++.+++||||+++++++...+    ..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQR-----IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEE
Confidence            7999999999999877654     39999986532   223456778999999999999999999987665    45999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          72 LAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            999999999999976  45789999999999999999999998   9999999999999999999999999999854322


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+   ...          
T Consensus       147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~~---~~~----------  208 (312)
T cd05585         147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRKI---LQE----------  208 (312)
T ss_pred             C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHHH---HcC----------
Confidence            1  12345679999999999999999999999999999999999999997543221   11111   000          


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCC---HHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPK---MSEVVE  378 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  378 (441)
                        ...++..++..+.+++.+||..||.+||+   +.+++.
T Consensus       209 --~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         209 --PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence              01122345678899999999999999986   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-42  Score=331.73  Aligned_cols=264  Identities=27%  Similarity=0.440  Sum_probs=209.0

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +|++.+.||+|+||.||+|.............+++|.+..... .....+.+|+.+++.++||||+++++.+...+..  
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL--   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc--
Confidence            4778889999999999999876544333445689998875443 2346788999999999999999999998876643  


Q ss_pred             eEEEEEeccCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRF----------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF  234 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  234 (441)
                        ++||||+++|+|.+++....                      ...+++..++.++.|++.||.|||+.   +|+||||
T Consensus        79 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di  153 (290)
T cd05045          79 --LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL  153 (290)
T ss_pred             --EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence              99999999999999986421                      13578899999999999999999988   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRN  313 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~  313 (441)
                      ||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986533322112233456778999999988889999999999999999998 99999654


Q ss_pred             CchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      .+..   +.+......              ....+..++..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       234 ~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         234 APER---LFNLLKTGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CHHH---HHHHHhCCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            4322   222211110              111122355678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-43  Score=343.77  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=201.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..+..    ..||+|.+.....   .....+.+|+.++..++||||+++++++.+.. 
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDF----PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCC----eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-
Confidence            579999999999999999998765432    2499998865322   23456788999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       105 ---~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        105 ---YLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCC
Confidence               45999999999999999976  46789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...........   +..      
T Consensus       177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---i~~------  242 (340)
T PTZ00426        177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK---ILE------  242 (340)
T ss_pred             CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH---Hhc------
Confidence            99865332     2346899999999999988899999999999999999999999976543221111   100      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVEV  379 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  379 (441)
                             ..  ..++..++..+.+++.+||+.||++|+     +++++++.
T Consensus       243 -------~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        243 -------GI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   00  011223456788999999999999995     88888773

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.1e-43  Score=341.44  Aligned_cols=243  Identities=25%  Similarity=0.416  Sum_probs=197.1

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.||+|+||.||++....++..     ||+|++.....   .....+.+|+.+++.++||||+++++++...+    ..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKY-----YAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEE
Confidence            3699999999999998776553     99999875432   23456788999999999999999999988766    359


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+++|+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          72 FVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            99999999999999865  45789999999999999999999998   99999999999999999999999999988543


Q ss_pred             CCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.      ..        
T Consensus       147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~~--------  210 (328)
T cd05593         147 TDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------  210 (328)
T ss_pred             Ccc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------cC--------
Confidence            221  12234679999999999999999999999999999999999999996543322111110      00        


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVEV  379 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  379 (441)
                          ...++..++..+.+++.+||..||++||     ++.++++.
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 ----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                0112234567789999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.4e-43  Score=355.92  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      .|.+.+.||+|+||.||+|....+..    ..|++|.+..........+.+|+.+|+.++||||+++++++...+    .
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~----~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPK----EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----K  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCC----eEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----E
Confidence            48889999999999999998765521    237888775554444556778999999999999999999998765    4


Q ss_pred             EEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                      .||||||+++|+|.+++...  ...++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            59999999999999988643  235688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      +..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+..   .    
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~---~----  286 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLY---G----  286 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---C----
Confidence            86543322223445679999999999999999999999999999999999999997543221   1111100   0    


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            . ....+..++..+.+++.+||..+|++||++.+++.
T Consensus       287 ------~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 ------K-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------C-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  0 00112245578999999999999999999999875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-42  Score=327.03  Aligned_cols=256  Identities=26%  Similarity=0.463  Sum_probs=207.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|.+.+.||+|+||.||+|.+...+..     |++|.+.... .....+.+|+.+++.++||||+++++++...+.   
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~-----~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   76 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP---   76 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCce-----EEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC---
Confidence            4588889999999999999998765543     9999886543 345678899999999999999999999887654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++.......+++..++.++.|++.||.|||++   +++||||||+|||+++++.+||+|||++.
T Consensus        77 -~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          77 -FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             -cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence             48999999999999999765556789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ........       
T Consensus       153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~-------  221 (263)
T cd05052         153 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKG-------  221 (263)
T ss_pred             ccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-------
Confidence            65432211 1112334678999999998999999999999999999998 999997543222   11111110       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                             .....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 -------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                   01112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.3e-43  Score=334.16  Aligned_cols=266  Identities=24%  Similarity=0.386  Sum_probs=201.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||.|+||.||+|....++..     ||+|.+...... ....+.+|+.+++.++||||+++++++....   
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---   76 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENL-----VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER---   76 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCE-----EEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC---
Confidence            5799999999999999999998776653     999988754322 2346778999999999999999999987655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++ +|.+++... +..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        77 -~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          77 -CLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             -eEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence             35999999974 999988653 34688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh-------
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP-------  327 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~-------  327 (441)
                      +......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....       
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         151 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             eeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            7543221  12234578999999998865 5689999999999999999999999976554333222211100       


Q ss_pred             -hcccccchhhhcCCCCCCc----chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 -HLTDAKKFTMILDPKLEGK----YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       .......+.....+.....    .....+.++.+++.+||..||.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             0000111111111111100    01124567889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-43  Score=340.64  Aligned_cols=242  Identities=27%  Similarity=0.419  Sum_probs=196.2

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.||+|+||.||++....++..     ||+|.+.....   .....+.+|+.+++.++||||+++++++...+    ..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEE
Confidence            3699999999999998766553     99999875422   23345678999999999999999999998765    459


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+++|+|..++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          72 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            99999999999998865  45789999999999999999999998   99999999999999999999999999987533


Q ss_pred             CCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..      .        
T Consensus       147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------~--------  210 (323)
T cd05595         147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------E--------  210 (323)
T ss_pred             CCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------C--------
Confidence            221  122346799999999999999999999999999999999999999975443221111110      0        


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                          ...++..+++.+.+++.+||+.||.+||     ++.++++
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                0012234567889999999999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-42  Score=328.32  Aligned_cols=263  Identities=27%  Similarity=0.452  Sum_probs=207.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+..++.. ....+++|.+..... ....++..|+.++..++||||+++++++...    
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC----
Confidence            4688889999999999999998765443 223478888764432 2345677888899999999999999987532    


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++++||+++|+|.+++... ...+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence             247899999999999999754 35789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............++..|+|||.+.++.++.++|||||||++|||++ |..||.........+.+..       ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~  229 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-------GER  229 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCc
Confidence            86543332222334567789999999998899999999999999999998 9999976543322222210       000


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                         ..       .+..++..+.+++.+||..+|++||++.++++.|..+.+.
T Consensus       230 ---~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         230 ---LA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ---CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence               00       0112345678899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-42  Score=329.51  Aligned_cols=263  Identities=23%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|++.+.||+|+||.||+|.+.+.........||+|.+..... ....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999876543333345699998865332 234568899999999999999999999876553


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF--------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                          .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+|||+++++
T Consensus        84 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          84 ----TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             ----eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence                499999999999999986532        12457788999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~  324 (441)
                      .++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||............. 
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            999999999986543322222223456788999999998899999999999999999999 788986544322211111 


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                        .    ...          ...+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       236 --~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 --E----GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --c----CCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              0    000          0111234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=368.20  Aligned_cols=267  Identities=30%  Similarity=0.480  Sum_probs=219.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+....+.||+|.||.||.|...+.........||||.+.+.. .+...+|++|..+|+.++|||||+++|+|.+.... 
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~-  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP-  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc-
Confidence            4456677899999999999999876665557789999998754 34567899999999999999999999999986544 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF-----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                         +|++|||+||+|..||.+..     ...+.....+.++.|||+|+.||+++   ++|||||..+|+||+....+||+
T Consensus       771 ---~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  771 ---LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             ---EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence               89999999999999997631     35688899999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+|+.....+.........-...|||||.+..+.++.++|||||||++||++| |..||...+..+....+  ..   
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~--~~---  919 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV--LE---  919 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--Hh---
Confidence            9999995444333332222234568999999999999999999999999999999 89999765543332211  11   


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                        ..          +-..+..|+..+.+++..||+.+|++||++..|++.+..+.+..
T Consensus       920 --gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  920 --GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             --CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence              11          12234568889999999999999999999999999999988654

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6e-43  Score=329.60  Aligned_cols=255  Identities=33%  Similarity=0.578  Sum_probs=198.9

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.+.||.|.||.||+|.+.. ........|+||.+..... ...+.+.+|+.++++++||||++++|++...+.    .+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EE
T ss_pred             EeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----cc
Confidence            45689999999999999984 2333456799999965433 236789999999999999999999999995443    48


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+++|+|.++|.......+++..++.|+.||+.||.|||++   +++|+||+++|||++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            999999999999999886567899999999999999999999998   99999999999999999999999999998763


Q ss_pred             CCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ............+...|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....+...    ..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~~----~~----  223 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQG----QR----  223 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHTT----EE----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----cc----
Confidence            3322233344567889999999999899999999999999999999 789986653322   22211111    00    


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                            ...+..++..+.+++..||..+|++||++.++++.|
T Consensus       224 ------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  112224567788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-42  Score=331.77  Aligned_cols=266  Identities=26%  Similarity=0.450  Sum_probs=210.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      ..++|++.+.||+|+||.||+|.+...........+|+|.+..... .....+.+|+.++.++ +||||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3467899999999999999999987655434455699999875432 2345688999999999 8999999999997765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                      .    .++||||+++|+|.+++..+              ....+++..++.++.|++.||.|||+.   +|+||||||+|
T Consensus        90 ~----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          90 P----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             C----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            4    49999999999999999642              235688999999999999999999988   99999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchh
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS  317 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~  317 (441)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999999999987554332222223345678999999988899999999999999999998 999986543322


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ......   .    .          .....+..++..+.+++.+||..+|++||++.++++.|++++
T Consensus       243 ~~~~~~---~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLK---E----G----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHH---c----C----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111111   0    0          001112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-42  Score=333.65  Aligned_cols=265  Identities=25%  Similarity=0.412  Sum_probs=209.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.............+|+|.+..... .....+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357999999999999999999875443333455699999876532 2345688999999999 79999999999977654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||+++|+|.+++.......+++.++..++.|++.||.|||++   +|+|+||||+|||++.++.++|+|||
T Consensus       114 ----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         114 ----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             ----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence                49999999999999999765445589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.........  .......    
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~~~----  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIKEG----  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHHcC----
Confidence            9986543322222233456788999999999899999999999999999998 99999654432211  1111100    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                .....+...+..+.+++.+||..+|++||++.++++.|+++
T Consensus       261 ----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 ----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                      00011123456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-42  Score=341.35  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=197.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|.+..++..     ||+|++.....   .....+.+|+.++..++||||+++++.+.+.. 
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHV-----YAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCE-----EEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence            4789999999999999999998776553     99999875432   22346778999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++||+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          75 ---NLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             ---eEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence               35999999999999999976  46799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC---------------------------------cceeeceecccCcCCccccccCCCCccccchhHHHHH
Q 013504          254 LARLGPSDGL---------------------------------SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL  300 (441)
Q Consensus       254 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il  300 (441)
                      +++.......                                 .......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            9875432110                                 0011245899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCchhHHHH-HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhc--ccCCCCCCHHHHH
Q 013504          301 YELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA--RQAKGRPKMSEVV  377 (441)
Q Consensus       301 ~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl  377 (441)
                      |||++|..||........... ..+... +        .+.+      ...++..+.+++.+++.  .++..||++++|+
T Consensus       227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~--------~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~  291 (363)
T cd05628         227 YEMLIGYPPFCSETPQETYKKVMNWKET-L--------IFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIK  291 (363)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHcCcCc-c--------cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence            999999999976543322211 111000 0        0000      01244667788887654  2333568999998


Q ss_pred             HH
Q 013504          378 EV  379 (441)
Q Consensus       378 ~~  379 (441)
                      +.
T Consensus       292 ~h  293 (363)
T cd05628         292 TN  293 (363)
T ss_pred             CC
Confidence            84

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-42  Score=344.71  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .|..++.||+|+||+||+|.+..++..     ||+|++.....   .....+.+|+.+++.++||||+++++++.+.+  
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~-----~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHAL-----YAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence            588899999999999999998776653     99999876432   22356789999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+
T Consensus        75 --~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          75 --NLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             --EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence              45999999999999999976  35789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCC---------------------------------------------cceeeceecccCcCCccccccCCCCc
Q 013504          255 ARLGPSDGL---------------------------------------------SHVSTAVVGTIGYAAPEYIQTGRLTY  289 (441)
Q Consensus       255 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~  289 (441)
                      ++.......                                             .......+||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            764211000                                             00112457999999999999889999


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhh--ccc
Q 013504          290 KSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCL--ARQ  366 (441)
Q Consensus       290 ~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~d  366 (441)
                      ++|||||||++|||++|..||.......... ...|..               .+.......+++++.+++.+|+  ..+
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~dli~~ll~~~~~  292 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPPQVKLSPEAVDLITKLCCSAEE  292 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCCCCCCCHHHHHHHHHHccCccc
Confidence            9999999999999999999997654332221 111110               0001111134567888998854  455


Q ss_pred             CCCCCCHHHHHH
Q 013504          367 AKGRPKMSEVVE  378 (441)
Q Consensus       367 P~~RPs~~evl~  378 (441)
                      |..||++.+++.
T Consensus       293 ~~~R~~~~~~l~  304 (381)
T cd05626         293 RLGRNGADDIKA  304 (381)
T ss_pred             ccCCCCHHHHhc
Confidence            666999999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-42  Score=324.96  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=205.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|......      .|++|.+.... ...+.+.+|+.+++.++||||+++++++...+.   
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   75 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNST------KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP---   75 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCc------eEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            57999999999999999999865432      38999876543 235678899999999999999999999876654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        76 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          76 -IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             -cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccce
Confidence             49999999999999999766567789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.........   ..+....      
T Consensus       152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~------  221 (261)
T cd05072         152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQRGY------  221 (261)
T ss_pred             ecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHHcCC------
Confidence            6543221 11223456778999999988889999999999999999998 99999654332211   1111100      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                          ..    .....++..+.+++.+||..+|++||+++++++.|++
T Consensus       222 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 ----RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                00    0112345678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-42  Score=338.88  Aligned_cols=270  Identities=23%  Similarity=0.361  Sum_probs=200.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC-
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER-  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-  174 (441)
                      +|++.+.||+|+||.||+|.+..++.     .||||.+....  ......+.+|+.+++.++||||+++++++...... 
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC-----EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence            47888999999999999999877655     39999886432  22345688999999999999999999988654322 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                      ....|+||||+ +++|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          76 FKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence            22469999999 5789999865  35799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCC-cceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc-
Q 013504          255 ARLGPSDGL-SHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT-  330 (441)
Q Consensus       255 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~-  330 (441)
                      ++....... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+........ 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            985432211 112234679999999999865  6789999999999999999999999976543222111110000000 


Q ss_pred             -------c--ccchhhhcCCCCCCcch---HHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 -------D--AKKFTMILDPKLEGKYS---IKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 -------~--~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .  .......+.+.......   ...+..+.+++.+||+.||++||+++++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   0  00000000000011111   123567889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-43  Score=344.70  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .||||++.....   .....+.+|+.+|..++||||+++++++.+.+ 
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGH-----IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence            479999999999999999999887665     399999875432   22345778999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        75 ---~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          75 ---YLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             ---eEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence               35999999999999999976  35799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc------------------------------------ceeeceecccCcCCccccccCCCCccccchhHH
Q 013504          254 LARLGPSDGLS------------------------------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG  297 (441)
Q Consensus       254 la~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  297 (441)
                      +++........                                    ......+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            98754321100                                    001134799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC---H
Q 013504          298 VFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK---M  373 (441)
Q Consensus       298 ~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  373 (441)
                      |++|||++|..||........... ..|..               .+.......+++.+.+++.+|+. +|.+|++   +
T Consensus       227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~  290 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV  290 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence            999999999999976543322111 11100               00000111345678899999997 8999998   8


Q ss_pred             HHHHH
Q 013504          374 SEVVE  378 (441)
Q Consensus       374 ~evl~  378 (441)
                      .+++.
T Consensus       291 ~~ll~  295 (364)
T cd05599         291 NEIKS  295 (364)
T ss_pred             HHHhc
Confidence            88887

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.2e-43  Score=340.33  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|....++..     ||+|.+.....   .....+.+|+.+++.++||||+++++++.+.+ 
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDI-----YAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence            4689999999999999999998776653     99999876432   23356778999999999999999999987655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          75 ---NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             ---eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence               359999999999999999764 35799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ++........ .......||+.|+|||++.      ...++.++|||||||++|||++|..||...........+.   .
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~---~  223 (330)
T cd05601         148 SAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM---N  223 (330)
T ss_pred             CCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH---c
Confidence            9986543321 1233457999999999986      4567899999999999999999999997554322111110   0


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .    ..       .+.......++..+.+|+..||. +|.+||++.+++.
T Consensus       224 ~----~~-------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 F----QR-------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C----CC-------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0    00       00001112355778899999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-42  Score=329.50  Aligned_cols=271  Identities=24%  Similarity=0.350  Sum_probs=199.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC---CCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV---EHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~  171 (441)
                      ++|.+.+.||+|+||.||+|.+...+.    ..||+|.+......  ....+.+|+.+++.+   +||||+++++++...
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCC----eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            368899999999999999998754321    24899988654322  224556777777665   699999999998643


Q ss_pred             cc-CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          172 DE-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       172 ~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .. .....++||||++ ++|.+++.......+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence            21 2224689999995 6999999765556789999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~  329 (441)
                      |||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|.+||......... .+........
T Consensus       153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            99999865432   1234567899999999998889999999999999999999999999765443222 1111111000


Q ss_pred             ccccc-----hhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKK-----FTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....     ....+.+....   .....++..+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000     00000000000   111235567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=323.63  Aligned_cols=261  Identities=27%  Similarity=0.491  Sum_probs=207.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+...+.  ....|+||.+...... ....+.+|+.+++.++||||+++++++.....  
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK--KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP--   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC--CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc--
Confidence            578999999999999999999865422  2335899988754332 34568899999999999999999999876654  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.++|+|||++
T Consensus        80 --~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          80 --VMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             --eEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence              49999999999999999764 34789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~-----  225 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDGY-----  225 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCC-----
Confidence            87642221222223345678999999998899999999999999999998 999996543222   112111100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                               ....+..++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       226 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         226 ---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                     00112235577899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-42  Score=326.49  Aligned_cols=256  Identities=29%  Similarity=0.490  Sum_probs=210.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ...+|.+.+.||.|+||.||+|.+.. +.     .+++|.+..........+.+|+.+++.++||||+++++++..... 
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-   76 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RV-----RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-   76 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CC-----cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC-
Confidence            34678999999999999999999876 33     399999887665556778899999999999999999999987664 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++++|.+++....+..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        77 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          77 ---VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             ---eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence               49999999999999999876567899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ........     
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~-----  220 (261)
T cd05148         151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAG-----  220 (261)
T ss_pred             hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhC-----
Confidence            986543221  1223456778999999988889999999999999999998 899996544222   11111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               .....+..++..+.+++.+||..+|.+||++.++++.|+.
T Consensus       221 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         221 ---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                     0111223456788999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-42  Score=337.69  Aligned_cols=266  Identities=24%  Similarity=0.359  Sum_probs=202.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+..++..     +|+|.+..... .....+.+|+.+++.++||||++++++|...+  
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~-----~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   76 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLI-----MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--   76 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcE-----EEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--
Confidence            46899999999999999999998776543     88888765432 23456889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+
T Consensus        77 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          77 --EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             --EEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence              45999999999999999976  35789999999999999999999974  2799999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh-hcccc-
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP-HLTDA-  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~-  332 (441)
                      +......    ......||..|+|||++.+..++.++|||||||++|+|++|+.||................. ..... 
T Consensus       151 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (333)
T cd06650         151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE  226 (333)
T ss_pred             chhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence            8754322    22345789999999999988899999999999999999999999975433222111100000 00000 


Q ss_pred             ----------------------c----chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 ----------------------K----KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ----------------------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                            .    ....+............++.++.+|+.+||+.||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  0    000000000000001124567899999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-42  Score=327.65  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=205.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|++.+.||+|+||.||+|.+...+. .....+++|.+..... .....+.+|+.+++.++||||+++++++.....  
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM-DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP--   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC-CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc--
Confidence            468888999999999999998754332 1234589999875433 233678899999999999999999999887664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF---------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                        .++||||+++++|.+++..+.               ...+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus        82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          82 --VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             --eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence              499999999999999985321               23578889999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~  319 (441)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-  235 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-  235 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence            99999999999999986544332223344556788999999988889999999999999999998 9999965433221 


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                        .+.+....              ....+..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       236 --~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 --IEMVRKRQ--------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              22111100              001222456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.8e-43  Score=339.80  Aligned_cols=243  Identities=26%  Similarity=0.402  Sum_probs=195.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.||+|+||.||++.+..++.     .||+|.+.....   .....+.+|+.++..++||||+++++++...+    ..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEE
Confidence            369999999999999877654     499999875432   22356678999999999999999999987765    359


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      +||||+++|+|..++..  ...+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          72 FVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            99999999999998865  3578999999999999999999997 5   8999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...             
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-------------  211 (325)
T cd05594         147 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------  211 (325)
T ss_pred             CCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------
Confidence            3221  1223467999999999999999999999999999999999999999654332211111100             


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVEV  379 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  379 (441)
                           ...++..+++.+.+++.+||+.||++|+     ++.++++.
T Consensus       212 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 -----EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                 0011223556789999999999999996     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-42  Score=328.58  Aligned_cols=262  Identities=23%  Similarity=0.415  Sum_probs=207.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|.+.+.||+|+||.||+|.+..+........||+|.+....... ...+.+|+.++..++||||+++++++.....  
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP--   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc--
Confidence            3477778899999999999998765444455679999997554332 3567889999999999999999999987664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                        .++++||+++++|.+++..+.              ...+++..++.++.|++.||.|||+.   +|+||||||+|||+
T Consensus        83 --~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          83 --LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             --eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence              489999999999999985321              23578889999999999999999988   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQK  320 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~  320 (441)
                      ++++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.......   
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  234 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---  234 (283)
T ss_pred             cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999886543322222334456789999999988899999999999999999998 888986543322   


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                      ....+...             . ....+..++..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       235 ~~~~i~~~-------------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNR-------------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcC-------------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22211110             0 011233567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-42  Score=354.14  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=208.2

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||.+.....  .....+.+|+.++..++|+||+++++.+...
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGE-----PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCC-----EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            345789999999999999999999876654     499999876433  2345678899999999999999998877654


Q ss_pred             ccC----CeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          172 DER----GIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       172 ~~~----~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      +..    ....++||||+++|+|.+++..+  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence            321    12357999999999999999653  235789999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~~~  257 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMHKT  257 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH
Confidence            999999999986543322223445789999999999999999999999999999999999999997543221   11111


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .   ..          . ....+..+++.+.+++.+||+.||.+||++.+++..
T Consensus       258 ~---~~----------~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 L---AG----------R-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             h---cC----------C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0   00          0 011223456789999999999999999999999873

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-42  Score=336.61  Aligned_cols=245  Identities=26%  Similarity=0.441  Sum_probs=194.8

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHh---ccCCCCCeeeEEeEEeccc
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVL---GVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~  172 (441)
                      |.+.+.||+|+||.||+|.+..++..     ||||.+.....   .....+.+|+.++   +.++||||+++++++...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGEL-----YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            67788999999999999998776653     99999875431   2234566666654   5678999999999998665


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||+++|+|..++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ----~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 ----HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             ----EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence                45999999999999988854   5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...       
T Consensus       146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-------  216 (324)
T cd05589         146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-------  216 (324)
T ss_pred             cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Confidence            9987543221  2234568999999999999999999999999999999999999999765432211111100       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                 ...++..++..+.+++.+||..||.+||     ++.++++
T Consensus       217 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 -----------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                       0012223567788999999999999999     4666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-42  Score=344.02  Aligned_cols=266  Identities=23%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCC-CCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+.+.........||+|++....... ...+.+|+.+|.++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            35688889999999999999998765444455679999997653322 346889999999997 9999999999987654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-------------------------------------------------------  198 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  198 (441)
                          .++||||+++|+|.+++....                                                       
T Consensus       116 ----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         116 ----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             ----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence                499999999999999996421                                                       


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          199 -----------------------------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       199 -----------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                                                               ...+++..++.++.|++.||.|||+.   +|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                     12367778899999999999999987   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986433221112223467889999999998889999999999999999998 89998654322


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ..  ....+...              .....+..++..+.+++.+||..+|.+||++.+|++.|++++
T Consensus       349 ~~--~~~~~~~~--------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQ--FYNAIKRG--------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HH--HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11  11111100              001112235678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-42  Score=326.17  Aligned_cols=275  Identities=29%  Similarity=0.448  Sum_probs=206.7

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      |...+.||+|+||+||++.+.... ......||+|.+..... .....+.+|+.+|+.++||||+++++++......  .
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK--G   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc--e
Confidence            488899999999999988754322 12234599999876533 2346788999999999999999999998765432  4


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||+++++|.+++..   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            5899999999999999975   4699999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++|..||....... .......... .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ-MTVVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc-cchhhhh
Confidence            54322111 1122345677999999988889999999999999999999999986433211 1111111000 0001111


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ...+.......+..++..+.+++.+||+.+|++||++++|++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111122223456678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-41  Score=347.85  Aligned_cols=274  Identities=20%  Similarity=0.311  Sum_probs=199.3

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC------CCCeee
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE------HPNLVK  163 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~  163 (441)
                      +++...+++|.+.++||+|+||.||+|.+..++.     .||||++.... .....+..|+.++..++      |++|++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE-----YCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCe-----EEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            3444556889999999999999999999876654     49999986432 22334556777766664      456899


Q ss_pred             EEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       164 l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                      +++++.....   +.|+|||++ +++|.+++..  ...+++..+..|+.||+.||.|||++  .+||||||||+|||++.
T Consensus       196 i~~~~~~~~~---~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~  267 (467)
T PTZ00284        196 IQRYFQNETG---HMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMET  267 (467)
T ss_pred             eEEEEEcCCc---eEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEec
Confidence            9998875432   468999998 8899999876  36799999999999999999999973  28999999999999987


Q ss_pred             CC----------------cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCC
Q 013504          244 QW----------------NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR  307 (441)
Q Consensus       244 ~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~  307 (441)
                      ++                .+||+|||++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence            65                499999998864322     234578999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHhhhhhccccc-------chhhhc------CCCCCCc----------c-hHHHHHHHHHHHHHhh
Q 013504          308 RPLDRNRPKSEQKLLEWVRPHLTDAK-------KFTMIL------DPKLEGK----------Y-SIKLAQKLAAVANKCL  363 (441)
Q Consensus       308 ~P~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~------~~~~~~~----------~-~~~~~~~l~~li~~cl  363 (441)
                      .||...........+......+....       ....+.      .+.....          . .......+.+||.+||
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            99976654333332222111100000       000000      0000000          0 0012356789999999


Q ss_pred             cccCCCCCCHHHHHH--HHHH
Q 013504          364 ARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       364 ~~dP~~RPs~~evl~--~L~~  382 (441)
                      +.||++||++.++++  +|.+
T Consensus       423 ~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        423 HYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CcChhhCCCHHHHhcCccccc
Confidence            999999999999998  5544

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6e-42  Score=326.39  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=206.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|...+.||+|+||.||++.............+++|.+..........+.+|+.+++.++||||+++++++.....   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP---   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc---
Confidence            46788889999999999999865433333445689999876665556788999999999999999999999887653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQ-------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                       .++||||+++++|.+++.....             ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++
T Consensus        82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          82 -LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             -eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence             4999999999999999875321             3588999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~  322 (441)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||............
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            99999999999975543222222233456788999999998899999999999999999998 89999654332221111


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .   ..    .          ....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       238 ~---~~----~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 T---QG----R----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H---cC----c----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1   00    0          00111235567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.5e-42  Score=337.64  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=193.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|+..+.||+|+||.||+|.+..++.     .||||++...... ....+.+|+.+++.++|+||+++++++...+   
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  145 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGR-----LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG---  145 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCC-----EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC---
Confidence            456677789999999999999876654     4999998654332 2456889999999999999999999987665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+..      ..++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       146 -~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        146 -EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             -eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence             359999999999986532      345678889999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +......  .......||..|+|||++..     ...+.++|||||||++|||++|+.||..................  
T Consensus       216 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--  291 (353)
T PLN00034        216 RILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--  291 (353)
T ss_pred             eeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--
Confidence            8654321  12234679999999998743     23456899999999999999999999743332222222111000  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                  ........++..+.+|+.+||..||++||++.++++.
T Consensus       292 ------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0011223456789999999999999999999999983

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=341.87  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++.....   .....+.+|+.++..++||||+++++++.+.+ 
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ-----VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCC-----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence            468999999999999999999886654     499999875432   23456788999999999999999999987765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          75 ---HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             ---eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence               459999999999999999764  6799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCC---------------------------CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC
Q 013504          254 LARLGPSDG---------------------------LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG  306 (441)
Q Consensus       254 la~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG  306 (441)
                      ++.......                           .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            998654332                           00123346799999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhHHHH-HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-HHHHHHH
Q 013504          307 RRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVEV  379 (441)
Q Consensus       307 ~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  379 (441)
                      +.||........... ..|..               .+.......+++.+.+++.+||. +|.+||+ +.++++.
T Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         227 FPPFYSDTLQETYNKIINWKE---------------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCHHHHHHHHhccCC---------------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            999976553222111 11100               00000111256788999999997 9999999 9999983

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-42  Score=325.89  Aligned_cols=262  Identities=25%  Similarity=0.428  Sum_probs=208.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.............|++|.+..... .....+.+|+.++..++||||+++++++..... 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP-   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC-
Confidence            367899999999999999999987655334456699999875432 334567899999999999999999999987654 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                         .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        84 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~  157 (277)
T cd05032          84 ---TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             ---cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence               499999999999999996532        23478889999999999999999988   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............+|..|+|||.+.+..++.++|||||||++||+++ |..||..........   ..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~  234 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FV  234 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HH
Confidence            99999999986544332222334567889999999988889999999999999999998 999996544332222   11


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .    ...          ....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       235 ~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 I----DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             h----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1    000          00112234678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.9e-42  Score=324.57  Aligned_cols=263  Identities=26%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+..++.. ....||+|.+...... ....+.+|+.++..++||||+++++++....  
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST--   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC--
Confidence            36788999999999999999998765543 2345899998754332 3467889999999999999999999987533  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .+++|||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        83 ---~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          83 ---VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             ---cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence               37999999999999999753 35689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||..........   ++....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~----  228 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---LLEKGE----  228 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHCCC----
Confidence            986543322111222345678999999988899999999999999999998 899996543322211   111100    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                                ....+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 ----------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      001122355678999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.6e-42  Score=337.60  Aligned_cols=268  Identities=25%  Similarity=0.396  Sum_probs=208.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+.+.........||||.+..... .....+.+|+.+|.++ +||||+++++++...+. 
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC-
Confidence            57999999999999999999977655555566799999975432 2345688999999999 78999999998865543 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------------------------------------------------
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------------------------------------------------  198 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------  198 (441)
                        ..++||||+++|+|.+++....                                                        
T Consensus        86 --~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          86 --PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             --ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence              3589999999999999986431                                                        


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeec
Q 013504          199 ---------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA  269 (441)
Q Consensus       199 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  269 (441)
                               ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12467888899999999999999998   999999999999999999999999999986533222122223


Q ss_pred             eecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcch
Q 013504          270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYS  348 (441)
Q Consensus       270 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (441)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ......    ....          ...+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~----~~~~----------~~~~  304 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK----EGTR----------MRAP  304 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHh----ccCC----------CCCC
Confidence            446678999999988899999999999999999997 9999965432111  111110    0000          0011


Q ss_pred             HHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          349 IKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       349 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ...++.+.+++..||+.+|++||++.+|++.|+.+++.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            12345788999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-42  Score=343.45  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=196.7

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .|..++.||+|+||.||+|....++..     ||+|++.....   .....+.+|+.+++.++||||+++++.+.+.+  
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~-----~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKAL-----YAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCE-----EEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence            588999999999999999998776654     99999875432   22356788999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+|||||++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        75 --~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          75 --NLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             --EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence              45999999999999999976  35789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCC---------------------------------------------CcceeeceecccCcCCccccccCCCCc
Q 013504          255 ARLGPSDG---------------------------------------------LSHVSTAVVGTIGYAAPEYIQTGRLTY  289 (441)
Q Consensus       255 a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~  289 (441)
                      ++......                                             ........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75321000                                             000112357999999999999999999


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCC
Q 013504          290 KSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK  368 (441)
Q Consensus       290 ~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  368 (441)
                      ++|||||||++|||++|+.||....+...... ..+..               .+.......+++.+.+++.+|+ .+|.
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l~-~~p~  291 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPPQAKLSPEASDLIIKLC-RGPE  291 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence            99999999999999999999976543322211 11100               0011111234567788888865 5999


Q ss_pred             CCCC---HHHHHH
Q 013504          369 GRPK---MSEVVE  378 (441)
Q Consensus       369 ~RPs---~~evl~  378 (441)
                      +|++   +.+++.
T Consensus       292 ~R~~~~~~~ei~~  304 (382)
T cd05625         292 DRLGKNGADEIKA  304 (382)
T ss_pred             HcCCCCCHHHHhc
Confidence            9987   887775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-42  Score=334.93  Aligned_cols=242  Identities=26%  Similarity=0.448  Sum_probs=194.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCC-CCeeeEEeEEecccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEH-PNLVKLIGYCAEDDE  173 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  173 (441)
                      +|.+.+.||+|+||.||+|....++.     .||+|++.....   .....+..|..++..+.| ++|+++++++...+ 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence            58889999999999999999877654     399999875422   234567789999999966 46888888887655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          75 ---RLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             ---EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence               35999999999999999975  35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+...     
T Consensus       147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~-----  216 (324)
T cd05587         147 MCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIMEH-----  216 (324)
T ss_pred             cceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC-----
Confidence            987532221  12345679999999999999999999999999999999999999997554322   11111100     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                                ...++..++..+.+++.+||..||.+|++.
T Consensus       217 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 ----------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                      011222355678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.4e-42  Score=333.94  Aligned_cols=242  Identities=25%  Similarity=0.451  Sum_probs=191.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     ||+|.+.....   .....+..|..++..+ +||||+++++++...+    ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEF-----FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence            3699999999999998876654     99999875421   2234456677777654 8999999999987665    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ++||||++||+|..++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            999999999999999976  35789999999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+...          
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~----------  211 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSILND----------  211 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC----------
Confidence            3222  22345679999999999999899999999999999999999999997544321   11111100          


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH-HHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS-EVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  378 (441)
                           ...++..++..+.+++.+||+.+|.+||++. ++++
T Consensus       212 -----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         212 -----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                 0112223556788999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-41  Score=325.89  Aligned_cols=267  Identities=22%  Similarity=0.408  Sum_probs=207.4

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|++.+.||+|+||.||+|..+..........||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3578999999999999999999876533333345699998865432 223457789999999999999999999876654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF--------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                          .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        84 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          84 ----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             ----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence                499999999999999996532        13456678899999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~  324 (441)
                      .++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~  233 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF  233 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999986543322222223355778999999998899999999999999999998 788986543322   1111


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      ...    ...          ...+..++..+.+++.+||+.+|++||++.++++.|.+.+.
T Consensus       234 ~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         234 VMD----GGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHc----CCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            110    000          01112345789999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=342.35  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=197.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||++....++..     ||||++.....   .....+.+|+.++..++||||+++++++.+.. 
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI-----YAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCE-----EEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence            4789999999999999999998776653     99999865432   22356778999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          75 ---YLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             ---eeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence               35999999999999999975  46789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-----------c----------------------------------ceeeceecccCcCCccccccCCCC
Q 013504          254 LARLGPSDGL-----------S----------------------------------HVSTAVVGTIGYAAPEYIQTGRLT  288 (441)
Q Consensus       254 la~~~~~~~~-----------~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~  288 (441)
                      +++.......           .                                  ......+||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            9963211000           0                                  000125799999999999999999


Q ss_pred             ccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccC
Q 013504          289 YKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQA  367 (441)
Q Consensus       289 ~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  367 (441)
                      .++|||||||++|||++|..||.......... ...|...               +.......++..+.+++.+||. +|
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~dli~~lL~-~~  290 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFPDDIHLSVEAEDLIRRLIT-NA  290 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCCCCCCCCHHHHHHHHHHhc-CH
Confidence            99999999999999999999997654322111 1111000               0000011245678899999997 66


Q ss_pred             CCC---CCHHHHHHH
Q 013504          368 KGR---PKMSEVVEV  379 (441)
Q Consensus       368 ~~R---Ps~~evl~~  379 (441)
                      .+|   +++.+++..
T Consensus       291 ~~r~~r~~~~~~l~h  305 (377)
T cd05629         291 ENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhcCCCCCHHHHhcC
Confidence            665   599998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.2e-42  Score=330.11  Aligned_cols=267  Identities=21%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|....++.     .||+|++...... ....+.+|+.+++.++||||+++++++....  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGK-----LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCC-----EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--
Confidence            3689999999999999999999876654     3999998754322 2345678999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||++ ++|.+++... ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        77 --~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          77 --TLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             --eEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence              3599999995 6888888653 35688999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhcccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~  332 (441)
                      ++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+..........
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (303)
T cd07869         150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED  227 (303)
T ss_pred             ceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence            87543221  12234578999999998865 45788999999999999999999999764332111 1111110000000


Q ss_pred             -----cchhhhcCCCCC----CcchH-----HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -----KKFTMILDPKLE----GKYSI-----KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -----~~~~~~~~~~~~----~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ............    .....     ..+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 000000000000    00000     12356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.7e-42  Score=323.07  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=201.9

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--C
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--R  174 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~  174 (441)
                      |.+.+.||+|+||.||+|.+...+.   ...+|+|.+....  ......+.+|+.+++.++||||+++++++.....  .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDS---ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCC---eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            3567789999999999999866543   2348999886542  2334678899999999999999999998754322  1


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR----FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      ....++||||+++|+|.+++...    ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence            12358999999999999987421    124588999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+++...............+++.|++||++.+..++.++|||||||++|||++ |..||.......   ....+..  
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~--  229 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ--  229 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc--
Confidence            9999987543322111223356778999999998899999999999999999999 889996543221   1111111  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                        ...          ...+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       230 --~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 --GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              000          011123556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-42  Score=321.70  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=204.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.+..+.      .||+|.+.... ...+.+.+|+.++++++||||+++++++.....  
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTT------PVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP--   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCe------EEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC--
Confidence            457899999999999999999865432      48999987543 235678899999999999999999999877653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++....+..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++
T Consensus        76 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          76 --IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             --eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence              49999999999999999765556789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.........   ..+....     
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~-----  221 (261)
T cd05068         151 RVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQVDQGY-----  221 (261)
T ss_pred             EEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCC-----
Confidence            865432111 1111223457999999998899999999999999999999 99999754432211   1111000     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               ....+..++..+.+++.+||+.+|.+||++.++++.|++
T Consensus       222 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 ---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                     001122355789999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-42  Score=320.09  Aligned_cols=271  Identities=24%  Similarity=0.319  Sum_probs=206.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCC-eeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPN-LVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  173 (441)
                      ..|..+++||+|+||+||+|+...++..     ||+|++......  -.....+|+.+|+.++|+| |+++++++.....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~-----VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKF-----VALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCE-----EEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            4566677899999999999999888754     999999866442  2355689999999999999 9999999988662


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRFQ--ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                        ....+++|+||+ .-+|..++.....  ..++...+..+++||+.||+|||++   +|+||||||+||||+++|.+||
T Consensus        86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEee
Confidence              122468999999 5699999986532  3677789999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +|||+|+......  ...+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+.........+-.... 
T Consensus       162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG-  238 (323)
T KOG0594|consen  162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG-  238 (323)
T ss_pred             eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-
Confidence            9999999654332  235567899999999999886 799999999999999999999999987665333322211110 


Q ss_pred             cccccchhhhc---C--CCCC-----CcchH---HHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          329 LTDAKKFTMIL---D--PKLE-----GKYSI---KLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~---~--~~~~-----~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .+....+..+.   +  ....     ..+..   .......+++.+||+.+|.+|.|++.++..
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            01111111110   0  0000     01111   112478899999999999999999999885

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=327.05  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=201.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +|++.++||+|+||.||++.+..++.     .||+|.+......   ....+.+|+.+++.++||||+++++++...+  
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc-----eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence            47888999999999999999876554     4999998754322   2245678999999999999999999987665  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          74 --ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             --eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence              359999999999999988765456799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~  333 (441)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ..+..      
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~------  219 (285)
T cd05605         149 AVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE------  219 (285)
T ss_pred             ceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh------
Confidence            98653321   123457899999999999889999999999999999999999999754332211111 11100      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                               ....++..++..+.+++.+||..||.+||     ++.+++.
T Consensus       220 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 ---------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                     01122334677889999999999999999     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=334.71  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=214.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCC-CCCeeeEEeEEec
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVE-HPNLVKLIGYCAE  170 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~-hpnIv~l~~~~~~  170 (441)
                      ....|++.+.||+|.||.||+++.+.++..     +|+|.+.+.....   ...+.+|+.+|+++. |||||.++++|.+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~-----~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKE-----VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCce-----eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence            346788889999999999999999988664     9999998766543   357889999999997 9999999999998


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC----CCc
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWN  246 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~----~~~  246 (441)
                      .+.    .++|||+|.||.|.+.+..+   .+++..+..++.|++.++.|||+.   ||+||||||+|+|+..    ++.
T Consensus       108 ~~~----~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  108 PDS----VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             CCe----EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence            874    49999999999999999875   399999999999999999999997   9999999999999953    357


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      +|++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+.  .
T Consensus       178 ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~--~  252 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL--R  252 (382)
T ss_pred             EEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--c
Confidence            99999999998665   335667899999999999999999999999999999999999999997654332222111  0


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                  .+..+.......++..+.+++..|+..||..|+++.++++.
T Consensus       253 ------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 ------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                        11123344556778899999999999999999999999983

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-42  Score=334.32  Aligned_cols=245  Identities=29%  Similarity=0.434  Sum_probs=194.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||++......  .....||+|.+.....    .....+..|+.+|+.++||||+++++++...+    ..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KL   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eE
Confidence            57999999999999864322  1234599999875322    22345678999999999999999999998765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|.+++..  .+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          76 YLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            999999999999999976  46788899999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+..           
T Consensus       151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~~~~-----------  214 (323)
T cd05584         151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDKILK-----------  214 (323)
T ss_pred             ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHHHHc-----------
Confidence            3221  123346799999999999988899999999999999999999999976443221   111100           


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                        ..  ...+..+++.+.+++.+||+.+|++||     ++.+++.
T Consensus       215 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         215 --GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              00  011223456789999999999999999     7888877

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-42  Score=343.91  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=198.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .+|++.+.||+|+||.||+|....++.     .||||++.....   .....+.+|+.+|+.++||||+++++.+.+.+ 
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNA-----LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC-----EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence            368999999999999999999877654     499999865432   12355778999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          75 ---NLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence               45999999999999999976  35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCC-----------------------------------------CcceeeceecccCcCCccccccCCCCcccc
Q 013504          254 LARLGPSDG-----------------------------------------LSHVSTAVVGTIGYAAPEYIQTGRLTYKSD  292 (441)
Q Consensus       254 la~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  292 (441)
                      ++.......                                         ........+||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            975321000                                         000112357999999999999999999999


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCchhHHHHH-HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC
Q 013504          293 IWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP  371 (441)
Q Consensus       293 vwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  371 (441)
                      ||||||++|||++|+.||...........+ .|..               .+.......++..+.+++.+|+ .+|.+|+
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            999999999999999999765543322211 1100               0000111234567788888876 5999999


Q ss_pred             ---CHHHHHHH
Q 013504          372 ---KMSEVVEV  379 (441)
Q Consensus       372 ---s~~evl~~  379 (441)
                         ++.+++..
T Consensus       291 ~~~t~~ell~h  301 (376)
T cd05598         291 GKNGADEIKAH  301 (376)
T ss_pred             CCCCHHHHhCC
Confidence               88998873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-41  Score=319.28  Aligned_cols=248  Identities=25%  Similarity=0.455  Sum_probs=196.3

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      .||+|+||.||+|.+..++.     .+|+|.+..... .....+.+|+.+++.++||||+++++++.....    .++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   72 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNT-----PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIVM   72 (252)
T ss_pred             ccCcccCccEEEEEEecCCc-----eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEEEE
Confidence            69999999999999876654     389998765432 234568899999999999999999999987654    49999


Q ss_pred             eccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG  262 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  262 (441)
                      ||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        73 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  148 (252)
T cd05084          73 ELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV  148 (252)
T ss_pred             eeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence            999999999999653 35689999999999999999999998   99999999999999999999999999987543221


Q ss_pred             CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       263 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      .........++..|+|||.+.++.++.++|||||||++|||++ |..||..............                 
T Consensus       149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-----------------  211 (252)
T cd05084         149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-----------------  211 (252)
T ss_pred             ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-----------------
Confidence            1111111223457999999999899999999999999999998 8899965433222111110                 


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      ......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            0011122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-41  Score=326.93  Aligned_cols=263  Identities=28%  Similarity=0.461  Sum_probs=205.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|....++..   ..+++|.+.... ....+.+.+|+.++.++ +||||+++++++..... 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK---MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY-   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCc---ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-
Confidence            4788999999999999999988765432   236788776422 23346788999999999 79999999999877653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                         .++||||+++++|.+++....              ...+++..++.++.|++.||.|||+.   +|+||||||+|||
T Consensus        78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil  151 (297)
T cd05089          78 ---LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVL  151 (297)
T ss_pred             ---ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEE
Confidence               499999999999999996531              13588899999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~  319 (441)
                      ++.++.+||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--  226 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--  226 (297)
T ss_pred             ECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            999999999999998743211   01111233557999999988889999999999999999997 999997544322  


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhcc
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAET  389 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  389 (441)
                       .......              ......+..++..+.+++.+||+.+|.+||++.++++.|..+.+....
T Consensus       227 -~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         227 -LYEKLPQ--------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence             1111100              001112223567789999999999999999999999999998876533

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-42  Score=333.90  Aligned_cols=242  Identities=25%  Similarity=0.441  Sum_probs=194.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      +|.+.+.||+|+||.||+|.+..++..     ||+|.+.....   .....+..|..++..+ +||+|+++++++...+ 
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDEL-----YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence            588899999999999999998776543     99999875432   2234566788888877 6899999999987765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          75 ---RLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             ---EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence               35999999999999999875  35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+...     
T Consensus       147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~~-----  216 (323)
T cd05616         147 MCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH-----  216 (323)
T ss_pred             CceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHhC-----
Confidence            997543221  12345679999999999999999999999999999999999999997654322   11111100     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                                ...++...+..+.+++.+||+.+|.+|++.
T Consensus       217 ----------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 ----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                      011223456778999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-42  Score=341.02  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=196.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|++.+.||+|+||.||+|.+..++..     ||+|....      ..+.+|+.+|++++||||+++++++.....   
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~-----vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---  157 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEH-----VVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKF---  157 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCE-----EEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe---
Confidence            5799999999999999999998877654     89997532      346789999999999999999999976553   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++|||++ +++|..++..+  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       158 -~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        158 -TCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             -eEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence             49999999 57899988663  5789999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh-----HH---HHHHhhhhh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS-----EQ---KLLEWVRPH  328 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~-----~~---~~~~~~~~~  328 (441)
                      ...... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......     ..   .++......
T Consensus       231 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~  309 (391)
T PHA03212        231 FPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH  309 (391)
T ss_pred             cccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence            533221 112334689999999999999999999999999999999999998874322110     00   111100000


Q ss_pred             c---c--cccchhhh---------cCCCCCC--cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 L---T--DAKKFTMI---------LDPKLEG--KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~---~--~~~~~~~~---------~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .   .  ........         ..+....  ......+..+.+|+.+||+.||++|||++++++
T Consensus       310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0   0  00000000         0000000  011235668999999999999999999999997

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-42  Score=334.11  Aligned_cols=237  Identities=26%  Similarity=0.443  Sum_probs=191.1

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++||+|+||.||+|.+..++..     ||+|++.....   .....+..|..++..+ +||||+++++++...+    ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRL-----YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCE-----EEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EE
Confidence            3699999999999998776543     99999875421   2345667888888876 7999999999997765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999999999999999876  35799999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+..   ..      
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~---~~------  212 (320)
T cd05590         147 IFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILN---DE------  212 (320)
T ss_pred             CcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhc---CC------
Confidence            3221  12344679999999999999999999999999999999999999997654322   1111110   00      


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                            ...+..++..+.+++.+||+.||++||++
T Consensus       213 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 ------VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                  01122355778999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-41  Score=322.83  Aligned_cols=262  Identities=25%  Similarity=0.429  Sum_probs=204.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+...........|++|.+...... ....+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999876332223445899988654322 235688999999999999999999998876543


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC---c
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQ-----ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---N  246 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~---~  246 (441)
                          ++||||+++++|.+++.....     ..+++..++.++.||+.||.|||++   +++||||||+|||++.++   .
T Consensus        85 ----~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          85 ----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             ----EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence                899999999999999975421     2589999999999999999999998   999999999999998765   5


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........+.  
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--  235 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT--  235 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence            89999999986533221111122334568999999998999999999999999999997 999997544332222111  


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                       ..              .....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       236 -~~--------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 -GG--------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -cC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             00              001112345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.5e-42  Score=333.82  Aligned_cols=242  Identities=25%  Similarity=0.451  Sum_probs=194.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++||+|+||.||+|.+..++..     ||+|++.....   .....+..|..++..+ +||||+++++++...+    ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEV-----YAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RL   71 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCE-----EEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eE
Confidence            3699999999999998776543     99999875422   2334567888998866 8999999999998765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999999875  45789999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+..   ..      
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~~---~~------  212 (321)
T cd05591         147 ILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESILH---DD------  212 (321)
T ss_pred             ccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHHc---CC------
Confidence            3221  12344679999999999999999999999999999999999999997654322   1111111   00      


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-------CHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-------KMSEVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~  378 (441)
                            ...+..++..+.+++.+||..||++||       ++.++++
T Consensus       213 ------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 ------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                  011123456788999999999999999       7777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.7e-42  Score=346.40  Aligned_cols=274  Identities=22%  Similarity=0.349  Sum_probs=200.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccc---
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD---  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  172 (441)
                      ..+|.+.+.||+|+||.||+|.+..++..     ||||++....    ....+|+.+|+.++||||+++++++....   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~-----vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEK-----VAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCE-----EEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            46799999999999999999998776553     9999885432    23347999999999999999999875432   


Q ss_pred             -cCCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEE
Q 013504          173 -ERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAK  248 (441)
Q Consensus       173 -~~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~k  248 (441)
                       .....+++||||++ ++|.+++..  +....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++ .+|
T Consensus       136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        136 NEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             CCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence             22234679999996 478777653  2356799999999999999999999998   999999999999998665 699


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVR  326 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~  326 (441)
                      |+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.......... .+....
T Consensus       212 L~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        212 LCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998654322   22346789999999988664 68999999999999999999999997654332211 111110


Q ss_pred             hhccc-----ccchhh-----hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          327 PHLTD-----AKKFTM-----ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       327 ~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      ....+     ...+..     .....+...++...+.++.+|+.+||..||.+||++.+++.  +++.+.+
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            00000     000000     00001111122234578999999999999999999999996  5666544

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.2e-42  Score=335.17  Aligned_cols=249  Identities=25%  Similarity=0.437  Sum_probs=194.7

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++||+|+||.||+|.+..++..     ||+|++.....   .....+.+|..++..+ +||||+++++++....    ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~-----~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRI-----YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EE
Confidence            3699999999999998876653     99999876432   2234577899999888 7999999999998765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            999999999999999865  46799999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh--HHHHHHhhhhhcccccchh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS--EQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~  336 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  ......+.....       
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------  217 (329)
T cd05588         147 IRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------  217 (329)
T ss_pred             ccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------
Confidence            2221  12345689999999999999999999999999999999999999996322111  100111110000       


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC------HHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK------MSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  378 (441)
                        ....  ...+..++..+.+++.+||+.||.+||+      +.++++
T Consensus       218 --~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         218 --LEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              0000  1122235567899999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-41  Score=319.38  Aligned_cols=251  Identities=25%  Similarity=0.503  Sum_probs=199.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||++.+....      .+|+|.+.... .....+.+|+.+|++++||||+++++++...+.   
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   73 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQI------KVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP---   73 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCc------eEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC---
Confidence            46888899999999999999876532      38999876443 234678899999999999999999999877653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        74 -~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          74 -LYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             -EEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence             499999999999999987542 4689999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ....+....    . 
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~~----~-  219 (256)
T cd05114         149 YVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGF----R-  219 (256)
T ss_pred             ccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC----C-
Confidence            6533221 11122345678999999988889999999999999999999 899996544322   222211100    0 


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                        ...       +...+..+.+++.+||+.+|++||++.++++.|
T Consensus       220 --~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 --LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              000       112346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=320.82  Aligned_cols=263  Identities=27%  Similarity=0.462  Sum_probs=205.1

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--C
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--R  174 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~  174 (441)
                      |.+.+.||+|+||.||+|.+.....  ....||+|.+.....  .....+.+|+.+++.++||||+++++++.....  .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG--SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC--CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            5677899999999999998765331  224599999875432  234578899999999999999999998876543  1


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR----FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      ....++||||+++|+|..++...    ....+++..+..++.|++.||.|||++   +|+||||||+||++++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence            12358999999999999998542    224689999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+.... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~~-  231 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRHG-  231 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-
Confidence            9999986544322222222345678999999988889999999999999999999 88999654322   222221110 


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                         .          ....+..++..+.+++.+||..||++||++.++++.|+++
T Consensus       232 ---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 ---N----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---C----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0          0112234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-41  Score=328.26  Aligned_cols=268  Identities=26%  Similarity=0.423  Sum_probs=209.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCc--ccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDS--HKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||++.+......  .....+|+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            35799999999999999999987543321  223459999987543 23345688899999999 899999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      +.    .++||||+++|+|.+++..+.              ...+++.+++.++.|++.||.|||+.   +++||||||+
T Consensus        97 ~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  169 (307)
T cd05098          97 GP----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  169 (307)
T ss_pred             Cc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence            53    499999999999999997532              13588899999999999999999987   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999999876543221111222334578999999988889999999999999999998 88998654332


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .....+.   ..              .....+..++..+.+++.+||..+|++||++.+|++.|+.++...
T Consensus       250 ~~~~~~~---~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 ELFKLLK---EG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHHH---cC--------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            2111111   00              001122245678899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-41  Score=319.58  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=204.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+..+.      .||+|.+..... ....+.+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----   73 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----   73 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc------eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCC-----
Confidence            56999999999999999999876543      389999875432 346788999999999999999999987532     


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence            248999999999999999765456789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ ......++..|+|||+..+..++.++|||||||++|+|++ |..||.............   .    .   
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~---~----~---  219 (262)
T cd05071         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----G---  219 (262)
T ss_pred             eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh---c----C---
Confidence            65433211 1223456778999999988899999999999999999999 888986554322111110   0    0   


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                             ........++..+.+++.+|++.+|++||++.+++++|++.+
T Consensus       220 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         220 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                   001122346678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8e-42  Score=331.29  Aligned_cols=242  Identities=27%  Similarity=0.468  Sum_probs=192.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhcc-CCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGV-VEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     ||+|.+.....   .....+..|..++.. ++||||+++++++.+.+    ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQF-----FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EE
Confidence            3699999999999998876554     99999876421   223456678888876 49999999999998765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999999999999975  35789999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+...          
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~----------  211 (316)
T cd05619         147 MLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMD----------  211 (316)
T ss_pred             CCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC----------
Confidence            2221  12345679999999999999899999999999999999999999997544322   22111100          


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH-HHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS-EVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  378 (441)
                       .+    .++..++..+.+++.+||+.||++||++. ++++
T Consensus       212 -~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 -NP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             01    11223456788999999999999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-42  Score=338.32  Aligned_cols=257  Identities=22%  Similarity=0.355  Sum_probs=200.3

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      ....++|++.+.||+|+||.||++.+..++..     +|+|.+.+...   .....+.+|+.+++.++||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            33457899999999999999999998876654     89999865321   22345778999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ...    ..|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       114 ~~~----~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         114 DDK----YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             cCC----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence            765    45999999999999999965   3588999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR----LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      +|||+++...... ........||+.|+|||++.+..    ++.++|||||||++|+|++|..||...........   +
T Consensus       184 ~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~---i  259 (370)
T cd05621         184 ADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK---I  259 (370)
T ss_pred             EecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence            9999998654322 11234568999999999987543    78899999999999999999999975543221111   1


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVEV  379 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  379 (441)
                      ..   ..        ..+.......++..+.+++..||..++.+  |+++.++++.
T Consensus       260 ~~---~~--------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 MD---HK--------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             Hh---CC--------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00   00        00011111235677889999999855543  8899999884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.7e-42  Score=333.74  Aligned_cols=254  Identities=28%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      +|++.+.||+|+||.||++......  .....||+|++.+...    ...+.+..|+.++..+ +||||+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH--DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            5888999999999999999864321  1234599999865322    2234577899999999 5999999999887665


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        79 ----~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          79 ----KLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             ----EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence                35999999999999999976  35789999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhcc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLT  330 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~  330 (441)
                      |+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.......... ....+..   
T Consensus       150 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---  225 (332)
T cd05614         150 GLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---  225 (332)
T ss_pred             cCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc---
Confidence            99986433221 123346799999999998765 47889999999999999999999996433221111 1111100   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                              .++    ..+..++..+.+++.+||..||++||     +++++++
T Consensus       226 --------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 --------CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --------CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                    111    12234567789999999999999999     6778776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.7e-42  Score=339.98  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=201.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ..++|++.+.||+|+||.||+|.+..++..     ||+|.+.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            457899999999999999999998876654     99999865321   2234567899999999999999999988766


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .    ..|+||||++||+|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       116 ~----~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         116 K----YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             C----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence            5    45999999999999999865   3688899999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG----RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+++....... .......||+.|+|||++.+.    .++.++|||||||++|||++|..||...........   +..
T Consensus       186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i~~  261 (370)
T cd05596         186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMD  261 (370)
T ss_pred             ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH---HHc
Confidence            999986543221 122346799999999998653    478899999999999999999999976443211111   100


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVEV  379 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  379 (441)
                         ..        ..+.......++..+.+++.+||..+|.+  ||++.+++..
T Consensus       262 ---~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 ---HK--------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---CC--------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               00        00000111135678899999999999987  9999999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-41  Score=324.76  Aligned_cols=269  Identities=26%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCc-----------ccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeee
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDS-----------HKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVK  163 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~-----------~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~  163 (441)
                      .++|++.+.||+|+||.||+|.+...+..           .....||+|.+...... ....+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35789999999999999999988764432           13456899998765433 3467889999999999999999


Q ss_pred             EEeEEeccccCCeeEEEEEeccCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 013504          164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF---------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF  234 (441)
Q Consensus       164 l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  234 (441)
                      +++++...+.    .++||||+++++|.+++....         ...+++..++.++.|++.||.|||+.   +|+||||
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl  156 (296)
T cd05051          84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL  156 (296)
T ss_pred             EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence            9999987653    499999999999999997532         12689999999999999999999988   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh--CCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT--GRRPLDR  312 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--G~~P~~~  312 (441)
                      ||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986544332233344567889999999988889999999999999999998  6788864


Q ss_pred             CCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .....   .+...........       .......+..++.++.+++.+||+.||++||++.+|++.|+
T Consensus       237 ~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQ---VIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHH---HHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            43222   2221111110000       00001112235578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=304.28  Aligned_cols=271  Identities=24%  Similarity=0.322  Sum_probs=215.2

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ...++|.+.+.||.|||+-||+++...++..     +|+|++.-....+.+..++|++..++++||||++++++...+..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~-----YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHL-----YALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccc-----hhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            3457899999999999999999997776665     99999987777778889999999999999999999988765443


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                       .....||+++|...|+|.+.+...  .+..+++.+++.|+.+|++||.+||.. .++.+||||||.|||+.+.+.++|.
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence             334579999999999999998743  345799999999999999999999987 3469999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcc-------eeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          251 DFGLARLGPSDGLSH-------VSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       251 DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      |||.+....-.-...       .......|..|.|||.+.-   ...+.++|||||||+||.|+.|..||+.....    
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----  247 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----  247 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----
Confidence            999988643221110       1123467899999998864   45688999999999999999999999632110    


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                                .+.....+..+.........++..+.++++.||+.||.+||++.+++..+++++
T Consensus       248 ----------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ----------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      011111112222222222347889999999999999999999999999998875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-41  Score=326.20  Aligned_cols=267  Identities=25%  Similarity=0.440  Sum_probs=209.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCC--CcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTE--DSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ..+|.+.+.||+|+||.||+|.+....  .......+++|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999864321  12233468999887543 23346788999999999 899999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      ..    .++||||+++|+|.+++..+.              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus        94 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          94 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             Cc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            53    499999999999999997532              23578889999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999986544332222333456778999999988889999999999999999998 78888654322


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      .   ....+..    ..          ....+..++..+.+++.+||..+|.+||++.++++.|++++.-
T Consensus       247 ~---~~~~~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E---LFKLLKE----GH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H---HHHHHHc----CC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            2   2211110    00          0011224567899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.2e-42  Score=331.64  Aligned_cols=241  Identities=26%  Similarity=0.473  Sum_probs=192.4

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     ||+|.+.....   .....+..|..++..+ +||||+++++++...+    ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEY-----FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EE
Confidence            3699999999999998876653     99999875421   2334566788888764 8999999999998765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999999999999999876  36789999999999999999999998   9999999999999999999999999998743


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|..||......   .....+...          
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~----------  211 (316)
T cd05620         147 VFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVD----------  211 (316)
T ss_pred             ccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----------
Confidence            2211  1234568999999999999999999999999999999999999999754432   222211110          


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH-HHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS-EVV  377 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  377 (441)
                       .+    .++..++..+.+++.+||+.||++||++. +++
T Consensus       212 -~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 -TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             01    11123456788999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.6e-42  Score=333.33  Aligned_cols=244  Identities=27%  Similarity=0.453  Sum_probs=190.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     +|+|++.....   .....+.+|+.++.++ +||||+++++++...+    ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERI-----YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EE
Confidence            3699999999999998877654     99999876422   2334567888888776 8999999999988765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ++||||+++|+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999999999999998865  46799999999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh--HHHHHHhhhhhcccccchh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS--EQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~  336 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+....        
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  216 (329)
T cd05618         147 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------  216 (329)
T ss_pred             cCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------
Confidence            3221  12345689999999999999999999999999999999999999995321110  00001111000        


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                       +....  ...+..++..+.+++.+||..||++||++
T Consensus       217 -i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         217 -ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -HhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             00000  11233456778899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-41  Score=316.98  Aligned_cols=250  Identities=30%  Similarity=0.477  Sum_probs=201.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|...+.       .+++|.+....  ..+.+.+|+.++++++|+||+++++++...+.   
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   73 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---   73 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCC-------cEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---
Confidence            5788999999999999999976543       38999886443  34578899999999999999999998755432   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..+....+++..++.++.|++.||.|||++   +|+||||||+||++++++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            358999999999999999876555689999999999999999999998   99999999999999999999999999988


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .....     .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   ....+...       
T Consensus       151 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~-------  215 (256)
T cd05082         151 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG-------  215 (256)
T ss_pred             ecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcC-------
Confidence            54332     122345678999999998889999999999999999998 999996543221   11111110       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                             .....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       216 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 -------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                   00111224567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-41  Score=326.24  Aligned_cols=262  Identities=27%  Similarity=0.476  Sum_probs=204.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++.   ...+++|.+.... ......+.+|+.++.++ +||||+++++++...+. 
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~-   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCc---eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC-
Confidence            578899999999999999999865542   2236777766432 22345788899999999 89999999999977654 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                         .++||||+++++|.+++....              ...+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus        83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nil  156 (303)
T cd05088          83 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL  156 (303)
T ss_pred             ---ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEE
Confidence               499999999999999996432              23578999999999999999999988   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~  319 (441)
                      ++.++.+||+|||+++.....   .......++..|+|||++.+..++.++|||||||++|||+| |..||........ 
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  232 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-  232 (303)
T ss_pred             ecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-
Confidence            999999999999998742211   11112234668999999988889999999999999999998 9999965433221 


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                        .......              .....+..++..+.+++.+||+.+|++||++.+++..|..++....
T Consensus       233 --~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         233 --YEKLPQG--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             --HHHHhcC--------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence              1111100              0001112345678999999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9e-42  Score=331.30  Aligned_cols=242  Identities=26%  Similarity=0.466  Sum_probs=195.1

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|..++..+ +||||+++++++...+    ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDEL-----YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence            3699999999999998776553     99999875422   2345567899999887 7999999999987765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999999999999999876  35799999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..           
T Consensus       147 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~~-----------  210 (318)
T cd05570         147 ILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSILE-----------  210 (318)
T ss_pred             CcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHHc-----------
Confidence            2221  12334679999999999999999999999999999999999999997544221   1111110           


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH-----HHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM-----SEVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  378 (441)
                        .  ...++..++..+.+++.+||..||.+||++     .+++.
T Consensus       211 --~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         211 --D--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --C--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              0  001122356778999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-41  Score=323.46  Aligned_cols=276  Identities=25%  Similarity=0.401  Sum_probs=205.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|....... .....|++|.+........+.+.+|+.+++.++||||+++++++...+..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR--   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--
Confidence            578899999999999999998643211 12335999998776655567888999999999999999999988654432  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            358999999999999999753 34689999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc---cc
Q 013504          257 LGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT---DA  332 (441)
Q Consensus       257 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~---~~  332 (441)
                      ......... ......++..|+|||++.+..++.++|||||||++|||++|..|+......    ..........   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  232 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIV  232 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccch
Confidence            754432111 111223445699999999889999999999999999999998776432111    0000000000   00


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ......+........+..++..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000001111111112234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-41  Score=317.31  Aligned_cols=253  Identities=28%  Similarity=0.472  Sum_probs=202.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|......      .+++|.+..... ....+.+|+.++++++||||+++++++...     
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----   73 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNT------KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE-----   73 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCc------eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC-----
Confidence            57889999999999999999876433      389998876443 345788999999999999999999987532     


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence            248999999999999999765456789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ........       
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~-------  219 (260)
T cd05070         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERG-------  219 (260)
T ss_pred             eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC-------
Confidence            65432211 1122345678999999988889999999999999999999 899996543322   11111100       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                             .....+...+..+.+++.+||..+|.+||++.+++++|++
T Consensus       220 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   0111223456779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-41  Score=335.87  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=200.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ...+|.+.+.||+|+||.||+|...+..   ....|++|.+...     ....+|+.+|+.++||||+++++++....  
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~---~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~--  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDE---QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS--  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCc---cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC--
Confidence            3467999999999999999999865432   2345889987643     23458999999999999999999987655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+|||++. ++|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+
T Consensus       160 --~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        160 --TVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             --EEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence              3599999994 789998844  46899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc---
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD---  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---  331 (441)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+...+..   
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            97654433222334568999999999999999999999999999999999999999654432211111111000000   


Q ss_pred             ----cc---------chhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          332 ----AK---------KFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       332 ----~~---------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                          ..         .+.....+....   .....++..+.++|.+||..||++||++.+++..
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                00         000000000000   0001235578899999999999999999999984

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=323.86  Aligned_cols=268  Identities=24%  Similarity=0.420  Sum_probs=203.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCC---------cccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTED---------SHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      ++|++.+.||+|+||.||+|....+..         ......||+|.+...... ....+.+|+.++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999998764321         122345899998754322 2356889999999999999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF----------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS  236 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp  236 (441)
                      ++.....    .++||||+++++|.+++....          ...+++..++.++.|++.||.|||+.   +++||||||
T Consensus        85 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          85 VCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             EEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            9987654    499999999999999986431          12468889999999999999999998   999999999


Q ss_pred             CcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCC
Q 013504          237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT--GRRPLDRNR  314 (441)
Q Consensus       237 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--G~~P~~~~~  314 (441)
                      +|||+++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999986543322222233455778999999988899999999999999999998  667876543


Q ss_pred             chhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .....   ............       ......+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       238 ~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DEQVI---ENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hHHHH---HHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            32211   111110000000       0000111234578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=309.72  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=204.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++.|++.+.||+|.|+.||++.+..++.....+.+-+|++...   ..+++.+|++|-+.|+|||||+|.+.+.+... 
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~-   84 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESF-   84 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccce-
Confidence            45678888899999999999999988877633333333333332   46788899999999999999999988876653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~D  251 (441)
                         .|||+|++.|++|..-|..+  ..+++..+-.+++||+.+|.|+|.+   +|||||+||+|+||-.   ..-+||+|
T Consensus        85 ---~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   85 ---HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             ---eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecc
Confidence               49999999999999888765  5678888999999999999999998   9999999999999943   34489999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+|..+..   .......+|||+|||||++...+|+..+|||+.|||||-||.|.+||.+....   .+.+.+...   
T Consensus       157 FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g---  227 (355)
T KOG0033|consen  157 FGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAG---  227 (355)
T ss_pred             cceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhcc---
Confidence            999997763   23445689999999999999999999999999999999999999999753221   222222111   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              +-...+.+...++++..+|+++||..||.+|.|+.|.|.
T Consensus       228 --------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  228 --------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                    011223345567889999999999999999999999886

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.4e-42  Score=332.24  Aligned_cols=238  Identities=27%  Similarity=0.425  Sum_probs=188.8

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHH-HhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVN-VLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||+||+|.+..++..     ||+|++......   ....+..|.. +++.++||||+++++++...+    ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKF-----YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EE
Confidence            3699999999999998776653     999998754321   2234555555 467799999999999987765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ++||||+++|+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          72 YFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999999999999999976  46789999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+.   .        
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~---~--------  210 (323)
T cd05575         147 IEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNIL---N--------  210 (323)
T ss_pred             ccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHHH---c--------
Confidence            3221  12344679999999999999999999999999999999999999997543221   111110   0        


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                        ...  ..+...+..+.+++.+||+.||.+||++.
T Consensus       211 --~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 --KPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              000  11123467789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.2e-41  Score=319.15  Aligned_cols=267  Identities=24%  Similarity=0.391  Sum_probs=210.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..+. ......|++|.+..... .....+.+|+.+++.++||||+++++++..... 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE-   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence            467899999999999999999987632 12234588998865432 234668899999999999999999999876432 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQ------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                        ..++++||+++++|.+++.....      ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+|
T Consensus        83 --~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          83 --PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             --CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence              34899999999999999865322      4689999999999999999999988   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....+..   ...+...
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~  234 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD  234 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc
Confidence            999999986543322222233456778999999988889999999999999999999 999997654322   2222211


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ..              .......++..+.+++.+||..+|++||++.++++.|+++.+.
T Consensus       235 ~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 GY--------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            10              0011123456789999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.6e-41  Score=316.78  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=200.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+.+..      .+|+|.+.... .....+.+|+.++.+++||||+++++++...+.   
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   73 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP---   73 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCC------cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC---
Confidence            46888899999999999999875532      38999887543 234678899999999999999999999976654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.+||+|||+++
T Consensus        74 -~~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          74 -IYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             -cEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence             49999999999999999754 23789999999999999999999998   99999999999999999999999999988


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.........   ..+.....     
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~~~~~-----  219 (256)
T cd05113         149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---EKVSQGLR-----  219 (256)
T ss_pred             ecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHHhcCCC-----
Confidence            6543221 11122345678999999988889999999999999999998 99999654432211   11110000     


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                               ...+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                     0011123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-41  Score=322.63  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=194.6

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||+|+||+||++.+..++..     +|+|.+......   ....+..|+.+++.++||||+++.+++....    ..++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKL-----YACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEccCCcE-----EEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEE
Confidence            79999999999998776553     999998754332   2345678999999999999999999887665    35999


Q ss_pred             EeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      |||+++|+|..++...  ....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.++|+|||++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            9999999999887532  245789999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhcccccchhhh
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......             
T Consensus       149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-------------  213 (280)
T cd05608         149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-------------  213 (280)
T ss_pred             CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-------------
Confidence            3221  22346799999999999999999999999999999999999999975432211 1111110             


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                      ....  ..++..++..+.+++.+||+.||++||     +++++++
T Consensus       214 ~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         214 LNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            0000  112334667899999999999999999     6677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-41  Score=315.31  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=204.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|.+.+.||+|+||.||+|.+..++..     |++|.+....  ......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~-----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   72 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRV-----YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG---   72 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcE-----EEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC---
Confidence            478888999999999999998766543     8999876543  234567889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          73 -KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             -EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence             459999999999999999875567899999999999999999999988   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      +.......  ......|++.|+|||++.+..++.++|||||||++++|++|..||......   .........       
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-------  216 (256)
T cd08529         149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRG-------  216 (256)
T ss_pred             eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcC-------
Confidence            86543321  223457899999999999989999999999999999999999999755421   111111100       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .....+..++..+.+++.+||+.+|++||++.++++
T Consensus       217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 -------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                   011122245678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=316.35  Aligned_cols=251  Identities=27%  Similarity=0.470  Sum_probs=199.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|.+.+.||+|+||.||+|.+....      .+|+|.+..... ....+.+|+.+++.++||||+++++++...+.   
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~------~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   73 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKI------DVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP---   73 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCc------cEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc---
Confidence            35788889999999999999876432      389998865432 34568889999999999999999999876653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++..+ ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        74 -~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          74 -IFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             -eEEEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence             49999999999999999754 24789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........   .....       
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~~-------  217 (256)
T cd05059         149 YVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---SVSAG-------  217 (256)
T ss_pred             eccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---HHHcC-------
Confidence            65432111 1112234567999999998899999999999999999999 899997544322111   11100       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                         .    ....+..++..+.+++.+||..+|++||++.++++.|
T Consensus       218 ---~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---Y----RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---C----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               0    0011123567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8e-41  Score=324.01  Aligned_cols=267  Identities=25%  Similarity=0.456  Sum_probs=207.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||+|.......  ......+|+|.+..... .....+..|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3578899999999999999998654322  12344589998875432 2345678899999999 699999999998765


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      ..    .++||||+++|+|.+++....              ...+++..+..++.|++.||.|||++   +|+||||||+
T Consensus        91 ~~----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          91 GP----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             Cc----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence            53    499999999999999996532              23588899999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986543221111122334567999999988899999999999999999999 88999654432


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      .....   ....    .          ....+..++..+.+++.+||..+|++||++.++++.|+++...
T Consensus       244 ~~~~~---~~~~----~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         244 ELFKL---LREG----H----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHHH---HHcC----C----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            22211   1110    0          0011224456788999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-42  Score=305.20  Aligned_cols=260  Identities=27%  Similarity=0.409  Sum_probs=209.9

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch----h----hHHHHHHHHHhccC-CCCCeee
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ----G----HKEWVTEVNVLGVV-EHPNLVK  163 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~E~~il~~l-~hpnIv~  163 (441)
                      +..-+.|...+.||+|..++|-++.++.++..     +|+|++......    .    .+.-.+|+.||+++ .||+|+.
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e-----~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKE-----FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccc-----eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            44557788899999999999999999888765     888887542211    1    23446799999997 7999999


Q ss_pred             EEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       164 l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                      +.+++..+..    .++|+|.|+.|.|.++|..  ...+++.....|++|+..|+.|||.+   +||||||||+|||+++
T Consensus        88 l~D~yes~sF----~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   88 LQDVYESDAF----VFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             eeeeccCcch----hhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            9999988764    4999999999999999987  46899999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      |.++||+|||++.......   .....+|||+|+|||.+..      ..|+..+|+|++|||+|-||.|.+||-.-....
T Consensus       159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            9999999999999876543   3456899999999998854      457889999999999999999999994221100


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCC--CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPK--LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                                      .+..++...  +......+.+....+||.+||+.||.+|.|++|+|+  ++..+..
T Consensus       236 ----------------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  236 ----------------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             ----------------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence                            111111111  122334577889999999999999999999999998  4544443

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.5e-41  Score=315.09  Aligned_cols=249  Identities=24%  Similarity=0.423  Sum_probs=196.7

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      .||+|+||.||+|.+.....   ...+|+|++.....  ...+.+.+|+.+++.+.||||+++++++...     ..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKS---EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCC---ceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcEEE
Confidence            58999999999998653322   23599999865432  2346788999999999999999999988543     24899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||.|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          74 MELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            999999999999975  35789999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          262 GLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       262 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      .... ......++..|+|||.+....++.++|||||||++|||++ |..||........   ...+...           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i~~~-----------  214 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMIESG-----------  214 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHCC-----------
Confidence            2111 1122334678999999988889999999999999999998 9999976543322   2221110           


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                         .....+..++..+.++|.+||+.||++||++.+|...|++
T Consensus       215 ---~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         215 ---ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence               0011222456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.2e-41  Score=316.23  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=206.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|+...++.     .||||.+.....   .....+.+|+.+++.++||||+++++++...+ 
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRK-----PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCC-----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence            478999999999999999999876654     389998764322   22356788999999999999999999988665 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                         ..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus        76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          76 ---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ---eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence               348999999999999988532  234688999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||++.......  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+..    
T Consensus       150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~----  222 (267)
T cd08228         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQ----  222 (267)
T ss_pred             cccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhc----
Confidence            99988654322  11234578899999999988889999999999999999999999996443211 111111110    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                               ..........++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       223 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         223 ---------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                     0001112234567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-41  Score=320.24  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=193.9

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||+|+||.||++....++..     +|+|.+......   ....+..|+.+++.++||||+++++++....    ..++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~-----~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKM-----YACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEccCCcE-----EEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEE
Confidence            79999999999998776554     999988653322   2234567999999999999999999987655    45999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||++|++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9999999999998765556789999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhcccccchhhhcC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTDAKKFTMILD  340 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  340 (441)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .....   .....         
T Consensus       149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~---------  213 (277)
T cd05607         149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLED---------  213 (277)
T ss_pred             c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhcc---------
Confidence            1   22345789999999999988899999999999999999999999965432111 11111   11100         


Q ss_pred             CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       341 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ... .....++.++.+++.+||+.||++||++.++++
T Consensus       214 -~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         214 -EVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             -ccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence             000 011235677899999999999999999987764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.5e-41  Score=330.31  Aligned_cols=268  Identities=24%  Similarity=0.293  Sum_probs=199.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .||+|.+....  ......+.+|+.+++.++||||+++++++....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGI-----NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCc-----eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            45789999999999999999999876654     49999986542  233466789999999999999999999987554


Q ss_pred             cC--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          173 ER--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       173 ~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      ..  ....|+||||+++ +|.+.+.    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            21  1246999999965 6766663    3578899999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhh----
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWV----  325 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~----  325 (441)
                      |||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .....    
T Consensus       166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            99999854322   12334678999999999999999999999999999999999999997554321110 00000    


Q ss_pred             -----------hhhccccc-----chhhhcCCCC---CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 -----------RPHLTDAK-----KFTMILDPKL---EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 -----------~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 ........     .+........   ........+..+.+++.+||+.||++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                       00000000     0000000000   00011123467889999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.9e-41  Score=316.93  Aligned_cols=260  Identities=25%  Similarity=0.478  Sum_probs=205.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|++.+.||+|+||.||+|.+..++..  ...|+||.+.... ......+..|+.+++.++||||+++++++.....  
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP--   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCC--ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc--
Confidence            4578889999999999999998765431  3458999987542 2234678899999999999999999999876653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        80 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          80 --VMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             --eEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccc
Confidence              49999999999999999754 35689999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceee-ce--ecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          256 RLGPSDGLSHVST-AV--VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       256 ~~~~~~~~~~~~~-~~--~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ............. ..  ..+..|+|||++.+..++.++|||||||++|||++ |..||......   ....++....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~--  228 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY--  228 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC--
Confidence            7654322111111 11  12457999999998999999999999999999886 99999654432   2222221110  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                  ....+.+++..+.+++.+||..+|++||++.+|+..|+++
T Consensus       229 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        0111224566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=315.03  Aligned_cols=250  Identities=30%  Similarity=0.507  Sum_probs=204.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|...+.       .|++|.+..... ..+++.+|+.+++.++|+||+++++++...+.  
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~-------~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQ-------KVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCc-------EEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC--
Confidence            35788999999999999999987532       399999976654 45778899999999999999999999886443  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++.......+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++
T Consensus        75 --~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          75 --LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             --eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence              49999999999999999875555799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +......     ....++..|+|||++....++.++||||||+++++|++ |..||.......   +.......      
T Consensus       150 ~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~------  215 (256)
T cd05039         150 KEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKG------  215 (256)
T ss_pred             ccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcC------
Confidence            8653221     12345678999999988889999999999999999997 999996543322   11111110      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                              .....+..+++.+.+++.+||..+|++||++.+++++|+.
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         216 --------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                    0011122356789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-41  Score=328.73  Aligned_cols=242  Identities=25%  Similarity=0.452  Sum_probs=194.0

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCC-CCCeeeEEeEEecccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDE  173 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  173 (441)
                      +|...+.||+|+||.||+|.+..++..     ||+|++.....   ...+.+..|..++..+. |++|+++++++...+ 
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDEL-----YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence            477889999999999999998776653     99999875422   22355778899998885 578888988887765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          75 ---RLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             ---EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence               35999999999999999875  36799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+...     
T Consensus       147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~-----  216 (323)
T cd05615         147 MCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEH-----  216 (323)
T ss_pred             cccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC-----
Confidence            988543221  12334679999999999999999999999999999999999999997654321   11111100     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                                ...++..++..+.+++.+||+.+|.+|++.
T Consensus       217 ----------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 ----------NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                      011223455678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.8e-41  Score=320.56  Aligned_cols=269  Identities=25%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC---CCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV---EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~  172 (441)
                      +|++.+.||+|+||.||+|.+..++..     ||+|.+......  ....+.+|+.+++.+   +||||+++++++....
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~   75 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHF-----VALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR   75 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcE-----EEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence            488889999999999999998877654     999988754322  123456777777665   7999999999886532


Q ss_pred             c-CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          173 E-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       173 ~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      . .....++||||++ ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          76 TDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             CCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            2 2234689999997 5899998765556689999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~~  330 (441)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......... ...........
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99998654321   123457899999999999889999999999999999999999999655433221 11111100000


Q ss_pred             ccc----c-hhhhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAK----K-FTMILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~----~-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...    . ......+...   ......++..+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000    0 0000000000   0111235667899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.9e-41  Score=316.26  Aligned_cols=262  Identities=24%  Similarity=0.491  Sum_probs=206.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|...+.||+|+||.||+|....++.  ....+++|.+.... ......+..|+.+++.++||||+++++++...+. 
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR--KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP-   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC--CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC-
Confidence            3578888999999999999999865432  12358999886543 2334678899999999999999999999987664 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++++|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        81 ---~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          81 ---AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             ---cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcc
Confidence               49999999999999999754 35789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcce-eeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +........... ......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ....+...    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~----  226 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDG----  226 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcC----
Confidence            986543221111 111223457999999988889999999999999999998 999996543322   11111110    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                                ........++..+.+++.+||..+|++||++.+|++.|++++
T Consensus       227 ----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         227 ----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                      000112235577899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-41  Score=330.05  Aligned_cols=244  Identities=26%  Similarity=0.421  Sum_probs=191.2

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++||+|+||.||+|....++..     +|+|++.....   ...+.+.+|+.++.++ +||||+++++++....    ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQI-----YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EE
Confidence            3699999999999998776553     99999876432   2235577899999888 6999999999987665    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999999999999998865  35799999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+....         +
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~  215 (327)
T cd05617         147 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---------I  215 (327)
T ss_pred             cCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---------H
Confidence            2221  1234568999999999999999999999999999999999999999643221111111111000         0


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                      ....  ...+...+..+.+++.+||..||.+|+++
T Consensus       216 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         216 LEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            0000  11223355678899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.6e-41  Score=315.45  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=204.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.++||+|+||.||+|.....      ..+|+|.+..... ....+.+|+.++++++||||+++++++...    
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   73 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQE----   73 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCC------ceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccC----
Confidence            46799999999999999999986543      2499999875443 346788999999999999999999987432    


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++....+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          74 -PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             -CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence             249999999999999999765566889999999999999999999987   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ........ .......++..|+|||++....++.++||||||+++|||++ |+.||...........   .....     
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~-----  220 (260)
T cd05067         150 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---LERGY-----  220 (260)
T ss_pred             eecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HHcCC-----
Confidence            76542221 11223456778999999988889999999999999999999 9999975443222111   11000     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               ....+...+..+.+++.+||..+|++||++++++..|++
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 ---------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                     001122345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-41  Score=334.59  Aligned_cols=260  Identities=23%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEe
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      .++....++|++.+.||+|+||.||+|.+..++..     +|+|++.....   .....+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~-----~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  110 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcE-----EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34445568999999999999999999998877654     89999865322   22345678999999999999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ++....    ..|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       111 ~~~~~~----~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         111 AFQDDR----YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             EEEcCC----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence            987655    45999999999999999865   3588899999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR----LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      +||+|||+++...... ........||+.|+|||++.+..    ++.++|||||||++|||++|..||........... 
T Consensus       181 ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-  258 (371)
T cd05622         181 LKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-  258 (371)
T ss_pred             EEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence            9999999998654322 11234568999999999987543    78899999999999999999999975443221111 


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVEV  379 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  379 (441)
                        +..   ..        ..+.......++..+.+++..||..++.+  |+++.++++.
T Consensus       259 --i~~---~~--------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         259 --IMN---HK--------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             --HHc---CC--------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence              100   00        00011111245677889999999844433  7899998884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.1e-41  Score=322.33  Aligned_cols=264  Identities=28%  Similarity=0.480  Sum_probs=207.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|+..+.||+|+||.||+|.+..++... ...+|+|.+....... ...+.+|+.+++.++||||+++++++....   
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~---   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETV-KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT---   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcc-eeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC---
Confidence            56888899999999999999987665432 3458999887544322 346789999999999999999999987543   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++++||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        83 --~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          83 --IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             --ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence              37899999999999998754 34688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||...........+.   ..    ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~----~~  229 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---KG----ER  229 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CC----CC
Confidence            86543322212223456778999999998899999999999999999997 899996543322222211   10    00


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                ...+..++..+.+++..||..+|++||++.++++.|..+.+..
T Consensus       230 ----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         230 ----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                      0011123457889999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=328.76  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=193.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ...+|.+.+.||+|+||.||+|....++..     ||+|.....      ....|+.++++++||||+++++++..... 
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-  131 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDP-----VVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-  131 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCce-----EEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCe-
Confidence            346799999999999999999998776543     888875432      23469999999999999999999987653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+ .++|.+++... ...+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       132 ---~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        132 ---TCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             ---eEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence               48999999 56898888653 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCC-CCCCchhH-------HHHHHhhh
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSE-------QKLLEWVR  326 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~-~~~~~~~~-------~~~~~~~~  326 (441)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||+++..|+ ........       ..+...+.
T Consensus       204 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~  280 (357)
T PHA03209        204 AQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS  280 (357)
T ss_pred             ccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence            9753221   1223467999999999999999999999999999999999965554 33221111       11111111


Q ss_pred             hhcccccch---------hhhcC------CCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDAKKF---------TMILD------PKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~---------~~~~~------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ........+         ...++      .....   .....++..+.++|.+||+.||++|||+.++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            000000000         00000      00000   000123456778999999999999999999986

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.3e-41  Score=315.81  Aligned_cols=260  Identities=25%  Similarity=0.474  Sum_probs=205.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|.+.+.||+|+||.||+|.+..++.  ....+|+|.+..... .....+.+|+.++..++||||+++++++...+.  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK--REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP--   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC--CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--
Confidence            578889999999999999998764432  123589998865432 234578899999999999999999999976653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++
T Consensus        80 --~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          80 --VMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             --cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence              49999999999999999764 35689999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcce-eeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +.......... .....++..|+|||.+.+..++.++|||||||++|++++ |..||........   ...+....    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~~----  226 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEGY----  226 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCCC----
Confidence            86543321111 112234568999999998899999999999999999887 9999965443221   11111100    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                ....+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ----------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                      0011223466789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-41  Score=330.18  Aligned_cols=241  Identities=26%  Similarity=0.389  Sum_probs=189.7

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHH-HhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVN-VLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||.||+|.+..++..     ||+|++.....   .....+..|.. +++.++||||+++++++...+    ..
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKF-----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eE
Confidence            3699999999999998776543     99999875432   12234444444 567789999999999988765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          72 YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999999999999999976  45788899999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..           
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~-----------  210 (325)
T cd05602         147 IEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN-----------  210 (325)
T ss_pred             ccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHHh-----------
Confidence            3221  12345679999999999999999999999999999999999999997544322   1111110           


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV  377 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  377 (441)
                        ..  ......++..+.+++.+||+.+|.+||++.+.+
T Consensus       211 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         211 --KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             --CC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence              00  011224567789999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-40  Score=313.76  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=202.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+..+.      .+++|.+.... .....+.+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT------KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-----   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc------eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----
Confidence            56888899999999999999876543      28999876543 2345688999999999999999999987532     


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||+++
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            248999999999999999765556689999999999999999999988   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ ......++..|+|||...+..++.++||||||+++|+|++ |..||.......   ...+.....      
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~------  220 (260)
T cd05069         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGY------  220 (260)
T ss_pred             EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC------
Confidence            65332211 1222346778999999988899999999999999999999 899997543322   111111100      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                              ....+...+..+.+++.+||..+|++||++.+|+++|++
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 --------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    011223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3e-41  Score=319.74  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      ++..|++.+.||+|+||.||+|....++.     .+|+|.+.... .....+.+|+.++.++ +||||+++++++.....
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCc-----EEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            45678889999999999999999876654     38999886543 3345678899999998 79999999999876543


Q ss_pred             C--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 R--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .  ....++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            2  12468999999999999999865556789999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      ||++.......  .......|++.|+|||++.     +..++.++|||||||++|||++|..||.............   
T Consensus       155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---  229 (272)
T cd06637         155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---  229 (272)
T ss_pred             CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---
Confidence            99998643221  1234467899999999986     3457889999999999999999999996543221111100   


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .     ..        ........++..+.+++.+||..+|.+||++.++++
T Consensus       230 ~-----~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 R-----NP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             c-----CC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0     00        001111234567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-41  Score=334.79  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=197.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|+..+.||+|+||.||++....++..     ||+|++.....   .....+.+|+.++..++||||+++++.+.+.+ 
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHI-----YAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence            4688999999999999999998876654     99999875322   22456778999999999999999999988765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++||+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          75 ---NLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             ---EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence               45999999999999999976  36789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC---------------------------------cceeeceecccCcCCccccccCCCCccccchhHHHHH
Q 013504          254 LARLGPSDGL---------------------------------SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL  300 (441)
Q Consensus       254 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il  300 (441)
                      +++.......                                 .......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            9875422110                                 0011235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCchhHHHHH-HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC---HHHH
Q 013504          301 YELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK---MSEV  376 (441)
Q Consensus       301 ~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev  376 (441)
                      |||++|+.||....+......+ .|..       .  ..+.+      ...++..+.+++.+|+ .+|.+|++   +.++
T Consensus       227 yel~tG~~Pf~~~~~~~~~~~i~~~~~-------~--~~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  290 (360)
T cd05627         227 YEMLIGYPPFCSETPQETYRKVMNWKE-------T--LVFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEI  290 (360)
T ss_pred             eecccCCCCCCCCCHHHHHHHHHcCCC-------c--eecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence            9999999999765443222111 1100       0  00000      0124567888888876 49999985   5666


Q ss_pred             HH
Q 013504          377 VE  378 (441)
Q Consensus       377 l~  378 (441)
                      +.
T Consensus       291 ~~  292 (360)
T cd05627         291 KS  292 (360)
T ss_pred             hc
Confidence            65

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.7e-41  Score=320.61  Aligned_cols=252  Identities=29%  Similarity=0.480  Sum_probs=201.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .|+..+.||+|+||.||++.+..++..     +|+|.+......   ....+.+|+.+++.++|+||+++++.+...+  
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--   73 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKM-----YACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--   73 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCce-----EEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence            377788999999999999998877654     999988654322   2245678999999999999999999987765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        74 --~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          74 --ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             --EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence              359999999999999998765455799999999999999999999987   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...................     
T Consensus       149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----  220 (285)
T cd05630         149 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----  220 (285)
T ss_pred             eeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----
Confidence            87643321   1223578999999999999999999999999999999999999997543221111111110000     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                               ....+..++..+.+++.+||+.||++||+     +.++++
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 ---------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                     01122235567899999999999999999     788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-41  Score=330.89  Aligned_cols=240  Identities=27%  Similarity=0.400  Sum_probs=189.2

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHH-HhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVN-VLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||+|+||+||+|.+..++..     +|+|++.....   .....+..|.. +++.++||||+++++++...+    ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKC-----YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCE-----EEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EE
Confidence            3699999999999998766543     99999875422   22344556655 467789999999999988765    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          72 YFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999999999999998865  46799999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..   .       
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~~---~-------  211 (325)
T cd05604         147 IAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNILH---K-------  211 (325)
T ss_pred             CCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHHc---C-------
Confidence            3221  12345679999999999999999999999999999999999999997543222   1111100   0       


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV  376 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  376 (441)
                         .+  ......+..+.+++.+||+.+|.+||++.+.
T Consensus       212 ---~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         212 ---PL--VLRPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             ---Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence               00  0111345678899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=315.61  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-----hhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-----GHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ++|...+.||+|+||.||+|....++.     .+++|.+......     ....+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGR-----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCc-----EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence            578999999999999999998776554     4899987643221     234678899999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|+|
T Consensus        77 ~----~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          77 E----TLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             C----eEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            5    45999999999999999976  35788999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++......... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........  .. ..    
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~-~~----  220 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--FK-IA----  220 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--HH-Hh----
Confidence            99987543321111 113356888999999999988999999999999999999999999654322111  11 00    


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                               ........+..++..+.+++.+||..+|.+||++.+++..
T Consensus       221 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 ---------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                     0001112333466788999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-40  Score=313.30  Aligned_cols=250  Identities=24%  Similarity=0.476  Sum_probs=197.1

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEe
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE  183 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E  183 (441)
                      ||+|+||.||+|.+.....   ...||+|.+...... ..+.+.+|+.++++++||||+++++++...     ..++|||
T Consensus         3 ig~G~~g~v~~~~~~~~~~---~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~e   74 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKK---QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVME   74 (257)
T ss_pred             cCCCCcccEEEEEEecCCC---ceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEEE
Confidence            8999999999998764322   234899998765432 235688999999999999999999988533     2489999


Q ss_pred             ccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCC
Q 013504          184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL  263 (441)
Q Consensus       184 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  263 (441)
                      |+++++|.+++..+ ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus        75 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          75 MASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             eCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            99999999998753 35789999999999999999999998   999999999999999999999999999986443321


Q ss_pred             cce-eeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          264 SHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       264 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      ... .....++..|+|||++.+..++.++|||||||++|++++ |..||...........+.   ..             
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~-------------  214 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE---QG-------------  214 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CC-------------
Confidence            111 112234678999999988889999999999999999996 999997654332221111   10             


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                       .....+..++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       215 -~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 -KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             01112234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-41  Score=330.62  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=192.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      +.||+|+||.||++......  ..+..+|+|++......  ....+.+|+.+|++++||||+++++++...+    ..|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGP--DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEE
Confidence            57999999999998764221  12335999998764322  2345678999999999999999999998765    4599


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        76 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          76 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            9999999999999965  35789999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcC
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD  340 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (441)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+...            
T Consensus       151 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~~~------------  213 (318)
T cd05582         151 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMILKA------------  213 (318)
T ss_pred             CC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHHcC------------
Confidence            21  123346799999999999988899999999999999999999999975433221   1111100            


Q ss_pred             CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHH
Q 013504          341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE  375 (441)
Q Consensus       341 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  375 (441)
                         ....+..++..+.+++.+||+.||++||++.+
T Consensus       214 ---~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 ---KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               00122235677889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.8e-41  Score=313.94  Aligned_cols=251  Identities=26%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +|++.+.||.|+||.||++.+..++.     .+++|.+.... ....+.+.+|+.+++.++||||+++++++...+    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ-----KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG----   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc-----eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----
Confidence            57888999999999999999876654     38999876432 233467788999999999999999999987665    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++.......+++..++.++.|++.||.|||++   +|+|+||||+||++++++.++|+|||+++
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            459999999999999998765566789999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........   ....     .  
T Consensus       149 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~-----~--  216 (255)
T cd08219         149 LLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK---VCQG-----S--  216 (255)
T ss_pred             eecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH---HhcC-----C--
Confidence            654322  123346789999999999988899999999999999999999999975432211111   1000     0  


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                             ....+..++..+.+++.+||+.||++||++.+++..
T Consensus       217 -------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   011223455678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-40  Score=322.44  Aligned_cols=266  Identities=26%  Similarity=0.367  Sum_probs=202.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||++.+..++.     .+++|.+...... ...++.+|+.++.+++||||+++++++...+   
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGL-----IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG---   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCe-----EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence            368999999999999999999877654     3888887654322 2356889999999999999999999998766   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.++|+|||++
T Consensus        73 -~~~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          73 -EISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             -EEEEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCc
Confidence             45999999999999999976  36789999999999999999999973  28999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc-
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK-  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  334 (441)
                      ......    ......|++.|+|||++.+..++.++|||||||++|+|++|..||........................ 
T Consensus       148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (308)
T cd06615         148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH  223 (308)
T ss_pred             cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence            754332    123467899999999998888999999999999999999999999654322222111110000000000 


Q ss_pred             -------------------hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          335 -------------------FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       335 -------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                         ................++..+.+++.+||..+|++||++.+|+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                               000000000000011256679999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.1e-41  Score=331.02  Aligned_cols=274  Identities=24%  Similarity=0.298  Sum_probs=202.8

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||++.+..++.     .||||.+.....  .....+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   88 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCc-----eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence            345789999999999999999998766554     399999875432  2345677899999999999999999998754


Q ss_pred             cc--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          172 DE--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       172 ~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ..  .....|+||||+++ +|.+.+..    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          89 KSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             ccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence            32  11246899999964 67777643    588899999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhh---
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWV---  325 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~---  325 (441)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+...   
T Consensus       161 ~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999864332   12344678999999999999999999999999999999999999997544222111 11100   


Q ss_pred             ------------hhhcccccchhhhcCCCC--------CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          326 ------------RPHLTDAKKFTMILDPKL--------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       326 ------------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                                  ...............+..        ........+..+.+++.+||..||++|||+.++++  ++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                        000000000000000000        00111223467889999999999999999999998  35443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-40  Score=319.81  Aligned_cols=268  Identities=25%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCC-----------cccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeE
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTED-----------SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l  164 (441)
                      ++|++.+.||+|+||.||++.+.....           ......+|+|.+..... .....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            569999999999999999987543211           11234589999875432 234678899999999999999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ---------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK  235 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK  235 (441)
                      ++++...+.    .++||||+++|+|.+++.....         ..+++..+..++.|++.||.|||+.   +++|||||
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          85 LAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             EEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            999987664    4999999999999999875321         2467889999999999999999998   99999999


Q ss_pred             CCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCC
Q 013504          236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT--GRRPLDRN  313 (441)
Q Consensus       236 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--G~~P~~~~  313 (441)
                      |+|||++.++.++|+|||+++...............+++.|++||...++.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999986543322122223345678999999888899999999999999999998  77888654


Q ss_pred             CchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .......   ...........  ..     ....+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       238 ~~~~~~~---~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SDEQVIE---NTGEFFRDQGR--QV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ChHHHHH---HHHHHHhhccc--cc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            3322111   11000000000  00     00111235578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-41  Score=317.71  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|....++.     .+|+|++..........+.+|+.++..++||||+++++++...+   
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~---   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGE-----LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE---   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCe-----EEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC---
Confidence            3579999999999999999999876654     49999987654444566788999999999999999999997665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        80 -~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          80 -KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             -EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence             45999999999999999865  35789999999999999999999988   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +......  .......|++.|+|||.+.   ...++.++|||||||++|||++|+.||....+.....  ....      
T Consensus       154 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~------  223 (267)
T cd06646         154 AKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK------  223 (267)
T ss_pred             eeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec------
Confidence            8653221  1123457899999999874   3457889999999999999999999986433221110  0000      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..   ...+..  .....++..+.+++.+||..+|++||+++++++.
T Consensus       224 ~~---~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         224 SN---FQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CC---CCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            00   000111  1112356789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-40  Score=336.15  Aligned_cols=264  Identities=20%  Similarity=0.268  Sum_probs=196.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ...|.+.+.||+|+||.||+|.+..++.     .||||....      ..+.+|+.+|++++|||||++++++.....  
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~-----~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~--  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQ-----RVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGL--  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCC-----EEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE--
Confidence            4579999999999999999999877654     389986422      345689999999999999999999877653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++|||++ .++|.+++..+ ...+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||++
T Consensus       235 --~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        235 --TCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             --EEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence              48999999 57999988654 34799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCch--------hHHHHHHhhhh
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK--------SEQKLLEWVRP  327 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~--------~~~~~~~~~~~  327 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|||++|..|+......        .....+.....
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            8654332222233467999999999999999999999999999999999988765322111        11112221111


Q ss_pred             hcccccc-----hh--------hhcCCCCCCcch---HHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          328 HLTDAKK-----FT--------MILDPKLEGKYS---IKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       328 ~~~~~~~-----~~--------~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .......     ..        ....+.......   ......+.+||.+||+.||++|||+.|+|+.
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000000     00        000000000000   0234578899999999999999999999973

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=325.23  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=213.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh--HHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      =|...+.||+|.|.+|-+|++.-++..     ||||++.+......  ..+.+|++.|+.++|||||+||.+.....   
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGek-----VAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT---   90 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEK-----VAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT---   90 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccce-----eEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc---
Confidence            466667899999999999998888765     99999998766543  56889999999999999999999987655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE-cCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl-~~~~~~kl~DFGl  254 (441)
                       .+|||+|+-++|+|++||-+. ...+.+..+.+++.||+.|+.|+|+-   ++|||||||+||.+ ..-|-|||+|||+
T Consensus        91 -KlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   91 -KLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             -eEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccc
Confidence             459999999999999999765 46899999999999999999999987   99999999999887 5668899999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCc-cccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +..+.+..   ..++.+|...|-|||++.+..|+. ++||||||||||.|++|++||+..+..                +
T Consensus       166 SNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------E  226 (864)
T KOG4717|consen  166 SNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------E  226 (864)
T ss_pred             cccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------h
Confidence            98665532   456789999999999999999974 689999999999999999999755432                2


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      .+.+++|-+.  ..+..++.+..+||..||..||.+|.+.++|+.  +|+.+
T Consensus       227 TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  227 TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            3344454432  356778899999999999999999999999987  45543

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.1e-41  Score=315.54  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=206.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|....++.     .++||.+.....   .....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGV-----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCc-----eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            468888899999999999999876654     389998765332   234578899999999999999999999987653


Q ss_pred             CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                          .++||||+++++|.+++..  .....+++..++.++.||+.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus        77 ----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          77 ----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ----EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence                4899999999999999863  2235689999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||++.......  .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..........    
T Consensus       150 fg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~----  222 (267)
T cd08229         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQ----  222 (267)
T ss_pred             chhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhc----
Confidence            99987654322  1123457899999999998888999999999999999999999999643321 1111111100    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                            ...+   ......++..+.+++.+||..+|++||++.+|++.+.++.
T Consensus       223 ------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         223 ------CDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ------CCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  0001   1112246678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-40  Score=319.05  Aligned_cols=262  Identities=27%  Similarity=0.456  Sum_probs=203.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+...........+|+|.+..... .....+.+|+.+++.++||||+++++++...+. 
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~-   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP-   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc-
Confidence            467999999999999999999875421112234699999875433 234668899999999999999999999887654 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF  234 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  234 (441)
                         .++||||+++|+|.+++....                    ...+++..++.++.|++.||.|||.+   +++||||
T Consensus        83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl  156 (288)
T cd05050          83 ---MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL  156 (288)
T ss_pred             ---cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence               499999999999999996421                    12478888999999999999999998   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRN  313 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~  313 (441)
                      ||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999875433221112223345678999999988899999999999999999998 88898654


Q ss_pred             CchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      ....   ....+..    ..         . ...+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus       237 ~~~~---~~~~~~~----~~---------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         237 AHEE---VIYYVRD----GN---------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CHHH---HHHHHhc----CC---------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            3322   1111110    00         0 0112235678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.2e-41  Score=317.76  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|+..+.||+|+||.||+|.............+++|.+...... ....+.+|+.++++++||||+++++++.+.+.  
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP--   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc--
Confidence            578899999999999999999877655555667999988765443 34678899999999999999999999877654  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQ-------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                        .++||||+++|+|.+++.....       ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++
T Consensus        83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          83 --HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             --ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence              4999999999999999975431       1689999999999999999999988   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |+|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......
T Consensus       158 l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA  233 (275)
T ss_pred             EcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence            99999987543221 112233466788999999988889999999999999999999 788986433221   2211110


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                                   .......+..++..+.+++.+||+.+|++||++.+++..|.
T Consensus       234 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                         00001112235578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=315.34  Aligned_cols=262  Identities=28%  Similarity=0.453  Sum_probs=208.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|++.+.||+|+||.||+|.+..++.. ....+++|.+...... ....+.+|+.++..++||||+++++++.. .   
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~---   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S---   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC-cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence            5688889999999999999998765532 2445899988765432 34678899999999999999999999976 2   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        82 -~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          82 -QVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             -ceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence             358999999999999999764 34689999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............++..|+|||.+....++.++||||||+++||+++ |..||..........   .+...    . 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~----~-  228 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLEKG----E-  228 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHhCC----C-
Confidence            87653322211222234678999999988889999999999999999998 999997654332221   11110    0 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                               ....+..++..+.+++.+||..+|.+||++.++++.|..+.+
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 ---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     001111244568899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8e-41  Score=352.64  Aligned_cols=264  Identities=22%  Similarity=0.338  Sum_probs=204.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.++||+|+||.||+|.+..++.     .||+|++.....   ...+++.+|+.+++.++||||+++++++.+.+ 
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~-----~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSR-----RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCc-----EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence            579999999999999999999877654     399999875322   22457889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF---------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                         ..++||||++||+|.+++....         ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+
T Consensus        76 ---~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d  149 (932)
T PRK13184         76 ---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF  149 (932)
T ss_pred             ---EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC
Confidence               3599999999999999986421         23456678899999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCC----------------cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCC
Q 013504          245 WNAKLSDFGLARLGPSDGL----------------SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR  308 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~  308 (441)
                      +.++|+|||+++.......                .......+||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            9999999999986521110                001123579999999999999999999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-CHHHHHHHHHHHHhhh
Q 013504          309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-KMSEVVEVLNKIVDAA  387 (441)
Q Consensus       309 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  387 (441)
                      ||........   ...  ....         ++. .......+++.+.+++.+||+.||++|| +++++++.|+..+...
T Consensus       230 PF~~~~~~ki---~~~--~~i~---------~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        230 PYRRKKGRKI---SYR--DVIL---------SPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             CCCCcchhhh---hhh--hhcc---------Chh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            9965322111   000  0000         000 0001124567788999999999999995 6777888888877643

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-40  Score=312.89  Aligned_cols=253  Identities=27%  Similarity=0.425  Sum_probs=202.6

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +.||+|+||.||+|.+....  .....||+|.+..... ...+.+.+|+.++++++||||+++++++.. .    ..++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCC--CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEE
Confidence            36899999999999986532  2233589999987766 456788899999999999999999999876 3    45999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++.......+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccc
Confidence            9999999999999765335789999999999999999999998   9999999999999999999999999999876442


Q ss_pred             CCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          262 GLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       262 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      ... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.............   ..   ..      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~---~~------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---KE---GE------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hc---CC------
Confidence            211 11223467889999999998899999999999999999999 999996544332211111   00   00      


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                          ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                00112235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-40  Score=329.54  Aligned_cols=273  Identities=24%  Similarity=0.292  Sum_probs=202.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||++....  ......+.+|+.+++.++||||+++++++....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILER-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCc-----EEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            35789999999999999999999876654     39999987542  223456789999999999999999999886543


Q ss_pred             c--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          173 E--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       173 ~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .  .....|+||||++ ++|.+++..    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          97 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             cccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence            2  1224699999996 477777743    578899999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhh--
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRP--  327 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~--  327 (441)
                      |||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +.....  
T Consensus       169 DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99999865332   123346789999999999999999999999999999999999999976543222111 110000  


Q ss_pred             -------------hcccccc-----hhhhcCCCC---CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          328 -------------HLTDAKK-----FTMILDPKL---EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       328 -------------~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                                   ...+...     +........   ...........+.+++.+||+.||.+|||+.++++  +++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                         0000000     000000000   00111123457889999999999999999999998  45443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=312.18  Aligned_cols=252  Identities=29%  Similarity=0.518  Sum_probs=199.7

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +.||+|+||.||+|.+.....  ....+|+|.+...... ..+.+.+|+.+++.+.||||+++++++...     ..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCC--CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEE
Confidence            369999999999998765542  2235999998866543 346788999999999999999999987643     24899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++|+|.+++...  ..+++..++.++.|++.||.|||..   +++|+||||+|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          74 MELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999999999763  4789999999999999999999988   9999999999999999999999999999865433


Q ss_pred             CCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhc
Q 013504          262 GLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL  339 (441)
Q Consensus       262 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (441)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ...++....          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~~----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESGE----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCC----------
Confidence            2111 1112234568999999998899999999999999999998 999997554322   222221110          


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       340 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                          ....+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                0011223456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-40  Score=318.58  Aligned_cols=251  Identities=28%  Similarity=0.451  Sum_probs=199.5

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      |+..+.||+|+||+||+|.+..++.     .+|+|.+......   ....+.+|+.+|+.++|+||+++++++...+   
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~---   73 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD---   73 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCc-----EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC---
Confidence            6777899999999999999877654     3999988654322   2245678999999999999999999887765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          74 -ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             -EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence             359999999999999998765455799999999999999999999988   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......   ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+...   ....   
T Consensus       150 ~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~---~~~~---  220 (285)
T cd05632         150 VKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR---VLET---  220 (285)
T ss_pred             eecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---hhcc---
Confidence            7543221   123457899999999999889999999999999999999999999754332211111110   0000   


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                              ...+...++..+.+|+..||+.||++||+     +.+++.
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 --------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                    01122345667889999999999999999     556665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-40  Score=319.84  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=204.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|.+.+.||+|+||.||+|....++.     .+++|.+..........+.+|+.+++.++||||+++++++....    
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~----   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCc-----EEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC----
Confidence            689999999999999999999766554     39999988766555677889999999999999999999987654    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..   ..+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            45999999999999999864   4688999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...  .......         
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~~---------  231 (296)
T cd06654         165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN---------  231 (296)
T ss_pred             hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhcC---------
Confidence            643321  112345789999999999888899999999999999999999999965443211  1111100         


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          .......+..++..+.+++.+||..+|++||++.+++.
T Consensus       232 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 ----GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                00001122345677899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-40  Score=314.02  Aligned_cols=245  Identities=24%  Similarity=0.419  Sum_probs=191.5

Q ss_pred             eeecccceeEEEEEEcCCCC-------cccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504          104 MIGEGGFGGVYRGVIRSTED-------SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .||+|+||.||+|+......       ......+++|.+..........+.+|+.++..++||||+++++++......  
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~--   79 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN--   79 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC--
Confidence            58999999999998654321       233456899988765544456788899999999999999999999876543  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-------EEE
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-------AKL  249 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-------~kl  249 (441)
                        ++||||+++|+|..++..+ ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.       +++
T Consensus        80 --~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 --IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             --EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence              8999999999999888653 35689999999999999999999998   9999999999999987664       899


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCchhHHHHHHhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELI-TGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~ell-tG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      +|||++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||.............   .
T Consensus       154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~  224 (262)
T cd05077         154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE---G  224 (262)
T ss_pred             CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh---c
Confidence            999998754321      2356788999999886 466899999999999999998 5888886443222111100   0


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                            .        ..  .....+..+.+|+.+||+.||++||++.+|++.|+
T Consensus       225 ------~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 ------Q--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ------C--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                  0        00  00112457889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.1e-41  Score=326.42  Aligned_cols=238  Identities=25%  Similarity=0.371  Sum_probs=187.8

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHH-HhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVN-VLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++||+|+||.||+|.+..++..     ||+|++.....   .....+..|.. +++.++||||+++++++...+    ..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSF-----YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE-----EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EE
Confidence            3699999999999998776543     99999875432   12334555554 578899999999999987665    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|..++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          72 YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999999999999998865  46788999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+..           
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~-----------  210 (321)
T cd05603         147 VEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNILH-----------  210 (321)
T ss_pred             CCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHhc-----------
Confidence            2221  12344679999999999998899999999999999999999999997543221   1111100           


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                        ..  ...+...+..+.+++.+||+.+|.+||++.
T Consensus       211 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 --KP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              00  011223456788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=311.61  Aligned_cols=253  Identities=33%  Similarity=0.558  Sum_probs=204.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +.||+|+||.||+|......  .....+++|.+....... ...+.+|+.++..++|+||+++++++....    ..++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEE
Confidence            36999999999999987541  123359999988765443 567889999999999999999999998744    35999


Q ss_pred             EeccCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          182 YEYMPNRSVQDHLTSRF-------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                      |||+++++|.+++....       ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||.
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence            99999999999997642       36799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +................++..|+|||.+....++.++||||||+++|+|++ |..||.......   .......    . 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~-  223 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK----G-  223 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----C-
Confidence            987655432223345678899999999988889999999999999999999 699997653222   2221111    0 


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                               .....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     011122345678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.6e-41  Score=323.85  Aligned_cols=266  Identities=23%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|....++..     ||+|.+...... ....+.+|+.++++++||||+++++++...+.  
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   78 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENL-----VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS--   78 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCe-----EEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe--
Confidence            5789999999999999999998766553     999988754322 23457789999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++ +|.+++... +..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        79 --~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          79 --LTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             --EEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence              5999999964 888888653 35688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh------
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH------  328 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~------  328 (441)
                      +......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......      
T Consensus       152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         152 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             eecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7543221  12234578999999998865 46889999999999999999999999765543332222111100      


Q ss_pred             --cccccchhhhcCCCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 --LTDAKKFTMILDPKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 --~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        +.....+.....+....    .....++.++.+++.+||..||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence              00000000000000000    011235667899999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-40  Score=312.20  Aligned_cols=260  Identities=23%  Similarity=0.406  Sum_probs=207.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|....++.     .+++|.+.....   .....+.+|+.++++++|+||+++++++...+ 
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGR-----VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCC-----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence            578999999999999999999875554     389998764322   23467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                         ..++||||+++++|.+++...  ....+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        76 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ---eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence               349999999999999998642  235689999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++.......  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ..........    
T Consensus       150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~----  222 (267)
T cd08224         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEK----  222 (267)
T ss_pred             cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhc----
Confidence            999876543221  123357899999999998888999999999999999999999999543311 1111111100    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                               ..........++..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 ---------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                     00011111255678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-40  Score=317.34  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=196.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.++||+|+||.||+|.+..++.     .+|+|.+.... ......+.+|+.++.+++||||+++++++...+.  
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRR-----ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR--   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCc-----EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE--
Confidence            368888999999999999999876654     39999886542 2234578899999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|..+      ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++
T Consensus        74 --~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          74 --ISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             --EEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence              4899999999999654      2467888999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~  334 (441)
                      ......    ......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .....        
T Consensus       143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  210 (279)
T cd06619         143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------  210 (279)
T ss_pred             eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------
Confidence            764332    23346789999999999998999999999999999999999999964322111000 00000        


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                        ...+...........+..+.+++.+||+.+|++||+++++++.
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         211 --CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              0000000001112345678999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-41  Score=333.56  Aligned_cols=269  Identities=23%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||+|.+..++.     .||+|.+....  ....+.+.+|+.+++.++||||+++++++...+...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK-----RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC-----EEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence            58889999999999999999866554     49999986532  233467889999999999999999999987655211


Q ss_pred             -eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 -IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 -~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ...|+||||+. ++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          76 FEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             cceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence             24699999995 688888865  46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc-
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA-  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-  332 (441)
                      ++...... ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+.......... 
T Consensus       150 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            98643322 1122345689999999998774 47899999999999999999999997665433222211110000000 


Q ss_pred             -----cchh-hhcC-CCCCC------cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -----KKFT-MILD-PKLEG------KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -----~~~~-~~~~-~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           .... .+.. +....      ......++.+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                 0000 0000 00000      111223567889999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-40  Score=310.95  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=196.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +.||+|+||.||+|.+.....  ....+|+|.+.... ......+.+|+.+++.++||||+++++++...+.   ..++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDG--QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCC--ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEE
Confidence            368999999999998754321  23459999886432 2345678899999999999999999998765432   24899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+.+|+|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          76 LPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            9999999999999754 34567788899999999999999988   9999999999999999999999999999754332


Q ss_pred             CCc--ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          262 GLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG-RRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       262 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ...  .......++..|+|||.+.+..++.++|||||||++|||++| .+||.......   .......    ..     
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~----~~-----  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQ----GR-----  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhc----CC-----
Confidence            111  111234567789999999888999999999999999999995 56665433221   1111110    00     


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                           ....+..++..+.+++.+||..+|++||++.+|+..|+++..
T Consensus       220 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 -----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                 001112345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.6e-40  Score=313.22  Aligned_cols=261  Identities=27%  Similarity=0.455  Sum_probs=206.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+....  .....|+||...... ....+.+.+|+.+++.++||||+++++++....   
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP---   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC---
Confidence            56888899999999999999876542  122348999887654 234567889999999999999999999886532   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++
T Consensus        81 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          81 --VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             --cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence              38999999999999999753 34689999999999999999999988   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +....... .......++..|+|||.+....++.++||||||+++|||++ |..||...........   ...    ...
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~~----~~~  226 (270)
T cd05056         155 RYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR---IEN----GER  226 (270)
T ss_pred             eecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHc----CCc
Confidence            86543321 11222344568999999988889999999999999999986 9999975543222111   110    000


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                ...+..++..+.+++.+|+..+|.+||++.+++..|+++.+.
T Consensus       227 ----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         227 ----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                      011224567899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-40  Score=323.93  Aligned_cols=267  Identities=26%  Similarity=0.442  Sum_probs=208.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      .+|.+.+.||+|+||.||+|.+.....  ......+|+|.+..... .....+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468999999999999999998754332  22334689998875432 2346788999999999 8999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                      .    .++||||+++|+|.+++..+.              ...+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus        92 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          92 P----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            3    499999999999999997532              23478889999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchh
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS  317 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~  317 (441)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543221111222344568999999999999999999999999999998 889986543322


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ....   +...              .....+..++..+.+++.+||..+|++||++.++++.|+++....
T Consensus       245 ~~~~---~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 LFKL---LKEG--------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHH---HHcC--------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            2111   1100              001112234567889999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=337.03  Aligned_cols=244  Identities=26%  Similarity=0.441  Sum_probs=204.5

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEe
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE  183 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E  183 (441)
                      +||+|+||+||.|++..+..     .+|||.+........+-+..|+.+.++|+|.|||+++|.+.+.+    .+-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqv-----rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQV-----RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccccee-----EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEEee
Confidence            69999999999999887764     49999998877766677889999999999999999999987665    3467899


Q ss_pred             ccCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeecCCCCCCCC
Q 013504          184 YMPNRSVQDHLTSRFQATL--PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       184 ~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~  260 (441)
                      -++||+|.+.|..+. +++  ++.++..+.+||++||.|||.+   .|||||||-+|||++ -.|.+||+|||.++.+..
T Consensus       653 qVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             cCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            999999999998765 456  7888999999999999999998   999999999999995 578899999999987543


Q ss_pred             CCCcceeeceecccCcCCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCc-hhHHHHHHhhhhhcccccchhh
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                        ......++.||..|||||++..+  .|+.++|||||||++.||.||++||-.... ...+-.+.          .   
T Consensus       729 --inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG----------m---  793 (1226)
T KOG4279|consen  729 --INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG----------M---  793 (1226)
T ss_pred             --CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc----------c---
Confidence              34456789999999999999875  488999999999999999999999953321 11111111          0   


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         -+.....+.+.+.+...+|.+|+.+||.+||+++++++
T Consensus       794 ---yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 ---YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ---eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence               11234567788999999999999999999999999987

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=312.54  Aligned_cols=255  Identities=30%  Similarity=0.495  Sum_probs=204.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+....      .++||.+..... ....+.+|+.++++++||||+++++++.....  
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~------~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   75 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTT------KVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP--   75 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCc------eEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc--
Confidence            467999999999999999999875432      389998875443 34678899999999999999999999876553  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++....+..+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++
T Consensus        76 --~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          76 --IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             --eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence              49999999999999999876556799999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +....... .......++..|+|||.+.+..++.++||||||+++++|++ |+.||.......   .........     
T Consensus       151 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~-----  221 (261)
T cd05034         151 RLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERGY-----  221 (261)
T ss_pred             eeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----
Confidence            86543211 11122335678999999998889999999999999999999 999996543221   222111100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               ....+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus       222 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ---------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                     001112335678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-41  Score=331.16  Aligned_cols=266  Identities=22%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-C-----CCeeeEEeEEecc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-H-----PNLVKLIGYCAED  171 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~  171 (441)
                      +|.+.++||+|+||.|.+|.+..+++.     ||||+++... ....+...|+.+|..|+ |     -|+|+++++|...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~-----VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEI-----VAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcE-----EEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            688899999999999999999988875     9999997653 33466678999999996 4     3999999999988


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC--CcEEE
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ--WNAKL  249 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~--~~~kl  249 (441)
                      ++    +|||+|.+ ..+|+++|+.+.-..++...+..|+.||+.||.+||+.   +|||+||||+||||.+.  ..|||
T Consensus       261 ~H----lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  261 NH----LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cc----eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence            75    49999999 67999999987778899999999999999999999987   99999999999999643  46999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh-
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH-  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~-  328 (441)
                      +|||.|......     ..+++-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+....+..+... 
T Consensus       333 IDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  333 IDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             EecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            999999875432     22678899999999999999999999999999999999998888776654443222111100 


Q ss_pred             --------------ccc---------ccc-----------------hhhhcCC----CCCCcchHHHHHHHHHHHHHhhc
Q 013504          329 --------------LTD---------AKK-----------------FTMILDP----KLEGKYSIKLAQKLAAVANKCLA  364 (441)
Q Consensus       329 --------------~~~---------~~~-----------------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~  364 (441)
                                    ...         ...                 ......|    .+...........+.+++.+||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence                          000         000                 0000001    00011111234568999999999


Q ss_pred             ccCCCCCCHHHHHH--HHHH
Q 013504          365 RQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       365 ~dP~~RPs~~evl~--~L~~  382 (441)
                      .||.+|+|..++++  +|..
T Consensus       488 ~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  488 WDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             cCchhcCCHHHHhcCccccc
Confidence            99999999999998  4553

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=316.75  Aligned_cols=244  Identities=23%  Similarity=0.422  Sum_probs=190.4

Q ss_pred             eeecccceeEEEEEEcCCC-------------------CcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeE
Q 013504          104 MIGEGGFGGVYRGVIRSTE-------------------DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  164 (441)
                      .||+|+||.||+|.+..++                   .......|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999865322                   122345689999876554445678889999999999999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++++.....    .++||||+++|+|..++... .+.+++..++.++.||+.||.|||++   +|+||||||+|||++..
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999987664    49999999999999988643 45789999999999999999999988   99999999999999764


Q ss_pred             C-------cEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHH-hCCCCCCCCCc
Q 013504          245 W-------NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELI-TGRRPLDRNRP  315 (441)
Q Consensus       245 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~ell-tG~~P~~~~~~  315 (441)
                      +       .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            3       3899999988643221      22457888999998865 56899999999999999995 69999975543


Q ss_pred             hhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                      ..........               ..    .+......+.+++.+||+.+|++||++.+|++.|
T Consensus       228 ~~~~~~~~~~---------------~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEKERFYEKK---------------HR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHHHhc---------------cC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            3222111100               00    0111234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=324.50  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=196.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||++.+..++..     ||+|++.+...   ...+.+.+|+.++..++||||+++++++.+.+ 
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQV-----YAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCE-----EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence            4789999999999999999998876653     99999865321   22355778999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             ---eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence               459999999999999999653 45789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      ++........ .......||+.|+|||++..     ..++.++|||||||++|+|++|+.||...........+.     
T Consensus       148 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~-----  221 (331)
T cd05597         148 SCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-----  221 (331)
T ss_pred             ceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH-----
Confidence            9875433221 12233579999999999863     457889999999999999999999997543322111110     


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCC--CCCCHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK--GRPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  379 (441)
                       ......      .+. .....++..+.+++.+||+.+++  .||++.+++..
T Consensus       222 -~~~~~~------~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 -NHKEHF------QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -cCCCcc------cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             000000      000 01112567788999998865443  37899998884

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-40  Score=316.94  Aligned_cols=276  Identities=25%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.|++.+.||+|+||.||++.+...+. .....||+|.+.... ......+.+|+.+++.++||||+++++++...+.. 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN-   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCC-CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC-
Confidence            457888999999999999998653221 223459999987543 23346788999999999999999999998775332 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++... ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++
T Consensus        82 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 -GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             -ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence             358999999999999999653 34689999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--c
Q 013504          256 RLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--A  332 (441)
Q Consensus       256 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~  332 (441)
                      +........ .......++..|+|||++.+..++.++|||||||++|+|++++.|........ ...   ..+....  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~---~~~~~~~~~~  232 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKM---IGPTHGQMTV  232 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-hhh---cccccccccH
Confidence            865433211 11224567778999999988889999999999999999999877653211000 000   0000000  0


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ......+........+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000000000111224567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=313.05  Aligned_cols=251  Identities=29%  Similarity=0.501  Sum_probs=195.9

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCeeEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +||+|+||.||+|.+..++..   ..+++|.+.... ......+.+|+.++.++ +||||+++++++.....    .++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv   74 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LYLA   74 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCe---eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ceEE
Confidence            689999999999998765432   347888887433 23345788999999999 89999999999987654    4999


Q ss_pred             EeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          182 YEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      |||+++|+|.+++....              ...+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~  151 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  151 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeE
Confidence            99999999999996532              13578999999999999999999988   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~  326 (441)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..||.......   ......
T Consensus       152 kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~  225 (270)
T cd05047         152 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP  225 (270)
T ss_pred             EECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHh
Confidence            99999998632211   11112234567999999988889999999999999999997 999996543221   111111


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ..              .....+..++..+.+++.+||..+|.+||++.+++..|+.++
T Consensus       226 ~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 QG--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC--------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00              000111234567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-40  Score=312.65  Aligned_cols=255  Identities=27%  Similarity=0.397  Sum_probs=191.2

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      .||+|+||.||+|.+.....   ...+++|.+..... .....+.+|+.+++.++||||+++++++.+...    .++||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~   74 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYT---PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVM   74 (269)
T ss_pred             cccccCCceEEEEEEcCCCC---ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEE
Confidence            59999999999998754322   23489998876543 233568889999999999999999999877654    48999


Q ss_pred             eccCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRF---QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      ||+++|+|.+++....   ....++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999999997532   23466778889999999999999998   99999999999999999999999999997544


Q ss_pred             CCCCcceeeceecccCcCCccccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQTG-------RLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ............|+..|+|||++.+.       .++.++||||||+++|||++ |..||...........  ....    
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~----  225 (269)
T cd05087         152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TVRE----  225 (269)
T ss_pred             CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hhhc----
Confidence            33222222345678899999988642       35789999999999999996 9999965443221111  0000    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                        .......+.+    ....+..+.+++..|+ .+|++||++.+|+..|+
T Consensus       226 --~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 --QQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --ccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence              0000111111    1124456888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-41  Score=314.64  Aligned_cols=252  Identities=33%  Similarity=0.553  Sum_probs=202.1

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhH--HHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |++++.||+|+||.||++....++.     .+|+|.+.........  ...+|+.++++++||||+++++++....    
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQ-----KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN----   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTE-----EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCe-----EEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----
Confidence            6778899999999999999887765     3999999877644332  3456999999999999999999998855    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..  ...+++..++.++.|++.||.+||+.   +|+|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            35899999999999999983  36889999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh-hcccccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP-HLTDAKK  334 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~~  334 (441)
                      ....  .........+|..|+|||++. +..++.++||||||+++++|++|..||................. ...... 
T Consensus       147 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  223 (260)
T PF00069_consen  147 KLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-  223 (260)
T ss_dssp             ESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-
T ss_pred             cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-
Confidence            5311  122345578899999999998 78899999999999999999999999986532233222221111 000000 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 .........+.+++.+||+.||++||++.++++
T Consensus       224 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       000011278999999999999999999999885

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.5e-41  Score=353.83  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=200.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .+|+|.+.....  .....+..|+.+|..++|||||+++++|...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~-----~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCe-----EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            445789999999999999999999877654     488888865432  2346788999999999999999999998765


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEecccCCCcEEEcC--
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMD----FQIIFRDFKSSNILLDE--  243 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~iiHrDlKp~NILl~~--  243 (441)
                      ...  .+||||||+++|+|.++|....  ...+++..++.|+.||+.||.|||+...    .+||||||||+||||+.  
T Consensus        85 ~~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         85 ANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             CCC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            433  4699999999999999997532  3579999999999999999999998421    25999999999999964  


Q ss_pred             ---------------CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhC
Q 013504          244 ---------------QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITG  306 (441)
Q Consensus       244 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG  306 (441)
                                     .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||+|++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           2348999999998653321   2334679999999999864  4588999999999999999999


Q ss_pred             CCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          307 RRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       307 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..||.......  .++..+..    .        +.+.   ....+..+.+||..||..+|.+||++.+++.
T Consensus       240 k~PF~~~~~~~--qli~~lk~----~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANNFS--QLISELKR----G--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCcHH--HHHHHHhc----C--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99996543211  11111110    0        0000   0123567899999999999999999999995

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-40  Score=322.22  Aligned_cols=256  Identities=20%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||++.+..++.     .+|+|.+.+...   .....+..|+.++..++|+||+++++++.+.+ 
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC-----EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence            478999999999999999999877654     399999864321   12344778999999999999999999988765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             ---EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence               359999999999999999753 35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      ++....... ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...........   +.. 
T Consensus       148 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~-  222 (332)
T cd05623         148 SCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMN-  222 (332)
T ss_pred             hheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH---HhC-
Confidence            987543322 12233467999999999986     34688999999999999999999999975433221111   100 


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  379 (441)
                        .....      .. ......++..+.+++.+|++.++..  |+++.++++.
T Consensus       223 --~~~~~------~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         223 --HKERF------QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --CCccc------cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              00000      00 0111235677889999988654444  6889999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=326.53  Aligned_cols=261  Identities=27%  Similarity=0.496  Sum_probs=218.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.....++||.|-||.||+|++.... ......||||.-+... ....+.|+.|..+|+.++||||++++|+|.+..   
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---
Confidence            44556678999999999999987653 3345669999988743 344678999999999999999999999998754   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .+||||+++-|.|..||+.+ ...++......+++||+.+|.|||+.   .+|||||...|||+.....|||+|||++
T Consensus       465 --~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  465 --MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             --eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence              38999999999999999865 46899999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +....+.... .+...-..-|||||-+.-..++.++|||.|||++||++. |..||.+....+                 
T Consensus       539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------  600 (974)
T KOG4257|consen  539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------  600 (974)
T ss_pred             hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------
Confidence            9876654332 334455678999999999999999999999999999987 999997543322                 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      .-..+....+...+++|++.|..|+.+||..+|.+||.+.++...|.+++.
T Consensus       601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            111222233456777899999999999999999999999999999988875

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=299.68  Aligned_cols=253  Identities=30%  Similarity=0.484  Sum_probs=199.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCC-CCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  173 (441)
                      .++.+.+..||+|+.|.|+++.++.++..     +|||.+.+.... ..++++..+.++...+ +|.||+.+|||..+..
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~i-----iAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHI-----IAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceE-----EEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            35566677799999999999999988765     999999887644 4577888888887764 9999999999998776


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .    ++.||.| ..-++. |..+..+++++..+-++...++.||.||-.+  .+|||||+||+|||||+.|++||||||
T Consensus       166 V----~IcMelM-s~C~ek-Llkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  166 V----FICMELM-STCAEK-LLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             H----HHHHHHH-HHHHHH-HHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccc
Confidence            5    7789987 323333 4344567899999999999999999999987  499999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ++..+....   ..+...|-+.|||||.+.-   ..|+.++||||||+.++||.||+.||......  ...+..+..   
T Consensus       238 IsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln---  309 (391)
T KOG0983|consen  238 ISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN---  309 (391)
T ss_pred             ccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh---
Confidence            998765543   2344678899999998864   46899999999999999999999999764321  111111111   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ...|.+.+  ...+++.+.+++..||.+|+.+||.+.++++
T Consensus       310 -------~ePP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 -------EEPPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------cCCCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   11122322  2238889999999999999999999999886

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.3e-40  Score=309.02  Aligned_cols=251  Identities=22%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|++|.||++.+..++.     .+++|.+.....  ...+.+.+|+.++++++||||+++++.+...+.  
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   73 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK-----QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG--   73 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc-----EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC--
Confidence            48889999999999999999876654     389999865432  234567889999999999999999988754332  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..|+||||+++++|.+++.......+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        74 -~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          74 -LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             -EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence             358999999999999999875556799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  .......|++.|+|||++.+..++.++||||||+++++|++|+.||..........  ......       
T Consensus       150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~~~-------  218 (257)
T cd08223         150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--RIIEGK-------  218 (257)
T ss_pred             EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHhcC-------
Confidence            8653322  12334678999999999999999999999999999999999999997543211110  000000       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ....+..++..+.+++.+||+.+|++||++.++++
T Consensus       219 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 --------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                    01122346678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-40  Score=313.40  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=198.9

Q ss_pred             ceeecccceeEEEEEEcCCCC-cccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTED-SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      +.||+|+||.||+|.+..... ......+++|.+..... .....+.+|+.+++.++||||+++++++...+.    .++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEE
Confidence            369999999999998765331 12234588888765432 335678899999999999999999999876653    499


Q ss_pred             EEeccCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-----cEEEe
Q 013504          181 IYEYMPNRSVQDHLTSRF-----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-----NAKLS  250 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-----~~kl~  250 (441)
                      ||||+++++|.+++....     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++     .++|+
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEEC
Confidence            999999999999997532     23478899999999999999999988   999999999999999887     89999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||.......   ....+..  
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~--  228 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTA--  228 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhc--
Confidence            9999976543322222233456788999999999999999999999999999998 999996543222   1111110  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                        .          .....+..++..+.+++.+||..+|.+||++.+|++.|+
T Consensus       229 --~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 --G----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --C----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              0          001122345678899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=306.66  Aligned_cols=248  Identities=29%  Similarity=0.502  Sum_probs=197.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ++||.|+||.||+|.+.. +.     .|++|.+...... ....+.+|+.+++.+.||||+++++++.....    .++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~-----~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NT-----EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC-CC-----cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEE
Confidence            369999999999999765 33     3999988765443 45678899999999999999999999887664    4999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++... ...+++..++.++.+++.||.|||++   +++||||||+|||++.++.++|+|||++......
T Consensus        71 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          71 MELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            9999999999999654 34688999999999999999999998   9999999999999999999999999999865422


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD  340 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (441)
                      ..........++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+.   ..            
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~~------------  211 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---SG------------  211 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---cC------------
Confidence            21111122334667999999988899999999999999999999 888986554322221111   00            


Q ss_pred             CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       341 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                        .....+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       212 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 --YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence              001122345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-40  Score=314.97  Aligned_cols=250  Identities=24%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeE
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      |++.+.||.|+||.||+|.+..++.     .+++|.+..........+.+|+.+++.++||||+++++++....    ..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGV-----LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCe-----EEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EE
Confidence            5777889999999999999877654     38888887665555677889999999999999999999988765    45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ++||||+++++|..++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence            9999999999999887643 35789999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ...  ........||+.|+|||++.     +..++.++|||||||++|+|++|..||.......  .........     
T Consensus       154 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~~-----  224 (282)
T cd06643         154 TRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSE-----  224 (282)
T ss_pred             ccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhcC-----
Confidence            322  11233467899999999874     3457789999999999999999999996543221  111111000     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .+.  ...+..++..+.+++.+||..+|.+||++.++++
T Consensus       225 ------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 ------PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ------CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000  0112235678999999999999999999998876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.2e-41  Score=315.02  Aligned_cols=245  Identities=24%  Similarity=0.438  Sum_probs=192.6

Q ss_pred             eeecccceeEEEEEEcCCCC--cccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      .||+|+||.||+|.....+.  ......+++|.+........+.+..|+.+++.+.||||+++++++......    ++|
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~----~lv   77 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES----IMV   77 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc----EEE
Confidence            59999999999998865432  223445888888665544556788999999999999999999999876543    899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc--------EEEeecC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--------AKLSDFG  253 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~--------~kl~DFG  253 (441)
                      |||+++|+|.+++..+ +..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.        ++++|||
T Consensus        78 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          78 QEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             EecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999999754 34689999999999999999999998   9999999999999987765        6999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCC-CCCCCCCchhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGR-RPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ++.....      .....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||.............       .
T Consensus       154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------~  220 (258)
T cd05078         154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-------D  220 (258)
T ss_pred             cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-------c
Confidence            8875432      233568899999999876 45789999999999999999984 6665433222111110       0


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      .            ...+......+.+++.+||+.+|++||+++++++.|+
T Consensus       221 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0            0111223457899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=338.96  Aligned_cols=262  Identities=26%  Similarity=0.470  Sum_probs=218.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ...+.++||.|.||+||+|.++..++  ....||||.++.-.. +...+|+.|+.||.++.||||++|.|+.......  
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgk--re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv--  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGK--REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV--  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCC--cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee--
Confidence            45577899999999999999987653  355799999986543 3456799999999999999999999999876654  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                        .||+|||++|+|..||..+. +.|.+.+...++++|+.|++||-+.   +.|||||...|||++.|..+|++|||++|
T Consensus       706 --MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  706 --MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             --EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence              89999999999999998775 5699999999999999999999976   99999999999999999999999999999


Q ss_pred             CCCCCCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          257 LGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       257 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      .+.++.... ......-...|.|||.+...+++.++||||||+++||.++ |..||.+....+..+.++           
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-----------  848 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------  848 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-----------
Confidence            764433111 1111222468999999999999999999999999999887 999997665444333222           


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                            ...+-..+.+|+..|.+|+..||++|-.+||.+.+|+..|++++.+
T Consensus       849 ------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  849 ------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                  1223345568999999999999999999999999999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=314.02  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+..........+.+|+.+++.++||||+++++++...+   
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~---   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGE-----LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD---   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCc-----EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Confidence            3578888899999999999998876654     38999987655445566788999999999999999999987765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..  .+.+++.+++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          80 -KLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             -EEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence             35999999999999999875  35789999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ......  ........|++.|+|||++.   ...++.++|||||||++|+|++|..||....+........  ...    
T Consensus       154 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~----  225 (267)
T cd06645         154 AQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSN----  225 (267)
T ss_pred             eEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccC----
Confidence            754322  11223457899999999874   4568889999999999999999999986543322111100  000    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ...+...  ....++..+.+++.+||..+|++||++.+|++
T Consensus       226 -----~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 -----FQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----CCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 0001110  01124567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-40  Score=315.56  Aligned_cols=276  Identities=25%  Similarity=0.422  Sum_probs=207.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|...+.||+|+||.||+|.+.... ......+|||.+...... ....+.+|+.+++.+.||||+++++++...... 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~-   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR-   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC-
Confidence            45777889999999999999876442 123446999998765543 456789999999999999999999998764432 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++... ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        82 -~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 -SLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             -ceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence             458999999999999999764 23689999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh--cccc
Q 013504          256 RLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH--LTDA  332 (441)
Q Consensus       256 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~--~~~~  332 (441)
                      ......... .......++..|++||.+.+..++.++||||||++++||++|..|+.........    +....  ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~  232 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIV  232 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccH
Confidence            876532211 1112234566799999998889999999999999999999999998543221100    00000  0000


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ......+........+..++..+.+++.+||..+|++||++.+|+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000001111111112234557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=329.47  Aligned_cols=246  Identities=32%  Similarity=0.454  Sum_probs=203.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +-|.-.+.||.|+||.||-+.+..+...     ||||++.-...+.   +..++.|+..|++++|||++.+.|+|..+..
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~ev-----VAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEV-----VAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccce-----eeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            3466677899999999999998877765     9999998766543   5678899999999999999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .+|||||| -|+-.|.+.-. .+++.+..+..|+.+.+.||.|||+.   +.||||||..||||++.|.|||+|||
T Consensus       101 ----aWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFG  171 (948)
T KOG0577|consen  101 ----AWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFG  171 (948)
T ss_pred             ----HHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecccc
Confidence                39999999 56777877543 47899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      .|....      ..++++|||.|||||++.   .+.|+-++||||||+++.||.-.++|+...+.....  .. +.    
T Consensus       172 SAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL--YH-IA----  238 (948)
T KOG0577|consen  172 SASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YH-IA----  238 (948)
T ss_pred             chhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH--HH-HH----
Confidence            987643      356799999999999874   578999999999999999999999998765432211  11 10    


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ..-.|-+   ...+++..+..++..||++-|.+|||.++++.
T Consensus       239 ------QNesPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  239 ------QNESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------hcCCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  0001111   24578899999999999999999999999886

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-40  Score=323.80  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=196.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||++.+..++..     ||+|.+.....   .....+.+|+.++..++|+||+++++++...+ 
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERI-----YAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence            4789999999999999999998776543     99999865321   22345778999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++||+|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          75 ---YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence               359999999999999999753 35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +++....... .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||...........   +.. 
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~-  222 (331)
T cd05624         148 SCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMN-  222 (331)
T ss_pred             ceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH---HHc-
Confidence            9976543321 12234679999999999875     5678899999999999999999999975443221111   100 


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  379 (441)
                        .....      .+. .....++..+.+++.+||+.++++  |++++++++.
T Consensus       223 --~~~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         223 --HEERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --CCCcc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              00000      000 011234678889999999865544  4678888763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-40  Score=317.16  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=204.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|++.+.||.|+||.||+|....++..     |++|.+........+.+.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~-----v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQE-----VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD----   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcE-----EEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----
Confidence            4699999999999999999987766543     9999887665555677889999999999999999999997655    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            45999999999999999865   4689999999999999999999998   99999999999999999999999999988


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      .......  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.............   ....      
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~------  232 (296)
T cd06655         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGT------  232 (296)
T ss_pred             hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCC------
Confidence            6443221  1234578999999999998889999999999999999999999997654322211111   0000      


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          +  ....+..++..+.+++.+||..||++||++.+++.
T Consensus       233 ----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 ----P--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ----c--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                0  00112245677889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.2e-40  Score=308.93  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=203.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+....      .+++|.+.... .....+.+|+.+++.++|+||+++++++.. .   
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~---   73 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHT------KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E---   73 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCc------cEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C---
Confidence            467899999999999999999865433      28999876543 234678899999999999999999999876 2   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..+++|||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          74 -PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             -CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence             248999999999999999765556788999999999999999999988   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ........ .......++..|+|||++....++.++|+|||||++|++++ |..||........   ..+.....     
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~-----  220 (260)
T cd05073         150 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALERGY-----  220 (260)
T ss_pred             eeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhCCC-----
Confidence            76533221 11222345678999999988889999999999999999999 9999975433221   11111100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               ........+..+.+++.+||+.+|++||++.+++..|+.
T Consensus       221 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                     001112355679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=320.59  Aligned_cols=250  Identities=28%  Similarity=0.443  Sum_probs=207.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .+.|..-++||+||||.||-++.+.++..     +|.|.+.+...+   .....+.|-.||.+++.+.||.+--.|.+.+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKM-----YAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKM-----YACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhh-----HHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            36799999999999999999999999876     777776554332   2345678999999999999999977777777


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    +||||..|+||+|.-+|.+.....|++..++.++.+|+.||.+||..   +||+|||||+|||||+.|+++|+|.
T Consensus       259 ~----LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  259 A----LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             c----eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            5    49999999999999999887777999999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+|.......   .....+||.+|||||++.++.|+...|+|||||+||||+.|+.||.........+-++  +..+.  
T Consensus       332 GLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~--  404 (591)
T KOG0986|consen  332 GLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE--  404 (591)
T ss_pred             ceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc--
Confidence            9998766543   2344599999999999999999999999999999999999999996543332221111  11111  


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                                ....++..++++..+|....|.+||.+|....
T Consensus       405 ----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ----------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                      12356678899999999999999999997543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5e-40  Score=311.08  Aligned_cols=255  Identities=26%  Similarity=0.400  Sum_probs=189.5

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      .||+|+||.||+|......   ....+++|.+..... .....+.+|+.+++.++||||+++++++.....    .++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGM---SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCC---CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eEEEE
Confidence            5999999999999764432   233488888765432 234567899999999999999999999987654    49999


Q ss_pred             eccCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRF---QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      ||+++|+|.+++....   ....++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence            9999999999997532   13356788899999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCcceeeceecccCcCCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          260 SDGLSHVSTAVVGTIGYAAPEYIQT-------GRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       260 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ............+++.|+|||++..       ..++.++|||||||++|||++ |..||..........  .......  
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~~~~~~~--  227 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK--QVVREQD--  227 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH--HHhhccC--
Confidence            3221112233456778999998743       356789999999999999999 788886543322111  1010000  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                          .....    ...+..++..+.+++..|+ .||++||++++|++.|.
T Consensus       228 ----~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 ----IKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ----ccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                00011    1223345677788999998 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.8e-40  Score=314.53  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=201.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.|++.+.||.|+||.||+|.+..++.     .+++|.+..........+.+|+.+++.++||||+++++++..+.    
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGA-----LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG----   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCc-----eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----
Confidence            568999999999999999999877654     38999987766555677889999999999999999999987665    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|..++... ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            359999999999999887653 35689999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      .....  ........+++.|+|||++.     ...++.++|||||||++|+|++|..||.......  .........   
T Consensus       159 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~---  231 (292)
T cd06644         159 KNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSE---  231 (292)
T ss_pred             ecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcCC---
Confidence            53322  11223457899999999884     3456789999999999999999999996543221  111111000   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              .+  ....+..++..+.+++.+||..+|++||+++++++
T Consensus       232 --------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 --------PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --------Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    00  00112245567889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=314.68  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||.|+||.||+|.+..++.     .+++|.+..........+.+|+.++++++||||+++++++....   
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   75 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGL-----FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN---   75 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCc-----EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC---
Confidence            3568899999999999999999876544     49999987665555677889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++... ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++
T Consensus        76 -~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          76 -KLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             -eEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence             359999999999999998753 35799999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      .......  .......||+.|+|||++.     ...++.++||||||+++|+|++|+.||........  ........  
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--  224 (280)
T cd06611         151 AKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILKSE--  224 (280)
T ss_pred             hhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhcCC--
Confidence            7643321  1233467899999999875     34567899999999999999999999975433211  11111000  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               .+.+  ..+..++..+.+++.+||..+|.+||++.++++
T Consensus       225 ---------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         225 ---------PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ---------CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                     0000  112245667889999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-40  Score=309.41  Aligned_cols=250  Identities=26%  Similarity=0.458  Sum_probs=199.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---------hhHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---------GHKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      +|.+...||.|+||.||+|.+..++.     .+++|.+......         ..+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE-----LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc-----EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            36778899999999999999765544     4899987654322         124577899999999999999999998


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                      ...+.    .++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++
T Consensus        76 ~~~~~----~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          76 LDADH----LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EeCCc----cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence            87654    4899999999999999976  36789999999999999999999988   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCC----cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          249 LSDFGLARLGPSDGL----SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       249 l~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      |+|||+++.......    ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......  .. ..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-~~  223 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI-FK  223 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-HH
Confidence            999999986542211    111223568899999999998889999999999999999999999997543211  11 10


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...          ..    ....+..++..+.+++.+||+.||.+||++.+|++
T Consensus       224 ~~~----------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGE----------NA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             Hhc----------cC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000          00    11122345678899999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.7e-40  Score=309.27  Aligned_cols=247  Identities=28%  Similarity=0.494  Sum_probs=198.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|...+.       .+++|.+....  ....+.+|+.+++.++||||+++++++....    
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   72 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQ-------KVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG----   72 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCC-------ceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC----
Confidence            5688999999999999999875322       38999886532  3457889999999999999999999986543    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence             38999999999999999865555789999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .....     ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.............   ..       
T Consensus       149 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~-------  213 (254)
T cd05083         149 VGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE---KG-------  213 (254)
T ss_pred             ecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---CC-------
Confidence            54321     112334568999999988899999999999999999998 999997554332211111   00       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                             .....+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       214 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   0001122456778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=307.98  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=205.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||.|+||.||+|.+..++.     .+++|.+........+.+.+|+.+++.++||||+++++++....    
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGE-----LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD----   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCC-----EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----
Confidence            578999999999999999999876554     38999987665555678889999999999999999999987655    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..+++|||+++++|.+++... ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++.
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            359999999999999998753 25789999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTG---RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ......  .......++..|+|||.+.+.   .++.++|||||||++|+|++|..||.............  ...+    
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~----  221 (262)
T cd06613         150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNF----  221 (262)
T ss_pred             hhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC----
Confidence            654321  122346789999999998776   78899999999999999999999997544322211110  0000    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .+ .........+..+.+++.+||..+|.+||++++|+.
T Consensus       222 ------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 ------PP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ------CC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  00 011123356678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.9e-40  Score=306.07  Aligned_cols=246  Identities=29%  Similarity=0.510  Sum_probs=194.6

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      +||+|+||.||+|......      .+|+|.+....... ...+.+|+.+++.++||||+++++++.....    .++||
T Consensus         2 ~ig~g~~g~vy~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   71 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKT------PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVM   71 (250)
T ss_pred             ccCCCCCceEEEEEecCCc------EEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEE
Confidence            6999999999999865322      48999887654322 3467899999999999999999999987654    49999


Q ss_pred             eccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG  262 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  262 (441)
                      ||+++++|.+++... ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        72 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (250)
T cd05085          72 ELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI  147 (250)
T ss_pred             ECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence            999999999998654 34688999999999999999999988   99999999999999999999999999987543221


Q ss_pred             CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       263 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      . .......++..|+|||++.+..++.++||||||+++|++++ |..||...........+.   ..             
T Consensus       148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~~-------------  210 (250)
T cd05085         148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---KG-------------  210 (250)
T ss_pred             c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cC-------------
Confidence            1 11122344677999999998889999999999999999998 999997554322211111   00             


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                       .....+..++..+.+++.+||..+|++||++.++++.|.
T Consensus       211 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 -YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             001112235678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.4e-40  Score=314.36  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=206.2

Q ss_pred             chHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEe
Q 013504           88 TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIG  166 (441)
Q Consensus        88 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  166 (441)
                      ++.++......|++.+.||.|+||.||+|.+..++.     .+|+|.+.... .....+..|+.++.++ +||||+++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~   80 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYG   80 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCc-----EEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence            444555667899999999999999999999876654     38999876543 2345678899999998 7999999999


Q ss_pred             EEecccc--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          167 YCAEDDE--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       167 ~~~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++.....  .....|++|||+++|+|.+++.......+++..++.++.||+.||.|||+.   +|+|+||||+||+++++
T Consensus        81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            9864321  123569999999999999999765556788999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ  319 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~  319 (441)
                      +.++|+|||++.......  .......|++.|+|||.+.     ...++.++|||||||++|+|++|..||....+....
T Consensus       158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            999999999987543221  1223467899999999875     346788999999999999999999999654322111


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....                ..........++..+.+++.+||..||.+||++.++++
T Consensus       236 ~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 FLIPR----------------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhHhh----------------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11100                00001111245678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-40  Score=316.80  Aligned_cols=251  Identities=26%  Similarity=0.423  Sum_probs=204.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ..+|.+.+.||+|+||.||+|....++.     .||+|.+........+.+.+|+.+++.++||||+++++++...+   
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---   89 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQ-----EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---   89 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCC-----EEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            3689999999999999999999766554     39999987665555677889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++
T Consensus        90 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          90 -ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             -EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence             45999999999999999865   4688999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+......  ..          
T Consensus       163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~~----------  228 (297)
T cd06656         163 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA----------  228 (297)
T ss_pred             eEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--ec----------
Confidence            7643322  112345789999999999988899999999999999999999999965432111000  00          


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .........+...+..+.+++.+||..+|++||++.++++
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         229 ---TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ---cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000001122345677899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-39  Score=315.69  Aligned_cols=201  Identities=27%  Similarity=0.432  Sum_probs=161.1

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ...||+|+||.||+|.+.....   ...+|+|.+.....  ...+.+|+.+|++++||||+++++++......  ..++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~---~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKD---DRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCC---CceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEE
Confidence            3579999999999998764321   23599999865432  34567899999999999999999998754433  46899


Q ss_pred             EeccCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE----cCCCcEEEe
Q 013504          182 YEYMPNRSVQDHLTSR-------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLS  250 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl----~~~~~~kl~  250 (441)
                      |||+. ++|.+++...       ....+++..+..++.||+.||.|||++   +|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            99994 5888887532       123588999999999999999999998   99999999999999    456789999


Q ss_pred             ecCCCCCCCCCCC-cceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013504          251 DFGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       251 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      |||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9999986543221 112234688999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-41  Score=326.35  Aligned_cols=241  Identities=27%  Similarity=0.383  Sum_probs=187.0

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccC---CCCCeeeEEeEEeccccCCeeE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVV---EHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ||+|+||.||+|.+..++..     ||+|++......   ....+..|..++..+   +||||+++++++...+.    .
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRI-----YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD----L   71 (330)
T ss_pred             CCCCCceEEEEEEECCCCCE-----EEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe----E
Confidence            79999999999998776554     999998654322   223445677777655   79999999999987663    4


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          72 YLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            999999999999999875  46789999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      ....  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........   ...+...   .     
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~i~~~---~-----  213 (330)
T cd05586         147 LTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNIAFG---K-----  213 (330)
T ss_pred             CCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHHHHcC---C-----
Confidence            3221  123456799999999998754 488999999999999999999999965432221   1111000   0     


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC----CHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP----KMSEVVE  378 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  378 (441)
                         ..+.   ...++..+.+++.+||+.||.+||    ++.++++
T Consensus       214 ---~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 ---VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               0000   012456788999999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.7e-40  Score=306.90  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|+..+.||.|+||.||.+....++.     .+++|.+....  ......+.+|+.++++++|+||+++++++.+.+   
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---   72 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDS-----LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN---   72 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCc-----EEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC---
Confidence            48889999999999999998776554     38888876543  233467889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        73 -~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          73 -TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             -eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence             459999999999999999875456789999999999999999999988   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........  ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.  ..        
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~~--------  216 (256)
T cd08221         149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--QG--------  216 (256)
T ss_pred             EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cC--------
Confidence            86543321  2334678999999999988889999999999999999999999996543322111110  00        


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                            .. ......++..+.+++.+||+.+|.+||++.++++.
T Consensus       217 ------~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         217 ------NY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ------CC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                  00 01113456778999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-39  Score=308.57  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=197.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-----hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .+|...+.||+|+||.||+|....++.     .|++|.+.....     .....+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR-----ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc-----EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            478999999999999999999876654     389998764321     2234678899999999999999999988754


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      ...  ..+++|||+++++|.+++..  ...+++...+.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        77 ~~~--~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          77 AEK--TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CCC--EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            322  45899999999999999975  35689999999999999999999988   999999999999999999999999


Q ss_pred             cCCCCCCCCCCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||.........  .. ...   
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~--~~-~~~---  223 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI--FK-IAT---  223 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--HH-Hhc---
Confidence            999875432111 11112356889999999999888999999999999999999999999654321111  10 000   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .......+..+...+.+++ +||..+|++||++++|++
T Consensus       224 ----------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 ----------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                      0001122334556677787 688899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-40  Score=324.76  Aligned_cols=268  Identities=24%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||.+.....  .....+.+|+.+|+.++||||+++++++...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA   86 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCC-----EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence            356789999999999999999999876654     399999875432  2335677899999999999999999988643


Q ss_pred             cc--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          172 DE--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       172 ~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ..  .....|++||++ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          87 TSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             ccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence            22  122458999988 8899888754   4699999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRP  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~  327 (441)
                      +|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ .....
T Consensus       160 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         160 LDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             cCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999865332     234678999999999876 56889999999999999999999999754432211111 10000


Q ss_pred             hccc------ccchhhhcC--CCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTD------AKKFTMILD--PKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~------~~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....      .........  +....    .......+.+.+|+.+||..||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000      000000000  00000    000112346789999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-40  Score=316.36  Aligned_cols=266  Identities=23%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|.+...... ....+.+|+.+++.++||||+++++++....   
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~---   77 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK---   77 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCc-----EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC---
Confidence            578999999999999999999876654     3999988654322 2345778999999999999999999998665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++
T Consensus        78 -~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          78 -SLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             -eEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence             3599999996 5999888654 45688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh-ccc--
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH-LTD--  331 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~--  331 (441)
                      .......  .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...... ...  
T Consensus       152 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  229 (301)
T cd07873         152 RAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW  229 (301)
T ss_pred             hccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence            7543221  11233467899999998865 35788999999999999999999999765433222111111000 000  


Q ss_pred             -----ccchhhhcCCCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 -----AKKFTMILDPKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 -----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ...+.....+....    .....+++.+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 00000000011100    111234667899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.8e-40  Score=311.81  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=197.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||+|.+..++.     .||+|.+.....  .....+.+|+.+++.++||||+++++++....   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   72 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ-----IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES---   72 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc-----EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC---
Confidence            57888999999999999999876654     499998865432  22356788999999999999999999998755   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ..++||||++ ++|.+++.... +..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+
T Consensus        73 -~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          73 -RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             -eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence             3599999996 68988886532 36789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhh-----
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRP-----  327 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~-----  327 (441)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........... ......     
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            87543221  122334678999999988654 478899999999999999999999975443221111 110000     


Q ss_pred             --hcccccchhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 --HLTDAKKFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 --~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        .......+....+.....   .....+++++.+++.+||+.||++||++.+|+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000000000000000   011125678889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.2e-40  Score=309.43  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=200.6

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      +..++++.....||+|+||.||+|.+..++.     .|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQV-----RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCc-----EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence            3445666677789999999999999876554     49999887766556678899999999999999999999988765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATL--PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKL  249 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl  249 (441)
                          ..++||||+++++|.+++.... ..+  ++..+..++.||+.||.|||++   +|+||||||+||+++. ++.++|
T Consensus        79 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          79 ----FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             ----EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEE
Confidence                3599999999999999997542 344  7888999999999999999998   9999999999999976 678999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR--LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      +|||++.......  .......|++.|+|||++....  ++.++||||||+++|+|++|..||..........   +...
T Consensus       151 ~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~  225 (268)
T cd06624         151 SDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVG  225 (268)
T ss_pred             ecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhh
Confidence            9999987543221  1122346899999999986644  7889999999999999999999996432211110   0000


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..            ......+..+++.+.+++.+||+.+|.+||++.+++.
T Consensus       226 ~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         226 MF------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hh------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00            0011223345678999999999999999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.5e-40  Score=319.05  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             ccceeecc--cceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504          101 RSLMIGEG--GFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus       101 ~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +..+||+|  +||+||++....++..     ||+|.+.....  .....+.+|+.+++.++||||+++++++..++.   
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---   73 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEY-----VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE---   73 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcE-----EEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE---
Confidence            45679999  7899999998877664     99999875432  223456789999999999999999999987663   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++|+|.+++..+....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++++|||.+.
T Consensus        74 -~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          74 -LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             -EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence             59999999999999999765456789999999999999999999998   99999999999999999999999998654


Q ss_pred             CCCCCCCc-----ceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          257 LGPSDGLS-----HVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       257 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      ........     .......++..|+|||++.+  ..++.++|||||||++|||++|..||........  .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  227 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV  227 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence            33211110     01122356788999999876  4588999999999999999999999975332111  111110000


Q ss_pred             c---cc-----cch----------------------hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 T---DA-----KKF----------------------TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~---~~-----~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .   +.     ...                      ...............+++.+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0   00     000                      0000000001122345678999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.8e-40  Score=307.34  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=203.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|+..+.||+|+||.||+|.+..++.     .+++|.+.....  ...+.+|+.+++.++||||+++++++....    
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQ-----VVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT----   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCc-----EEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC----
Confidence            578999999999999999999876543     389998865432  567889999999999999999999998765    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..|++|||+++++|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            359999999999999998653 46789999999999999999999998   99999999999999999999999999988


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.......   ..         
T Consensus       148 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~---------  213 (256)
T cd06612         148 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PN---------  213 (256)
T ss_pred             hcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---cc---------
Confidence            654332  1223456899999999999989999999999999999999999999754332211110   00         


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         ........+..++..+.+++.+||+.+|++||++.+++.
T Consensus       214 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 ---KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               000011123345678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-39  Score=307.45  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-----chhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-----LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .|++|.+....     ....+.+.+|+.++++++||||+++++++.+.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGR-----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCc-----EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            578999999999999999999877654     49999875322     12235678899999999999999999988764


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      ...  ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|
T Consensus        77 ~~~--~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          77 MER--TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             CCc--eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            432  458999999999999998753  5688899999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........  .....     
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-----  222 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIA-----  222 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHHh-----
Confidence            9998854321111 112335689999999999888899999999999999999999999965422211  11100     


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               ........+...+..+.+++.+|+. +|++||++++|++
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 ---------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                     0001122344566778899999995 8999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.9e-40  Score=306.76  Aligned_cols=244  Identities=27%  Similarity=0.478  Sum_probs=192.3

Q ss_pred             ceeecccceeEEEEEEcCCCC-----cccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504          103 LMIGEGGFGGVYRGVIRSTED-----SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +.||+|+||.||+|.+..+..     ......+++|.+...... ...+.+|+.+++.++||||+++++++.. ..    
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE----   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC----
Confidence            369999999999999987652     223345788877654433 5778899999999999999999999877 33    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-------cEEEe
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-------NAKLS  250 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-------~~kl~  250 (441)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++       .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            38999999999999999764 23789999999999999999999988   999999999999999887       79999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccC--CCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhh
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |||++.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||..............   
T Consensus       151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~---  221 (259)
T cd05037         151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---  221 (259)
T ss_pred             CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc---
Confidence            9999986433      2234567889999998876  78999999999999999999 5778865432221111110   


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                          ..        ...    ......+.+++.+||..+|.+||++.++++.|+
T Consensus       222 ----~~--------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 ----QH--------RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----CC--------CCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                00        000    001167889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.6e-40  Score=314.04  Aligned_cols=267  Identities=28%  Similarity=0.396  Sum_probs=204.8

Q ss_pred             cchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEE
Q 013504           87 FTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLI  165 (441)
Q Consensus        87 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  165 (441)
                      +.++.+....++|++.+.||+|+||.||+|.+..++.     .+++|.+.... .....+.+|+.+++.+ +||||++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~   81 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS-----KAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFY   81 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCc-----eeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeee
Confidence            3445556678899999999999999999999876654     38999876532 2235677899999999 799999999


Q ss_pred             eEEeccc-cCCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          166 GYCAEDD-ERGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       166 ~~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                      +++.... ..+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~  158 (286)
T cd06638          82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLT  158 (286)
T ss_pred             eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEEC
Confidence            9886432 2233569999999999999987532  245688999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      .++.++|+|||+++......  .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||.......
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~  236 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR  236 (286)
T ss_pred             CCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence            99999999999988654321  12234579999999998753     457889999999999999999999996543221


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .  ......     . .     .+.  ...+..++..+.+++.+||+.+|++||++.+|++.
T Consensus       237 ~--~~~~~~-----~-~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 A--LFKIPR-----N-P-----PPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             H--Hhhccc-----c-C-----CCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1  111000     0 0     000  00111244678899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=317.19  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=202.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|+..+.||+|+||.||+|....++.     .+|+|.+......   ..+.+..|+.++..++||||+++++++.... 
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGK-----LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCc-----EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence            368889999999999999999877554     4999998765433   3456788999999999999999999987655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        75 ---~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          75 ---YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             ---EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence               459999999999999999865567899999999999999999999988   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc---------------------------ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC
Q 013504          254 LARLGPSDGLS---------------------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG  306 (441)
Q Consensus       254 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG  306 (441)
                      ++.........                           .......||..|+|||++.+..++.++||||||+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98754321100                           011235789999999999988899999999999999999999


Q ss_pred             CCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC----HHHHHH
Q 013504          307 RRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK----MSEVVE  378 (441)
Q Consensus       307 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  378 (441)
                      ..||.........  ...              .+...........+..+.+++.+||+.+|++||+    +.+++.
T Consensus       229 ~~pf~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         229 TTPFKGSNRDETF--SNI--------------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCCchHHHH--HHH--------------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9999654432111  110              0001111111125678999999999999999999    667666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=310.61  Aligned_cols=249  Identities=31%  Similarity=0.455  Sum_probs=202.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||.|+||.||+|.+..++.     .+++|.+.... ......+.+|+.+++.++||||+++++++.+..   
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQ-----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS---   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCe-----EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC---
Confidence            368888999999999999999876654     49999987553 233456789999999999999999999988764   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++|+||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        73 -~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          73 -KLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             -eEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence             45999999999999999975   3789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      +......  .......|++.|+|||++.+..++.++|||||||++|+|++|..||....+...   ...+...       
T Consensus       146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~-------  213 (274)
T cd06609         146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPKN-------  213 (274)
T ss_pred             eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhhc-------
Confidence            8754432  123346788999999999988899999999999999999999999965442211   1111100       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         ..+.+..   ..++..+.+++.+||..+|++||++++++.
T Consensus       214 ---~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 ---NPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---CCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               0011111   115667899999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=316.39  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=217.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh-HHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +...+.+.||+|-||.|.+|...+.      ..||||.++....... ++|.+|+++|.+|+||||++++|+|..++.. 
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi-  610 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGP------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL-  610 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCc------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch-
Confidence            4566778899999999999987662      3499999988765554 7899999999999999999999999998875 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         ++|+||+++|+|.+|+.......+.-.....|+.||+.|++||.+-   ++|||||.+.|+|++.++++||+|||++
T Consensus       611 ---cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  611 ---CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             ---HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence               9999999999999999876444456667788999999999999987   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT--GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +-+......+.....+-...|||+|.+..++++.++|||+||+++||+++  ...||.......   .++.....+....
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~  761 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG  761 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC
Confidence            97777666666667788899999999999999999999999999999876  678986544332   2222222222222


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ...       ....+.-|+..+.+++.+||..|-.+||+++++...|++.
T Consensus       762 ~~~-------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQV-------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cce-------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111       1223345788999999999999999999999999998864

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-39  Score=307.12  Aligned_cols=263  Identities=25%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC-
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG-  175 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~-  175 (441)
                      |.+.+.||+|+||.||+|.+....  .....+|||.+.....  ...+++.+|+.+++.++||||+++++++......+ 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED--GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC--CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            567788999999999999876432  1234599998875432  23467889999999999999999999887643322 


Q ss_pred             -eeEEEEEeccCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          176 -IQRLLIYEYMPNRSVQDHLTSRF----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       176 -~~~~lv~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                       ...++++||+++|+|.+++....    ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence             12378899999999998875321    12578899999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+++...............+++.|++||.+....++.++|||||||++|+|++ |..||.......   ...+...  
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~--  230 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIK--  230 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHc--
Confidence            9999986543322222233456678999999988889999999999999999999 889986543322   1111110  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                        ...          ...+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       231 --~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 --GNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --CCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              000          001123456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-39  Score=304.69  Aligned_cols=256  Identities=32%  Similarity=0.572  Sum_probs=202.7

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      |.+.+.||.|+||.||+|.+...+. .....||+|.+...... ..+.+..|+.++..++||||+++++++.+.+.    
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP----   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe----
Confidence            4567789999999999999876542 22345999999765543 45678899999999999999999999987653    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence            49999999999999999764333389999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ........ .....+++.|+|||.+.+..++.++||||||+++++|++ |..||.......   .........       
T Consensus       153 ~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~-------  221 (258)
T smart00219      153 LYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKGY-------  221 (258)
T ss_pred             cccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCC-------
Confidence            55432211 112347889999999988889999999999999999998 788886533221   111111100       


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                             ....+...+..+.+++.+||..+|++||++.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0011123567899999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=309.05  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=212.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      -|.++.+||+|+||.||++.++.++..     +|||++.-.  .+.+++..|+.|+.+++.|+||++||.+.....    
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v-----~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHV-----LAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcE-----EEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----
Confidence            366677899999999999999988775     999998654  356889999999999999999999997765554    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      +++|||||..|++.+.+..+ .+++.+.++..+++..+.||+|||.-   .-||||||..||||+.+|..||+|||.|..
T Consensus       103 LWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence            49999999999999999865 58999999999999999999999976   789999999999999999999999999987


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      +...  ....+++.|||.|||||++..-.|+.++||||||++..||..|++||.+..+.-               ..+-.
T Consensus       179 LTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMI  241 (502)
T KOG0574|consen  179 LTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMI  241 (502)
T ss_pred             hhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEec
Confidence            6543  234567899999999999999999999999999999999999999997544321               01111


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      -..|...-..+..++.++.++++.||-+.|++|-++-++++
T Consensus       242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            12344445567789999999999999999999999998887

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-39  Score=308.69  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=203.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ..|+..+.||.|+||.||+|.+..++.     .||+|.+..... .....+.+|+.+++.++||||+++++++....   
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT---   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCE-----EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC---
Confidence            357778889999999999999876554     489998875432 33567889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        76 -~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          76 -KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             -EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence             45999999999999999864   4688999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  .......++..|+|||++.+..++.++|+|||||++|||++|..||....+........            
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------  214 (277)
T cd06640         149 GQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------  214 (277)
T ss_pred             eeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh------------
Confidence            7654322  12234568899999999988889999999999999999999999997543322111110            


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                           ..........++..+.+++.+||+.+|++||++.+++..
T Consensus       215 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -----KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                 001122344577889999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-39  Score=305.03  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||.|+||.||++.+..++..     +++|.+.....  .....+..|+.+++.++||||+++++++...... 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~-----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKI-----LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ-   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCE-----EEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC-
Confidence            478889999999999999998776543     88998865432  2345678899999999999999999988754432 


Q ss_pred             eeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLH-----EGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                       ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||     +.   +++|+||||+||+++.++.+|
T Consensus        75 -~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          75 -TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             -EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEE
Confidence             468999999999999998653  2467899999999999999999999     65   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      |+|||++........  ......|++.|+|||.+.+..++.++||||||+++++|++|..||......   .....+...
T Consensus       151 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~  225 (265)
T cd08217         151 LGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEG  225 (265)
T ss_pred             EecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcC
Confidence            999999987644321  123457899999999999888999999999999999999999999754421   122211110


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                    .....+..++..+.+++.+||..+|++||++.+|++.
T Consensus       226 --------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 --------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                          0112333566789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=306.39  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=207.7

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhH---HHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK---EWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ..++|...++||+|.||+|.+++.+.++..     +|+|++++.......   .-+.|-++|...+||.+..|--.|+..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~-----YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKL-----YAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCce-----eehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            347889999999999999999998887765     999999876544333   346799999999999999988778776


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    ++|+||||+.||.|.-+|.+  ...+++.....+-.+|+.||.|||++   +||+||||.+|+|||.+|.+||+|
T Consensus       241 d----rlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 D----RLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             c----eEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence            6    45999999999999999976  46899999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++.....+  ....+++|||.|+|||++....|+.++|+|.+||++|||++|+.||-....   .++...+.     
T Consensus       312 FGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl-----  381 (516)
T KOG0690|consen  312 FGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELIL-----  381 (516)
T ss_pred             cccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHH-----
Confidence            99999755443  346789999999999999999999999999999999999999999954322   22222111     


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                              -.  .-.++..++++...|+..+|.+||.+|..     +.||.+
T Consensus       382 --------~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  382 --------ME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             --------hh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                    00  12355567788999999999999999953     555554

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-41  Score=329.99  Aligned_cols=243  Identities=23%  Similarity=0.406  Sum_probs=193.8

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccC----chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG----LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      .+||+|+|-+||+|.+..++..     ||.-.++...    .....+|..|+.+|+.|+||||+++|.++.+....  ..
T Consensus        46 evLGrGafKtVYka~De~~giE-----VAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~--~i  118 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIE-----VAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK--TI  118 (632)
T ss_pred             hhcccccceeeeeccccccchh-----hHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc--ee
Confidence            3699999999999998776654     4443333221    12347899999999999999999999999987764  45


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeecCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARL  257 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~  257 (441)
                      .+|+|++..|+|..|+.+  .+.++...+..|++||++||.|||++ .++|||||||.+||+|+ ..|.|||+|+|||..
T Consensus       119 n~iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            789999999999999977  46788899999999999999999997 78999999999999996 458899999999987


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCch--hHHHHHHhhhhhcccccch
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK--SEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....    ....++|||.|||||+.. ..|+..+||||||++++||+|+..||..-...  ...++...+.|.     .+
T Consensus       196 ~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-----sl  265 (632)
T KOG0584|consen  196 LRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-----AL  265 (632)
T ss_pred             hhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-----Hh
Confidence            5443    234489999999999876 79999999999999999999999999543221  111222211111     11


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..+            -.+++.++|.+||.. ..+||++.|+|.
T Consensus       266 ~kV------------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SKV------------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hcc------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111            135789999999999 999999999997

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-39  Score=306.97  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=197.4

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc------hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL------QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      +|.+.+.||+|+||.||+|.... +.     .+|+|.+.....      .....+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-~~-----~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-GQ-----LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-CC-----eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            47888999999999999997643 22     389998764321      1234578899999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|
T Consensus        75 ~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          75 N----TISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             C----eEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence            4    45999999999999999975  35788999999999999999999988   999999999999999999999999


Q ss_pred             cCCCCCCCCCC----CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          252 FGLARLGPSDG----LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       252 FGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||................ 
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-  224 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-  224 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc-
Confidence            99987543211    1112234578999999999998889999999999999999999999996543222111100000 


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ...+    ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       225 ----------~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 ----------GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----------CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      0001    122245677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-39  Score=304.74  Aligned_cols=255  Identities=21%  Similarity=0.385  Sum_probs=188.6

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      .||+|+||.||+|.......   ...+++|.+..... ...+.+.+|+.+++.++||||+++++++.....    .|+||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP----YLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCC---cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc----cEEEE
Confidence            59999999999997654332   22356776654432 345678999999999999999999999987653    49999


Q ss_pred             eccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      ||+++|+|.+++....  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence            9999999999997532  23567778889999999999999998   999999999999999999999999999864322


Q ss_pred             CCCcceeeceecccCcCCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQT-------GRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ...........|+..|+|||++..       ..++.++|||||||++|||++ |..||...........  ....     
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~~-----  224 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH--VIKD-----  224 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHhh-----
Confidence            211122234578899999998753       245778999999999999997 5678864433211111  0100     


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                       ......++.+.    ..++..+.+++..|| .+|++||++++|++.|.
T Consensus       225 -~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             00111222222    224567888999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=310.75  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=203.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||++.+..++.     .+|+|++..... ...+.+.+|+.+++.++||||+++++++....   
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   76 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGT-----VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN---   76 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCc-----EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC---
Confidence            568888899999999999999876554     388888765432 23467889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       .+++||||+++++|.+++..  .+.+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++
T Consensus        77 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          77 -NICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             -EEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence             45999999999999999865  45789999999999999999999963  27999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh-----HHHHHHhhhhhcc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS-----EQKLLEWVRPHLT  330 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~-----~~~~~~~~~~~~~  330 (441)
                      ......    ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......     .............
T Consensus       152 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd06620         152 GELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ  227 (284)
T ss_pred             cchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence            754222    1234578999999999988899999999999999999999999997544321     1111111111110


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                      ..       .+.   .....++..+.+++.+||..||.+||++.++++..
T Consensus       228 ~~-------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         228 EP-------PPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             cc-------CCC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            00       011   11123667899999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=329.08  Aligned_cols=252  Identities=23%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +-|.++..||.|+||.||+|+.+.++-.     .|.|++..........++-|+.||..+.||+||+|++.|+..+.   
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~l-----AAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk---  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLL-----AAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK---  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhh-----hhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc---
Confidence            4577888899999999999998866543     56677777666677889999999999999999999998776664   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       ++|+.|||.||.+...+... +..+.+.++..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+.
T Consensus       104 -LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  104 -LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             -eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence             48999999999998887654 67899999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      .....  .....++.|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++.   .++-.+...  +
T Consensus       179 Kn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKS--e  251 (1187)
T KOG0579|consen  179 KNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKS--E  251 (1187)
T ss_pred             cchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhc--C
Confidence            54332  23456799999999999764     468999999999999999999999998654432   222111110  0


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              .|  .--.+..++..+.+++.+||.+||..||++.++++
T Consensus       252 --------PP--TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 --------PP--TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --------CC--cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                    01  11234567888999999999999999999999987

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-39  Score=310.81  Aligned_cols=266  Identities=29%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             cchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEE
Q 013504           87 FTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLI  165 (441)
Q Consensus        87 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  165 (441)
                      +.++++...+++|.+.+.||+|+||.||+|....++.     .+|+|.+.... .....+.+|+.++.++ +||||++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~-----~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS-----LAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC-----EEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            4445555667899999999999999999999876654     38999886532 2235677899999998 899999999


Q ss_pred             eEEecccc-CCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          166 GYCAEDDE-RGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       166 ~~~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                      +++...+. .+...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~  162 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence            99876442 223569999999999999988632  245789999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----RLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      .++.+||+|||++........  ......|+..|+|||.+...     .++.++|||||||++|+|++|+.||.......
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            999999999999886543221  12345789999999987643     36889999999999999999999997543221


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  +........           +.  ...+......+.+++.+||..+|++||++.++++
T Consensus       241 ~--~~~~~~~~~-----------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 T--LFKIPRNPP-----------PT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H--HHHHhcCCC-----------CC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1  111110000           00  0112234567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-39  Score=310.84  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=199.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .+|+|.+.... ......+.+|+.++.+++||||+++++++...+   
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   72 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGV-----TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG---   72 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCc-----EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC---
Confidence            368888999999999999999876654     38999886542 223467889999999999999999999887755   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ..++||||+++++|..++.... ...+++..+..++.|++.||.|||++  .+|+||||||+||+++.++.++|+|||+
T Consensus        73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          73 -AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             -eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence             4599999999999999886521 24789999999999999999999963  2899999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +......    ......|++.|+|||++.+..      ++.++|||||||++|+|++|..||...............   
T Consensus       150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---  222 (286)
T cd06622         150 SGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI---  222 (286)
T ss_pred             cccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH---
Confidence            8764322    123356888999999985543      478999999999999999999999654322211111111   


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .+. .....+..++..+.+++.+||..+|++||++.+++.
T Consensus       223 ----------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 ----------VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----------hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                      000 011223346788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-39  Score=313.37  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||++.+..++.     .|++|.+.....   .....+.+|+.+++.++||||+++++.+...+ 
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQ-----RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCc-----EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence            468899999999999999999877654     399998875432   22356778999999999999999999987655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||++|++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        75 ---~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          75 ---HLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             ---EEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence               35999999999999999976  35789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-------------cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          254 LARLGPSDGL-------------SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       254 la~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      +++.......             ........|+..|+|||.+.+..++.++|||||||++|||++|..||.......   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---  223 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---  223 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            9874211100             001123467889999999988889999999999999999999999996543221   


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                      ........   .     ...+.    ....++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~---~-----~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 LFGQVISD---D-----IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHhc---c-----cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11111000   0     00010    111356778999999999999999998777666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.3e-40  Score=314.49  Aligned_cols=250  Identities=27%  Similarity=0.403  Sum_probs=199.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      .|.....||+|+||.||++....++.     .||||.+........+.+.+|+.+++.++||||+++++.+...+    .
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~   93 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGK-----QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----E   93 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCC-----EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----e
Confidence            34444569999999999998766554     39999987655555667889999999999999999999987665    3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||+++++|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+||+++.++.++|+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            5999999999999998854   4688999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      .....  .......|+..|+|||.+.+..++.++||||||+++|||++|..||...........+   ...         
T Consensus       168 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~---------  233 (292)
T cd06658         168 VSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDN---------  233 (292)
T ss_pred             ccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc---------
Confidence            43321  1223467899999999998888999999999999999999999999754432211111   110         


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                       ..+.+.  .....+..+.+++.+||..||.+||+++++++.
T Consensus       234 -~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 -LPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -CCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             111111  111345678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-39  Score=304.12  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||++....++.     .+++|.+....  ....+++.+|+.+++.++||||+++++++...+   
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK-----QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG---   72 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC-----EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC---
Confidence            48889999999999999999876554     49999886432  233457889999999999999999999987665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++.......+++..++.++.|++.||.|||++   +++|+||+|+|||++.++.++|+|||++
T Consensus        73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          73 -NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence             459999999999999999765455789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  .......|++.|+|||++.+..++.++|+|||||++++|++|..||.........  .......       
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~--~~~~~~~-------  217 (256)
T cd08218         149 RVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV--LKIIRGS-------  217 (256)
T ss_pred             eecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH--HHHhcCC-------
Confidence            8654322  1123456889999999999888999999999999999999999999654322111  1111000       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ....+..++..+.+++.+||+.+|.+||++.+|++
T Consensus       218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                    01122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.3e-40  Score=311.82  Aligned_cols=248  Identities=28%  Similarity=0.448  Sum_probs=199.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .|+..+.||+|+||.||+|.+..++.     .||+|.+..... ...+.+.+|+.+++.++||||+++++++....    
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT----   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCe-----EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC----
Confidence            46667789999999999999866543     489998875432 23456889999999999999999999987655    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence            35999999999999999864   5789999999999999999999988   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  .......|+..|+|||++.+..++.++|||||||++|||++|..||....+...   ......         
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~---------  215 (277)
T cd06642         150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIPK---------  215 (277)
T ss_pred             cccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhhhhc---------
Confidence            654321  122335688999999999988999999999999999999999999864332211   111100         


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                           .........++..+.+++.+||..+|++||++.+++..
T Consensus       216 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 -----NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                 00111223456778999999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.5e-39  Score=303.45  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=201.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|+..+.||+|+||.||++....++.     .+++|.+.....  .....+.+|+.+++.++||||+++++.+...+   
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   72 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK-----LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK---   72 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc-----EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC---
Confidence            58888999999999999999876554     489998865432  23467889999999999999999999887655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGl  254 (441)
                       ..++||||+++++|.+++.......+++..+..++.|++.||.|||++   +|+|+||||+||+++.+ +.++|+|||+
T Consensus        73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          73 -ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             -EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence             359999999999999999876556789999999999999999999998   99999999999999855 4589999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ........     
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~-----  217 (256)
T cd08220         149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGT-----  217 (256)
T ss_pred             ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHHhcC-----
Confidence            98654332   22345789999999999988899999999999999999999999975443221   11110000     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               ....+..++..+.+++.+||..+|.+||++.+++.
T Consensus       218 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 ---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     00112235677899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=305.92  Aligned_cols=258  Identities=31%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .+++|++.+.||+|+||.||+|.+..++.     .+++|.+..... ....+.+|+.+++++ .||||+++++++.....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQ-----LVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCc-----EEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            45789999999999999999999876544     389998875543 346788999999998 79999999999977552


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                        .+...++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence              2345699999999999999986533  46789999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +|||++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|..||........  ....
T Consensus       155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~  230 (275)
T cd06608         155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI  230 (275)
T ss_pred             CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh
Confidence            9999987643321  12334678999999998754     3467889999999999999999999964332211  1111


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..             ........+..++..+.+++.+||..||++||++.++++
T Consensus       231 ~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PR-------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hc-------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            10             000011122346678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=310.72  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .|++|.+.....  ...+.+.+|+.+++.++|+||+++++++...+  
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGE-----IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCc-----EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--
Confidence            368899999999999999999877654     499998865432  23467889999999999999999999998755  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||++++.+..++..  ...+++..+..++.||+.||.|||++   +++|+||+|+||++++++.+||+|||+
T Consensus        74 --~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          74 --RLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             --EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence              45999999998777665544  35689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  331 (441)
                      +........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||..................+..  
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07833         147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH  225 (288)
T ss_pred             ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            987554332 123346788999999999888 7899999999999999999999999754432221111111000000  


Q ss_pred             ------ccchhh--hcCCC----CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ------AKKFTM--ILDPK----LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ------~~~~~~--~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ......  ..+..    ....++..++..+.+++.+||..+|++||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  000000  00000    000112234778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-39  Score=313.11  Aligned_cols=200  Identities=27%  Similarity=0.436  Sum_probs=160.5

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      ..||+|+||.||+|.......   ...||+|.+.....  ...+.+|+.+++.++||||+++++++......  ..++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~---~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~   79 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKD---EKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLLF   79 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCc---cceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEEE
Confidence            579999999999999764322   23599998865432  34577899999999999999999998754433  468999


Q ss_pred             eccCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE----cCCCcEEEee
Q 013504          183 EYMPNRSVQDHLTSR-------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSD  251 (441)
Q Consensus       183 E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl----~~~~~~kl~D  251 (441)
                      ||++ ++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            9985 5788877421       123588899999999999999999998   99999999999999    5667899999


Q ss_pred             cCCCCCCCCCCCc-ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013504          252 FGLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       252 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      ||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9999865432211 12234678999999999876 45789999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-39  Score=304.75  Aligned_cols=257  Identities=28%  Similarity=0.463  Sum_probs=204.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||.|+||+||+|....++.     .+++|++..... .....+.+|+.+++.++|+||+++++.+....   
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNE-----KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD---   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCc-----EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC---
Confidence            478999999999999999999776544     489999875432 24567889999999999999999999887655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQ-ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence             45999999999999999976432 5789999999999999999999988   999999999999999999999999999


Q ss_pred             CCCCCCCCCc--ceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          255 ARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +.........  .......|+..|+|||++... .++.++|+|||||++|+|++|+.||........  .......   .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~  223 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D  223 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C
Confidence            8765443222  123445789999999998776 789999999999999999999999965433211  1111110   0


Q ss_pred             ccchhhhcCCCCCCc-chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGK-YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              .+.+... ....++..+.+++.+||..||++||++.+++.
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    0111111 11256678899999999999999999999886

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=322.13  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=215.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +..+..+||-|-||.||.|+|+.-.-     .||||.++... ...++|+.|..+|+.++|||+|+|+|+|.....    
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkysl-----TvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP----  337 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP----  337 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccce-----eeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC----
Confidence            44556689999999999999986543     39999997654 446899999999999999999999999987664    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      +|||+|||..|+|.+||.+.....++.-..+.++.||..|+.||..+   ++|||||...|+|+.++..||++|||++++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            49999999999999999987777888888999999999999999998   999999999999999999999999999998


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ...+.... .....-.+-|.|||-+....++.++|||+|||+|||+.| |..||.+........+++             
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------------  480 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------------  480 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------------
Confidence            76554322 122334567999999999999999999999999999998 899997654333322222             


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                          ...+-..+..|++.+.+|++.||+.+|.+||++.|+-+.++.++
T Consensus       481 ----kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  481 ----KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ----ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                22333445678999999999999999999999999999998877

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-39  Score=305.57  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=198.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch----------hhHHHHHHHHHhccCCCCCeeeEEeE
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ----------GHKEWVTEVNVLGVVEHPNLVKLIGY  167 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~  167 (441)
                      +|...+.||.|+||.||+|....++.     .+|+|.+......          ..+.+..|+.+++.++||||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGE-----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCc-----eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            47778899999999999999776554     3899987532110          12457789999999999999999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      +...+    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+
T Consensus        77 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          77 ETTEE----YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             eccCC----ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence            87655    349999999999999999763  6789999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR--LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      +|+|||+++...............|+..|+|||.+....  ++.++||||||+++|++++|..||.......  ......
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~  225 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLG  225 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhh
Confidence            999999998644322122233457899999999987654  7899999999999999999999996432211  111100


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .          ....+.+.......++..+.+++.+||..+|.+||++.+|++
T Consensus       226 ~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         226 N----------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             c----------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0          000111111222345678999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-39  Score=304.80  Aligned_cols=254  Identities=26%  Similarity=0.447  Sum_probs=201.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc------hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL------QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      +|+..+.||+|+||.||+|....++.     .+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT-----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc-----EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence            47888999999999999998766654     399998865331      1246788999999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEe
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLS  250 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~  250 (441)
                      +.    .++||||+++++|.+++..  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++ .++|+
T Consensus        76 ~~----~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          76 SH----FNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             Ce----EEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence            53    4999999999999999975  35789999999999999999999998   999999999999998776 59999


Q ss_pred             ecCCCCCCCCCCCc--ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          251 DFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       251 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      |||++.........  .......||..|+|||.+.+..++.++||||||+++++|++|..||................. 
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  225 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-  225 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-
Confidence            99998865443211  112345789999999999888899999999999999999999999964433222221111100 


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                  .......+...+..+.+++.+||..+|.+||++.+++.
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                        00112233456788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-39  Score=308.39  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=200.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|+....||+|+||.||+|.+..++.     .||+|.+.....  ...+.+.+|+.+++.++||||+++++++....  
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQ-----IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCc-----EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--
Confidence            468889999999999999999876654     389998765432  22355778999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|..++..  ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        74 --~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          74 --KLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             --EEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence              35999999999888887754  35689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH-hhhhhccc-
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE-WVRPHLTD-  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~-~~~~~~~~-  331 (441)
                      +........  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+. ........ 
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            986544321  1233567889999999876 457889999999999999999999997655433222111 11000000 


Q ss_pred             ------ccchhhhcCCCCCCc-----chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ------AKKFTMILDPKLEGK-----YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ------~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .........+.....     .....+..+.+++.+||+.+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  000000000110000     01134677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-39  Score=313.40  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=199.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      .|.....||+|+||.||+|....++.     .|++|.+........+.+.+|+.++..++||||+++++++...+    .
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~   92 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGR-----QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----E   92 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCC-----EEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----e
Confidence            34455579999999999998765544     49999987655455567889999999999999999999987755    3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||+++++|..++..   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++..
T Consensus        93 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            5999999999999998754   4689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      .....  .......|+..|+|||++.+..++.++|||||||++|||++|+.||...........   ......       
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~-------  234 (297)
T cd06659         167 ISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPP-------  234 (297)
T ss_pred             ccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhccCC-------
Confidence            43321  122346789999999999988999999999999999999999999975443222111   111000       


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                         +  ........+..+.+++.+||+.+|.+||++.++++.
T Consensus       235 ---~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 ---P--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ---C--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               0  001112345678899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-39  Score=305.73  Aligned_cols=260  Identities=26%  Similarity=0.362  Sum_probs=203.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|...+.||.|++|.||+|.+..++.     .+|+|.+..... .....+.+|++++++++||||+++++++...... 
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGM-----IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS-   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCe-----EEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC-
Confidence            368888999999999999999876543     499998875433 3346788999999999999999999998765432 


Q ss_pred             eeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                       ..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        75 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          75 -SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             -eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence             469999999999999987532  245688999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCc--hhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP--KSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~  331 (441)
                      ++.......    .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ....+...+...... 
T Consensus       151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  225 (287)
T cd06621         151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-  225 (287)
T ss_pred             ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-
Confidence            987543321    1235678899999999989999999999999999999999999975522  112222232221000 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          .. +....  ......+..+.+++.+||..+|.+||++.++++
T Consensus       226 ----~~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 ----PE-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ----hh-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                00 00000  011235678899999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-39  Score=309.12  Aligned_cols=245  Identities=25%  Similarity=0.432  Sum_probs=199.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||++.+..++.     .+|+|.+.....   .....+.+|+.++++++||||+++++++.... 
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGK-----YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence            468899999999999999999876554     499998865432   23456788999999999999999999997765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||+|+|||++.++.+||+|||
T Consensus        75 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          75 ---NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             ---eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence               359999999999999999763  6789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ......   ..  
T Consensus       147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---~~--  213 (290)
T cd05580         147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKIL---EG--  213 (290)
T ss_pred             CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh---cC--
Confidence            99865433     234578999999999988888999999999999999999999997544221   111110   00  


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                ....+..++..+.+++.+||..+|.+|+     ++++++.
T Consensus       214 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         214 ----------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ----------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                      0012223467889999999999999998     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.1e-39  Score=302.31  Aligned_cols=251  Identities=27%  Similarity=0.521  Sum_probs=198.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|.+.+.||.|+||.||+|.+....      .+++|.+..... ....+.+|+.+++.++||||+++++++.....   
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   73 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKR------KVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP---   73 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCC------eEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc---
Confidence            46888899999999999999875322      389998865432 34578899999999999999999999876653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        74 -~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          74 -ICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             -eEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence             49999999999999998753 34688999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......++..|+|||++.++.++.++||||||+++|||++ |..||.......   ........    .  
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~----~--  218 (256)
T cd05112         149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAG----F--  218 (256)
T ss_pred             ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHhCC----C--
Confidence            5433211 11122345678999999988899999999999999999998 999996543221   12111100    0  


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                       ....+       ...+..+.+++.+||+.+|++||++.++++.|
T Consensus       219 -~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 -RLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             00111       11346799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=296.37  Aligned_cols=258  Identities=23%  Similarity=0.306  Sum_probs=209.0

Q ss_pred             HhcCCccc-ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRS-LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      .+++|++. ++||-|-.|.|-.+.++.+++.     +|+|++...     ....+|+++.-.. .|||||.+++++...-
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ek-----fALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEK-----FALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhh-----hHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            45677764 5799999999999999998876     999998543     4566899886655 7999999999998766


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc---CCCcEEE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKL  249 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~---~~~~~kl  249 (441)
                      .....+++|||.++||.|...+.++....+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .|..+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            5555678999999999999999998888999999999999999999999987   999999999999995   4556999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPH  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~  328 (441)
                      +|||+|+....   .....+.+.||.|.|||++....|+..+|+||+||++|-||+|.+||-.+...... ..-..++. 
T Consensus       206 tDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~-  281 (400)
T KOG0604|consen  206 TDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT-  281 (400)
T ss_pred             cccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-
Confidence            99999996543   22345678999999999999999999999999999999999999999544321100 00000000 


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                -.-.+.......+++...++|+.+|..+|.+|.++.++++.
T Consensus       282 ----------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  282 ----------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ----------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                      00112233445788899999999999999999999999883

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7e-39  Score=301.68  Aligned_cols=252  Identities=28%  Similarity=0.451  Sum_probs=207.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|++|.||+|.+..++.     .+++|.+..... .....+.+|+.++.+++||||+++++++....   
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGK-----IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG---   72 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC---
Confidence            368889999999999999999887654     399999876654 34567889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ .   +++||||+|+||+++.++.++|+|||+
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          73 -EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             -eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence             459999999999999999763  678999999999999999999998 7   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||..................      
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------  218 (264)
T cd06623         147 SKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG------  218 (264)
T ss_pred             ceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC------
Confidence            986543321  123457899999999999888999999999999999999999999765432222333222110      


Q ss_pred             hhhhcCCCCCCcchHH-HHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIK-LAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             . ....+.. ++..+.+++.+||..+|++||++.++++
T Consensus       219 -------~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         219 -------P-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -------C-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                   0 0111223 5678999999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-39  Score=311.08  Aligned_cols=266  Identities=26%  Similarity=0.367  Sum_probs=199.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .+|+|.+......  ..+.+.+|+.+++.++||||+++++++....  
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQ-----IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCC-----EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--
Confidence            468899999999999999999876554     4999987654322  2356778999999999999999999997655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.++...  ...+++..++.++.||+.||.|||+.   +|+|+||+|+||++++++.++|+|||+
T Consensus        74 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          74 --RLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             --eEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence              45999999999999887754  34689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc-
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA-  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-  332 (441)
                      +.......  .......++..|+|||++.+ ..++.++||||||+++|||++|..||...........+......+... 
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence            88654332  12234568899999998865 347789999999999999999999997544322111111100000000 


Q ss_pred             -------cchhhhcCCCCCC-----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -------KKFTMILDPKLEG-----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ........+....     .....++..+.+++.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                   0000000010000     011245678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.9e-39  Score=301.73  Aligned_cols=248  Identities=28%  Similarity=0.453  Sum_probs=199.0

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-----hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      +|+..+.||+|+||.||+|....++.     .|++|.+.....     ...+.+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD-----FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc-----EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            46777899999999999999875544     389998765432     23467889999999999999999999987665


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+||
T Consensus        76 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 ----NLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             ----eEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence                35999999999999999976  35689999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |++.......   ......|+..|++||.+.... ++.++|+||||+++|+|++|..||.......  ....... . . 
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~-~-~-  218 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIGR-S-K-  218 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHHh-c-c-
Confidence            9988654332   234467899999999987766 8999999999999999999999996544211  1111110 0 0 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        .         ....+..++..+.+++.+||..+|.+||++.+++.
T Consensus       219 --~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 --E---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --c---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              0         01122245677889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-39  Score=332.45  Aligned_cols=276  Identities=19%  Similarity=0.285  Sum_probs=190.9

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccc--------------eeEEEEEccccCchhhHHHHHHHHHhccCCC
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK--------------IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH  158 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~E~~il~~l~h  158 (441)
                      ....++|++++.||+|+||+||+|.++........              ..++.|.+.. .......+.+|+.+|++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence            34567899999999999999999876543221100              0011111111 11223567899999999999


Q ss_pred             CCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 013504          159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF---QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK  235 (441)
Q Consensus       159 pnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK  235 (441)
                      |||+++++++...+.    .|+|+|++ +++|.+++....   ........+..|+.||+.||.|||++   +|+|||||
T Consensus       223 pnIv~l~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK  294 (501)
T PHA03210        223 ENILKIEEILRSEAN----TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK  294 (501)
T ss_pred             CCcCcEeEEEEECCe----eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            999999999987664    48999998 567888775321   12234567788999999999999998   99999999


Q ss_pred             CCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCC-CCCCCC
Q 013504          236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR-PLDRNR  314 (441)
Q Consensus       236 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~-P~~~~~  314 (441)
                      |+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|.. |+....
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~  373 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG  373 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence            9999999999999999999986543221 12334689999999999999999999999999999999999875 454433


Q ss_pred             chhHHHHHHhhhhhccccc-------chhhhcCCC-C---CCcc-----hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          315 PKSEQKLLEWVRPHLTDAK-------KFTMILDPK-L---EGKY-----SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~---~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ......+...+........       .....++.. +   ....     ....+..+.+++.+||..||.+||++.|++.
T Consensus       374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            3322222221111000000       000000000 0   0000     0113456788899999999999999999987

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.4e-39  Score=304.48  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC----------chhhHHHHHHHHHhcc-CCCCCeeeEEe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG----------LQGHKEWVTEVNVLGV-VEHPNLVKLIG  166 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~-l~hpnIv~l~~  166 (441)
                      +|++.+.||+|+||.||+|.+..+..    ..+|+|.+....          .....++.+|+.++.+ ++||||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~----~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQ----NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCC----ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            47788899999999999999876221    248888875322          1223456788888875 79999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++...+    ..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.  .+++|+||||+|||++.+
T Consensus        77 ~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~  150 (269)
T cd08528          77 TFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGED  150 (269)
T ss_pred             eEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCC
Confidence            998765    35999999999999998853  2245789999999999999999999963  289999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +.++|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+. 
T Consensus       151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-  226 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV-  226 (269)
T ss_pred             CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh-
Confidence            999999999998654332   2345678999999999998889999999999999999999999996543222111110 


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                        .             ..........++..+.+++.+||+.||++||++.++..++.
T Consensus       227 --~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 --E-------------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --h-------------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              0             00000011134567899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-38  Score=303.34  Aligned_cols=266  Identities=24%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||.|+||.||+|.+..++.     .|++|.+.....  .....+.+|+.++++++||||+++++++....   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   72 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE-----TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS---   72 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc-----eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC---
Confidence            47888999999999999999876654     389999876542  23467889999999999999999999998754   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        73 -~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          73 -GFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             -eeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence             459999999 99999998754 36799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhh-------
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVR-------  326 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~-------  326 (441)
                      ........ .......|+..|+|||++.+. .++.++|||||||++++|++|.+||........... .....       
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW  225 (286)
T ss_pred             ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence            86544321 122345789999999988654 468899999999999999999888865443221111 11100       


Q ss_pred             hhcccccchhhhcCCCCC----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDAKKFTMILDPKLE----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +.............+...    .....+.+..+.+++.+||..+|++||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000000000000000    0011134578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-38  Score=313.46  Aligned_cols=276  Identities=24%  Similarity=0.286  Sum_probs=205.1

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|+..+.||+|+||.||+|.+..++..     ||+|.+....  ......+.+|+.++++++||||+++++++...
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQN-----VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCE-----EEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            3457899999999999999999998776553     9999986532  22345677899999999999999999998754


Q ss_pred             cc--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          172 DE--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       172 ~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ..  .....|+||||+. ++|.+.+..    .++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          88 KSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence            32  1124599999995 588888854    288899999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhh-
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRP-  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~-  327 (441)
                      +|||+++......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||......... ........ 
T Consensus       160 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999998654321   123456899999999999999999999999999999999999999654322111 11110000 


Q ss_pred             --------------hcccc-----cchhhhcCC----CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          328 --------------HLTDA-----KKFTMILDP----KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       328 --------------~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                                    .....     ..+......    ..........+..+.+++.+||+.||++||++.+++.  +|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                          00000     000000000    0000112234667889999999999999999999997  4554


Q ss_pred             HHh
Q 013504          383 IVD  385 (441)
Q Consensus       383 ~~~  385 (441)
                      ...
T Consensus       317 ~~~  319 (353)
T cd07850         317 WYD  319 (353)
T ss_pred             ccC
Confidence            443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=323.17  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=210.0

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ...++||+|.||.|++|.|....  .+.+.||||.+...... ....|++|+.+|.+|+|||+++|||+..+..     .
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----~  185 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----A  185 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----h
Confidence            34457999999999999998743  45678999999876544 5688999999999999999999999998733     3


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      .+|||+++.|+|.+.|..-....|.....-.++.||+.|+.||.++   ++|||||...|+||-..-.|||+||||.+-+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence            7999999999999999875567888899999999999999999998   9999999999999999989999999999977


Q ss_pred             CCCCCcce-eeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          259 PSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       259 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ...+.... .....-...|+|||.+....++.++|||+|||++|||+| |+.||-+-......+.+              
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i--------------  328 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI--------------  328 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc--------------
Confidence            65443322 223344567999999999999999999999999999999 78999765543333222              


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                         |....-.-+..|++++.++++.||..+|++||++..|.+.
T Consensus       329 ---D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  329 ---DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence               2222223445789999999999999999999999999853

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.1e-39  Score=305.35  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=199.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      .|...+.||+|++|.||++....++.     .+++|.+........+.+.+|+.+++.++||||+++++++...+    .
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGR-----QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----E   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCC-----EEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----e
Confidence            45556789999999999999776554     38999886555445567889999999999999999999987655    3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++|+||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            5999999999999999876   4689999999999999999999998   999999999999999999999999998875


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      .....  .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+......   .....        
T Consensus       165 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~--------  231 (285)
T cd06648         165 VSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNL--------  231 (285)
T ss_pred             hccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcC--------
Confidence            43321  122345789999999999888899999999999999999999999965443222111   11110        


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        .+...  ....++..+.+++.+||..+|++||++.++++
T Consensus       232 --~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 --PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              00000  11125567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-39  Score=307.92  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=195.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||+|.+..++.     .+++|.+......  ....+.+|+.+++.++||||+++++++.+..   
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~-----~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---   72 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK---   72 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc-----EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC---
Confidence            47888999999999999999877665     3899988653221  2345778999999999999999999987665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++|+||++ ++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        73 -~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          73 -KLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             -ceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence             3599999996 5888887653 35799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--c
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--A  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~  332 (441)
                      +......  .......+++.|+|||++.+. .++.++|||||||++|+|++|..|+.........  ...+......  .
T Consensus       147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  222 (284)
T cd07839         147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTE  222 (284)
T ss_pred             hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCCh
Confidence            8543321  112335678999999988764 4789999999999999999999886433322111  1111000000  0


Q ss_pred             cc---hhhhcC----CCCC-----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KK---FTMILD----PKLE-----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~---~~~~~~----~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..   .....+    +...     ......++..+.+++.+||+.||.+|||+++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00   000000    0000     0111235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8e-39  Score=306.99  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=202.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|....++.     .|++|.+..........+.+|+.+++.++||||+++++++...+.   
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~---   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQ-----EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE---   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCC-----EEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc---
Confidence            689999999999999999998765544     399999875554555678899999999999999999999987653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++|+||+++++|.+++..   ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.
T Consensus        91 -~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          91 -LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             -EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence             4999999999999999865   3578999999999999999999998   99999999999999999999999999887


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      .......  ......|++.|+|||.+....++.++|||||||++|++++|..||............  .           
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--~-----------  228 (293)
T cd06647         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--A-----------  228 (293)
T ss_pred             ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--h-----------
Confidence            5443321  223457899999999998888999999999999999999999999754332111000  0           


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                        .........+...+..+.+++.+||..+|++||++.+++..
T Consensus       229 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 --TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000111223456678999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=305.51  Aligned_cols=265  Identities=23%  Similarity=0.349  Sum_probs=194.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|....++.     .||+|.+...... ....+.+|+.+++.++||||+++++++.+.+   
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   76 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK---   76 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCc-----EEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC---
Confidence            578999999999999999999875544     4999998654322 2245678999999999999999999998665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        77 -~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          77 -TLTLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             -eEEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence             4599999997 4999988754 34789999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~  333 (441)
                      +......  .......++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ............ ..
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~  227 (291)
T cd07844         151 RAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT-EE  227 (291)
T ss_pred             cccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC-hh
Confidence            7543221  11223457889999998865 4588999999999999999999999965442111 111110000000 00


Q ss_pred             chhhh---------cCCCC-CCc---chHHH--HHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMI---------LDPKL-EGK---YSIKL--AQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~---------~~~~~-~~~---~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....         ..+.. ...   .....  ...+.+++.+||+.+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000         00000 000   00011  267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=305.81  Aligned_cols=264  Identities=17%  Similarity=0.198  Sum_probs=190.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh-----------HHHHHHHHHhccCCCCCeeeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-----------KEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~hpnIv~l  164 (441)
                      .++|.+.++||+|+||.||+|.+..+...  ...+++|..........           .....+...+..+.|+||+++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~--~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCI--NNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCccc--ccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            36899999999999999999998765221  12256665432221110           112234455667799999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++++..........+++||++ ..++.+.+..  ....++..+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            997765544333457888887 4467666654  23467888999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH
Q 013504          245 WNAKLSDFGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ  319 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~  319 (441)
                      +.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999865322111     1123357999999999999999999999999999999999999999765322111


Q ss_pred             -HH--HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          320 -KL--LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       320 -~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                       ..  .++... +..         ...   ....++..+.+++..|+..+|++||++.++++.|
T Consensus       243 ~~~~~~~~~~~-~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAKCDFIKR-LHE---------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhHHHHHHH-hhh---------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             10  111111 000         100   0113457799999999999999999999999876

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-39  Score=306.70  Aligned_cols=266  Identities=22%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|+..+.||.|+||.||+|.+..++.     .|+||.+......  ....+.+|+.++++++||||+++++++.+.+.  
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC-----EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc--
Confidence            48888999999999999999876654     3899988654322  23567899999999999999999999876553  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+. ++|.+++.......+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++
T Consensus        74 --~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          74 --LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             --EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence              499999995 6899998765567889999999999999999999988   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhcc---
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHLT---  330 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~~---  330 (441)
                      .......  .......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... ...........   
T Consensus       148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence            7543321  1123345788999999887644 588899999999999999999999754432211 11111100000   


Q ss_pred             ----cccchhhhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 ----DAKKFTMILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ----~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          ........+.....   ......++..+.+++.+||+.||.+||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                00000000000000   0001134567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.6e-39  Score=304.17  Aligned_cols=254  Identities=30%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|+..+.||.|+||.||++.+..++..     +++|.+..... ....++.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~-----~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   72 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKI-----MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG---   72 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcE-----EEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC---
Confidence            3678888999999999999998766543     89998876543 33467889999999999999999999988764   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                       ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.++|+|||.
T Consensus        73 -~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          73 -DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             -EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence             4599999999999999997642 678999999999999999999998 6   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..........     
T Consensus       148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-----  217 (265)
T cd06605         148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-----  217 (265)
T ss_pred             chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-----
Confidence            87543221    1126789999999999999999999999999999999999999965421111 0111111100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ...........++..+.++|.+||..+|++||++.+++.
T Consensus       218 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         218 -----NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -----cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                 000000111126678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-38  Score=302.07  Aligned_cols=248  Identities=28%  Similarity=0.435  Sum_probs=199.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      -|+..+.||+|+||.||+|.+..++.     .+|+|.+..... .....+.+|+.++..++||||+++++++....    
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCc-----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC----
Confidence            47778889999999999998766554     499998765432 23456888999999999999999999998765    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            35999999999999999864   4689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........   +..    .    
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~----~----  216 (277)
T cd06641         150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---IPK----N----  216 (277)
T ss_pred             ecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---Hhc----C----
Confidence            654321  122345788999999999888889999999999999999999999965432211111   100    0    


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                            ........++..+.+++.+||+.+|.+||++.+++..
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0011223456778899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-39  Score=314.81  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ....|++.+.||+||-+.||++...+...      +|+|++....  .+...-|..|+..|.+| .|.+|++|++|-..+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~i------yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQI------YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcc------hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            34679999999999999999998655443      6776665432  23456789999999999 699999999998876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    .+|+||||= ..+|..+|.++......| .+..+..|++.++.++|+.   ||||.||||.|+|+-. |.+||+|
T Consensus       433 ~----~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLID  502 (677)
T KOG0596|consen  433 G----YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLID  502 (677)
T ss_pred             c----eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeee
Confidence            5    469999975 679999998765444444 8889999999999999998   9999999999999975 4899999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-----------LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      ||+|.....+.........+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....     
T Consensus       503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----  577 (677)
T KOG0596|consen  503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----  577 (677)
T ss_pred             echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----
Confidence            99999888877777778899999999999886433           45789999999999999999999964221     


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHH-HHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLA-QKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .+          .++..+.+|...-.++.--. .++.++++.||..||.+||+..++|+
T Consensus       578 ~~----------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 QI----------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HH----------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11          12333444433222222111 12899999999999999999999987

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=321.92  Aligned_cols=277  Identities=28%  Similarity=0.404  Sum_probs=208.0

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--CC
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--RG  175 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~  175 (441)
                      |...+.||+|+||.||+|+++.++..     ||||.++.... ...+.+.+|+++|++++|||||+++++-.+...  ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~-----vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRL-----VAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccc-----hhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            44556799999999999999888875     99999987553 334678899999999999999999887655441  12


Q ss_pred             eeEEEEEeccCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--CCCc--EEEe
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--EQWN--AKLS  250 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--~~~~--~kl~  250 (441)
                      ...++|||||.||+|...|.+- +...+++.+.+.++.++..||.|||++   +|+||||||.||++-  .+|+  .||+
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence            2458999999999999999743 356899999999999999999999998   999999999999993  3343  7999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh-
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH-  328 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~-  328 (441)
                      |||.|+......   ...+++||+.|++||++.. +.|+..+|.|||||++|+++||..||..........-+.|.... 
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk  243 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK  243 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence            999999876543   5677999999999999984 88999999999999999999999999654332211111111110 


Q ss_pred             cccc----------cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC--CHHHHHHHHHHHHhh
Q 013504          329 LTDA----------KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP--KMSEVVEVLNKIVDA  386 (441)
Q Consensus       329 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~  386 (441)
                      .++.          +.+.....-.............+...+..+|.-+|++|.  ...+....+.++++.
T Consensus       244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            0110          000000000112223334455677788889999999999  888888888887753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-38  Score=304.81  Aligned_cols=267  Identities=22%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +++|.+.+.||+|+||.||+|....++..     |++|.+....... ...+.+|+.+++.++|+||+++++++...+  
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~-----~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--   76 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQL-----VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE--   76 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcE-----EEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--
Confidence            46899999999999999999998766553     9999987543322 245678999999999999999999987655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||+
T Consensus        77 --~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          77 --TLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             --eEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence              3599999995 6887777543 35678888999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  331 (441)
                      ++......  .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........-...|.......  
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         150 ARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             ccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence            87543321  112334678999999998754 5788999999999999999999999755432211111010000000  


Q ss_pred             -------ccchh-hhcCCCCCCcch-----HHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 -------AKKFT-MILDPKLEGKYS-----IKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 -------~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ..... ............     ...+..+.+++.+|+..||++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                   00000 000000000000     012457889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-38  Score=303.93  Aligned_cols=252  Identities=29%  Similarity=0.423  Sum_probs=193.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHH-hccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNV-LGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++..     ||+|.+..... .....+..|+.+ ++.++||||+++++++..... 
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTI-----MAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD-   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcE-----EEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-
Confidence            4788999999999999999998876654     99998875432 233456667765 556799999999999986653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                         .++||||++ |+|.+++...  ....+++..++.++.||+.||.|||++  .+++||||||+|||++.++.+||+||
T Consensus        75 ---~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          75 ---VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             ---EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence               499999995 6888887642  235789999999999999999999974  27999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      |+++......   ......|+..|+|||++.+    ..++.++|+|||||++|+|++|..||...... ...+...... 
T Consensus       149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-  223 (283)
T cd06617         149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVEE-  223 (283)
T ss_pred             cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHhc-
Confidence            9998653221   1233568899999998865    45688999999999999999999999643211 1111111100 


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ..+.+   ....++..+.+++.+||..+|.+||++.+++.
T Consensus       224 ----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 ----------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ----------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      00011   11235678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-38  Score=297.76  Aligned_cols=253  Identities=31%  Similarity=0.471  Sum_probs=200.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|.+.+.||+|+||.||+|....++.     .+++|.+......  ..+.+.+|+.+++.++|+||+++++++...+   
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---   72 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE-----LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE---   72 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc-----EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC---
Confidence            47888999999999999999876554     3999998766543  4577889999999999999999999987655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++|+||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.+||+|||++
T Consensus        73 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          73 -KVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             -EEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence             35999999999999999976  35688999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcce--eeceecccCcCCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          256 RLGPSDGLSHV--STAVVGTIGYAAPEYIQTGR---LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       256 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ...........  .....+++.|+|||++.+..   ++.++||||||+++++|++|..||........  .......  .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~--~  222 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGA--G  222 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhc--C
Confidence            87543322111  12356889999999998766   88999999999999999999999965432111  1111100  0


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ..+.+.  ....++..+.+++.+||+.+|.+||++.+++.
T Consensus       223 --------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 --------HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --------CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    001111  11134677889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=314.96  Aligned_cols=277  Identities=23%  Similarity=0.307  Sum_probs=202.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      +++|++.+.||+|+||.||+|.+..++.     .||+|.+..... .....+.+|+.+++.++||||+++++++..... 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGV-----KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCC-----eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            4689999999999999999999877654     399999864322 234567889999999999999999998765442 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .....|+||||++ ++|.+.+..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          79 SFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             ccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence            1224689999995 588887754   5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLS-HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +++........ .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.................. ..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~~  230 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PS  230 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CC
Confidence            98865332211 11233578999999998654 56889999999999999999999999654322211111000000 00


Q ss_pred             ccchhhhcCC-----------CCCCc---chHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH--HHHHHh
Q 013504          332 AKKFTMILDP-----------KLEGK---YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV--LNKIVD  385 (441)
Q Consensus       332 ~~~~~~~~~~-----------~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  385 (441)
                      ......+.+.           .....   .....+..+.+++.+||+.+|++||++.++++.  ++....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0000000000           00000   011245678999999999999999999999984  665543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-38  Score=304.73  Aligned_cols=268  Identities=24%  Similarity=0.337  Sum_probs=199.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||.|+||.||+|.+..++.     .+++|.+......  ....+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGE-----IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCc-----EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence            578888999999999999999876654     3899988654322  123567899999999999999999998766322


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+||||++ ++|.+++... ...+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.++|+|||+
T Consensus        80 --~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          80 --KIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             --cEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence              4699999996 5999988754 24689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhh-----
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRP-----  327 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~-----  327 (441)
                      +.......  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+ .....     
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         153 AREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            98654432  122335678899999988764 4688999999999999999999999755433222111 10000     


Q ss_pred             --h---cccc--cchhhhcCCCCCCcchHH-HHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 --H---LTDA--KKFTMILDPKLEGKYSIK-LAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 --~---~~~~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        .   +...  ..........+...++.. +++.+.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0   0000  000000001111112222 4677899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-38  Score=305.57  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=198.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-----hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-----GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      +|...+.||+|+||.||+|.+..++.     .|++|.+......     ....+..|+.+++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR-----IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc-----EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence            47788899999999999999876654     4999998765432     2345678999999999999999999998754


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++   +|+|+||||+|||++.++.++|+||
T Consensus        76 ----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 ----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             ----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence                459999999 999999997642 4799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhcc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLT  330 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~  330 (441)
                      |+++.......  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||............ ........
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  224 (298)
T cd07841         147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE  224 (298)
T ss_pred             eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence            99986544321  1223456889999998855 45788999999999999999998888654432221111 11000000


Q ss_pred             cc----cchhhhcCCCCC-----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DA----KKFTMILDPKLE-----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~----~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..    ............     .......+..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00    000000000000     0011234678899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.3e-38  Score=293.45  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=203.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +|...+.||+|++|.||++.+..++.     .+++|++..........+.+|+.+++.++||||+++++++....    .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGK-----EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----E   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCc-----EEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----e
Confidence            47788899999999999999876544     39999987765545678889999999999999999999988765    3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++++||+++++|.+++.... ..+++..+..++.|++.||.|||..   +++||||+|+||++++++.++|+|||.+..
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            599999999999999987642 5789999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      ......   .....|+..|+|||.+.+..++.++||||||+++++|++|..||.............   ..     ..  
T Consensus       148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~-----~~--  214 (253)
T cd05122         148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TN-----GP--  214 (253)
T ss_pred             cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hc-----CC--
Confidence            554321   345678999999999988889999999999999999999999997543222111111   00     00  


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         +.+  .....++..+.+++.+||..||++||++.++++
T Consensus       215 ---~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 ---PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ---CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               000  011123577999999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.5e-39  Score=301.45  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +|++.+.||.|+||.||+|.+..++.     .+++|.+.....   ...+.+.+|+.++++++||||+++++++.+..  
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK-----MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc-----EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence            48889999999999999999876554     399999875432   23567889999999999999999999887655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||+
T Consensus        74 --~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          74 --NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             --eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence              459999999999999999763  5889999999999999999999988   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.................       
T Consensus       147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  216 (258)
T cd05578         147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-------  216 (258)
T ss_pred             ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-------
Confidence            88654432   22345788999999999888899999999999999999999999976554322222211110       


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH--HHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM--SEVV  377 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  377 (441)
                              .....+...+..+.+++.+||..||.+||++  ++++
T Consensus       217 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                    0112233456889999999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=348.53  Aligned_cols=264  Identities=28%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ...|....+||+|+||.||+|.+..++.     .||||.+......    ...|+.++++++|||||+++++|.+.+.. 
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~-  758 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGM-----QFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGA-  758 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCc-----EEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCC-
Confidence            4567788899999999999999866554     4999988654321    13568899999999999999999876643 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         |+||||+++|+|.+++.     .++|..+..++.|++.||.|||..+..+|+||||||+||+++.++.+++. ||..
T Consensus       759 ---~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        759 ---YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             ---EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence               99999999999999995     38899999999999999999996555699999999999999999888875 6665


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .....      .....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.+..... ...
T Consensus       830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~  901 (968)
T PLN00113        830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHL  901 (968)
T ss_pred             ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cch
Confidence            53321      1224689999999999999999999999999999999999999954322 122344444433222 223


Q ss_pred             hhhcCCCCCC--cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          336 TMILDPKLEG--KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       336 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ...+++.+..  ........++.+++.+||+.+|++||+|.+|++.|+++...
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            3445555433  23345566788999999999999999999999999998754

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-38  Score=299.00  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=200.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||+|....++..     +++|.+.....  ...+.+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~-----~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~---   72 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEH-----CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG---   72 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCce-----EEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC---
Confidence            478889999999999999998776554     89998865422  23456789999999999999999999987665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-EEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-~kl~DFGl  254 (441)
                       ..++|+||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++. ++|+|||.
T Consensus        73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          73 -RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence             359999999999999999765555689999999999999999999998   9999999999999988864 69999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......  .......|++.|+|||++.+..++.++|+||||+++++|++|..||........  .......       
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-------  217 (257)
T cd08225         149 ARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQG-------  217 (257)
T ss_pred             chhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHhcc-------
Confidence            88654322  122335689999999999888899999999999999999999999965432111  1111100       


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .+ ......++..+.+++.+||..+|++||++.+++.
T Consensus       218 -------~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 -------YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -------cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                   00 0111234567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-38  Score=311.59  Aligned_cols=272  Identities=21%  Similarity=0.282  Sum_probs=204.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..+|++.+.||.|+||.||+|....++.     .|++|.+.....  .....+.+|+.+|+.++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGK-----KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            3689999999999999999999887665     399998875432  234567789999999999999999998876554


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .....++||||+. ++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            4456799999995 689999865  35699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc--ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLS--HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ++.........  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            99764332211  11234578999999998765 4688999999999999999999999976543322211111000000


Q ss_pred             c-------ccchhh---hcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 D-------AKKFTM---ILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~-------~~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .       ......   ........   ......+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0       000000   00000000   011235678999999999999999999999988

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.2e-38  Score=301.48  Aligned_cols=253  Identities=30%  Similarity=0.474  Sum_probs=204.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++.|+....||.|+||.||+|.+..++.     .+++|++..... ....+.+|+.+++.++|+||+++++++....  
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   88 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGK-----EVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD--   88 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCc-----EEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--
Confidence            45678888999999999999999875543     489999876543 4567889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||+
T Consensus        89 --~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          89 --ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             --EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence              4599999999999999998742 4799999999999999999999997   999999999999999999999999998


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......  .......+++.|+|||++.+..++.++|||||||++|+|++|..||....+......  ......     
T Consensus       163 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~--~~~~~~-----  233 (286)
T cd06614         163 AAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--ITTKGI-----  233 (286)
T ss_pred             hhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcCC-----
Confidence            87543321  122345688999999999888899999999999999999999999975443221111  110000     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +.  ......++..+.+++.+||+.+|.+||++.+++.
T Consensus       234 ------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 ------PP--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ------CC--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  00  0111235678999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=297.47  Aligned_cols=253  Identities=24%  Similarity=0.385  Sum_probs=199.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc-----CchhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-----GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .+|.+.+.||+|+||.||+|.+..++.     .+++|.+...     .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGR-----ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCC-----EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            478999999999999999999876654     4899987432     122345788999999999999999999998664


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      ...  ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus        77 ~~~--~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          77 EEK--KLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CCC--EEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            432  45899999999999999975  35688999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++....... ........|+..|+|||++.+..++.++|||||||++++|++|+.||.......  ...+..     
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-----  222 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIA-----  222 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHH-----
Confidence            999986432111 111234568999999999988889999999999999999999999996542211  111111     


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               ........+..+++.+.+++.+||. +|..||++.+++.
T Consensus       223 ---------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 ---------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                     0111122344567889999999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=336.63  Aligned_cols=256  Identities=26%  Similarity=0.376  Sum_probs=208.8

Q ss_pred             HHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeE
Q 013504           91 ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGY  167 (441)
Q Consensus        91 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~  167 (441)
                      +++...++|.++++||+|+||.|..++++.++..     ||+|++++-.   ......|..|-.||..-+.+-|++++-.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~V-----YAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA  143 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKV-----YAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA  143 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccc-----hhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence            4555668999999999999999999999998875     9999998732   2334568889999999999999999888


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      |++..    ++|+||||++||+|...+...  ..+|+..+.+++..|+.||.-||+-   |+|||||||+|||||..|.+
T Consensus       144 FQD~~----~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  144 FQDER----YLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             hcCcc----ceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence            88776    459999999999999999764  3899999999999999999999987   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccc----c-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ----T-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      ||+|||.|-....++ ...+...+|||.|++||+++    + +.|+..+|+||+||++|||+.|..||-...-      +
T Consensus       215 kLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------v  287 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------V  287 (1317)
T ss_pred             eeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------H
Confidence            999999998776555 33566789999999999985    2 5789999999999999999999999953322      2


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcch--HHHHHHHHHHHHHhhcccCCCCCC---HHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYS--IKLAQKLAAVANKCLARQAKGRPK---MSEVVE  378 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  378 (441)
                      .....          +++-.-.-.+|  .+++....+||.+.++ +|+.|..   ++++-.
T Consensus       288 eTY~K----------Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  288 ETYGK----------IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHHH----------HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            11111          11111111122  3477889999999887 6888888   777766

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.6e-38  Score=303.69  Aligned_cols=247  Identities=31%  Similarity=0.447  Sum_probs=196.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +.|...+.||+|+||.||+|....++.     .|++|.+.....   .....+.+|+.+++.++||||+++++++...+.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCc-----EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence            568888999999999999999876554     499998864432   223568899999999999999999999987653


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        90 ----~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 ----AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             ----EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence                499999996 6777777543 35789999999999999999999988   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ++......      ....|++.|+|||++.   ...++.++||||||+++|||++|..||..............      
T Consensus       161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------  228 (307)
T cd06607         161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------  228 (307)
T ss_pred             cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc------
Confidence            98764322      2357889999999874   45688899999999999999999999965432221111100      


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                       ..      .+   ......++..+.+++.+||..+|++||++.+|+..
T Consensus       229 -~~------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 -ND------SP---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -CC------CC---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00      00   01122466789999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=346.82  Aligned_cols=254  Identities=29%  Similarity=0.383  Sum_probs=205.4

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .+-+|+....||.|.||.||-|+...+++.     .|+|.+.....  ...+.+.+|..+|..++|||+|++||+-..++
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGel-----lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGEL-----LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccch-----hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence            446788889999999999999999998886     67777654332  23456779999999999999999999988877


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      ..    +|.||||++|+|.+.+..  +...++.....+..|++.|+.|||+.   |||||||||+||||+.+|.+|++||
T Consensus      1308 kv----~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KV----YIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             HH----HHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence            65    889999999999999976  56778888888999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCC--CcceeeceecccCcCCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          253 GLARLGPSDG--LSHVSTAVVGTIGYAAPEYIQTG---RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       253 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |.|.......  .........||+.|||||++.+.   ....+.|||||||+++||+||+.||...... .+-+.     
T Consensus      1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy----- 1452 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMY----- 1452 (1509)
T ss_pred             cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHh-----
Confidence            9998765432  11223467899999999999764   3566899999999999999999999643321 00000     


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .+...-.+..|..++.+-.+++.+||..||+.|.++.++++
T Consensus      1453 ----------~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 ----------HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ----------HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                      01111233455668889999999999999999988887765

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.1e-38  Score=308.12  Aligned_cols=275  Identities=25%  Similarity=0.365  Sum_probs=202.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc--CchhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR--GLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .+++|.+...  .......+.+|+.+++++ +||||+++++++...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKE-----VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCe-----EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            45789999999999999999999876554     3899987542  223345677899999999 999999999998764


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +..  ..++||||++ ++|..++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~--~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          80 NDK--DIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             CCc--eEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            432  4699999996 599998865   2788999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCc---ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          252 FGLARLGPSDGLS---HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       252 FGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+++........   .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999865433211   12334678999999998755 4578899999999999999999999965443322111111100


Q ss_pred             hcccc-------cchhhhcC----CCC--CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH--HHHH
Q 013504          328 HLTDA-------KKFTMILD----PKL--EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV--LNKI  383 (441)
Q Consensus       328 ~~~~~-------~~~~~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  383 (441)
                      .....       .....+++    ...  .......++..+.+++.+||+.+|++||++.++++.  +...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            00000       00000000    000  001111256789999999999999999999999983  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.8e-39  Score=335.99  Aligned_cols=260  Identities=24%  Similarity=0.379  Sum_probs=195.4

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ....+|+..++||+||||.||+++++-++..     ||||++.... ......+.+|+.+|++|+|||||+++..+.+..
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~-----YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGRE-----YAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchh-----hhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            4567899999999999999999998876654     9999998764 223467889999999999999999987665432


Q ss_pred             --------------------------------------------------------------------------------
Q 013504          173 --------------------------------------------------------------------------------  172 (441)
Q Consensus       173 --------------------------------------------------------------------------------  172 (441)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------cCC--------eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 013504          173 ---------------------------ERG--------IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG  217 (441)
Q Consensus       173 ---------------------------~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~  217 (441)
                                                 ...        ..+||-||||+..+|.+++..+... -.....++++++|++|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHH
Confidence                                       000        2457889999988888777653211 1467889999999999


Q ss_pred             HHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC----C------------CCCcceeeceecccCcCCccc
Q 013504          218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP----S------------DGLSHVSTAVVGTIGYAAPEY  281 (441)
Q Consensus       218 L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~  281 (441)
                      |.|+|++   |||||||||.||+|++++.|||+|||+|....    .            .......+..+||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999998   99999999999999999999999999998621    0            001113456899999999999


Q ss_pred             cccCC---CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHH
Q 013504          282 IQTGR---LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV  358 (441)
Q Consensus       282 ~~~~~---~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  358 (441)
                      +.+..   |+.|+|+||||||++||+.   ||....  +....+..++....+          .. ..+..+..+.-..+
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR~g~iP----------~~-~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLRKGSIP----------EP-ADFFDPEHPEEASL  850 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcccCCCC----------CC-cccccccchHHHHH
Confidence            97654   9999999999999999984   575332  222222222211110          00 11222233456689


Q ss_pred             HHHhhcccCCCCCCHHHHHH
Q 013504          359 ANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       359 i~~cl~~dP~~RPs~~evl~  378 (441)
                      |++|++.||.+|||+.++|.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.5e-38  Score=300.42  Aligned_cols=242  Identities=27%  Similarity=0.405  Sum_probs=186.6

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhc---cCCCCCeeeEEeEEeccccCCee
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLG---VVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +||+|+||.||++....++.     .+|+|.+......   ....+.+|..++.   ..+||||+.+++++...+.    
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~----   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK----   71 (279)
T ss_pred             CcccCCCeEEEEEEECCCCc-----EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence            48999999999999876554     4899988654321   1223344544433   3479999999999887653    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus        72 ~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            4999999999999999875  35799999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      .....    .....||+.|+|||.+.. ..++.++|||||||++|+|++|..||................          
T Consensus       147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------  212 (279)
T cd05633         147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------  212 (279)
T ss_pred             ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------
Confidence            43221    223578999999998864 568899999999999999999999996543322211111100          


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                           ......+..++..+.+++.+||..||.+||     +++++++
T Consensus       213 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 -----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                 001122344667899999999999999999     5888877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=300.59  Aligned_cols=248  Identities=29%  Similarity=0.448  Sum_probs=197.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCC---CCCeeeEEeEEecccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVE---HPNLVKLIGYCAEDDE  173 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~  173 (441)
                      .|+..+.||+|+||.||+|.+..++.     .+++|.+..... .....+.+|+.+++.++   ||||+++++++.... 
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGR-----VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCc-----EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-
Confidence            47778899999999999999876654     499998865432 33456788999999986   999999999987654 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||
T Consensus        76 ---~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          76 ---RLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             ---EEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence               45999999999999999865   3789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++.......  .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||.........   .....    .
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~----~  217 (277)
T cd06917         147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIPK----S  217 (277)
T ss_pred             ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hcccc----C
Confidence            998654432  122345789999999988654 4688999999999999999999999754322111   11000    0


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ..+.+..   ..++..+.+++.+||..||++||++.+++.
T Consensus       218 ------~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 ------KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ------CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                  0011111   125567899999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-38  Score=299.55  Aligned_cols=266  Identities=22%  Similarity=0.360  Sum_probs=198.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +|+..+.||.|++|.||+|.+..++.     .||||.+...... ....+.+|+.+++.++||||+++++++...+.   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK---   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCe-----EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc---
Confidence            58889999999999999999876654     4999988754332 24567789999999999999999999987653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       .++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++
T Consensus        73 -~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          73 -LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             -EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence             4999999975 8988886532 24689999999999999999999988   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhh-----
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPH-----  328 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~-----  328 (441)
                      +......  .......+|..|++||++.+. .++.++|||||||++|+|++|..||.......... ........     
T Consensus       148 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            7543321  112335678999999988664 56889999999999999999999997554322211 11111000     


Q ss_pred             --cccccchhhhcCCCC---CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 --LTDAKKFTMILDPKL---EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 --~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        +.....+........   ........+..+.+++.+||+.||.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              000000000000000   00111234678899999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-38  Score=310.26  Aligned_cols=278  Identities=23%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+....  ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNE-----KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCC-----eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            4579999999999999999999876654     39999886532  2234567789999999999999999998865432


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                       .....|+||||+. ++|.+++..  ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence             1124699999995 789998865  46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |+++......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....................
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9998654332  12334578999999998765 46889999999999999999999999654322211111100000000


Q ss_pred             -------ccchhhh---c----CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH--HHHHHhhh
Q 013504          332 -------AKKFTMI---L----DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV--LNKIVDAA  387 (441)
Q Consensus       332 -------~~~~~~~---~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~  387 (441)
                             .......   .    ++... .....+++.+.+++.+||+.+|++||+++++++.  +..+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence                   0000000   0    00000 1112456788999999999999999999999984  76665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=304.84  Aligned_cols=254  Identities=29%  Similarity=0.426  Sum_probs=193.7

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  175 (441)
                      +|...+.||+|+||.||++.+..++.     .+|+|.+..... .....+.+|+.++.++. ||||+++++++.....  
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~--   77 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGT-----IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD--   77 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCC-----EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc--
Confidence            45566789999999999999877654     399999875432 23456789999999995 9999999999876553  


Q ss_pred             eeEEEEEeccCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          176 IQRLLIYEYMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                        .+++|||+. ++|.++.   .......+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.++|+||
T Consensus        78 --~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          78 --CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             --EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeec
Confidence              489999985 4555543   333346799999999999999999999963  28999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG---RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |+++......   ......|++.|+|||++.+.   .++.++|||||||++|+|++|+.||..... ..........   
T Consensus       153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~---  225 (288)
T cd06616         153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVK---  225 (288)
T ss_pred             chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcC---
Confidence            9987543321   12334689999999998776   688999999999999999999999964431 1111111000   


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       .       ..+.+.......++..+.+++.+||..+|++||++.+|+.
T Consensus       226 -~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         226 -G-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -C-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0       0011111222346778999999999999999999999988

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-38  Score=300.55  Aligned_cols=245  Identities=28%  Similarity=0.438  Sum_probs=193.2

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||+|+||+||+|....++..     +++|.+.....   .....+..|+.+|+.++||||+++++++...+    ..|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~-----~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKM-----YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcE-----EEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEE
Confidence            69999999999988766543     89998865332   22345678999999999999999999987665    35999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            9999999999999765445799999999999999999999998   9999999999999999999999999998764331


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                         .......++..|+|||++.+..++.++|||||||++++|++|+.||...........+...  ...           
T Consensus       149 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-----------  212 (277)
T cd05577         149 ---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLE-----------  212 (277)
T ss_pred             ---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--ccc-----------
Confidence               1223456788999999998888999999999999999999999999654432111111100  000           


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                       .....+..+++.+.+++.+||+.+|.+||     ++.+++.
T Consensus       213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence             01112234567889999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-39  Score=315.26  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=208.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ...|.+...||+|.|+.|.+|++..++..     ||||.+.+.....  ...+.+|+++|..++|||||+++.+......
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~-----VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTE-----VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCce-----EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            45789999999999999999999887654     9999998765433  3457899999999999999999999987764


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          +|+||||+.+|.+++++..  .+...+..+..++.|+..+++|||++   .|+|||||.+||||+.+.++||+|||
T Consensus       130 ----lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  130 ----LYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             ----eEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence                5999999999999999987  46677789999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++.++...   ....+.+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-..               
T Consensus       201 fS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------  262 (596)
T KOG0586|consen  201 FSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------  262 (596)
T ss_pred             cceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------
Confidence            99987643   35677899999999999999887 478999999999999999999998643221               


Q ss_pred             cchhhhcCCCCCCcchH--HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSI--KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           +.++.+.+.+..  -.+.+..++|+++|-.+|.+|++++++.+
T Consensus       263 -----Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  263 -----LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -----ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                 122222222222  24457889999999999999999999988

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-38  Score=298.50  Aligned_cols=263  Identities=23%  Similarity=0.289  Sum_probs=193.3

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~  176 (441)
                      |++.+.||+|+||.||+|....++..     +|+|.+...... ......+|+.++.++. ||||+++++++.+....  
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~-----~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~--   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKY-----YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG--   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcE-----EEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC--
Confidence            66788999999999999998766543     899988754221 2234457889998884 99999999999876222  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||++ ++|.+++..+ ...+++..++.++.|++.||.|||+.   +++||||||+||+++. +.+||+|||+++
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          74 RLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             cEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            4599999996 5888888653 35789999999999999999999998   9999999999999999 999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc----
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD----  331 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----  331 (441)
                      ......   ......++..|+|||++.. ..++.++|||||||++|||++|..||......+..............    
T Consensus       148 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         148 GIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             ccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            654322   1223568899999997654 55788999999999999999999999765432221111100000000    


Q ss_pred             ----ccchhhhcCCCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ----AKKFTMILDPKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          .... ....+....    .....++..+.+++.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         225 KFRKSRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             hhcccccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                0000 000000000    011245788999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=300.82  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=197.0

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |++.+.||.|++|.||+|.+..++.     .|++|++.....  .....+.+|+.+++.++||||+++++++.+.+    
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~----   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN----   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC-----EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----
Confidence            6677899999999999999876554     489998865432  22356788999999999999999999987664    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||++ ++|.+++.......+++..++.++.|++.||.|||++   +++||||+|+||+++.++.++|+|||+++
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            4599999994 6999999765445789999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhc-----
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHL-----  329 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~-----  329 (441)
                      .......  ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......... ..........     
T Consensus       148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            5433211  12234568899999987664 5788999999999999999999999765432211 1111110000     


Q ss_pred             --ccccchhhhcC---CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 --TDAKKFTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 --~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        .....+.....   ..........++..+.+++.+||+.+|.+||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00000000000   00001112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.3e-38  Score=300.63  Aligned_cols=269  Identities=20%  Similarity=0.278  Sum_probs=197.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .||+|.+......  ....+.+|+.+++.+ +||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   75 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK-----LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK   75 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc-----EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence            468899999999999999999877654     3899987654322  235678899999999 46999999999876554


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEE
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRF---QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAK  248 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~k  248 (441)
                       .....|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||++   +|+||||||+||+++. ++.+|
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence             22235899999975 8988886432   34689999999999999999999998   9999999999999998 88999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVR  326 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~  326 (441)
                      |+|||+++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999885433211  1223467889999998765 457899999999999999999999997544322211 111110


Q ss_pred             hhcccccchhhhc-------CCCCC----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDAKKFTMIL-------DPKLE----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  .....+....       .+...    ....+.++..+.++|.+||..||.+||++.+++.
T Consensus       230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 T--PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             C--CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  0000000000       00000    0011235677899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.2e-38  Score=302.57  Aligned_cols=273  Identities=22%  Similarity=0.329  Sum_probs=199.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|....++.     .||||.+......  ....+.+|+.++++++||||+++++++.....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCc-----EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            4579999999999999999999877654     4999988643322  22345689999999999999999999876542


Q ss_pred             C----CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          174 R----GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       174 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      .    ....++||||+. ++|.+++... ...+++..++.++.||+.||.|||++   +++|+||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence            1    234699999995 5888888653 34789999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCc--ceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          250 SDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       250 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      +|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+..+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999865432211  112335678899999988664 47889999999999999999999997665443333333222


Q ss_pred             hhcccc-----cc---hhhhc-CCCCCCcchH-----HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDA-----KK---FTMIL-DPKLEGKYSI-----KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~-----~~---~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ......     ..   ..... ..........     .....+.++|.+||..||.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            111100     00   00000 0000000000     12346779999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8e-38  Score=294.71  Aligned_cols=243  Identities=26%  Similarity=0.407  Sum_probs=194.9

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||.|+||.||+|.+..++.     .+++|.+......   ..+.+.+|+.+++.++||||+++++++.+...    .++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNR-----TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY----IYML   71 (262)
T ss_pred             CCCCCceEEEEEEECCCCc-----EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc----cEEE
Confidence            6999999999999876544     4999998754332   34568899999999999999999999876654    4999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          72 MEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             EecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999999999763  5689999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      .   ......|++.|++||.+.+..++.++|+||||+++|+|++|..||....... ........             ..
T Consensus       147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-------------~~  209 (262)
T cd05572         147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDIL-------------KG  209 (262)
T ss_pred             c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHh-------------cc
Confidence            2   2234578999999999988889999999999999999999999997554211 11111110             00


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                      .....++...+..+.+++.+||+.+|++||+     +.++++
T Consensus       210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            0111222334678999999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.8e-38  Score=293.33  Aligned_cols=254  Identities=28%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|...+.||+|++|.||+|....++.     .|++|++.....  .....+.+|+.++++++||||+++++.+....  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE-----LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--K   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--C
Confidence            47788899999999999999876554     399998876543  34567889999999999999999999998763  1


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                      ...++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            2459999999999999999764  4899999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ................++..|+|||.+.+..++.++||||||+++++|++|..||......  .......          
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~----------  216 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKI----------  216 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhc----------
Confidence            8765443211133467899999999998888999999999999999999999999765411  1111100          


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .........+...+..+.+++.+||..+|++||++.+++.
T Consensus       217 ---~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         217 ---GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               0011112233345788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=303.12  Aligned_cols=272  Identities=22%  Similarity=0.324  Sum_probs=196.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +|.+.+.||+|+||.||+|.....+   ....||+|.+....   ......+.+|+.++..++||||+++++++......
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~---~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGK---DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCC---CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            4788889999999999999987620   12349999988733   23345677899999999999999999999876322


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC----CCcE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR---FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNA  247 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~----~~~~  247 (441)
                        ..++||||+++ +|.+++...   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.    ++.+
T Consensus        78 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          78 --SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             --eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence              46999999964 777766432   123789999999999999999999998   9999999999999999    9999


Q ss_pred             EEeecCCCCCCCCCCC-cceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-------
Q 013504          248 KLSDFGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-------  318 (441)
Q Consensus       248 kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-------  318 (441)
                      ||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++++|++|..||........       
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9999999986543322 112234578999999998766 4578999999999999999999999975543220       


Q ss_pred             HHH---HHhhhh-------hcccccchhhh---c-CCCCC-Cc----chH--HHHHHHHHHHHHhhcccCCCCCCHHHHH
Q 013504          319 QKL---LEWVRP-------HLTDAKKFTMI---L-DPKLE-GK----YSI--KLAQKLAAVANKCLARQAKGRPKMSEVV  377 (441)
Q Consensus       319 ~~~---~~~~~~-------~~~~~~~~~~~---~-~~~~~-~~----~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl  377 (441)
                      ..+   +..+..       ...........   . ..... ..    ...  ..+..+.+++.+||+.||++||++.+++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            000   000000       00000000000   0 00000 00    000  2345788999999999999999999998


Q ss_pred             H
Q 013504          378 E  378 (441)
Q Consensus       378 ~  378 (441)
                      .
T Consensus       312 ~  312 (316)
T cd07842         312 E  312 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.9e-38  Score=301.44  Aligned_cols=267  Identities=24%  Similarity=0.332  Sum_probs=197.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|++|.||+|.+..++.     .|++|.+.....  .....+.+|+.+++.++||||+++++++....  
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCc-----EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--
Confidence            478899999999999999999876654     399998865432  22356788999999999999999999998665  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEEeecC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFG  253 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFG  253 (441)
                        ..++||||++ ++|.+++.......+++..+..++.||+.||.|||++   +|+||||+|+||+++. ++.+||+|||
T Consensus        75 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         75 --RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             --eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence              4599999995 5888888665445578889999999999999999998   9999999999999985 5679999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~  331 (441)
                      ++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ...........
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            997543321  11233567899999998866 457889999999999999999999997654322211 11110000000


Q ss_pred             -------ccchhhhcC---CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 -------AKKFTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 -------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .........   +..........++.+.+++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000000000   00000011234567899999999999999999999997

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=301.18  Aligned_cols=242  Identities=27%  Similarity=0.457  Sum_probs=204.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      .+|..+.+||+|+||.|.+|..+++.+.     +|||++++.....   .+--+.|-++|... +-|.+++++.+|+..+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdEL-----yAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDEL-----YAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchh-----hhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            5788899999999999999999988876     9999998765432   23345788888887 6789999999998887


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    +|+||||+.||+|.-++++  -+.+.+..+..++.+|+.||-+||++   |||+||||.+||||+.+|.+||+||
T Consensus       424 R----LyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  424 R----LYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             h----eeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence            5    4999999999999999987  46888999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++.....+  ....+++|||.|+|||++...+|+..+|+|||||+||||+.|++||++....   .+.+.+       
T Consensus       495 GmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI-------  562 (683)
T KOG0696|consen  495 GMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAI-------  562 (683)
T ss_pred             ccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-------
Confidence            9999755443  3456799999999999999999999999999999999999999999875433   222222       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK  372 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  372 (441)
                            .+.  ...++..++.+..+++...|.+.|.+|..
T Consensus       563 ------~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 ------MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------HHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  111  12456678889999999999999999954

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.9e-38  Score=303.16  Aligned_cols=269  Identities=26%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||+|.+......  ....+.+|+.++++++|+||+++++++.....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEI-----VALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL   80 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcE-----EEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence            46899999999999999999998776553     899988644322  12345689999999999999999999876542


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .  ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~--~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          81 D--SIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             C--eEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            2  4599999996 5888888653 36789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~  331 (441)
                      ++........  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+ .........
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES  231 (309)
T ss_pred             eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            9986543221  1223356888999998865 45789999999999999999999999765443322211 111000000


Q ss_pred             c-------cchhhh-cC-CCCC--CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 A-------KKFTMI-LD-PKLE--GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~-------~~~~~~-~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .       ...... .. ....  .......++.+.++|.+||+.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0       000000 00 0000  0000124667889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.8e-38  Score=301.44  Aligned_cols=244  Identities=27%  Similarity=0.421  Sum_probs=196.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      ..||+|+||.||++....++.     .|++|++..........+.+|+.+++.++||||+++++++...+    ..++||
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~   96 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVVM   96 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCe-----EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEEEE
Confidence            469999999999999876655     39999886554445567889999999999999999999998765    359999


Q ss_pred             eccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 013504          183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG  262 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  262 (441)
                      ||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            99999999998754   4689999999999999999999998   99999999999999999999999999987543321


Q ss_pred             CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCC
Q 013504          263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK  342 (441)
Q Consensus       263 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (441)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............   .....          +.
T Consensus       171 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~~~~----------~~  235 (292)
T cd06657         171 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLP----------PK  235 (292)
T ss_pred             --ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhhCC----------cc
Confidence              1223457899999999998888999999999999999999999999754332221111   11110          11


Q ss_pred             CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       343 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +.  ....++..+.+++.+||..+|.+||++.+++.
T Consensus       236 ~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            10  01134567889999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.5e-38  Score=292.76  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=204.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|.+.+.||+|+||.||++.+..++.     .+++|.+.....  .....+.+|+++++.++|||++++++.+....   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~---   72 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGK-----LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG---   72 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCc-----EEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC---
Confidence            57888999999999999999876544     499999876543  34567889999999999999999999987764   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                       ..++||||+++++|.+++....  ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          73 -KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             -EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence             4599999999999999997643  47899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++.......  .......|++.|+|||.+.+..++.++||||||+++++|++|..||.......   .......      
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~------  217 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKILK------  217 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHHhc------
Confidence            998654432  23344678999999999988889999999999999999999999996543221   1111100      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .. ....+..++..+.+++.+||..+|++||++.++++
T Consensus       218 -------~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 -------GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   00 01122245677899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-37  Score=302.37  Aligned_cols=250  Identities=30%  Similarity=0.441  Sum_probs=197.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .|...+.||+|+||.||+|.+..++.     .+|+|.+.....   .....+.+|+.+++.++|||++++++++..... 
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNE-----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT-   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCc-----EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-
Confidence            47778889999999999999876654     399998865432   223568889999999999999999999987653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||++ |+|.+.+... ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||+
T Consensus       100 ---~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635         100 ---AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             ---EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence               499999996 5787777543 45789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +.....      .....|++.|+|||++.   .+.++.++|||||||++|+|++|..||..........  .+....   
T Consensus       172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~~---  240 (317)
T cd06635         172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNE---  240 (317)
T ss_pred             ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhcc---
Confidence            875432      22357889999999874   4568899999999999999999999986543221111  111000   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                 ........++..+.+++.+||+.+|.+||++.++++.+...
T Consensus       241 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         241 -----------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             -----------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence                       00111224566789999999999999999999999865543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-37  Score=303.56  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             eeecc--cceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          104 MIGEG--GFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       104 ~LG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      .||+|  +||+||++.+..++..     ||+|.+.....  ...+.+.+|+.+++.++||||++++++|...+.    .+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----~~   75 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTL-----VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW----LW   75 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcE-----EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc----eE
Confidence            46666  9999999998766554     99999875432  234667889999999999999999999987653    49


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++++|||.+....
T Consensus        76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence            999999999999999875556789999999999999999999988   99999999999999999999999998654322


Q ss_pred             CCCCcc-----eeeceecccCcCCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc-c
Q 013504          260 SDGLSH-----VSTAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT-D  331 (441)
Q Consensus       260 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~  331 (441)
                      ......     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  .......... .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~  230 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSP  230 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCC
Confidence            111000     01112356679999998763  478899999999999999999999975432211  1111100000 0


Q ss_pred             --------c-----------------cc-----hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--H
Q 013504          332 --------A-----------------KK-----FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--V  379 (441)
Q Consensus       332 --------~-----------------~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~  379 (441)
                              .                 ..     ........+.......++..+.+|+.+||+.||++|||+.++++  +
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                    0                 00     00011111222233457788999999999999999999999987  5


Q ss_pred             HHHHHh
Q 013504          380 LNKIVD  385 (441)
Q Consensus       380 L~~~~~  385 (441)
                      +..+.+
T Consensus       311 ~~~~~~  316 (328)
T cd08226         311 FKQVKE  316 (328)
T ss_pred             HHHHHH
Confidence            555544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=290.39  Aligned_cols=248  Identities=31%  Similarity=0.485  Sum_probs=202.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|++|.||+|.....+.     .+++|.+.....  .....+.+|++++++++|||++++++++....   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD-----FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD---   72 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc-----EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Confidence            47888999999999999999876654     399999877654  34567889999999999999999999987654   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        73 -~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          73 -SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             -EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence             359999999999999999763  6799999999999999999999988   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........  ......++..|+|||.+.+..++.++|||+||+++++|++|..||........  ..... .        
T Consensus       147 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~~-~--------  213 (254)
T cd06627         147 TKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRIV-Q--------  213 (254)
T ss_pred             eecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHh-c--------
Confidence            86544321  12345789999999999888889999999999999999999999965432111  11100 0        


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ......+...+..+.+++.+||..+|++||++.+++.
T Consensus       214 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 ------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                  0011122345678899999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=293.05  Aligned_cols=244  Identities=27%  Similarity=0.351  Sum_probs=188.9

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHh-ccCCCCCeeeEEeEEeccccCCeeE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.||.|+||.||+|....++.     .||+|.+.......   ...+..|..++ ...+||||+++++++...+    ..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCC-----eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eE
Confidence            468999999999999876654     39999987543221   23344555544 4458999999999998665    35


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |+||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++..
T Consensus        73 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          73 YLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            999999999999999976  35789999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       259 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ..      .....|+..|++||.+.+..++.++||||||+++|+|++|..||................            
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------  209 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------  209 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------
Confidence            32      233568899999999988888999999999999999999999996544322111111000            


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                        ..........++..+.+++.+||..+|++||++.++.+.|
T Consensus       210 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         210 --INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             --cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence              0001111224567899999999999999999876555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-37  Score=292.14  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=193.1

Q ss_pred             HHHHHHhcCCccccee--ecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEe
Q 013504           90 SELKTATKNFSRSLMI--GEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIG  166 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~L--G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  166 (441)
                      .+.....++|.+.+.+  |+|+||.||++....++..     +++|.+.......     .|+.+...+ +||||+++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~-----~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKL-----FVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcE-----EEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEE
Confidence            3445556778887777  9999999999998776543     8888876543221     123222222 7999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-  245 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-  245 (441)
                      ++...+    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++ 
T Consensus        77 ~~~~~~----~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         77 SVTTLK----GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             EEecCC----eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCC
Confidence            998766    359999999999999999763  4899999999999999999999998   999999999999999988 


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .++|+|||+++.....      ....|+..|+|||++.+..++.++||||||+++|+|++|..||........ ....+.
T Consensus       148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~  220 (267)
T PHA03390        148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLL  220 (267)
T ss_pred             eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHH
Confidence            9999999998764322      234689999999999988999999999999999999999999974432211 111111


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-HHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  378 (441)
                      ...           ...  ......++..+.+++.+||+.+|.+||+ ++++++
T Consensus       221 ~~~-----------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 KRQ-----------QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             Hhh-----------ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            100           000  0112246678999999999999999996 588874

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-37  Score=298.38  Aligned_cols=273  Identities=25%  Similarity=0.334  Sum_probs=201.2

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|++.+.||+|+||.||+|.+..++.     .|++|.+.....  .....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGE-----LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCc-----EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            456789999999999999999999876654     389998865432  2234567899999999999999999998765


Q ss_pred             cc------CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          172 DE------RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       172 ~~------~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      ..      .....++||||+++ +|...+... ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~  153 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            41      11246999999975 777777653 35789999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      .+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++++|++|+.||...........+..
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999986543321 11223456888999998765 3578899999999999999999999976544333222222


Q ss_pred             hhhhcccccchhhh--------cCCCC--C---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMI--------LDPKL--E---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~--------~~~~~--~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....... ..+..+        .++..  .   ......++..+.+++.+||..+|.+||++.+++.
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCP-AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCCh-hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1100000 000000        00000  0   0001124678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-37  Score=291.60  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=201.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|++.+.||+|+||.||++....++.     .+++|.+.....  .....+.+|+.+++.++||||+++++++....   
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ-----FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN---   72 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC-----EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC---
Confidence            47888999999999999998876654     389998875432  23456778999999999999999999987764   


Q ss_pred             eeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                       ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          73 -KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             -EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence             459999999999999998652  235689999999999999999999988   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....    ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........   ...      
T Consensus       149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~------  215 (256)
T cd08530         149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---VQR------  215 (256)
T ss_pred             chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhc------
Confidence            99876543    12235688999999999998899999999999999999999999975543211111   100      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ......+..++.++.+++.+||..+|++||++.++++
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    0011222356778999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=297.20  Aligned_cols=267  Identities=25%  Similarity=0.346  Sum_probs=198.3

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |++.+.||.|+||.||+|....++.     .+++|.+....  ......+.+|+.+++.++|||++++++++....  ..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCe-----EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CC
Confidence            6678899999999999999877654     49999988653  223456788999999999999999999998762  12


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.   +++|+||||+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          74 SIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            4599999997 4898888654 25789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc---
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA---  332 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---  332 (441)
                      ....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..........   
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence            6544321 11233467889999998765 457899999999999999999999997655332222111110000000   


Q ss_pred             --cch--hhhc------CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 --KKF--TMIL------DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 --~~~--~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        ...  ....      ...+...+...++..+.+++.+||..+|.+||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              000  0000      000000011113678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=294.06  Aligned_cols=242  Identities=26%  Similarity=0.394  Sum_probs=186.9

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHH---HhccCCCCCeeeEEeEEeccccCCee
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVN---VLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~---il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +||+|+||.||+|.+..++.     .||+|.+.......   ...+..|..   +++...||||+.+++++...+    .
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----K   71 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC-----EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----E
Confidence            48999999999998876554     39999887643221   122334433   444568999999999988765    3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||++||+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            5999999999999998865  46799999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ....    ......|+..|+|||++.++ .++.++||||+||++|+|++|..||................          
T Consensus       147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------  212 (278)
T cd05606         147 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------  212 (278)
T ss_pred             cCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh----------
Confidence            4322    12345789999999998754 68999999999999999999999997553222211111000          


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                       ...    ...+..++..+.+++.+||..+|.+||     ++.++++
T Consensus       213 -~~~----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 -TMA----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -ccC----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             001    112223467899999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=303.64  Aligned_cols=278  Identities=26%  Similarity=0.327  Sum_probs=207.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc-cC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD-ER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~  174 (441)
                      +|.+.+.||.|+||.||+|....++.     .+++|.+....  ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGR-----KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCc-----EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence            47888999999999999999876554     39999887643  233467889999999999999999999987765 12


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                      ....|+||||++ ++|.+++..  ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          76 FNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             ccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            224699999996 589998865  34899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCC-cceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh-hhhhccc
Q 013504          255 ARLGPSDGL-SHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW-VRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~  331 (441)
                      +........ ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.. .......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            986544321 0112345689999999999887 789999999999999999999999976553322211110 0000000


Q ss_pred             ------ccchhhh---cCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHhh
Q 013504          332 ------AKKFTMI---LDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVDA  386 (441)
Q Consensus       332 ------~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~  386 (441)
                            .......   ......   .......+..+.+++.+||+.+|.+||++.+++.  +++.+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                  0000000   000000   0011225678899999999999999999999998  57766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-37  Score=300.12  Aligned_cols=273  Identities=25%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     +++|.+......  ....+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-----~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRV-----VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD   81 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcE-----EEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence            47899999999999999999998776553     899987654322  12456789999999999999999998765442


Q ss_pred             C----CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          174 R----GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       174 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      .    ....++||||+. ++|...+... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||+++++.++|
T Consensus        82 ~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          82 KSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             cccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            2    234689999995 4777777543 45799999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCc---------ceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHH
Q 013504          250 SDFGLARLGPSDGLS---------HVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ  319 (441)
Q Consensus       250 ~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~  319 (441)
                      +|||+++........         .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999864332211         112345778999999987654 5789999999999999999999999765443322


Q ss_pred             HHHHhhhhhccc-c----cchhh----hcCCCCCCcch---HHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          320 KLLEWVRPHLTD-A----KKFTM----ILDPKLEGKYS---IKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       320 ~~~~~~~~~~~~-~----~~~~~----~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..+........+ .    .....    ...........   ......+.+++.+||..+|.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            221111000000 0    00000    00000000000   123367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.1e-38  Score=294.28  Aligned_cols=247  Identities=27%  Similarity=0.427  Sum_probs=194.8

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||.|+||.||++++..++.     .+++|.+.....   .....+.+|+.++++++||||+++++.+....    ..|+|
T Consensus         1 lg~g~~~~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECCCCC-----EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEE
Confidence            6899999999999876654     399999876543   23456888999999999999999998887654    45999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          72 MEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999999999763  4789999999999999999999998   9999999999999999999999999998864433


Q ss_pred             CC------cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          262 GL------SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       262 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ..      ........++..|++||.+....++.++||||||+++|+|++|..||.........   .....        
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~--------  215 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---QNILN--------  215 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc--------
Confidence            21      11233457888999999998888999999999999999999999999755432211   11100        


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                           ...........+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus       216 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 -----GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -----CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                 00000001113678899999999999999999966555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=296.97  Aligned_cols=268  Identities=28%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc--CCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  171 (441)
                      ....+....+.||+|.||+||+|.|++..       ||||++..++   ...+.+|.+|...  |+|+||+.+++.-..+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~-------VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWRGED-------VAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccccCCc-------eEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            45567888899999999999999999865       9999998765   3456677777665  6999999999887666


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecccCCCcEEEcCCCc
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG-----MDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ...-.+++||++|.+.|+|+|||..   ..++....++++..++.||++||..     .++.|.|||||..|||+..++.
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            6666788999999999999999986   6899999999999999999999963     4678999999999999999999


Q ss_pred             EEEeecCCCCCCCCC--CCcceeeceecccCcCCccccccCC----C--CccccchhHHHHHHHHHhC----------CC
Q 013504          247 AKLSDFGLARLGPSD--GLSHVSTAVVGTIGYAAPEYIQTGR----L--TYKSDIWSFGVFLYELITG----------RR  308 (441)
Q Consensus       247 ~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlG~il~elltG----------~~  308 (441)
                      +.|+|+|||......  ......+..+||.+|||||++...-    +  -..+||||||+++||+...          +.
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999999999765433  2233445689999999999986532    1  2358999999999999862          24


Q ss_pred             CCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcc-----hHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY-----SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       309 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ||.+..+.+...           ......+...++++..     ..+....+.++++.||..+|.-|.|+=.|-+.|.++
T Consensus       435 Pyyd~Vp~DPs~-----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  435 PYYDVVPSDPSF-----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CcccCCCCCCCH-----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            664332221110           0000001111111111     124566789999999999999999999999999888


Q ss_pred             Hh
Q 013504          384 VD  385 (441)
Q Consensus       384 ~~  385 (441)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            74

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=299.64  Aligned_cols=277  Identities=26%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc--CCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .....++||+|+||.||+|.+.+.       .||||++....   ...|..|-+|.+.  ++|+||++++++-...+...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~-------~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNR-------LVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCc-------eeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            345566799999999999998763       39999997643   4567777777665  58999999998876655445


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEecccCCCcEEEcCCCcEEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM------DFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ...+||+||.+.|+|.+||+.   ..++|....+|+..+++||+|||+..      +++|+|||||..||||..++.+.|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            567999999999999999986   58999999999999999999999743      568999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHH
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LT-----YKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLL  322 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~  322 (441)
                      +|||+|..+.........-..+||.+|||||++.+.- +.     .+.||||+|.+||||++...-++.....+.+ -..
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999999876554444445589999999999997642 22     3589999999999999976544311110000 000


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchH-----HHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSI-----KLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ..+..+..-......++..+.+..++.     ....-+.+.+..||..||+.|.|+.=+.+.+.++....
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            000000000001111111222222222     23456889999999999999999999999988886544

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=304.08  Aligned_cols=272  Identities=25%  Similarity=0.342  Sum_probs=200.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.....||+|+||.||+|++..++.     .||+|.+.....  .....+.+|+.+++.++||||+++++++.....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGE-----KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCc-----EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            4789999999999999999999876654     399998865322  223567889999999999999999999875432


Q ss_pred             C--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 R--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .  ....++||||+. .+|..++    +..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          89 GDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             CCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence            1  124589999995 4777665    24689999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh--
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH--  328 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~--  328 (441)
                      ||+++.....     .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......  
T Consensus       161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (342)
T cd07879         161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  235 (342)
T ss_pred             CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999864322     233577899999999876 46889999999999999999999999765432221111111000  


Q ss_pred             ------cccc--cchhhhcCCCCCCcc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          329 ------LTDA--KKFTMILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       329 ------~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                            ..+.  ...............   ....+..+.+++.+||+.||.+||++.+++.  +++...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                  0000  000000000000000   1124567889999999999999999999995  5777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=295.21  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=199.4

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |.+.+.||.|++|.||+|....++.     .+++|.+......  ....+.+|+.++++++||||+++++++...+    
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGE-----IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG----   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCc-----EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC----
Confidence            5677889999999999999865554     3899988765433  3456788999999999999999999987664    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++ +|.+++..+ ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            35999999965 888888764 35789999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhcccc-c
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDA-K  333 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~-~  333 (441)
                      ......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ .......... .
T Consensus       147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence            654432  122335688899999998776 7899999999999999999999999665433221111 1100000000 0


Q ss_pred             chhh-------hc---CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTM-------IL---DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....       ..   +..........++..+.+++.+||..||.+||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000       00   000001122356788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=291.70  Aligned_cols=268  Identities=24%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC---CCCCeeeEEeEEecccc
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV---EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~  173 (441)
                      |++.+.||+|+||.||+|.+..++.     .+|+|.+......  ....+.+|+.++.++   +||||+++++++...+.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   75 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGR-----FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT   75 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCC-----EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence            6678899999999999999876543     4999998743322  123456788777665   69999999999987654


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                       .....+++|||++ ++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        76 ~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          76 DRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence             2223689999996 5899988765445699999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~  331 (441)
                      |++.......   ......++..|+|||++.+..++.++|||||||++|+|++|..||.......... ...........
T Consensus       152 g~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         152 GLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             CcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence            9998654332   1223457889999999999899999999999999999999999997544322211 11111000000


Q ss_pred             ccch-----hhhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKF-----TMILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....     .........   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000     000000000   1112245677889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.5e-37  Score=300.12  Aligned_cols=272  Identities=21%  Similarity=0.241  Sum_probs=195.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      +|.+.+.||+|+||.||++.......   ...||+|.+.....  ...+.+.+|+.+++++ +||||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSE---EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCc---CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            47888999999999999999876511   22499998864321  2245678899999999 599999999876543222


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                      ....+++|||+. ++|.+++..  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            234588899985 689999865  46789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc--ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhh--
Q 013504          255 ARLGPSDGLS--HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPH--  328 (441)
Q Consensus       255 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~--  328 (441)
                      ++........  .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ........  
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11234578999999998765 468999999999999999999999997544221111 11100000  


Q ss_pred             -----ccc--ccchhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 -----LTD--AKKFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 -----~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           +..  ..............   ......+..+.+++.+||+.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 000  00000000000000   011123567899999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-37  Score=300.16  Aligned_cols=269  Identities=22%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             HHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           91 ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        91 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      ++..++++|++.+.||.|+||.||+|....++..     ||+|.+.....  ...+.+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   78 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQN-----VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF   78 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCE-----EEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence            3445678999999999999999999998776654     99998764322  2345677899999999999999999998


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                      .....   ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||+|+|||++.++.++
T Consensus        79 ~~~~~---~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          79 ISPLE---DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             ecCCC---cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence            65432   358999999 6789888864   4688888999999999999999998   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH-hhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE-WVR  326 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~-~~~  326 (441)
                      |+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+. ...
T Consensus       149 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         149 ICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             eCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998754321     233567889999998765 568999999999999999999999997554322211111 100


Q ss_pred             hh-------cccccchhhhcCCCCCCcch-----HHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          327 PH-------LTDAKKFTMILDPKLEGKYS-----IKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       327 ~~-------~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..       ...................+     ..++..+.+++.+||+.+|++||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00       00000000000000000111     1245789999999999999999999998773

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-37  Score=305.93  Aligned_cols=274  Identities=19%  Similarity=0.297  Sum_probs=200.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC-
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG-  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~-  175 (441)
                      .+|.+.+.||.|+||.||+|....++..     |++|.+........+.+.+|+.+++.++||||+++++++....... 
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~-----v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKR-----VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcE-----EEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            6799999999999999999998776553     9999987766555677889999999999999999998776543211 


Q ss_pred             ---------eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCC
Q 013504          176 ---------IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQW  245 (441)
Q Consensus       176 ---------~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~  245 (441)
                               ...++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||+++ +++
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                     14589999996 589888854   4689999999999999999999988   999999999999997 456


Q ss_pred             cEEEeecCCCCCCCCCCCc-ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          246 NAKLSDFGLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      .++|+|||+++........ .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.............
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999999764322111 11123467889999997654 567889999999999999999999997654433222111


Q ss_pred             hhhhhccc--ccchh----h-h----cCCCCC-CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          324 WVRPHLTD--AKKFT----M-I----LDPKLE-GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       324 ~~~~~~~~--~~~~~----~-~----~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                      ...+....  .....    . .    ..+... .......+..+.+++.+||..||.+||++.+++.  +++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            11000000  00000    0 0    000000 0011134567889999999999999999999996  4543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5e-37  Score=297.19  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=191.2

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeE
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      +++.+|.|+++.||++  ..++.     .||||++....  ......+.+|+.+++.++||||+++++++...+.    .
T Consensus         6 i~~~~~~~~~v~~~~~--~~~~~-----~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~   74 (314)
T cd08216           6 IGKCFEDLMIVHLAKH--KPTNT-----LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----L   74 (314)
T ss_pred             hhHhhcCCceEEEEEe--cCCCC-----EEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----E
Confidence            3334455555544444  44333     49999987642  2345678899999999999999999999887653    4


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      +++|||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        75 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          75 YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceee
Confidence            9999999999999999876566789999999999999999999998   9999999999999999999999999988754


Q ss_pred             CCCCC-----cceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc-
Q 013504          259 PSDGL-----SHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT-  330 (441)
Q Consensus       259 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~-  330 (441)
                      .....     ........++..|+|||++..  ..++.++|||||||++|||++|..||........  ..+....... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  229 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPC  229 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcc
Confidence            32211     111234567889999999876  3588999999999999999999999975432211  1111110000 


Q ss_pred             --ccc-------chhh----hcC----CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 --DAK-------KFTM----ILD----PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 --~~~-------~~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        ...       ....    ..+    ..........++..+.+++.+||..||++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence              000       0000    000    00112233356678999999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-37  Score=301.03  Aligned_cols=275  Identities=24%  Similarity=0.319  Sum_probs=202.3

Q ss_pred             chHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEE
Q 013504           88 TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLI  165 (441)
Q Consensus        88 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  165 (441)
                      ...++...+++|.+.+.||+|+||.||+|....++.     .||+|++.....  ...+.+.+|+.++++++||||++++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~   82 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL-----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   82 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCe-----EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence            344566778999999999999999999998766554     499998875322  2245677899999999999999999


Q ss_pred             eEEeccccC--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          166 GYCAEDDER--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       166 ~~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                      +++......  ....|++++++ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~  155 (345)
T cd07877          83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence            988654321  12357888887 8899888864   4689999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-  321 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-  321 (441)
                      ++.+||+|||+++.....     .....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... 
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998864321     234578999999998766 5688899999999999999999999965433221111 


Q ss_pred             HHhhh-------hhccccc--chhhhcCCCCCCcc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          322 LEWVR-------PHLTDAK--KFTMILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       322 ~~~~~-------~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .....       ..+....  .....+.......+   ....+..+.+++.+||+.||.+||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11100       0000000  00000000000000   01235678899999999999999999999983

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=292.27  Aligned_cols=267  Identities=21%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-C-C----CeeeEEe
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-H-P----NLVKLIG  166 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-p----nIv~l~~  166 (441)
                      ...+++|.+...+|+|+||.|..+.++.++.     .||||+++.-. ...+..+-|+++|.++. + |    -+|.+.+
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~-----~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKE-----HVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCc-----eehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            3457899999999999999999999887744     49999986543 22355677999999993 2 2    4667777


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---  243 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---  243 (441)
                      ||...+..    |||+|.+ |-+++++|..+.-.+++...+..|++|++.++.|||+.   +++|.||||+|||+.+   
T Consensus       159 wFdyrghi----Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  159 WFDYRGHI----CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             hhhccCce----EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccce
Confidence            78766644    9999998 77999999987778999999999999999999999998   9999999999999931   


Q ss_pred             -----------------CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC
Q 013504          244 -----------------QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG  306 (441)
Q Consensus       244 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG  306 (441)
                                       +..++|+|||.|++....     .+..+.|..|.|||++.+-+++..+||||+||||+|++||
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             345999999999875443     3568899999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhHHHHHHhhhhhcccc------------------------cchhhhcCCCCC----CcchHHHHHHHHHH
Q 013504          307 RRPLDRNRPKSEQKLLEWVRPHLTDA------------------------KKFTMILDPKLE----GKYSIKLAQKLAAV  358 (441)
Q Consensus       307 ~~P~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~----~~~~~~~~~~l~~l  358 (441)
                      ..-|+.....+...+.+.+...++..                        .+...+.++...    ..........|.+|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            99998877665554444332221110                        000111111111    01112345579999


Q ss_pred             HHHhhcccCCCCCCHHHHHH
Q 013504          359 ANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       359 i~~cl~~dP~~RPs~~evl~  378 (441)
                      +++||..||.+|+|+.|++.
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-37  Score=295.10  Aligned_cols=250  Identities=26%  Similarity=0.432  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCC-CCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  172 (441)
                      ++|.+.+.||+|+||.||+|....++.     .|++|++.....   .....+.+|+.++++++ ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNK-----EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCC-----EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            478899999999999999999876554     389998865322   23456788999999998 999999999887655


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++..  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        76 ----~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 ----NLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             ----eEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence                35999999999999999976  35799999999999999999999988   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCc------------------ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013504          253 GLARLGPSDGLS------------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR  314 (441)
Q Consensus       253 Gla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~  314 (441)
                      |++.........                  .......|+..|+|||.+....++.++||||||++++++++|..||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            998865432210                  12234568899999999988889999999999999999999999997544


Q ss_pred             chhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH----HHHHH
Q 013504          315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM----SEVVE  378 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  378 (441)
                      ..   ........               .....+..+++.+.+++.+||..+|.+||++    ++++.
T Consensus       227 ~~---~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 EY---LTFQKILK---------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HH---HHHHHHHh---------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            21   11111110               0112223446778999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.3e-37  Score=297.14  Aligned_cols=247  Identities=30%  Similarity=0.433  Sum_probs=194.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +.|...+.||+|+||.||+|....++.     .+++|.+.....   ....++.+|+.+++.++|||++++++++.... 
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCc-----EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-
Confidence            447777889999999999999876554     389998764322   23456788999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        89 ---~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          89 ---TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             ---eeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence               3499999996 6888877543 35689999999999999999999988   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ++.....      .....|++.|+|||.+.   ...++.++|||||||++|+|++|..||..........  ....... 
T Consensus       161 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~-  231 (308)
T cd06634         161 SASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNES-  231 (308)
T ss_pred             cceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhhcCC-
Confidence            9876432      22356889999999874   3567889999999999999999999986543221111  1110000 


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                +   ......++..+.+++.+||..+|++||++.+++..
T Consensus       232 ----------~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ----------P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ----------C---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                      0   01122456778999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=313.59  Aligned_cols=264  Identities=30%  Similarity=0.434  Sum_probs=220.4

Q ss_pred             hHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeE
Q 013504           89 FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGY  167 (441)
Q Consensus        89 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  167 (441)
                      ++.+..-+..|++...||.|.+|.||+++.+.++..     .|+|++.... ....++..|.++|+.. .|||++.++|+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~-----aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQL-----AAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCce-----eeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEE
Confidence            333444567899999999999999999998877654     7788776543 3346677899999987 79999999998


Q ss_pred             Eecccc-CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          168 CAEDDE-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       168 ~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      +.-.+. .+.+++||||||.||+..|.++...+..+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            865433 345789999999999999999887788999999999999999999999998   8999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      |||+|||++..+...  .....+.+|||.|||||++...     .|+..+|+||||++..||--|.+|+.+..+.-.   
T Consensus       162 VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---  236 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---  236 (953)
T ss_pred             EEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---
Confidence            999999999876543  3456778999999999998653     477899999999999999999999976654221   


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                  .+....+|...-..+..+.+++.++|..||.+|-+.||++.++++
T Consensus       237 ------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 ------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                        222334455555667889999999999999999999999999886

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=293.11  Aligned_cols=264  Identities=24%  Similarity=0.324  Sum_probs=196.2

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~  176 (441)
                      |.+.+.||+|+||.||+|....++.     .|+||.+...... ......+|+..+++++ ||||+++++++...+    
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~----   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGE-----LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND----   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCc-----EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----
Confidence            5678899999999999999876654     3899988654321 2234457999999998 999999999987754    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+ +|+|.+++.......+++..+..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++.
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            359999999 88999999765445789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhcc----
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLT----  330 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~~----  330 (441)
                      ......   ......++..|+|||++.. ..++.++|+||||+++++|++|+.||........... .........    
T Consensus       148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         148 EIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            654322   1233568899999998754 4578999999999999999999999965543322111 111100000    


Q ss_pred             ccc----chhhhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAK----KFTMILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +..    .....+.....   .......+..+.+++.+||+.+|++||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000    00000000000   0001112467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.8e-37  Score=300.26  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             cCCcc-cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--------------hHHHHHHHHHhccCCCCCe
Q 013504           97 KNFSR-SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--------------HKEWVTEVNVLGVVEHPNL  161 (441)
Q Consensus        97 ~~f~~-~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~hpnI  161 (441)
                      ++|.. .+.||.|+||.||+|.+..++.     .||||.+.......              ...+.+|+.+++.++||||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGK-----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCC-----eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            45554 4679999999999999876554     49999886543221              1246789999999999999


Q ss_pred             eeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       162 v~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                      +++++++...+.    .++||||++ |+|.+++..  ...+++.....++.|++.||.|||+.   +|+|+||||+||++
T Consensus        83 v~~~~~~~~~~~----~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill  152 (335)
T PTZ00024         83 MGLVDVYVEGDF----INLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI  152 (335)
T ss_pred             eeeeEEEecCCc----EEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence            999999987653    599999996 699999865  35689999999999999999999988   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCC------------CcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCC
Q 013504          242 DEQWNAKLSDFGLARLGPSDG------------LSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRR  308 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~  308 (441)
                      +.++.++|+|||+++......            .........+++.|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999997654111            01112234578899999998764 46889999999999999999999


Q ss_pred             CCCCCCchhHHHHH-Hhhhhhccc----ccchh--hhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          309 PLDRNRPKSEQKLL-EWVRPHLTD----AKKFT--MILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       309 P~~~~~~~~~~~~~-~~~~~~~~~----~~~~~--~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ||...........+ .........    .....  .........   ......+..+.+++.+||+.+|++||++.+++.
T Consensus       233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            99765543222111 111000000    00000  000000000   001123567889999999999999999999997

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-37  Score=300.66  Aligned_cols=273  Identities=25%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|....++.     .||||.+.....  .....+.+|+.+|+.++||||+++++++...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGA-----KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCc-----EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            356789999999999999999999876654     399998864322  2235678999999999999999999998765


Q ss_pred             ccCC--eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          172 DERG--IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       172 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ....  ...++||||+ +++|.+++..   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            4321  2358999999 7899888864   5789999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRP  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~  327 (441)
                      +|||++......     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .......
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07880         160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT  234 (343)
T ss_pred             eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999864332     223567899999998876 458889999999999999999999997544321111 1110000


Q ss_pred             -------hccc--ccchhhhcCCCCC----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          328 -------HLTD--AKKFTMILDPKLE----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       328 -------~~~~--~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                             .+..  .......+ +...    ......++..+.+++.+||+.||++||++.+++.  +++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                   0000  00000000 0000    0011234567889999999999999999999995  555543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-36  Score=294.20  Aligned_cols=245  Identities=31%  Similarity=0.446  Sum_probs=192.8

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      |...+.||+|+||.||+|+...++.     .|++|.+.....   .....+.+|+.+++.++|||++++++++.+...  
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   95 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNE-----VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT--   95 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCc-----EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE--
Confidence            5666779999999999999866654     389998865432   223567889999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+. |+|.+++... ...+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++
T Consensus        96 --~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          96 --AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             --EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence              499999995 5788877643 35789999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      .....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||..............  ..    
T Consensus       169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--~~----  236 (313)
T cd06633         169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--ND----  236 (313)
T ss_pred             cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cC----
Confidence            64322      23457899999999974   45688899999999999999999999965433221111100  00    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                ........++..+.+++.+||+.+|.+||++.+++..
T Consensus       237 ----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 ----------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0001112345678899999999999999999999963

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-37  Score=292.55  Aligned_cols=258  Identities=26%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      +|++.+.||+|+||.||++.......  ....||||.+.....    .....+.+|+.++.++ +||||+++++.+....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD--AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc--CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            47888999999999999998654321  234599998865322    2235677899999999 6999999999887655


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        79 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          79 ----KLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             ----EEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence                35899999999999999875  35789999999999999999999988   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCchh-HHHHHHhhhhhc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR--LTYKSDIWSFGVFLYELITGRRPLDRNRPKS-EQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltG~~P~~~~~~~~-~~~~~~~~~~~~  329 (441)
                      |+++....... .......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||....... ..........  
T Consensus       150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--  226 (288)
T cd05583         150 GLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--  226 (288)
T ss_pred             ccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--
Confidence            99886543321 1223456899999999987655  7889999999999999999999996432211 1111111100  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                               ..    ...+..++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       227 ---------~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 ---------SK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---------cC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                     00    11223355678999999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-37  Score=294.32  Aligned_cols=253  Identities=29%  Similarity=0.477  Sum_probs=192.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||.+...... ....+..|+.++.++ .||||+++++++.+... 
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGH-----VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD-   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCe-----EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe-
Confidence            678889999999999999999876554     4999998754332 335566788777666 59999999999987653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.  .+|+||||+|+||+++.++.+||+|||+
T Consensus        89 ---~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          89 ---VFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             ---EEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence               599999984 5777776543 35889999999999999999999973  2899999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR----LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +.......   ......++..|+|||++.+..    ++.++||||||+++|+|++|+.||......  .......   ..
T Consensus       162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---~~  233 (296)
T cd06618         162 SGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI---LQ  233 (296)
T ss_pred             chhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH---hc
Confidence            87643321   122345788999999987554    788999999999999999999999643211  1111111   00


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ...       +..  .....++..+.+++.+||..||.+||++.+++..
T Consensus       234 ~~~-------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         234 EEP-------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCC-------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000       000  0011345678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7e-37  Score=287.95  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=192.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccc---cCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR---RGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      +|.+.+.||+|+||.||++.+......     +++|.++.   ...  .....+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAE-----ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCc-----ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            478889999999999999988765432     44444332   111  12345667999999999999999999987665


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .    .++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||||+||+++. +.++|+
T Consensus        76 ~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          76 A----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             c----eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeec
Confidence            3    4899999999999998864  2245789999999999999999999998   9999999999999975 569999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++......  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   .......   
T Consensus       148 d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~---  219 (260)
T cd08222         148 DFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRIVE---  219 (260)
T ss_pred             ccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHc---
Confidence            999987654322  12234568899999999988889999999999999999999999996433211   1111100   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 ......+..++..+.+++.+||..+|++||++.++++
T Consensus       220 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 -----------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                       0011123456678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=312.46  Aligned_cols=261  Identities=28%  Similarity=0.452  Sum_probs=220.6

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      ....++||+|+||+||+|.+...++ ..+++||||++..... +...++++|+.+|.+++|||+++|+|+|....     
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege-~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGE-NVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCc-eecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            4445689999999999999987744 4567799999876543 34678999999999999999999999998776     


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..||++|++.|+|.+|++.. ...+-....+.|..||++||.|||.+   .++||||..+|||+..-..+||.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            36899999999999999864 46788899999999999999999988   999999999999999999999999999999


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ...++.........-.+-|||-|.+....|+.++|||||||++||++| |..|+++....+..++++.-           
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-----------  916 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-----------  916 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------
Confidence            877765554555555678999999999999999999999999999999 99999876655444433311           


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                            .+-..++.++.++..++.+||..|+..||+++++...+..+...
T Consensus       917 ------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 ------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                  12234556888999999999999999999999999999887653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=280.65  Aligned_cols=284  Identities=24%  Similarity=0.370  Sum_probs=212.6

Q ss_pred             cchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEE
Q 013504           87 FTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLI  165 (441)
Q Consensus        87 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  165 (441)
                      -.|+++...|.     ++||+|+|+.|--++...++..     +|||++.+.......++.+|++++..+ .|+||+.|+
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~E-----YAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLi  142 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKE-----YAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLI  142 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchh-----hhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHH
Confidence            34667666665     4799999999999988777654     999999988666678899999999998 699999999


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      +||.+++.    +|||||-|.||+|..+|++  ...|++.++..+..+|+.||.|||.+   ||.||||||+|||-.+..
T Consensus       143 efFEdd~~----FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn  213 (463)
T KOG0607|consen  143 EFFEDDTR----FYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPN  213 (463)
T ss_pred             HHhcccce----EEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCC
Confidence            99988774    5999999999999999987  46899999999999999999999998   999999999999997655


Q ss_pred             c---EEEeecCCCCCCCCCC-----CcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 013504          246 N---AKLSDFGLARLGPSDG-----LSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDR  312 (441)
Q Consensus       246 ~---~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~  312 (441)
                      .   +|||||.+..-.....     ......+.+|+..|||||++.     ...|+.++|.||||||+|-||+|.+||.+
T Consensus       214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence            5   7999998865322111     111234578999999999763     24588999999999999999999999975


Q ss_pred             CCchhHHHHHHhhhhhccc---ccchhhhcCCC--CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          313 NRPKSEQKLLEWVRPHLTD---AKKFTMILDPK--LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      .-..+-.    |-+...-.   ...+..+-+..  +...-...++.+..+++..+|..|+.+|.++..++.  +++....
T Consensus       294 ~Cg~dCG----WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  294 HCGADCG----WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             ccCCcCC----ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            4321110    00000000   00111111111  122233467888999999999999999999999988  4544444


Q ss_pred             hhccCCCC
Q 013504          386 AAETGTPQ  393 (441)
Q Consensus       386 ~~~~~~p~  393 (441)
                      ....++|+
T Consensus       370 ekalptp~  377 (463)
T KOG0607|consen  370 EKALPTPQ  377 (463)
T ss_pred             hccCCCCc
Confidence            33333443

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-36  Score=290.47  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=194.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      +|++.+.||.|+||.||++......  .....||+|.+.....    ...+.+.+|+.++..+ +||||+++++++....
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            4788899999999999999875321  1223599999875332    2235677899999999 6999999998887654


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        79 ----~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          79 ----KLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ----eEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence                35899999999999999976  35788999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCchh-HHHHHHhhhhhc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPLDRNRPKS-EQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltG~~P~~~~~~~~-~~~~~~~~~~~~  329 (441)
                      |+++....... .......|+..|+|||.+...  .++.++||||||+++|+|++|..||....... ..........  
T Consensus       150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--  226 (290)
T cd05613         150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  226 (290)
T ss_pred             ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--
Confidence            99986533221 122345789999999998653  46789999999999999999999996432211 1111111100  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                               .    ...++..++..+.+++.+||..+|.+||     ++.+++.
T Consensus       227 ---------~----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 ---------S----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------c----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     0    0112234567789999999999999997     5666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=299.16  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      .++||+|-||+||-|+++.++..     ||||++.+.....  ...+..|+.||..++||.||.+...|...+.    .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrd-----VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----vF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRD-----VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----VF  639 (888)
T ss_pred             HhhccCCcceeeecceecccCce-----eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----EE
Confidence            35899999999999999988875     9999998765433  3568899999999999999999999988775    49


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC---CcEEEeecCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLSDFGLAR  256 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~  256 (441)
                      +|||-+ .|+..+.|-....+.+++.....++.||+.||.|||.+   +|+|+||||+||||...   .++||||||+|+
T Consensus       640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            999999 55666666555578999999999999999999999998   99999999999999644   569999999999


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      +....   ......+|||.|+|||+++...|...-|+||.|||+|--|+|..||......  .+.++...          
T Consensus       716 iIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAa----------  780 (888)
T KOG4236|consen  716 IIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAA----------  780 (888)
T ss_pred             ecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccc----------
Confidence            87654   3456789999999999999999999999999999999999999999644321  11121111          


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ++-|   .....+++....+||..+|+..-++|-+....+.
T Consensus       781 -FMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  781 -FMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -cccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             1111   1223467788999999999999999999888766

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=292.08  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=202.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-ch------hhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQ------GHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      ++|-...+||+|||+.||++.+......     ||||+-.... +.      ..+...+|.+|.+.|.||.||++|+||.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRY-----vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRY-----VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhhe-----eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            5688889999999999999987665544     8888754321 11      1245678999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc---CCCc
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWN  246 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~---~~~~  246 (441)
                      -+...   +|-|+|||+|.+|.-||+.  ...+++.++..|+.||+.||.||... +++|||-||||.||||-   .-|.
T Consensus       538 lDtds---FCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  538 LDTDS---FCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             ecccc---ceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence            76654   5899999999999999977  57899999999999999999999986 78999999999999994   4578


Q ss_pred             EEEeecCCCCCCCCCCCcc-----eeeceecccCcCCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          247 AKLSDFGLARLGPSDGLSH-----VSTAVVGTIGYAAPEYIQTG----RLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      +||+|||+++....+....     ......||.+|++||++.-+    ..+.++||||+|||+|+++.|+.||+.+..  
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--  689 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--  689 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--
Confidence            9999999999876554332     23457899999999987543    468899999999999999999999986543  


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .+++++.- ..+...         .+.-..-+.++.+..++|++||++..++|....++..
T Consensus       690 QQdILqeN-TIlkAt---------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  690 QQDILQEN-TILKAT---------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHHHhhh-chhcce---------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            23333221 111100         0011112245678899999999999999988877765

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=257.39  Aligned_cols=265  Identities=24%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +|...++||+|.||+||+|+.+.+.+.     ||+|.++.....  -....++|+.+|+.++|.|||+++++...+..  
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~ei-----valkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk--   75 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEI-----VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK--   75 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccce-----EEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce--
Confidence            456667899999999999999888775     999998764432  23578899999999999999999999877664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        +-+|+||| ..+|..+.... .+.++.+.+..++.|++.||.|+|+.   ++.||||||+|.||+.||++||+|||++
T Consensus        76 --ltlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   76 --LTLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             --eEEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence              58999999 56888888764 57899999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc-
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA-  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-  332 (441)
                      +...-.  -...+..+-|.+|.+|.++.+.. |+...|+||.|||+.|+.. |++-|.++...+....+-|......+. 
T Consensus       149 rafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  149 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence            965432  22345567899999999998865 7889999999999999987 555566555444444443332222111 


Q ss_pred             -cchhhhcCCCCCCcchH---------HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -KKFTMILDPKLEGKYSI---------KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ..+..+-|-.....++.         .....=.+++.+.|.-+|..|.++++.++
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence             01111111111111111         22234568899999999999999988775

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-37  Score=301.13  Aligned_cols=268  Identities=24%  Similarity=0.318  Sum_probs=200.4

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++..     ||+|.+....  ......+.+|+.+++.++||||+++++++...
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRK-----VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcE-----EEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            3467899999999999999999998776543     9999886532  22335677899999999999999999877654


Q ss_pred             cc--CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          172 DE--RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       172 ~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      +.  .....++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence            43  122368999999 6799999865   5799999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +|||++......     .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999865332     234578899999998865 36788999999999999999999999755432221111100000


Q ss_pred             ccc----------ccchhhhcCCCCCCcc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 LTD----------AKKFTMILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~~~----------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..+          ...+...+.......+   ...++..+.+++.+||..+|++||++.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000          0000000000000001   1123678999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=287.73  Aligned_cols=264  Identities=26%  Similarity=0.355  Sum_probs=198.0

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |+....||+|+||.||+|+...++.     .+++|.+....  ......+..|+.+++.++||||+++++++...+    
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE-----IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER----   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc-----EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----
Confidence            5667789999999999999877654     39999987653  223456778999999999999999999988764    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++   +|+||||+|+||++++++.++|+|||+++
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            3599999997 59999997642 4799999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhh-------
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRP-------  327 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~-------  327 (441)
                      .......  ......++..|+|||.+.+. .++.++|||||||+++||++|..||.......... .......       
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence            6543321  22334567889999998776 78999999999999999999999996654322211 1111000       


Q ss_pred             hcccccchhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...+..............   ......+..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000000000   001123567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-39  Score=283.31  Aligned_cols=265  Identities=28%  Similarity=0.431  Sum_probs=201.4

Q ss_pred             CCccccchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCC
Q 013504           82 SNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHP  159 (441)
Q Consensus        82 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hp  159 (441)
                      ..+..|+-++++...       .||.|+||+|++-.++..+..     +|||+++.... ...++++.|.+...+- +.|
T Consensus        56 ~~~~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~-----mAVKrIr~~n~~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKL-----MAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             ccccccccchHHHHH-------HhcCCcchhhhhhhcCccCcE-----EEEEEeeeccchHHHHHHHHHHHHHHhhcCCc
Confidence            344556655655544       499999999999998877764     99999987665 5567888898876665 899


Q ss_pred             CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 013504          160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS  236 (441)
Q Consensus       160 nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp  236 (441)
                      |||++||.+..++.    +++.||+| ..+|..+.   .......++++..-+|....+.||.||-..  ..||||||||
T Consensus       124 ~IVkfyGa~F~EGd----cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKP  196 (361)
T KOG1006|consen  124 NIVKFYGALFSEGD----CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKP  196 (361)
T ss_pred             HHHHHhhhhhcCCc----eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCCh
Confidence            99999999877664    38999999 44665543   333456899999999999999999999976  5899999999


Q ss_pred             CcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013504          237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNR  314 (441)
Q Consensus       237 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~  314 (441)
                      +||||+..|.+||||||++..+...   ...+.-.|-..|||||.+..  ..|+.++||||||++|||+.||..|+....
T Consensus       197 SNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  197 SNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             hheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence            9999999999999999999765432   22344578889999998854  458999999999999999999999997544


Q ss_pred             chhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..     .+.+......  ....+.    ......+++..+..+|..||.+|..+||.+.++..+
T Consensus       274 sv-----feql~~Vv~g--dpp~l~----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  274 SV-----FEQLCQVVIG--DPPILL----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HH-----HHHHHHHHcC--CCCeec----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            31     1111111111  000111    111223567889999999999999999999998874

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.9e-37  Score=280.27  Aligned_cols=209  Identities=26%  Similarity=0.395  Sum_probs=171.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ...|+.+..||+|+||.||+|+..++... ..+.+|||+++.....  --....+|+.+++.++||||+.|..+|...+.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35799999999999999999987665442 2346999998765321  12456799999999999999999999887532


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC----Cc
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSR---FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ----WN  246 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~----~~  246 (441)
                         ..++++||.+. +|.+.|+..   ....++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.
T Consensus       102 ---~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  102 ---KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ---eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence               46999999954 888888532   235789999999999999999999998   79999999999999776    89


Q ss_pred             EEEeecCCCCCCCCCCCcc-eeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCC
Q 013504          247 AKLSDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDR  312 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~  312 (441)
                      |||+|||+++.....-... ....++-|.+|.|||.+.+. .|+.+.|||+.|||+.||+|-.+-|..
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999999999865543221 34457889999999998875 589999999999999999998887754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.1e-36  Score=318.53  Aligned_cols=146  Identities=27%  Similarity=0.400  Sum_probs=128.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++......   ....+.+|+.++..++||||+++++++.... 
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSK-----LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-
Confidence            679999999999999999999886554     3999998754322   2356788999999999999999998887655 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..||||||+++++|.+++..  ...+++..++.|+.||+.||.|||..   +|+||||||+||||+.++.+||+|||
T Consensus        78 ---~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          78 ---NVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             ---EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence               45999999999999999975  35688999999999999999999998   99999999999999999999999999


Q ss_pred             CCC
Q 013504          254 LAR  256 (441)
Q Consensus       254 la~  256 (441)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=280.62  Aligned_cols=237  Identities=30%  Similarity=0.445  Sum_probs=191.3

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      ||.|+||.||++.....+.     .+++|.+......   ....+..|+.+++.++||||+++++.+....    ..++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGK-----LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECCCCc-----EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEE
Confidence            6999999999999876544     4899988765432   3457888999999999999999999887655    35999


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          72 LEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999999999763  4789999999999999999999997   9999999999999999999999999998865432


Q ss_pred             CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      .  .......++..|++||.+.+...+.++|+||||+++|+|++|..||.....   ......+..   .          
T Consensus       147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~---~----------  208 (250)
T cd05123         147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK---D----------  208 (250)
T ss_pred             C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc---C----------
Confidence            1  123446789999999999888889999999999999999999999965432   111111110   0          


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE  375 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  375 (441)
                        ....+...+..+.+++.+||..||++||++.+
T Consensus       209 --~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 --PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence              01122233677899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=312.25  Aligned_cols=266  Identities=28%  Similarity=0.485  Sum_probs=211.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCc--ccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDS--HKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++..+.+.||+|.||.|++|...+....  .....||||.++..... ..+.+..|+.+|+.+ +||||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            34556666899999999999987654433  23677999999865443 457788999999998 699999999999885


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF------Q--------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      ..    .++|+||+..|+|.++|..+.      .        ..++....+.++.||+.|+.||++.   ++|||||..+
T Consensus       375 ~~----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  375 GP----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             Cc----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            43    499999999999999998653      0        1388899999999999999999998   8999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeecee--cccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV--GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNR  314 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~  314 (441)
                      |||+..+..+||+|||+|+........... ...  -...|||||.+....|+.++|||||||+||||+| |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            999999999999999999965544332211 122  2345999999999999999999999999999999 889997532


Q ss_pred             chhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      .  ...+.++++..              .+...+..+++++.++++.||+.+|++||++.++.+.|+..+.
T Consensus       527 ~--~~~l~~~l~~G--------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 P--TEELLEFLKEG--------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             c--HHHHHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            1  12223333221              1123344578899999999999999999999999999999654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=297.69  Aligned_cols=242  Identities=25%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      +++.|.....+|.|+|+.|-.+.+..+...     .++|++.+...    ...+|+.++... .||||+++.+.+.+...
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~-----~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQE-----PAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccc-----hhheecccccc----ccccccchhhhhcCCCcceeecceecCCce
Confidence            456788888899999999999998877654     89999877622    223577676665 79999999999987654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE-cCCCcEEEeec
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNAKLSDF  252 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl-~~~~~~kl~DF  252 (441)
                          .|+|||++.|+-|.+.+...   +.....+..|+.+|+.++.|||.+   |||||||||+|||+ +..++++|+||
T Consensus       391 ----~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  391 ----IYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             ----eeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence                49999999999998888653   233377788999999999999998   99999999999999 68999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |.++.....     ..+.+-|..|.|||++...+|+.++||||||++||+||+|+.||......  ..+...+       
T Consensus       461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i-------  526 (612)
T KOG0603|consen  461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI-------  526 (612)
T ss_pred             chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh-------
Confidence            999876543     33456789999999999999999999999999999999999999754433  1111111       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                ..+.+...++...++|+.+||+.||.+||++.++...
T Consensus       527 ----------~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  527 ----------QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ----------cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                      1123335678899999999999999999999999873

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-37  Score=273.61  Aligned_cols=273  Identities=22%  Similarity=0.360  Sum_probs=203.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..|+...+||+|.||+||+|....++..     ||+|++...+..  .....++|+.+|..++|+|++.++..|......
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kk-----valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKK-----VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccch-----hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            4566677899999999999998887754     777765443221  224567999999999999999999988765443


Q ss_pred             Ce----eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 GI----QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      ..    .+|+||.+|+ .+|.-.|..+ ...++...+.+++.++..||.|+|..   .|+|||+||+|+||+.+|.+||+
T Consensus        92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             cccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence            33    3799999995 4888888654 46789999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCC--CcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          251 DFGLARLGPSDG--LSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       251 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |||+++......  .....+..+-|.+|.+||.+.+ ..|+++.|||+.|||+.||+||.+-++++.......++..+..
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999998654322  1222455677999999998876 5699999999999999999999999987766555444433221


Q ss_pred             hc--------ccccchhhhc-CCCCCCcchH--H------HHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          328 HL--------TDAKKFTMIL-DPKLEGKYSI--K------LAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       328 ~~--------~~~~~~~~~~-~~~~~~~~~~--~------~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..        .+...+..+- .|...+.+..  +      -.++..+|+..++..||.+|+.+.+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            11        1111111111 1111111110  1      12367799999999999999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=295.11  Aligned_cols=243  Identities=23%  Similarity=0.354  Sum_probs=203.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .+++.+..||-||||.|=++.......     .+|+|.+++....+   .+.+..|-.||..++.|.||++|..|.+...
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~-----~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKA-----TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccch-----HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            456677789999999999988766543     27888888766543   3457789999999999999999998887664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .|++||-|-||.|+..|..  .+.|+..++..++..+++|+.|||++   +||+|||||+|.||+.+|.+||.|||
T Consensus       495 ----vYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  495 ----VYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             ----hhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence                4999999999999999977  47899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+.....   ..+.+++|||.|.|||++.+...+.++|.||||+++||||+|.+||...++.....++-   ..+.   
T Consensus       566 FAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---kGid---  636 (732)
T KOG0614|consen  566 FAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---KGID---  636 (732)
T ss_pred             hHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---hhhh---
Confidence            99987654   35788999999999999999999999999999999999999999998766543332221   1110   


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK  372 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  372 (441)
                                ...+|..++....+|+++++..+|.+|..
T Consensus       637 ----------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ----------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                      11234456677889999999999999976

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-35  Score=275.86  Aligned_cols=222  Identities=21%  Similarity=0.248  Sum_probs=176.8

Q ss_pred             ccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCC
Q 013504          108 GGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN  187 (441)
Q Consensus       108 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~  187 (441)
                      |.||.||++.+..++..     +|+|.+....     ...+|...+....||||+++++++...+    ..++||||+++
T Consensus         4 g~~~~v~~~~~~~~~~~-----~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTRTQQT-----FILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEccCCcE-----EEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCC
Confidence            89999999998877654     9999987643     2234555555567999999999988765    35999999999


Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCccee
Q 013504          188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS  267 (441)
Q Consensus       188 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  267 (441)
                      |+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||.+......     .
T Consensus        70 ~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~  139 (237)
T cd05576          70 GKLWSHISKF--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C  139 (237)
T ss_pred             CCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence            9999999763  4689999999999999999999998   9999999999999999999999999987654332     2


Q ss_pred             eceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcc
Q 013504          268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY  347 (441)
Q Consensus       268 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (441)
                      ....++..|+|||.+.+..++.++||||+|+++|||++|..|+.......            ..          ......
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~----------~~~~~~  197 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT----------HTTLNI  197 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc----------ccccCC
Confidence            23456778999999988889999999999999999999998875321100            00          000012


Q ss_pred             hHHHHHHHHHHHHHhhcccCCCCCCHHH
Q 013504          348 SIKLAQKLAAVANKCLARQAKGRPKMSE  375 (441)
Q Consensus       348 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  375 (441)
                      +..++..+.+++.+||+.||++||++.+
T Consensus       198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         198 PEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             cccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            2335677899999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=275.54  Aligned_cols=274  Identities=24%  Similarity=0.378  Sum_probs=223.9

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      .++.....+++...++-+|.||.||.|.++......+...|-+|.++....+ ....++.|--.+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3444555678888899999999999999998777777777888888765433 346788999999999999999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTS------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                      .++..   ..+.++.++.-|+|..||..      .....+...+...++.|++.|+.|||..   +|||.||..+|.+||
T Consensus       357 ie~~~---~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  357 IEDYA---TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             eeccC---cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            87654   35888999999999999972      2234677788899999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKL  321 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~  321 (441)
                      +..++||+|=.++|.+-+.+.............||+||.+....|+.++|||||||++|||+| |+.|+...++.+....
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999999999997666555544455556778999999999999999999999999999999 9999976655433322


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      +       .++..          -..+.+||+++..++.-||...|++||++++++.-|.+.-.+
T Consensus       511 l-------kdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  511 L-------KDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             H-------hccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            2       12211          123447899999999999999999999999999999876543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=274.91  Aligned_cols=250  Identities=25%  Similarity=0.442  Sum_probs=199.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|...++||+|+|.+|.++.+..+...     +|+|++++.-..   +..-...|-.+.... +||.+|-++.+|+..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qi-----yamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQI-----YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehccccee-----eehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            36899999999999999999999888765     999998764332   223345677777765 899999999999877


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .    .+++|.||++||+|.-++++  +..++++.+..+..+|+.||.|||++   |||+||||.+|||||..|.+||+|
T Consensus       324 s----rlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  324 S----RLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             c----eEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence            6    45999999999999988876  57899999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCc-hhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~-~~~~~~~~~~~~~~~  330 (441)
                      +|+++.....+  ...++++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||+.... ...+...+++-.   
T Consensus       395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq---  469 (593)
T KOG0695|consen  395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ---  469 (593)
T ss_pred             cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH---
Confidence            99999765443  346789999999999999999999999999999999999999999963221 111111111111   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK  372 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  372 (441)
                            .++...+  ..+...+.....+++.-|.+||.+|..
T Consensus       470 ------vilekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 ------VILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ------HHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                  1111111  123344556778899999999999854

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-35  Score=289.15  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=193.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh---HHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH---KEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      -|..++.||-|+||+|.++...++...     +|+|.+.+.+.-..   .....|-.||.....+-||+||-.|++++. 
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~l-----YAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn-  703 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRAL-----YAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-  703 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhH-----HHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-
Confidence            477888999999999999988777554     89999887654332   235679999999999999999999998885 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         +|+||+|++||++..+|.+  .+.|++..+..++.++.+|+.+.|.-   |+|||||||+|||||.+|.+||+||||
T Consensus       704 ---LYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  704 ---LYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             ---eEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence               5999999999999999987  47899999999999999999999986   999999999999999999999999999


Q ss_pred             CCCCCC--------CCCc--------------------------------ceeeceecccCcCCccccccCCCCccccch
Q 013504          255 ARLGPS--------DGLS--------------------------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIW  294 (441)
Q Consensus       255 a~~~~~--------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  294 (441)
                      |.-+..        .+..                                ......+||+.|+|||++....|+..+|+|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            853211        0000                                011246899999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC
Q 013504          295 SFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP  371 (441)
Q Consensus       295 SlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  371 (441)
                      |.|||||||+.|+.||-...+.+.+ +++.|-.           .+    .-.+..+++.+..++|.++++ ++++|.
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----------~l----~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----------FL----HIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----------cc----ccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            9999999999999999777665443 3334432           11    222334555666677766544 566664

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.1e-34  Score=297.68  Aligned_cols=271  Identities=18%  Similarity=0.206  Sum_probs=170.7

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEec-c-c
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAE-D-D  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~-~  172 (441)
                      ..++|.+.+.||+|+||.||+|++..+.. .....||+|++......  +.+..|  .+....+.+++.++..+.. . .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            45789999999999999999999887622 22345999987643321  111111  1122223333332222111 0 0


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQ------------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF  234 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  234 (441)
                      ......+|||||+++++|.+++.....                  .......+..++.||+.||.|||++   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            122246999999999999999865311                  0112334668999999999999998   9999999


Q ss_pred             CCCcEEEcC-CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC----------------------CCCccc
Q 013504          235 KSSNILLDE-QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG----------------------RLTYKS  291 (441)
Q Consensus       235 Kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  291 (441)
                      ||+|||++. ++.+||+|||+++...... ........||+.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 6789999999998643322 2233457899999999965432                      234567


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcch------HHHHHHHHHHHHHhhcc
Q 013504          292 DIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYS------IKLAQKLAAVANKCLAR  365 (441)
Q Consensus       292 DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~  365 (441)
                      |||||||++|||+++..|++...    ..+...+...-.+...+.....+.......      ........+|+.+||+.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999999877654221    111000000000000111111111000000      00123456899999999


Q ss_pred             cCCCCCCHHHHHH
Q 013504          366 QAKGRPKMSEVVE  378 (441)
Q Consensus       366 dP~~RPs~~evl~  378 (441)
                      ||++|||+.++++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=285.90  Aligned_cols=274  Identities=18%  Similarity=0.259  Sum_probs=183.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCC-----------cccceeEEEEEccccCchhhHH--------------HHHH
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTED-----------SHKKIDIAVKQLSRRGLQGHKE--------------WVTE  149 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~--------------~~~E  149 (441)
                      ..++|++.++||+|+||.||+|.+...+.           ......||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            45789999999999999999998643321           1233469999986543222222              3347


Q ss_pred             HHHhccCCCCCe-----eeEEeEEecccc----CCeeEEEEEeccCCCChHHHHhhcC----------------------
Q 013504          150 VNVLGVVEHPNL-----VKLIGYCAEDDE----RGIQRLLIYEYMPNRSVQDHLTSRF----------------------  198 (441)
Q Consensus       150 ~~il~~l~hpnI-----v~l~~~~~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~----------------------  198 (441)
                      +.++.+++|.++     ++++++|.....    .....+|||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677787764311    1123599999999999999986421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCC
Q 013504          199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA  278 (441)
Q Consensus       199 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  278 (441)
                      ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ........+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence            12346778899999999999999998   99999999999999999999999999997543321 111122345899999


Q ss_pred             ccccccCC--------------------C--CccccchhHHHHHHHHHhCCC-CCCCCCchh-HHHHHHhhhhhcccccc
Q 013504          279 PEYIQTGR--------------------L--TYKSDIWSFGVFLYELITGRR-PLDRNRPKS-EQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       279 PE~~~~~~--------------------~--~~~~DvwSlG~il~elltG~~-P~~~~~~~~-~~~~~~~~~~~~~~~~~  334 (441)
                      ||.+....                    +  ..+.||||+||++++|++|.. ||....... ........      ...
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~------~~~  452 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND------LNR  452 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch------HHH
Confidence            99875432                    1  124799999999999999875 764321110 00000000      000


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccC---CCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQA---KGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  378 (441)
                      +.........-......+....+|+.+||..+|   .+|+|++++++
T Consensus       453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            000000111111122356788999999999766   68999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-33  Score=260.35  Aligned_cols=239  Identities=31%  Similarity=0.478  Sum_probs=191.7

Q ss_pred             cceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCC
Q 013504          109 GFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN  187 (441)
Q Consensus       109 ~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~  187 (441)
                      +||.||+|.+..++.     .+++|++....... .+.+.+|+.++++++|+||+++++++....    ..+++|||+++
T Consensus         1 ~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKKTGK-----LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECCCCc-----EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCC
Confidence            589999999876554     39999987765444 678889999999999999999999998764    35999999999


Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCccee
Q 013504          188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS  267 (441)
Q Consensus       188 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  267 (441)
                      ++|.+++...  ..+++..++.++.+++.+|.|||+.   +++|+||+|.||+++.++.++|+|||.+.......   ..
T Consensus        72 ~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~  143 (244)
T smart00220       72 GDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL  143 (244)
T ss_pred             CCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence            9999999763  3389999999999999999999998   99999999999999999999999999998755432   23


Q ss_pred             eceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcc
Q 013504          268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY  347 (441)
Q Consensus       268 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (441)
                      ....++..|++||.+.+..++.++|||+||+++++|++|..||.....  .....+.........            ...
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~------------~~~  209 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF------------PPP  209 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC------------ccc
Confidence            446788999999999888899999999999999999999999965211  111222111100000            000


Q ss_pred             hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       348 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...++..+.+++.+||..+|++||++.++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            0015568999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=265.21  Aligned_cols=138  Identities=20%  Similarity=0.302  Sum_probs=122.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-----C---CCeeeEEeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-----H---PNLVKLIGY  167 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---pnIv~l~~~  167 (441)
                      ..+|.+.++||=|.|++||+|.+......     ||+|+.+... ...+..+.||.+|++++     |   .+||+|+++
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~-----VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRY-----VALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeE-----EEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            36899999999999999999998776654     9999987543 23456788999999873     2   489999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD  242 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~  242 (441)
                      |...+..+.+.|+|+|++ |.+|..+|.......++...+..|++||+.||.|||..|  +|||.||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            999999999999999999 889999998877889999999999999999999999985  999999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6e-34  Score=247.60  Aligned_cols=262  Identities=21%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++++.+|+|.|++||.|....+...     +.||+++..   ..+.+.+|+.||..|+ ||||+++++...+....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK-----~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEK-----CVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCce-----EEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            47899999999999999999987665543     889998764   3467789999999996 99999999999876654


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEeecC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDFG  253 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFG  253 (441)
                        ...||+||+++.+.....     ..++...+..++.+++.||.|||+.   ||+|||+||.|++||.. -.++|+|+|
T Consensus       109 --tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  109 --TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             --CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence              458999999887776554     3577788999999999999999998   99999999999999864 569999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-----------HH
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-----------KL  321 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-----------~~  321 (441)
                      +|.+.....   ..+..+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||........+           ++
T Consensus       179 LAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  179 LAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             hHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            999876643   2344577888999998865 56899999999999999999999999654433222           11


Q ss_pred             HHhhhhhcc-cccchhhhcCCCCCCcc--------hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          322 LEWVRPHLT-DAKKFTMILDPKLEGKY--------SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       322 ~~~~~~~~~-~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..++...-. -...+..++....+..+        ..-..++..+++.++|..|-.+|||+.|.+.
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111111100 01111111111111000        0113477889999999999999999999887

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=243.07  Aligned_cols=202  Identities=25%  Similarity=0.375  Sum_probs=165.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++...+..||+|+||.|=+-++..++..     .|+|.+..+- .+..++.++|+.+..+. .+|.+|.+||........
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~i-----mAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTI-----MAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeE-----EEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4455556699999999988888777654     8999987643 34567788999987775 899999999977766543


Q ss_pred             CeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ++.||.| .-+|..+..+  ..++.+++..+-+|+..|+.||.|||++  +.|||||+||+||||+.+|++|+|||
T Consensus       121 ----wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  121 ----WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ----EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccc
Confidence                8999999 4588777543  2367899999999999999999999997  58999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      |++..+...-   ..+...|-..|||||.+..    ..|+.++||||||+++.||.+++.||+..
T Consensus       194 GIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  194 GISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            9998764432   2233567788999998753    46899999999999999999999999754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=284.22  Aligned_cols=245  Identities=28%  Similarity=0.414  Sum_probs=182.7

Q ss_pred             Ccccceeeccccee-EEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGG-VYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~-Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |...+++|.|+-|+ ||+|.+.+.       .||||.+-...   ..-..+|+..|+.- +|||||++|+.-.++.    
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R-------~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q----  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGR-------EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ----  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCc-------eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc----
Confidence            44445789999876 799998765       39999885432   33456899999998 7999999966544433    


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---C--CcEEE
Q 013504          177 QRLLIYEYMPNRSVQDHLTSR-FQA-TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---Q--WNAKL  249 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~-~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~--~~~kl  249 (441)
                      .+||..|.| ..+|.+++... ... .......+.+..|++.||++||+-   +||||||||+||||+.   +  ..++|
T Consensus       577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEe
Confidence            569999999 67999999763 111 111134578899999999999986   9999999999999965   2  46899


Q ss_pred             eecCCCCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCchhHHHHHHhhhh
Q 013504          250 SDFGLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG-RRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       250 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG-~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      +|||+++........ .......||.+|+|||++....-+.++|||||||++|+.++| .+||+..-..+..-+      
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl------  726 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL------  726 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh------
Confidence            999999987654422 224567899999999999998888899999999999999996 899975432211100      


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        ........ +.+.      .++  +..+||.+|+..+|..||++.+|+.
T Consensus       727 --~~~~~L~~-L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 --TGNYTLVH-LEPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --cCccceee-eccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence              00000000 0000      112  7889999999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=255.78  Aligned_cols=272  Identities=23%  Similarity=0.308  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc--CchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR--GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .+.+..+.||-|+||.||.+++...+..     ||+|++...  +....+++.+|+.+|.-++|.|++..+++.......
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrr-----valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKR-----VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccc-----hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            3566678899999999999987666544     899888653  223457889999999999999999998877654322


Q ss_pred             C-eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          175 G-IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       175 ~-~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      . ...|+|+|++ ..+|...|..  ...++...+.-+++||++||.|||+.   +|+||||||.|.|++.|..+||||||
T Consensus       128 fFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  128 FFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence            1 1247788888 5688888866  46788888999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc---
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL---  329 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~---  329 (441)
                      +++....... ...+..+-|-.|.|||++.+. .|+.++||||.|||+.||+..+.-|+...+....+++..+....   
T Consensus       202 LARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  202 LARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             cccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            9997654432 234445779999999999874 58999999999999999999999998776665554433221100   


Q ss_pred             -----ccccchhhhc----CCCCCCcc----hHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          330 -----TDAKKFTMIL----DPKLEGKY----SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       330 -----~~~~~~~~~~----~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                           -++.+...+.    .|.+...+    +..-..+...+...++..||++|.+..+.+..+
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                 0011111111    11111111    112233566788889999999999998888754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.7e-33  Score=275.49  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.....+|+|+||.||++++..+++.     .|+|+++........-+.+|+-+++..+||||+.++|.+...+.. 
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~el-----aavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl-   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGEL-----AAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL-   87 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCch-----hhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc-
Confidence            36799999999999999999998877765     888888877666667777899999999999999999999887754 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         +++||||.||+|.+..+-  .+++++.++..++++.+.||.|||+.   +-+|||||-.|||+++.|.+|++|||.+
T Consensus        88 ---wicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   88 ---WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             ---EEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence               999999999999998865  68999999999999999999999998   8899999999999999999999999998


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ..+...-  .....+.||+.|||||+.   ..+.|...+|||++|+...|+---++|.....+.....+...   .    
T Consensus       160 aqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk---S----  230 (829)
T KOG0576|consen  160 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK---S----  230 (829)
T ss_pred             hhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc---c----
Confidence            7654432  234568999999999975   457899999999999999999888888654443322222111   0    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ..+|. ...-.....+.+.++++.||.++|++||+++.++.
T Consensus       231 -----~~qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 -----GFQPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -----CCCCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                 01111 11122356778999999999999999999988765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=262.50  Aligned_cols=197  Identities=25%  Similarity=0.437  Sum_probs=168.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--------hHHHHHHHHHhccCC---CCCeeeEE
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--------HKEWVTEVNVLGVVE---HPNLVKLI  165 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~---hpnIv~l~  165 (441)
                      .+|...+.||.|+||.|++|+++....     .|.||.+.+...-.        .-..-.|+.||..++   |+||++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~-----eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNY-----EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccce-----EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            468999999999999999999987643     48999987654211        112346999999997   99999999


Q ss_pred             eEEeccccCCeeEEEEEecc-CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          166 GYCAEDDERGIQRLLIYEYM-PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++|.+++.    .||+||-- +|.+|.++|..  ...+++..+..|+.||+.|+++||++   +|||||||-+||.++.+
T Consensus       636 dfFEddd~----yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  636 DFFEDDDY----YYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN  706 (772)
T ss_pred             heeecCCe----eEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence            99998874    49999974 67899999976  47899999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCC-ccccchhHHHHHHHHHhCCCCCC
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLD  311 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltG~~P~~  311 (441)
                      |-+||+|||.+......    ....++||..|.|||++.+..|- ..-|||++|++||-++....||-
T Consensus       707 g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999998765443    34568999999999999998874 55899999999999999888873

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.2e-30  Score=231.32  Aligned_cols=211  Identities=38%  Similarity=0.613  Sum_probs=179.9

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEe
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE  183 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E  183 (441)
                      ||+|++|.||++....++.     .+++|.+...... ....+.+|+.+++.+.|++|+++++++....    ..+++||
T Consensus         1 l~~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGK-----KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecCCCc-----EEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEe
Confidence            6899999999999876443     3899998765432 2467889999999999999999999998764    3599999


Q ss_pred             ccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEEeecCCCCCCCCCC
Q 013504          184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLARLGPSDG  262 (441)
Q Consensus       184 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~  262 (441)
                      |+++++|.+++.... ..+++..+..++.+++.+|.+||+.   +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999999999997632 4689999999999999999999998   9999999999999999 8999999999998654332


Q ss_pred             CcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCC
Q 013504          263 LSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP  341 (441)
Q Consensus       263 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (441)
                      .  ......+...|++||.+... .++.+.|+|++|+++++|                                      
T Consensus       148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            1  12335678899999998877 788999999999999998                                      


Q ss_pred             CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       342 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                 ..+.+++..|++.+|.+||++.++++.
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                       347789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=240.60  Aligned_cols=266  Identities=25%  Similarity=0.292  Sum_probs=194.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc--CchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR--GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..+|...+.+|.|.- .|..+.+.-.+     .+||+|++...  +....++..+|..++..+.|+||++++.+|.....
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~-----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLG-----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhcc-----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            356777788999988 56666544333     34899887754  22345778899999999999999999999876442


Q ss_pred             C--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 R--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .  ....|+||||| .++|...+.    -.++-..+..|++|++.|+.|||+.   +|+||||||+||++..++.+||.|
T Consensus        90 l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   90 LEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence            2  12358999999 568888886    3577889999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-H-----------
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-Q-----------  319 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~-----------  319 (441)
                      ||+|+.....   ...+.++.|..|.|||++.+..|...+||||+||++.||++|..-|.+....+. .           
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            9999864432   345668899999999999998899999999999999999999998864322111 0           


Q ss_pred             ----HHHHhhhhhcccc-----cchhhhc-CCCCCCc--chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          320 ----KLLEWVRPHLTDA-----KKFTMIL-DPKLEGK--YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       320 ----~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          ++...++......     ..+...+ |..+...  .+.--...+.+++.+||-.+|++|.++.++|.
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                1111111111100     0011111 1111100  01112345779999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.3e-31  Score=255.11  Aligned_cols=269  Identities=22%  Similarity=0.294  Sum_probs=201.9

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC------CCCeeeEE
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE------HPNLVKLI  165 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~  165 (441)
                      .+.....|.+....|+|=|++|..|.+...+.     .||||++...... .+.=+.|++||++|+      .-|+++|+
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~-----~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQ-----EVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCC-----eeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            34567889999999999999999998876655     4999999876533 344468999999995      24889988


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      -.|...+    ++|||+|-+ .-+|.+.|+... ...|....+..+++|+..||..|-..   +|+|.||||+|||+++.
T Consensus       501 r~F~hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  501 RHFKHKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHhhhcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            8877665    469999988 669999997542 34678889999999999999999976   99999999999999876


Q ss_pred             C-cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          245 W-NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       245 ~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      - .+||||||.|.......    -+.+.-+..|.|||++.+.+|+...|+||.||+||||+||+..|.+........+..
T Consensus       573 k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            4 57999999998765543    233455678999999999999999999999999999999999997665444333322


Q ss_pred             hhhhhccc-----ccchhhhcC--------------------------C------CC-----CCcchHHHHHHHHHHHHH
Q 013504          324 WVRPHLTD-----AKKFTMILD--------------------------P------KL-----EGKYSIKLAQKLAAVANK  361 (441)
Q Consensus       324 ~~~~~~~~-----~~~~~~~~~--------------------------~------~~-----~~~~~~~~~~~l~~li~~  361 (441)
                      -+...+++     ..-....+|                          |      .+     ...........|.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            11111111     000000000                          0      00     011122455678999999


Q ss_pred             hhcccCCCCCCHHHHHH
Q 013504          362 CLARQAKGRPKMSEVVE  378 (441)
Q Consensus       362 cl~~dP~~RPs~~evl~  378 (441)
                      ||..||++|.+..++|.
T Consensus       729 ml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALK  745 (752)
T ss_pred             HhccChhhcCCHHHHhc
Confidence            99999999999988875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.2e-29  Score=230.67  Aligned_cols=199  Identities=34%  Similarity=0.509  Sum_probs=170.2

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      |...+.||.|++|.||+|....++.     .+++|.+...... ..+.+.+|+..+.+++|+|++++++++.....    
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~----   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE-----LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP----   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc-----EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc----
Confidence            5667889999999999999876544     3999999876554 56788899999999999999999999877653    


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQAT-LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      .++++||+++++|.+++...  .. +++..+..++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|||++.
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            48999999999999999763  23 88999999999999999999998   99999999999999999999999999988


Q ss_pred             CCCCCCCcceeeceecccCcCCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPLDR  312 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltG~~P~~~  312 (441)
                      ....... .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7544320 122346788899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=229.36  Aligned_cols=251  Identities=22%  Similarity=0.378  Sum_probs=185.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEE-eccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYC-AEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~-~~~~  172 (441)
                      ..+.|.+.+.||+|.||.+-++.++.+...     +++|.+.+.. ...++|.+|..---.| .|.||+.-|+.. +..+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~-----ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTR-----IVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceE-----EEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            346788999999999999999999988754     8999987654 3467899998776566 689999988654 4333


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE-c-CCCcEEEe
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-D-EQWNAKLS  250 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl-~-~~~~~kl~  250 (441)
                          ..+++|||++.|+|...+..   ..+.+.....++.|++.||.|+|++   ++||||||.+|||| + +...+|||
T Consensus        96 ----~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   96 ----AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             ----eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence                24789999999999998865   5688888999999999999999998   99999999999999 2 33479999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCc--hhHHHHHH
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----RLTYKSDIWSFGVFLYELITGRRPLDRNRP--KSEQKLLE  323 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltG~~P~~~~~~--~~~~~~~~  323 (441)
                      |||+.+.....     ......+..|.+||.....     ...+.+|||.||++++.++||+.||+....  .......+
T Consensus       166 DFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~  240 (378)
T KOG1345|consen  166 DFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ  240 (378)
T ss_pred             ecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence            99998864332     1223446679999976432     246779999999999999999999973321  11122333


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      |......           .+.. .-..+++.+.++.++-|..++++|-...++-+
T Consensus       241 w~~rk~~-----------~~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  241 WLKRKNP-----------ALPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             HhcccCc-----------cCch-hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            3322111           1111 11235677889999999999999944444333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=8.9e-30  Score=239.89  Aligned_cols=270  Identities=24%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ....+.|..+.+||.|.|++||++.+...  ......||+|.+.....  ..++..|+++|..+ .+.||+++.+++...
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34567899999999999999999987762  22334599999977653  46788999999998 699999999999887


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEEe
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLS  250 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl~  250 (441)
                      +..    ++||||++.....+++.     .++...+..+++.++.||.++|++   |||||||||.|+|.+. .+.-.|+
T Consensus       108 d~v----~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  108 DQV----AIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             Cee----EEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence            754    99999999999888875     366889999999999999999998   9999999999999975 4567999


Q ss_pred             ecCCCCCCC-----------------C-CC------------------------CcceeeceecccCcCCcccccc-CCC
Q 013504          251 DFGLARLGP-----------------S-DG------------------------LSHVSTAVVGTIGYAAPEYIQT-GRL  287 (441)
Q Consensus       251 DFGla~~~~-----------------~-~~------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~  287 (441)
                      |||+|....                 . .+                        .........||++|.|||++.. ...
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            999997210                 0 00                        0001123579999999998864 557


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCchhH--HHHH---------Hh---hhh--hcc--c---cc----chhhh----
Q 013504          288 TYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLL---------EW---VRP--HLT--D---AK----KFTMI----  338 (441)
Q Consensus       288 ~~~~DvwSlG~il~elltG~~P~~~~~~~~~--~~~~---------~~---~~~--~~~--~---~~----~~~~~----  338 (441)
                      +.++||||.|||++.+++++.||........  .++.         +.   ...  .+.  +   ..    .+..+    
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            8899999999999999999999954321111  1100         00   000  000  0   00    00000    


Q ss_pred             cCC--C--CC-CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          339 LDP--K--LE-GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       339 ~~~--~--~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..+  .  .. ......++..+.+++.+||+.||.+|.++++.|.
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            000  0  01 1111224457889999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.8e-29  Score=270.55  Aligned_cols=200  Identities=17%  Similarity=0.208  Sum_probs=139.7

Q ss_pred             cCCC-CCeeeEEeEEeccc---cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 013504          155 VVEH-PNLVKLIGYCAEDD---ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII  230 (441)
Q Consensus       155 ~l~h-pnIv~l~~~~~~~~---~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  230 (441)
                      .++| +||++++++|....   .....++++|||+ +++|.++|... ...+++..++.++.||+.||.|||++   +|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            3455 68888888873322   1112346778887 67999999753 45699999999999999999999998   999


Q ss_pred             ecccCCCcEEEcCCC-------------------cEEEeecCCCCCCCCCCC--------------cceeeceecccCcC
Q 013504          231 FRDFKSSNILLDEQW-------------------NAKLSDFGLARLGPSDGL--------------SHVSTAVVGTIGYA  277 (441)
Q Consensus       231 HrDlKp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  277 (441)
                      ||||||+||||+..+                   .+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455566666553211000              00011246899999


Q ss_pred             CccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHH
Q 013504          278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA  357 (441)
Q Consensus       278 aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  357 (441)
                      |||++.+..|+.++|||||||+||||++|..|+.....     ........         ...+..     .........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~---------~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR---------VLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh---------hcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999888742111     11100000         001100     011234568


Q ss_pred             HHHHhhcccCCCCCCHHHHHH
Q 013504          358 VANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       358 li~~cl~~dP~~RPs~~evl~  378 (441)
                      ++.+||+.+|.+||++.++++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999987

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.9e-27  Score=209.24  Aligned_cols=169  Identities=25%  Similarity=0.281  Sum_probs=129.3

Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCccee
Q 013504          188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS  267 (441)
Q Consensus       188 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  267 (441)
                      |+|.+++..+ +..+++..++.++.||+.||.|||++   +      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899999754 45799999999999999999999987   4      999999999999999  9998865432      


Q ss_pred             eceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcc
Q 013504          268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY  347 (441)
Q Consensus       268 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (441)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||........ ........ ....       ++. ....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~-------~~~-~~~~  131 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNG-MPAD-------DPR-DRSN  131 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHH-hccC-------Ccc-cccc
Confidence             12689999999999999999999999999999999999999965432111 11111100 0000       000 0011


Q ss_pred             hHHHHH--HHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          348 SIKLAQ--KLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       348 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      ...+..  .+.+++.+||..+|.+||++.++++.+..+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            223444  69999999999999999999999998877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-26  Score=224.90  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=200.4

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC----CCeeeEEeEEe-ccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH----PNLVKLIGYCA-EDD  172 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~~-~~~  172 (441)
                      +|.+.+.||+|+||.||.|......    ...+|+|............+..|+.++..+..    +++..+++... ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            7999999999999999999987654    33588888776543333367789999988863    58888888874 332


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-----CcE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-----WNA  247 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-----~~~  247 (441)
                          ..|+||+.+ |.+|.++......+.++..+++.|+.|++.+|.+||+.   |++||||||+|+++...     ..+
T Consensus        95 ----~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 ----FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             ----eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence                349999998 99999988665567899999999999999999999998   99999999999999765     459


Q ss_pred             EEeecCCCC--CCCCCCC-----cce-eeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-
Q 013504          248 KLSDFGLAR--LGPSDGL-----SHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-  318 (441)
Q Consensus       248 kl~DFGla~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-  318 (441)
                      .|.|||+++  .......     ... .....||..|+++....+.+.+.+.|+||++.++.+++.|..||........ 
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            999999998  3221111     111 2345699999999999999999999999999999999999999965543222 


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ..+..........         .     .....+..+.++...+-..+..++|.+..+...|.+.....
T Consensus       247 ~~~~~~~~~~~~~---------~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  247 SKFEKDPRKLLTD---------R-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHhhhhccc---------c-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1111111111100         0     11223456667777777789999999999999998887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-26  Score=209.40  Aligned_cols=265  Identities=16%  Similarity=0.251  Sum_probs=207.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  175 (441)
                      -.|.++++||+|.||+++.|+..-++.     +||||.-....  ...++..|.+..+.| ..++|...|-|..+.-.  
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne-----~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~--   98 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNE-----PVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY--   98 (449)
T ss_pred             ccceeccccccCcceeeecccccccCc-----eEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccch--
Confidence            369999999999999999998766655     49999876543  345677888888887 57888888755544332  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-----CcEEEe
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-----WNAKLS  250 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-----~~~kl~  250 (441)
                        -.||||++ |.+|+|++.- .+..|+..+++.++.|++.-++|+|++   .+|+|||||+|+||...     ..+.|+
T Consensus        99 --NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   99 --NILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             --hhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence              38999999 9999998864 367899999999999999999999998   99999999999999643     458999


Q ss_pred             ecCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          251 DFGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       251 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      |||+|+.+......     .......||..||+--...+.+.+.+.|+-|||-+++..|-|..||++..........+.+
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            99999987655422     2345678999999999888999999999999999999999999999876655444433333


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ....... .         ...+...+|.++..-+.-.-..+-.+-|.+.-+...+.++++..
T Consensus       252 Ge~Kr~T-~---------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  252 GETKRST-P---------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             ccccccC-C---------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            2111100 0         01233456777777777778888999999999999988888643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.2e-26  Score=220.92  Aligned_cols=171  Identities=18%  Similarity=0.154  Sum_probs=128.8

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-----chhhHHHHHHHHHhccCCCCCeeeEEe
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-----LQGHKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      ......+|.+.+.||+|+||+||+|.+..+...    .+|||++....     ......+.+|+.+|+.++|+||++.+.
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGT----ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCe----EEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            344567899999999999999999987653221    37998865331     112456889999999999999985332


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc-CCCcEEEcCCC
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF-KSSNILLDEQW  245 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl-Kp~NILl~~~~  245 (441)
                      .+   +    ..||||||++|++|.. +..     ..   ...++.|++.+|.|||+.   ||+|||| ||+|||++.++
T Consensus        89 ~~---~----~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         89 AT---G----KDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             Ec---C----CcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence            21   2    2399999999999963 211     11   146789999999999998   9999999 99999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcce------eeceecccCcCCccccccC
Q 013504          246 NAKLSDFGLARLGPSDGLSHV------STAVVGTIGYAAPEYIQTG  285 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  285 (441)
                      .+||+|||+|+..........      .....+++.|+|||.+...
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999997644331111      1356789999999988643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=9.7e-26  Score=197.96  Aligned_cols=264  Identities=19%  Similarity=0.272  Sum_probs=204.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC-CCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH-PNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  173 (441)
                      ...+|.+++.||+|+||.+|.|.....+..     ||||.-+...  ...++..|..+.+.|++ ..|..+..|..+...
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~-----VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEE-----VAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCce-----EEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            346799999999999999999998877664     9999876543  34567789999988864 677777777766664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~  250 (441)
                      .    .+||+.+ |.+|++.+.-. ...++..+++-++-|++.-++|+|.+   ++|||||||+|+|..-   ...+.|+
T Consensus        86 n----vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   86 N----VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             c----eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence            4    8999999 99999988632 46789999999999999999999998   9999999999999953   3568999


Q ss_pred             ecCCCCCCCCCCC-----cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          251 DFGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       251 DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      |||+|+...+...     ........||..|.+--...+...+.+.|+-|+|.+|..+.-|..||++..+....+..+.+
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            9999987544321     12234678999999988777778889999999999999999999999987766555444433


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      .......          .....+..+|.++.-.+.-|-..--++-|...-+-+.+.-+.
T Consensus       237 ~EkK~s~----------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  237 SEKKMST----------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             HHhhcCC----------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            2211110          011233456677888888899988999999887777665554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=6e-24  Score=204.37  Aligned_cols=260  Identities=32%  Similarity=0.480  Sum_probs=196.5

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh---hHHHHHHHHHhccCCCC-CeeeEEeEEeccccC
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHP-NLVKLIGYCAEDDER  174 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~  174 (441)
                      |.....||.|+||.||++.+.        ..+++|.+.......   ...+.+|+.++..+.|+ +|+++++++..... 
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-
Confidence            667788999999999999987        248888887655432   56788999999999988 79999999954443 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQ-ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DF  252 (441)
                         .+++++|+.+++|.+++..... ..++......++.|++.++.|+|..   +++||||||+||+++..+ .++++||
T Consensus        73 ---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          73 ---LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             ---EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEecc
Confidence               4899999999999977765321 2788999999999999999999998   899999999999999998 7999999


Q ss_pred             CCCCCCCCCCCcc----eeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCch-hHHHHHHh
Q 013504          253 GLARLGPSDGLSH----VSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPK-SEQKLLEW  324 (441)
Q Consensus       253 Gla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~-~~~~~~~~  324 (441)
                      |+++.........    ......||..|++||.+.+   ..+....|+|++|++++++++|..||...... ........
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            9998554432221    3466899999999999987   57888999999999999999999997654431 01111111


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      +......      .................+.+++..|+..+|..|.+..+....
T Consensus       227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111110      000000000002233578899999999999999998887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.2e-26  Score=236.41  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=190.5

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEc-cccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      ....++|.|++|.|+...............++++ . ....... ...+..|+.+-..++|||++..+..+.+....   
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~---  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI---  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc---
Confidence            4567899999998888776655443233333333 2 1111111 12266788888889999998887776665543   


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                       +-+||||++ +|..++..  ...+....+--++.|++.||.|||+.   ||.||||||+|+++..+|.+||+|||.+..
T Consensus       397 -~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  397 -LQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             -hhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence             344999999 99999976  24688888999999999999999998   999999999999999999999999999886


Q ss_pred             CCCCCCc--ceeeceecccCcCCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhccccc
Q 013504          258 GPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYK-SDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHLTDAK  333 (441)
Q Consensus       258 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~  333 (441)
                      .......  ......+|+..|+|||.+.+..|++. .||||.|++++.|++|+.||........+. ....        .
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------~  541 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------S  541 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--------c
Confidence            5444333  55677899999999999999999875 899999999999999999996543322211 0000        0


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  ..-...-.......++.....++.+||+.+|.+|.++++|++
T Consensus       542 ~--~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  542 D--QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             c--ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0  000000011233356778889999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=200.06  Aligned_cols=246  Identities=24%  Similarity=0.423  Sum_probs=191.2

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +|.....|+.|+|++.+..       +++|++.-+....  .+.|..|.-.|+.+.||||+.++|.|.....    +.++
T Consensus       197 kl~e~hsgelwrgrwqgnd-------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----lv~i  265 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGND-------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----LVII  265 (448)
T ss_pred             hhccCCCcccccccccCcc-------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----ceEe
Confidence            4888899999999998765       5667766544322  3568889999999999999999999987753    4899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD  261 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  261 (441)
                      ..||+.|+|+..|+...+...+..++.+++.+++.|+.|||+- .+-|.---|....+++|++...+|+ .+-+++    
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kf----  339 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF----  339 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-ccccee----
Confidence            9999999999999987667788899999999999999999986 3334455799999999999888775 222221    


Q ss_pred             CCcceeeceecccCcCCccccccCCCC---ccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          262 GLSHVSTAVVGTIGYAAPEYIQTGRLT---YKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       262 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                        +.........|.||+||.++..+-+   .++|+|||++++|||.|...||....+.+..-.+                
T Consensus       340 --sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------------  401 (448)
T KOG0195|consen  340 --SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------------  401 (448)
T ss_pred             --eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------------
Confidence              1112223557899999999876644   4689999999999999999999766543321111                


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      --..++...++..+..+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            0112334556677888999999999999999999999999998864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.4e-23  Score=190.06  Aligned_cols=176  Identities=11%  Similarity=0.093  Sum_probs=133.4

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHH---------HHHHHHHhccCCCCCeeeE
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---------WVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~hpnIv~l  164 (441)
                      ...++|...++||.|+||.||+....  ..     .++||.+..........         +.+|+..+.++.||+|..+
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~--~~-----~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTD--YG-----KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecC--CC-----cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            45689999999999999999996542  22     39999997544332222         5789999999999999999


Q ss_pred             EeEEeccccC----CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          165 IGYCAEDDER----GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       165 ~~~~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                      .+++......    ....+|||||++|.+|.++..      ++.    ....+++.+|..||..   |++||||||+||+
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nil  167 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFI  167 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEE
Confidence            9987654321    123589999999999988742      222    3456999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI  304 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ell  304 (441)
                      ++.++ ++|+|||...........              ..++....|+.++|+|+||+++..+.
T Consensus       168 i~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        168 VSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99988 999999988754322100              01334455778899999999988655

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=4.1e-24  Score=207.60  Aligned_cols=171  Identities=25%  Similarity=0.353  Sum_probs=129.3

Q ss_pred             EEEEEeccCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTS-RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      +||.|++|...+|.+||.. +.....++...+.++.|++.|+.|   +   +.+|||+||.||++..+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhee
Confidence            5788999999999999973 345667888999999999999999   5   89999999999999999999999999987


Q ss_pred             CCCCCC----CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          257 LGPSDG----LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       257 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ......    .....+..+||..||+||.+.+..|+.++||||||+||+|+++ =..++...                  
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------------  466 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------------  466 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------------
Confidence            654443    1223456799999999999999999999999999999999997 22222110                  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                       ..+..+.+..+...+..+.+ .-..|+.+++...|.+||++.
T Consensus       467 -~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  467 -ATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             -HhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHH
Confidence             01111112222111112222 344799999999999999443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=9.5e-23  Score=182.22  Aligned_cols=139  Identities=13%  Similarity=0.104  Sum_probs=105.5

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--h-------h-----------------HHHHHHHHHhcc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--G-------H-----------------KEWVTEVNVLGV  155 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~il~~  155 (441)
                      ...||+|+||.||+|.+. ++.     .||||+++.....  .       .                 .....|+.+|.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~-----~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGE-----ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEECC-CCC-----EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            357999999999999875 333     4999998754211  0       0                 112349999999


Q ss_pred             CCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccc
Q 013504          156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-HEGMDFQIIFRDF  234 (441)
Q Consensus       156 l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiHrDl  234 (441)
                      +.++++.....+...  .    .+|||||++|++|...+..  ...++...+..++.|++.+|.|| |+.   +|+||||
T Consensus        76 l~~~~v~~p~~~~~~--~----~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          76 LVTAGIPCPEPILLK--S----HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             HHHCCCCCCcEEEec--C----CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            988776443332221  1    2899999998877655432  35788999999999999999999 676   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ||+|||++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-23  Score=208.27  Aligned_cols=229  Identities=27%  Similarity=0.363  Sum_probs=181.0

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      .+|.|.||.|+++.-....  ....-+|+|++.+.....  ......|..++..++ ||.+|++.-.++.+...    ++
T Consensus         1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl----~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL----YL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccc--cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccch----hH
Confidence            3799999999986543322  223347777776543321  113346788888886 99999999888877654    99


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      +++|..||.|...+..  ...+.+.....+...++.++.++|+.   +|+|||+|++||+++.+|.+++.|||+++....
T Consensus        75 ~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            9999999999998876  46778888889999999999999988   999999999999999999999999999997544


Q ss_pred             CCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcC
Q 013504          261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD  340 (441)
Q Consensus       261 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (441)
                      ...      .+||..|||||++.  .....+|+||||++++||+||..||..    +....+.                 
T Consensus       150 ~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il-----------------  200 (612)
T KOG0603|consen  150 EKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL-----------------  200 (612)
T ss_pred             hhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh-----------------
Confidence            321      29999999999987  677889999999999999999999975    1111111                 


Q ss_pred             CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       341 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                       +.....+...+..+.+++..++..+|.+|.-.
T Consensus       201 -~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  201 -KAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence             11234566788889999999999999999765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-23  Score=215.32  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=175.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +|...+.||++.|=+|.+|+++.+.       |.||++-+...    ...++-+.|+. ...++|||++++.-+...+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-------VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-------EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence            6778888999999999999876543       77888766542    22334445555 556799999998766544443


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .    |||-+|+ ..+|+|.|..+  .-+..-+...|+.|++.||..+|..   ||+|+|||.+||||+.-+.+.|+||.
T Consensus        96 A----ylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   96 A----YLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             H----HHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            3    7888888 56999998763  4567778899999999999999998   99999999999999999999999998


Q ss_pred             CCCCC--CCCC---CcceeeceecccCcCCccccccC----------C-CCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          254 LARLG--PSDG---LSHVSTAVVGTIGYAAPEYIQTG----------R-LTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       254 la~~~--~~~~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      .-+..  +.+.   ......+...-.+|+|||.+...          . .+++-||||+||+++||++ |++||.-.   
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---  242 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---  242 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence            76632  2211   11112222334479999987542          2 5778999999999999998 68888521   


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                         ++..+-+..   ......++.. +       ....++.++..|++.||.+|.++++.|+.
T Consensus       243 ---QL~aYr~~~---~~~~e~~Le~-I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  243 ---QLLAYRSGN---ADDPEQLLEK-I-------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ---HHHhHhccC---ccCHHHHHHh-C-------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence               222221110   0000111100 0       11257899999999999999999999985

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.3e-21  Score=176.57  Aligned_cols=140  Identities=18%  Similarity=0.238  Sum_probs=107.7

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-----CCCCeeeEEeEEeccccC
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-----EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~  174 (441)
                      ....+||+|+||.||.  +..+..      .+||++........+.+.+|+.+++.+     .||||++++|++.++...
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~------k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQ------RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcC------eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            3456899999999995  433322      468887665444557789999999999     579999999999887543


Q ss_pred             CeeEEEEEec--cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEecccCCCcEEEcC----CCcE
Q 013504          175 GIQRLLIYEY--MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL-AYLHEGMDFQIIFRDFKSSNILLDE----QWNA  247 (441)
Q Consensus       175 ~~~~~lv~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~iiHrDlKp~NILl~~----~~~~  247 (441)
                      +....+||||  +++|+|.+++.+   ..+++.  ..++.+++.++ .|||++   +|+||||||+|||++.    ++.+
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence            3333478999  557999999965   245555  35678888888 899998   9999999999999974    3479


Q ss_pred             EEeecCCC
Q 013504          248 KLSDFGLA  255 (441)
Q Consensus       248 kl~DFGla  255 (441)
                      +|+||+.+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=9.9e-22  Score=176.12  Aligned_cols=140  Identities=14%  Similarity=0.113  Sum_probs=108.3

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---------------------h-----hHHHHHHHHHhcc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---------------------G-----HKEWVTEVNVLGV  155 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~il~~  155 (441)
                      ...||+|+||.||+|.+. ++.     .||||++......                     .     ...+..|...+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~-----~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGE-----ELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCC-----EEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            457999999999999876 333     4999998764211                     0     1123578999999


Q ss_pred             CCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccc
Q 013504          156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDF  234 (441)
Q Consensus       156 l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDl  234 (441)
                      +.|++|.....+....      .+|||||++|+++......  ...++......++.|++.+|.+||+ .   ||+||||
T Consensus        76 l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl  144 (190)
T cd05145          76 LYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL  144 (190)
T ss_pred             HHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence            9999875554443322      2899999998865443222  2467788999999999999999999 7   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      ||+|||++ ++.++|+|||++....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999 7899999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.7e-21  Score=172.95  Aligned_cols=187  Identities=18%  Similarity=0.115  Sum_probs=135.3

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh----hHHHHHHHHHhccCC-CCCeeeEEeEEeccccC
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG----HKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDER  174 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  174 (441)
                      .+...|++|+||+||.+...+       ..++.+.+.....-.    ...+.+|+++|++|. |++|++++++.      
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~-------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGE-------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------   71 (218)
T ss_pred             ccceeecCCCcceEEEeecCC-------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------
Confidence            456689999999999765421       125655555433211    124778999999994 58899998861      


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc-CCCcEEEcCCCcEEEeecC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF-KSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl-Kp~NILl~~~~~~kl~DFG  253 (441)
                        ..+++|||+.|.+|...+..         ....++.|++.+|.++|.+   ||+|||| ||+|||++.++.++|+|||
T Consensus        72 --~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         72 --GRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             --CEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence              13899999999998755421         1235788999999999998   9999999 7999999999999999999


Q ss_pred             CCCCCCCCCCc----ce-------eeceecccCcCCccccccC-CCC-ccccchhHHHHHHHHHhCCCCCCCC
Q 013504          254 LARLGPSDGLS----HV-------STAVVGTIGYAAPEYIQTG-RLT-YKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       254 la~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      ++.........    ..       ..-..+++.|+.|+...-. ..+ ...++++.|+-+|.++|+..|+-..
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            99865433210    00       0112368888888854322 223 4578999999999999999887443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=7e-22  Score=185.07  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=175.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCc------------------------------ccceeEEEEEccccCchh-h--
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDS------------------------------HKKIDIAVKQLSRRGLQG-H--  143 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~------------------------------~~~~~vavK~~~~~~~~~-~--  143 (441)
                      ++|+++..||+|....||.+.....+..                              .+..+.|||.+..-..+. .  
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            5799999999999999999877652210                              123456777765433221 1  


Q ss_pred             --HHHHHHH------HH-----------hc----c-CCCCCeeeEEeEEeccc-----------------------cCCe
Q 013504          144 --KEWVTEV------NV-----------LG----V-VEHPNLVKLIGYCAEDD-----------------------ERGI  176 (441)
Q Consensus       144 --~~~~~E~------~i-----------l~----~-l~hpnIv~l~~~~~~~~-----------------------~~~~  176 (441)
                        +.+-+|.      ..           +.    + -+|||||++.++|.+.-                       ..+.
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence              1111221      01           11    1 26999999999887642                       1234


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE--cCCC--cEEEeec
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL--DEQW--NAKLSDF  252 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl--~~~~--~~kl~DF  252 (441)
                      .+|+||..+ ..+|.+++..   ...+.....-|+.|+++|+.|||++   ||.|||+|.+||||  |+++  .+.|+||
T Consensus       317 tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  317 TLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             eEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEccc
Confidence            679999887 4599999975   3455667778899999999999998   99999999999999  4443  4789999


Q ss_pred             CCCCCCCCCCCc----ceeeceecccCcCCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          253 GLARLGPSDGLS----HVSTAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       253 Gla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      |++--....+..    ...-..-|.-.-||||+....+      .-.+.|.|+.|.+.||+++...||-.-. +...+. 
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~-  467 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDT-  467 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheech-
Confidence            987543321111    0111245777899999876432      1247999999999999999999995311 100000 


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                                ..+.+.-    -...+..+++.+.+++...|+.||.+|++..-....|
T Consensus       468 ----------r~Yqe~q----LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  468 ----------RTYQESQ----LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             ----------hhhhhhh----CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence                      0111111    1234456778899999999999999999976555544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=5.4e-21  Score=178.37  Aligned_cols=237  Identities=22%  Similarity=0.326  Sum_probs=149.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCC----------CCeeeE
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEH----------PNLVKL  164 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h----------pnIv~l  164 (441)
                      .+...+.||.|+++.||.+++..+++.     +|+|+.......   ..+++.+|.-....+.+          -.++-.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~-----~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEE-----FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEE-----EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEccCCce-----EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            456677899999999999999888765     899887654422   34566666655554322          122222


Q ss_pred             EeEEec---------cccC-Ce---eEEEEEeccCCCChHHHHh---hcCC--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 013504          165 IGYCAE---------DDER-GI---QRLLIYEYMPNRSVQDHLT---SRFQ--ATLPWNTRLKIAQDAARGLAYLHEGMD  226 (441)
Q Consensus       165 ~~~~~~---------~~~~-~~---~~~lv~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~  226 (441)
                      ++....         .... ..   +.+++|+-+ .++|.+++.   ....  ..+....++.+..|+++.+++||..  
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--  164 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--  164 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--
Confidence            222211         1100 01   347788877 678888754   2211  1233445567778999999999998  


Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC--------CCCccccchhHHH
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG--------RLTYKSDIWSFGV  298 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlG~  298 (441)
                       ||+|+||||+|+|++.+|.++|+||+........     ......+..|.|||.....        .++.+.|.|+||+
T Consensus       165 -GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  165 -GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             -TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             -ceEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence             9999999999999999999999999877643221     1113456789999976442        4688899999999


Q ss_pred             HHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCC
Q 013504          299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR  370 (441)
Q Consensus       299 il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  370 (441)
                      ++|.|++|..||+...+.....            .        .+ ..+. +.++.+..||..+|+.+|++|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~------------~--------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPE------------W--------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSG------------G--------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCcccccc------------c--------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999997543211100            0        11 1233 788999999999999999987

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=9.7e-21  Score=199.80  Aligned_cols=252  Identities=18%  Similarity=0.208  Sum_probs=177.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC---CCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE---HPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  171 (441)
                      ..+.|.+.+.||+|+||.||+|...+ ++     .||+|+-+....-   +|.-=.+++.+|+   -+-|+.+.......
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~-----~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GK-----LVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-Cc-----EEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            34678899999999999999999776 32     4999997765432   1111122333333   23344444333333


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-------CC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-------EQ  244 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-------~~  244 (441)
                      +..    +||+||.+.|+|.+++..  .+.+++..++.++.|++..+..||..   +|||+||||+|+||.       ++
T Consensus       767 ~~S----~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  767 NAS----VLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             Ccc----eeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcc
Confidence            333    899999999999999974  67899999999999999999999998   999999999999993       23


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      -.++|+|||.+-..............++|-.+-.+|+..|..++..+|.|.|+-+++-||.|+.-=              
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------  903 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------  903 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------
Confidence            458999999987543333334556788999999999999999999999999999999999987421              


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                          ..++  ....++..+......+...   ++...+|..|-..=|...++...|+..+...
T Consensus       904 ----~~~g--~~~~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  904 ----VKNG--SSWMVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             ----hcCC--cceeccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence                0000  0011111122222233444   4444555555555588888888888877543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=187.08  Aligned_cols=219  Identities=28%  Similarity=0.460  Sum_probs=163.2

Q ss_pred             hccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 013504          153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR  232 (441)
Q Consensus       153 l~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  232 (441)
                      |+.+.|.|+.+++|.+.+...    .++|.+||..|+|.+.+... ...+++.....++++|+.||.|||..  +-..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~----~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE----MIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCc----eEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeee
Confidence            467899999999999998743    48999999999999999763 56789999999999999999999986  223999


Q ss_pred             ccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC-------CCccccchhHHHHHHHHHh
Q 013504          233 DFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-------LTYKSDIWSFGVFLYELIT  305 (441)
Q Consensus       233 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlG~il~ellt  305 (441)
                      .+++.|.+++....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            999999999999999999999988764211111122223445699999987642       4567999999999999999


Q ss_pred             CCCCCCCCCchhH-HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          306 GRRPLDRNRPKSE-QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       306 G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ...||+....... .+++..+....      .....|.+...  .+..+.+..++..||..+|.+||++..|-..+..+.
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~------~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGG------SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcC------CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9999975332221 33444332200      01111221111  144557899999999999999999999998887765


Q ss_pred             hh
Q 013504          385 DA  386 (441)
Q Consensus       385 ~~  386 (441)
                      ..
T Consensus       226 ~~  227 (484)
T KOG1023|consen  226 KG  227 (484)
T ss_pred             cc
Confidence            43

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=2e-21  Score=201.39  Aligned_cols=216  Identities=25%  Similarity=0.408  Sum_probs=150.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .+|..+++|-.|+||.||...++.+...     +|+| +++.+..     .+-  +|.....|.+|              
T Consensus        83 ~df~~IklisngAygavylvrh~~trqr-----fa~k-iNkq~li-----lRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQR-----FAMK-INKQNLI-----LRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccc-----hhhc-ccccchh-----hhc--cccccCCccee--------------
Confidence            6899999999999999999998877654     7773 3332211     110  22222333333              


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                                 |+-...++.  -+.++...        +.+++|||+.   +|+|||+||+|.+|+.-|.+|++|||+++
T Consensus       136 -----------gDc~tllk~--~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  136 -----------GDCATLLKN--IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             -----------chhhhhccc--CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence                       343444433  23444332        7899999987   99999999999999999999999999988


Q ss_pred             CCCCCCCc-------------ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          257 LGPSDGLS-------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       257 ~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      ...-....             .....++|||.|+|||++....|+..+|||++|+|+||.+.|+.||++..+++....+-
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence            64221100             11234689999999999999999999999999999999999999998876654332211


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .+...+.+         -....+.++.+++.++|+.+|.+|--....++
T Consensus       272 ------sd~i~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  272 ------SDDIEWPE---------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             ------hhhccccc---------cCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence                  11111110         12235578999999999999999954434333

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.3e-19  Score=165.86  Aligned_cols=142  Identities=15%  Similarity=0.130  Sum_probs=108.5

Q ss_pred             CCcccceeecccceeEEEEE-EcCCCCcccceeEEEEEccccCch------------------------hhHHHHHHHHH
Q 013504           98 NFSRSLMIGEGGFGGVYRGV-IRSTEDSHKKIDIAVKQLSRRGLQ------------------------GHKEWVTEVNV  152 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~-~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~i  152 (441)
                      -|.+.+.||+|+||.||+|. +..++.     .||+|.+......                        ....+.+|+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGK-----ERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCc-----EEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            48889999999999999998 433433     4999998753210                        01234679999


Q ss_pred             hccCCCC--CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-e
Q 013504          153 LGVVEHP--NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ-I  229 (441)
Q Consensus       153 l~~l~hp--nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-i  229 (441)
                      +.++.+.  .+.+++++   . .    .+|||||++|++|...+..  ...+.......++.|++.+|.+||+.   + |
T Consensus       104 L~~L~~~~i~~p~~~~~---~-~----~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~i  170 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW---R-R----NVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GEL  170 (237)
T ss_pred             HHHHHhcCCCCCeeeEe---c-C----ceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence            9999753  34444432   1 1    2899999999888776533  23556667789999999999999998   8 9


Q ss_pred             EecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          230 IFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       230 iHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      +||||||+||+++ ++.++|+|||.+...
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999999 889999999998753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.1e-19  Score=160.70  Aligned_cols=134  Identities=20%  Similarity=0.345  Sum_probs=108.2

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +.||+|++|.||+|.+.+..       +++|+.......        ....+.+|+.++..+.|++|.....++..... 
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~-------~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIK-------AVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-   73 (211)
T ss_pred             cccccCceEEEEEEeeCCCc-------eEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-
Confidence            46999999999999874332       788875533211        12356789999999999998777766655443 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||++|++|.+++...  .   . ....++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||+
T Consensus        74 ---~~lv~e~~~G~~L~~~~~~~--~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         74 ---FIIVMEYIEGEPLKDLINSN--G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             ---CEEEEEEeCCcCHHHHHHhc--c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence               38999999999999998642  1   1 7889999999999999998   999999999999999 78899999998


Q ss_pred             CCC
Q 013504          255 ARL  257 (441)
Q Consensus       255 a~~  257 (441)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=6.1e-19  Score=182.67  Aligned_cols=139  Identities=18%  Similarity=0.315  Sum_probs=109.4

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc--Cc------hhhHHHHHHHHHhccCCCCCeeeEE
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR--GL------QGHKEWVTEVNVLGVVEHPNLVKLI  165 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~il~~l~hpnIv~l~  165 (441)
                      .....|...+.||+|+||.||+|.+....       +++|+....  ..      ....++.+|+.++..++|++|+...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            33455677889999999999999876543       222221111  00      1124678999999999999998887


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      .++......    ++||||++|++|.+++.          ....++.+++.+|.+||+.   +|+||||||+|||+ .++
T Consensus       403 ~~~~~~~~~----~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        403 IYDVDPEEK----TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             EEEEeCCCC----EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECC
Confidence            776654433    89999999999999885          3467899999999999998   99999999999999 677


Q ss_pred             cEEEeecCCCCC
Q 013504          246 NAKLSDFGLARL  257 (441)
Q Consensus       246 ~~kl~DFGla~~  257 (441)
                      .++|+|||+++.
T Consensus       465 ~~~liDFGla~~  476 (535)
T PRK09605        465 RLYLIDFGLGKY  476 (535)
T ss_pred             cEEEEeCccccc
Confidence            899999999985

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.3e-18  Score=157.10  Aligned_cols=130  Identities=19%  Similarity=0.363  Sum_probs=101.7

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +||+|+||.||+|.+.+.       .+++|........        ...++.+|+.++..+.|+++.....++.....  
T Consensus         1 ~ig~G~~~~vy~~~~~~~-------~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGL-------KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--   71 (199)
T ss_pred             CCCCCceEEEEEeecCCc-------cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--
Confidence            489999999999985432       3888875543211        12456789999999988875554444444333  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||++|++|.+++...  ..       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++
T Consensus        72 --~~lv~e~~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        72 --KTIVMEYIEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             --CEEEEEEECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence              38999999999999987542  11       7899999999999998   999999999999999 789999999998


Q ss_pred             CC
Q 013504          256 RL  257 (441)
Q Consensus       256 ~~  257 (441)
                      +.
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            75

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=6.5e-18  Score=152.46  Aligned_cols=143  Identities=16%  Similarity=0.124  Sum_probs=106.9

Q ss_pred             HHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch----------------------hhHHHHH
Q 013504           91 ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ----------------------GHKEWVT  148 (441)
Q Consensus        91 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~  148 (441)
                      ++......|.+.+.||+|+||.||+|.... +.     .||||++......                      ....+.+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~-g~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPD-GN-----PVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQK   82 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCC-CC-----EEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHH
Confidence            333333458888999999999999998752 32     4999986543200                      0112567


Q ss_pred             HHHHhccCCCC--CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 013504          149 EVNVLGVVEHP--NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMD  226 (441)
Q Consensus       149 E~~il~~l~hp--nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  226 (441)
                      |+.++..+.|+  .++..++.    ..    .++||||++|++|......        .....++.+++.++.++|+.  
T Consensus        83 E~~~l~~l~~~~i~v~~~~~~----~~----~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~--  144 (198)
T cd05144          83 EFAALKALYEEGFPVPKPIDW----NR----HAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH--  144 (198)
T ss_pred             HHHHHHHHHHcCCCCCceeec----CC----ceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC--
Confidence            88899988777  44444432    11    2899999999998765431        34567889999999999997  


Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                       +|+||||||+||++++++.++|+|||++...
T Consensus       145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             -CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence             9999999999999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=4.9e-17  Score=150.58  Aligned_cols=139  Identities=20%  Similarity=0.225  Sum_probs=104.9

Q ss_pred             cceee-cccceeEEEEEEcCCCCcccceeEEEEEccccCc-------------hhhHHHHHHHHHhccCCCCCe--eeEE
Q 013504          102 SLMIG-EGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-------------QGHKEWVTEVNVLGVVEHPNL--VKLI  165 (441)
Q Consensus       102 ~~~LG-~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~hpnI--v~l~  165 (441)
                      ...|| .||.|+||.+...+.       .++||.+.....             .....+.+|+.++.++.|++|  +..+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~-------~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGV-------NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             CceeecCCCCccEEEEEeCCc-------eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            34688 889999999876532       378887754221             122457889999999998875  6777


Q ss_pred             eEEeccccCCeeEEEEEeccCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPN-RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++...........++||||++| .+|.+++..   ..++..    .+.+|+.+|.+||+.   ||+||||||.|||++.+
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            7655443322233699999997 699988854   345443    367899999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCC
Q 013504          245 WNAKLSDFGLARL  257 (441)
Q Consensus       245 ~~~kl~DFGla~~  257 (441)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1e-18  Score=180.84  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=189.5

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDER  174 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  174 (441)
                      .|...+-||+|+|+.|-.........    ..+|+|.+....  .........|..+-..+. |+|++.+++.....+..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~----~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPE----SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCc----ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            45556669999999998776533322    236667666554  122234445777777776 99999999887776644


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecccCCCcEEEcCCC-cEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQIIFRDFKSSNILLDEQW-NAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiHrDlKp~NILl~~~~-~~kl~DF  252 (441)
                          +++++|..|+++.+.+........+...+-.++.|+..++.|+| ..   ++.||||||+|.+++..+ .++++||
T Consensus        97 ----~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   97 ----LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             ----ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence                88999999999999883222225666778889999999999999 76   999999999999999999 9999999


Q ss_pred             CCCCCCCC-CCCcceeeceec-ccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          253 GLARLGPS-DGLSHVSTAVVG-TIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |+|..... .+........+| ++.|+|||...+.. .....|+||.|+++.-+++|..|++........ ...|.... 
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-
Confidence            99997766 555555666788 99999999988754 466789999999999999999999755433211 11111000 


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 ................+++.+++..+|..|.+.+++-.
T Consensus       248 -----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 -----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                       00011122345566788999999999999999887765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2e-16  Score=135.35  Aligned_cols=136  Identities=21%  Similarity=0.233  Sum_probs=110.1

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC--CCeeeEEeEEeccccCCeeE
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH--PNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~  178 (441)
                      +.+.||+|.++.||++.....       .+++|.......  ...+.+|+.++..++|  .++++++++....+    ..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~-------~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDE-------DYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG----WS   68 (155)
T ss_pred             cceecccccccceEEEEecCC-------eEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----cc
Confidence            456799999999999987542       389998866543  4567889999999976  58999888776543    34


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      +++|||++++.+..+         +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.++..
T Consensus        69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999999998877644         44566788999999999999853347999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.4e-16  Score=140.79  Aligned_cols=135  Identities=19%  Similarity=0.141  Sum_probs=93.8

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHH----------------------HHHHHHHhccCC
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKE----------------------WVTEVNVLGVVE  157 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~il~~l~  157 (441)
                      .+.||+|+||.||+|.+. ++     ..||||++.......  ...                      ...|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DG-----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC-CC-----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            457999999999999876 22     249999876532111  111                      124555666654


Q ss_pred             CC--CeeeEEeEEeccccCCeeEEEEEeccCCCChHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecc
Q 013504          158 HP--NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH-LTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRD  233 (441)
Q Consensus       158 hp--nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrD  233 (441)
                      +.  .+.+.+++.        ..++||||++++++... +...   ... ..+..++.+++.++.++|. .   +|+|||
T Consensus        76 ~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          76 EAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             HcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            33  244444321        13899999999554322 2111   011 5678899999999999998 6   999999


Q ss_pred             cCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          234 FKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       234 lKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      |||+||+++ ++.++|+|||.+...
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccc
Confidence            999999999 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=4.3e-15  Score=136.83  Aligned_cols=206  Identities=23%  Similarity=0.270  Sum_probs=143.8

Q ss_pred             HHhccCCCCCeeeEEeEEecccc-CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 013504          151 NVLGVVEHPNLVKLIGYCAEDDE-RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDF  227 (441)
Q Consensus       151 ~il~~l~hpnIv~l~~~~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  227 (441)
                      .-|-.+.|-|||+++.|+.+... ......+++||+..|+|..+|++  +.+..+....-.+|+-||+.||.|||+. ++
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            34555679999999999877544 23345788999999999999974  3456788888889999999999999985 88


Q ss_pred             CeEecccCCCcEEEcCCCcEEEeecCCCCCCCC--CCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh
Q 013504          228 QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS--DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT  305 (441)
Q Consensus       228 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt  305 (441)
                      .|+|+++..+.|++..+|-+|+.--.-......  ...........+-++|.+||.=...+.+.++|||+||+..++|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888752111100000  001111223456789999998666677889999999999999998


Q ss_pred             CCCCCCCC-CchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          306 GRRPLDRN-RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       306 G~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      |..--... ........+......+.+                     ..-..++..|++.+|..||+|.+++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~len---------------------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLEN---------------------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeeccC---------------------ccccCcCcccccCCCCCCcchhhhhc
Confidence            87543221 111111111111001111                     11236889999999999999999876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2.4e-14  Score=142.30  Aligned_cols=250  Identities=24%  Similarity=0.263  Sum_probs=179.5

Q ss_pred             cCCcccceeec--ccceeEEEEEE--cCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccC-CCCCeeeEEeEEe
Q 013504           97 KNFSRSLMIGE--GGFGGVYRGVI--RSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVV-EHPNLVKLIGYCA  169 (441)
Q Consensus        97 ~~f~~~~~LG~--G~~g~Vy~~~~--~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  169 (441)
                      ..|.+...+|.  |.+|.||.+..  .....     .+|+|.-+....  .....-++|+.-..++ .|+|.++.+..+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~-----~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPH-----KFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCc-----ccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            45777788999  99999999887  33333     378877333222  2223345677777777 5999999888887


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEecccCCCcEEEcCC-
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----GLAYLHEGMDFQIIFRDFKSSNILLDEQ-  244 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~iiHrDlKp~NILl~~~-  244 (441)
                      ..+..    |+-+|+| +.+|..+.... ...++....+.++.+...    ||.++|+.   +++|-|+||.||+...+ 
T Consensus       189 ~~~~l----fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGIL----FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCcc----eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence            76654    8888988 57888887654 345788888999999999    99999998   99999999999999999 


Q ss_pred             CcEEEeecCCCCCCCCCCCcce---eeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          245 WNAKLSDFGLARLGPSDGLSHV---STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      ..++++|||+............   .....|...|++||..+ +-++...|+|++|.++.+..+|..+........    
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----  334 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS----  334 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC----
Confidence            8899999999987665542221   12236778899999864 578889999999999999999876653221100    


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                        |.           .+..-.+...+...-..++...+..+++.+|..|++.+.+..
T Consensus       335 --W~-----------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 --WS-----------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --cc-----------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              10           000000111222233445666999999999999999877765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.2e-13  Score=138.86  Aligned_cols=141  Identities=18%  Similarity=0.163  Sum_probs=94.6

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh------------------------------H--------
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH------------------------------K--------  144 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~--------  144 (441)
                      +.||+|++|.||+|+..++.      .||||+.........                              +        
T Consensus       123 ~plasaSigQVh~A~l~~G~------~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGK------EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEecCCC------EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            57999999999999986532      499999764321100                              0        


Q ss_pred             --HHHHHHHHhccC----CCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH-H
Q 013504          145 --EWVTEVNVLGVV----EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR-G  217 (441)
Q Consensus       145 --~~~~E~~il~~l----~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-~  217 (441)
                        .+.+|...+.++    +|.+-+.+..++.+...   ..+|||||++|++|.++..... ...   ....++..++. .
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~---~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~  269 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTS---ERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSF  269 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC---CceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHH
Confidence              133455554444    23333333333332211   2389999999999998765321 122   23456666655 4


Q ss_pred             HHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       218 L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +..+|..   |++|+|+||.||+++.++.++|+|||++....
T Consensus       270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            6788887   99999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4.9e-13  Score=117.24  Aligned_cols=131  Identities=18%  Similarity=0.124  Sum_probs=93.3

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCee-eEEeEEeccccCCeeEEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV-KLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~l  180 (441)
                      ++.|+.|.++.||++...+       ..+++|....... ....+..|+.++..+.+.+++ +++.+..  ..    .++
T Consensus         3 ~~~l~~G~~~~vy~~~~~~-------~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~----~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVAN-------KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ET----GVL   68 (170)
T ss_pred             eeecCCcccCceEEEEECC-------eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC----CeE
Confidence            3568999999999988642       2389998755431 123456899999988655544 4444332  21    289


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM--DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ||||++|.++....          .....++.+++.+|..||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        69 v~e~i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          69 ITEFIEGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEEecCCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999998876430          111345678999999999872  12369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=2.3e-12  Score=131.25  Aligned_cols=145  Identities=14%  Similarity=0.121  Sum_probs=92.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh----------------------------------
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG----------------------------------  142 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------  142 (441)
                      .+|+. +.||+|++|+||+|+++.++.     .||||+....-...                                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~-----~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~  193 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGR-----EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF  193 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCC-----EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence            35666 689999999999999987444     39999987432100                                  


Q ss_pred             hH------HHHHHHHHhccC----CCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCC----CCCHHHHH
Q 013504          143 HK------EWVTEVNVLGVV----EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQA----TLPWNTRL  208 (441)
Q Consensus       143 ~~------~~~~E~~il~~l----~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~----~l~~~~~~  208 (441)
                      .+      .+.+|+..+.++    .+.+.+.+-.++.+-..   ..+|||||++|+.+.+.-.-...+    .+....+.
T Consensus       194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st---~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~  270 (537)
T PRK04750        194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS---ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE  270 (537)
T ss_pred             HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC---CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence            01      133444444444    24444444444432111   248999999999998753211111    12222333


Q ss_pred             HHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC----cEEEeecCCCCCCCC
Q 013504          209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW----NAKLSDFGLARLGPS  260 (441)
Q Consensus       209 ~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~~~~~  260 (441)
                      .++.|+.       ..   |++|+|+||.||+++.++    .++++|||++.....
T Consensus       271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3344433       34   999999999999999888    999999999886644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1.1e-11  Score=110.07  Aligned_cols=141  Identities=15%  Similarity=0.111  Sum_probs=96.1

Q ss_pred             ceeecccceeEEEEEEcCCC-CcccceeEEEEEccccCc--h-------------------h-hHHH----HHHHHHhcc
Q 013504          103 LMIGEGGFGGVYRGVIRSTE-DSHKKIDIAVKQLSRRGL--Q-------------------G-HKEW----VTEVNVLGV  155 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~--~-------------------~-~~~~----~~E~~il~~  155 (441)
                      ..||.|--+.||.|...... .......+|||+.+....  +                   . .+.+    .+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754310 011233589998753110  0                   0 1112    379999998


Q ss_pred             CCC--CCeeeEEeEEeccccCCeeEEEEEeccCCCChHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEe
Q 013504          156 VEH--PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD-HLTSRFQATLPWNTRLKIAQDAARGLAYL-HEGMDFQIIF  231 (441)
Q Consensus       156 l~h--pnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH  231 (441)
                      +..  -++...+++  .  ..    +|||||+.++.+.. .+..   ..++......+..+++.+|..| |..   +|||
T Consensus        83 l~~~Gv~vP~pi~~--~--~~----~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH  148 (197)
T cd05146          83 MQKAGIPCPEVVVL--K--KH----VLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH  148 (197)
T ss_pred             HHHcCCCCCeEEEe--c--CC----EEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            843  456666654  2  22    89999997654422 2222   2445556678889999999998 776   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      +||++.|||+++ +.+.|+|||.+...
T Consensus       149 GDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         149 ADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            999999999974 67999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=2.6e-11  Score=122.16  Aligned_cols=160  Identities=16%  Similarity=0.244  Sum_probs=118.2

Q ss_pred             EEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHH
Q 013504          130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK  209 (441)
Q Consensus       130 vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~  209 (441)
                      |.|...............+-+.-|+.++||||+++++.+..++    ..|||+|.+.  .|..++.+.     .......
T Consensus        40 vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV~--Pl~~~lk~l-----~~~~v~~  108 (690)
T KOG1243|consen   40 VSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERVR--PLETVLKEL-----GKEEVCL  108 (690)
T ss_pred             eEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeeccc--cHHHHHHHh-----HHHHHHH
Confidence            7777766655433345667788899999999999999888776    3599999873  677777653     2556677


Q ss_pred             HHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCc
Q 013504          210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY  289 (441)
Q Consensus       210 i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  289 (441)
                      -+.||+.||.|||..+  +++|++|.-+.|+++..|..||++|-++........  ......---.|..|+.+....  -
T Consensus       109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence            7899999999999653  899999999999999999999999988764322211  111122223456666543322  4


Q ss_pred             cccchhHHHHHHHHHhC
Q 013504          290 KSDIWSFGVFLYELITG  306 (441)
Q Consensus       290 ~~DvwSlG~il~elltG  306 (441)
                      ..|.|.|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            56999999999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.33  E-value=3e-13  Score=141.34  Aligned_cols=248  Identities=19%  Similarity=0.218  Sum_probs=166.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +.|.+..-+-+|.++.++.+.-...+..     .++|.......   ...+....+-.++-..++|.++...--+.-.. 
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~-----~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-  877 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHT-----RPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-  877 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccc-----cchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-
Confidence            4455555677788888887665555432     23333222111   11222233334444445666665543322222 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..+|||+|+.+++|...|+.-  +..+.+.....+..+..+++|||..   .+.|||++|.|+|+..++..+++|||
T Consensus       878 ---P~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  878 ---PLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             ---CcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence               348999999999999999763  4566667777888899999999986   69999999999999999999999998


Q ss_pred             CCCCCCCC-----------------------------CCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHH
Q 013504          254 LARLGPSD-----------------------------GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI  304 (441)
Q Consensus       254 la~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ell  304 (441)
                      ........                             ..........||+.|.+||.+.+......+|+|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            43221100                             0001233568999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCC-CCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          305 TGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       305 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                      +|.+||....+....   +.+             ..... ....+...+....+++...+..+|.+|-.+.
T Consensus      1030 ~g~pp~na~tpq~~f---~ni-------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIF---ENI-------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cCCCCCCCcchhhhh---hcc-------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999765543221   111             00000 0112234556788999999999999997765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.6e-12  Score=129.49  Aligned_cols=247  Identities=20%  Similarity=0.189  Sum_probs=172.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHH--HHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE--WVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      ..+|..+..||.|.|+.|+....+..++    ..+++|.+.+.......+  -+.|+.+...+ -|.+++.++..+....
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~----~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGD----CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCC----ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4579999999999999999987553322    237888776544333222  24677777766 5888888776666555


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEee
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSD  251 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~D  251 (441)
                      ..    |+--|||+++++...+.-  ...+++...+.+..|++.++.++|+.   .++|+|+||+||++..+ +..++.|
T Consensus       340 ~~----~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~  410 (524)
T KOG0601|consen  340 QG----YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGD  410 (524)
T ss_pred             cc----cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccc
Confidence            43    788899999998877632  45678888999999999999999987   99999999999999876 7789999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcC--CccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYA--APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      ||+.......     .....++.+++  ++.......+..+.|++|||.-+.+.++|..--....        +|..   
T Consensus       411 ~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~---  474 (524)
T KOG0601|consen  411 FGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT---  474 (524)
T ss_pred             ccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee---
Confidence            9988642211     22233444555  4555556678889999999999999998864322110        0110   


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                              +. .......+ .....+..+.+.+...++..||.+.++.....
T Consensus       475 --------i~-~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 --------IR-SGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             --------ee-cccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                    00 00001111 22266778888999999999999887766443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5.6e-11  Score=101.83  Aligned_cols=143  Identities=21%  Similarity=0.250  Sum_probs=102.2

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-----h---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-----Q---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ...+|-+|+-+.|+++.+.+..       ..||.-....+     .   ..++..+|+++|.+++--.|.-..-++.+..
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~-------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEA-------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccCCce-------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            5567899999999999876543       33443222111     1   1245678999999886444444444555544


Q ss_pred             cCCeeEEEEEeccCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc---EE
Q 013504          173 ERGIQRLLIYEYMPN-RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AK  248 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~---~k  248 (441)
                      ..    .|+|||++| .++.+++...............++..|-..|.-||.+   +|||+||..+||+|..++.   +.
T Consensus        84 ~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence            43    899999977 5888888765444444444478899999999999998   9999999999999965543   58


Q ss_pred             EeecCCCCC
Q 013504          249 LSDFGLARL  257 (441)
Q Consensus       249 l~DFGla~~  257 (441)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=6e-11  Score=102.12  Aligned_cols=130  Identities=22%  Similarity=0.343  Sum_probs=95.3

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+++|+-+.+|.+.+.+..       +.+|.-......        ...+-.+|+.+|.+++--.|...+=|..+.+.. 
T Consensus         3 ~i~~GAEa~i~~~~~~g~~-------av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~-   74 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLP-------AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG-   74 (204)
T ss_pred             hhhCCcceeEEeeeccCcc-------eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-
Confidence            5789999999998764432       444442222211        123456899999988655554444445555543 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         .|+|||++|..|.+.+...         ...++..|-.-+.-||..   +|+|+||.++||++...+ +.++|||++
T Consensus        75 ---~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg  138 (204)
T COG3642          75 ---LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG  138 (204)
T ss_pred             ---EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence               7999999999999898653         256777888888999998   999999999999998775 999999998


Q ss_pred             CC
Q 013504          256 RL  257 (441)
Q Consensus       256 ~~  257 (441)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            75

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=2.1e-10  Score=104.87  Aligned_cols=146  Identities=19%  Similarity=0.244  Sum_probs=106.8

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCC--CCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEH--PNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.||.|..+.||++...++      ..+++|....... .....+..|+.++..+.+  .++.+++.+....... ...+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g------~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~-~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGG------RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL-GTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecCC------cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc-CCce
Confidence            4689999999999986541      2388998765432 134567889999999865  3457777776543211 1238


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM----------------------------------  225 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------  225 (441)
                      +||||++|.+|.+.+..   ..++......++.+++.+|..||+..                                  
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999988776532   35677777788888888888888520                                  


Q ss_pred             -------------------CCCeEecccCCCcEEEcC--CCcEEEeecCCCCCC
Q 013504          226 -------------------DFQIIFRDFKSSNILLDE--QWNAKLSDFGLARLG  258 (441)
Q Consensus       226 -------------------~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~  258 (441)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                               246799999999999998  666899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=9.4e-10  Score=107.82  Aligned_cols=218  Identities=16%  Similarity=0.229  Sum_probs=152.3

Q ss_pred             ceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCC-C
Q 013504          110 FGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN-R  188 (441)
Q Consensus       110 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~-g  188 (441)
                      -.+.|++....++..     |.+|++.............-+++++++.|+|||++.++|.........+++|++|.++ +
T Consensus       289 ~~Ttyk~~s~~DG~~-----YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  289 SITTYKATSNVDGNA-----YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             cceeEeeeeccCCce-----eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            356789988777665     8889885444443434445688999999999999999998665555567999999886 6


Q ss_pred             ChHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          189 SVQDHLTSR-------------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       189 sL~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                      +|.+.....             .+...++...|.++.|+..||.++|+.   |+..+-|.|.+||++.+..++|+..|+.
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence            888765321             123567889999999999999999998   9999999999999999999999988877


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~  334 (441)
                      .....+.              .  |-+.+   -.+-|.=.||.+++.|.||..--....  ..++. ..           
T Consensus       441 Dvl~~d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d--~~~~s~~~-----------  488 (655)
T KOG3741|consen  441 DVLQEDP--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTD--STQSSHLT-----------  488 (655)
T ss_pred             eeecCCC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccccccccc--chHHHHHH-----------
Confidence            6544331              0  11111   134688899999999999965421111  00110 11           


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                 .....++.++.+++.-....++++ -+..+++.+
T Consensus       489 -----------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  489 -----------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             -----------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                       112245566667777777777765 556666554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.09  E-value=8.7e-09  Score=98.83  Aligned_cols=267  Identities=16%  Similarity=0.216  Sum_probs=160.5

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeE----EeccccC
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGY----CAEDDER  174 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~----~~~~~~~  174 (441)
                      ..++-||+|+-+.+|-.-.-.+        .+.|+..........   .-+..|... .||-+..-+.+    ....+. 
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d--------~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~-   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD--------QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRR-   81 (637)
T ss_pred             CCCccccCCccceeeecchhhc--------hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCc-
Confidence            4556799999999995422111        233555543322222   223334443 56644331111    111111 


Q ss_pred             CeeEEEEEeccCCC-ChHHHHh---h-cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          175 GIQRLLIYEYMPNR-SVQDHLT---S-RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~g-sL~~~l~---~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      +...-++|..+.|. ....++.   . +......|...++.++.++.+..-||..   |.+-+|+.++|+|+.+++.+.|
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEE
Confidence            11134677777664 2222221   1 1124578999999999999999999988   8999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCc-----hh-
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITG-RRPLDRNRP-----KS-  317 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG-~~P~~~~~~-----~~-  317 (441)
                      .|=..-.....   ....-..+|.+.|.+||.-.     +..-+...|.|.||++++++|.| ++||.+...     .. 
T Consensus       159 VdsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~  235 (637)
T COG4248         159 VDSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL  235 (637)
T ss_pred             EcccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence            97543332211   22334568999999999644     34456789999999999999986 999965321     11 


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcc--cCCCCCCHHHHHHHHHHHHhhh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR--QAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      +..+...   .+....+...-..+.-...-..-+++.+..+..+|+..  ++.-||+++..+..|..+.++.
T Consensus       236 E~~Ia~g---~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         236 ETDIAHG---RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hhhhhcc---eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            1111111   01111110000001101111124567889999999964  3678999999999888876543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.09  E-value=1.9e-09  Score=101.17  Aligned_cols=110  Identities=13%  Similarity=0.099  Sum_probs=82.0

Q ss_pred             HHHHHHHHhccCCCC--CeeeEEeEEeccccC-CeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013504          145 EWVTEVNVLGVVEHP--NLVKLIGYCAEDDER-GIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAARGLAY  220 (441)
Q Consensus       145 ~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~-~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  220 (441)
                      .+.+|...+.+|..-  .++..+++....... ...-+||||++++. +|.+++........+......++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            477899988887432  333445555332111 12348999999886 89999864323455667778999999999999


Q ss_pred             HhhCCCCCeEecccCCCcEEEcC-------CCcEEEeecCCCCC
Q 013504          221 LHEGMDFQIIFRDFKSSNILLDE-------QWNAKLSDFGLARL  257 (441)
Q Consensus       221 LH~~~~~~iiHrDlKp~NILl~~-------~~~~kl~DFGla~~  257 (441)
                      ||..   ||+|+|+++.|||++.       ++.+.|+||+.++.
T Consensus       154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9998   9999999999999975       46799999998863

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=9e-09  Score=93.27  Aligned_cols=109  Identities=25%  Similarity=0.257  Sum_probs=86.0

Q ss_pred             HHHHHHHHHhccCC--CCCeeeEEeEEeccccCCeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013504          144 KEWVTEVNVLGVVE--HPNLVKLIGYCAEDDERGIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAARGLAY  220 (441)
Q Consensus       144 ~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  220 (441)
                      ....+|...+..|.  .=.+...+++..........-+||+|++++. +|.+++....  ..+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence            46778888887774  3345566666665443334558999999884 8999987632  26667788999999999999


Q ss_pred             HhhCCCCCeEecccCCCcEEEcCCC---cEEEeecCCCCC
Q 013504          221 LHEGMDFQIIFRDFKSSNILLDEQW---NAKLSDFGLARL  257 (441)
Q Consensus       221 LH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~  257 (441)
                      ||..   ||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9998   999999999999998887   899999998775

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.97  E-value=4.6e-09  Score=93.08  Aligned_cols=96  Identities=20%  Similarity=0.266  Sum_probs=64.1

Q ss_pred             HHHHHHHhccCCCC--CeeeEEeEEeccccCCeeEEEEEeccC--CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-
Q 013504          146 WVTEVNVLGVVEHP--NLVKLIGYCAEDDERGIQRLLIYEYMP--NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY-  220 (441)
Q Consensus       146 ~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-  220 (441)
                      ..+|.+.|.++..-  ++.+++++-  ..      +|||||++  |..+..+...    .++......++.+++..+.. 
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~--~~------~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN--RN------VIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE--TT------EEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe--CC------EEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHH
Confidence            46799999999765  456665442  22      89999998  5555443322    22234566778888886665 


Q ss_pred             HhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       221 LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      +|..   ||+|+||.+.|||++++ .+.|+|||.+..
T Consensus       123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             HHhc---CceecCCChhhEEeecc-eEEEEecCccee
Confidence            4666   99999999999999988 999999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.91  E-value=3.3e-08  Score=88.24  Aligned_cols=143  Identities=19%  Similarity=0.135  Sum_probs=104.0

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccC------chhhHHHHHHHHHhccCCC--CCeeeEEeEEeccccCCe
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG------LQGHKEWVTEVNVLGVVEH--PNLVKLIGYCAEDDERGI  176 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~  176 (441)
                      -|+||.+.|+.-...+.       .+-+|.-....      ......|.+|+..|.+|..  -.+.+...+.........
T Consensus        26 ~~rgG~SgV~r~~~~g~-------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~   98 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW   98 (216)
T ss_pred             cCCCCcceEEEEEeCCc-------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence            47799999998776543       27777754211      1134678999999998842  235555422223333334


Q ss_pred             eEEEEEeccCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc--EEEeecC
Q 013504          177 QRLLIYEYMPN-RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--AKLSDFG  253 (441)
Q Consensus       177 ~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFG  253 (441)
                      .-+||+|-++| .+|.+++....-.+.+......++.+|+..|.-||..   |+.|+|+.+.|||++.++.  ++++||.
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            56899997754 6899998664334567777889999999999999998   9999999999999986667  9999998


Q ss_pred             CCCC
Q 013504          254 LARL  257 (441)
Q Consensus       254 la~~  257 (441)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            7764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.84  E-value=8.2e-10  Score=111.89  Aligned_cols=150  Identities=21%  Similarity=0.332  Sum_probs=105.8

Q ss_pred             HHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCC-------cceeeceecccCcCCccccccC
Q 013504          213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL-------SHVSTAVVGTIGYAAPEYIQTG  285 (441)
Q Consensus       213 qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~  285 (441)
                      +++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+........       ........-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            345999999975  5899999999999999999999999998765433111       0111123445679999999988


Q ss_pred             CCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhc
Q 013504          286 RLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA  364 (441)
Q Consensus       286 ~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  364 (441)
                      ..+.++|+||+||++|.+.. |+.-+.............    .          .+..-...+..+++.++.+-+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~----~----------~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR----N----------LLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh----c----------ccccccccccccCcHHHHHHHHHHhc
Confidence            88999999999999999995 444444332221111110    0          11111123445788899999999999


Q ss_pred             ccCCCCCCHHHHHH
Q 013504          365 RQAKGRPKMSEVVE  378 (441)
Q Consensus       365 ~dP~~RPs~~evl~  378 (441)
                      .++.-||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999997766654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=3.6e-08  Score=90.10  Aligned_cols=136  Identities=18%  Similarity=0.127  Sum_probs=93.1

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch----------------------hhHHHHHHHHHhcc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ----------------------GHKEWVTEVNVLGV  155 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~~  155 (441)
                      =..++..||-|.-+.||.|......      +++||.-+.-...                      ......+|.++|.+
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~------~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGR------KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCC------EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            3556778999999999999876433      4888874321000                      11235689999999


Q ss_pred             CCCC--CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecc
Q 013504          156 VEHP--NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD  233 (441)
Q Consensus       156 l~hp--nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  233 (441)
                      |.-.  .|.+.+++-        .-.+||||++|-.|...-       ++....-.++..|+.-+.-+-..   ||||+|
T Consensus       166 L~~~G~~VP~P~~~n--------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGD  227 (304)
T COG0478         166 LYPEGVKVPKPIAWN--------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGD  227 (304)
T ss_pred             hhhcCCCCCCccccc--------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence            8644  566655432        128999999986665432       12333444555555555544444   999999


Q ss_pred             cCCCcEEEcCCCcEEEeecCCCCC
Q 013504          234 FKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       234 lKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      +.+-||+++++|.+.++||-.+..
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CchheEEEecCCCEEEEeCccccc
Confidence            999999999999999999986654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=1.4e-06  Score=78.98  Aligned_cols=154  Identities=16%  Similarity=0.117  Sum_probs=99.0

Q ss_pred             ccchHHHHHHhcCCcccceeec---ccceeEEEEEEcCCCCcccceeEEEEEccccCchh-------------------h
Q 013504           86 VFTFSELKTATKNFSRSLMIGE---GGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-------------------H  143 (441)
Q Consensus        86 ~~~~~~~~~~~~~f~~~~~LG~---G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~  143 (441)
                      ..+++.+....+...+..+.|.   |.-+.||+|.....      ..+|||+........                   .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~------~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG------RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC------ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            3456666666677766666554   55567999875322      249999976432211                   0


Q ss_pred             HH-----HHHHHHHhccCC--CCCeeeEEeEEeccccCCeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHH
Q 013504          144 KE-----WVTEVNVLGVVE--HPNLVKLIGYCAEDDERGIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAA  215 (441)
Q Consensus       144 ~~-----~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~  215 (441)
                      ++     ...|+.-|.++.  +-.+.+-+++..        -.|||||+... .-.-.|..   .++.......+..+++
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v  176 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVV  176 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHH
Confidence            11     135777777763  344455554442        18999999543 11111221   2333346778888899


Q ss_pred             HHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCC
Q 013504          216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP  259 (441)
Q Consensus       216 ~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  259 (441)
                      +.+.-|-..  .++||+||..-|||+. ++.+.|+|||.|....
T Consensus       177 ~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         177 EYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            999888763  2999999999999999 7799999999887543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.48  E-value=1.2e-08  Score=102.49  Aligned_cols=190  Identities=21%  Similarity=0.152  Sum_probs=131.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC-eeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN-LVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  173 (441)
                      .+..+....-+++|+++++||.+-..+.-      ...+.+...     ....-++++|.+++||| .+..++-+..++ 
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaekl------L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~-  307 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKL------LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED-  307 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhh------eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc-
Confidence            34445555568999999999875433221      224443322     34456889999999999 555444433333 


Q ss_pred             CCeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 RGIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 ~~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                         ...++|+++.++ +........ ...+...+...+.+.-+++|++||+.   .=+|||    ||+..+ +..+..||
T Consensus       308 ---~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  308 ---YLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             ---ccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccc
Confidence               347889999877 222211110 12233445566777778999999975   458998    777766 57899999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD  311 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~  311 (441)
                      +....+....   ...+..+|+.++|||+...+.+....|+|++|+-..++--|-+|-.
T Consensus       376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            9987665432   3456789999999999999999999999999998788887877754

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.47  E-value=1.6e-06  Score=79.61  Aligned_cols=145  Identities=19%  Similarity=0.210  Sum_probs=83.0

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCC--CeeeEEeEEeccccCCeeEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP--NLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~~~~~  179 (441)
                      ++.|+.|..+.||+....+ +      .+++|.....  .....+.+|..+++.+...  .+.+++.+.......+ ..+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~------~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~-~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G------RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG-FPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S------EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS-EEE
T ss_pred             CccCCCCCeeeEEEEEECC-c------EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc-cce
Confidence            3578999999999998765 2      3889987554  3446677898888887432  3566666553333322 358


Q ss_pred             EEEeccCCCChHH----------------HHh---hc--CCCCCCHHH---------HHHH------------HHHHHH-
Q 013504          180 LIYEYMPNRSVQD----------------HLT---SR--FQATLPWNT---------RLKI------------AQDAAR-  216 (441)
Q Consensus       180 lv~E~~~~gsL~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~qi~~-  216 (441)
                      ++|++++|..+..                .+.   ..  ....+....         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999988877                111   11  001111110         0000            111222 


Q ss_pred             HHHHHhh----CCCCCeEecccCCCcEEEc-CCCcEEEeecCCCC
Q 013504          217 GLAYLHE----GMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLAR  256 (441)
Q Consensus       217 ~L~~LH~----~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~  256 (441)
                      .+..++.    .....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2333332    1234799999999999999 66666899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=8.8e-07  Score=90.14  Aligned_cols=143  Identities=18%  Similarity=0.132  Sum_probs=89.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh------------------------------H--------
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH------------------------------K--------  144 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~--------  144 (441)
                      .-|+.++-|+||+|++..+.      .||||+....-....                              .        
T Consensus       131 ~PiAsASIaQVH~A~L~sG~------~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGE------EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEecCCC------EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            46899999999999998743      499999764221100                              0        


Q ss_pred             --HHHHHHHHhccC----CCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 013504          145 --EWVTEVNVLGVV----EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL  218 (441)
Q Consensus       145 --~~~~E~~il~~l----~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L  218 (441)
                        .+.+|..-+.++    +...-+.+-.++.+-..   ..+|+|||++|-.+.+...-+. ..++...+.....++.--.
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~---~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTT---RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccC---CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence              123444444443    22222333333332111   2389999999999988853221 4455333333333322222


Q ss_pred             HHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       219 ~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      -+-|     |++|.|..|-||+++.+|.+.+.|||+......
T Consensus       281 ~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhc-----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2223     899999999999999999999999999876544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.45  E-value=3.8e-06  Score=75.45  Aligned_cols=143  Identities=12%  Similarity=0.095  Sum_probs=91.0

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHH---------HHHHHHhccCC---CCCe
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---------VTEVNVLGVVE---HPNL  161 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~il~~l~---hpnI  161 (441)
                      ....+|...+++-.....-|.+-...+.       .+.+|..........+.|         .+++..+.+++   --..
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~-------kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~  100 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGK-------KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP  100 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCc-------EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence            3557888888888877777777655443       278888765443322222         24444444442   2233


Q ss_pred             eeEEeEEecccc-CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          162 VKLIGYCAEDDE-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       162 v~l~~~~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                      +.++.+..-... .....+|||||++|..|.+...      ++.    .++..+..++.-||..   |++|+|..|.|++
T Consensus       101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFl  167 (229)
T PF06176_consen  101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFL  167 (229)
T ss_pred             ccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEE
Confidence            333322222111 1123368999999988876542      222    3456677889999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCC
Q 013504          241 LDEQWNAKLSDFGLARL  257 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~  257 (441)
                      ++++ .++++||+..+.
T Consensus       168 v~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  168 VSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EECC-cEEEEECccccc
Confidence            9965 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=5.6e-06  Score=76.07  Aligned_cols=139  Identities=18%  Similarity=0.163  Sum_probs=79.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC--eeeEEeEEeccccCCeeEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN--LVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~l  180 (441)
                      ..||+|..+.||+..    +.     .+++|......  ......+|.++++.+..-+  +.+.+++....+.    ..+
T Consensus         7 ~~i~~G~t~~~y~~~----~~-----~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TG-----KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGL   71 (226)
T ss_pred             eeecCCCCcceeEec----CC-----CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eee
Confidence            468999999999831    11     26777765432  2345678999998885333  4556666644443    368


Q ss_pred             EEeccCCCC-hHHHH---------------------hhcCCCCCCHHHHH-HHHH----------HHHH-HHHHHhhC-C
Q 013504          181 IYEYMPNRS-VQDHL---------------------TSRFQATLPWNTRL-KIAQ----------DAAR-GLAYLHEG-M  225 (441)
Q Consensus       181 v~E~~~~gs-L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------qi~~-~L~~LH~~-~  225 (441)
                      |||+++|.+ +...+                     +.......+..... .+..          .+.. ...+|... .
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999998864 21111                     10000011111100 0000          0111 11222211 1


Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            23578999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=1.4e-05  Score=71.18  Aligned_cols=100  Identities=24%  Similarity=0.305  Sum_probs=80.4

Q ss_pred             HHHHHhccCCC-CCeeeEEeEEeccccCCeeEEEEEeccCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 013504          148 TEVNVLGVVEH-PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH---LTSRFQATLPWNTRLKIAQDAARGLAYLHE  223 (441)
Q Consensus       148 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  223 (441)
                      .|.-+|..+.+ +++.+++|+|..        ++|.||...+++...   +.+  -...+|..+.+|+.+++..+.+|+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhc
Confidence            57888888865 699999999942        789999987766421   111  1246899999999999999999998


Q ss_pred             CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       224 ~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .....+.-.|++|+|+-+++++.+|++|...+..
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            6433577799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=1.1e-05  Score=74.97  Aligned_cols=139  Identities=19%  Similarity=0.181  Sum_probs=79.5

Q ss_pred             eecccc-eeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeEEEEE
Q 013504          105 IGEGGF-GGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       105 LG~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      |-.|.. ..||+....+ .      .+.+|......   ...+.+|+.+++.+. +--+.+++++....+.    .++||
T Consensus         6 ~~~g~~~~~v~~~~~~~-~------~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~----~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-P------GLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGR----AWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-C------cEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc----cEEEE
Confidence            334444 7899886432 2      27788775543   334667998888873 4445667766654432    38999


Q ss_pred             eccCCCChHHHH-------------------hhcC--CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 013504          183 EYMPNRSVQDHL-------------------TSRF--QATLPWN--TRLKIAQ--------------------DAARGLA  219 (441)
Q Consensus       183 E~~~~gsL~~~l-------------------~~~~--~~~l~~~--~~~~i~~--------------------qi~~~L~  219 (441)
                      |+++|.+|....                   +...  ..++...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            999998776432                   1000  0011100  0000000                    0111112


Q ss_pred             HHhh----CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          220 YLHE----GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       220 ~LH~----~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .|-.    ...+.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            2211    1124689999999999999987788999997764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.30  E-value=1.5e-05  Score=70.73  Aligned_cols=139  Identities=24%  Similarity=0.318  Sum_probs=95.3

Q ss_pred             CCccccchHHHHHHhcCCcccceeecccc-eeEEEEEEcCCCCcccceeEEEEEccc---cCc-----------------
Q 013504           82 SNLRVFTFSELKTATKNFSRSLMIGEGGF-GGVYRGVIRSTEDSHKKIDIAVKQLSR---RGL-----------------  140 (441)
Q Consensus        82 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~-----------------  140 (441)
                      ..+..|+.     .+.+++..+.||.|.- |.||++...+.       .+|+|.+..   ...                 
T Consensus        27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~-------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~   94 (207)
T PF13095_consen   27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGR-------IYALKLFRFWDYTEPDYTRERFAGHETSLSTP   94 (207)
T ss_pred             CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCe-------EEEEEEeeccccCCCccccccccccccccchh
Confidence            34555555     2278999999999999 99999988664       399999321   100                 


Q ss_pred             -hhhHHHHHHHHHhccC---CCCCe--eeEEeEEeccc--------------cCCeeEEEEEeccCCCChHHHHhhcCCC
Q 013504          141 -QGHKEWVTEVNVLGVV---EHPNL--VKLIGYCAEDD--------------ERGIQRLLIYEYMPNRSVQDHLTSRFQA  200 (441)
Q Consensus       141 -~~~~~~~~E~~il~~l---~hpnI--v~l~~~~~~~~--------------~~~~~~~lv~E~~~~gsL~~~l~~~~~~  200 (441)
                       ....-|..|.+...+|   .+.++  |+++||..-..              .....+-||.||++...           
T Consensus        95 ~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------  163 (207)
T PF13095_consen   95 AHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------  163 (207)
T ss_pred             hhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------
Confidence             0112467788887776   45566  99999985431              11223467888876543           


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       201 ~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                      .+.    ..-+.+|..-|..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       164 ~~~----~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  164 PLQ----IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccc----hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            111    23356677888899987   9999999999985     2389999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=6.2e-06  Score=83.80  Aligned_cols=143  Identities=18%  Similarity=0.136  Sum_probs=87.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-------------------------------hH------H
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-------------------------------HK------E  145 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~  145 (441)
                      +.||.-+.|.||+|+.++..      .||||+-+..-...                               .+      .
T Consensus       167 ~piaaASlaQVhrA~L~~G~------~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGE------DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             chhhhcchhheEEEEecCCC------EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            46999999999999998843      39999865422110                               00      1


Q ss_pred             HHHHHHHh----ccCCCCC---eeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 013504          146 WVTEVNVL----GVVEHPN---LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL  218 (441)
Q Consensus       146 ~~~E~~il----~~l~hpn---Iv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L  218 (441)
                      |.+|.+-.    +.++|-+   -|.+-.++.+-..   .+.|+||||+|..+.+.-.-. ...++...+..-+.++..-+
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st---~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST---KRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc---ceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHH
Confidence            23343322    2334555   1222223322211   359999999998777653211 13455555444444443333


Q ss_pred             HHHhhCCCCCeEecccCCCcEEEcC----CCcEEEeecCCCCCCCC
Q 013504          219 AYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSDFGLARLGPS  260 (441)
Q Consensus       219 ~~LH~~~~~~iiHrDlKp~NILl~~----~~~~kl~DFGla~~~~~  260 (441)
                      -+.|     |++|.|-.|-||+++.    ++.+.+-|||+......
T Consensus       317 If~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  317 IFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3333     8999999999999984    67799999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.20  E-value=1e-05  Score=69.61  Aligned_cols=130  Identities=17%  Similarity=0.192  Sum_probs=86.4

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      ...+.||+|++|.||+|.+.+..       +|+|+-....  ....+..|+++|..+.--++.+=+ |+...+      +
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~-------~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~v-y~yg~~------~   88 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGE-------VALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEV-YFYGED------F   88 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCce-------EEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceE-EEechh------h
Confidence            34567999999999999987653       8888865543  346778899999998766655433 222222      5


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC-CCcEEEcCCCcEEEeecCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK-SSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK-p~NILl~~~~~~kl~DFGla~~  257 (441)
                      +.|||+.|-.|.++-..     .+-...    ..+++.---|-..   ||-|..|. |..++|..++.+.|+||.-|..
T Consensus        89 i~me~i~G~~L~~~~~~-----~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          89 IRMEYIDGRPLGKLEIG-----GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcCcchhhhhhc-----ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            67999999888776542     022222    2344442223333   89999887 4444444444899999998874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.18  E-value=2.7e-05  Score=85.09  Aligned_cols=155  Identities=19%  Similarity=0.257  Sum_probs=91.4

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCC-CCCe--eeEEeEEeccccCCee
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVE-HPNL--VKLIGYCAEDDERGIQ  177 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~~~~~~~  177 (441)
                      ++.|+.|.++.+|+......+.   ...+++|+..... ......+.+|+.+|+.+. |++|  .+++.+|.+....+ .
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~---~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G-~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGS---VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG-T  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCc---ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC-C
Confidence            5668999999999987644321   1236667654322 123356789999999985 6665  77777776543222 2


Q ss_pred             EEEEEeccCCCChHH--------------------HH---hhcC---------CCCCCH--HHHHHHHH-----------
Q 013504          178 RLLIYEYMPNRSVQD--------------------HL---TSRF---------QATLPW--NTRLKIAQ-----------  212 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~--------------------~l---~~~~---------~~~l~~--~~~~~i~~-----------  212 (441)
                      .|+||||++|..+.+                    .|   +...         +.+..+  .++..+..           
T Consensus       119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~  198 (822)
T PLN02876        119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP  198 (822)
T ss_pred             ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence            489999998865321                    11   1100         001011  11211111           


Q ss_pred             ----HHHHHHHHHhhCCC--------CCeEecccCCCcEEEcC-CCc-EEEeecCCCCCCCC
Q 013504          213 ----DAARGLAYLHEGMD--------FQIIFRDFKSSNILLDE-QWN-AKLSDFGLARLGPS  260 (441)
Q Consensus       213 ----qi~~~L~~LH~~~~--------~~iiHrDlKp~NILl~~-~~~-~kl~DFGla~~~~~  260 (441)
                          .+...+.+|..+..        ..+||+|+++.|||++. ++. +-|.||+++.....
T Consensus       199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence                12233556644321        35999999999999985 333 57999999886543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.10  E-value=5.8e-05  Score=67.54  Aligned_cols=133  Identities=17%  Similarity=0.263  Sum_probs=86.6

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccC----------------chhhHHHHHHHHHhccCC------CC
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG----------------LQGHKEWVTEVNVLGVVE------HP  159 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------hp  159 (441)
                      ...||+|+.-.||.--  ....      ..||+.....                ....++..+|+.-...+.      +.
T Consensus         6 ~~~i~~G~~R~cy~HP--~dp~------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~   77 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP--DDPN------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS   77 (199)
T ss_pred             CcccccCCCceEEECC--CCCC------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence            4579999999999632  2221      6777776655                112345566666554444      88


Q ss_pred             CeeeEEeEEeccccCCeeEEEEEeccCC------CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecc
Q 013504          160 NLVKLIGYCAEDDERGIQRLLIYEYMPN------RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD  233 (441)
Q Consensus       160 nIv~l~~~~~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  233 (441)
                      +|.+++|+..++-..    -+|+|.+.+      -+|.+++..   ..++. .....+.+   -..||-..   +|+.+|
T Consensus        78 ~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~---f~~~l~~~---~Iv~~d  143 (199)
T PF10707_consen   78 HIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDE---FKRYLLDH---HIVIRD  143 (199)
T ss_pred             ccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHH---HHHHHHHc---CCeecC
Confidence            999999999887655    567776522      478888854   34554 33333333   34566655   799999


Q ss_pred             cCCCcEEEcCCC----cEEEee-cCCCC
Q 013504          234 FKSSNILLDEQW----NAKLSD-FGLAR  256 (441)
Q Consensus       234 lKp~NILl~~~~----~~kl~D-FGla~  256 (441)
                      |+|.||++..+.    .+.|+| ||-..
T Consensus       144 l~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            999999995332    578887 55433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.07  E-value=6.5e-06  Score=88.55  Aligned_cols=197  Identities=23%  Similarity=0.275  Sum_probs=138.3

Q ss_pred             HHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 013504          148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDF  227 (441)
Q Consensus       148 ~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  227 (441)
                      -|+..+.++.|+|++.+++|-.+....+....+..|+|..-++...+..  -...+....+.+..++.+||.|+|+.   
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~---  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL---  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence            4666777889999999999988776555333455789999999988876  46788899999999999999999986   


Q ss_pred             CeEecccCCC---cEEEcCCCcEEEe--ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCcc--ccchhHHHHH
Q 013504          228 QIIFRDFKSS---NILLDEQWNAKLS--DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK--SDIWSFGVFL  300 (441)
Q Consensus       228 ~iiHrDlKp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwSlG~il  300 (441)
                      ...|.-+...   +.-.+..+.+.++  ||+.++.......   .-....+..+.++|......++.+  .|+|.+|.++
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            4444444443   4444556667777  8888876554321   122344556778887776666554  7999999999


Q ss_pred             HHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          301 YELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       301 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..+..|..+-.....                   ...+++.        .......+...+|+..++++|+++.+++..
T Consensus       383 ~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            999988765321110                   0000100        111146688899999999999999999875

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=9.4e-05  Score=68.42  Aligned_cols=31  Identities=19%  Similarity=0.296  Sum_probs=26.5

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++|+|+.|.|||++.+...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998776567999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.92  E-value=0.00022  Score=68.34  Aligned_cols=80  Identities=14%  Similarity=0.118  Sum_probs=53.3

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC---CCeeeEEeEEeccccCCee
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH---PNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~~~~~  177 (441)
                      ..+.||.|..+.||.....+..       +.+|..+.  ......+..|...|+.+.-   -.+.++++++......+ .
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-------~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g-~   87 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-------PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG-P   87 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-------EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC-C
Confidence            3456999999999987543321       56666432  1123467789999988842   36788888775432211 2


Q ss_pred             EEEEEeccCCCCh
Q 013504          178 RLLIYEYMPNRSV  190 (441)
Q Consensus       178 ~~lv~E~~~~gsL  190 (441)
                      .+||||+++|+++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            4999999998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=0.00013  Score=68.34  Aligned_cols=137  Identities=15%  Similarity=0.077  Sum_probs=74.7

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCe-eeEEeEEeccccCCeeEEEEEe
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL-VKLIGYCAEDDERGIQRLLIYE  183 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~lv~E  183 (441)
                      +..|-.+.+|+....+  .     .+.+|..........-...+|..+++.+..-++ .+++...  .+      ++|||
T Consensus         4 ~~~G~tn~~y~~~~~~--~-----~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~------~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPG--I-----SFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH------WLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEeCC--c-----cEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC------EEEEE
Confidence            5567788999876322  1     277776544322110124578888888854333 3333332  11      68999


Q ss_pred             ccCCCChHHH-----------------HhhcC--CCCCCHH-HHHHHHHHH---------HHHHHHHhhC-----CCCCe
Q 013504          184 YMPNRSVQDH-----------------LTSRF--QATLPWN-TRLKIAQDA---------ARGLAYLHEG-----MDFQI  229 (441)
Q Consensus       184 ~~~~gsL~~~-----------------l~~~~--~~~l~~~-~~~~i~~qi---------~~~L~~LH~~-----~~~~i  229 (441)
                      |++|..+...                 |+...  ..+++.. ....+..++         ...+..+-..     ....+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9998765421                 11110  1112211 111211111         1111212111     12358


Q ss_pred             EecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          230 IFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       230 iHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      +|+|+.|.||++++++ +.|+||..+..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.78  E-value=0.00032  Score=64.68  Aligned_cols=31  Identities=26%  Similarity=0.387  Sum_probs=27.1

Q ss_pred             CCeEecccCCCcEEEcC-CCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDE-QWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~  257 (441)
                      ..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            46999999999999998 57899999987764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.00022  Score=68.30  Aligned_cols=146  Identities=18%  Similarity=0.148  Sum_probs=80.9

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC--eeeEEeEEeccc--cCCee
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN--LVKLIGYCAEDD--ERGIQ  177 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~--~~~~~  177 (441)
                      ++.|..|....+|+....+.       .+++|+...   .....+..|+.++..+.+-+  +.+++.......  .....
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-------~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-------RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             eecccCccccceEEEEeCCC-------cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            45677788789998764332       278888754   22345667888887774322  444433110000  00113


Q ss_pred             EEEEEeccCCCChHH----H----------Hhhc---CCC------CCCHHHHH----------HHHHHHHHHHHHHhh-
Q 013504          178 RLLIYEYMPNRSVQD----H----------LTSR---FQA------TLPWNTRL----------KIAQDAARGLAYLHE-  223 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~----~----------l~~~---~~~------~l~~~~~~----------~i~~qi~~~L~~LH~-  223 (441)
                      .++|++|++|..+..    .          ++..   ...      ...|....          .....+...+.++.. 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            488999999876532    0          1100   000      01111110          011112333444442 


Q ss_pred             ---CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          224 ---GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       224 ---~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                         ....+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence               1234799999999999999987778999997764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.63  E-value=0.0016  Score=64.71  Aligned_cols=76  Identities=17%  Similarity=0.149  Sum_probs=50.0

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEcccc------C-chhhHHHHHHHHHhccCC---CCCeeeEEeEEeccc
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR------G-LQGHKEWVTEVNVLGVVE---HPNLVKLIGYCAEDD  172 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  172 (441)
                      +.||.|.++.||++....+..     .+.||.-...      . .-...+...|.+.|..+.   -.++.+++.+-.  +
T Consensus        32 ~elggGn~N~VyrV~~~~g~~-----svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~  104 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGK-----SVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E  104 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCe-----EEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C
Confidence            468999999999998754321     3888874321      1 113456677888888762   245777776633  2


Q ss_pred             cCCeeEEEEEeccCCCC
Q 013504          173 ERGIQRLLIYEYMPNRS  189 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gs  189 (441)
                      .    .++||||+++..
T Consensus       105 ~----~~lVME~L~~~~  117 (401)
T PRK09550        105 L----AVTVMEDLSDHK  117 (401)
T ss_pred             C----CEEEEecCCCcc
Confidence            2    289999998744

>PRK05231 homoserine kinase; Provisional

Probab=97.58  E-value=0.0023  Score=61.97  Aligned_cols=32  Identities=22%  Similarity=0.245  Sum_probs=27.0

Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++||+|+.|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            34899999999999999765568999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.57  E-value=9.8e-06  Score=89.13  Aligned_cols=177  Identities=11%  Similarity=0.038  Sum_probs=123.3

Q ss_pred             EEEEEccccCchhhHH-----HHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCC--CCC
Q 013504          130 IAVKQLSRRGLQGHKE-----WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ--ATL  202 (441)
Q Consensus       130 vavK~~~~~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~l  202 (441)
                      +.+++.+....+...+     ...|..-++...|+++...+.-.......  ..+.+++|+.+|.+.+.|.+...  ..+
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~--ee~~r~~~~~~g~~f~iIikg~ee~~~l 1332 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST--EEYIRSLYVEFGKLFSIIIKGLEESPDL 1332 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh--HHHHHHHHHHHhHHHHHHHhccccCCcc
Confidence            4566665544443333     33455555667899988776554433322  44889999999999999864321  223


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCC--CeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcc
Q 013504          203 PWNTRLKIAQDAARGLAYLHEGMDF--QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE  280 (441)
Q Consensus       203 ~~~~~~~i~~qi~~~L~~LH~~~~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  280 (441)
                      +..-+.....+.+.+..-+|+..+.  -.+|+++|+-|.+|..+..+|++++|+.+.....  ........+++.|+.|+
T Consensus      1333 d~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~ql 1410 (2724)
T KOG1826|consen 1333 DRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQL 1410 (2724)
T ss_pred             hhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHH
Confidence            3222333333336666666654322  3689999999999999999999999999943322  22345678899999999


Q ss_pred             ccccCCCCccccchhHHHHHHHHHhCCCCC
Q 013504          281 YIQTGRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       281 ~~~~~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                      +...-.++.++|+|..|+.+|+..-|..+|
T Consensus      1411 i~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1411 IKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            988888999999999999999998888776

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0032  Score=60.71  Aligned_cols=147  Identities=15%  Similarity=0.122  Sum_probs=78.3

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC--eeeEEeEEecc--ccCCee
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN--LVKLIGYCAED--DERGIQ  177 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~--~~~~~~  177 (441)
                      ++.++.|....+|+....+.       .+.+|+.....  ....+..|+.++..|...+  +.+++......  ......
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-------~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-------RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             ccccCCccccceEEEEeCCC-------cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            45677777789998764322       26778764421  1234556777777663222  34443321100  000113


Q ss_pred             EEEEEeccCCCChHH-----------H---HhhcC-C--CC-------CCHHHHH------------HHHHHHHHHHHHH
Q 013504          178 RLLIYEYMPNRSVQD-----------H---LTSRF-Q--AT-------LPWNTRL------------KIAQDAARGLAYL  221 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~-----------~---l~~~~-~--~~-------l~~~~~~------------~i~~qi~~~L~~L  221 (441)
                      .++||+|++|..+..           .   ++... +  ..       -.|....            .....+...+.++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            589999998854321           1   11100 0  00       0111100            0011223345555


Q ss_pred             hh----CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          222 HE----GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       222 H~----~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..    ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            32    2245899999999999999887778999997753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.35  E-value=0.0017  Score=62.38  Aligned_cols=32  Identities=28%  Similarity=0.304  Sum_probs=27.8

Q ss_pred             CCCeEecccCCCcEEEcCC----CcEEEeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQ----WNAKLSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~  257 (441)
                      ...++|+|+.|.|||++++    +.+.|+||..|..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            4578999999999999985    7899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.21  E-value=0.00036  Score=65.92  Aligned_cols=145  Identities=15%  Similarity=0.123  Sum_probs=90.6

Q ss_pred             cchHHHHHHhc---CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccc--cCc---------------hhh---
Q 013504           87 FTFSELKTATK---NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGL---------------QGH---  143 (441)
Q Consensus        87 ~~~~~~~~~~~---~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~---------------~~~---  143 (441)
                      +.+-.+++..+   =+++++.||-|.-+.||.+.+.....      .++|.-+.  ...               ..+   
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~------~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyL  152 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNP------LILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYL  152 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCc------hhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhh
Confidence            33444444443   36788899999999999998764432      45544221  000               001   


Q ss_pred             --HHHHHHHHHhccCC-CC-CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 013504          144 --KEWVTEVNVLGVVE-HP-NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA  219 (441)
Q Consensus       144 --~~~~~E~~il~~l~-hp-nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~  219 (441)
                        -...+|+..|+.|. |- -|.+.+++.        ..++|||++.|-.|...-+-     .+..   .+...+..-+.
T Consensus       153 SRlaa~kEfafmkaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv  216 (465)
T KOG2268|consen  153 SRLAATKEFAFMKALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIV  216 (465)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHH
Confidence              12357888888873 32 233443332        23889999999887654322     1222   23333333444


Q ss_pred             HHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       220 ~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      -|-..   |+||+|..-=||++++++.++++||-...
T Consensus       217 ~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  217 RLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHc---CceecccchheeEEecCCCEEEeechHhh
Confidence            55555   99999999999999999999999997554

>PLN02236 choline kinase

Probab=97.05  E-value=0.0086  Score=58.70  Aligned_cols=144  Identities=14%  Similarity=0.172  Sum_probs=78.4

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCee-eEEeEEeccccCCeeEEEEE
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV-KLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~lv~  182 (441)
                      .|-.|-...+|+........ .....+.+|........... -.+|..++..+..-++. ++++++..        ..|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~-~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~  112 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEG-NLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN--------GRVE  112 (344)
T ss_pred             EcCCcccceeEEEEeCCCCC-CCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC--------ceEE
Confidence            45457788999987543211 11234778877654322222 25788888888543333 44555421        2478


Q ss_pred             eccCCCChHHH-----------------HhhcC--CC--CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 013504          183 EYMPNRSVQDH-----------------LTSRF--QA--TLPWNTRLKIAQDA-----------------ARGLAYL---  221 (441)
Q Consensus       183 E~~~~gsL~~~-----------------l~~~~--~~--~l~~~~~~~i~~qi-----------------~~~L~~L---  221 (441)
                      +|+++.+|...                 ++...  ..  ...+..+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99988776421                 11100  00  11123332332211                 1111112   


Q ss_pred             -hh-CCCCCeEecccCCCcEEEcC-CCcEEEeecCCCCC
Q 013504          222 -HE-GMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLARL  257 (441)
Q Consensus       222 -H~-~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~  257 (441)
                       .. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             21 11336899999999999986 46799999987764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.96  E-value=0.0014  Score=65.48  Aligned_cols=165  Identities=21%  Similarity=0.267  Sum_probs=92.2

Q ss_pred             HHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 013504          144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE  223 (441)
Q Consensus       144 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  223 (441)
                      .+++-...+++.+.|+|...++++.......   ..+|||++ +.+|++.+..+.   +-.      ....      -| 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~---l~~------~s~~------~~-   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGN---LKD------ESLL------AH-   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhcc---cch------hhhc------cc-
Confidence            4555667888899999999999887655443   57899999 779999987642   111      1101      11 


Q ss_pred             CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHH
Q 013504          224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL  303 (441)
Q Consensus       224 ~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el  303 (441)
                          ++.|-.+            ++++| -++...                    |-     ...+++|||++|.++.|+
T Consensus        87 ----~~~~~~~------------~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~el  124 (725)
T KOG1093|consen   87 ----GVLHLNI------------IYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIILEL  124 (725)
T ss_pred             ----ccceehh------------hhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHHHH
Confidence                3333221            23333 111000                    00     111499999999999999


Q ss_pred             HhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHH
Q 013504          304 ITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV  376 (441)
Q Consensus       304 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  376 (441)
                      .-|..-+.....   .+....+...............   .......+...+.++...|+-..|..||...+.
T Consensus       125 ~L~~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  125 YLGISLEAELTE---SEYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHhhHHHHHHHH---HHHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            998766532221   1111222121111111110000   012333566778889999999999888754443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.92  E-value=0.0054  Score=55.06  Aligned_cols=135  Identities=16%  Similarity=0.134  Sum_probs=82.2

Q ss_pred             EEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHH
Q 013504          130 IAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL  208 (441)
Q Consensus       130 vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~  208 (441)
                      ..+|++...... ...-+..+.+++.+++  .|+++.    .+  .+...-++.|+|-...              ....-
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~----ND--n~~~yGvIlE~Cy~~~--------------i~~~N  145 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK----ND--NNYKYGVILERCYKIK--------------INFSN  145 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee----cC--CCceeEEEEeeccCcc--------------cchhH
Confidence            556666554433 3345677888888875  477775    22  2234467889883211              11112


Q ss_pred             HHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCC
Q 013504          209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT  288 (441)
Q Consensus       209 ~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  288 (441)
                      .|..+ +..|.-.|+. +.+.+|+|-.|+||+-|..|.+||.|-+..-.-              +..|.--   .....+
T Consensus       146 ~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~---~Y~~lT  206 (308)
T PF07387_consen  146 FITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNI---EYESLT  206 (308)
T ss_pred             HHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEee---eccccC
Confidence            22222 4678888965 458999999999999999999999998754310              1112111   123456


Q ss_pred             ccccchhHHHHHHHHHh
Q 013504          289 YKSDIWSFGVFLYELIT  305 (441)
Q Consensus       289 ~~~DvwSlG~il~ellt  305 (441)
                      .++.+-+|=.-++++..
T Consensus       207 ~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  207 QEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             hHHHHHHHHHHHHHHHH
Confidence            66666666666666655

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.79  E-value=0.025  Score=56.18  Aligned_cols=73  Identities=16%  Similarity=0.105  Sum_probs=47.6

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-------hhhHHHHHHHHHhccCC---CCCeeeEEeEEecc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-------QGHKEWVTEVNVLGVVE---HPNLVKLIGYCAED  171 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  171 (441)
                      .+.||-|....||+..... +      .+.||+-.....       -...+-..|...|..+.   ..++.+++.++.+.
T Consensus        37 ~~eiggGn~N~VyrV~~~~-~------svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS-G------SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC-c------cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC
Confidence            4568999999999977532 1      277877542111       12334455677776653   24788888887743


Q ss_pred             ccCCeeEEEEEeccCC
Q 013504          172 DERGIQRLLIYEYMPN  187 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~  187 (441)
                      .      +++|||+++
T Consensus       110 ~------vlvME~L~~  119 (418)
T PLN02756        110 A------LIGMRYLEP  119 (418)
T ss_pred             C------EEEEeecCC
Confidence            3      889999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.75  E-value=0.02  Score=54.97  Aligned_cols=35  Identities=23%  Similarity=0.460  Sum_probs=30.7

Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      ...++|+|+.+.||+++.+.-+=+.||+++.....
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            34699999999999999988899999999987554

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.74  E-value=0.012  Score=56.93  Aligned_cols=139  Identities=15%  Similarity=0.172  Sum_probs=90.1

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---------------------hhHH-----HHHHHHHhcc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---------------------GHKE-----WVTEVNVLGV  155 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~-----~~~E~~il~~  155 (441)
                      -..|..|.-+.||.+...++.      .+|||+++..-..                     ..+.     ...|++-|.+
T Consensus       149 nGCiSTGKEANVYHat~~dG~------~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR  222 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGS------EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR  222 (520)
T ss_pred             ccccccCccceeEeeecCCCc------eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence            346777888889998765543      3899987632110                     0011     2357777888


Q ss_pred             CCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 013504          156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ-DHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF  234 (441)
Q Consensus       156 l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  234 (441)
                      |+.-.|.-.--+.. ..     .+|||+|+...... -.|.   ...++...+..+-.|++.-+.-|-+.|  ++||.||
T Consensus       223 l~~aGIP~PePIlL-k~-----hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL  291 (520)
T KOG2270|consen  223 LNNAGIPCPEPILL-KN-----HVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL  291 (520)
T ss_pred             HHhcCCCCCCceee-ec-----ceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence            76544332111111 11     27999999532211 1122   245667778888888988888888765  8999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCCCCC
Q 013504          235 KSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       235 Kp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      .--|+|+.++ .+.|+|-+.+...
T Consensus       292 SEfN~LyhdG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  292 SEFNLLYHDG-KLYIIDVSQSVEH  314 (520)
T ss_pred             hhhhheEECC-EEEEEEccccccC
Confidence            9999998754 7999999887643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.029  Score=54.73  Aligned_cols=73  Identities=14%  Similarity=0.114  Sum_probs=43.9

Q ss_pred             eeecccceeEEEEEEcCCCCcccceeEEEEEcccc------C-chhhHHHHHHHHHhccCC--CC-CeeeEEeEEecccc
Q 013504          104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR------G-LQGHKEWVTEVNVLGVVE--HP-NLVKLIGYCAEDDE  173 (441)
Q Consensus       104 ~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~  173 (441)
                      .||-|....||++....+.     ..|.||.-...      . .-...+...|...|+...  -| .+.+++.|-.  +.
T Consensus         2 EigdGnlN~VfrV~~~~g~-----~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGD-----RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCC-----eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--cc
Confidence            4799999999999864321     23788774321      1 112345567888887653  34 4555544432  22


Q ss_pred             CCeeEEEEEeccCC
Q 013504          174 RGIQRLLIYEYMPN  187 (441)
Q Consensus       174 ~~~~~~lv~E~~~~  187 (441)
                          ..+|||+++.
T Consensus        75 ----~~~vMEdL~~   84 (370)
T TIGR01767        75 ----AVTVMEDLSH   84 (370)
T ss_pred             ----ceehHhhCcc
Confidence                2789999955

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.65  E-value=0.02  Score=54.29  Aligned_cols=31  Identities=29%  Similarity=0.527  Sum_probs=26.1

Q ss_pred             CeEecccCCCcEEEcCCCc-EEEeecCCCCCC
Q 013504          228 QIIFRDFKSSNILLDEQWN-AKLSDFGLARLG  258 (441)
Q Consensus       228 ~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~  258 (441)
                      .++|+|+.|.|||+++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            5899999999999997555 569999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.58  E-value=0.01  Score=57.19  Aligned_cols=71  Identities=24%  Similarity=0.290  Sum_probs=55.0

Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .|++|++- |+++.- +     +.-.+.++..++.+.+..+.-+..+  ...=|||+.-.||||+ +|+|-|+||-++|.
T Consensus       301 ~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         301 LYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            46666664 444431 1     2346788999999988877777764  5889999999999999 99999999999995


Q ss_pred             C
Q 013504          258 G  258 (441)
Q Consensus       258 ~  258 (441)
                      .
T Consensus       371 ~  371 (488)
T COG5072         371 S  371 (488)
T ss_pred             c
Confidence            3

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.35  E-value=0.059  Score=51.85  Aligned_cols=30  Identities=23%  Similarity=0.375  Sum_probs=26.2

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            48999999999999988 6789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.29  E-value=0.035  Score=52.79  Aligned_cols=74  Identities=20%  Similarity=0.264  Sum_probs=42.6

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC---CCCCeeeEEeEEeccccCCee
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV---EHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      ..+.|+.|....+|+..  ..+.     .+.||.-..   .....|..|..-|+.|   .--.+.+++++....+..   
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~-----~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~---   87 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGG-----SYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA---   87 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS------EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC---
T ss_pred             eeEecCCCChhheEEEE--CCCc-----cEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc---
Confidence            34568889999999876  2222     388888652   2234566788777776   334577788877665544   


Q ss_pred             EEEEEeccCCC
Q 013504          178 RLLIYEYMPNR  188 (441)
Q Consensus       178 ~~lv~E~~~~g  188 (441)
                       ||||||++.+
T Consensus        88 -fLlle~l~~~   97 (288)
T PF03881_consen   88 -FLLLEFLEMG   97 (288)
T ss_dssp             -EEEEE-----
T ss_pred             -eEEEEeecCC
Confidence             9999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.94  E-value=0.085  Score=51.41  Aligned_cols=30  Identities=23%  Similarity=0.356  Sum_probs=25.6

Q ss_pred             CeEecccCCCcEEEcC-CCcEEEeecCCCCC
Q 013504          228 QIIFRDFKSSNILLDE-QWNAKLSDFGLARL  257 (441)
Q Consensus       228 ~iiHrDlKp~NILl~~-~~~~kl~DFGla~~  257 (441)
                      -++|+|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4789999999999975 56899999997753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.68  E-value=0.14  Score=49.64  Aligned_cols=143  Identities=22%  Similarity=0.297  Sum_probs=77.7

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-C--CC---eeeEEeEEeccccCCeeE
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-H--PN---LVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h--pn---Iv~l~~~~~~~~~~~~~~  178 (441)
                      |.+ .-..||+....+..       +.+|+....  ....++..|...|..|. +  +=   |..+-|-....-..+...
T Consensus        34 l~s-~eN~~f~~~~~~g~-------~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~  103 (331)
T COG2334          34 LNS-EENSNFRVQTEDGR-------YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP  103 (331)
T ss_pred             ccc-ccCceEEEEecCCC-------eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence            444 45568887765543       677777654  23455566777777663 1  11   222212111110111245


Q ss_pred             EEEEeccCCCChHH-H--------------Hhh--c-C-------CCCCCHHH-------------HHHHHHHHHHHHHH
Q 013504          179 LLIYEYMPNRSVQD-H--------------LTS--R-F-------QATLPWNT-------------RLKIAQDAARGLAY  220 (441)
Q Consensus       179 ~lv~E~~~~gsL~~-~--------------l~~--~-~-------~~~l~~~~-------------~~~i~~qi~~~L~~  220 (441)
                      +-|++|++|..+.. .              |+.  + .       .....|..             ......++...+..
T Consensus       104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~  183 (331)
T COG2334         104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR  183 (331)
T ss_pred             EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence            77899999987772 1              110  0 0       00122220             01123334444444


Q ss_pred             HhhCC----CC-C--eEecccCCCcEEEcCCCc-EEEeecCCCCC
Q 013504          221 LHEGM----DF-Q--IIFRDFKSSNILLDEQWN-AKLSDFGLARL  257 (441)
Q Consensus       221 LH~~~----~~-~--iiHrDlKp~NILl~~~~~-~kl~DFGla~~  257 (441)
                      +....    .. +  +||+|+.|.||+++.+.. +.++|||-+..
T Consensus       184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            44321    22 3  999999999999999885 89999997763

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.57  E-value=0.11  Score=51.50  Aligned_cols=75  Identities=20%  Similarity=0.189  Sum_probs=45.9

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEcccc-----C-chhhHHHHHHHHHhccCC--CC-CeeeEEeEEeccc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-----G-LQGHKEWVTEVNVLGVVE--HP-NLVKLIGYCAEDD  172 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~  172 (441)
                      .+.||-|.-.-||++.......     .|.||+-...     . .-...+...|..+|+...  -| ++.+++.+-.  +
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~-----svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNI-----SVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--V  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCc-----eEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--H
Confidence            4568999999999998742122     2777774321     1 112356667888888763  34 4555654432  2


Q ss_pred             cCCeeEEEEEeccCC
Q 013504          173 ERGIQRLLIYEYMPN  187 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~  187 (441)
                      .    ..+|||+++.
T Consensus       107 ~----~~~vMEdL~~  117 (409)
T PRK12396        107 M----NCCVMEDLSD  117 (409)
T ss_pred             H----hhHHHHhCcc
Confidence            2    2789999865

>PTZ00384 choline kinase; Provisional

Probab=95.37  E-value=0.19  Score=49.98  Aligned_cols=29  Identities=28%  Similarity=0.237  Sum_probs=24.0

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ...+|.|+-+.|||.+++ .+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence            367899999999997654 69999997664

>PRK06148 hypothetical protein; Provisional

Probab=95.17  E-value=0.22  Score=55.97  Aligned_cols=32  Identities=38%  Similarity=0.391  Sum_probs=26.7

Q ss_pred             CCCeEecccCCCcEEEcCCC--cEE-EeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQW--NAK-LSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~--~~k-l~DFGla~~  257 (441)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            44799999999999998875  554 999998764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.10  E-value=0.09  Score=51.66  Aligned_cols=60  Identities=18%  Similarity=0.232  Sum_probs=42.2

Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecccCCCcEEEcCC
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      .|+=+|..|-++..++...   ..++....+++.--+.||--+- -.   +++|.|+.|.||++..+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEEec
Confidence            6677889999999999763   4455555666655555554322 22   79999999999999543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.26  E-value=0.33  Score=44.19  Aligned_cols=56  Identities=23%  Similarity=0.335  Sum_probs=35.9

Q ss_pred             eEEEEEccccCchhhHHHHHHHHHhccCC---CCCeeeEEeEEeccccCCeeEEEEEeccCCCChH
Q 013504          129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVE---HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ  191 (441)
Q Consensus       129 ~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~  191 (441)
                      ++.||.-...   ....|..|+.-|..|.   --++.+++.+-...+.    .|+||||++-|.+.
T Consensus        41 ~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~----sylVle~L~~~~~d   99 (286)
T COG3001          41 PFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDH----SYLVLEYLPTGPLD   99 (286)
T ss_pred             ceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe----eEEEEeeccCCCCC
Confidence            3777765432   2345667877776663   3456666665555443    49999999887665

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.00  E-value=0.091  Score=50.41  Aligned_cols=80  Identities=16%  Similarity=0.139  Sum_probs=44.4

Q ss_pred             EEEEeccCC--CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCcEEEcCC-----------
Q 013504          179 LLIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG-MDFQIIFRDFKSSNILLDEQ-----------  244 (441)
Q Consensus       179 ~lv~E~~~~--gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDlKp~NILl~~~-----------  244 (441)
                      .+|++++-.  ..+..-.....+-..-.+-+..++.||+.-.--+-.. +-.+.+|-||||+|||+-+.           
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            577776422  2222222222233333455667777875433113222 12379999999999999332           


Q ss_pred             -------CcEEEeecCCCCCC
Q 013504          245 -------WNAKLSDFGLARLG  258 (441)
Q Consensus       245 -------~~~kl~DFGla~~~  258 (441)
                             -.++|.||.+++..
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             EEEecccceeeecccCHHHhc
Confidence                   23677888887753

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=93.78  E-value=0.79  Score=46.46  Aligned_cols=81  Identities=10%  Similarity=0.087  Sum_probs=45.3

Q ss_pred             ccceeecccceeEEEEEEcCCCCc---ccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCee-eEEeEEeccccCCe
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDS---HKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV-KLIGYCAEDDERGI  176 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~  176 (441)
                      .++.|..|-...+|++........   .....|.+++......... .-.+|..++..+..-+|. ++++.+.  +    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC--C----
Confidence            345566677788998875432111   1123477777654322211 224678887777544444 3444442  1    


Q ss_pred             eEEEEEeccCCCCh
Q 013504          177 QRLLIYEYMPNRSV  190 (441)
Q Consensus       177 ~~~lv~E~~~~gsL  190 (441)
                        ..|.||++|.+|
T Consensus       182 --g~I~efi~g~~l  193 (442)
T PTZ00296        182 --GRIEEWLYGDPL  193 (442)
T ss_pred             --CEEEEeeCCccC
Confidence              568999998754

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.42  E-value=0.071  Score=47.10  Aligned_cols=29  Identities=17%  Similarity=0.196  Sum_probs=25.9

Q ss_pred             CeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          228 QIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       228 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      -.+|+|+.|.||++++++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            568999999999998887 89999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	441
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-34
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 120/305 (39%), Positives = 172/305 (56%), Gaps = 19/305 (6%)
Query: 82  SNLRVFTFSELKTATKNFS-RSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGL 140
             L+ F+  EL+ A+ NFS ++++            +   T        +AVK+L     
Sbjct: 23  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-------VAVKRLKEERX 75
Query: 141 QGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-- 197
           QG + ++ TEV ++ +  H NL++L G+C    ER    LL+Y YM N SV   L  R  
Sbjct: 76  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPE 131
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
            Q  L W  R +IA  +ARGLAYLH+  D +II RD K++NILLDE++ A + DFGLA+L
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191
Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
                  HV  AV GTIG+ APEY+ TG+ + K+D++ +GV L ELITG+R  D  R  +
Sbjct: 192 MDYKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 250
Query: 318 EQK--LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
           +    LL+WV+  L + KK   ++D  L+G Y  +  ++L  VA  C       RPKMSE
Sbjct: 251 DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 309
Query: 376 VVEVL 380
           VV +L
Sbjct: 310 VVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/256 (42%), Positives = 153/256 (59%), Gaps = 11/256 (4%)
Query: 130 IAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK+L     QG + ++ TEV ++ +  H NL++L G+C    ER    LL+Y YM N 
Sbjct: 57  VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANG 112
Query: 189 SVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
           SV   L  R   Q  L W  R +IA  +ARGLAYLH+  D +II RD K++NILLDE++ 
Sbjct: 113 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG 306
           A + DFGLA+L       HV  AV G IG+ APEY+ TG+ + K+D++ +GV L ELITG
Sbjct: 173 AVVGDFGLAKLMDYKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
Query: 307 RRPLDRNRPKSEQK--LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA 364
           +R  D  R  ++    LL+WV+  L + KK   ++D  L+G Y  +  ++L  VA  C  
Sbjct: 232 QRAFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 290
Query: 365 RQAKGRPKMSEVVEVL 380
                RPKMSEVV +L
Sbjct: 291 SSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 112/293 (38%), Positives = 161/293 (54%), Gaps = 24/293 (8%)
Query: 91  ELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV 150
           +L+ AT NF    +I           V+R   D  K   +A+K+ +    QG +E+ TE+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAK---VALKRRTPESSQGIEEFETEI 86
Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP-----WN 205
             L    HP+LV LIG+C E +E     +LIY+YM N +++ HL   + + LP     W 
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEM----ILIYKYMENGNLKRHL---YGSDLPTMSMSWE 139
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
            RL+I   AARGL YLH      II RD KS NILLDE +  K++DFG+++ G   G +H
Sbjct: 140 QRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTH 196
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW- 324
           +   V GT+GY  PEY   GRLT KSD++SFGV L+E++  R  + ++ P+    L EW 
Sbjct: 197 LXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
           V  H  +  +   I+DP L  K   +  +K    A KCLA  ++ RP M +V+
Sbjct: 257 VESH--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 160/293 (54%), Gaps = 24/293 (8%)
Query: 91  ELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV 150
           +L+ AT NF    +I           V+R   D  K   +A+K+ +    QG +E+ TE+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAK---VALKRRTPESSQGIEEFETEI 86
Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP-----WN 205
             L    HP+LV LIG+C E +E     +LIY+YM N +++ HL   + + LP     W 
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEM----ILIYKYMENGNLKRHL---YGSDLPTMSMSWE 139
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
            RL+I   AARGL YLH      II RD KS NILLDE +  K++DFG+++ G     +H
Sbjct: 140 QRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW- 324
           +   V GT+GY  PEY   GRLT KSD++SFGV L+E++  R  + ++ P+    L EW 
Sbjct: 197 LXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
           V  H  +  +   I+DP L  K   +  +K    A KCLA  ++ RP M +V+
Sbjct: 257 VESH--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 165/309 (53%), Gaps = 31/309 (10%)
Query: 87  FTFSELKTATKNFS-RSLMIXXXXXXXXXXXVI-----RSTEDSHKK----IDIAVKQLS 136
           F+F ELK  T NF  R + +           V+      +T  + KK    +DI  ++L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 137 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
           +       ++  E+ V+   +H NLV+L+G+ ++ D+      L+Y YMPN S+ D L S
Sbjct: 75  Q-------QFDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL-S 122
Query: 197 RFQATLP--WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
               T P  W+ R KIAQ AA G+ +LHE      I RD KS+NILLDE + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
           AR       + + + +VGT  Y APE ++ G +T KSDI+SFGV L E+ITG   +D +R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS 374
               Q LL+       + K     +D K+    S  + + + +VA++CL  +   RP + 
Sbjct: 239 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIK 295
Query: 375 EVVEVLNKI 383
           +V ++L ++
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 164/309 (53%), Gaps = 31/309 (10%)
Query: 87  FTFSELKTATKNFS-RSLMIXXXXXXXXXXXVI-----RSTEDSHKK----IDIAVKQLS 136
           F+F ELK  T NF  R + +           V+      +T  + KK    +DI  ++L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 137 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
           +       ++  E+ V+   +H NLV+L+G+ ++ D+      L+Y YMPN S+ D L S
Sbjct: 75  Q-------QFDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL-S 122
Query: 197 RFQATLP--WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
               T P  W+ R KIAQ AA G+ +LHE      I RD KS+NILLDE + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
           AR       + +   +VGT  Y APE ++ G +T KSDI+SFGV L E+ITG   +D +R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS 374
               Q LL+       + K     +D K+    S  + + + +VA++CL  +   RP + 
Sbjct: 239 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIK 295
Query: 375 EVVEVLNKI 383
           +V ++L ++
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 163/309 (52%), Gaps = 31/309 (10%)
Query: 87  FTFSELKTATKNFS-RSLMIXXXXXXXXXXXVI-----RSTEDSHKK----IDIAVKQLS 136
           F+F ELK  T NF  R + +           V+      +T  + KK    +DI  ++L 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 137 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
           +       ++  E+ V+   +H NLV+L+G+ ++ D+      L+Y YMPN S+ D L S
Sbjct: 69  Q-------QFDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL-S 116
Query: 197 RFQATLP--WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
               T P  W+ R KIAQ AA G+ +LHE      I RD KS+NILLDE + AK+SDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 173
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
           AR         +   +VGT  Y APE ++ G +T KSDI+SFGV L E+ITG   +D +R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS 374
               Q LL+       + K     +D K+    S  + + + +VA++CL  +   RP + 
Sbjct: 233 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIK 289
Query: 375 EVVEVLNKI 383
           +V ++L ++
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 108/308 (35%), Positives = 159/308 (51%), Gaps = 31/308 (10%)
Query: 87  FTFSELKTATKNFS-RSLMIXXXXXXXXXXXVI-----RSTEDSHKK----IDIAVKQLS 136
           F+F ELK  T NF  R + +           V+      +T  + KK    +DI  ++L 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 137 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
           +       ++  E+ V    +H NLV+L+G+ ++ D+      L+Y Y PN S+ D L S
Sbjct: 66  Q-------QFDQEIKVXAKCQHENLVELLGFSSDGDDL----CLVYVYXPNGSLLDRL-S 113
Query: 197 RFQATLP--WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
               T P  W+ R KIAQ AA G+ +LHE      I RD KS+NILLDE + AK+SDFGL
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
           AR           + +VGT  Y APE ++ G +T KSDI+SFGV L E+ITG   +D +R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS 374
               Q LL+       + K     +D K     S  + +   +VA++CL  +   RP + 
Sbjct: 230 --EPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSV-EAXYSVASQCLHEKKNKRPDIK 286
Query: 375 EVVEVLNK 382
           +V ++L +
Sbjct: 287 KVQQLLQE 294

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 124/262 (47%), Gaps = 31/262 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + R G    ++++ E  V+  + HP LV+L G C E         L++E+M +  
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVFEFMEHGC 88
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 89  LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 144
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 145 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 204 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPE 246
Query: 369 GRPKMSEVVEVLNKIVDAAETG 390
            RP  S    +L ++ + AE+G
Sbjct: 247 DRPAFS---RLLRQLAEIAESG 265

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 124/262 (47%), Gaps = 31/262 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + R G    ++++ E  V+  + HP LV+L G C E         L++E+M +  
Sbjct: 32  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVFEFMEHGC 86
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 87  LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 142
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 143 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 202 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPE 244
Query: 369 GRPKMSEVVEVLNKIVDAAETG 390
            RP  S    +L ++ + AE+G
Sbjct: 245 DRPAFS---RLLRQLAEIAESG 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 124/262 (47%), Gaps = 31/262 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + R G    ++++ E  V+  + HP LV+L G C E         L++E+M +  
Sbjct: 37  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVFEFMEHGC 91
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 92  LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 147
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 148 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 207 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPE 249
Query: 369 GRPKMSEVVEVLNKIVDAAETG 390
            RP  S    +L ++ + AE+G
Sbjct: 250 DRPAFS---RLLRQLAEIAESG 268

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 119/255 (46%), Gaps = 28/255 (10%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + R G    ++++ E  V+  + HP LV+L G C E         L++E+M +  
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVFEFMEHGC 88
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 89  LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKV 144
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 145 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 204 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPE 246
Query: 369 GRPKMSEVVEVLNKI 383
            RP  S ++  L  I
Sbjct: 247 DRPAFSRLLRQLAAI 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 31/262 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + R G    ++++ E  V+  + HP LV+L G C E         L+ E+M +  
Sbjct: 35  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVTEFMEHGC 89
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 90  LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 145
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 146 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 205 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPE 247
Query: 369 GRPKMSEVVEVLNKIVDAAETG 390
            RP  S    +L ++ + AE+G
Sbjct: 248 DRPAFS---RLLRQLAEIAESG 266

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 31/262 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K + + G     +++ E  V+  + HP LV+L G C E         L++E+M +  
Sbjct: 54  VAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ----APICLVFEFMEHGC 108
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D+L ++ +      T L +  D   G+AYL E     +I RD  + N L+ E    K+
Sbjct: 109 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 164
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           SDFG+ R    D  +  ST     + +A+PE     R + KSD+WSFGV ++E+ + G+ 
Sbjct: 165 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 223
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAK 368
           P + NR  SE          + D      +  P+L   +  +       + N C   + +
Sbjct: 224 PYE-NRSNSEV---------VEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPE 266
Query: 369 GRPKMSEVVEVLNKIVDAAETG 390
            RP  S    +L ++ + AE+G
Sbjct: 267 DRPAFS---RLLRQLAEIAESG 285

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 26/262 (9%)
Query: 129 DIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           D+AVK L  +     +  E++ EV ++  + HPN+V  +G   +     I    + EY+ 
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI----VTEYLS 117
Query: 187 NRSVQDHL-TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
             S+   L  S  +  L    RL +A D A+G+ YLH   +  I+ R+ KS N+L+D+++
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY 176
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             K+ DFGL+RL  S  LS  S A  GT  + APE ++      KSD++SFGV L+EL T
Sbjct: 177 TVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR 365
            ++P     P             +  A  F      +LE      L  ++AA+   C   
Sbjct: 235 LQQPWGNLNPA-----------QVVAAVGFKC---KRLE--IPRNLNPQVAAIIEGCWTN 278
Query: 366 QAKGRPKMSEVVEVLNKIVDAA 387
           +   RP  + ++++L  ++ +A
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSA 300

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 129 DIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           D+AVK L  +     +  E++ EV ++  + HPN+V  +G   +     I    + EY+ 
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI----VTEYLS 117
Query: 187 NRSVQDHL-TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
             S+   L  S  +  L    RL +A D A+G+ YLH   +  I+ RD KS N+L+D+++
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKY 176
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             K+ DFGL+RL  S  L   S    GT  + APE ++      KSD++SFGV L+EL T
Sbjct: 177 TVKVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR 365
            ++P     P             +  A  F      +LE      L  ++AA+   C   
Sbjct: 235 LQQPWGNLNPA-----------QVVAAVGFKC---KRLE--IPRNLNPQVAAIIEGCWTN 278
Query: 366 QAKGRPKMSEVVEVLNKIVDAA 387
           +   RP  + ++++L  ++ +A
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSA 300

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 96/179 (53%), Gaps = 12/179 (6%)
Query: 130 IAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L +  G Q    W  E+++L  + H +++K  G C +  E+ +Q  L+ EY+P  
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLG 103
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++D+L    + ++     L  AQ    G+AYLH       I R+  + N+LLD     K
Sbjct: 104 SLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVK 157
Query: 249 LSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGLA+  P +G  +      G   + + APE ++  +  Y SD+WSFGV LYEL+T
Sbjct: 158 IGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 96/179 (53%), Gaps = 12/179 (6%)
Query: 130 IAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L +  G Q    W  E+++L  + H +++K  G C +  E+ +Q  L+ EY+P  
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLG 103
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++D+L    + ++     L  AQ    G+AYLH       I R+  + N+LLD     K
Sbjct: 104 SLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVK 157
Query: 249 LSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGLA+  P +G  +      G   + + APE ++  +  Y SD+WSFGV LYEL+T
Sbjct: 158 IGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 28  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 82
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 83  NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 135
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 136 QGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 32  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 86
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 87  NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 139
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 140 QGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 195
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 196 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 238

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 48  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 102
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 103 NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 155
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 156 QGVVKVSDFGLSRYVLDDE----ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNR 188
           + +K+L R   +  + ++ EV V+  +EHPN++K IG   +D     +RL  I EY+   
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLNFITEYIKGG 92
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           +++  + S   +  PW+ R+  A+D A G+AYLH      II RD  S N L+ E  N  
Sbjct: 93  TLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVV 148
Query: 249 LSDFGLARL-----GPSDGLSHVST-------AVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           ++DFGLARL        +GL  +          VVG   + APE I       K D++SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 297 GVFLYELI 304
           G+ L E+I
Sbjct: 209 GIVLCEII 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 48  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 102
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 103 NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 155
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 156 QGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 33  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 87
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 88  NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 140
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 141 QGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 196
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 197 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 239

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 39  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 93
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 94  NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 146
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           Q   K+SDFGL+R    D      T+ VG+   + ++ PE +   + + KSDIW+FGV +
Sbjct: 147 QGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 202
Query: 301 YELIT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
           +E+ + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 203 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 245

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/179 (34%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 130 IAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L    G Q    W  E+ +L  + H ++VK  G C +  E+ +Q  L+ EY+P  
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLG 98
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++D+L    +  +     L  AQ    G+AYLH       I R   + N+LLD     K
Sbjct: 99  SLRDYLP---RHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVK 152
Query: 249 LSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGLA+  P +G  +      G   + + APE ++  +  Y SD+WSFGV LYEL+T
Sbjct: 153 IGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/179 (34%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 130 IAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L    G Q    W  E+ +L  + H ++VK  G C +  E+ +Q  L+ EY+P  
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLG 97
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++D+L    +  +     L  AQ    G+AYLH       I R   + N+LLD     K
Sbjct: 98  SLRDYLP---RHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVK 151
Query: 249 LSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGLA+  P +G  +      G   + + APE ++  +  Y SD+WSFGV LYEL+T
Sbjct: 152 IGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 30  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 81
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 82  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 138
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 139 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 197
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 198 IVTHGRIP 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 36  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 87
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 88  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 144
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 145 DTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 203
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 204 IVTHGRIP 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 35  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 86
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 144 DTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 203 IVTHGRIP 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 35  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 86
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 144 DTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 203 IVTHGRIP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 43  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 94
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 95  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 151
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 152 DTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 210
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 211 IVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 37  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 88
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 89  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 145
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 146 DTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 204
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 205 IVTHGRIP 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 41  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 92
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 93  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 149
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 150 DTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 209 IVTHGRIP 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 44  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 95
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 96  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 152
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 153 DTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 211
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 212 IVTHGRIP 219

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 41  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 92
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 93  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 149
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 150 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 209 IVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 40  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 91
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 92  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 148
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 149 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 207
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 208 IVTHGRIP 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 35  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 86
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   D            I + APE I  G  T KSD+WSFG+ L E
Sbjct: 144 DTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 203 IVTHGRIP 210

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+A+K + + G     E++ E  V+  + H  LV+L G C +  +R I   +I EYM 
Sbjct: 33  QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI--FIITEYMA 87
Query: 187 NRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           N  + ++L     RFQ        L++ +D    + YL      Q + RD  + N L+++
Sbjct: 88  NGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND 140
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
           Q   K+SDFGL+R    D  +  S      + ++ PE +   + + KSDIW+FGV ++E+
Sbjct: 141 QGVVKVSDFGLSRYVLDDEYTS-SRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199
Query: 304 IT-GRRPLDR--NRPKSEQ--KLLEWVRPHLTDAKKFTMI 338
            + G+ P +R  N   +E   + L   RPHL   K +T++
Sbjct: 200 YSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 239

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 35  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 86
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 203 IVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 45  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 96
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I RD +++NIL+ 
Sbjct: 97  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 153
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 154 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 212
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 213 IVTHGRIP 220

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/178 (33%), Positives = 91/178 (51%), Gaps = 10/178 (5%)
Query: 130 IAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L +  G Q    W  E+++L  + H +++K  G C +     +Q  L+ EY+P  
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ--LVMEYVPLG 120
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++D+L      ++     L  AQ    G+AYLH       I RD  + N+LLD     K
Sbjct: 121 SLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVK 174
Query: 249 LSDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGLA+  P     + V       + + APE ++  +  Y SD+WSFGV LYEL+T
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/188 (33%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H K+  AVK L ++G      ++ E N++  ++H  LV+L     ++        +I 
Sbjct: 31  NGHTKV--AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----IYIIT 82
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D L +     L  N  L +A   A G+A++ E      I R+ +++NIL+ 
Sbjct: 83  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANILVS 139
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  + K++DFGLARL   +  +    A    I + APE I  G  T KSD+WSFG+ L E
Sbjct: 140 DTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 198
Query: 303 LIT-GRRP 309
           ++T GR P
Sbjct: 199 IVTHGRIP 206

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 97/189 (51%), Gaps = 20/189 (10%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 36  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 87
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           +    S+  HL +  +        + IA+  ARG+ YLH      II RD KS+NI L E
Sbjct: 88  WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHE 143
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFL 300
               K+ DFGLA +      SH    + G+I + APE I+   +   +++SD+++FG+ L
Sbjct: 144 DNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 203
Query: 301 YELITGRRP 309
           YEL+TG+ P
Sbjct: 204 YELMTGQLP 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 120/271 (44%), Gaps = 35/271 (12%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK L + G    + ++ E N++  ++H  LV+L  Y     E  I   +I EYM   S
Sbjct: 40  VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL--YAVVTREEPI--YIITEYMAKGS 94
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L S     +     +  +   A G+AY+        I RD +++N+L+ E    K+
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 151
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLAR+   +  +    A    I + APE I  G  T KSD+WSFG+ LYE++T G+ 
Sbjct: 152 ADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKI 210
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD----PKLEGKYSIKLAQKLAAVANKCLA 364
           P                 P  T+A   T +      P++E         +L  +   C  
Sbjct: 211 PY----------------PGRTNADVMTALSQGYRMPRVE-----NCPDELYDIMKMCWK 249
Query: 365 RQAKGRPKMSEVVEVLNKIVDAAETGTPQTP 395
            +A+ RP    +  VL+    A E    Q P
Sbjct: 250 EKAEERPTFDYLQSVLDDFYTATEGQYQQQP 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 96/189 (50%), Gaps = 20/189 (10%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 99
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           +    S+  HL +  +        + IA+  ARG+ YLH      II RD KS+NI L E
Sbjct: 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHE 155
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFL 300
               K+ DFGLA        SH    + G+I + APE I+   +   +++SD+++FG+ L
Sbjct: 156 DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 301 YELITGRRP 309
           YEL+TG+ P
Sbjct: 216 YELMTGQLP 224

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 17/189 (8%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + D+AVK + + G     E+  E   +  + HP LVK  G C+++        ++ EY+ 
Sbjct: 32  QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE----YPIYIVTEYIS 86
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
           N  + ++L S  +   P +  L++  D   G+A+L      Q I RD  + N L+D    
Sbjct: 87  NGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLC 142
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
            K+SDFG+ R    D   +VS+  VGT   + ++APE     + + KSD+W+FG+ ++E+
Sbjct: 143 VKVSDFGMTRYVLDD--QYVSS--VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 304 IT-GRRPLD 311
            + G+ P D
Sbjct: 199 FSLGKMPYD 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           V  +T + H K+  AVK + + G    + ++ E NV+  ++H  LVKL     ++     
Sbjct: 198 VWMATYNKHTKV--AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE----- 249
Query: 177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS 236
              +I E+M   S+ D L S   +  P    +  +   A G+A++ +      I RD ++
Sbjct: 250 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 306
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           +NIL+      K++DFGLAR+G               I + APE I  G  T KSD+WSF
Sbjct: 307 ANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIKSDVWSF 355
Query: 297 GVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKL 355
           G+ L E++T GR P          + LE         + + M   P+ E        ++L
Sbjct: 356 GILLMEIVTYGRIPYPGMSNPEVIRALE---------RGYRM---PRPEN-----CPEEL 398
Query: 356 AAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTP 395
             +  +C   + + RP    +  VL+    A E+   Q P
Sbjct: 399 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXQQQP 438

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 99  LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 154
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 94/170 (55%), Gaps = 16/170 (9%)
Query: 146 WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           ++ E +V+  + H NLV+L+G   E  E+G    ++ EYM   S+ D+L SR ++ L  +
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGD 102
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
             LK + D    + YL EG +F  + RD  + N+L+ E   AK+SDFGL +         
Sbjct: 103 CLLKFSLDVCEAMEYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK-------EA 152
Query: 266 VSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
            ST   G   + + APE ++  + + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 153 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 94/170 (55%), Gaps = 16/170 (9%)
Query: 146 WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           ++ E +V+  + H NLV+L+G   E  E+G    ++ EYM   S+ D+L SR ++ L  +
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
             LK + D    + YL EG +F  + RD  + N+L+ E   AK+SDFGL +         
Sbjct: 118 CLLKFSLDVCEAMEYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK-------EA 167
Query: 266 VSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
            ST   G   + + APE ++  + + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 104
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 105 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 160
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 102
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 103 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 103
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 104 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 159
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 105
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 106 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 161
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 130
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 131 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 186
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY         Q  ++ +
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTAP-----QLAIVTQ 99
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           +    S+  HL +  +        + IA+  ARG+ YLH      II RD KS+NI L E
Sbjct: 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHE 155
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFL 300
               K+ DFGLA        SH    + G+I + APE I+   +   +++SD+++FG+ L
Sbjct: 156 DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 301 YELITGRRP 309
           YEL+TG+ P
Sbjct: 216 YELMTGQLP 224

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 106
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 107 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 162
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 97
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 98  LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 153
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 94/170 (55%), Gaps = 16/170 (9%)
Query: 146 WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           ++ E +V+  + H NLV+L+G   E  E+G    ++ EYM   S+ D+L SR ++ L  +
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
             LK + D    + YL EG +F  + RD  + N+L+ E   AK+SDFGL +         
Sbjct: 290 CLLKFSLDVCEAMEYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK-------EA 339
Query: 266 VSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
            ST   G   + + APE ++  + + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 340 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 117
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 118 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 173
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 94/172 (54%), Gaps = 16/172 (9%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           + ++ E +V+  + H NLV+L+G   E  E+G    ++ EYM   S+ D+L SR ++ L 
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLG 106
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
            +  LK + D    + YL EG +F  + RD  + N+L+ E   AK+SDFGL +       
Sbjct: 107 GDCLLKFSLDVCEAMEYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK------- 156
Query: 264 SHVSTAVVG--TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
              ST   G   + + APE ++    + KSD+WSFG+ L+E+ + GR P  R
Sbjct: 157 EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPR 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 102
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L +  +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 103 LRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 117
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 118 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 173
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 34  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 85
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 86  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 138
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 139 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 198
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 199 IVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 88
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 89  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 141
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 202 IVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 59  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 110
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 111 WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 163
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 164 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 224 IVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 111
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 112 WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 164
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 165 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 225 IVLYELMTGQLP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 88
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 89  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 141
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 202 IVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 83
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 84  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 136
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 197 IVLYELMTGQLP 208

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 127 KIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----I 181
           KI +A+K L+   G + + E++ E  ++  ++HP+LV+L+G C     + + +L+    +
Sbjct: 44  KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCL 103
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL 241
            EY+     +D++ S  Q  L W  ++      A+G+ YL E    +++ RD  + N+L+
Sbjct: 104 LEYVHEH--KDNIGS--QLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLV 150
Query: 242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
               + K++DFGLARL   D   + +      I + A E I   + T++SD+WS+GV ++
Sbjct: 151 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIW 210
Query: 302 ELIT-GRRPLDRNRPKSEQKLLE 323
           EL+T G +P D    +    LLE
Sbjct: 211 ELMTFGGKPYDGIPTREIPDLLE 233

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI EY+P  S
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 100
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D+L  + +  +     L+      +G+ YL      + I R+  + NIL++ +   K+
Sbjct: 101 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENRVKI 156
Query: 250 SDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D   + V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 97/192 (50%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY         Q  ++ +
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTAP-----QLAIVTQ 83
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 84  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 136
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA +      SH    + G+I + APE I+       +++SD+++FG
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 197 IVLYELMTGQLP 208

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 127 KIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           KI +A+K L+   G + + E++ E  ++  ++HP+LV+L+G C       IQ  L+ + M
Sbjct: 67  KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT---IQ--LVTQLM 121
Query: 186 PNRSVQDHLTSR-----FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           P+  + +++         Q  L W  ++      A+G+ YL E    +++ RD  + N+L
Sbjct: 122 PHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVL 172
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           +    + K++DFGLARL   D   + +      I + A E I   + T++SD+WS+GV +
Sbjct: 173 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 232
Query: 301 YELIT-GRRPLDRNRPKSEQKLLE 323
           +EL+T G +P D    +    LLE
Sbjct: 233 WELMTFGGKPYDGIPTREIPDLLE 256

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           V  +T + H K+  AVK + + G    + ++ E NV+  ++H  LVKL     ++     
Sbjct: 204 VWMATYNKHTKV--AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE----- 255
Query: 177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS 236
              +I E+M   S+ D L S   +  P    +  +   A G+A++ +      I RD ++
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 312
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           +NIL+      K++DFGLAR+   +  +    A    I + APE I  G  T KSD+WSF
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSF 371
Query: 297 GVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKL 355
           G+ L E++T GR P          + LE         + + M   P+ E        ++L
Sbjct: 372 GILLMEIVTYGRIPYPGMSNPEVIRALE---------RGYRM---PRPE-----NCPEEL 414
Query: 356 AAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTP 395
             +  +C   + + RP    +  VL+    A E+   + P
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXEEIP 454

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 37  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 91
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 148
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 149 KVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 207
Query: 307 RRPLDRNRPKSEQKLLE 323
             P     P    +LLE
Sbjct: 208 MSPYPGIDPSQVYELLE 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 97/192 (50%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 52  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 103
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 104 WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 156
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA        SH    + G+I + APE I+       +++SD+++FG
Sbjct: 157 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 216
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 217 IVLYELMTGQLP 228

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 35/271 (12%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK L + G    + ++ E N++  ++H  LV+L  Y     E  I   +I E+M   S
Sbjct: 39  VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL--YAVVTKEEPI--YIITEFMAKGS 93
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L S     +     +  +   A G+AY+        I RD +++N+L+ E    K+
Sbjct: 94  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 150
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLAR+   +  +    A    I + APE I  G  T KS++WSFG+ LYE++T G+ 
Sbjct: 151 ADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKI 209
Query: 309 PLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD----PKLEGKYSIKLAQKLAAVANKCLA 364
           P                 P  T+A   + +      P++E         +L  +   C  
Sbjct: 210 PY----------------PGRTNADVMSALSQGYRMPRME-----NCPDELYDIMKMCWK 248
Query: 365 RQAKGRPKMSEVVEVLNKIVDAAETGTPQTP 395
            +A+ RP    +  VL+    A E    Q P
Sbjct: 249 EKAEERPTFDYLQSVLDDFYTATEGQYQQQP 279

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 37  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 91
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 148
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 149 KVADFGLSRLMTGD----TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204
Query: 305 T-GRRPLDRNRPKSEQKLLE 323
           T G  P     P    +LLE
Sbjct: 205 TYGMSPYPGIDPSQVYELLE 224

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 34/269 (12%)
Query: 122 EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           ++  KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L+
Sbjct: 52  DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 108
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKS 236
           +  YM +  +++ + +        N  +K         A+G+ YL      + + RD  +
Sbjct: 109 VLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAA 160
Query: 237 SNILLDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
            N +LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 295 SFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQK 354
           SFGV L+EL+T   P     P  +    + +  +L   ++        L+ +Y       
Sbjct: 221 SFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDP 264
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           L  V  KC   +A+ RP  SE+V  ++ I
Sbjct: 265 LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGLAR+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           L+   M    ++ H+    QA  P    +  A +   GL  LH     +I++RD K  NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENI 317
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           LLD+  + ++SD GLA   P           VGT+GY APE ++  R T+  D W+ G  
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 300 LYELITGRRPLDRNRPKSEQKLLE 323
           LYE+I G+ P  + + K +++ +E
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           L+   M    ++ H+    QA  P    +  A +   GL  LH     +I++RD K  NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENI 317
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           LLD+  + ++SD GLA   P           VGT+GY APE ++  R T+  D W+ G  
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 300 LYELITGRRPLDRNRPKSEQKLLE 323
           LYE+I G+ P  + + K +++ +E
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK+L     +  +++  E+ +L  ++H N+VK  G C     R ++  LI E++P  S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEFLPYGS 102
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++++L  + +  +     L+      +G+ YL      + I RD  + NIL++ +   K+
Sbjct: 103 LREYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 250 SDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            DFGL ++ P D     V       I + APE +   + +  SD+WSFGV LYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 37  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTY 91
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 148
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 149 KVADFGLSRLMTGD----TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204
Query: 305 T-GRRPLDRNRPKSEQKLLE 323
           T G  P     P    +LLE
Sbjct: 205 TYGMSPYPGIDPSQVYELLE 224

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 97/192 (50%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 83
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 84  WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 136
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA        SH    + G+I + APE I+       +++SD+++FG
Sbjct: 137 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 197 IVLYELMTGQLP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 97/192 (50%), Gaps = 26/192 (13%)
Query: 129 DIAVKQL-----SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           D+AVK L     + + LQ  K    EV VL    H N++  +GY  +      Q  ++ +
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNILLFMGYSTKP-----QLAIVTQ 111
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +    S+  HL    ++F+        + IA+  A+G+ YLH      II RD KS+NI 
Sbjct: 112 WCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIF 164
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFG 297
           L E    K+ DFGLA        SH    + G+I + APE I+       +++SD+++FG
Sbjct: 165 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 298 VFLYELITGRRP 309
           + LYEL+TG+ P
Sbjct: 225 IVLYELMTGQLP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 34/269 (12%)
Query: 122 EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           ++  KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L+
Sbjct: 72  DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 128
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKS 236
           +  YM +  +++ + +        N  +K         A+G+ YL      + + RD  +
Sbjct: 129 VLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAA 180
Query: 237 SNILLDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
            N +LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+W
Sbjct: 181 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 240
Query: 295 SFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQK 354
           SFGV L+EL+T   P     P  +    + +  +L   ++        L+ +Y       
Sbjct: 241 SFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDP 284
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           L  V  KC   +A+ RP  SE+V  ++ I
Sbjct: 285 LYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 28/266 (10%)
Query: 122 EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           ++  KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L+
Sbjct: 71  DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 127
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           +  YM +  +++ +  R +   P    L       A+G+ YL      + + RD  + N 
Sbjct: 128 VLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNC 182
Query: 240 LLDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFG
Sbjct: 183 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 242
Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
           V L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  
Sbjct: 243 VLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYE 286
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKI 383
           V  KC   +A+ RP  SE+V  ++ I
Sbjct: 287 VMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 34/269 (12%)
Query: 122 EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           ++  KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L+
Sbjct: 45  DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 101
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKS 236
           +  YM +  +++ + +        N  +K         A+G+ YL      + + RD  +
Sbjct: 102 VLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAA 153
Query: 237 SNILLDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
            N +LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+W
Sbjct: 154 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 213
Query: 295 SFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQK 354
           SFGV L+EL+T   P     P  +    + +  +L   ++        L+ +Y       
Sbjct: 214 SFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDP 257
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           L  V  KC   +A+ RP  SE+V  ++ I
Sbjct: 258 LYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 113
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ YL      + + RD  + N +
Sbjct: 114 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCM 165
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 166 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 226 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 269
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 270 MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 58  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 114
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ +L      + + RD  + N +LDE
Sbjct: 115 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE 169
Query: 244 QWNAKLSDFGLAR--LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR  L       H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 170 KFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 229
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 230 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 273
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 274 CWHPKAEMRPSFSELVSRISAI 295

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 54  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 110
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ YL      + + RD  + N +
Sbjct: 111 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCM 162
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 163 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 223 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 266
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           V  +T + H K+  AVK + + G    + ++ E NV+  ++H  LVKL     ++     
Sbjct: 31  VWMATYNKHTKV--AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP---- 83
Query: 177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS 236
              +I E+M   S+ D L S   +  P    +  +   A G+A++ +      I RD ++
Sbjct: 84  -IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 139
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           +NIL+      K++DFGLAR+   +  +    A    I + APE I  G  T KSD+WSF
Sbjct: 140 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSF 198
Query: 297 GVFLYELIT-GRRP 309
           G+ L E++T GR P
Sbjct: 199 GILLMEIVTYGRIP 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 113
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ YL      + + RD  + N +
Sbjct: 114 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCM 165
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 166 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 226 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 269
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 270 MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVIEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   D            I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARL-IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 55  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 111
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ YL      + + RD  + N +LDE
Sbjct: 112 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDE 166
Query: 244 QWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 167 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 226
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 227 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 270
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 271 CWHPKAEMRPSFSELVSRISAI 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 52  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 108
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ YL      + + RD  + N +
Sbjct: 109 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCM 160
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 221 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 264
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 265 MLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 56  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 112
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ YL      + + RD  + N +
Sbjct: 113 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCM 164
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR +   +  S H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 165 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 224
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 225 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 268
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 269 MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 41  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 96
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 97  EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 152
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 153 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 213 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 256
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 257 -----CWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVIEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVCEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 34/260 (13%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           D+A+KQ+     +  K ++ E+  L  V HPN+VKL G C           L+ EY    
Sbjct: 34  DVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP------VCLVMEYAEGG 85
Query: 189 SVQDHLTSRFQATLPWNTR---LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           S+ + L       LP+ T    +      ++G+AYLH      +I RD K  N+LL    
Sbjct: 86  SLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 143
Query: 246 NA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
              K+ DFG A     D  +H+ T   G+  + APE  +    + K D++S+G+ L+E+I
Sbjct: 144 TVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 198
Query: 305 TGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA 364
           T R+P D     + + +  W    + +  +  +I +          L + + ++  +C +
Sbjct: 199 TRRKPFDEIGGPAFRIM--WA---VHNGTRPPLIKN----------LPKPIESLMTRCWS 243
Query: 365 RQAKGRPKMSEVVEVLNKIV 384
           +    RP M E+V+++  ++
Sbjct: 244 KDPSQRPSMEEIVKIMTHLM 263

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 58  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 113
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 114 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 169
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 170 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 229
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 230 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 273
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 274 -----CWQKDRNNRPKFEQIVSILDKLI 296

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 34/260 (13%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           D+A+KQ+     +  K ++ E+  L  V HPN+VKL G C           L+ EY    
Sbjct: 33  DVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP------VCLVMEYAEGG 84
Query: 189 SVQDHLTSRFQATLPWNTR---LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           S+ + L       LP+ T    +      ++G+AYLH      +I RD K  N+LL    
Sbjct: 85  SLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142
Query: 246 NA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
              K+ DFG A     D  +H+ T   G+  + APE  +    + K D++S+G+ L+E+I
Sbjct: 143 TVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197
Query: 305 TGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA 364
           T R+P D     + + +  W    + +  +  +I +          L + + ++  +C +
Sbjct: 198 TRRKPFDEIGGPAFRIM--WA---VHNGTRPPLIKN----------LPKPIESLMTRCWS 242
Query: 365 RQAKGRPKMSEVVEVLNKIV 384
           +    RP M E+V+++  ++
Sbjct: 243 KDPSQRPSMEEIVKIMTHLM 262

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 294 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 347
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 404
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 405 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 309 P 309
           P
Sbjct: 464 P 464

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 126 KKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           ++I +A+K L S    +  +++++E +++G  +HPN++ L G       +    ++I E+
Sbjct: 60  REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----KSTPVMIITEF 115
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
           M N S+ D    +          + + +  A G+ YL    D   + RD  + NIL++  
Sbjct: 116 MENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSN 171
Query: 245 WNAKLSDFGLARLGPSDGLSHVSTAVVG---TIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
              K+SDFGL+R    D      T+ +G    I + APE IQ  + T  SD+WS+G+ ++
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 231
Query: 302 ELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVAN 360
           E+++ G RP             +     + +A +    L P ++          L  +  
Sbjct: 232 EVMSYGERPY-----------WDMTNQDVINAIEQDYRLPPPMD------CPSALHQLML 274
Query: 361 KCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPL 396
            C  +    RPK  ++V  L+K++    +     PL
Sbjct: 275 DCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPL 310

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 34  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 87
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 88  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 144
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 145 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 203
Query: 309 P 309
           P
Sbjct: 204 P 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 36  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 89
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 90  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 146
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 147 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 205
Query: 309 P 309
           P
Sbjct: 206 P 206

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 68  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 123
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 124 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 179
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 180 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 239
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 240 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 283
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 284 -----CWQKDRNNRPKFEQIVSILDKLI 306

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E  +  +++HPN++ L G C ++        L+ E+     +   L+ +    +P +  +
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEP----NLCLVMEFARGGPLNRVLSGK---RIPPDILV 108
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--------AKLSDFGLARLGPS 260
             A   ARG+ YLH+     II RD KSSNIL+ ++           K++DFGLAR    
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---- 164
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           +       +  G   + APE I+    +  SD+WS+GV L+EL+TG  P 
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 264
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 321
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 322 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 309 P 309
           P
Sbjct: 381 P 381

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  ++  ++H  LV+L    +E+        ++ EYM   S
Sbjct: 36  VAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEP-----IYIVTEYMNKGS 89
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  I RD +S+NIL+      K+
Sbjct: 90  LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMNY--IHRDLRSANILVGNGLICKI 146
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   D            I + APE    GR T KSD+WSFG+ L EL+T GR 
Sbjct: 147 ADFGLARL-IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205
Query: 309 P 309
           P
Sbjct: 206 P 206

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EYM N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 264
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 321
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 322 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 309 P 309
           P
Sbjct: 381 P 381

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 35  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IXIVTEYMSKGS 88
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 89  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 145
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   D            I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 146 ADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 204
Query: 309 P 309
           P
Sbjct: 205 P 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVGEYMSKGS 264
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 321
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 322 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 309 P 309
           P
Sbjct: 381 P 381

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 38  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 91
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 92  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 148
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 149 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 207
Query: 309 P 309
           P
Sbjct: 208 P 208

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 8/178 (4%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L       H  +   E+ +L  + H N+VK  G C ED   GI+  LI E++P+ 
Sbjct: 53  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSG 110
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++++L    +  +    +LK A    +G+ YL      Q + RD  + N+L++ +   K
Sbjct: 111 SLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166
Query: 249 LSDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGL +   +D     V       + + APE +   +    SD+WSFGV L+EL+T
Sbjct: 167 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 16/186 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C  +    I    + EYMP 
Sbjct: 58  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYI----VTEYMPY 112
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 113 GNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVV 169
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +     + KSD+W+FGV L+E+ 
Sbjct: 170 KVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIA 225
Query: 305 T-GRRP 309
           T G  P
Sbjct: 226 TYGMSP 231

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD  ++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLAAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM    
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVMEYMSKGC 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 37/253 (14%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATL 202
           +++++E +++G  +HPN+++L G       RG   +++ EYM N S+   L T   Q T+
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD- 261
                + + +    G+ YL    D   + RD  + N+L+D     K+SDFGL+R+   D 
Sbjct: 151 --MQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL----DRNRPK 316
             ++ +T     I + APE I     +  SD+WSFGV ++E++  G RP     +R+   
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           S ++      P         ++LD                     C  +    RP+ S++
Sbjct: 266 SVEEGYRLPAPMGCPHALHQLMLD---------------------CWHKDRAQRPRFSQI 304
Query: 377 VEVLNKIVDAAET 389
           V VL+ ++ + E+
Sbjct: 305 VSVLDALIRSPES 317

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 8/178 (4%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L       H  +   E+ +L  + H N+VK  G C ED   GI+  LI E++P+ 
Sbjct: 41  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSG 98
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S++++L    +  +    +LK A    +G+ YL      Q + RD  + N+L++ +   K
Sbjct: 99  SLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 154
Query: 249 LSDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + DFGL +   +D     V       + + APE +   +    SD+WSFGV L+EL+T
Sbjct: 155 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 113
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ +L      + + RD  + N +LDE
Sbjct: 114 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE 168
Query: 244 QWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 228
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 229 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 272
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 273 CWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 55  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 111
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ +L      + + RD  + N +LDE
Sbjct: 112 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE 166
Query: 244 QWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 167 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 226
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 227 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 270
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 271 CWHPKAEMRPSFSELVSRISAI 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 127 KIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           KI + +K +  + G Q  +     +  +G ++H ++V+L+G C      G    L+ +Y+
Sbjct: 60  KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYL 114
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           P  S+ DH+     A  P    L      A+G+ YL E     ++ R+  + N+LL    
Sbjct: 115 PLGSLLDHVRQHRGALGP-QLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPS 170
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             +++DFG+A L P D    + +     I + A E I  G+ T++SD+WS+GV ++EL+T
Sbjct: 171 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230
Query: 306 -GRRPLDRNRPKSEQKLLE 323
            G  P    R      LLE
Sbjct: 231 FGAEPYAGLRLAEVPDLLE 249

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 58  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 114
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ +L      + + RD  + N +LDE
Sbjct: 115 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE 169
Query: 244 QWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 170 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 229
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 230 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 273
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 274 CWHPKAEMRPSFSELVSRISAI 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 122 EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           ++  KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L+
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 168
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           +  YM +  +++ +  R +   P    L       A+G+ +L      + + RD  + N 
Sbjct: 169 VLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNC 223
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +LDE++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFG
Sbjct: 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283
Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
           V L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  
Sbjct: 284 VLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYE 327
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKI 383
           V  KC   +A+ RP  SE+V  ++ I
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 34/265 (12%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 113
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLK----IAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           M +  +++ + +        N  +K         A+G+ +L      + + RD  + N +
Sbjct: 114 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCM 165
Query: 241 LDEQWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LDE++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFGV
Sbjct: 166 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V
Sbjct: 226 LLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEV 269
Query: 359 ANKCLARQAKGRPKMSEVVEVLNKI 383
             KC   +A+ RP  SE+V  ++ I
Sbjct: 270 MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           KKI  AVK L+R    G   +++TE  ++    HPN++ L+G C   +      L++  Y
Sbjct: 62  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPY 118
Query: 185 MPNRSVQDHLTSRFQATLPWNTRL-KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           M +  +++ +  R +   P    L       A+G+ +L      + + RD  + N +LDE
Sbjct: 119 MKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE 173
Query: 244 QWNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
           ++  K++DFGLAR          H  T     + + A E +QT + T KSD+WSFGV L+
Sbjct: 174 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 233
Query: 302 ELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANK 361
           EL+T   P     P  +    + +  +L   ++        L+ +Y       L  V  K
Sbjct: 234 ELMTRGAP-----PYPDVNTFD-ITVYLLQGRRL-------LQPEYC---PDPLYEVMLK 277
Query: 362 CLARQAKGRPKMSEVVEVLNKI 383
           C   +A+ RP  SE+V  ++ I
Sbjct: 278 CWHPKAEMRPSFSELVSRISAI 299

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM    
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGC 98
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 156 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214
Query: 309 P 309
           P
Sbjct: 215 P 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E N+L  V+HP +V LI Y  +    G +  LI EY+    +   L    +     +T  
Sbjct: 71  ERNILEEVKHPFIVDLI-YAFQT---GGKLYLILEYLSGGELFMQLER--EGIFMEDTAC 124
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
               + +  L +LH+     II+RD K  NI+L+ Q + KL+DFGL +    DG   V+ 
Sbjct: 125 FYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTH 179
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEW--- 324
              GTI Y APE +         D WS G  +Y+++TG  P    NR K+  K+L+    
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 325 VRPHLT 330
           + P+LT
Sbjct: 240 LPPYLT 245

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 127 KIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           KI + +K +  + G Q  +     +  +G ++H ++V+L+G C      G    L+ +Y+
Sbjct: 42  KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYL 96
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           P  S+ DH+     A  P    L      A+G+ YL E     ++ R+  + N+LL    
Sbjct: 97  PLGSLLDHVRQHRGALGP-QLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPS 152
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             +++DFG+A L P D    + +     I + A E I  G+ T++SD+WS+GV ++EL+T
Sbjct: 153 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
Query: 306 -GRRPLDRNRPKSEQKLLE 323
            G  P    R      LLE
Sbjct: 213 FGAEPYAGLRLAEVPDLLE 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E N+L  V+HP +V LI Y  +    G +  LI EY+    +   L    +     +T  
Sbjct: 71  ERNILEEVKHPFIVDLI-YAFQT---GGKLYLILEYLSGGELFMQLER--EGIFMEDTAC 124
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
               + +  L +LH+     II+RD K  NI+L+ Q + KL+DFGL +    DG   V+ 
Sbjct: 125 FYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTH 179
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEW--- 324
              GTI Y APE +         D WS G  +Y+++TG  P    NR K+  K+L+    
Sbjct: 180 XFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 325 VRPHLT 330
           + P+LT
Sbjct: 240 LPPYLT 245

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 212 VAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMSKGS 265
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + +A   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 266 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 322
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGL RL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 323 ADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 309 P 309
           P
Sbjct: 382 P 382

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVKQL   G    +++  E+ +L  +    +VK  G       + ++  L+ EY+P+  
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGC 99
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D L  R +A L  +  L  +    +G+ YL      + + RD  + NIL++ + + K+
Sbjct: 100 LRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 155
Query: 250 SDFGLARLGPSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +DFGLA+L P D   +V        I + APE +     + +SD+WSFGV LYEL T
Sbjct: 156 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P   V   
Sbjct: 50  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPRGEVYKE 103
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 104 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 154
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 155 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
Query: 310 LDRN 313
            + N
Sbjct: 211 FEAN 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 18/167 (10%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL---TSRFQATLPWN 205
           EV VL    H N++  +GY  +D+       ++ ++    S+  HL    ++FQ      
Sbjct: 82  EVAVLRKTRHVNILLFMGYMTKDN-----LAIVTQWCEGSSLYKHLHVQETKFQMF---- 132
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
             + IA+  A+G+ YLH      II RD KS+NI L E    K+ DFGLA +      S 
Sbjct: 133 QLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 266 VSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRP 309
                 G++ + APE I+       +++SD++S+G+ LYEL+TG  P
Sbjct: 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 37/248 (14%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           ++++ E +++G  +HPN+V L G       RG   +++ E+M N ++ D    +      
Sbjct: 89  RDFLCEASIMGQFDHPNVVHLEGVVT----RGKPVMIVIEFMENGAL-DAFLRKHDGQFT 143
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
               + + +  A G+ YL    D   + RD  + NIL++     K+SDFGL+R+   D  
Sbjct: 144 VIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IEDDP 199
Query: 264 SHVSTAVVGTIG--YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL----DRNRPK 316
             V T   G I   + APE IQ  + T  SD+WS+G+ ++E+++ G RP     +++  K
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK 259
Query: 317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           + ++      P    A    ++LD                     C  ++   RPK  ++
Sbjct: 260 AIEEGYRLPAPMDCPAGLHQLMLD---------------------CWQKERAERPKFEQI 298
Query: 377 VEVLNKIV 384
           V +L+K++
Sbjct: 299 VGILDKMI 306

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 62  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 115
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 116 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 166
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 167 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222
Query: 310 LDRN 313
            + N
Sbjct: 223 FEAN 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVKQL   G    +++  E+ +L  +    +VK  G       + ++  L+ EY+P+  
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGC 112
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D L  R +A L  +  L  +    +G+ YL      + + RD  + NIL++ + + K+
Sbjct: 113 LRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 168
Query: 250 SDFGLARLGPSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +DFGLA+L P D   +V        I + APE +     + +SD+WSFGV LYEL T
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 37/253 (14%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATL 202
           +++++E +++G  +HPN+++L G       RG   +++ EYM N S+   L T   Q T+
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD- 261
                + + +    G+ YL    D   + RD  + N+L+D     K+SDFGL+R+   D 
Sbjct: 151 --MQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL----DRNRPK 316
             +  +T     I + APE I     +  SD+WSFGV ++E++  G RP     +R+   
Sbjct: 206 DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           S ++      P         ++LD                     C  +    RP+ S++
Sbjct: 266 SVEEGYRLPAPMGCPHALHQLMLD---------------------CWHKDRAQRPRFSQI 304
Query: 377 VEVLNKIVDAAET 389
           V VL+ ++ + E+
Sbjct: 305 VSVLDALIRSPES 317

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVKQL   G    +++  E+ +L  +    +VK  G       + ++  L+ EY+P+  
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGC 100
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D L  R +A L  +  L  +    +G+ YL      + + RD  + NIL++ + + K+
Sbjct: 101 LRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 156
Query: 250 SDFGLARLGPSDGLSHV-STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +DFGLA+L P D   +V        I + APE +     + +SD+WSFGV LYEL T
Sbjct: 157 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 42  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMNKGS 95
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + ++   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 96  LLDFLKGETGKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 152
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 153 ADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 211
Query: 309 P 309
           P
Sbjct: 212 P 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 71  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 124
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 125 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 175
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 176 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 310 LDRN 313
            + N
Sbjct: 232 FEAN 235

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 40  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 94
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 95  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 151
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 152 KVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 210
Query: 307 RRP 309
             P
Sbjct: 211 MSP 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 44  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 98
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 99  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 155
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 214
Query: 307 RRP 309
             P
Sbjct: 215 MSP 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 41  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 95
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 152
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 153 KVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 211
Query: 307 RRP 309
             P
Sbjct: 212 MSP 214

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 16/186 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 40  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTY 94
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 95  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 151
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 152 KVADFGLSRLMTGD----TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207
Query: 305 T-GRRP 309
           T G  P
Sbjct: 208 TYGMSP 213

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           +L +V HP ++++ G   +D +   Q  +I +Y+    +   L  R     P       A
Sbjct: 59  MLSIVTHPFIIRMWG-TFQDAQ---QIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYA 112
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
            +    L YLH      II+RD K  NILLD+  + K++DFG A+  P      V+  + 
Sbjct: 113 AEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLC 164
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLL 322
           GT  Y APE + T       D WSFG+ +YE++ G  P  D N  K+ +K+L
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/185 (33%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKE--AKRIPE 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    RGLAYL E    QI+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 114 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 167
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y APE +Q    + +SDIWS G+ L EL  GR P+    P  + K LE 
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI----PPPDAKELEA 223
Query: 325 V--RP 327
           +  RP
Sbjct: 224 IFGRP 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 30/197 (15%)
Query: 127 KIDIAVKQLSRRGLQG-HKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           ++D A+K++     +  H+++  E+ VL  +  HPN++ L+G C   + RG   L I EY
Sbjct: 52  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI-EY 107
Query: 185 MPNRSVQDHL--------------TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            P+ ++ D L               +   +TL     L  A D ARG+ YL +    Q I
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 164
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLT 288
            RD  + NIL+ E + AK++DFGL+R     G        +G   + + A E +     T
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYT 219
Query: 289 YKSDIWSFGVFLYELIT 305
             SD+WS+GV L+E+++
Sbjct: 220 TNSDVWSYGVLLWEIVS 236

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 117 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 165
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 166 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 44  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTY 98
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 155
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 214
Query: 307 RRP 309
             P
Sbjct: 215 MSP 217

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 127 KIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           KI +A+K L      + +KE + E  V+  V  P + +L+G C     +     L+ + M
Sbjct: 46  KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-----LVTQLM 100
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           P   + DH+    +  L     L      A+G++YL    D +++ RD  + N+L+    
Sbjct: 101 PYGCLLDHVREN-RGRLGSQDLLNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPN 156
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + K++DFGLARL   D   + +      I + A E I   R T++SD+WS+GV ++EL+T
Sbjct: 157 HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216
Query: 306 -GRRPLDRNRPKSEQKLLE 323
            G +P D    +    LLE
Sbjct: 217 FGAKPYDGIPAREIPDLLE 235

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 41  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 95
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 152
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 153 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 211
Query: 307 RRP 309
             P
Sbjct: 212 MSP 214

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+K L + G    + ++ E  V+  + H  LV+L    +E+        ++ EYM   S
Sbjct: 42  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----IYIVTEYMNKGS 95
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           + D L       L     + ++   A G+AY+ E M++  + RD +++NIL+ E    K+
Sbjct: 96  LLDFLKGETGKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRDLRAANILVGENLVCKV 152
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRR 308
           +DFGLARL   +  +    A    I + APE    GR T KSD+WSFG+ L EL T GR 
Sbjct: 153 ADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 211
Query: 309 P 309
           P
Sbjct: 212 P 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 16/186 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 41  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 95
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 152
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 153 KVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 305 T-GRRP 309
           T G  P
Sbjct: 209 TYGMSP 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 41  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 96
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           E M N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 97  EXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 152
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 153 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 213 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 256
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 257 -----CWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 50  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 103
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 104 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 154
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 155 ADFGWSVHAPSSR----RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210
Query: 310 LDRN 313
            + N
Sbjct: 211 FEAN 214

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 44  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 98
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 155
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 214
Query: 307 RRP 309
             P
Sbjct: 215 MSP 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 16/186 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 44  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 98
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 155
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 156 KVADFGLSRLMTGD----TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 305 T-GRRP 309
           T G  P
Sbjct: 212 TYGMSP 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 52  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 106
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 107 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 163
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 164 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 222
Query: 307 RRP 309
             P
Sbjct: 223 MSP 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 28/273 (10%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V+++   + KK  +A+K+++    Q    E + E+  +    HPN+V         DE  
Sbjct: 30  VVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL- 88
Query: 176 IQRLLIYEYMPNRSVQD---HLTSRFQ---ATLPWNTRLKIAQDAARGLAYLHEGMDFQI 229
               L+ + +   SV D   H+ ++ +     L  +T   I ++   GL YLH+      
Sbjct: 89  ---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--- 142
Query: 230 IFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG---LSHVSTAVVGTIGYAAPEYIQTGR 286
           I RD K+ NILL E  + +++DFG++    + G    + V    VGT  + APE ++  R
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 287 -LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLE 344
              +K+DIWSFG+   EL TG  P  +  P     L L+   P L      T + D ++ 
Sbjct: 203 GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE-----TGVQDKEML 257
Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
            KY  K  +K+ ++   CL +  + RP  +E++
Sbjct: 258 KKYG-KSFRKMISL---CLQKDPEKRPTAAELL 286

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 30/197 (15%)
Query: 127 KIDIAVKQLSRRGLQG-HKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           ++D A+K++     +  H+++  E+ VL  +  HPN++ L+G C   + RG   L I EY
Sbjct: 42  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI-EY 97
Query: 185 MPNRSVQDHL--------------TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            P+ ++ D L               +   +TL     L  A D ARG+ YL +    Q I
Sbjct: 98  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 154
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLT 288
            RD  + NIL+ E + AK++DFGL+R     G        +G   + + A E +     T
Sbjct: 155 HRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYT 209
Query: 289 YKSDIWSFGVFLYELIT 305
             SD+WS+GV L+E+++
Sbjct: 210 TNSDVWSYGVLLWEIVS 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 126 KKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           ++I +A+K L S    +  +++++E +++G  +HPN++ L G       +    ++I E+
Sbjct: 34  REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----KSTPVMIITEF 89
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
           M N S+ D    +          + + +  A G+ YL    D   + R   + NIL++  
Sbjct: 90  MENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSN 145
Query: 245 WNAKLSDFGLARLGPSDGLSHVSTAVVG---TIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
              K+SDFGL+R    D      T+ +G    I + APE IQ  + T  SD+WS+G+ ++
Sbjct: 146 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 205
Query: 302 ELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVAN 360
           E+++ G RP             +     + +A +    L P ++          L  +  
Sbjct: 206 EVMSYGERPY-----------WDMTNQDVINAIEQDYRLPPPMD------CPSALHQLML 248
Query: 361 KCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPL 396
            C  +    RPK  ++V  L+K++    +     PL
Sbjct: 249 DCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPL 284

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 119 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 167
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 168 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 44  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 98
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 155
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 214
Query: 307 RRP 309
             P
Sbjct: 215 MSP 217

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           E M N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 36/268 (13%)
Query: 124 SHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           S K+I +A+K L     +  + +++ E +++G  +HPN+++L G   +        +++ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV----MIVT 125
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           E M N S+ D    +  A       + + +  A G+ YL    D   + RD  + NIL++
Sbjct: 126 EXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILIN 181
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLY 301
                K+SDFGL+R+   D  +  +T      I + +PE I   + T  SD+WS+G+ L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 302 ELIT-GRRPL----DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           E+++ G RP     +++  K+  +      P    A  + ++LD                
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------- 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIV 384
                C  +    RPK  ++V +L+K++
Sbjct: 286 -----CWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 43  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 97
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 98  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 154
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 307 RRP 309
             P
Sbjct: 214 MSP 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 48  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 101
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 102 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 152
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS        A+ GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 153 ADFGWSVHAPSSR----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
Query: 310 LDRN 313
            + N
Sbjct: 209 FEAN 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 39  LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 93
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL +      I RD  + N L+ E    
Sbjct: 94  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-G 306
           K++DFGL+RL   D  +  + A    I + APE +   + + KSD+W+FGV L+E+ T G
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 307 RRP 309
             P
Sbjct: 210 MSP 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 114 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 162
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 163 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 28/273 (10%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V+++   + KK  +A+K+++    Q    E + E+  +    HPN+V         DE  
Sbjct: 25  VVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL- 83
Query: 176 IQRLLIYEYMPNRSVQD---HLTSRFQ---ATLPWNTRLKIAQDAARGLAYLHEGMDFQI 229
               L+ + +   SV D   H+ ++ +     L  +T   I ++   GL YLH+      
Sbjct: 84  ---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--- 137
Query: 230 IFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG---LSHVSTAVVGTIGYAAPEYIQTGR 286
           I RD K+ NILL E  + +++DFG++    + G    + V    VGT  + APE ++  R
Sbjct: 138 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 287 -LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHLTDAKKFTMILDPKLE 344
              +K+DIWSFG+   EL TG  P  +  P     L L+   P L      T + D ++ 
Sbjct: 198 GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE-----TGVQDKEML 252
Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
            KY  K  +K+ ++   CL +  + RP  +E++
Sbjct: 253 KKYG-KSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 50  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 103
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 104 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 154
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 155 ADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
Query: 310 LDRN 313
            + N
Sbjct: 211 FEAN 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 26/225 (11%)
Query: 130 IAVKQLSR---RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +AVK L+R   R L    +   E+  L +  HP+++KL    +   +      ++ EY+ 
Sbjct: 44  VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI----FMVMEYVS 99
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              + D++       L      ++ Q    G+ Y H  M   ++ RD K  N+LLD   N
Sbjct: 100 GGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMN 154
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELI 304
           AK++DFGL+ +  SDG         G+  YAAPE I +GRL    + DIWS GV LY L+
Sbjct: 155 AKIADFGLSNMM-SDG--EFLRXSCGSPNYAAPEVI-SGRLYAGPEVDIWSSGVILYALL 210
Query: 305 TGRRPLDRNR-PKSEQKLL-------EWVRPHLTDAKKFTMILDP 341
            G  P D +  P   +K+        +++ P +    K  + +DP
Sbjct: 211 CGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 255

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 7/177 (3%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVKQL   G    +++  E+ +L  +    +VK  G         ++  L+ EY+P+  
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELR--LVMEYLPSGC 96
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           ++D L  R +A L  +  L  +    +G+ YL      + + RD  + NIL++ + + K+
Sbjct: 97  LRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 152
Query: 250 SDFGLARLGPSD-GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           +DFGLA+L P D     V       I + APE +     + +SD+WSFGV LYEL T
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 117 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 165
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 166 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 114 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 162
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 163 --RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 46  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 99
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 100 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 150
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 151 ADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
Query: 310 LDRN 313
            + N
Sbjct: 207 FEAN 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 45  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 98
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 99  LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 149
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 150 ADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
Query: 310 LDRN 313
            + N
Sbjct: 206 FEAN 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 117
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 118 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 166
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 167 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 115 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR-- 163
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 164 --RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 114 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 162
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
               A+ GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 163 --RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 45  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 98
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 99  LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 149
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS       T + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 150 ADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
Query: 310 LDRN 313
            + N
Sbjct: 206 FEAN 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 112
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 113 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 161
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 162 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 123 DSHKKIDIAVK-----QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ 177
           +  +K  +A+K     QL + G++   +   EV +   + HPN+++L GY  +      +
Sbjct: 26  EKQRKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATR 79
Query: 178 RLLIYEYMPNRSVQDHLT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
             LI EY P  +V   L   S+F  Q T  + T L      A  L+Y H     ++I RD
Sbjct: 80  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRD 130
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K  N+LL      K++DFG +   PS       T + GT+ Y  PE I+      K D+
Sbjct: 131 IKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDL 186
Query: 294 WSFGVFLYELITGRRPLDRN 313
           WS GV  YE + G+ P + N
Sbjct: 187 WSLGVLCYEFLVGKPPFEAN 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 45  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHDS----TRVYLILEYAPLGTVYRE 98
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 99  LQKLSKFDEQRTATYITEL------ANALSYCHSK---KVIHRDIKPENLLLGSAGELKI 149
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS        A+ GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 150 ADFGWSVHAPSSR----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
Query: 310 LDRN 313
            + N
Sbjct: 206 FEAN 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 122 EDSHKKIDIAVKQL---SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR 178
           ED+   I +A+K +    R   +  K +  EV+    + H N+V +I    EDD      
Sbjct: 31  EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD----CY 86
Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            L+ EY+   ++ +++ S     L  +T +        G+ + H   D +I+ RD K  N
Sbjct: 87  YLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQN 141
Query: 239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           IL+D     K+ DFG+A+      L+  +  V+GT+ Y +PE  +       +DI+S G+
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 299 FLYELITGRRPLD 311
            LYE++ G  P +
Sbjct: 201 VLYEMLVGEPPFN 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 114 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 162
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 163 --RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 49  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 108
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 109 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 157
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 158 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 216
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 217 VTVWELMTFGSKPYD-GIPASE 237

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 105
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 106 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 154
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 213
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 214 VTVWELMTFGSKPYD-GIPASE 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 43  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 102
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 103 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 151
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 152 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 210
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 211 VTVWELMTFGSKPYD-GIPASE 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 101
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 102 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 150
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 209
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 210 VTVWELMTFGSKPYD-GIPASE 230

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 40  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 99
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 100 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 148
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 149 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 207
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 208 VTVWELMTFGSKPYD-GIPASE 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 96/186 (51%), Gaps = 16/186 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 246 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 300
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL E  +F  I R+  + N L+ E    
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF--IHRNLAARNCLVGENHLV 357
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 358 KVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
Query: 305 T-GRRP 309
           T G  P
Sbjct: 414 TYGMSP 419

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 40  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 99
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 100 PFGXLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 148
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 149 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 207
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 208 VTVWELMTFGSKPYD-GIPASE 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 105
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 106 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 154
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 213
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 214 VTVWELMTFGSKPYD-GIPASE 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 100
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 101 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 149
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 150 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 208
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 209 VTVWELMTFGSKPYD-GIPASE 229

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 115/247 (46%), Gaps = 35/247 (14%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           ++++ E +++G  +HPN++ L G   +        +++ EYM N S+ D    +      
Sbjct: 68  RDFLGEASIMGQFDHPNIIHLEGVVTKSK----PVMIVTEYMENGSL-DTFLKKNDGQFT 122
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
               + + +  + G+ YL    D   + RD  + NIL++     K+SDFGL+R+   D  
Sbjct: 123 VIQLVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 264 SHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL----DRNRPKS 317
           +  +T      I + APE I   + T  SD+WS+G+ ++E+++ G RP     +++  K+
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKA 239
Query: 318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
            ++      P    A  + ++LD                     C  ++   RPK  E+V
Sbjct: 240 VEEGYRLPSPMDCPAALYQLMLD---------------------CWQKERNSRPKFDEIV 278
Query: 378 EVLNKIV 384
            +L+K++
Sbjct: 279 NMLDKLI 285

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 45  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 104
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 105 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 153
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 154 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 212
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 213 VTVWELMTFGSKPYD-GIPASE 233

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 115
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K+++FG +   PS    
Sbjct: 116 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR-- 164
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 165 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P   V   
Sbjct: 50  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPRGEVYKE 103
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 104 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 154
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 155 ADFGWSVHAPSSR----RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
Query: 310 LDRN 313
            + N
Sbjct: 211 FEAN 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 101
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 102 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 150
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 209
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 210 VTVWELMTFGSKPYD-GIPASE 230

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 30/197 (15%)
Query: 127 KIDIAVKQLSRRGLQG-HKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           ++D A+K++     +  H+++  E+ VL  +  HPN++ L+G C   + RG   L I EY
Sbjct: 49  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI-EY 104
Query: 185 MPNRSVQDHL--------------TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            P+ ++ D L               +   +TL     L  A D ARG+ YL +    Q I
Sbjct: 105 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 161
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLT 288
            R+  + NIL+ E + AK++DFGL+R     G        +G   + + A E +     T
Sbjct: 162 HRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYT 216
Query: 289 YKSDIWSFGVFLYELIT 305
             SD+WS+GV L+E+++
Sbjct: 217 TNSDVWSYGVLLWEIVS 233

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 15/164 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++L  V HP +VKL  Y  + + +     LI +++    +   L+     T   + + 
Sbjct: 80  ERDILADVNHPFVVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFT-EEDVKF 134
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +A+  A GL +LH      II+RD K  NILLDE+ + KL+DFGL++    + + H   
Sbjct: 135 YLAE-LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----EAIDHEKK 186
Query: 269 A--VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           A    GT+ Y APE +     ++ +D WS+GV ++E++TG  P 
Sbjct: 187 AYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 105
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 106 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 154
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 213
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 214 VTVWELMTFGSKPYD-GIPASE 234

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 101
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 102 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 150
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 209
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 210 VTVWELMTFGSKPYD-GIPASE 230

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGXLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 64  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 123
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 124 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 172
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 173 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 231
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 232 VTVWELMTFGSKPYD-GIPASE 252

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 101
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 102 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 150
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 209
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 210 VTVWELMTFGSKPYD-GIPASE 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 33  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 92
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 93  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 141
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 200
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 201 VTVWELMTFGSKPYD-GIPASE 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 100
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 101 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 149
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 150 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 208
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 209 VTVWELMTFGSKPYD-GIPASE 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 47  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 100
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 101 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 151
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 152 ADFGWSVHAPSSR----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207
Query: 310 LDRN 313
            + N
Sbjct: 208 FEAN 211

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           KI +AVK L        K++  E  +L  ++H ++VK  G C E D      ++++EYM 
Sbjct: 43  KILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL----IMVFEYMK 98
Query: 187 NRSVQDHLTSRFQ-----------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           +  +   L +                L  +  L IAQ  A G+ YL        + RD  
Sbjct: 99  HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLA 155
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWS 295
           + N L+ E    K+ DFG++R   S     V    +  I +  PE I   + T +SD+WS
Sbjct: 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 215
Query: 296 FGVFLYELIT-GRRP 309
            GV L+E+ T G++P
Sbjct: 216 LGVVLWEIFTYGKQP 230

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPW 204
           V+EVN+L  ++HPN+V+   Y    D       ++ EY     +   +T  ++ +  L  
Sbjct: 53  VSEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 205 NTRLKIAQDAARGLAYLHEGMD--FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
              L++       L   H   D    ++ RD K +N+ LD + N KL DFGLAR+   D 
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 169
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
            +  + A VGT  Y +PE  Q  R++Y  KSDIWS G  LYEL     P 
Sbjct: 170 -TSFAKAFVGTPYYMSPE--QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 15/181 (8%)
Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           + +AVK L    ++  +E++ E  V+  ++HPNLV+L+G C     R     +I E+M  
Sbjct: 285 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTY 339
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            ++ D+L    +  +     L +A   +  + YL E  +F  I R+  + N L+ E    
Sbjct: 340 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNF--IHRNLAARNCLVGENHLV 396
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
           K++DFGL+RL   D      TA  G    I + APE +   + + KSD+W+FGV L+E+ 
Sbjct: 397 KVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 452
Query: 305 T 305
           T
Sbjct: 453 T 453

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 153 LGVVEHPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L+  CA    +R I+  L++E++ ++ ++ +L       LP  T   + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
           +   RGL +LH      I+ RD K  NIL+      KL+DFGLAR+          T VV
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVV 180
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T+ Y APE +         D+WS G    E+   R+PL
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 71  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 124
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 125 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 175
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 176 ADFGWSVHAPSSR----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 310 LDRN 313
            + N
Sbjct: 232 FEAN 235

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 130 IAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-------LI 181
           +A+KQ  +     ++E W  E+ ++  + HPN+V      A +   G+Q+L       L 
Sbjct: 43  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-----AREVPDGLQKLAPNDLPLLA 97
Query: 182 YEYMPNRSVQDHLTSRFQATL-----PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS 236
            EY     ++ +L ++F+        P  T L    D +  L YLHE    +II RD K 
Sbjct: 98  MEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLS---DISSALRYLHEN---RIIHRDLKP 150
Query: 237 SNILLD---EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            NI+L    ++   K+ D G A+         + T  VGT+ Y APE ++  + T   D 
Sbjct: 151 ENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDY 207
Query: 294 WSFGVFLYELITGRRPLDRN----------RPKSEQKLLEWVRPHLTDAKKFTMIL 339
           WSFG   +E ITG RP   N          R KS + ++  V   LT A KF+ +L
Sbjct: 208 WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV--VYDDLTGAVKFSSVL 261

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDD--ERGIQ 177
            ED   +  +A+K ++++ L+G +  +  E+ VL  ++HPN+V L      DD  E G  
Sbjct: 37  AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGH 90
Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKS 236
             LI + +    + D +  +   T    +RL     DA +   YLH   D  I+ RD K 
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH---DLGIVHRDLKP 144
Query: 237 SNIL---LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            N+L   LDE     +SDFGL+++   D  S +STA  GT GY APE +     +   D 
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDC 201
Query: 294 WSFGVFLYELITGRRPL-DRNRPKSEQKLLE 323
           WS GV  Y L+ G  P  D N  K  +++L+
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 130 IAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-------LI 181
           +A+KQ  +     ++E W  E+ ++  + HPN+V      A +   G+Q+L       L 
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-----AREVPDGLQKLAPNDLPLLA 96
Query: 182 YEYMPNRSVQDHLTSRFQATL-----PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS 236
            EY     ++ +L ++F+        P  T L    D +  L YLHE    +II RD K 
Sbjct: 97  MEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLS---DISSALRYLHEN---RIIHRDLKP 149
Query: 237 SNILLD---EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            NI+L    ++   K+ D G A+         + T  VGT+ Y APE ++  + T   D 
Sbjct: 150 ENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDY 206
Query: 294 WSFGVFLYELITGRRPLDRN----------RPKSEQKLLEWVRPHLTDAKKFTMIL 339
           WSFG   +E ITG RP   N          R KS + ++  V   LT A KF+ +L
Sbjct: 207 WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV--VYDDLTGAVKFSSVL 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 46  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 99
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 100 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 150
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 151 ADFGWSVHAPSSR----RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
Query: 310 LDRN 313
            + N
Sbjct: 207 FEAN 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 112/250 (44%), Gaps = 27/250 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 103
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K  E 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAK--ED 211
Query: 325 VRPHLTDAKKFTMILD---PKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV-VEV 379
            RP +   +    I++   PKL  G +S++         NKCL +    R  + ++ V  
Sbjct: 212 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD----FVNKCLIKNPAERADLKQLMVHA 267
Query: 380 LNKIVDAAET 389
             K  DA E 
Sbjct: 268 FIKRSDAEEV 277

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 140 LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ 199
           ++  +E+  EV ++  + HPN+VKL G             ++ E++P   +   L  +  
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAH 117
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWN--AKLSDFGL 254
             + W+ +L++  D A G+ Y+ +  +  I+ RD +S NI L   DE     AK++DFGL
Sbjct: 118 P-IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDR 312
           ++        H  + ++G   + APE I     +Y  K+D +SF + LY ++TG  P D 
Sbjct: 176 SQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK 372
               S  K+           K   MI +  L          +L  V   C +   K RP 
Sbjct: 231 ---YSYGKI-----------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 373 MSEVVEVLNKI 383
            S +V+ L+++
Sbjct: 277 FSYIVKELSEL 287

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K+++FG +   PS    
Sbjct: 117 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR-- 165
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
              T + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 166 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 133 KQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD 192
           K L++  +QG  E   E++ L ++ HP+++KL       DE     +++ EY  N  + D
Sbjct: 50  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFD 102
Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
           ++  R + +     R    Q     + Y H     +I+ RD K  N+LLDE  N K++DF
Sbjct: 103 YIVQRDKMSEQEARRF--FQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADF 157
Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
           GL+ +  +DG + + T+  G+  YAAPE I +G+L    + D+WS GV LY ++  R P 
Sbjct: 158 GLSNIM-TDG-NFLKTS-CGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPF 213
Query: 311 D--------RNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           D        +N       L +++ P      K  +I++P
Sbjct: 214 DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 128/272 (47%), Gaps = 28/272 (10%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL 179
           T    K++ +A+K L     +  + +++ E  ++G   H N+++L G  ++        +
Sbjct: 67  TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM----M 122
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           +I EYM N ++   L  +          + + +  A G+ YL    +   + RD  + NI
Sbjct: 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNI 178
Query: 240 LLDEQWNAKLSDFGLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           L++     K+SDFGL+R+   D   ++ ++     I + APE I   + T  SD+WSFG+
Sbjct: 179 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238
Query: 299 FLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
            ++E++T G RP       S  ++++     + D  +    +D              +  
Sbjct: 239 VMWEVMTYGERPYWE---LSNHEVMK----AINDGFRLPTPMD----------CPSAIYQ 281
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKIVDAAET 389
           +  +C  ++   RPK +++V +L+K++ A ++
Sbjct: 282 LMMQCWQQERARRPKFADIVSILDKLIRAPDS 313

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 133 KQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD 192
           K L++  +QG  E   E++ L ++ HP+++KL       DE     +++ EY  N  + D
Sbjct: 49  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFD 101
Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
           ++  R + +     R    Q     + Y H     +I+ RD K  N+LLDE  N K++DF
Sbjct: 102 YIVQRDKMSEQEARRF--FQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADF 156
Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
           GL+ +  +DG + + T+  G+  YAAPE I +G+L    + D+WS GV LY ++  R P 
Sbjct: 157 GLSNIM-TDG-NFLKTS-CGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPF 212
Query: 311 D--------RNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           D        +N       L +++ P      K  +I++P
Sbjct: 213 DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   SRF  Q T  +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 118 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR-- 166
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
              T + GT+ Y  PE I+      K D+WS GV  YE + G  P +
Sbjct: 167 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 36  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 95
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A G+ YL    D +++ RD  + N
Sbjct: 96  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AEGMNYLE---DRRLVHRDLAARN 144
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 145 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 203
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 204 VTVWELMTFGSKPYD-GIPASE 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 96/181 (53%), Gaps = 18/181 (9%)
Query: 133 KQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD 192
           K L++  +QG  E   E++ L ++ HP+++KL       DE     +++ EY  N  + D
Sbjct: 40  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFD 92
Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
           ++  R + +     R    Q     + Y H     +I+ RD K  N+LLDE  N K++DF
Sbjct: 93  YIVQRDKMSEQEARRF--FQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADF 147
Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
           GL+ +  +DG + + T+  G+  YAAPE I +G+L    + D+WS GV LY ++  R P 
Sbjct: 148 GLSNIM-TDG-NFLKTS-CGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPF 203
Query: 311 D 311
           D
Sbjct: 204 D 204

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 117 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 165
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
                + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 166 --RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATL 202
           +++ E  +L    HPN+V+LIG C        Q+  IY  M      D LT      A L
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
              T L++  DAA G+ YL        I RD  + N L+ E+   K+SDFG++R   +DG
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADG 266
Query: 263 LSHVSTAVVGT-IGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +   S  +    + + APE +  GR + +SD+WSFG+ L+E
Sbjct: 267 VXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDD--ERGIQ 177
            ED   +  +A+K +++  L+G +  +  E+ VL  ++HPN+V L      DD  E G  
Sbjct: 37  AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGH 90
Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKS 236
             LI + +    + D +  +   T    +RL     DA +   YLH   D  I+ RD K 
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH---DLGIVHRDLKP 144
Query: 237 SNIL---LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            N+L   LDE     +SDFGL+++   D  S +STA  GT GY APE +     +   D 
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDC 201
Query: 294 WSFGVFLYELITGRRPL-DRNRPKSEQKLL 322
           WS GV  Y L+ G  P  D N  K  +++L
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDD--ERGIQ 177
            ED   +  +A+K +++  L+G +  +  E+ VL  ++HPN+V L      DD  E G  
Sbjct: 37  AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGH 90
Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKS 236
             LI + +    + D +  +   T    +RL     DA +   YLH   D  I+ RD K 
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH---DLGIVHRDLKP 144
Query: 237 SNIL---LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            N+L   LDE     +SDFGL+++   D  S +STA  GT GY APE +     +   D 
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDC 201
Query: 294 WSFGVFLYELITGRRPL-DRNRPKSEQKLL 322
           WS GV  Y L+ G  P  D N  K  +++L
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDD--ERGIQ 177
            ED   +  +A+K +++  L+G +  +  E+ VL  ++HPN+V L      DD  E G  
Sbjct: 37  AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGH 90
Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKS 236
             LI + +    + D +  +   T    +RL     DA +   YLH   D  I+ RD K 
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH---DLGIVHRDLKP 144
Query: 237 SNIL---LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            N+L   LDE     +SDFGL+++   D  S +STA  GT GY APE +     +   D 
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDC 201
Query: 294 WSFGVFLYELITGRRPL-DRNRPKSEQKLL 322
           WS GV  Y L+ G  P  D N  K  +++L
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 127/267 (47%), Gaps = 38/267 (14%)
Query: 126 KKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           ++I +A+K L + G   +  +++++E +++G  +HPN++ L G       +    ++I E
Sbjct: 56  REICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVT----KCKPVMIITE 110
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           YM N S+   L     RF         + + +    G+ YL    D   + RD  + NIL
Sbjct: 111 YMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS---DMSAVHRDLAARNIL 163
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           ++     K+SDFG++R+   D  +  +T      I + APE I   + T  SD+WS+G+ 
Sbjct: 164 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 223
Query: 300 LYELIT-GRRPL-DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
           ++E+++ G RP  D +     + + E  R            L P ++    I L Q +  
Sbjct: 224 MWEVMSYGERPYWDMSNQDVIKAIEEGYR------------LPPPMD--CPIALHQLML- 268
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKIV 384
               C  ++   RPK  ++V +L+K++
Sbjct: 269 ---DCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           K+ +AVK L    L   K++  E  +L  ++H ++VK  G C + D      ++++EYM 
Sbjct: 45  KMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL----IMVFEYMK 100
Query: 187 NRSVQDHLTS--------------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR 232
           +  +   L +              + +  L  +  L IA   A G+ YL        + R
Sbjct: 101 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHR 157
Query: 233 DFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSD 292
           D  + N L+      K+ DFG++R   S     V    +  I +  PE I   + T +SD
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 217
Query: 293 IWSFGVFLYELIT-GRRP 309
           +WSFGV L+E+ T G++P
Sbjct: 218 VWSFGVILWEIFTYGKQP 235

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATL 202
           +++ E  +L    HPN+V+LIG C        Q+  IY  M      D LT      A L
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
              T L++  DAA G+ YL        I RD  + N L+ E+   K+SDFG++R   +DG
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADG 266
Query: 263 LSHVSTAVVGT-IGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +   S  +    + + APE +  GR + +SD+WSFG+ L+E
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 96/181 (53%), Gaps = 18/181 (9%)
Query: 133 KQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQD 192
           K L++  +QG  E   E++ L ++ HP+++KL       DE     +++ EY  N  + D
Sbjct: 44  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFD 96
Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
           ++  R + +     R    Q     + Y H     +I+ RD K  N+LLDE  N K++DF
Sbjct: 97  YIVQRDKMSEQEARRF--FQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADF 151
Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
           GL+ +  +DG + + T+  G+  YAAPE I +G+L    + D+WS GV LY ++  R P 
Sbjct: 152 GLSNIM-TDG-NFLKTS-CGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPF 207
Query: 311 D 311
           D
Sbjct: 208 D 208

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 145 EWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + EY+    +  H+    Q  L
Sbjct: 65  DWVQTEKHVFEQASNHPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQR--QRKL 118
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
           P       + + +  L YLHE     II+RD K  N+LLD + + KL+D+G+ + G   G
Sbjct: 119 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 175
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
               ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 176 --DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 17/171 (9%)
Query: 145 EWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + EY+    +  H+    Q  L
Sbjct: 97  DWVQTEKHVFEQASNHPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQR--QRKL 150
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PS 260
           P       + + +  L YLHE     II+RD K  N+LLD + + KL+D+G+ + G  P 
Sbjct: 151 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           D     ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 208 D----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   S+F  Q T  +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 114 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 162
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
                + GT+ Y  PE I+      K D+WS GV  YE + G+ P + N
Sbjct: 163 --RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 127/267 (47%), Gaps = 38/267 (14%)
Query: 126 KKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           ++I +A+K L + G   +  +++++E +++G  +HPN++ L G       +    ++I E
Sbjct: 41  REICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVT----KCKPVMIITE 95
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           YM N S+   L     RF         + + +    G+ YL    D   + RD  + NIL
Sbjct: 96  YMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS---DMSYVHRDLAARNIL 148
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           ++     K+SDFG++R+   D  +  +T      I + APE I   + T  SD+WS+G+ 
Sbjct: 149 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 208
Query: 300 LYELIT-GRRPL-DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
           ++E+++ G RP  D +     + + E  R            L P ++    I L Q +  
Sbjct: 209 MWEVMSYGERPYWDMSNQDVIKAIEEGYR------------LPPPMD--CPIALHQLML- 253
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKIV 384
               C  ++   RPK  ++V +L+K++
Sbjct: 254 ---DCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 126 KKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           K+ID+A+K L +   +   +E + E  ++  +++P +V+LIG C  +       +L+ E 
Sbjct: 36  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEM 90
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
                +   L  + +  +P +   ++    + G+ YL E      + RD  + N+LL  +
Sbjct: 91  AGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR 146
Query: 245 WNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             AK+SDFGL++ LG  D      +A    + + APE I   + + +SD+WS+GV ++E 
Sbjct: 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206
Query: 304 IT-GRRPLDRNRPKSEQKLLE 323
           ++ G++P  + +       +E
Sbjct: 207 LSYGQKPYKKMKGPEVMAFIE 227

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 127/267 (47%), Gaps = 38/267 (14%)
Query: 126 KKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           ++I +A+K L + G   +  +++++E +++G  +HPN++ L G   +        ++I E
Sbjct: 35  REICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPV----MIITE 89
Query: 184 YMPNRSVQDHL---TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           YM N S+   L     RF         + + +    G+ YL    D   + RD  + NIL
Sbjct: 90  YMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS---DMSYVHRDLAARNIL 142
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           ++     K+SDFG++R+   D  +  +T      I + APE I   + T  SD+WS+G+ 
Sbjct: 143 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 202
Query: 300 LYELIT-GRRPL-DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
           ++E+++ G RP  D +     + + E  R            L P ++    I L Q +  
Sbjct: 203 MWEVMSYGERPYWDMSNQDVIKAIEEGYR------------LPPPMD--CPIALHQLML- 247
Query: 358 VANKCLARQAKGRPKMSEVVEVLNKIV 384
               C  ++   RPK  ++V +L+K++
Sbjct: 248 ---DCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPW 204
           V+EVN+L  ++HPN+V+   Y    D       ++ EY     +   +T  ++ +  L  
Sbjct: 53  VSEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 205 NTRLKIAQDAARGLAYLHEGMD--FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
              L++       L   H   D    ++ RD K +N+ LD + N KL DFGLAR+   D 
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 169
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
            +  +   VGT  Y +PE  Q  R++Y  KSDIWS G  LYEL     P 
Sbjct: 170 -TSFAKTFVGTPYYMSPE--QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+ +L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 73  EGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 132
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 133 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 181
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFGLA+ LG  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 182 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 240
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 241 VTVWELMTFGSKPYD-GIPASE 261

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           K+ +AVK L        +++  E  +L +++H ++V+  G C E    G   L+++EYM 
Sbjct: 48  KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----GRPLLMVFEYMR 103
Query: 187 ----NRSVQDH-----LTSRFQATLP----WNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
               NR ++ H     L +  +   P        L +A   A G+ YL  G+ F  + RD
Sbjct: 104 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLHF--VHRD 160
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + N L+ +    K+ DFG++R   S     V    +  I +  PE I   + T +SD+
Sbjct: 161 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV 220
Query: 294 WSFGVFLYELIT-GRRP 309
           WSFGV L+E+ T G++P
Sbjct: 221 WSFGVVLWEIFTYGKQP 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW---- 204
           E +++     P +V+L  +CA  D++ +   ++ EYMP   + + L S +     W    
Sbjct: 125 ERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVN-LMSNYDVPEKWAKFY 179
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              + +A DA   +  +H         RD K  N+LLD+  + KL+DFG        G+ 
Sbjct: 180 TAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 265 HVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPL 310
           H  TA VGT  Y +PE +++    G    + D WS GVFL+E++ G  P 
Sbjct: 231 HCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 153 LGVVEHPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L+  CA    +R I+  L++E++ ++ ++ +L       LP  T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
           +   RGL +LH      I+ RD K  NIL+      KL+DFGLAR+            VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVV 172
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T+ Y APE +         D+WS G    E+   R+PL
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           K+ +AVK L        +++  E  +L +++H ++V+  G C E    G   L+++EYM 
Sbjct: 42  KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----GRPLLMVFEYMR 97
Query: 187 ----NRSVQDH-----LTSRFQATLP----WNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
               NR ++ H     L +  +   P        L +A   A G+ YL  G+ F  + RD
Sbjct: 98  HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLHF--VHRD 154
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + N L+ +    K+ DFG++R   S     V    +  I +  PE I   + T +SD+
Sbjct: 155 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV 214
Query: 294 WSFGVFLYELIT-GRRP 309
           WSFGV L+E+ T G++P
Sbjct: 215 WSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           K+ +AVK L        +++  E  +L +++H ++V+  G C E    G   L+++EYM 
Sbjct: 71  KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----GRPLLMVFEYMR 126
Query: 187 ----NRSVQDH-----LTSRFQATLP----WNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
               NR ++ H     L +  +   P        L +A   A G+ YL  G+ F  + RD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLHF--VHRD 183
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + N L+ +    K+ DFG++R   S     V    +  I +  PE I   + T +SD+
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV 243
Query: 294 WSFGVFLYELIT-GRRP 309
           WSFGV L+E+ T G++P
Sbjct: 244 WSFGVVLWEIFTYGKQP 260

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 17/171 (9%)
Query: 145 EWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + EY+    +  H+    Q  L
Sbjct: 50  DWVQTEKHVFEQASNHPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQR--QRKL 103
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PS 260
           P       + + +  L YLHE     II+RD K  N+LLD + + KL+D+G+ + G  P 
Sbjct: 104 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 160
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           D     ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 161 D----TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++L  V HP +VKL  Y  + + +     LI +++    +   L+     T   + + 
Sbjct: 76  ERDILVEVNHPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFT-EEDVKF 130
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +A+  A  L +LH      II+RD K  NILLDE+ + KL+DFGL++    + + H   
Sbjct: 131 YLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK 182
Query: 269 A--VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           A    GT+ Y APE +     T  +D WSFGV ++E++TG  P 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++L  V HP +VKL  Y  + + +     LI +++    +   L+     T   + + 
Sbjct: 77  ERDILVEVNHPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFT-EEDVKF 131
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +A+  A  L +LH      II+RD K  NILLDE+ + KL+DFGL++    + + H   
Sbjct: 132 YLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK 183
Query: 269 A--VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           A    GT+ Y APE +     T  +D WSFGV ++E++TG  P 
Sbjct: 184 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 100
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 101 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 149
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 208
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 209 VTVWELMTFGSKPYD-GIPASE 229

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 100
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 101 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 149
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 208
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 209 VTVWELMTFGSKPYD-GIPASE 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH 193
           QL + G++   +   EV +   + HPN+++L GY  +      +  LI EY P  +V   
Sbjct: 48  QLEKAGVE--HQLRREVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRE 101
Query: 194 LT--SRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           L   S+F  Q T  + T L      A  L+Y H     ++I RD K  N+LL      K+
Sbjct: 102 LQKLSKFDEQRTATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 152
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+WS GV  YE + G+ P
Sbjct: 153 ADFGWSVHAPSSR----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
Query: 310 LDRN 313
            + N
Sbjct: 209 FEAN 212

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 17/171 (9%)
Query: 145 EWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +WV TE +V      HP LV L   C + + R      + EY+    +  H+    Q  L
Sbjct: 54  DWVQTEKHVFEQASNHPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQR--QRKL 107
Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG--PS 260
           P       + + +  L YLHE     II+RD K  N+LLD + + KL+D+G+ + G  P 
Sbjct: 108 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
           D     ++   GT  Y APE ++     +  D W+ GV ++E++ GR P D
Sbjct: 165 D----TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++L  V HP +VKL  Y  + + +     LI +++    +   L+     T   + + 
Sbjct: 76  ERDILVEVNHPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFT-EEDVKF 130
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +A+  A  L +LH      II+RD K  NILLDE+ + KL+DFGL++    + + H   
Sbjct: 131 YLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK 182
Query: 269 A--VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           A    GT+ Y APE +     T  +D WSFGV ++E++TG  P 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 43  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLM 102
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 103 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 151
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 152 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 210
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 211 VTVWELMTFGSKPYD-GIPASE 231

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 153 LGVVEHPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L+  CA    +R I+  L++E++ ++ ++ +L       LP  T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
           +   RGL +LH      I+ RD K  NIL+      KL+DFGLAR+            VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVV 172
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T+ Y APE +         D+WS G    E+   R+PL
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 34/251 (13%)
Query: 140 LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ 199
           ++  +E+  EV ++  + HPN+VKL G             ++ E++P   +   L  +  
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAH 117
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWN--AKLSDFGL 254
             + W+ +L++  D A G+ Y+ +  +  I+ RD +S NI L   DE     AK++DFG 
Sbjct: 118 P-IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT 175
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDR 312
           ++        H  + ++G   + APE I     +Y  K+D +SF + LY ++TG  P D 
Sbjct: 176 SQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK 372
               S  K+           K   MI +  L          +L  V   C +   K RP 
Sbjct: 231 ---YSYGKI-----------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 373 MSEVVEVLNKI 383
            S +V+ L+++
Sbjct: 277 FSYIVKELSEL 287

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 105
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 106 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 154
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 155 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 213
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 214 VTVWELMTFGSKPYD-GIPASE 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 98
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 99  PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 147
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 148 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 206
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 207 VTVWELMTFGSKPYD-GIPASE 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           E    KI +A+K+L      + +KE + E  V+  V++P++ +L+G C     + I +L+
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 100
Query: 181 IYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            +  + +  R  +D++ S++   L W  ++      A+G+ YL    D +++ RD  + N
Sbjct: 101 PFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLE---DRRLVHRDLAARN 149
Query: 239 ILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           +L+    + K++DFG A+L G  +   H     V  I + A E I     T++SD+WS+G
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYG 208
Query: 298 VFLYELIT-GRRPLDRNRPKSE 318
           V ++EL+T G +P D   P SE
Sbjct: 209 VTVWELMTFGSKPYD-GIPASE 229

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPW 204
           V+EVN+L  ++HPN+V+   Y    D       ++ EY     +   +T  ++ +  L  
Sbjct: 53  VSEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 205 NTRLKIAQDAARGLAYLHEGMD--FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
              L++       L   H   D    ++ RD K +N+ LD + N KL DFGLAR+   D 
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 169
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPL 310
               +   VGT  Y +PE  Q  R++Y  KSDIWS G  LYEL     P 
Sbjct: 170 -EDFAKEFVGTPYYMSPE--QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 22/195 (11%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +++STED  + + I    +SR   +  +E   EV VL  ++HPN+V+   Y    +E G 
Sbjct: 42  LVKSTEDGRQYV-IKEINISRMSSKEREESRREVAVLANMKHPNIVQ---YRESFEENG- 96
Query: 177 QRLLIYEYMPNRSVQDHLTSR----FQ--ATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              ++ +Y     +   + ++    FQ    L W  ++ +A      L ++H   D +I+
Sbjct: 97  SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVH---DRKIL 147
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK 290
            RD KS NI L +    +L DFG+AR+   +    ++ A +GT  Y +PE  +      K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 291 SDIWSFGVFLYELIT 305
           SDIW+ G  LYEL T
Sbjct: 206 SDIWALGCVLYELCT 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 129 DIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK + +  L     ++   EV ++ V+ HPN+VKL     E  E      L+ EY  
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYAS 96
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              V D+L +  +       R K  Q  +  + Y H+     I+ RD K+ N+LLD   N
Sbjct: 97  GGEVFDYLVAHGRMK-EKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADMN 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELIT 305
            K++DFG +         +   A  G   YAAPE  Q  +    + D+WS GV LY L++
Sbjct: 152 IKIADFGFSN---EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 306 GRRPLD 311
           G  P D
Sbjct: 209 GSLPFD 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 153 LGVVEHPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L+  CA    +R I+  L++E++ ++ ++ +L       LP  T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
           +   RGL +LH      I+ RD K  NIL+      KL+DFGLAR+            VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVV 172
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T+ Y APE +         D+WS G    E+   R+PL
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +C +DDE+    L    Y 
Sbjct: 64  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGL---SYA 119
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 120 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 172
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 173 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 232
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 233 VAGLPPF 239

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRF--QATLPW 204
           EV +   + HPN+++L GY  +      +  LI EY P  +V   L   SRF  Q T  +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
            T L      A  L+Y H     ++I RD K  N+LL      K++DFG +   PS    
Sbjct: 118 ITEL------ANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR-- 166
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
                + GT+ Y  PE I+      K D+WS GV  YE + G  P +
Sbjct: 167 --RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 122 EDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           + +  +I  A+K LSR   +Q  + ++ E  ++  + HPN++ LIG     +  G+  +L
Sbjct: 44  DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--GLPHVL 101
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           +  YM +  +   + S  Q        +      ARG+ YL E    + + RD  + N +
Sbjct: 102 L-PYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCM 156
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG------TIGYAAPEYIQTGRLTYKSDIW 294
           LDE +  K++DFGLAR    D L     +V         + + A E +QT R T KSD+W
Sbjct: 157 LDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVW 212
Query: 295 SFGVFLYELITGRRPLDRN 313
           SFGV L+EL+T   P  R+
Sbjct: 213 SFGVLLWELLTRGAPPYRH 231

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 34/251 (13%)
Query: 140 LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ 199
           ++  +E+  EV ++  + HPN+VKL G             ++ E++P   +   L  +  
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAH 117
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWN--AKLSDFGL 254
             + W+ +L++  D A G+ Y+ +  +  I+ RD +S NI L   DE     AK++DF L
Sbjct: 118 P-IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL 175
Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDR 312
           ++        H  + ++G   + APE I     +Y  K+D +SF + LY ++TG  P D 
Sbjct: 176 SQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK 372
               S  K+           K   MI +  L          +L  V   C +   K RP 
Sbjct: 231 ---YSYGKI-----------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 373 MSEVVEVLNKI 383
            S +V+ L+++
Sbjct: 277 FSYIVKELSEL 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ VL   + P + K  G   +D +  I    I EY+   S  D L       L      
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEP---GPLDETQIA 107
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++  +GL YLH     + I RD K++N+LL E    KL+DFG+A  G          
Sbjct: 108 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRN 162
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  + APE I+      K+DIWS G+   EL  G  P     P     L+    P 
Sbjct: 163 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP- 221
Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       P LEG YS  L + + A    CL ++   RP   E+++
Sbjct: 222 ------------PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 255

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ VL   + P + K  G   +D +  I    I EY+   S  D L       L      
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEP---GPLDETQIA 127
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++  +GL YLH     + I RD K++N+LL E    KL+DFG+A  G          
Sbjct: 128 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRN 182
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  + APE I+      K+DIWS G+   EL  G  P     P     L+    P 
Sbjct: 183 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP- 241
Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       P LEG YS  L + + A    CL ++   RP   E+++
Sbjct: 242 ------------PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 275

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L  +    +P 
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVL--KKAGRIPE 165
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 166 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 219
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 275
Query: 325 V 325
           +
Sbjct: 276 M 276

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 126
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NI++      K+ DFG+AR     G S   TA V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 118 IRSTEDSHKKIDIAVKQLSRRGL--QGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDDER 174
           +   E  H  +++A+K + ++ +   G  + V  EV +   ++HP++++L  Y  + +  
Sbjct: 27  VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-- 84
Query: 175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
                L+ E   N  +  +L +R +     N           G+ YLH      I+ RD 
Sbjct: 85  --YVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHS---HGILHRDL 138
Query: 235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
             SN+LL    N K++DFGLA         H +  + GT  Y +PE         +SD+W
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVW 196
Query: 295 SFGVFLYELITGRRPLDRNRPKS 317
           S G   Y L+ GR P D +  K+
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ VL   + P + K  G   +D +  I    I EY+   S  D L       L      
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEP---GPLDETQIA 122
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++  +GL YLH     + I RD K++N+LL E    KL+DFG+A  G          
Sbjct: 123 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRN 177
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  + APE I+      K+DIWS G+   EL  G  P     P     L+    P 
Sbjct: 178 XFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP- 236
Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       P LEG YS  L + + A    CL ++   RP   E+++
Sbjct: 237 ------------PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 270

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 18/173 (10%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL---TSRFQA 200
           +E+++E +++G  EHPN+++L G         +  +++ E+M N ++   L     +F  
Sbjct: 62  REFLSEASIMGQFEHPNIIRLEGVVTNS----MPVMILTEFMENGALDSFLRLNDGQFTV 117
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
                  + + +  A G+ YL E      + RD  + NIL++     K+SDFGL+R    
Sbjct: 118 I----QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 170
Query: 261 DGLSHVSTAVVG---TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +      T+ +G    I + APE I   + T  SD WS+G+ ++E+++ G RP
Sbjct: 171 NSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 18/187 (9%)
Query: 130 IAVKQLSR---RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +AVK L+R   R L    +   E+  L +  HP+++KL    +   +      ++ EY+ 
Sbjct: 39  VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF----FMVMEYVS 94
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              + D++    +       RL   Q     + Y H  M   ++ RD K  N+LLD   N
Sbjct: 95  GGELFDYICKHGRVEEMEARRL--FQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMN 149
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELI 304
           AK++DFGL+ +  SDG   + T+  G+  YAAPE I +GRL    + DIWS GV LY L+
Sbjct: 150 AKIADFGLSNM-MSDG-EFLRTS-CGSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALL 205
Query: 305 TGRRPLD 311
            G  P D
Sbjct: 206 CGTLPFD 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 126
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NI++      K+ DFG+AR     G S   TA V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ VL   + P + K  G   +D +  I    I EY+   S  D L       L      
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEP---GPLDETQIA 107
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++  +GL YLH     + I RD K++N+LL E    KL+DFG+A  G          
Sbjct: 108 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRN 162
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  + APE I+      K+DIWS G+   EL  G  P     P     L+    P 
Sbjct: 163 XFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP- 221
Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       P LEG YS  L + + A    CL ++   RP   E+++
Sbjct: 222 ------------PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 255

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 12/186 (6%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +A+KQ+        +E + E++++   + P++VK  G   ++ +  I    + EY    S
Sbjct: 57  VAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI----VMEYCGAGS 110
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           V D +  R   TL  +    I Q   +GL YLH     + I RD K+ NILL+ + +AKL
Sbjct: 111 VSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKL 166
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG+A  G           V+GT  + APE IQ       +DIWS G+   E+  G+ P
Sbjct: 167 ADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
Query: 310 LDRNRP 315
                P
Sbjct: 225 YADIHP 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 126
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NIL+      K+ DFG+AR     G S   TA V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 130
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 131 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 184
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 240
Query: 325 V 325
           +
Sbjct: 241 M 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           ++ +  D   ++ IA+K++  R  +  +    E+ +   ++H N+V+ +G  +E+   G 
Sbjct: 37  IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN---GF 93
Query: 177 QRLLIYEYMPNRSVQDHLTSRF------QATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            ++ + E +P  S+   L S++      + T+ + T+         GL YLH   D QI+
Sbjct: 94  IKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLH---DNQIV 144
Query: 231 FRDFKSSNILLDEQWNA-KLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
            RD K  N+L++      K+SDFG + RL    G++  +    GT+ Y APE I  G   
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 289 Y--KSDIWSFGVFLYELITGRRPL 310
           Y   +DIWS G  + E+ TG+ P 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV ++ ++ HPN+VKL     E  E      LI EY     V D+L +  +       R 
Sbjct: 64  EVRIMKILNHPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARS 118
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           K  Q  +  + Y H+    +I+ RD K+ N+LLD   N K++DFG +      G      
Sbjct: 119 KFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLD 171
Query: 269 AVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLYELITGRRPLD 311
           A  G   YAAPE  Q  +    + D+WS GV LY L++G  P D
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 153 LGVVEHPNLVKLIGYC-AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L   C     +R  +  L++E++ ++ +  +L    +  +P  T   + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
               RGL +LH     +++ RD K  NIL+      KL+DFGLAR+          T+VV
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
            T+ Y APE +         D+WS G    E+   R+PL R     +Q
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 126
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NI++      K+ DFG+AR     G S   TA V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 126
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NI++      K+ DFG+AR     G S   TA V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 18/173 (10%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL---TSRFQA 200
           +E+++E +++G  EHPN+++L G         +  +++ E+M N ++   L     +F  
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNS----MPVMILTEFMENGALDSFLRLNDGQFTV 115
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
                  + + +  A G+ YL E      + RD  + NIL++     K+SDFGL+R    
Sbjct: 116 I----QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 168
Query: 261 DGLSHVSTAVVG---TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +      T+ +G    I + APE I   + T  SD WS+G+ ++E+++ G RP
Sbjct: 169 NSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 126 KKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           K+ID+A+K L ++G +    +E + E  ++  +++P +V+LIG C  +       +L+ E
Sbjct: 362 KQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVME 415
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
                 +   L  + +  +P +   ++    + G+ YL E      + R+  + N+LL  
Sbjct: 416 MAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVN 471
Query: 244 QWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
           +  AK+SDFGL++ LG  D      +A    + + APE I   + + +SD+WS+GV ++E
Sbjct: 472 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531
Query: 303 LIT-GRRPLDRNR 314
            ++ G++P  + +
Sbjct: 532 ALSYGQKPYKKMK 544

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 129 DIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK + +  L     ++   EV ++ V+ HPN+VKL     E  E      L+ EY  
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYAS 96
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              V D+L +  +       R K  Q  +  + Y H+     I+ RD K+ N+LLD   N
Sbjct: 97  GGEVFDYLVAHGRMK-EKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADMN 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELIT 305
            K++DFG +         +      G+  YAAPE  Q  +    + D+WS GV LY L++
Sbjct: 152 IKIADFGFSN---EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 306 GRRPLD 311
           G  P D
Sbjct: 209 GSLPFD 214

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 153 LGVVEHPNLVKLIGYC-AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L   C     +R  +  L++E++ ++ +  +L    +  +P  T   + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
               RGL +LH     +++ RD K  NIL+      KL+DFGLAR+          T+VV
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
            T+ Y APE +         D+WS G    E+   R+PL R     +Q
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 129 DIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK + +  L     ++   EV ++ V+ HPN+VKL     E  E      L+ EY  
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYAS 96
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              V D+L +  +       R K  Q  +  + Y H+     I+ RD K+ N+LLD   N
Sbjct: 97  GGEVFDYLVAHGRMK-EKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADMN 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELIT 305
            K++DFG +         +      G+  YAAPE  Q  +    + D+WS GV LY L++
Sbjct: 152 IKIADFGFSN---EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 306 GRRPLD 311
           G  P D
Sbjct: 209 GSLPFD 214

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 147 VTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           + E  VL +  EHP L  +  +C    +  +    + EY+    +  H+ S  +  L   
Sbjct: 65  MVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSRA 120
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDG 262
           T    A +   GL +LH      I++RD K  NILLD+  + K++DFG+ +   LG +  
Sbjct: 121 TF--YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
               +    GT  Y APE +   +  +  D WSFGV LYE++ G+ P      + E++L 
Sbjct: 175 ----TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELF 227
Query: 323 EWVR 326
             +R
Sbjct: 228 HSIR 231

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 147 VTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           + E  VL +  EHP L  +  +C    +  +    + EY+    +  H+ S  +  L   
Sbjct: 66  MVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSRA 121
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDG 262
           T    A +   GL +LH      I++RD K  NILLD+  + K++DFG+ +   LG +  
Sbjct: 122 TF--YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 175
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
               +    GT  Y APE +   +  +  D WSFGV LYE++ G+ P      + E++L 
Sbjct: 176 ----TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELF 228
Query: 323 EWVR 326
             +R
Sbjct: 229 HSIR 232

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 103
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 325 V 325
           +
Sbjct: 214 M 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HP +V +      +   G    ++ EY+   +++D + +  +  +     +++  DA 
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 143
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA-VVGTI 274
           + L + H+     II RD K +NI++      K+ DFG+AR     G S   TA V+GT 
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS 317
            Y +PE  +   +  +SD++S G  LYE++TG  P   + P S
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 243

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 130 IAVKQLSR---RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +AVK L+R   R L    +   E+  L +  HP+++KL    +   +      ++ EY+ 
Sbjct: 39  VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF----FMVMEYVS 94
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              + D++    +       RL   Q     + Y H  M   ++ RD K  N+LLD   N
Sbjct: 95  GGELFDYICKHGRVEEMEARRL--FQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMN 149
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELI 304
           AK++DFGL+ +  SDG         G+  YAAPE I +GRL    + DIWS GV LY L+
Sbjct: 150 AKIADFGLSNM-MSDG--EFLRDSCGSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALL 205
Query: 305 TGRRPLD 311
            G  P D
Sbjct: 206 CGTLPFD 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW---- 204
           E +++     P +V+L  Y  +DD       ++ EYMP   +  +L S +     W    
Sbjct: 119 ERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNYDVPEKWARFY 173
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              + +A DA   + ++H         RD K  N+LLD+  + KL+DFG       +G+ 
Sbjct: 174 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 265 HVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPL 310
              TA VGT  Y +PE +++    G    + D WS GVFLYE++ G  P 
Sbjct: 225 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 103
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 325 V 325
           +
Sbjct: 214 M 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 153 LGVVEHPNLVKLIGYC-AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   EHPN+V+L   C     +R  +  L++E++ ++ +  +L    +  +P  T   + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
               RGL +LH     +++ RD K  NIL+      KL+DFGLAR+          T+VV
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
            T+ Y APE +         D+WS G    E+   R+PL R     +Q
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 103
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 325 V 325
           +
Sbjct: 214 M 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 103
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 325 V 325
           +
Sbjct: 214 M 214

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW---- 204
           E +++     P +V+L  Y  +DD       ++ EYMP   +  +L S +     W    
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNYDVPEKWARFY 178
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              + +A DA   + ++H         RD K  N+LLD+  + KL+DFG       +G+ 
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 265 HVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPL 310
              TA VGT  Y +PE +++    G    + D WS GVFLYE++ G  P 
Sbjct: 230 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW---- 204
           E +++     P +V+L  Y  +DD       ++ EYMP   +  +L S +     W    
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNYDVPEKWARFY 178
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              + +A DA   + ++H         RD K  N+LLD+  + KL+DFG       +G+ 
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 265 HVSTAVVGTIGYAAPEYIQT----GRLTYKSDIWSFGVFLYELITGRRPL 310
              TA VGT  Y +PE +++    G    + D WS GVFLYE++ G  P 
Sbjct: 230 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 147 VTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLP 203
           +TE  +L +   HP L +L   C +  +R      + E++    +  H+  + RF     
Sbjct: 71  MTEKRILSLARNHPFLTQLF-CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRRFDEA-- 124
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
              R   A +    L +LH   D  II+RD K  N+LLD + + KL+DFG+ + G  +G+
Sbjct: 125 -RARF-YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
           +  +    GT  Y APE +Q        D W+ GV LYE++ G  P +    ++E  L E
Sbjct: 180 T--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFE 234
Query: 324 WV 325
            +
Sbjct: 235 AI 236

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 122
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 123 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 176
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            ++ + VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 86/186 (46%), Gaps = 15/186 (8%)
Query: 129 DIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK + +  L     ++   EV +  V+ HPN+VKL     E  E      L+ EY  
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF----EVIETEKTLYLVXEYAS 96
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              V D+L +  +       R K  Q  +  + Y H+     I+ RD K+ N+LLD   N
Sbjct: 97  GGEVFDYLVAHGRXK-EKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADXN 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLYELIT 305
            K++DFG +         +   A  G   YAAPE  Q  +    + D+WS GV LY L++
Sbjct: 152 IKIADFGFSN---EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 306 GRRPLD 311
           G  P D
Sbjct: 209 GSLPFD 214

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 26/185 (14%)
Query: 140 LQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR 197
           LQ  + W +E  +     ++H NL++ I          ++  LI  +    S+ D+L   
Sbjct: 48  LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN 107
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHE--------GMDFQIIFRDFKSSNILLDEQWNAKL 249
               + WN    +A+  +RGL+YLHE        G    I  RDFKS N+LL     A L
Sbjct: 108 I---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVL 164
Query: 250 SDFGLA---RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS------DIWSFGVFL 300
           +DFGLA     G   G +H     VGT  Y APE ++ G + ++       D+++ G+ L
Sbjct: 165 ADFGLAVRFEPGKPPGDTH---GQVGTRRYMAPEVLE-GAINFQRDAFLRIDMYAMGLVL 220
Query: 301 YELIT 305
           +EL++
Sbjct: 221 WELVS 225

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV ++ V+ HPN+VKL     E  E      L+ EY     V D+L +  +       R 
Sbjct: 63  EVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARA 117
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           K  Q  +  + Y H+     I+ RD K+ N+LLD   N K++DFG +         +   
Sbjct: 118 KFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLD 170
Query: 269 AVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLD 311
              G+  YAAPE  Q  +    + D+WS GV LY L++G  P D
Sbjct: 171 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 13/182 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  VL +++ P  +  +  C +  +R      + EY+    +  H+    +   P   
Sbjct: 67  MVEKRVLALLDKPPFLTQLHSCFQTVDR---LYFVMEYVNGGDLMYHIQQVGKFKEP--Q 121
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +  A + + GL +LH+     II+RD K  N++LD + + K++DFG+ +    DG++  
Sbjct: 122 AVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT-- 176
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           +    GT  Y APE I         D W++GV LYE++ G+ P D    + E +L + + 
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIM 233
Query: 327 PH 328
            H
Sbjct: 234 EH 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           ++ +  D   ++ IA+K++  R  +  +    E+ +   ++H N+V+ +G  +E+   G 
Sbjct: 23  IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN---GF 79
Query: 177 QRLLIYEYMPNRSVQDHLTSRF------QATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
            ++ + E +P  S+   L S++      + T+ + T+         GL YLH   D QI+
Sbjct: 80  IKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLH---DNQIV 130
Query: 231 FRDFKSSNILLDEQWNA-KLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
            RD K  N+L++      K+SDFG + RL    G++  +    GT+ Y APE I  G   
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 289 Y--KSDIWSFGVFLYELITGRRPL 310
           Y   +DIWS G  + E+ TG+ P 
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV ++ ++ HPN+VKL     E  E      LI EY     V D+L +  +       R 
Sbjct: 61  EVRIMKILNHPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARS 115
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           K  Q  +  + Y H+    +I+ RD K+ N+LLD   N K++DFG +      G      
Sbjct: 116 KFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLD 168
Query: 269 AVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLYELITGRRPLD 311
              G+  YAAPE  Q  +    + D+WS GV LY L++G  P D
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 129 DIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK + +  L     ++   EV ++ V+ HPN+VKL     E  E      L+ EY  
Sbjct: 34  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYAS 89
Query: 187 NRSVQDHLTSRFQATLPW----NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
              V D+L +       W      R K  Q  +  + Y H+     I+ RD K+ N+LLD
Sbjct: 90  GGEVFDYLVAH-----GWMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 140
Query: 243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLY 301
              N K++DFG +         +      G+  YAAPE  Q  +    + D+WS GV LY
Sbjct: 141 ADMNIKIADFGFSN---EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 197
Query: 302 ELITGRRPLD 311
            L++G  P D
Sbjct: 198 TLVSGSLPFD 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ VL   + P + +  G       +  +  +I EY+   S  D L       L      
Sbjct: 67  EITVLSQCDSPYITRYFGSYL----KSTKLWIIMEYLGGGSALDLLKP---GPLEETYIA 119
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++  +GL YLH     + I RD K++N+LL EQ + KL+DFG+A  G          
Sbjct: 120 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRN 174
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
             VGT  + APE I+     +K+DIWS G+   EL  G  P     P     L+    P 
Sbjct: 175 XFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP- 233
Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       P LEG++S    + + A    CL +  + RP   E+++
Sbjct: 234 ------------PTLEGQHSKPFKEFVEA----CLNKDPRFRPTAKELLK 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV ++ V+ HPN+VKL     E  E      L+ EY     V D+L +  +       R 
Sbjct: 63  EVRIMKVLNHPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARA 117
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           K  Q  +  + Y H+     I+ RD K+ N+LLD   N K++DFG +         +   
Sbjct: 118 KFRQIVS-AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLD 170
Query: 269 AVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLD 311
              G+  YAAPE  Q  +    + D+WS GV LY L++G  P D
Sbjct: 171 EFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 140 LQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR 197
           +Q  + W  E  V  +  ++H N+++ IG         +   LI  +    S+ D L + 
Sbjct: 57  IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHE-------GMDFQIIFRDFKSSNILLDEQWNAKLS 250
               + WN    IA+  ARGLAYLHE       G    I  RD KS N+LL     A ++
Sbjct: 117 ---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 251 DFGLA---RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS------DIWSFGVFLY 301
           DFGLA     G S G +H     VGT  Y APE ++ G + ++       D+++ G+ L+
Sbjct: 174 DFGLALKFEAGKSAGDTH---GQVGTRRYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLW 229
Query: 302 ELIT----GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM 337
           EL +       P+D      E+++ +   P L D ++  +
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQ--HPSLEDMQEVVV 267

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 112
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 113 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 165
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     + A VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 226 VAGLPPF 232

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           ++A++Q++ +     +  + E+ V+   ++PN+V  +      DE  +    + EY+   
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV----VMEYLAGG 102
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S+ D +T   +  +       + ++  + L +LH     Q+I RD KS NILL    + K
Sbjct: 103 SLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 156
Query: 249 LSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           L+DFG  A++ P    S  ST +VGT  + APE +       K DIWS G+   E+I G 
Sbjct: 157 LTDFGFCAQITPEQ--SKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 308 RP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            P L+ N  ++   +     P L + +K + I 
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 82/170 (48%), Gaps = 21/170 (12%)
Query: 149 EVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           EV++L  V  HPN+++L     +  E      L+++ M    + D+LT +   TL     
Sbjct: 73  EVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET 126
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHV 266
            KI +     +  LH+     I+ RD K  NILLD+  N KL+DFG + +L P + L   
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-- 181
Query: 267 STAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPL 310
             +V GT  Y APE I+            + D+WS GV +Y L+ G  P 
Sbjct: 182 --SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           + + E+ VL     P +V   G    D E  I      E+M   S+   L       +P 
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKK--AGRIPE 106
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
               K++    +GL YL E    +I+ RD K SNIL++ +   KL DFG++       + 
Sbjct: 107 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 160
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            ++   VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P     P +  +LL++
Sbjct: 161 EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDY 217
Query: 325 V--RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV-VEVLN 381
           +   P             PKL    S   + +     NKCL +    R  + ++ V    
Sbjct: 218 IVNEP------------PPKLP---SAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 262
Query: 382 KIVDAAET 389
           K  DA E 
Sbjct: 263 KRSDAEEV 270

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 129 DIAVK-----QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           ++AVK     QL+   LQ   +   EV ++ ++ HPN+VKL     E  E      L+ E
Sbjct: 42  EVAVKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKLF----EVIETEKTLYLVME 94
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
           Y     V D+L +  +       R K  Q     + Y H+     I+ RD K+ N+LLD 
Sbjct: 95  YASGGEVFDYLVAHGRMK-EKEARAKFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDG 149
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY-KSDIWSFGVFLYE 302
             N K++DFG +       + +      G+  YAAPE  Q  +    + D+WS GV LY 
Sbjct: 150 DMNIKIADFGFSN---EFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 206
Query: 303 LITGRRPLD 311
           L++G  P D
Sbjct: 207 LVSGSLPFD 215

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 19/187 (10%)
Query: 130 IAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +A+K +SR+ L+    H     E++ L ++ HP+++KL        +     +++ EY  
Sbjct: 37  VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI----VMVIEY-A 91
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
              + D++  + + T     R    Q     + Y H     +I+ RD K  N+LLD+  N
Sbjct: 92  GGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLN 146
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELI 304
            K++DFGL+ +  +DG + + T+  G+  YAAPE I  G+L    + D+WS G+ LY ++
Sbjct: 147 VKIADFGLSNIM-TDG-NFLKTS-CGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVML 202
Query: 305 TGRRPLD 311
            GR P D
Sbjct: 203 VGRLPFD 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 48/283 (16%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN- 187
           +AVK L          ++  E  ++   ++PN+VKL+G CA     G    L++EYM   
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----VGKPMCLLFEYMAYG 135
Query: 188 ------RSVQDH---------LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMD 226
                 RS+  H         L++R + + P         +L IA+  A G+AYL E   
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 193
Query: 227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
            + + RD  + N L+ E    K++DFGL+R   S             I +  PE I   R
Sbjct: 194 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252
Query: 287 LTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEG 345
            T +SD+W++GV L+E+ + G +P       + ++++ +VR    D        +  LE 
Sbjct: 253 YTTESDVWAYGVVLWEIFSYGLQPYYG---MAHEEVIYYVR----DGNILACPENCPLE- 304
Query: 346 KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE 388
                    L  +   C ++    RP    +  +L ++ + AE
Sbjct: 305 ---------LYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +   +++P++V   G+  +DD       ++ E    RS+ + L  R +A      R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
             + Q   +G+ YLH     ++I RD K  N+ L++  + K+ DFGLA     DG     
Sbjct: 146 YFMRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERK 199
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
             + GT  Y APE +     +++ DIWS G  LY L+ G+ P +
Sbjct: 200 KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 149 EVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           EV++L  V  HPN+++L     +  E      L+++ M    + D+LT +   TL     
Sbjct: 60  EVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET 113
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHV 266
            KI +     +  LH+     I+ RD K  NILLD+  N KL+DFG + +L P + L  V
Sbjct: 114 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 170
Query: 267 STAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPL 310
                GT  Y APE I+            + D+WS GV +Y L+ G  P 
Sbjct: 171 C----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 149 EVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           EV++L  V  HPN+++L     +  E      L+++ M    + D+LT +   TL     
Sbjct: 73  EVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET 126
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHV 266
            KI +     +  LH+     I+ RD K  NILLD+  N KL+DFG + +L P + L  V
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 267 STAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPL 310
                GT  Y APE I+            + D+WS GV +Y L+ G  P 
Sbjct: 184 C----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           ++A++Q++ +     +  + E+ V+   ++PN+V  +      DE  +    + EY+   
Sbjct: 48  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV----VMEYLAGG 103
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S+ D +T   +  +       + ++  + L +LH     Q+I RD KS NILL    + K
Sbjct: 104 SLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 157
Query: 249 LSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           L+DFG  A++ P        + +VGT  + APE +       K DIWS G+   E+I G 
Sbjct: 158 LTDFGFCAQITPEQS---KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 308 RP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            P L+ N  ++   +     P L + +K + I 
Sbjct: 215 PPYLNENPLRALYLIATNGTPELQNPEKLSAIF 247

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +   +++P++V   G+  +DD       ++ E    RS+ + L  R +A      R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
             + Q   +G+ YLH     ++I RD K  N+ L++  + K+ DFGLA     DG     
Sbjct: 146 YFMRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERK 199
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
             + GT  Y APE +     +++ DIWS G  LY L+ G+ P +
Sbjct: 200 KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           ++A++Q++ +     +  + E+ V+   ++PN+V  +      DE  +    + EY+   
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV----VMEYLAGG 102
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S+ D +T   +  +       + ++  + L +LH     Q+I RD KS NILL    + K
Sbjct: 103 SLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 156
Query: 249 LSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           L+DFG  A++ P        + +VGT  + APE +       K DIWS G+   E+I G 
Sbjct: 157 LTDFGFCAQITPEQS---KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 308 RP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            P L+ N  ++   +     P L + +K + I 
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNV-LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           IAVKQ+ R G  + +K  + +++V L   + P +V+  G    + +  I   L+      
Sbjct: 53  IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM------ 106
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
            +  + L  R Q  +P     K+     + L YL E     +I RD K SNILLDE+   
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQI 164
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-----YKSDIWSFGVFLYE 302
           KL DFG++     D     S    G   Y APE I     T      ++D+WS G+ L E
Sbjct: 165 KLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 303 LITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD---PKLEGKYSIKLAQKLAAVA 359
           L TG+ P    +               TD +  T +L    P L G   +  +    +  
Sbjct: 222 LATGQFPYKNCK---------------TDFEVLTKVLQEEPPLLPG--HMGFSGDFQSFV 264
Query: 360 NKCLARQAKGRPKMSEVVE 378
             CL +  + RPK ++++E
Sbjct: 265 KDCLTKDHRKRPKYNKLLE 283

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 56  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 110
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+  +  L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 111 RFYGAEIVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 165 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI- 220
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 221 --LMEEIRFPRTLSPE 234

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGCLLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     + + VGT  Y +PE +     +  SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           ++A++Q++ +     +  + E+ V+   ++PN+V  +      DE  +    + EY+   
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV----VMEYLAGG 102
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S+ D +T   +  +       + ++  + L +LH     Q+I RD KS NILL    + K
Sbjct: 103 SLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 156
Query: 249 LSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           L+DFG  A++ P        + +VGT  + APE +       K DIWS G+   E+I G 
Sbjct: 157 LTDFGFCAQITPEQS---KRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 308 RP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            P L+ N  ++   +     P L + +K + I 
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 42/275 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 117
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQD---AARGLAY---LHEGMDF----QIIFRDFKSS 237
            ++  +L S+    +P+ T   + +D       + Y   + +GM+F    + I RD  + 
Sbjct: 118 GNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 298 VFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIKL 351
           V L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD           
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----------- 286
Query: 352 AQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                     C   +   RP  SE+VE L  ++ A
Sbjct: 287 ----------CWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+  +  L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 108 RFYGAEIVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI- 217
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 218 --LMEEIRFPRTLSPE 231

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+     L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 108 RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI- 217
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 218 --LMEEIRFPRTLSPE 231

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +   +++P++V   G+  +DD       ++ E    RS+ + L  R +A      R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
             + Q   +G+ YLH     ++I RD K  N+ L++  + K+ DFGLA     DG     
Sbjct: 146 YFMRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERK 199
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
             + GT  Y APE +     +++ DIWS G  LY L+ G+ P +
Sbjct: 200 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 37  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 92
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 93  KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 145
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 146 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 205
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 206 VAGLPPF 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +   +++P++V   G+  +DD       ++ E    RS+ + L  R +A      R
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 129
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
             + Q   +G+ YLH     ++I RD K  N+ L++  + K+ DFGLA     DG     
Sbjct: 130 YFMRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERK 183
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
             + GT  Y APE +     +++ DIWS G  LY L+ G+ P +
Sbjct: 184 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 91/167 (54%), Gaps = 17/167 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E++++  ++H N+V+L      ++    +  L++E+M N  ++ ++ SR     P   
Sbjct: 51  IREISLMKELKHENIVRLYDVIHTEN----KLTLVFEFMDN-DLKKYMDSRTVGNTPRGL 105
Query: 207 RLKIAQ----DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
            L + +       +GLA+ HE    +I+ RD K  N+L++++   KL DFGLAR      
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIP 161
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           ++  S+ VV T+ Y AP+ +   R TY +  DIWS G  L E+ITG+
Sbjct: 162 VNTFSSEVV-TLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 34  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 89
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 90  KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 142
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 143 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 202
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 203 VAGLPPF 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+     L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 108 RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI- 217
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 218 --LMEEIRFPRTLSPE 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 90
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 91  KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 143
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 144 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 203
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 204 VAGLPPF 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 36  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 91
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 92  KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 144
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 145 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 204
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 205 VAGLPPF 211

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+     L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 108 RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI- 217
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 218 --LMEEIRFPRTLSPE 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 111
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 112 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 164
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     + + VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 165 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 224
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 225 VAGLPPF 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 115
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 116 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 168
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     + + VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 169 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 228
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 229 VAGLPPF 235

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
           ++ S     +P     KI     + L +L E +  +II RD K SNILLD   N KL DF
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDF 170
Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ--TGRLTY--KSDIWSFGVFLYELITGRR 308
           G++     D ++    A  G   Y APE I     R  Y  +SD+WS G+ LYEL TGR 
Sbjct: 171 GISG-QLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
Query: 309 PLDRNRPKSEQKLLEW--VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQ 366
           P     PK       W  V   LT   K      P+L      + +       N CL + 
Sbjct: 228 PY----PK-------WNSVFDQLTQVVKGD---PPQLSNSEEREFSPSFINFVNLCLTKD 273
Query: 367 AKGRPKMSEVVE 378
              RPK  E+++
Sbjct: 274 ESKRPKYKELLK 285

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+     L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 108 RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFELI- 217
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 218 --LMEEIRFPRTLSPE 231

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 41  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 96
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 97  KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 149
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 150 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 209
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 210 VAGLPPF 216

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 112
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 113 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 165
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 226 VAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 112
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 113 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 165
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 226 VAGLPPF 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 112
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 113 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 165
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 226 VAGLPPF 232

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL 179
           T    +KI++AVK   +     +KE +++E  ++  ++HP++VKLIG   E+    I  L
Sbjct: 46  TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMEL 105
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
             Y  +       H   R + +L   T +  +    + +AYL        + RD    NI
Sbjct: 106 YPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNI 156
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           L+      KL DFGL+R    +     S   +  I + +PE I   R T  SD+W F V 
Sbjct: 157 LVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVC 215
Query: 300 LYELIT-GRRPL 310
           ++E+++ G++P 
Sbjct: 216 MWEILSFGKQPF 227

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           VTE  VL    HP L  L  Y  +  +R      + EY     +  HL SR +       
Sbjct: 58  VTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERVFTEERA 112
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   A+     L YLH      +++RD K  N++LD+  + K++DFGL + G SDG +  
Sbjct: 113 RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 166
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                GT  Y APE ++        D W  GV +YE++ GR P      +  ++L E + 
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFELI- 222
Query: 327 PHLTDAKKFTMILDPK 342
             L +  +F   L P+
Sbjct: 223 --LMEEIRFPRTLSPE 236

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           ++A++Q++ +     +  + E+ V+   ++PN+V  +      DE  +    + EY+   
Sbjct: 48  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV----VMEYLAGG 103
Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK 248
           S+ D +T   +  +       + ++  + L +LH     Q+I R+ KS NILL    + K
Sbjct: 104 SLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVK 157
Query: 249 LSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
           L+DFG  A++ P    S  ST +VGT  + APE +       K DIWS G+   E+I G 
Sbjct: 158 LTDFGFCAQITPEQ--SKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 308 RP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            P L+ N  ++   +     P L + +K + I 
Sbjct: 215 PPYLNENPLRALYLIATNGTPELQNPEKLSAIF 247

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 25  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 76
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 77  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 130
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 191 SCGIVLTAMLAGELPWDQ 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 115
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 116 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 168
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 169 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 228
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 229 VAGLPPF 235

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 24/259 (9%)
Query: 128 IDIAVKQLSRRGLQGHK---EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
           + +A+K++    L   K   + + E+++L  + HPN++K      ED+E  I   L    
Sbjct: 58  VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 185 MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
             +R ++ H   + +  +P  T  K        L ++H     +++ RD K +N+ +   
Sbjct: 118 DLSRMIK-HFKKQ-KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172
Query: 245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI 304
              KL D GL R   S   +  + ++VGT  Y +PE I      +KSDIWS G  LYE+ 
Sbjct: 173 GVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 305 TGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLA 364
             + P   ++               +  KK      P L   +    +++L  + N C+ 
Sbjct: 231 ALQSPFYGDKMNL-----------YSLCKKIEQCDYPPLPSDH---YSEELRQLVNMCIN 276
Query: 365 RQAKGRPKMSEVVEVLNKI 383
              + RP ++ V +V  ++
Sbjct: 277 PDPEKRPDVTYVYDVAKRM 295

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL 179
           T    +KI++AVK   +     +KE +++E  ++  ++HP++VKLIG   E+    I  L
Sbjct: 30  TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMEL 89
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
             Y  +       H   R + +L   T +  +    + +AYL        + RD    NI
Sbjct: 90  YPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNI 140
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           L+      KL DFGL+R    +     S   +  I + +PE I   R T  SD+W F V 
Sbjct: 141 LVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVC 199
Query: 300 LYELIT-GRRPL 310
           ++E+++ G++P 
Sbjct: 200 MWEILSFGKQPF 211

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 111
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 112 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 164
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 165 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 224
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 225 VAGLPPF 231

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 126 KKIDIAVKQLSRRGLQGHKE---WVTEVNVL-GVVEHPNLVKL-IGYCAEDDERGIQRLL 180
           +++  AVK L ++ +   KE    ++E NVL   V+HP LV L   +   D     +   
Sbjct: 62  EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYF 116
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
           + +Y+    +  HL  R +  L    R   A + A  L YLH      I++RD K  NIL
Sbjct: 117 VLDYINGGELFYHL-QRERCFLEPRARF-YAAEIASALGYLH---SLNIVYRDLKPENIL 171
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVST--AVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           LD Q +  L+DFGL +    + + H ST     GT  Y APE +         D W  G 
Sbjct: 172 LDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 299 FLYELITGRRPL-DRNRPKSEQKLLE---WVRPHLTDAKKFTM 337
            LYE++ G  P   RN  +    +L     ++P++T++ +  +
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 62  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 117
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 118 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 170
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 171 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 230
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 231 VAGLPPF 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EYMP   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYMPGGDMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   K++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 118 IRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ 177
           +   E++   + +A K +  RG++  +E   E++V+  ++H NL++L  Y A + +  I 
Sbjct: 105 VHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL--YDAFESKNDI- 161
Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS 237
            +L+ EY+    + D +          +T L + Q    G+ ++H+     I+  D K  
Sbjct: 162 -VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ-ICEGIRHMHQ---MYILHLDLKPE 216
Query: 238 NILL--DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
           NIL    +    K+ DFGLAR   P + L        GT  + APE +    +++ +D+W
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLK----VNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 295 SFGVFLYELITGRRPL 310
           S GV  Y L++G  P 
Sbjct: 273 SVGVIAYMLLSGLSPF 288

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL 179
           T    +KI++AVK   +     +KE +++E  ++  ++HP++VKLIG   E+    I  L
Sbjct: 34  TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMEL 93
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
             Y  +       H   R + +L   T +  +    + +AYL        + RD    NI
Sbjct: 94  YPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNI 144
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           L+      KL DFGL+R    +     S   +  I + +PE I   R T  SD+W F V 
Sbjct: 145 LVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVC 203
Query: 300 LYELIT-GRRPL 310
           ++E+++ G++P 
Sbjct: 204 MWEILSFGKQPF 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EYMP   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYMPGGDMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   K++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
           S G+ L  ++ G  P D+    S Q+  +W
Sbjct: 192 SCGIVLTAMLAGELPWDQPS-DSXQEYSDW 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 129 DIAVKQLSRRGL--QGHKEWVT-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + A+K L +R +  +    +VT E +V+  ++HP  VKL  +  +DDE+    L    Y 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGL---SYA 114
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            N  +  ++     F  T    TR   A+  +  L YLH      II RD K  NILL+E
Sbjct: 115 KNGELLKYIRKIGSFDETC---TRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNE 167
Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
             + +++DFG A++   +     +   VGT  Y +PE +        SD+W+ G  +Y+L
Sbjct: 168 DMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQL 227
Query: 304 ITGRRPL 310
           + G  P 
Sbjct: 228 VAGLPPF 234

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +L  ++HPN+VKL+     DD       +++E +    V +  T +    L  +   
Sbjct: 86  EIAILKKLDHPNVVKLVEVL--DDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQAR 140
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVS 267
              QD  +G+ YLH     +II RD K SN+L+ E  + K++DFG++     SD L    
Sbjct: 141 FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---L 194
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKS---DIWSFGVFLYELITGRRPLDRNR 314
           +  VGT  + APE +   R  +     D+W+ GV LY  + G+ P    R
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 27  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 78
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 132
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 193 SCGIVLTAMLAGELPWDQ 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-------NRSVQDHLTSR 197
           E + E NV+  +++P +V++IG C  + E  +  + + E  P       NR V+D     
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 468
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
                     +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ 
Sbjct: 469 -------KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           L   +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 26/226 (11%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V+ + E +  K+  AVK + ++ L+G +  +  E+ VL  ++H N+V L     ED    
Sbjct: 38  VVLAEEKATGKL-FAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL-----EDIYES 91
Query: 176 IQRL-LIYEYMPNRSVQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              L L+ + +    + D +  + F      +T ++   DA   + YLH      I+ RD
Sbjct: 92  PNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA---VYYLHR---MGIVHRD 145
Query: 234 FKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK 290
            K  N+L    DE+    +SDFGL+++   +G   V +   GT GY APE +     +  
Sbjct: 146 LKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKA 202
Query: 291 SDIWSFGVFLYELITGRRPL-DRNRPKSEQKLL----EWVRPHLTD 331
            D WS GV  Y L+ G  P  D N  K  +++L    E+  P+  D
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDD 248

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-------NRSVQDHLTSR 197
           E + E NV+  +++P +V++IG C  + E  +  + + E  P       NR V+D     
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 126
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
                     +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ 
Sbjct: 127 -------KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 176
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           L   +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 177 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-------NRSVQDHLTSR 197
           E + E NV+  +++P +V++IG C  + E  +  + + E  P       NR V+D     
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 126
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
                     +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ 
Sbjct: 127 -------KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 176
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           L   +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 177 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  VL +   P  +  +  C +  +R      + EY+    +  H+    RF+     
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP--- 442
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              +  A + A GL +L       II+RD K  N++LD + + K++DFG+ +    DG++
Sbjct: 443 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
             +    GT  Y APE I         D W+FGV LYE++ G+ P +    + E +L + 
Sbjct: 499 --TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQS 553
Query: 325 VRPH 328
           +  H
Sbjct: 554 IMEH 557

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMP-NRSVQDHLTSRFQ 199
           E + E NV+  +++P +V++IG C  +    +  +     + +Y+  NR V+D       
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD------- 116
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG 258
                   +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ L 
Sbjct: 117 -----KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-------NRSVQDHLTSR 197
           E + E NV+  +++P +V++IG C  + E  +  + + E  P       NR V+D     
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 124
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
                     +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ 
Sbjct: 125 -------KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 174
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           L   +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 175 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 116
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY---LHEGMDF----QIIFRDFKSSNIL 240
            ++  +L S+    +P+    K        + Y   + +GM+F    + I RD  + NIL
Sbjct: 117 GNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNIL 176
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           L E+   K+ DFGLAR    D            + + APE I     T +SD+WSFGV L
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 301 YELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIKLAQK 354
           +E+ + G  P    +   E  ++L E  R   P  T  + +  +LD              
Sbjct: 237 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-------------- 282
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                  C   +   RP  SE+VE L  ++ A
Sbjct: 283 -------CWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMP-NRSVQDHLTSRFQ 199
           E + E NV+  +++P +V++IG C  +    +  +     + +Y+  NR V+D       
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD------- 106
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG 258
                   +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ L 
Sbjct: 107 -----KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMP-NRSVQDHLTSRFQ 199
           E + E NV+  +++P +V++IG C  +    +  +     + +Y+  NR V+D       
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD------- 104
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG 258
                   +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ L 
Sbjct: 105 -----KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 156
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 157 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-------NRSVQDHLTSR 197
           E + E NV+  +++P +V++IG C  + E  +  + + E  P       NR V+D     
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 469
Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
                     +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ 
Sbjct: 470 -------KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 519
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           L   +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 520 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMP-NRSVQDHLTSRFQ 199
           E + E NV+  +++P +V++IG C  +    +  +     + +Y+  NR V+D       
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD------- 110
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG 258
                   +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ L 
Sbjct: 111 -----KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 163 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  VL +   P  +  +  C +  +R      + EY+    +  H+    RF+     
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP--- 121
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              +  A + A GL +L       II+RD K  N++LD + + K++DFG+ +    DG++
Sbjct: 122 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
             +    GT  Y APE I         D W+FGV LYE++ G+ P +    + E +L + 
Sbjct: 178 --TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQS 232
Query: 325 VRPH 328
           +  H
Sbjct: 233 IMEH 236

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 117 VIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           V R TE++     +AVK +  +R +   +    E+ +  ++ H N+VK  G+  E +   
Sbjct: 26  VNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--- 77
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK 235
           IQ L + EY     + D +        P   R         G+ YLH      I  RD K
Sbjct: 78  IQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHRDIK 131
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIW 294
             N+LLDE+ N K+SDFGLA +   +    +   + GT+ Y APE ++      +  D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 295 SFGVFLYELITGRRPLDR 312
           S G+ L  ++ G  P D+
Sbjct: 192 SCGIVLTAMLAGELPWDQ 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL----IYEYMP-NRSVQDHLTSRFQ 199
           E + E NV+  +++P +V++IG C  +    +  +     + +Y+  NR V+D       
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD------- 110
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG 258
                   +++    + G+ YL E      + RD  + N+LL  Q  AK+SDFGL++ L 
Sbjct: 111 -----KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +      T     + + APE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 163 ADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 33  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 93  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 143
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +   +V          + APE ++T   ++
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEP 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 27  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 86
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 87  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 137
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +   +V          + APE ++T   ++
Sbjct: 138 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEP 218

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 36  SSASNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELK 93
           S   N + +     ++S  EF ++   DF    ES ++NT A L Q         F  +K
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIK 68
Query: 94  T-ATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV 152
           T  T +F R +++                  +H  + I  KQ   + L+  +  + E  +
Sbjct: 69  TLGTGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRI 115
Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + R   AQ
Sbjct: 116 LQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQ 170
Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
                  YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + G
Sbjct: 171 -IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCG 221
Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           T  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 27  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 86
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 87  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 137
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +   +V          + APE ++T   ++
Sbjct: 138 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEP 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 143 HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--FQA 200
           H+E   E+++L  ++HPN++KL  +   +D++     L+ E+     + + + +R  F  
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKL--FDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDE 145
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLSDFGLARL 257
               N    I +    G+ YLH+     I+ RD K  NILL+ +    N K+ DFGL+  
Sbjct: 146 CDAAN----IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
              D   +     +GT  Y APE ++  +   K D+WS GV +Y L+ G  P 
Sbjct: 199 FSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 23  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 83  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 133
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +   +V          + APE ++T   ++
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEP 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 23  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 83  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 133
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT-IGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +   +V          + APE ++T   ++
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEP 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 130 IAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +A+K++S  G Q +++W   + EV  L  + HPN ++  G C   +       L+ EY  
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTA---WLVMEYCL 98
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
             S  D L    +  L       +   A +GLAYLH      +I RD K+ NILL E   
Sbjct: 99  G-SASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 153
Query: 247 AKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYE 302
            KL DFG A  + P++         VGT  + APE I     G+   K D+WS G+   E
Sbjct: 154 VKLGDFGSASIMAPANXF-------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 303 LITGRRPL 310
           L   + PL
Sbjct: 207 LAERKPPL 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 130 IAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +A+K++S  G Q +++W   + EV  L  + HPN ++  G C   +       L+ EY  
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTA---WLVMEYCL 137
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
             S  D L    +  L       +   A +GLAYLH      +I RD K+ NILL E   
Sbjct: 138 G-SASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192
Query: 247 AKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYE 302
            KL DFG A  + P++         VGT  + APE I     G+   K D+WS G+   E
Sbjct: 193 VKLGDFGSASIMAPANXF-------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
Query: 303 LITGRRPL 310
           L   + PL
Sbjct: 246 LAERKPPL 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 144 KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQR-LLIYEYMPNRSVQDHLT-SRFQAT 201
           +E+++E   +    HPN+++L+G C E   +GI + ++I  +M    +  +L  SR +  
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 202 ---LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
              +P  T LK   D A G+ YL    +   + RD  + N +L +     ++DFGL++  
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            S             + + A E +     T KSD+W+FGV ++E+ T G  P
Sbjct: 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 116
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY---LHEGMDF----QIIFRDFKSSNIL 240
            ++  +L S+    +P+    K        + Y   + +GM+F    + I RD  + NIL
Sbjct: 117 GNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNIL 176
Query: 241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFL 300
           L E+   K+ DFGLAR    D            + + APE I     T +SD+WSFGV L
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 301 YELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIKLAQK 354
           +E+ + G  P    +   E  ++L E  R   P  T  + +  +LD              
Sbjct: 237 WEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLD-------------- 282
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                  C   +   RP  SE+VE L  ++ A
Sbjct: 283 -------CWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  Y  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  Y  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  Y  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
           +G +  +I EY+   S  D L +         T LK   +  +GL YLH     + I RD
Sbjct: 92  KGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE---KKIHRD 145
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K++N+LL EQ + KL+DFG+A  G            VGT  + APE IQ      K+DI
Sbjct: 146 IKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 294 WSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQ 353
           WS G+   EL  G  P     P     L+    P             P L G ++    +
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLVGDFTKSFKE 250
Query: 354 KLAAVANKCLARQAKGRPKMSEVVE 378
            + A    CL +    RP   E+++
Sbjct: 251 FIDA----CLNKDPSFRPTAKELLK 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 33  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 93  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 143
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGP-SDGLSHVSTAVVGTIGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +D    +         + APE ++T   ++
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEP 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 62/113 (54%), Gaps = 10/113 (8%)
Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A +   GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A 
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
           VGT GY APE +Q G + Y S  D +S G  L++L+ G  P  +++ K + ++
Sbjct: 351 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 62/113 (54%), Gaps = 10/113 (8%)
Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A +   GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A 
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
           VGT GY APE +Q G + Y S  D +S G  L++L+ G  P  +++ K + ++
Sbjct: 351 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 118
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 119 GNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 62/113 (54%), Gaps = 10/113 (8%)
Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A +   GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A 
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 349
Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
           VGT GY APE +Q G + Y S  D +S G  L++L+ G  P  +++ K + ++
Sbjct: 350 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 62/113 (54%), Gaps = 10/113 (8%)
Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A +   GL ++H      +++RD K +NILLDE  + ++SD GLA     D       A 
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 271 VGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
           VGT GY APE +Q G + Y S  D +S G  L++L+ G  P  +++ K + ++
Sbjct: 351 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 117 VIRSTE---DSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 170
           V+R  E    S K + +AVK L    L   +   +++ EVN +  ++H NL++L G    
Sbjct: 23  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
              +     ++ E  P  S+ D L  + Q      T  + A   A G+ YL      + I
Sbjct: 83  PPMK-----MVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFI 133
Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGP-SDGLSHVSTAVVGTIGYAAPEYIQTGRLTY 289
            RD  + N+LL  +   K+ DFGL R  P +D    +         + APE ++T   ++
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 290 KSDIWSFGVFLYELIT-GRRP 309
            SD W FGV L+E+ T G+ P
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEP 214

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   K++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 318
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F 
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFP 372
Query: 337 MILDPK 342
             L P+
Sbjct: 373 RTLGPE 378

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 107
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 108 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 164
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 165 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 219
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 220 HQSDVWSFGVLLWEIFT 236

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 315
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F 
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFP 369
Query: 337 MILDPK 342
             L P+
Sbjct: 370 RTLGPE 375

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   K++DFGLA+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    ES ++NT A L Q         F  +KT  
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTLG 51
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 52  TGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 98
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + R   AQ   
Sbjct: 99  VNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 152
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 204
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L         ++ ++E NVL  V HP+++KL G C++D       LLI EY    
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG----PLLLIVEYAKYG 111
Query: 189 SVQ-------------------------DHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           S++                         DH   R    L     +  A   ++G+ YL E
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER---ALTMGDLISFAWQISQGMQYLAE 168
Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI 282
               +++ RD  + NIL+ E    K+SDFGL+R +   D     S   +  + + A E +
Sbjct: 169 ---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI-PVKWMAIESL 224
Query: 283 QTGRLTYKSDIWSFGVFLYELIT 305
                T +SD+WSFGV L+E++T
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 34/240 (14%)
Query: 150 VNVLGVVEHPNLVKLIG-YCAEDDERGIQRL-----LIYEYMPNRSVQDHLTSRFQATLP 203
           VN+LG   H   V +I  YC   D     R      L Y Y P+ + ++ L+SR      
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR------ 166
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
               L  +   A+G+A+L        I RD  + N+LL     AK+ DFGLAR   +D  
Sbjct: 167 --DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL 322
             V       + + APE I     T +SD+WS+G+ L+E+ + G  P             
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY------------ 269
Query: 323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK 382
               P +    KF  ++    +        + + ++   C A +   RP   ++   L +
Sbjct: 270 ----PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L         ++ ++E NVL  V HP+++KL G C++D       LLI EY    
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG----PLLLIVEYAKYG 111
Query: 189 SVQ-------------------------DHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           S++                         DH   R    L     +  A   ++G+ YL E
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER---ALTMGDLISFAWQISQGMQYLAE 168
Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI 282
               +++ RD  + NIL+ E    K+SDFGL+R +   D     S   +  + + A E +
Sbjct: 169 ---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI-PVKWMAIESL 224
Query: 283 QTGRLTYKSDIWSFGVFLYELIT 305
                T +SD+WSFGV L+E++T
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 111
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 112 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 168
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 169 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 223
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 224 HQSDVWSFGVLLWEIFT 240

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    ES ++NT A L Q         F  +KT  
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTLG 51
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 52  TGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 98
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + R   AQ   
Sbjct: 99  VNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 152
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 204
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    ES ++NT A L Q         F  +KT  
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTLG 51
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 52  TGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 98
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + R   AQ   
Sbjct: 99  VNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 152
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+++D+Q   K++DFG A+      +   +  + GT  
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPE 204
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 118
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 119 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 110
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 111 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 167
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 168 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 222
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 223 HQSDVWSFGVLLWEIFT 239

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ ++  +EHP LV L  Y  +D+E      ++ + +    ++ HL            +L
Sbjct: 65  ELQIMQGLEHPFLVNL-WYSFQDEE---DMFMVVDLLLGGDLRYHLQQNVHFK-EETVKL 119
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I +     L YL      +II RD K  NILLDE  +  ++DF +A + P +  + ++T
Sbjct: 120 FICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITT 173
Query: 269 AVVGTIGYAAPEYIQTGR---LTYKSDIWSFGVFLYELITGRRP 309
            + GT  Y APE   + +    ++  D WS GV  YEL+ GRRP
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 118
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 119 GNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    ES ++NT A L Q         F  +KT  
Sbjct: 2   GNAAAAKKGXEQESVKEFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTLG 51
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 52  TGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 98
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + R   AQ   
Sbjct: 99  VNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 152
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 204
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 176
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F 
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFP 230
Query: 337 MILDPK 342
             L P+
Sbjct: 231 RTLGPE 236

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 92  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 147
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 204
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR     G        +  + +  PE    G  T
Sbjct: 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 309
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 310 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 177
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F 
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFP 231
Query: 337 MILDPK 342
             L P+
Sbjct: 232 RTLGPE 237

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L YLH   +  +++RD K  N++LD+  + K++DFGL + G  DG +       GT  Y
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 175
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            APE ++        D W  GV +YE++ GR P      +  +KL E +   L +  +F 
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI---LMEEIRFP 229
Query: 337 MILDPK 342
             L P+
Sbjct: 230 RTLGPE 235

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 38/203 (18%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK L         ++ ++E NVL  V HP+++KL G C++D       LLI EY    
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG----PLLLIVEYAKYG 111
Query: 189 SVQ-------------------------DHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           S++                         DH   R    L     +  A   ++G+ YL E
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER---ALTMGDLISFAWQISQGMQYLAE 168
Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYI 282
                ++ RD  + NIL+ E    K+SDFGL+R +   D     S   +  + + A E +
Sbjct: 169 ---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI-PVKWMAIESL 224
Query: 283 QTGRLTYKSDIWSFGVFLYELIT 305
                T +SD+WSFGV L+E++T
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 103
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L +                 +  A   ARG+ YL      + I RD
Sbjct: 104 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 160
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 161 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 216 HQSDVWSFGVLLWEIFT 232

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 34/266 (12%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L        KE  ++E+ ++  + +H N+V L+G C      G   L+I EY 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYC 132
Query: 186 PNRSVQDHLTSRFQATL------PWNTR--LKIAQDAARGLAYLHEGMDFQIIFRDFKSS 237
               + + L  + +A L      P   R  L  +   A+G+A+L        I RD  + 
Sbjct: 133 CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 189
Query: 238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           N+LL     AK+ DFGLAR   +D    V       + + APE I     T +SD+WS+G
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 298 VFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           + L+E+ + G  P                 P +    KF  ++    +        + + 
Sbjct: 250 ILLWEIFSLGLNPY----------------PGILVNSKFYKLVKDGYQMAQPAFAPKNIY 293
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNK 382
           ++   C A +   RP   ++   L +
Sbjct: 294 SIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 69  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 124
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 125 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 181
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR     G        +  + +  PE    G  T
Sbjct: 182 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 241
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 242 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 286
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 287 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 332

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 36  SSASNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELK 93
           S   N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +K
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIK 68
Query: 94  T-ATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV 152
           T  T +F R +++                  +H  + I  KQ   + L+  +  + E  +
Sbjct: 69  TLGTGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRI 115
Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L  V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ
Sbjct: 116 LQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ 170
Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
                  YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + G
Sbjct: 171 -IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGATWTLCG 221
Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           T  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 159
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L ++                +  A   ARG+ YL      + I RD
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 217 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 272 HQSDVWSFGVLLWEIFT 288

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 107
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 277
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 278 -----------CWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 90  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 144
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 145 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 195
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 116
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 286
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 287 -----------CWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 49/281 (17%)
Query: 38  ASNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT- 94
           ASN+S     DV+    EF ++   DF    ES ++NT A L Q         F  +KT 
Sbjct: 2   ASNSS-----DVK----EFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTL 42
Query: 95  ATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG 154
            T +F R +++                  +H  + I  KQ   + L+  +  + E  +L 
Sbjct: 43  GTGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
            V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + R   AQ  
Sbjct: 90  AVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQ-I 143
Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
                YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT 
Sbjct: 144 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 195
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
            Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 130 IAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L     +    + ++E+ ++ ++ +H N++ L+G C +D    +    I EY   
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYASK 118
Query: 188 RSVQDHLTSRFQATLPWNTR--------------LKIAQDAARGLAYLHEGMDFQIIFRD 233
            +++++L +R    L +                 +  A   ARG+ YL      + I RD
Sbjct: 119 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLT 288
             + N+L+ E    K++DFGLAR      + H+      T G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 289 YKSDIWSFGVFLYELIT 305
           ++SD+WSFGV L+E+ T
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVITEFCKF 107
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 277
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 278 -----------CWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 34/266 (12%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L        KE  ++E+ ++  + +H N+V L+G C      G   L+I EY 
Sbjct: 69  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYC 124
Query: 186 PNRSVQDHLTSRFQATL------PWNTR--LKIAQDAARGLAYLHEGMDFQIIFRDFKSS 237
               + + L  + +A L      P   R  L  +   A+G+A+L        I RD  + 
Sbjct: 125 CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 181
Query: 238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           N+LL     AK+ DFGLAR   +D    V       + + APE I     T +SD+WS+G
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 298 VFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLA 356
           + L+E+ + G  P                 P +    KF  ++    +        + + 
Sbjct: 242 ILLWEIFSLGLNPY----------------PGILVNSKFYKLVKDGYQMAQPAFAPKNIY 285
Query: 357 AVANKCLARQAKGRPKMSEVVEVLNK 382
           ++   C A +   RP   ++   L +
Sbjct: 286 SIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           LI +Y+    +  HL+ R + T     ++ + +     L +LH+     II+RD K  NI
Sbjct: 136 LILDYINGGELFTHLSQRERFT-EHEVQIYVGE-IVLALEHLHK---LGIIYRDIKLENI 190
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
           LLD   +  L+DFGL++   +D  +  +    GTI Y AP+ ++ G   +    D WS G
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249
Query: 298 VFLYELITGRRPLDRNRPKSEQ 319
           V +YEL+TG  P   +  K+ Q
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQ 271

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
           + H    +AVK++  R  Q  +    EV ++    H N+V +       DE  +    + 
Sbjct: 66  EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWV----VM 121
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA------RGLAYLHEGMDFQIIFRDFKS 236
           E++   ++ D +T         +TR+   Q A       R L+YLH   +  +I RD KS
Sbjct: 122 EFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKS 169
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTYK 290
            +ILL      KLSDFG          + VS  V      VGT  + APE I   RL Y 
Sbjct: 170 DSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKXLVGTPYWMAPEVIS--RLPYG 219
Query: 291 S--DIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRPHLTDAKKFTMIL 339
           +  DIWS G+ + E+I G  P     P ++ +++ + + P + D  K + +L
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVL 271

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 53/283 (18%)
Query: 38  ASNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT- 94
           ASN+S     DV+    EF ++   DF    ES ++NT A L Q         F  +KT 
Sbjct: 2   ASNSS-----DVK----EFLAKAKEDFLKKWESPAQNT-AHLDQ---------FERIKTL 42
Query: 95  ATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG 154
            T +F R +++                  +H  + I  KQ   + L+  +  + E  +L 
Sbjct: 43  GTGSFGRVMLVK------------HKETGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQ 212
            V  P LVKL  +  +D+       ++ EY+P   +  HL    RF      + R   AQ
Sbjct: 90  AVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEP---HARFYAAQ 142
Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
                  YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + G
Sbjct: 143 -IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           T  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 90  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 144
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 145 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 195
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   +++DFGLA+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    + + P + 
Sbjct: 75  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEP-HA 129
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 130 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 180
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 181 TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   K++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 39/266 (14%)
Query: 129 DIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           DI VK L  R     K  ++  E   L +  HPN++ ++G C           LI  +MP
Sbjct: 35  DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC--QSPPAPHPTLITHWMP 92
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
             S+ + L       +  +  +K A D ARG+A+LH  ++  I      S ++++DE   
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMT 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLY 301
           A++S   +         S  S   +    + APE +Q     T R +  +D+WSF V L+
Sbjct: 152 ARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKPEDTNRRS--ADMWSFAVLLW 202
Query: 302 ELITGRRPLD--RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVA 359
           EL+T   P     N     +  LE +RP +                     ++  ++ + 
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLRPTIPPG------------------ISPHVSKLM 244
Query: 360 NKCLARQAKGRPKMSEVVEVLNKIVD 385
             C+      RPK   +V +L K+ D
Sbjct: 245 KICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 116
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 286
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 287 -----------CWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    RF      
Sbjct: 90  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEP--- 142
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      + 
Sbjct: 143 HARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VK 193
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    RF      
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEP--- 141
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      + 
Sbjct: 142 HARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VK 192
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  +L  V  P LVKL  +  +D+       ++ EY+P   +  HL    RF      
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEP--- 141
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      + 
Sbjct: 142 HARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VK 192
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  +L  V  P LVKL  +  +D+       ++ EY P   +  HL    RF      
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFXEP--- 141
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R   AQ       YLH      +I+RD K  N+++D+Q   K++DFG A+      + 
Sbjct: 142 HARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VK 192
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 153
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 154 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 274 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 323
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 324 -----------CWHGEPSQRPTFSELVEHLGNLLQA 348

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 126 KKIDIAVKQLSRRGLQGHKEWVT-EVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYE 183
           K +++  ++LS   L+  +E    E ++L  V  HP+++ LI    +  E      L+++
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI----DSYESSSFMFLVFD 180
Query: 184 YMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
            M    + D+LT +    L       I +     +++LH      I+ RD K  NILLD+
Sbjct: 181 LMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDD 235
Query: 244 QWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR------LTYKSDIWSF 296
               +LSDFG +  L P + L      + GT GY APE ++            + D+W+ 
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRE----LCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 297 GVFLYELITGRRPL 310
           GV L+ L+ G  P 
Sbjct: 292 GVILFTLLAGSPPF 305

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+  + V+ HP LV L     +D+E     ++IYE+M    + + +       +  +  +
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAV 152
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGL-ARLGPSDGLSH 265
           +  +   +GL ++HE      +  D K  NI+   + +   KL DFGL A L P   +  
Sbjct: 153 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK- 208
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                 GT  +AAPE  +   + Y +D+WS GV  Y L++G  P 
Sbjct: 209 ---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 47/277 (16%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 118
Query: 188 RSVQDHLTSRFQATLPWNTR------------LKIAQDAARGLAYLHEGMDFQIIFRDFK 235
            ++  +L S+    +P+               +  +   A+G+ +L      + I RD  
Sbjct: 119 GNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLA 175
Query: 236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWS 295
           + NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WS
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 296 FGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSI 349
           FGV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD         
Sbjct: 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--------- 286
Query: 350 KLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                       C   +   RP  SE+VE L  ++ A
Sbjct: 287 ------------CWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 118/279 (42%), Gaps = 49/279 (17%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 118
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH----------EGMDF----QIIFRD 233
            ++  +L S+    +P+    +  +D  +    L           +GM+F    + I RD
Sbjct: 119 GNLSTYLRSKRNEFVPYK---EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 175
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + NILL E+   K+ DFGLAR    D            + + APE I     T +SD+
Sbjct: 176 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 235
Query: 294 WSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKY 347
           WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD       
Sbjct: 236 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD------- 288
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                         C   +   RP  SE+VE L  ++ A
Sbjct: 289 --------------CWHGEPSQRPTFSELVEHLGNLLQA 313

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKF 116
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 286
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 287 -----------CWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK  S R  Q    W  E  +   V   H N++  I           Q  LI  Y  +
Sbjct: 34  VAVKIFSSRDEQS---WFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEH 90
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILLD 242
            S+ D L  +   TL  +  L++A  AA GLA+LH E    Q    I  RDFKS N+L+ 
Sbjct: 91  GSLYDFLQRQ---TLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVK 147
Query: 243 EQWNAKLSDFGLARLGP--SDGLSHVSTAVVGTIGYAAPEYIQTGRLT-----YK-SDIW 294
                 ++D GLA +    SD L   +   VGT  Y APE +     T     YK +DIW
Sbjct: 148 SNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIW 207
Query: 295 SFGVFLYEL 303
           +FG+ L+E+
Sbjct: 208 AFGLVLWEI 216

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVITEFCKF 107
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 277
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 278 -----------CWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 143
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 144 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 197
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 198 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 130 IAVKQLSRRGLQG-HKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
           +AVK L        H+  ++E+ +L  +  H N+V L+G C +    G   ++I E+   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVITEFCKF 107
Query: 188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL-------HEGMDF----QIIFRDFKS 236
            ++  +L S+    +P+    +        L +L        +GM+F    + I RD  +
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 237 SNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
            NILL E+   K+ DFGLAR    D            + + APE I     T +SD+WSF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 297 GVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDAKKFTMILDPKLEGKYSIK 350
           GV L+E+ + G  P    +   E  ++L E  R   P  T  + +  +LD          
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---------- 277
Query: 351 LAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
                      C   +   RP  SE+VE L  ++ A
Sbjct: 278 -----------CWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 121
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 122 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 175
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 119
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 120 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 173
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN----RS 189
           QL + G++   +   E+ +   + HPN++++  Y    D + I   L+ E+ P     + 
Sbjct: 52  QLEKEGVE--HQLRREIEIQSHLRHPNILRMYNYF--HDRKRI--YLMLEFAPRGELYKE 105
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           +Q H   RF             ++ A  L Y HE    ++I RD K  N+L+  +   K+
Sbjct: 106 LQKH--GRFDE----QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKI 156
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+W  GV  YE + G  P
Sbjct: 157 ADFGWSVHAPSLR----RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212
Query: 310 LD 311
            D
Sbjct: 213 FD 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN----RS 189
           QL + G++   +   E+ +   + HPN++++  Y    D + I   L+ E+ P     + 
Sbjct: 51  QLEKEGVE--HQLRREIEIQSHLRHPNILRMYNYF--HDRKRI--YLMLEFAPRGELYKE 104
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL 249
           +Q H   RF             ++ A  L Y HE    ++I RD K  N+L+  +   K+
Sbjct: 105 LQKH--GRFDE----QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKI 155
Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG +   PS         + GT+ Y  PE I+      K D+W  GV  YE + G  P
Sbjct: 156 ADFGWSVHAPSLR----RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 310 LD 311
            D
Sbjct: 212 FD 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 121
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 122 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 175
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 125
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 126 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 179
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 180 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 60/128 (46%), Gaps = 21/128 (16%)
Query: 194 LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
           L S+F+  LP      +   + IA D+   L Y+H         RD K  NIL+D   + 
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHI 214
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYE 302
           +L+DFG       DG    S A VGT  Y +PE +Q      GR   + D WS GV +YE
Sbjct: 215 RLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 303 LITGRRPL 310
           ++ G  P 
Sbjct: 274 MLYGETPF 281

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+++   + H ++V   G+  ++D       ++ E    RS+ + L  R +A      R 
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDND----FVFVVLELCRRRSLLE-LHKRRKALTEPEARY 145
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G  YLH     ++I RD K  N+ L+E    K+ DFGLA     DG      
Sbjct: 146 YLRQ-IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKK 199
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 44/285 (15%)
Query: 36  SSASNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELK 93
           S   N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +K
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIK 68
Query: 94  T-ATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV 152
           T  T +F R +++                  +H  + I  KQ   + L+  +  + E  +
Sbjct: 69  TLGTGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRI 115
Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKI 210
           L  V  P LVKL  +  +D+       ++ EY+    +  HL    RF      + R   
Sbjct: 116 LQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 168
Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  +
Sbjct: 169 AQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXL 219
Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
            GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+  + V+ HP LV L     +D+E     ++IYE+M    + + +       +  +  +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNK-MSEDEAV 258
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGL-ARLGPSDGLSH 265
           +  +   +GL ++HE      +  D K  NI+   + +   KL DFGL A L P   +  
Sbjct: 259 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK- 314
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                 GT  +AAPE  +   + Y +D+WS GV  Y L++G  P 
Sbjct: 315 ---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 149 EVNVLG-VVEHPNLVKLIGYCAEDDERGI--QRLLIYEYMPNRSVQDHLTSRFQATLPWN 205
           E+N+L     H N+    G   + +  G+  Q  L+ E+    SV D + +    TL   
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLS 264
               I ++  RGL++LH+    ++I RD K  N+LL E    KL DFG+ A+L  + G  
Sbjct: 130 WIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 265 HVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
           +     +GT  + APE I           +KSD+WS G+   E+  G  PL    P    
Sbjct: 187 NT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV 379
            L+    P             P+L+ K   K ++K  +    CL +    RP   ++++ 
Sbjct: 244 FLIP-RNP------------APRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLMK- 286
Query: 380 LNKIVDAAETGTPQTPLKNLSLKDDFETSKKER 412
                       P      + LKD  + +KK+R
Sbjct: 287 -----HPFIRDQPNERQVRIQLKDHIDRTKKKR 314

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLI-GYCAEDDERG 175
           ++    + H    +AVK +  R  Q  +    EV ++   +H N+V++   Y       G
Sbjct: 60  IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----G 114
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQIIFRDF 234
            +  ++ E++   ++ D ++   Q  L       + +   + LAYLH +G    +I RD 
Sbjct: 115 EELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQG----VIHRDI 167
Query: 235 KSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIW 294
           KS +ILL      KLSDFG       D        +VGT  + APE I       + DIW
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 295 SFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRPHLTDAKKFTMILDPKLE 344
           S G+ + E++ G  P   + P ++ ++L +   P L ++ K + +L   LE
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 112
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 113 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 163
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 164 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELI--SRLPYGPEVDIWSLGI 213
Query: 299 FLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K++ + + P L +  K +    P L+G
Sbjct: 214 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS----PSLKG 257

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 234
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 235 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 285
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 286 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELI--SRLPYGPEVDIWSLGI 335
Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K ++ +R +L    K    + P L+G
Sbjct: 336 MVIEMVDGEPPYFNEPP---LKAMKMIRDNLPPRLKNLHKVSPSLKG 379

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++  + H N+V+ IG   +     +
Sbjct: 52  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQS----L 107
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 108 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 164
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 165 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 224
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 225 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 269
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                  +  +  +C   Q + RP  + ++E
Sbjct: 270 --NCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 114
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 115 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 165
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 166 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELI--SRLPYGPEVDIWSLGI 215
Query: 299 FLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K++ + + P L +  K +    P L+G
Sbjct: 216 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS----PSLKG 259

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 103
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 104 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 154
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 155 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELI--SRLPYGPEVDIWSLGI 204
Query: 299 FLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K++ + + P L +  K +    P L+G
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS----PSLKG 248

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQA---TLPW 204
            E+ VL  ++HPN++K+     E  E      ++ E      + + + S  QA    L  
Sbjct: 69  AEIEVLKSLDHPNIIKIF----EVFEDYHNMYIVMETCEGGELLERIVSA-QARGKALSE 123
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLSDFGLARLGPSD 261
               ++ +     LAY H      ++ +D K  NIL  +       K+ DFGLA L  SD
Sbjct: 124 GYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
              H ST   GT  Y APE  +   +T+K DIWS GV +Y L+TG  P 
Sbjct: 181 --EH-STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 107
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 108 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 158
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 159 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDIWSLGI 208
Query: 299 FLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K++ + + P L +  K +    P L+G
Sbjct: 209 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS----PSLKG 252

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 40/267 (14%)
Query: 52  SGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-ATKNFSRSLMIXXX 108
           S  EF ++   DF    E+ S+NT A L Q         F  +KT  T +F R +++   
Sbjct: 1   SVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLGTGSFGRVMLVK-- 48
Query: 109 XXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYC 168
                          +H  + I  KQ   + L+  +  + E  +L  V  P LVKL  + 
Sbjct: 49  ----------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL-EFS 96
Query: 169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ 228
            +D+       ++ EY+    +  HL    + + P + R   AQ       YLH      
Sbjct: 97  FKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IVLTFEYLH---SLD 148
Query: 229 IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           +I+RD K  N+L+DEQ   +++DFG A+      +   +  + GT  Y APE I +    
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 289 YKSDIWSFGVFLYELITGRRPLDRNRP 315
              D W+ GV +YE+  G  P   ++P
Sbjct: 204 KAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 169
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 226
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 285 QSDVWSFGVLMWEIFT 300

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 88/166 (53%), Gaps = 20/166 (12%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLPW 204
           + E+++L  + HPN+V LI       ER +   L++E+M    + V D   +  Q     
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHS--ERCLT--LVFEFMEKDLKKVLDENKTGLQ----- 117
Query: 205 NTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
           ++++KI      RG+A+ H+    +I+ RD K  N+L++     KL+DFGLAR   + G+
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR---AFGI 171
Query: 264 SHVS-TAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGR 307
              S T  V T+ Y AP+ +  + + +   DIWS G    E+ITG+
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 88/166 (53%), Gaps = 20/166 (12%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLPW 204
           + E+++L  + HPN+V LI       ER +   L++E+M    + V D   +  Q     
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHS--ERCLT--LVFEFMEKDLKKVLDENKTGLQ----- 117
Query: 205 NTRLKI-AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
           ++++KI      RG+A+ H+    +I+ RD K  N+L++     KL+DFGLAR   + G+
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR---AFGI 171
Query: 264 SHVS-TAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGR 307
              S T  V T+ Y AP+ +  + + +   DIWS G    E+ITG+
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++  + H N+V+ IG   +     +
Sbjct: 66  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQS----L 121
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 122 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 178
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 179 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 283
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                  +  +  +C   Q + RP  + ++E
Sbjct: 284 --NCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 58  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 113
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 114 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 170
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 171 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 230
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 231 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 275
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 276 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 321

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P L KL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 90  LNEKRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 144
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   K++DFG A+      +   
Sbjct: 145 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGR 195
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P L KL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 90  LNEKRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEP-HA 144
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+++D+Q   K++DFG A+      +   
Sbjct: 145 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGR 195
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 52  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 107
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 108 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 164
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 165 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 224
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 225 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 269
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 270 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 315

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 37/278 (13%)
Query: 128 IDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           + +AVK L      Q   +++ E  ++    H N+V+ IG   +     + R ++ E M 
Sbjct: 88  LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----LPRFILLELMA 143
Query: 187 NRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL 241
              ++  L  +R + + P +      L +A+D A G  YL E      I RD  + N LL
Sbjct: 144 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 200
Query: 242 DEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
                   AK+ DFG+AR              +  + +  PE    G  T K+D WSFGV
Sbjct: 201 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 260
Query: 299 FLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAA 357
            L+E+ + G  P      KS Q++LE+V    T   +    +DP             +  
Sbjct: 261 LLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK------NCPGPVYR 303
Query: 358 VANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
           +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 304 IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 341

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 66  VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 121
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 122 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 178
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 179 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 283
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 284 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 329

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 13/163 (7%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +   + HPN+++L  Y    D R I   LI EY P   +   L      T       
Sbjct: 73  EIEIQAHLHHPNILRLYNYFY--DRRRI--YLILEYAPRGELYKELQK--SCTFDEQRTA 126
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            I ++ A  L Y H     ++I RD K  N+LL  +   K++DFG +   PS        
Sbjct: 127 TIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR----RK 179
Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            + GT+ Y  PE I+      K D+W  GV  YEL+ G  P +
Sbjct: 180 TMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 68  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 123
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 124 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 180
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 181 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 240
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 241 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 285
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 286 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 331

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +   V  P LVKL  +  +D+       ++ EY P   +  HL    + + P + 
Sbjct: 90  LNEKRIQQAVNFPFLVKL-EFSFKDNS---NLYMVLEYAPGGEMFSHLRRIGRFSEP-HA 144
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   K++DFG A+      +   
Sbjct: 145 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGR 195
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 51
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 52  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 98
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 99  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 152
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 204
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 29/194 (14%)
Query: 129 DIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + AVK +S+R ++     +  + EV +L  ++HPN++KL  +    +++G    L+ E  
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF---EDKGY-FYLVGEVY 108
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ- 244
               + D + SR + +     R  I +    G+ Y+H+    +I+ RD K  N+LL+ + 
Sbjct: 109 TGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 163
Query: 245 --WNAKLSDFGLARLGPSDGLSHVSTAV-----VGTIGYAAPEYIQTGRLTYKSDIWSFG 297
              N ++ DFGL+        +H   +      +GT  Y APE +  G    K D+WS G
Sbjct: 164 KDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 214
Query: 298 VFLYELITGRRPLD 311
           V LY L++G  P +
Sbjct: 215 VILYILLSGCPPFN 228

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           A K +  +  +  ++++ E+ +L   +HP +VKL+G    D +  I    + E+ P  +V
Sbjct: 48  AAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI----MIEFCPGGAV 103
Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
            D +       L       + +     L +LH     +II RD K+ N+L+  + + +L+
Sbjct: 104 -DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 159
Query: 251 DFGLARLGPSDGLSHVST--AVVGTIGYAAPEYIQTGRLT-----YKSDIWSFGVFLYEL 303
           DFG++    +  L  +    + +GT  + APE +    +      YK+DIWS G+ L E+
Sbjct: 160 DFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 304 ITGRRPLDRNRP 315
                P     P
Sbjct: 216 AQIEPPHHELNP 227

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 66  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 121
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 122 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 178
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 179 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 283
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 284 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 329

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 44/205 (21%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAEDDER-----GIQRLLIY 182
           +AVK  S       + ++ E N+  V  +EH N+ + I      DER      ++ LL+ 
Sbjct: 39  VAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFI----VGDERVTADGRMEYLLVM 91
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH----EGMDFQ--IIFRDFKS 236
           EY PN S+  +L+     T  W +  ++A    RGLAYLH     G  ++  I  RD  S
Sbjct: 92  EYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 237 SNILLDEQWNAKLSDFGLA---------RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
            N+L+       +SDFGL+         R G  D   + + + VGTI Y APE ++ G +
Sbjct: 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED---NAAISEVGTIRYMAPEVLE-GAV 204
Query: 288 TYKS--------DIWSFGVFLYELI 304
             +         D+++ G+  +E+ 
Sbjct: 205 NLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 125 HKKID--IAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLLI 181
           HKK +   AVK +S+R ++ + +   E+  L + E HPN+VKL     E     +   L+
Sbjct: 32  HKKSNQAFAVKIISKR-MEANTQ--KEITALKLCEGHPNIVKL----HEVFHDQLHTFLV 84
Query: 182 YEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
            E +    + + +  +  F  T        I +     ++++H   D  ++ RD K  N+
Sbjct: 85  MELLNGGELFERIKKKKHFSET----EASYIMRKLVSAVSHMH---DVGVVHRDLKPENL 137
Query: 240 LL-DEQWN--AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSF 296
           L  DE  N   K+ DFG ARL P D     +     T+ YAAPE +         D+WS 
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGYDESCDLWSL 195
Query: 297 GVFLYELITGRRPL 310
           GV LY +++G+ P 
Sbjct: 196 GVILYTMLSGQVPF 209

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 18/171 (10%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPW 204
           + E  +L  V  P L KL  +  +D+       ++ EY P   +  HL    RF      
Sbjct: 90  LNEKRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFXEP--- 142
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R   AQ       YLH      +I+RD K  N+++D+Q   K++DFG A+      + 
Sbjct: 143 HARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VK 193
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 51  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 106
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 107 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 163
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 224 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 268
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                  +  +  +C   Q + RP  + ++E
Sbjct: 269 --NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           +AVK++  R  Q  +    EV ++   +H N+V++       DE  +    + E++   +
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV----VMEFLEGGA 157
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ---IIFRDFKSSNILLDEQWN 246
           + D +T         +TR+   Q AA  LA L          +I RD KS +ILL     
Sbjct: 158 LTDIVT---------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 208
Query: 247 AKLSDFGLARLGPSDGLSHVSTAV------VGTIGYAAPEYIQTGRLTY--KSDIWSFGV 298
            KLSDFG          + VS  V      VGT  + APE I   RL Y  + DIWS G+
Sbjct: 209 VKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDIWSLGI 258
Query: 299 FLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDAKKFTMILDPKLEG 345
            + E++ G  P     P    K++ + + P L +  K +    P L+G
Sbjct: 259 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS----PSLKG 302

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAACKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQD 213
           V  P LVKL  +  +D+       ++ EY+    +  HL    RF      + R   AQ 
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYAAQ- 149
Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
                 YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGT 201
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS 291
           RD  + N+L+ E    K++DFGLAR   +      +T     + + APE +     T++S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 292 DIWSFGVFLYELIT 305
           D+WSFGV ++E+ T
Sbjct: 241 DVWSFGVLMWEIFT 254

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLAGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 55  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 110
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 111 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 167
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 168 RDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 225
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 226 QSDVWSFGVLMWEIFT 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 29/194 (14%)
Query: 129 DIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + AVK +S+R ++     +  + EV +L  ++HPN++KL  +    +++G    L+ E  
Sbjct: 76  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF---EDKGY-FYLVGEVY 131
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ- 244
               + D + SR + +     R  I +    G+ Y+H+    +I+ RD K  N+LL+ + 
Sbjct: 132 TGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 186
Query: 245 --WNAKLSDFGLARLGPSDGLSHVSTAV-----VGTIGYAAPEYIQTGRLTYKSDIWSFG 297
              N ++ DFGL+        +H   +      +GT  Y APE +  G    K D+WS G
Sbjct: 187 KDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 237
Query: 298 VFLYELITGRRPLD 311
           V LY L++G  P +
Sbjct: 238 VILYILLSGCPPFN 251

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           A K +  +  +  ++++ E+ +L   +HP +VKL+G    D +  I    + E+ P  +V
Sbjct: 40  AAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI----MIEFCPGGAV 95
Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
            D +       L       + +     L +LH     +II RD K+ N+L+  + + +L+
Sbjct: 96  -DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 151
Query: 251 DFGLARLGPSDGLSHVS--TAVVGTIGYAAPEYIQTGRL-----TYKSDIWSFGVFLYEL 303
           DFG++    +  L  +    + +GT  + APE +    +      YK+DIWS G+ L E+
Sbjct: 152 DFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207
Query: 304 ITGRRPLDRNRP 315
                P     P
Sbjct: 208 AQIEPPHHELNP 219

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 51  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 106
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 163
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 224 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 268
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                  +  +  +C   Q + RP  + ++E
Sbjct: 269 --NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 40/269 (14%)
Query: 50  RKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-ATKNFSRSLMIX 106
           ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  T +F R +++ 
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLGTGSFGRVMLVK 61
Query: 107 XXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIG 166
                            +H  + I  KQ   + L+  +  + E  +L  V  P LVKL  
Sbjct: 62  ------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL-E 107
Query: 167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMD 226
           +  +D+       ++ EY+    +  HL    + + P + R   AQ       YLH    
Sbjct: 108 FSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IVLTFEYLH---S 159
Query: 227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
             +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  Y APE I +  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKG 214
Query: 287 LTYKSDIWSFGVFLYELITGRRPLDRNRP 315
                D W+ GV +YE+  G  P   ++P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 60  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 115
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 116 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 172
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 173 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 230
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 231 QSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 57  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 112
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 113 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 169
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 170 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 227
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 228 QSDVWSFGVLMWEIFT 243

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 43  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 98
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 99  PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 155
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+AR              +  + +  PE    G  T
Sbjct: 156 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 215
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 216 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 260
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                  +  +  +C   Q + RP  + ++E
Sbjct: 261 --NCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 29/194 (14%)
Query: 129 DIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + AVK +S+R ++     +  + EV +L  ++HPN++KL  +    +++G    L+ E  
Sbjct: 77  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF---EDKGY-FYLVGEVY 132
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ- 244
               + D + SR + +     R  I +    G+ Y+H+    +I+ RD K  N+LL+ + 
Sbjct: 133 TGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 187
Query: 245 --WNAKLSDFGLARLGPSDGLSHVSTAV-----VGTIGYAAPEYIQTGRLTYKSDIWSFG 297
              N ++ DFGL+        +H   +      +GT  Y APE +  G    K D+WS G
Sbjct: 188 KDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 238
Query: 298 VFLYELITGRRPLD 311
           V LY L++G  P +
Sbjct: 239 VILYILLSGCPPFN 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSR--------------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R               +  + +   +      ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS 291
           RD  + N+L+ E    K++DFGLAR   +      +T     + + APE +     T++S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 292 DIWSFGVFLYELIT 305
           D+WSFGV ++E+ T
Sbjct: 241 DVWSFGVLMWEIFT 254

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQD 213
           V  P LVKL  +  +D+       ++ EY+    +  HL    RF      + R   AQ 
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYAAQ- 149
Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
                 YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGT 201
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLXGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 40/269 (14%)
Query: 50  RKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-ATKNFSRSLMIX 106
           ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  T +F R +++ 
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLGTGSFGRVMLVK 61
Query: 107 XXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIG 166
                            +H  + I  KQ   + L+  +  + E  +L  V  P LVKL  
Sbjct: 62  ------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL-E 107
Query: 167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMD 226
           +  +D+       ++ EY+    +  HL    + + P + R   AQ       YLH    
Sbjct: 108 FSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IVLTFEYLH---S 159
Query: 227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
             +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  Y APE I +  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKG 214
Query: 287 LTYKSDIWSFGVFLYELITGRRPLDRNRP 315
                D W+ GV +YE+  G  P   + P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQ 99
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 100 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 142
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGXEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQD 213
           V  P LVKL  +  +D+       ++ EY+    +  HL    RF      + R   AQ 
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYAAQ- 149
Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
                 YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGT 201
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 109/270 (40%), Gaps = 38/270 (14%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L        KE  ++E+ ++  + +H N+V L+G C      G   L+I EY 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYC 132
Query: 186 PNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLH------EGMDF----QIIFRD 233
               + + L   SR   T P      IA   A     LH      +GM F      I RD
Sbjct: 133 CYGDLLNFLRRKSRVLETDP---AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + N+LL     AK+ DFGLAR   +D    V       + + APE I     T +SD+
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 294 WSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLA 352
           WS+G+ L+E+ + G  P                 P +    KF  ++    +        
Sbjct: 250 WSYGILLWEIFSLGLNPY----------------PGILVNSKFYKLVKDGYQMAQPAFAP 293
Query: 353 QKLAAVANKCLARQAKGRPKMSEVVEVLNK 382
           + + ++   C A +   RP   ++   L +
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGXEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    +   P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFAEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L        KE  ++E+ ++  + +H N+V L+G C      G   L+I EY 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYC 132
Query: 186 PNRSVQDHL--TSRFQATLP--------WNTR--LKIAQDAARGLAYLHEGMDFQIIFRD 233
               + + L   SR   T P         +TR  L  +   A+G+A+L        I RD
Sbjct: 133 CYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRD 189
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
             + N+LL     AK+ DFGLAR   +D    V       + + APE I     T +SD+
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 294 WSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLA 352
           WS+G+ L+E+ + G  P                 P +    KF  ++    +        
Sbjct: 250 WSYGILLWEIFSLGLNPY----------------PGILVNSKFYKLVKDGYQMAQPAFAP 293
Query: 353 QKLAAVANKCLARQAKGRPKMSEVVEVLNK 382
           + + ++   C A +   RP   ++   L +
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 44/271 (16%)
Query: 50  RKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-ATKNFSRSLMIX 106
           ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  T +F R +++ 
Sbjct: 7   QESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLGTGSFGRVMLVK 56
Query: 107 XXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIG 166
                            +H  + I  KQ   + L+  +  + E  +L  V  P LVKL  
Sbjct: 57  ------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKL-E 102
Query: 167 YCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +  +D+       ++ EY+    +  HL    RF      + R   AQ       YLH  
Sbjct: 103 FSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYAAQ-IVLTFEYLH-- 153
Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
               +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  Y APE I +
Sbjct: 154 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 207
Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
                  D W+ GV +YE+  G  P   ++P
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 29/194 (14%)
Query: 129 DIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + AVK +S+R ++     +  + EV +L  ++HPN++KL  +    +++G    L+ E  
Sbjct: 59  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF---EDKGY-FYLVGEVY 114
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ- 244
               + D + SR + +     R  I +    G+ Y+H+    +I+ RD K  N+LL+ + 
Sbjct: 115 TGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 169
Query: 245 --WNAKLSDFGLARLGPSDGLSHVSTAV-----VGTIGYAAPEYIQTGRLTYKSDIWSFG 297
              N ++ DFGL+        +H   +      +GT  Y APE +  G    K D+WS G
Sbjct: 170 KDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 220
Query: 298 VFLYELITGRRPLD 311
           V LY L++G  P +
Sbjct: 221 VILYILLSGCPPFN 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 26/183 (14%)
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
           T+P +   KIA    + L +LH  +   +I RD K SN+L++     K+ DFG++     
Sbjct: 105 TIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162
Query: 261 DGLSHVSTAVVGTIGYAAPEYI-----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           D    +     G   Y APE I     Q G  + KSDIWS G+ + EL   R P D    
Sbjct: 163 DVAKDIDA---GCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD---- 214
Query: 316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
                   W  P     K+      P+L      K + +     ++CL + +K RP   E
Sbjct: 215 -------SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPE 263
Query: 376 VVE 378
           +++
Sbjct: 264 LMQ 266

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++D + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKDFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 162 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+++D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E  +L  V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + 
Sbjct: 89  LNEKRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HA 143
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           R   AQ       YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   
Sbjct: 144 RFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           +  + GT  Y APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y APE I +       D W+ GV +Y++  G  P   ++P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I EY 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVEYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    +++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 102 MKDVYIVQDLMETDLYKLLKCQHLSN----DHICYFLYQIL-------------RGLKYI 144
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 99
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 100 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 142
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQ 99
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 100 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 142
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 26/183 (14%)
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
           T+P +   KIA    + L +LH  +   +I RD K SN+L++     K+ DFG++     
Sbjct: 149 TIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 206
Query: 261 DGLSHVSTAVVGTIGYAAPEYI-----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
              S   T   G   Y APE I     Q G  + KSDIWS G+ + EL   R P D    
Sbjct: 207 ---SVAKTIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD---- 258
Query: 316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
                   W  P     K+      P+L      K + +     ++CL + +K RP   E
Sbjct: 259 -------SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPE 307
Query: 376 VVE 378
           +++
Sbjct: 308 LMQ 310

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 43  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 102
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 103 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 145
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 44  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 103
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 104 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 146
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 147 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 35  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 94
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 95  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 137
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 138 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 102 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 144
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 98  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 140
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 36  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 95
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 96  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 138
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 36  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 95
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 96  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 138
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 118 IRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI 176
           +    +    + +AVK L      Q   +++ E  ++    H N+V+ IG   +     +
Sbjct: 52  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----L 107
Query: 177 QRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR----LKIAQDAARGLAYLHEGMDFQIIF 231
            R ++ E M    ++  L  +R + + P +      L +A+D A G  YL E      I 
Sbjct: 108 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 164
Query: 232 RDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT 288
           RD  + N LL        AK+ DFG+A+              +  + +  PE    G  T
Sbjct: 165 RDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 224
Query: 289 YKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY 347
            K+D WSFGV L+E+ + G  P      KS Q++LE+V    T   +    +DP      
Sbjct: 225 SKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFV----TSGGR----MDPPK---- 269
Query: 348 SIKLAQKLAAVANKCLARQAKGRPKMS---EVVEVLNKIVDAAETGTP 392
                  +  +  +C   Q + RP  +   E +E   +  D   T  P
Sbjct: 270 --NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 315

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTAVVGT 273
           GL +LH+     II+RD K  N+LLD+  N ++SD GLA   + G +      +    GT
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-----TKGYAGT 352
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            G+ APE +      +  D ++ GV LYE+I  R P      K E K L+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++  +++HP++V+L+   + D        +++E+M    +   +  R  A   ++  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 209 --KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA---KLSDFGLA-RLGPSDG 262
                +     L Y H   D  II RD K  N+LL  + N+   KL DFG+A +LG S G
Sbjct: 132 ASHYMRQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-G 187
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           L  V+   VGT  + APE ++        D+W  GV L+ L++G  P 
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTAVVGT 273
           GL +LH+     II+RD K  N+LLD+  N ++SD GLA   + G +      +    GT
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-----TKGYAGT 352
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            G+ APE +      +  D ++ GV LYE+I  R P      K E K L+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTAVVGT 273
           GL +LH+     II+RD K  N+LLD+  N ++SD GLA   + G +      +    GT
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-----TKGYAGT 352
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            G+ APE +      +  D ++ GV LYE+I  R P      K E K L+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 21/128 (16%)
Query: 194 LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
           L S+F+  LP      +   + +A D+   L Y+H         RD K  N+LLD   + 
Sbjct: 164 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHI 214
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYE 302
           +L+DFG       DG    S A VGT  Y +PE +Q      G+   + D WS GV +YE
Sbjct: 215 RLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 273
Query: 303 LITGRRPL 310
           ++ G  P 
Sbjct: 274 MLYGETPF 281

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTAVVGT 273
           GL +LH+     II+RD K  N+LLD+  N ++SD GLA   + G +      +    GT
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-----TKGYAGT 352
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
            G+ APE +      +  D ++ GV LYE+I  R P      K E K L+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 21/128 (16%)
Query: 194 LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
           L S+F+  LP      +   + +A D+   L Y+H         RD K  N+LLD   + 
Sbjct: 180 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHI 230
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYE 302
           +L+DFG       DG    S A VGT  Y +PE +Q      G+   + D WS GV +YE
Sbjct: 231 RLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 289
Query: 303 LITGRRPL 310
           ++ G  P 
Sbjct: 290 MLYGETPF 297

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 102 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 144
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 46  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 105
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 106 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 148
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 149 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 98  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 140
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 15/166 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + EV++L  ++H N+V L  +     E+ +   L++EY+ ++ ++ +L          N 
Sbjct: 48  IREVSLLKDLKHANIVTL--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNIINMHNV 102
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           +L + Q   RGLAY H     +++ RD K  N+L++E+   KL+DFGLAR       ++ 
Sbjct: 103 KLFLFQ-LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           +  V  T+ Y  P+ I  G   Y +  D+W  G   YE+ TG RPL
Sbjct: 159 NEVV--TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 124 SHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI 181
           S   + +AVK L     L   +  ++E+ VL  +  H N+V L+G C      G   L+I
Sbjct: 66  SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVI 121
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKI----------------AQDAARGLAYLHEGM 225
            EY     + + L  +  + +   T   I                +   A+G+A+L    
Sbjct: 122 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 180
Query: 226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
               I RD  + NILL      K+ DFGLAR   +D    V       + + APE I   
Sbjct: 181 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 238
Query: 286 RLTYKSDIWSFGVFLYELIT-GRRP 309
             T++SD+WS+G+FL+EL + G  P
Sbjct: 239 VYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 129 DIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + AVK +S+R ++     +  + EV +L  ++HPN+ KL  +    +++G    L+ E  
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFF---EDKGY-FYLVGEVY 108
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ- 244
               + D + SR + +     R  I +    G+ Y H+    +I+ RD K  N+LL+ + 
Sbjct: 109 TGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKS 163
Query: 245 --WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
              N ++ DFGL+    +   S      +GT  Y APE +  G    K D+WS GV LY 
Sbjct: 164 KDANIRIIDFGLSTHFEA---SKKXKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYI 219
Query: 303 LITGRRPLD 311
           L++G  P +
Sbjct: 220 LLSGCPPFN 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 98  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 140
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++ VV H N++ L+  +  +   
Sbjct: 39  IVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS GV + E+I G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 102 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 144
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ +  ++D + +     +P   
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKDFMDASALTGIPLPL 106
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 107 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 164 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 58  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 117
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 118 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 160
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 161 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 98  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 140
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++ VV H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS GV + E+I G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ +  ++D + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKDFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 15/190 (7%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           A K +  +  +  ++++ E+++L   +HPN+VKL+     ++   I    + E+    +V
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI----LIEFCAGGAV 121
Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
            D +    +  L  +    + +     L YLH   D +II RD K+ NIL     + KL+
Sbjct: 122 -DAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI--QTGR---LTYKSDIWSFGVFLYELIT 305
           DFG++    +        + +GT  + APE +  +T +     YK+D+WS G+ L E+  
Sbjct: 178 DFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 306 GRRPLDRNRP 315
              P     P
Sbjct: 236 IEPPHHELNP 245

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 15/190 (7%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           A K +  +  +  ++++ E+++L   +HPN+VKL+     ++   I    + E+    +V
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI----LIEFCAGGAV 121
Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
            D +    +  L  +    + +     L YLH   D +II RD K+ NIL     + KL+
Sbjct: 122 -DAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI--QTGR---LTYKSDIWSFGVFLYELIT 305
           DFG++    +        + +GT  + APE +  +T +     YK+D+WS G+ L E+  
Sbjct: 178 DFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 306 GRRPLDRNRP 315
              P     P
Sbjct: 236 IEPPHHELNP 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTI 274
           RGL Y+H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGR 307
            Y APE +   +   KS DIWS G  L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 124 SHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI 181
           S   + +AVK L        +E  ++E+ VL  +  H N+V L+G C      G   L+I
Sbjct: 50  SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVI 105
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKI----------------AQDAARGLAYLHEGM 225
            EY     + + L  +  + +   T   I                +   A+G+A+L    
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 164
Query: 226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
               I RD  + NILL      K+ DFGLAR   +D    V       + + APE I   
Sbjct: 165 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
Query: 286 RLTYKSDIWSFGVFLYELIT-GRRP 309
             T++SD+WS+G+FL+EL + G  P
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF---------------QA 200
           ++HPN+V L+G   +D        +I+ Y  +  + + L  R                 A
Sbjct: 86  LQHPNVVCLLGVVTKDQPLS----MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGP 259
             P +    +AQ AA G+ YL       ++ +D  + N+L+ ++ N K+SD GL R +  
Sbjct: 142 LEPPDFVHLVAQIAA-GMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE 318
           +D    +  +++  I + APE I  G+ +  SDIWS+GV L+E+ + G +P       S 
Sbjct: 198 ADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG---YSN 253
Query: 319 QKLLEWVR 326
           Q ++E +R
Sbjct: 254 QDVVEMIR 261

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           Y AP  I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 124 SHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI 181
           S   + +AVK L        +E  ++E+ VL  +  H N+V L+G C      G   L+I
Sbjct: 73  SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVI 128
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKI----------------AQDAARGLAYLHEGM 225
            EY     + + L  +  + +   T   I                +   A+G+A+L    
Sbjct: 129 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 187
Query: 226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
               I RD  + NILL      K+ DFGLAR   +D    V       + + APE I   
Sbjct: 188 --NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNC 245
Query: 286 RLTYKSDIWSFGVFLYELIT-GRRP 309
             T++SD+WS+G+FL+EL + G  P
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 124 SHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI 181
           S   + +AVK L     L   +  ++E+ VL  +  H N+V L+G C      G   L+I
Sbjct: 68  SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVI 123
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKI----------------AQDAARGLAYLHEGM 225
            EY     + + L  +  + +   T   I                +   A+G+A+L    
Sbjct: 124 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 182
Query: 226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
               I RD  + NILL      K+ DFGLAR   +D    V       + + APE I   
Sbjct: 183 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 240
Query: 286 RLTYKSDIWSFGVFLYELIT-GRRP 309
             T++SD+WS+G+FL+EL + G  P
Sbjct: 241 VYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 158
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 159 TYTHEVVTLWYRAPE-ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +L  ++HPNLV L+    E   R  +  L++EY  +  +  H   R+Q  +P +   
Sbjct: 52  EIRMLKQLKHPNLVNLL----EVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVK 105
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHV 266
            I     + + + H+      I RD K  NIL+ +    KL DFG ARL  GPSD     
Sbjct: 106 SITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD----Y 158
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
               V T  Y +PE +  G   Y    D+W+ G    EL++G
Sbjct: 159 YDDEVATRWYRSPELL-VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 98  MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 140
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 111
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 112 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 165
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 166 TYTHEVVTLWYRAPE-ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 47/279 (16%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L        KE  ++E+ ++  + +H N+V L+G C      G   L+I EY 
Sbjct: 62  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYC 117
Query: 186 PNRSVQDHLTSRFQATL-------------------PWNTR--LKIAQDAARGLAYLHEG 224
               + + L  + +A L                   P   R  L  +   A+G+A+L   
Sbjct: 118 CYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK 177
Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD  + N+LL     AK+ DFGLAR   +D    V       + + APE I  
Sbjct: 178 ---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 234
Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
              T +SD+WS+G+ L+E+ + G  P                 P +    KF  ++    
Sbjct: 235 CVYTVQSDVWSYGILLWEIFSLGLNPY----------------PGILVNSKFYKLVKDGY 278
Query: 344 EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK 382
           +        + + ++   C A +   RP   ++   L +
Sbjct: 279 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 317

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 137 RRGLQGHKEWVTEVNVLGVVEH-PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           RRG     E + E+ VL + +  P ++ L     E  E   + +LI EY     +     
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINL----HEVYENTSEIILILEYAAGGEIFSLCL 121
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---NAKLSDF 252
                 +  N  +++ +    G+ YLH+     I+  D K  NILL   +   + K+ DF
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 253 GLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           G++R +G +  L  +    +GT  Y APE +    +T  +D+W+ G+  Y L+T   P 
Sbjct: 179 GMSRKIGHACELREI----MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I  Y 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVAYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF---------------QA 200
           ++HPN+V L+G   +D        +I+ Y  +  + + L  R                 A
Sbjct: 69  LQHPNVVCLLGVVTKDQPLS----MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGP 259
             P +    +AQ AA G+ YL       ++ +D  + N+L+ ++ N K+SD GL R +  
Sbjct: 125 LEPPDFVHLVAQIAA-GMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE 318
           +D    +  +++  I + APE I  G+ +  SDIWS+GV L+E+ + G +P       S 
Sbjct: 181 ADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG---YSN 236
Query: 319 QKLLEWVR 326
           Q ++E +R
Sbjct: 237 QDVVEMIR 244

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 124 SHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLI 181
           S   + +AVK L        +E  ++E+ VL  +  H N+V L+G C      G   L+I
Sbjct: 73  SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVI 128
Query: 182 YEYMPNRSVQDHLTSRFQATLPWNTRLKI----------------AQDAARGLAYLHEGM 225
            EY     + + L  +  + +   T   I                +   A+G+A+L    
Sbjct: 129 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 187
Query: 226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
               I RD  + NILL      K+ DFGLAR   +D    V       + + APE I   
Sbjct: 188 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 245
Query: 286 RLTYKSDIWSFGVFLYELIT-GRRP 309
             T++SD+WS+G+FL+EL + G  P
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 15/190 (7%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSV 190
           A K +  +  +  ++++ E+++L   +HPN+VKL+     ++   I    + E+    +V
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI----LIEFCAGGAV 121
Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS 250
            D +    +  L  +    + +     L YLH   D +II RD K+ NIL     + KL+
Sbjct: 122 -DAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI--QTGR---LTYKSDIWSFGVFLYELIT 305
           DFG++    +          +GT  + APE +  +T +     YK+D+WS G+ L E+  
Sbjct: 178 DFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 306 GRRPLDRNRP 315
              P     P
Sbjct: 236 IEPPHHELNP 245

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 108
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 109 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 162
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 163 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTI 274
           RGL Y+H      ++ RD K SN+L++   + K+ DFGLAR+  P    +   T  V T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGR 307
            Y APE +   +   KS DIWS G  L E+++ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTI 274
           RGL Y+H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +   T  V T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGR 307
            Y APE +   +   KS DIWS G  L E+++ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 59  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 114
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 115 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 172 DIXETDXXRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 157
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 158 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 123
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 181 DIXETDXXRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 158
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 159 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 105
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 106 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 159
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 160 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 128 IDIAVKQLSRRGLQGH-KEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           + +AVK L     +    + V+E+ ++ ++ +H N++ L+G C +D    +    I  Y 
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV----IVGYA 123
Query: 186 PNRSVQDHLTSRFQATLPWNTRLK--------------IAQDAARGLAYLHEGMDFQIIF 231
              +++++L +R    + ++  +                    ARG+ YL      + I 
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG--TIGYAAPEYIQTGRLTY 289
           RD  + N+L+ E    K++DFGLAR    + + +      G   + + APE +     T+
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 290 KSDIWSFGVFLYELIT 305
           +SD+WSFGV ++E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 157
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 158 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 50/288 (17%)
Query: 128 IDIAVKQLSRRGLQGHKE-WVTEVNVLGVV-EHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           I +AVK L  +     +E  ++E+ ++  +  H N+V L+G C           LI+EY 
Sbjct: 76  IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG----PIYLIFEYC 131
Query: 186 PNRSVQDHLTSRFQA---------------------TLPWNTRLKIAQDAARGLAYLHEG 224
               + ++L S+ +                       L +   L  A   A+G+ +L   
Sbjct: 132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--- 188
Query: 225 MDFQ-IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
            +F+  + RD  + N+L+      K+ DFGLAR   SD    V       + + APE + 
Sbjct: 189 -EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 284 TGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
            G  T KSD+WS+G+ L+E+ + G  P                 P +     F  ++   
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVNPY----------------PGIPVDANFYKLIQNG 291
Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN-KIVDAAET 389
            +        +++  +   C A  ++ RP    +   L  ++ DA E 
Sbjct: 292 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 111
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 112 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 165
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 166 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 158
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 159 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 157
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 158 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 105 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 158
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 159 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 47  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 102
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 103 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 157
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 158 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 216
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 217 VVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 105
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 160
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 219
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 220 VVLWEITS 227

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 105
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 160
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 219
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 220 VVLWEITS 227

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 102 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 144
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +      V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLVKLIG--------- 166
           ++ S  D+  K+ +A+K++S    Q + +  + E+ +L    H N++ +           
Sbjct: 43  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 102
Query: 167 ----YCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
               Y  +D  E  + +LL  +++ N    DH+       L             RGL Y+
Sbjct: 103 MKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQIL-------------RGLKYI 145
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG-PSDGLSHVSTAVVGTIGYAAPE 280
           H      ++ RD K SN+LL+   + K+ DFGLAR+  P    +      V T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 281 YIQTGRLTYKS-DIWSFGVFLYELITGR 307
            +   +   KS DIWS G  L E+++ R
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 162 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
            E++++  + HP L+ L  + A +D+   + +LI E++    + D + +     +     
Sbjct: 97  NEISIMNQLHHPKLINL--HDAFEDK--YEMVLILEFLSGGELFDRIAAE-DYKMSEAEV 151
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ--WNAKLSDFGLA-RLGPSDGLS 264
           +   + A  GL ++HE     I+  D K  NI+ + +   + K+ DFGLA +L P D + 
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIV 207
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            V+TA   T  +AAPE +    + + +D+W+ GV  Y L++G  P 
Sbjct: 208 KVTTA---TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ VL  + HPN++KL     E  E   +  L+ E +    + D +  +   +      
Sbjct: 97  TEIGVLLRLSHPNIIKL----KEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----- 147
Query: 208 LKIAQDAAR----GLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKLSDFGLARLGPS 260
            + A DA +     +AYLHE     I+ RD K  N+L          K++DFGL+++   
Sbjct: 148 -RDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
             L      V GT GY APE ++      + D+WS G+  Y L+ G  P    R
Sbjct: 204 QVLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 51  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 105
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 106 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 161 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSS--ESSSRNTFAVLSQRQSNLRVFTFSELKT-A 95
            N + +     ++S  EF ++   DF    E+ S+NT A L Q         F  +KT  
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQ---------FDRIKTLG 50
Query: 96  TKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
           T +F R +++                  +H  + I  KQ   + L+  +  + E  +L  
Sbjct: 51  TGSFGRVMLVK------------HKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQA 97
Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           V  P LVKL  +  +D+       ++ EY+    +  HL    + + P + R   AQ   
Sbjct: 98  VNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQ-IV 151
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
               YLH      +I+RD K  N+L+D+Q   +++DFG A+      +   +  + GT  
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPE 203
Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
             APE I +       D W+ GV +YE+  G  P   ++P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 105
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 106 IKSYLFQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 163 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 51  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 105
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 106 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 161 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++ VV H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 162 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 162 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 105 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 161
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 162 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 160
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 161 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 106
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 107 IKSYLFQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 164 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 106
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 107 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 164 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 160
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 161 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 106
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 107 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 164 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 105
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 106 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 163 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 108
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 109 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 165
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 166 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++ VV H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 105
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 106 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 163 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGVS-REDIEREVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKTFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEHV-HQDLKTFMDASALTGIPLPL 103
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 104 IKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 157
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 158 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 86  VFTFSELKTATKNFSRSLMIXXXXXXXXXXXVIRSTEDSHKKIDIAVKQLSRRG-LQGHK 144
           VF   E + A +  + S  +           V +       +  +A+K ++    ++   
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 178 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 16/167 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + EV VL +++HPN++KL  +   +D+R     L+ E      + D +  R +     + 
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFF--EDKRNY--YLVMECYKGGELFDEIIHRMKFN-EVDA 138
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGL 263
            + I Q    G+ YLH+     I+ RD K  N+LL+ +      K+ DFGL+ +  +   
Sbjct: 139 AVIIKQ-VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--- 191
Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                  +GT  Y APE ++  +   K D+WS GV L+ L+ G  P 
Sbjct: 192 QKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASALTGIPLPL 104
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-H 265
                    +GL++ H     +++ RD K  N+L++ +   KL+DFGLAR   + G+   
Sbjct: 105 IKSYLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVR 158
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             T  V T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 159 TYTHEVVTLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 76/183 (41%), Gaps = 26/183 (14%)
Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
           T+P +   KIA    + L +LH  +   +I RD K SN+L++     K  DFG++     
Sbjct: 132 TIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVD 189
Query: 261 DGLSHVSTAVVGTIGYAAPEYI-----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
           D    +     G   Y APE I     Q G  + KSDIWS G+   EL   R P D    
Sbjct: 190 DVAKDIDA---GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYD---- 241
Query: 316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
                   W  P     K+      P+L      K + +     ++CL + +K RP   E
Sbjct: 242 -------SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPE 290
Query: 376 VVE 378
           + +
Sbjct: 291 LXQ 293

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 89  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 144
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 145 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 201
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 202 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 174 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +A+K ++    ++   E++ E +V+      ++V+L+G  ++    G   L+I E M   
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRG 113
Query: 189 SVQDHLTS--------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
            ++ +L S           A    +  +++A + A G+AYL+     + + RD  + N +
Sbjct: 114 DLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           + E +  K+ DFG+ R +  +D        ++  + + +PE ++ G  T  SD+WSFGV 
Sbjct: 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 300 LYELIT 305
           L+E+ T
Sbjct: 230 LWEIAT 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 194
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 146 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 197
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 198 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +A+K ++    ++   E++ E +V+      ++V+L+G  ++    G   L+I E M   
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRG 113
Query: 189 SVQDHLTS--------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL 240
            ++ +L S           A    +  +++A + A G+AYL+     + + RD  + N +
Sbjct: 114 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 241 LDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           + E +  K+ DFG+ R +  +D        ++  + + +PE ++ G  T  SD+WSFGV 
Sbjct: 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 300 LYELIT 305
           L+E+ T
Sbjct: 230 LWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANN 119
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 177 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 135 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 186
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 187 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 69  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLST 122
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R          S   +  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKW 178
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 180 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 105
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 160
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 219
Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKY---SIKLAQK 354
           V L+E+ +               L E     L++ +    ++D    G Y        ++
Sbjct: 220 VVLWEITS---------------LAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPER 260
Query: 355 LAAVANKCLARQAKGRPKMSEVVEVL 380
           +  +   C     K RP   E+V +L
Sbjct: 261 VTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 123
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 181 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 147 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 199 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 105
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 160
Query: 239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
            ++   +  K+ DFG+ R              +  + + APE ++ G  T  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 299 FLYELIT 305
            L+E+ +
Sbjct: 221 VLWEITS 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   ++   EV++L  ++HPN++ L     E  E     +LI E +    + D L 
Sbjct: 52  SRRGV-SREDIEREVSILKEIQHPNVITL----HEVYENKTDVILIGELVAGGELFDFLA 106
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE----QWNAKLSD 251
            +   +L      +  +    G+ YLH     QI   D K  NI+L +    +   K+ D
Sbjct: 107 EK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA         +    + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 162 FGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 49  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 104
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + RD  + N
Sbjct: 105 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 159
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 160 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 218
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 219 VVLWEITS 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 165 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 216
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 217 YRAPE-IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ +  ++  + +     +P   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKKFMDASALTGIPLPL 105
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 106 IKSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 163 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 180 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ +  ++  + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKKFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 159 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 210
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 211 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 185 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAED-DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           E+ VL  ++H N+V L     ED  E      L+ + +    + D +  R   T   +  
Sbjct: 56  EIAVLKKIKHENIVTL-----EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK-DAS 109
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL-LDEQWNAKL--SDFGLARLGPSDGLS 264
           L I Q     + YLHE     I+ RD K  N+L L  + N+K+  +DFGL+++   +G+ 
Sbjct: 110 LVI-QQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGI- 163
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
            +STA  GT GY APE +     +   D WS GV  Y L+ G  P      ++E KL E 
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF---YEETESKLFEK 218
Query: 325 VR 326
           ++
Sbjct: 219 IK 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 208 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 208 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 207 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 69  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 122
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 185 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 207 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 110
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 66  DHPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 119
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 69  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 122
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 158 HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
           H N+V L+     D++R +   L+++YM       H   R     P + +  + Q   + 
Sbjct: 68  HENIVNLLNVLRADNDRDV--YLVFDYM---ETDLHAVIRANILEPVHKQYVVYQ-LIKV 121
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-------------LGPSDGLS 264
           + YLH G    ++ RD K SNILL+ + + K++DFGL+R             L  ++   
Sbjct: 122 IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 265 H------VSTAVVGTIGYAAPE-YIQTGRLTYKSDIWSFGVFLYELITGR 307
           +      + T  V T  Y APE  + + + T   D+WS G  L E++ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + E+++L  + HPN+VKL+     ++    +  L++E++ ++ ++  + +     +P   
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEHV-DQDLKKFMDASALTGIPLPL 107
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    +GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR       ++ 
Sbjct: 108 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              V  T+ Y APE I  G   Y +  DIWS G    E++T R
Sbjct: 165 HEVV--TLWYRAPE-ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 71  DHPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 124
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 125 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 180
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV +L  ++HPN++KL     E  E      ++ E      + D +  R       +   
Sbjct: 71  EVELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAA 124
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLSDFGLARLGPSDGLSH 265
           +I +    G+ Y+H+     I+ RD K  NILL+ +    + K+ DFGL+     +    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                +GT  Y APE ++ G    K D+WS GV LY L++G  P 
Sbjct: 179 KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 147 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 199 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 18/183 (9%)
Query: 153 LGVVEHPNLVKLIGY---CAEDDERGIQRLLIYEYMPN---RSVQDHLTSRFQATLPWNT 206
           L V+ HPN+V+L  Y     E D R I   ++ EY+P+   R  +++   R  A  P   
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY-RRQVAPPPILI 131
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLA-RLGPSDGLS 264
           ++ + Q   R +  LH      +  RD K  N+L++E     KL DFG A +L PS+   
Sbjct: 132 KVFLFQ-LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-- 187
Query: 265 HVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
             + A + +  Y APE I      T   DIWS G    E++ G  P+ R    S  +L E
Sbjct: 188 --NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGD-NSAGQLHE 243
Query: 324 WVR 326
            VR
Sbjct: 244 IVR 246

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 134 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 185
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 186 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 89  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 144
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 145 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 201
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 202 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 151
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R
Sbjct: 152 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 209 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 72  DHPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 125
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 181
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 449 DHPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLST 502
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 558
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 12/191 (6%)
Query: 128 IDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG--IQRLLIYE 183
           + +AVK L    +     +E++ E   +   +HP++ KL+G       +G     ++I  
Sbjct: 52  VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 184 YMPNRSVQDHL-TSRFQAT---LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
           +M +  +   L  SR       LP  T ++   D A G+ YL        I RD  + N 
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNC 168
Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           +L E     ++DFGL+R   S        A    + + A E +     T  SD+W+FGV 
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 300 LYELIT-GRRP 309
           ++E++T G+ P
Sbjct: 229 MWEIMTRGQTP 239

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V HPN++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-CREEIEREVSILRQVLHPNIITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 100 EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 152
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 210 WSVGCIMGEMIKG 222

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 110
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 110
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 74  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 127
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 128 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 183
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 109
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 167 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 97  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 150
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 206
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 52  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 107
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 108 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 164
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 165 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 222 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 50  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 105
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 106 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 162
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 163 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 219
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 220 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 273

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 52  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 107
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 108 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 164
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 165 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 222 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 116
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 172
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 173 --LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     K W  E  +   V   H N++  I           Q  LI  Y  
Sbjct: 33  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
             S+ D+L      TL   + L+I    A GLA+LH E    Q    I  RD KS NIL+
Sbjct: 90  MGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 242 DEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIGYAAPEY----IQTGRL-TYKS-DI 293
            +     ++D GLA +    ++ L   +   VGT  Y APE     IQ     +YK  DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 294 WSFGVFLYEL 303
           W+FG+ L+E+
Sbjct: 207 WAFGLVLWEV 216

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +      T  V T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 69  DHPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLST 122
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     K W  E  +   V   H N++  I           Q  LI  Y  
Sbjct: 62  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 118
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
             S+ D+L      TL   + L+I    A GLA+LH E    Q    I  RD KS NIL+
Sbjct: 119 MGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 175
Query: 242 DEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIGYAAPEY----IQTGRL-TYK-SDI 293
            +     ++D GLA +    ++ L   +   VGT  Y APE     IQ     +YK  DI
Sbjct: 176 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 235
Query: 294 WSFGVFLYEL 303
           W+FG+ L+E+
Sbjct: 236 WAFGLVLWEV 245

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV +L  ++HPN++KL     E  E      ++ E      + D +  R       +   
Sbjct: 71  EVELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAA 124
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLSDFGLARLGPSDGLSH 265
           +I +    G+ Y+H+     I+ RD K  NILL+ +    + K+ DFGL+     +    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                +GT  Y APE ++ G    K D+WS GV LY L++G  P 
Sbjct: 179 KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 45  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 100
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 101 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 157
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 158 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 45  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 100
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 101 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 157
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 158 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           +HP++VKLIG   E+        +I E      ++  L  R + +L   + +  A   + 
Sbjct: 449 DHPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLST 502
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            LAYL      + + RD  + N+L+      KL DFGL+R    D   + ++     I +
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 558
Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYE-LITGRRPL 310
            APE I   R T  SD+W FGV ++E L+ G +P 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 44  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 99
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 100 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 157 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L+   Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDX 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     K W  E  +   V   H N++  I           Q  LI  Y  
Sbjct: 33  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
             S+ D+L      TL   + L+I    A GLA+LH E    Q    I  RD KS NIL+
Sbjct: 90  MGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 242 DEQWNAKLSDFGLARLG--PSDGLSHVSTAVVGTIGYAAPEY----IQTGRL-TYKS-DI 293
            +     ++D GLA +    ++ L   +   VGT  Y APE     IQ     +YK  DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 294 WSFGVFLYEL 303
           W+FG+ L+E+
Sbjct: 207 WAFGLVLWEV 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV +L  ++HPN++KL     E  E      ++ E      + D +  R       +   
Sbjct: 71  EVELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAA 124
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLSDFGLARLGPSDGLSH 265
           +I +    G+ Y+H+     I+ RD K  NILL+ +    + K+ DFGL+     +    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178
Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                +GT  Y APE ++ G    K D+WS GV LY L++G  P 
Sbjct: 179 KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 49/94 (52%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR    +   +V+T       
Sbjct: 159 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----W 210
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 211 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ D+GLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR        H    + G + 
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVA 204
Query: 276 ---YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 205 TRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS-------- 196
           E++ E +V+      ++V+L+G  ++    G   L+I E M    ++ +L S        
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              A    +  +++A + A G+AYL+     + + RD  + N  + E +  K+ DFG+ R
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173
Query: 257 -LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            +  +D        ++  + + +PE ++ G  T  SD+WSFGV L+E+ T
Sbjct: 174 DIYETDYYRKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 44  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV----YL 99
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 100 VMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDX 156
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 157 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR        H    + G + 
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVA 184
Query: 276 ---YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 185 TRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR        H    + G + 
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVA 184
Query: 276 ---YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 185 TRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 104/266 (39%), Gaps = 39/266 (14%)
Query: 129 DIAVKQLSRRGLQGHK--EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           DI VK L  R     K  ++  E   L +  HPN++ ++G C           LI  + P
Sbjct: 35  DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC--QSPPAPHPTLITHWXP 92
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN 246
             S+ + L       +  +  +K A D ARG A+LH  ++  I      S ++ +DE   
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSRSVXIDEDXT 151
Query: 247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLY 301
           A++S   +     S G  +          + APE +Q     T R +  +D WSF V L+
Sbjct: 152 ARISXADVKFSFQSPGRXYAP-------AWVAPEALQKKPEDTNRRS--ADXWSFAVLLW 202
Query: 302 ELITGRRPLD--RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVA 359
           EL+T   P     N     +  LE +RP +                     ++  ++ + 
Sbjct: 203 ELVTREVPFADLSNXEIGXKVALEGLRPTIPPG------------------ISPHVSKLX 244
Query: 360 NKCLARQAKGRPKMSEVVEVLNKIVD 385
             C       RPK   +V +L K  D
Sbjct: 245 KICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDX 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EVN+L  + HPN++ L        E     +LI E +    + D L 
Sbjct: 53  SRRGVS-REEIEREVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ----WNAKLSD 251
            +   +L  +   +  +    G+ YLH     +I   D K  NI+L ++       KL D
Sbjct: 108 EK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 162
Query: 252 FGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FG+A ++   +   ++     GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGIAHKIEAGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDX 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 235
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 293 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 25/139 (17%)
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EY  NR++ D + S        +   ++ +     L+Y+H      II RD K  NI +D
Sbjct: 95  EYCENRTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID 150
Query: 243 EQWNAKLSDFGLAR----------------LGPSDGLSHVSTAVVGTIGYAAPEYIQ-TG 285
           E  N K+ DFGLA+                 G SD L    T+ +GT  Y A E +  TG
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL----TSAIGTAMYVATEVLDGTG 206
Query: 286 RLTYKSDIWSFGVFLYELI 304
               K D++S G+  +E+I
Sbjct: 207 HYNEKIDMYSLGIIFFEMI 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+   I++AVK+LSR    Q H K    E+ +L  V H N++ L+  +  +   
Sbjct: 39  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L       L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   ++ +    T  V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYAANVDI 208
Query: 294 WSFGVFLYELITG 306
           WS G  + EL+ G
Sbjct: 209 WSVGCIMGELVKG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EVN+L  + HPN++ L        E     +LI E +    + D L 
Sbjct: 46  SRRGVS-REEIEREVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLA 100
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L  +   +  +    G+ YLH     +I   D K  NI LLD+       KL D
Sbjct: 101 EK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155
Query: 252 FGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FG+A ++   +   ++     GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 156 FGIAHKIEAGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGLAR        H    + G + 
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVA 180
Query: 276 ---YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
              Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 181 TRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+ +L  + HP ++K+  +   +D       ++ E M    + D +          N R
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVG--------NKR 249
Query: 208 LKIAQ------DAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLG 258
           LK A            + YLHE     II RD K  N+LL   +E    K++DFG +++ 
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306
Query: 259 PSDGLSHVSTAVVGTIGYAAPE-YIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNR 314
              G + +   + GT  Y APE  +  G   Y    D WS GV L+  ++G  P   +R
Sbjct: 307 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 129 DIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRLLIYEYM 185
           ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +      Q +    Y+
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV----YL 106
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               +  +L    Q  L       +      G+ +LH      II RD K SNI++    
Sbjct: 107 VMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDX 163
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELI- 304
             K+ DFGLAR   + G S + T  V T  Y APE I         DIWS G  + E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220
Query: 305 -----TGRRPLDR-NR---------PKSEQKLLEWVRPHLTDAKKFTMILDPKL 343
                 GR  +D+ N+         P+  +KL   VR ++ +  K+  +  PKL
Sbjct: 221 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EVN+L  + HPN++ L        E     +LI E +    + D L 
Sbjct: 67  SRRGVS-REEIEREVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLA 121
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L  +   +  +    G+ YLH     +I   D K  NI LLD+       KL D
Sbjct: 122 EK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 176
Query: 252 FGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FG+A ++   +   ++     GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 177 FGIAHKIEAGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 41  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 100
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 101 EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 153
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S +    V T  Y APE I         DI
Sbjct: 154 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDI 210
Query: 294 WSFGVFLYELITG 306
           WS G  + E+I G
Sbjct: 211 WSVGCIMGEMIKG 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 51  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 106
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + R+  + N
Sbjct: 107 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRNLAARN 161
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 162 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 220
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 221 VVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 130 IAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNR 188
           +AVK ++    L+   E++ E +V+      ++V+L+G  +    +G   L++ E M + 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHG 105
Query: 189 SVQDHLTS----------RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ +L S          R   TL     +++A + A G+AYL+     + + R+  + N
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADGMAYLNAK---KFVHRNLAARN 160
Query: 239 ILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
            ++   +  K+ DFG+ R +  +D        ++  + + APE ++ G  T  SD+WSFG
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFG 219
Query: 298 VFLYELIT 305
           V L+E+ +
Sbjct: 220 VVLWEITS 227

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 14/160 (8%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +L  + H NLV L+  C    ++  +  L++E++ +  + D     F   L +    
Sbjct: 74  EIKLLKQLRHENLVNLLEVC----KKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQ 127
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
           K       G+ + H      II RD K  NIL+ +    KL DFG AR   + G   V  
Sbjct: 128 KYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYD 182
Query: 269 AVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
             V T  Y APE +  G + Y    D+W+ G  + E+  G
Sbjct: 183 DEVATRWYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DFGL R    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMP 186
           ++A+K++    LQ  +    E+ ++ +V+HPN+V L    Y   D +  +   L+ EY+P
Sbjct: 66  EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 187 N---RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE 243
               R+ + +  ++ + T+P            R LAY+H      I  RD K  N+LLD 
Sbjct: 122 ETVYRASRHY--AKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDP 176
Query: 244 QWNA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFL 300
                KL DFG A++  + G  +VS   + +  Y APE I  G   Y +  DIWS G  +
Sbjct: 177 PSGVLKLIDFGSAKILIA-GEPNVSX--ICSRYYRAPELI-FGATNYTTNIDIWSTGCVM 232
Query: 301 YELITGR 307
            EL+ G+
Sbjct: 233 AELMQGQ 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 13/193 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+   I++AVK+LSR    Q H K    E+ +L  V H N++ L+  +  +   
Sbjct: 37  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 96
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L       L       +      G+ +LH      II RD
Sbjct: 97  EEFQDV----YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 149
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   ++ +    T  V T  Y APE I         DI
Sbjct: 150 LKPSNIVVKSDCTLKILDFGLARTASTNFM---MTPYVVTRYYRAPEVILGMGYKENVDI 206
Query: 294 WSFGVFLYELITG 306
           WS G  + EL+ G
Sbjct: 207 WSVGCIMGELVKG 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GL Y+H      II RD K  N+ ++E    K+ DFGLAR   S+    V T       
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----W 190
Query: 276 YAAPEYIQT-GRLTYKSDIWSFGVFLYELITGR 307
           Y APE I    R T   DIWS G  + E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDGLSHVSTAVVG 272
           RGL Y+H     Q+I RD K SN+L++E    K+ DFG+AR     P++   +  T  V 
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH-QYFMTEYVA 224
Query: 273 TIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRR 308
           T  Y APE + +    T   D+WS G    E++  R+
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSDGLSHVSTAVVG 272
           RGL Y+H     Q+I RD K SN+L++E    K+ DFG+AR     P++   +  T  V 
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH-QYFMTEYVA 225
Query: 273 TIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRR 308
           T  Y APE + +    T   D+WS G    E++  R+
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++  +++HP++V+L+   + D        +++E+M    +   +  R  A   ++  +
Sbjct: 78  EASICHMLKHPHIVELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 209 --KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA---KLSDFGLA-RLGPSDG 262
                +     L Y H   D  II RD K   +LL  + N+   KL  FG+A +LG S G
Sbjct: 134 ASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-G 189
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           L  V+   VGT  + APE ++        D+W  GV L+ L++G  P 
Sbjct: 190 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E ++  +++HP++V+L+   + D        +++E+M    +   +  R  A   ++  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 209 --KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA---KLSDFGLA-RLGPSDG 262
                +     L Y H   D  II RD K   +LL  + N+   KL  FG+A +LG S G
Sbjct: 132 ASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-G 187
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           L  V+   VGT  + APE ++        D+W  GV L+ L++G  P 
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+  FGLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           T++   KI I  K+LS R    H++   E  +  +++HPN+V+L    +E+   G    L
Sbjct: 56  TQEYAAKI-INTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEE---GFH-YL 107
Query: 181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDF----QIIFRDFKS 236
           +++ +    + + + +R   +           DA+  +  + E ++      I+ RD K 
Sbjct: 108 VFDLVTGGELFEDIVAREYYS---------EADASHCIHQILESVNHIHQHDIVHRDLKP 158
Query: 237 SNILLDEQWNA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            N+LL  +      KL+DFGLA      G         GT GY +PE ++        DI
Sbjct: 159 ENLLLASKCKGAAVKLADFGLAI--EVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDI 216
Query: 294 WSFGVFLYELITGRRPL-DRNRPKSEQKL 321
           W+ GV LY L+ G  P  D ++ K  Q++
Sbjct: 217 WACGVILYILLVGYPPFWDEDQHKLYQQI 245

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ DF LAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 58/139 (41%), Gaps = 14/139 (10%)
Query: 180 LIYEYMPNRSVQDH------LTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
           +IYEYM N S+         L   +   +P      I +      +Y+H   +  I  RD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRD 177
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI--QTGRLTYKS 291
            K SNIL+D+    KLSDFG +       +        GT  +  PE+   ++     K 
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIK----GSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 292 DIWSFGVFLYELITGRRPL 310
           DIWS G+ LY +     P 
Sbjct: 234 DIWSLGICLYVMFYNVVPF 252

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 24/105 (22%)
Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR----------------LGPS 260
            L+Y+H      II RD K  NI +DE  N K+ DFGLA+                 G S
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 261 DGLSHVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELI 304
           D L    T+ +GT  Y A E +  TG    K D++S G+  +E+I
Sbjct: 185 DNL----TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ D GLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 43/208 (20%)
Query: 118 IRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           + S  D+  +  +AVK+LSR  + L   +    E+ +L  ++H N++ L+          
Sbjct: 36  VCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV-------- 87
Query: 176 IQRLLIYEYMPNRSVQDH-----LTSRFQATLPWNTRLKIAQDA---------ARGLAYL 221
                   + P  S++D      +T+   A L    + +   D           RGL Y+
Sbjct: 88  --------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II RD K SN+ ++E    ++ DFGLAR    +      T  V T  Y APE 
Sbjct: 140 HSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPE- 190
Query: 282 IQTGRLTYKS--DIWSFGVFLYELITGR 307
           I    + Y    DIWS G  + EL+ G+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 13/194 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 44  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 103
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 104 EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 156
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         D+
Sbjct: 157 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDL 213
Query: 294 WSFGVFLYELITGR 307
           WS G  + E++  +
Sbjct: 214 WSVGCIMGEMVCHK 227

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM+F    + I RD  + NILL E+   K+ DFGLAR    D            + + A
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDA 332
           PE I     T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323
Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           + +  +LD                     C   +   RP  SE+VE L  ++ A
Sbjct: 324 EMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQA 356

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM+F    + I RD  + NILL E+   K+ DFGLAR    D            + + A
Sbjct: 202 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 261
Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDA 332
           PE I     T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  
Sbjct: 262 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 321
Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           + +  +LD                     C   +   RP  SE+VE L  ++ A
Sbjct: 322 EMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQA 354

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 13/194 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 33  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 92
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 93  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 145
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S + T  V T  Y APE I         D+
Sbjct: 146 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDL 202
Query: 294 WSFGVFLYELITGR 307
           WS G  + E++  +
Sbjct: 203 WSVGCIMGEMVCHK 216

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 67  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 124 HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 241 YAMGLVFWEI 250

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM+F    + I RD  + NILL E+   K+ DFGLAR    D            + + A
Sbjct: 211 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 270
Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDA 332
           PE I     T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  
Sbjct: 271 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 330
Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           + +  +LD                     C   +   RP  SE+VE L  ++ A
Sbjct: 331 EMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQA 363

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 28/195 (14%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R    H++   E  +  +++HPN+V+L    +E+        LI++ +    
Sbjct: 55  INTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEEG----HHYLIFDLVTGGE 107
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM----DFQIIFRDFKSSNILLDEQW 245
           + + + +R   +           DA+  +  + E +       ++ RD K  N+LL  + 
Sbjct: 108 LFEDIVAREYYS---------EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKL 158
Query: 246 NA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
                KL+DFGLA     +G         GT GY +PE ++        D+W+ GV LY 
Sbjct: 159 KGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 303 LITGRRPL---DRNR 314
           L+ G  P    D++R
Sbjct: 217 LLVGYPPFWDEDQHR 231

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ D GLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 223 EGMDF----QIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           +GM+F    + I RD  + NILL E+   K+ DFGLAR    D            + + A
Sbjct: 209 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 268
Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSE--QKLLEWVR---PHLTDA 332
           PE I     T +SD+WSFGV L+E+ + G  P    +   E  ++L E  R   P  T  
Sbjct: 269 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 328
Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           + +  +LD                     C   +   RP  SE+VE L  ++ A
Sbjct: 329 EMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQA 361

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           RGL Y+H      II RD K SN+ ++E    K+ D GLAR    +      T  V T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRW 187
Query: 276 YAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           Y APE I    + Y    DIWS G  + EL+TGR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 36/174 (20%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSH--VSTAVVGTIGYAAPEYIQTG 285
           ++ RD K  NIL+D  +  AKL DFG      S  L H    T   GT  Y+ PE+I   
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFG------SGALLHDEPYTDFDGTRVYSPPEWISRH 213
Query: 286 RL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLE 344
           +     + +WS G+ LY+++ G  P +R+     Q++LE                    E
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERD-----QEILE-------------------AE 249
Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKN 398
             +   ++    A+  +CLA +   RP + E+  +L+  +       P  P K 
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI--LLDPWMQTPAEDVPLNPSKG 301

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
           + EV VL  ++HPN++KL  Y   +D+R     L+ E      + D +  R Q     + 
Sbjct: 52  LDEVAVLKQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILR-QKFSEVDA 106
Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGL 263
            + I +    G  YLH+     I+ RD K  N+LL+ +      K+ DFGL+      G 
Sbjct: 107 AV-IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG- 161
Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                  +GT  Y APE ++  +   K D+WS GV LY L+ G  P 
Sbjct: 162 --KMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 28  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 85  HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 202 YAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 54  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 110
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 111 HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 167
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 168 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 227
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 228 YAMGLVFWEI 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQI- 274
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 275 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 29  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 85
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 86  HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 142
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 143 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 202
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 203 YAMGLVFWEI 212

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS 291
           RD K  NIL+     A L DFG+A     + L+ +    VGT+ Y APE       TY++
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYXAPERFSESHATYRA 216
Query: 292 DIWSFGVFLYELITGRRP 309
           DI++    LYE +TG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
           TE+    ++ H N++  I    +      Q  LI +Y  N S+ D+L S    TL   + 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSM 136
Query: 208 LKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPS 260
           LK+A  +  GL +LH E    Q    I  RD KS NIL+ +     ++D GLA   +  +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 261 DGLSHVSTAVVGTIGYAAPEYI--QTGRLTYKS----DIWSFGVFLYEL 303
           + +       VGT  Y  PE +     R  ++S    D++SFG+ L+E+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R  Q  +    E  +   ++HPN+V+L     E+        L+++ +    
Sbjct: 62  INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEES----FHYLVFDLVTGGE 114
Query: 190 VQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA- 247
           + + + +R F +    +  +   Q     +AY H      I+ R+ K  N+LL  +    
Sbjct: 115 LFEDIVAREFYSEADASHCI---QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168
Query: 248 --KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             KL+DFGLA +  +D  S       GT GY +PE ++    +   DIW+ GV LY L+ 
Sbjct: 169 AVKLADFGLA-IEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 306 GRRPL 310
           G  P 
Sbjct: 226 GYPPF 230

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 34/179 (18%)
Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR--LGPSDGLSHVSTAVV 271
            ARG+ +L      + I RD  + NILL E    K+ DFGLAR      D +    T + 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP-----LDRNRPKSEQKLLEWV 325
             + + APE I     + KSD+WS+GV L+E+ + G  P     +D +     ++ +   
Sbjct: 264 -PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMR 322
Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
            P  +  + + ++LD                     C  R  K RP+ +E+VE L  ++
Sbjct: 323 APEYSTPEIYQIMLD---------------------CWHRDPKERPRFAELVEKLGDLL 360

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 31  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 87
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 88  HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 144
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 145 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 204
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 205 YAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVV--EHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           ++AVK  S R     + W  E  +   V   H N++  I    +D+    Q  L+ +Y  
Sbjct: 34  EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 90
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-EGMDFQ----IIFRDFKSSNILL 241
           + S+ D+L +R+  T+     +K+A   A GLA+LH E +  Q    I  RD KS NIL+
Sbjct: 91  HGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 147
Query: 242 DEQWNAKLSDFGLA--RLGPSDGLSHVSTAVVGTIGYAAPEYIQTG------RLTYKSDI 293
            +     ++D GLA      +D +       VGT  Y APE +             ++DI
Sbjct: 148 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 207
Query: 294 WSFGVFLYEL 303
           ++ G+  +E+
Sbjct: 208 YAMGLVFWEI 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQIS 275
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 276 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQG      E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 48  VAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 188 --RSVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 104 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 158
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 159 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 210
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 211 CVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQG      E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 48  VAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 188 --RSVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 104 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 158
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 159 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 210
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 211 CVLAELLLGQ 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 26/170 (15%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           EV VL  ++HPN++KL  Y   +D+R     L+ E      + D +  R Q     +  +
Sbjct: 71  EVAVLKQLDHPNIMKL--YEFFEDKR--NYYLVMEVYRGGELFDEIILR-QKFSEVDAAV 125
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSH 265
            I +    G  YLH+     I+ RD K  N+LL+ +      K+ DFGL+        +H
Sbjct: 126 -IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLS--------AH 173
Query: 266 VSTAV-----VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
                     +GT  Y APE ++  +   K D+WS GV LY L+ G  P 
Sbjct: 174 FEVGGKMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 43/208 (20%)
Query: 118 IRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           + S  D+  +  +AVK+LSR  + L   +    E+ +L  ++H N++ L+          
Sbjct: 44  VCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV-------- 95
Query: 176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA--------------RGLAYL 221
                   + P  S++D        TL       I +  A              RGL Y+
Sbjct: 96  --------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II RD K SN+ ++E    ++ DFGLAR    +      T  V T  Y APE 
Sbjct: 148 HSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPE- 198
Query: 282 IQTGRLTYKS--DIWSFGVFLYELITGR 307
           I    + Y    DIWS G  + EL+ G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 43/208 (20%)
Query: 118 IRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG 175
           + S  D+  +  +AVK+LSR  + L   +    E+ +L  ++H N++ L+          
Sbjct: 44  VCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV-------- 95
Query: 176 IQRLLIYEYMPNRSVQDH-----LTSRFQATLPWNTRLKIAQDA---------ARGLAYL 221
                   + P  S++D      +T+   A L    + +   D           RGL Y+
Sbjct: 96  --------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II RD K SN+ ++E    ++ DFGLAR    +      T  V T  Y APE 
Sbjct: 148 HSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPE- 198
Query: 282 IQTGRLTYKS--DIWSFGVFLYELITGR 307
           I    + Y    DIWS G  + EL+ G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 82  VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 138 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 192
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 193 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 244
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 245 CVLAELLLGQ 254

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQIS 228
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 229 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQG      E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 48  VAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA 103
Query: 188 RS--VQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 104 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 158
Query: 245 WNA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLY 301
               KL DFG A+     G  +VS   + +  Y APE I  G   Y S  D+WS G  L 
Sbjct: 159 TAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLA 214
Query: 302 ELITGR 307
           EL+ G+
Sbjct: 215 ELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 84  VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 139
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 140 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 194
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 195 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 246
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 247 CVLAELLLGQ 256

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V H N++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-SREEIEREVSILRQVLHHNVITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 14/180 (7%)
Query: 126 KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM 185
           KKI +  +  ++ G+  ++  + E+ +L  + HPN++ L+              L++++M
Sbjct: 41  KKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNIIGLLDAFGHKSNIS----LVFDFM 94
Query: 186 PNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
               ++  +        P + +  +     +GL YLH+     I+ RD K +N+LLDE  
Sbjct: 95  -ETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLEYLHQ---HWILHRDLKPNNLLLDENG 149
Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELI 304
             KL+DFGLA+   S   ++    V  T  Y APE +   R+     D+W+ G  L EL+
Sbjct: 150 VLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 86  VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 141
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 142 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 196
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 197 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 248
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 249 CVLAELLLGQ 258

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 82  VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 138 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 192
Query: 245 WNA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLY 301
               KL DFG A+     G  +VS   + +  Y APE I  G   Y S  D+WS G  L 
Sbjct: 193 TAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLA 248
Query: 302 ELITGR 307
           EL+ G+
Sbjct: 249 ELLLGQ 254

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQIS 231
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 232 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQI- 246
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 247 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V H N++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-SREEIEREVSILRQVLHHNVITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 76  VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 131
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 132 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 186
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 187 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 238
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 239 CVLAELLLGQ 248

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN 187
           +A+K++    LQ  +    E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P 
Sbjct: 127 VAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 182
Query: 188 R--SVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
               V  H  SR + TLP    +L + Q   R LAY+H    F I  RD K  N+LLD  
Sbjct: 183 TVYRVARHY-SRAKQTLPVIYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPD 237
Query: 245 WNA-KLSDFG----LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFG 297
               KL DFG    L R  P+  +S++ +       Y APE I  G   Y S  D+WS G
Sbjct: 238 TAVLKLCDFGSAKQLVRGEPN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAG 289
Query: 298 VFLYELITGR 307
             L EL+ G+
Sbjct: 290 CVLAELLLGQ 299

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R  Q  +    E  +   ++HPN+V+L     E+        L+++ +    
Sbjct: 39  INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEES----FHYLVFDLVTGGE 91
Query: 190 VQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA- 247
           + + + +R F +    +  +   Q     +AY H      I+ R+ K  N+LL  +    
Sbjct: 92  LFEDIVAREFYSEADASHCI---QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 145
Query: 248 --KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             KL+DFGLA +  +D  S       GT GY +PE ++    +   DIW+ GV LY L+ 
Sbjct: 146 AVKLADFGLA-IEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 306 GRRPL 310
           G  P 
Sbjct: 203 GYPPF 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 180 LIYEYMPNRSVQDHLTSR-----FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
           L++E M   S+  H+  R      +A++       + QD A  L +LH   +  I  RD 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALDFLH---NKGIAHRDL 137
Query: 235 KSSNILLDEQWNA---KLSDFGLARLGPSDG-LSHVST----AVVGTIGYAAPEYIQT-- 284
           K  NIL +        K+ DFGL      +G  S +ST       G+  Y APE ++   
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 285 ---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
                   + D+WS GV LY L++G  P    R  S+     W R     A +  M+ + 
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPF-VGRCGSD---CGWDRGEACPACQ-NMLFES 252
Query: 342 KLEGKYSI------KLAQKLAAVANKCLARQAKGRPKMSEVVE 378
             EGKY         ++     + +K L R AK R   ++V++
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R  Q  +    E  +   ++HPN+V+L     E+        L+++ +    
Sbjct: 38  INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEES----FHYLVFDLVTGGE 90
Query: 190 VQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA- 247
           + + + +R F +    +  +   Q     +AY H      I+ R+ K  N+LL  +    
Sbjct: 91  LFEDIVAREFYSEADASHCI---QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 144
Query: 248 --KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             KL+DFGLA +  +D  S       GT GY +PE ++    +   DIW+ GV LY L+ 
Sbjct: 145 AVKLADFGLA-IEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 201
Query: 306 GRRPL 310
           G  P 
Sbjct: 202 GYPPF 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R  Q  +    E  +   ++HPN+V+L     E+        L+++ +    
Sbjct: 39  INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEES----FHYLVFDLVTGGE 91
Query: 190 VQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA- 247
           + + + +R F +    +  +   Q     +AY H      I+ R+ K  N+LL  +    
Sbjct: 92  LFEDIVAREFYSEADASHCI---QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 145
Query: 248 --KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             KL+DFGLA +  +D  S       GT GY +PE ++    +   DIW+ GV LY L+ 
Sbjct: 146 AVKLADFGLA-IEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 306 GRRPL 310
           G  P 
Sbjct: 203 GYPPF 207

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VGT+ Y 
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQI- 226
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 227 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V H N++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-SREEIEREVSILRQVLHHNVITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V H N++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-SREEIEREVSILRQVLHHNVITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 61/139 (43%), Gaps = 25/139 (17%)
Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD 242
           EY  NR++ D + S        +   ++ +     L+Y+H      II R+ K  NI +D
Sbjct: 95  EYCENRTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRNLKPXNIFID 150
Query: 243 EQWNAKLSDFGLAR----------------LGPSDGLSHVSTAVVGTIGYAAPEYIQ-TG 285
           E  N K+ DFGLA+                 G SD L    T+ +GT  Y A E +  TG
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL----TSAIGTAXYVATEVLDGTG 206
Query: 286 RLTYKSDIWSFGVFLYELI 304
               K D +S G+  +E I
Sbjct: 207 HYNEKIDXYSLGIIFFEXI 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S +    V T  Y APE I         DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDI 208
Query: 294 WSFGVFLYELITGR 307
           WS G  + E++  +
Sbjct: 209 WSVGCIMGEMVCHK 222

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
           SRRG+   +E   EV++L  V H N++ L     +  E     +LI E +    + D L 
Sbjct: 53  SRRGV-SREEIEREVSILRQVLHHNVITL----HDVYENRTDVVLILELVSGGELFDFLA 107
Query: 196 SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI-LLDEQW---NAKLSD 251
            +   +L         +    G+ YLH     +I   D K  NI LLD+     + KL D
Sbjct: 108 QK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           FGLA     DG+   +  + GT  + APE +    L  ++D+WS GV  Y L++G  P 
Sbjct: 163 FGLAH-EIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 140
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 141 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 195
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 196 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 126
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFG----LARLG 258
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG    L R  
Sbjct: 127 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           P+  +S++ +       Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 183 PN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 38/178 (21%)
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           L++ +   +G+ Y+H     ++I RD K SNI L +    K+ DFGL     +DG     
Sbjct: 139 LELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KR 192
Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP 327
           T   GT+ Y +PE I +     + D+++ G+ L EL+                       
Sbjct: 193 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----------------------- 229
Query: 328 HLTD-----AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
           H+ D     +K FT + D    G  S    +K   +  K L+++ + RP  SE++  L
Sbjct: 230 HVCDTAFETSKFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 133
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 134 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 188
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 189 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 99/263 (37%), Gaps = 47/263 (17%)
Query: 158 HPNLVKLIGYCA----EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
           HPN+V+     +    E D    + LL+ E    + V+       +  L  +T LKI   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL---GPSDGLSHVSTAV 270
             R + ++H      II RD K  N+LL  Q   KL DFG A      P    S    A+
Sbjct: 145 TCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 271 V-------GTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK 320
           V        T  Y  PE I       +  K DIW+ G  LY L   + P +         
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--------- 254
Query: 321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK----MSEV 376
                     D  K  ++      GKYSI        V +  +    +  P+    ++EV
Sbjct: 255 ----------DGAKLRIV-----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299
Query: 377 VEVLNKIVDAAETGTPQTPLKNL 399
           V  L +I  AA    P++P+  L
Sbjct: 300 VHQLQEIA-AARNVNPKSPITEL 321

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 129
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 130 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 184
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 185 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 25/188 (13%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R    H++   E  +  +++HPN+V+L    +E+   G    L+++ +    
Sbjct: 37  INTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEE---GFH-YLVFDLVTGGE 89
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDF----QIIFRDFKSSNILLDEQW 245
           + + + +R   +           DA+  +  + E ++      I+ RD K  N+LL  + 
Sbjct: 90  LFEDIVAREYYS---------EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 246 NA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
                KL+DFGLA     D  +    A  GT GY +PE ++        D+W+ GV LY 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 303 LITGRRPL 310
           L+ G  P 
Sbjct: 199 LLVGYPPF 206

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 50/249 (20%)
Query: 149 EVNVLGVVEHPNLVKLIG------YCAEDDERGIQR------LLIYEYMPNRSVQDHLTS 196
           EV  L  ++H N+V   G      Y  E   +   R       +  E+    +++  +  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
           R    L     L++ +   +G+ Y+H     ++I RD K SNI L +    K+ DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK 316
              +DG    S    GT+ Y +PE I +     + D+++ G+ L EL+            
Sbjct: 171 SLKNDGKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL------------ 215
Query: 317 SEQKLLEWVRPHLTD-----AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
                      H+ D     +K FT + D    G  S    +K   +  K L+++ + RP
Sbjct: 216 -----------HVCDTAFETSKFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRP 260
Query: 372 KMSEVVEVL 380
             SE++  L
Sbjct: 261 NTSEILRTL 269

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 133
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 134 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 188
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 189 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPNR--SVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 134
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFG----LARLG 258
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG    L R  
Sbjct: 135 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           P+  +S++ +       Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 191 PN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 131 AVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRS 189
           A+KQ+   G+        E+ +L  ++HPN++ L        +R +  L  Y E+     
Sbjct: 52  ALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHI 109
Query: 190 VQDHLTSRFQ---ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----D 242
           ++ H  S+       LP      +      G+ YLH      ++ RD K +NIL+     
Sbjct: 110 IKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166
Query: 243 EQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS-DIWSFGVF 299
           E+   K++D G ARL   P   L+ +   VV T  Y APE +   R   K+ DIW+ G  
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCI 225
Query: 300 LYELIT 305
             EL+T
Sbjct: 226 FAELLT 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 122 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 176
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 177 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R    H++   E  +  +++HPN+V+L    +E+        LI++ +    
Sbjct: 44  INTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEEG----HHYLIFDLVTGGE 96
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM----DFQIIFRDFKSSNILLDEQW 245
           + + + +R   +           DA+  +  + E +       ++ R+ K  N+LL  + 
Sbjct: 97  LFEDIVAREYYS---------EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL 147
Query: 246 NA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
                KL+DFGLA     +G         GT GY +PE ++        D+W+ GV LY 
Sbjct: 148 KGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 205
Query: 303 LITGRRPL-DRNRPKSEQKL 321
           L+ G  P  D ++ +  Q++
Sbjct: 206 LLVGYPPFWDEDQHRLYQQI 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 194 LTSRFQATLP------WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA 247
           L S+F   +P      +   + +A D+   L Y+H         RD K  NILLD   + 
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH---------RDIKPDNILLDRCGHI 201
Query: 248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY-------KSDIWSFGVFL 300
           +L+DFG      +DG    S   VGT  Y +PE +Q             + D W+ GVF 
Sbjct: 202 RLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 301 YELITGRRPL 310
           YE+  G+ P 
Sbjct: 261 YEMFYGQTPF 270

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 122
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 123 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 177
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 178 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 122 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 176
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 177 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 122 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 176
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 177 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFG----LARLG 258
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG    L R  
Sbjct: 122 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
           P+  +S++ +       Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 178 PN--VSYICSRY-----YRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 149 EVNVLGVVEHPNLVKL--IGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLP- 203
           E+ ++  ++H N+V+L    Y + + +  +   L+ +Y+P     V  H  SR + TLP 
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 125
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDG 262
              +L + Q   R LAY+H    F I  RD K  N+LLD      KL DFG A+     G
Sbjct: 126 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 180
Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGR 307
             +VS   + +  Y APE I  G   Y S  D+WS G  L EL+ G+
Sbjct: 181 EPNVSX--ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VG + Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQIS 275
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 276 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL------------GPSDGL 263
           R +  LH      +I RD K SN+L++   + K+ DFGLAR+            G   G+
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 264 SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
               T  V T  Y APE + T  + +   D+WS G  L EL   RRP+   R    Q LL
Sbjct: 180 ----TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 117 VIRSTEDSHKKIDIAVKQLSRRGL-QGH-KEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
           ++ +  D+  + ++A+K+LSR    Q H K    E+ ++  V H N++ L+  +  +   
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
              Q +    Y+    +  +L    Q  L       +      G+ +LH      II RD
Sbjct: 99  EEFQDV----YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRD 151
Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDI 293
            K SNI++      K+ DFGLAR   + G S +    V T  Y APE I         D+
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDL 208
Query: 294 WSFGVFLYELITGR 307
           WS G  + E++  +
Sbjct: 209 WSVGCIMGEMVCHK 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL------------GPSDGL 263
           R +  LH      +I RD K SN+L++   + K+ DFGLAR+            G   G+
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 264 SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
               T  V T  Y APE + T  + +   D+WS G  L EL   RRP+   R    Q LL
Sbjct: 180 ----TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L  +H      I+  D K +N L+ +    KL DFG+A     D    V  + VGT+ Y 
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 278 APEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            PE I+             +++ KSD+WS G  LY +  G+ P         Q+++  + 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQI- 246
Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV 377
                  K   I+DP  E ++     + L  V   CL R  K R  + E++
Sbjct: 247 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 25/188 (13%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRS 189
           I  K+LS R    H++   E  +  +++HPN+V+L    +E+   G    L+++ +    
Sbjct: 37  INTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEE---GFH-YLVFDLVTGGE 89
Query: 190 VQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDF----QIIFRDFKSSNILLDEQW 245
           + + + +R   +           DA+  +  + E ++      I+ RD K  N+LL  + 
Sbjct: 90  LFEDIVAREYYS---------EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 246 NA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
                KL+DFGLA     D  +    A  GT GY +PE ++        D+W+ GV LY 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 303 LITGRRPL 310
           L+ G  P 
Sbjct: 199 LLVGYPPF 206

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 220 YLH-EGMDFQIIFRDFKSSNIL-LDEQWNA---KLSDFGLAR-LGPSDGLSHVSTAVVGT 273
           YLH +G    ++ RD K SNIL +DE  N    ++ DFG A+ L   +GL         T
Sbjct: 131 YLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY---T 183
Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
             + APE ++        DIWS GV LY ++TG  P       + +++L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD--HLTSRFQATLP 203
           + E+++L  ++H N+VKL      D     +RL L++E++     QD   L    +  L 
Sbjct: 48  IREISILKELKHSNIVKLY-----DVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLE 98
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSD 261
             T          G+AY H   D +++ RD K  N+L++ +   K++DFGLAR  G P  
Sbjct: 99  SVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
             +H     V T+ Y AP+ +  G   Y +  DIWS G    E++ G
Sbjct: 156 KYTH----EVVTLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD--HLTSRFQATLP 203
           + E+++L  ++H N+VKL      D     +RL L++E++     QD   L    +  L 
Sbjct: 48  IREISILKELKHSNIVKLY-----DVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLE 98
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSD 261
             T          G+AY H   D +++ RD K  N+L++ +   K++DFGLAR  G P  
Sbjct: 99  SVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
             +H     V T+ Y AP+ +  G   Y +  DIWS G    E++ G
Sbjct: 156 KYTH----EVVTLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GL Y+H      ++ RD K  N+ ++E    K+ DFGLAR   ++      T  V T  
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 188
Query: 276 YAAPEYIQT-GRLTYKSDIWSFGVFLYELITGR 307
           Y APE I +        DIWS G  + E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GL Y+H      ++ RD K  N+ ++E    K+ DFGLAR   ++      T  V T  
Sbjct: 155 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 206
Query: 276 YAAPEYIQT-GRLTYKSDIWSFGVFLYELITGR 307
           Y APE I +        DIWS G  + E++TG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD--HLTSRFQATLP 203
           + E+++L  ++H N+VKL      D     +RL L++E++     QD   L    +  L 
Sbjct: 48  IREISILKELKHSNIVKLY-----DVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLE 98
Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSD 261
             T          G+AY H   D +++ RD K  N+L++ +   K++DFGLAR  G P  
Sbjct: 99  SVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITG 306
             +H     + T+ Y AP+ +  G   Y +  DIWS G    E++ G
Sbjct: 156 KYTH----EIVTLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 223
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 224 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 273

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 229 IIFRDFKSSNILLDEQWNA---KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG 285
           ++ RD K  N+LL  +      KL+DFGLA     D  +    A  GT GY +PE ++  
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKE 181
Query: 286 RLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKL 321
                 DIW+ GV LY L+ G  P  D ++ K  Q++
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 218

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 217
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 173
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 171
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 172 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 177
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 178 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 227

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 178
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 179 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 228

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 180 LIYEYMPNRSVQDHLTSR-----FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
           L++E M   S+  H+  R      +A++       + QD A  L +LH   +  I  RD 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALDFLH---NKGIAHRDL 137
Query: 235 KSSNILLDEQWNA---KLSDFGLARLGPSDG-LSHVST----AVVGTIGYAAPEYIQT-- 284
           K  NIL +        K+ DF L      +G  S +ST       G+  Y APE ++   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 285 ---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
                   + D+WS GV LY L++G  P    R  S+     W R     A +  M+ + 
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPF-VGRCGSD---CGWDRGEACPACQ-NMLFES 252
Query: 342 KLEGKYSI------KLAQKLAAVANKCLARQAKGRPKMSEVVE 378
             EGKY         ++     + +K L R AK R   ++V++
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 54/120 (45%), Gaps = 21/120 (17%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL------------GPSDGL 263
           R +  LH      +I RD K SN+L++   + K+ DFGLAR+            G   G+
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 264 SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
                  V T  Y APE + T  + +   D+WS G  L EL   RRP+   R    Q LL
Sbjct: 180 ----VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 172
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 173 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 179
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 180 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 173
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 220 YLHEGMDFQIIFRDFKSSNIL-LDEQWNA---KLSDFGLAR-LGPSDGLSHVSTAVVGTI 274
           YLH      ++ RD K SNIL +DE  N    ++ DFG A+ L   +GL         T 
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY---TA 184
Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
            + APE ++        DIWS GV LY  +TG  P       + +++L
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 187
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 188 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 237

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 171
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D+WS GV +Y L+ G  P   N 
Sbjct: 172 NSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 32/191 (16%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT-----SRFQATLPWNTRLKIA 211
           +HPN++ L      DD  G    L+ E M    + D +      S  +A+   +T     
Sbjct: 79  QHPNIITLKD--VYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT----- 129
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNIL-LDEQWNA---KLSDFGLAR-LGPSDGLSHV 266
               + + YLH      ++ RD K SNIL +DE  N    ++ DFG A+ L   +GL   
Sbjct: 130 --IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                 T  + APE ++        DIWS G+ LY ++ G  P       + +++L  + 
Sbjct: 185 PCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI- 240
Query: 327 PHLTDAKKFTM 337
                + KFT+
Sbjct: 241 ----GSGKFTL 247

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 32/191 (16%)
Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT-----SRFQATLPWNTRLKIA 211
           +HPN++ L      DD  G    L+ E M    + D +      S  +A+   +T     
Sbjct: 79  QHPNIITLKD--VYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT----- 129
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNIL-LDEQWNA---KLSDFGLAR-LGPSDGLSHV 266
               + + YLH      ++ RD K SNIL +DE  N    ++ DFG A+ L   +GL   
Sbjct: 130 --IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                 T  + APE ++        DIWS G+ LY ++ G  P       + +++L  + 
Sbjct: 185 PCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI- 240
Query: 327 PHLTDAKKFTM 337
                + KFT+
Sbjct: 241 ----GSGKFTL 247

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-HVSTAVVGTI 274
           +GL + H      ++ RD K  N+L++     KL+DFGLAR   + G+     +A V T+
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLAR---AFGIPVRCYSAEVVTL 165
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPL 310
            Y  P+ +   +L   S D+WS G    EL    RPL
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFGLARL 257
           Q  LP +  L     A  GL YLH     +I+  D K+ N+LL     +A L DFG A  
Sbjct: 179 QGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVC 235
Query: 258 GPSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
              DGL         + GT  + APE +       K D+WS    +  ++ G  P
Sbjct: 236 LQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFGLARL 257
           Q  LP +  L     A  GL YLH     +I+  D K+ N+LL     +A L DFG A  
Sbjct: 160 QGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVC 216
Query: 258 GPSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
              DGL         + GT  + APE +       K D+WS    +  ++ G  P
Sbjct: 217 LQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 18/188 (9%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +I  A K++ +  ++    +  E+ ++  ++HPN+++L  Y   +D   I   L+ E   
Sbjct: 51  RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YETFEDNTDI--YLVMELCT 106
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DE 243
              + + +  +       +   +I +D    +AY H+     +  RD K  N L      
Sbjct: 107 GGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSP 161
Query: 244 QWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
               KL DFGL AR  P   +       VGT  Y +P+ ++ G    + D WS GV +Y 
Sbjct: 162 DSPLKLIDFGLAARFKPGKMMR----TKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 216
Query: 303 LITGRRPL 310
           L+ G  P 
Sbjct: 217 LLCGYPPF 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 18/188 (9%)
Query: 127 KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           +I  A K++ +  ++    +  E+ ++  ++HPN+++L  Y   +D   I   L+ E   
Sbjct: 34  RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YETFEDNTDI--YLVMELCT 89
Query: 187 NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DE 243
              + + +  +       +   +I +D    +AY H+     +  RD K  N L      
Sbjct: 90  GGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSP 144
Query: 244 QWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYE 302
               KL DFGL AR  P   +       VGT  Y +P+ ++ G    + D WS GV +Y 
Sbjct: 145 DSPLKLIDFGLAARFKPGKMMR----TKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 199
Query: 303 LITGRRPL 310
           L+ G  P 
Sbjct: 200 LLCGYPPF 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 34/201 (16%)
Query: 126 KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD-----ERGIQRLL 180
           K+I +  ++L+R  +      + EV  L  +EHP +V+      E +     +    ++ 
Sbjct: 36  KRIRLPNRELAREKV------MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 181 IYEYMP---NRSVQDHLTSRFQATLPWNTR---LKIAQDAARGLAYLHEGMDFQIIFRDF 234
           +Y  M      +++D +  R   T+    R   L I    A  + +LH      ++ RD 
Sbjct: 90  LYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL 144
Query: 235 KSSNILLDEQWNAKLSDFGLAR-----------LGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
           K SNI        K+ DFGL             L P    +   T  VGT  Y +PE I 
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR-HTGQVGTKLYMSPEQIH 203
Query: 284 TGRLTYKSDIWSFGVFLYELI 304
               ++K DI+S G+ L+EL+
Sbjct: 204 GNSYSHKVDIFSLGLILFELL 224

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR 207
           E+++L +  H N++ L     E  E   + ++I+E++    + + + TS F+  L     
Sbjct: 51  EISILNIARHRNILHL----HESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREI 104
Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSDGLS 264
           +         L +LH      I   D +  NI+   + ++  K+ +FG AR L P D   
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 265 HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
            + TA      Y APE  Q   ++  +D+WS G  +Y L++G  P 
Sbjct: 162 LLFTAP----EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 48/114 (42%), Gaps = 7/114 (6%)
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGLARLG 258
             LP +  L     A  GL YLH     +I+  D K+ N+LL    + A L DFG A   
Sbjct: 161 GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 217
Query: 259 PSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             DGL         + GT  + APE +       K DIWS    +  ++ G  P
Sbjct: 218 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 48/114 (42%), Gaps = 7/114 (6%)
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGLARLG 258
             LP +  L     A  GL YLH     +I+  D K+ N+LL    + A L DFG A   
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 259 PSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             DGL         + GT  + APE +       K DIWS    +  ++ G  P
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 49/110 (44%), Gaps = 11/110 (10%)
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-DEQWNA--KLSDFGLARLGPSDGLSH 265
           +I +     + YLH      I  RD K  N+L   ++ NA  KL+DFG A+    +  SH
Sbjct: 165 EIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 217
Query: 266 VS-TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR 314
            S T    T  Y APE +   +     D WS GV  Y L+ G  P   N 
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNH 267

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 48/114 (42%), Gaps = 7/114 (6%)
Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGLARLG 258
             LP +  L     A  GL YLH     +I+  D K+ N+LL    + A L DFG A   
Sbjct: 159 GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 215
Query: 259 PSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             DGL         + GT  + APE +       K DIWS    +  ++ G  P
Sbjct: 216 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 26/194 (13%)
Query: 130 IAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLI------GYCAEDDERGIQRL---- 179
           +A+K++     Q  K  + E+ ++  ++H N+VK+       G    DD   +  L    
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 180 LIYEYMPNRSVQDHLTSRFQ--ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS 237
           ++ EYM     +  L +  +    L  + RL + Q   RGL Y+H      ++ RD K +
Sbjct: 99  IVQEYM-----ETDLANVLEQGPLLEEHARLFMYQ-LLRGLKYIHSA---NVLHRDLKPA 149
Query: 238 NILLD-EQWNAKLSDFGLAR-LGPS-DGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDI 293
           N+ ++ E    K+ DFGLAR + P      H+S  +V T  Y +P  + +    T   D+
Sbjct: 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDM 208
Query: 294 WSFGVFLYELITGR 307
           W+ G    E++TG+
Sbjct: 209 WAAGCIFAEMLTGK 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 98/248 (39%), Gaps = 61/248 (24%)
Query: 123 DSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
           D + + ++A+K+++R    L   K  + E+ +L  ++   +++L      DD      L 
Sbjct: 47  DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 181 IYEYMPNRSVQD------HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDF 234
           I   + +  ++        LT     T+ +N  L        G  ++HE     II RD 
Sbjct: 107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL--------GENFIHES---GIIHRDL 155
Query: 235 KSSNILLDEQWNAKLSDFGLARL-------------------GPSD-GLSHVSTAVVGTI 274
           K +N LL++  + K+ DFGLAR                    GP +  L    T+ V T 
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR 215
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELI----------TGRRPL-----------DR 312
            Y APE I       KS DIWS G    EL+          T R PL           DR
Sbjct: 216 WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDR 275
Query: 313 NRPKSEQK 320
           N  K  +K
Sbjct: 276 NSKKVHEK 283

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYC---AEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPW 204
           E+ +L +++H N+V LI  C   A    R    + L++++  +      L S        
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG--LLSNVLVKFTL 124
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSD 261
           +   ++ Q    GL Y+H     +I+ RD K++N+L+      KL+DFGLAR   L  + 
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
             +     VV T+ Y  PE +  G   Y    D+W  G  + E+ T R P+ +   +  Q
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYC---AEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPW 204
           E+ +L +++H N+V LI  C   A    R    + L++++  +      L S        
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTL 124
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSD 261
           +   ++ Q    GL Y+H     +I+ RD K++N+L+      KL+DFGLAR   L  + 
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
             +     VV T+ Y  PE +  G   Y    D+W  G  + E+ T R P+ +   +  Q
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS-HVSTAVVGTI 274
           +GL + H      ++ RD K  N+L++     KL++FGLAR   + G+     +A V T+
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR---AFGIPVRCYSAEVVTL 165
Query: 275 GYAAPEYIQTGRLTYKS-DIWSFGVFLYELITGRRPL 310
            Y  P+ +   +L   S D+WS G    EL    RPL
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYC---AEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPW 204
           E+ +L +++H N+V LI  C   A    R    + L++++  +      L S        
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTL 123
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSD 261
           +   ++ Q    GL Y+H     +I+ RD K++N+L+      KL+DFGLAR   L  + 
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
             +     VV T+ Y  PE +  G   Y    D+W  G  + E+ T R P+ +   +  Q
Sbjct: 181 QPNRYXNRVV-TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 237

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYC---AEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPW 204
           E+ +L +++H N+V LI  C   A    R    + L++++  +      L S        
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTL 124
Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR---LGPSD 261
           +   ++ Q    GL Y+H     +I+ RD K++N+L+      KL+DFGLAR   L  + 
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPLDRNRPKSEQ 319
             +     VV T+ Y  PE +  G   Y    D+W  G  + E+ T R P+ +   +  Q
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 10/166 (6%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +L  + H N+++L+     ++++  +  ++ EY     +Q+ L S  +   P     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQ--KMYMVMEYC-VCGMQEMLDSVPEKRFPVCQAH 112
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
                   GL YLH      I+ +D K  N+LL      K+S  G+A             
Sbjct: 113 GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 269 AVVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
              G+  +  PE I  G  T+   K DIWS GV LY + TG  P +
Sbjct: 170 TSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 55/138 (39%), Gaps = 10/138 (7%)
Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
           L+I E M    +   +  R           +I +D    + +LH      I  RD K  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPEN 139
Query: 239 ILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWS 295
           +L    ++    KL+DFG A+    + L         T  Y APE +   +     D+WS
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWS 195
Query: 296 FGVFLYELITGRRPLDRN 313
            GV +Y L+ G  P   N
Sbjct: 196 LGVIMYILLCGFPPFYSN 213

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 55/138 (39%), Gaps = 10/138 (7%)
Query: 179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
           L+I E M    +   +  R           +I +D    + +LH      I  RD K  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPEN 158
Query: 239 ILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWS 295
           +L    ++    KL+DFG A+    + L         T  Y APE +   +     D+WS
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 296 FGVFLYELITGRRPLDRN 313
            GV +Y L+ G  P   N
Sbjct: 215 LGVIMYILLCGFPPFYSN 232

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQ-RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L  V HP++V++  +    D  G     ++ EY+  +S++    S+ Q  LP    +   
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQ-KLPVAEAIAYL 188
Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
            +    L+YLH      +++ D K  NI+L E+   KL D G      S G  +      
Sbjct: 189 LEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY------ 238
Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
           GT G+ APE ++TG  T  +DI++ G  L  L
Sbjct: 239 GTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 270

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 271

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 285

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 271

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 270

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 205
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 238
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFEHD 265

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 205
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 270

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E+ +L  VEH N++K++      + +G  +L++ ++     +   +    +   P  + +
Sbjct: 79  EIAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
                +A G   L +     II RD K  NI++ E +  KL DFG A       L +   
Sbjct: 136 FRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--- 187
Query: 269 AVVGTIGYAAPEYIQTGRLTYKS---DIWSFGVFLYELITGRRPL 310
              GTI Y APE +      Y+    ++WS GV LY L+    P 
Sbjct: 188 TFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 225
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 191
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 190
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 190
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 191
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 189
Query: 288 TYKSD-IWSFGVFLYELITGRRPLD------------RNRPKSE-QKLLEWV 325
             +S  +WS G+ LY+++ G  P +            R R  SE Q L+ W 
Sbjct: 190 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 241

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 229 IIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL 287
           ++ RD K  NIL+D  +   KL DFG   L        V T   GT  Y+ PE+I+  R 
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 213
Query: 288 TYKSD-IWSFGVFLYELITGRRPLDRN 313
             +S  +WS G+ LY+++ G  P + +
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFEHD 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	441
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-173
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-160
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-147
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-88
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-56
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-45
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-38
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-30
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  485 bits (1251), Expect = e-173
 Identities = 112/321 (34%), Positives = 170/321 (52%), Gaps = 29/321 (9%)

Query: 77  LSQRQSNLRVFTFSELKTATKNFSRSLM------IGEGGFGGVYRGVIRSTEDSHKKIDI 130
           L    +    F+F ELK  T NF    +      +GEGGFG VY+G + +T        +
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-------V 57

Query: 131 AVKQLS----RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP 186
           AVK+L+        +  +++  E+ V+   +H NLV+L+G+ ++ D       L+Y YMP
Sbjct: 58  AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLVYVYMP 113

Query: 187 NRSVQDHL-TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
           N S+ D L        L W+ R KIAQ AA G+ +LHE      I RD KS+NILLDE +
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170

Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
            AK+SDFGLAR       + +++ +VGT  Y APE +  G +T KSDI+SFGV L E+IT
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229

Query: 306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR 365
           G   +D +R    Q LL+       + K     +D K+         + + +VA++CL  
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHE 286

Query: 366 QAKGRPKMSEVVEVLNKIVDA 386
           +   RP + +V ++L ++  +
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  454 bits (1171), Expect = e-160
 Identities = 119/331 (35%), Positives = 177/331 (53%), Gaps = 17/331 (5%)

Query: 62  SDFSSESSSRN-TFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRS 120
           S +S  ++S N   +               +L+ AT NF    +IG G FG VY+GV+R 
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL 180
                    +A+K+ +    QG +E+ TE+  L    HP+LV LIG+C E +    + +L
Sbjct: 63  GAK------VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EMIL 112

Query: 181 IYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
           IY+YM N +++ HL  +     ++ W  RL+I   AARGL YLH      II RD KS N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169

Query: 239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
           ILLDE +  K++DFG+++ G     +H+ST V GT+GY  PEY   GRLT KSD++SFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 299 FLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAV 358
            L+E++  R  + ++ P+    L EW      +  +   I+DP L  K   +  +K    
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDT 288

Query: 359 ANKCLARQAKGRPKMSEVVEVLNKIVDAAET 389
           A KCLA  ++ RP M +V+  L   +   E+
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  420 bits (1081), Expect = e-147
 Identities = 127/304 (41%), Positives = 181/304 (59%), Gaps = 19/304 (6%)

Query: 83  NLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRS-TEDSHKKIDIAVKQLSRRGLQ 141
            L+ F+  EL+ A+ NFS   ++G GGFG VY+G +   T        +AVK+L     Q
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-------VAVKRLKEERTQ 68

Query: 142 GHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRF 198
           G + ++ TEV ++ +  H NL++L G+C        +RLL+Y YM N SV   L      
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLVYPYMANGSVASCLRERPES 124

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
           Q  L W  R +IA  +ARGLAYLH+  D +II RD K++NILLDE++ A + DFGLA+L 
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE 318
                +HV+TAV GTIG+ APEY+ TG+ + K+D++ +GV L ELITG+R  D  R  ++
Sbjct: 185 D-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

Query: 319 QK--LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
               LL+WV+  L + KK   ++D  L+G Y  +  ++L  VA  C       RPKMSEV
Sbjct: 244 DDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 377 VEVL 380
           V +L
Sbjct: 303 VRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  271 bits (696), Expect = 1e-88
 Identities = 73/324 (22%), Positives = 121/324 (37%), Gaps = 30/324 (9%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR 137
               S+        L   +       +   G FG V++  + +         +AVK    
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-------YVAVKIFPI 57

Query: 138 RGLQGHK-EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
           +  Q  + E   EV  L  ++H N+++ IG         +   LI  +    S+ D L +
Sbjct: 58  QDKQSWQNE--YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115

Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ-------IIFRDFKSSNILLDEQWNAKL 249
                + WN    IA+  ARGLAYLHE +          I  RD KS N+LL     A +
Sbjct: 116 N---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----RLTYKSDIWSFGVFLYELI 304
           +DFGLA    +   +  +   VGT  Y APE ++           + D+++ G+ L+EL 
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 305 TGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI----LDPKLEGKY-SIKLAQKLAAVA 359
           +     D    +      E +  H +      ++      P L   +        L    
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292

Query: 360 NKCLARQAKGRPKMSEVVEVLNKI 383
            +C    A+ R     V E + ++
Sbjct: 293 EECWDHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (561), Expect = 2e-68
 Identities = 76/342 (22%), Positives = 128/342 (37%), Gaps = 43/342 (12%)

Query: 87  FTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW 146
              SE      N     +IG G +G VY+G +           +AVK  S    Q    +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-------PVAVKVFSFANRQ---NF 52

Query: 147 VTEVNV--LGVVEHPNLVKLIGYCAEDDERG-IQRLLIYEYMPNRSVQDHLTSRFQATLP 203
           + E N+  + ++EH N+ + I         G ++ LL+ EY PN S+  +L+     T  
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSD 109

Query: 204 WNTRLKIAQDAARGLAYLHEGMDF------QIIFRDFKSSNILLDEQWNAKLSDFGLAR- 256
           W +  ++A    RGLAYLH  +         I  RD  S N+L+       +SDFGL+  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 257 -----LGPSDGLSHVSTAVVGTIGYAAPEYIQ-------TGRLTYKSDIWSFGVFLYELI 304
                L       + + + VGTI Y APE ++             + D+++ G+  +E+ 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 305 TGRRPLDRNRPKSEQKL----LEWVRPHLTDAKKF--TMILDPKLEGKYSI--KLAQKLA 356
                L       E ++         P   D +         PK    +       + L 
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 357 AVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKN 398
                C  + A+ R       E + +++   E     +P  +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (522), Expect = 6e-63
 Identities = 84/304 (27%), Positives = 139/304 (45%), Gaps = 44/304 (14%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEW 146
           + +L    K       IG G FG V+R     +       D+AVK L  +        E+
Sbjct: 36  WCDLNIKEK-------IGAGSFGTVHRAEWHGS-------DVAVKILMEQDFHAERVNEF 81

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWN 205
           + EV ++  + HPN+V  +G   +     I    + EY+   S+   L  S  +  L   
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSI----VTEYLSRGSLYRLLHKSGAREQLDER 137

Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
            RL +A D A+G+ YLH   +  I+ R+ KS N+L+D+++  K+ DFGL+RL  S  LS 
Sbjct: 138 RRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS- 195

Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK--SEQKLLE 323
            S +  GT  + APE ++      KSD++SFGV L+EL T ++P     P         +
Sbjct: 196 -SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254

Query: 324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
             R  +           P+        L  ++AA+   C   +   RP  + ++++L  +
Sbjct: 255 CKRLEI-----------PR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

Query: 384 VDAA 387
           + +A
Sbjct: 297 IKSA 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  201 bits (514), Expect = 3e-62
 Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 49/302 (16%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEW 146
           F +L   TK       + E   G +++G  +         DI VK L  R       +++
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQGN-------DIVVKVLKVRDWSTRKSRDF 54

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
             E   L +  HPN++ ++G C           LI  +MP  S+ + L       +  + 
Sbjct: 55  NEECPRLRIFSHPNVLPVLGACQSPPAPHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQ 112

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +K A D ARG+A+LH  ++  I      S ++++DE   A++S   +         S  
Sbjct: 113 AVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQ 164

Query: 267 STAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS--EQKL 321
           S   +    + APE +Q          +D+WSF V L+EL+T   P           +  
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224

Query: 322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN 381
           LE +RP +         + P             ++ +   C+      RPK   +V +L 
Sbjct: 225 LEGLRPTIPPG------ISP------------HVSKLMKICMNEDPAKRPKFDMIVPILE 266

Query: 382 KI 383
           K+
Sbjct: 267 KM 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  200 bits (510), Expect = 4e-61
 Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 53/337 (15%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT 148
           + E++           +G G FG V +   R+        D+A+KQ+        K ++ 
Sbjct: 7   YKEIEVEEV-------VGRGAFGVVCKAKWRAK-------DVAIKQI--ESESERKAFIV 50

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR 207
           E+  L  V HPN+VKL G C           L+ EY    S+ + L  +           
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA 104

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGLARLGPSDGLSHV 266
           +      ++G+AYLH      +I RD K  N+LL       K+ DFG A       +   
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTH 159

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP---LDRNRPKSEQKLLE 323
            T   G+  + APE  +    + K D++S+G+ L+E+IT R+P   +     +    +  
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219

Query: 324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
             RP L            K        L + + ++  +C ++    RP M E+V+++  +
Sbjct: 220 GTRPPL-----------IK-------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

Query: 384 ---VDAAETGTPQTPLKNLSLKDDFETSKKERLKRRF 417
                 A+         +L   +D            +
Sbjct: 262 MRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFY 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (507), Expect = 1e-60
 Identities = 82/342 (23%), Positives = 130/342 (38%), Gaps = 55/342 (16%)

Query: 85  RVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK 144
           R+F  S+L            +G+G FG   +   R T        + +K+L R   +  +
Sbjct: 5   RIFRPSDLIHGEV-------LGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQR 52

Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
            ++ EV V+  +EHPN++K IG   +D     +   I EY+   +++  + S   +  PW
Sbjct: 53  TFLKEVKVMRCLEHPNVLKFIGVLYKDK----RLNFITEYIKGGTLRGIIKSM-DSQYPW 107

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
           + R+  A+D A G+AYLH      II RD  S N L+ E  N  ++DFGLARL   +   
Sbjct: 108 SQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

Query: 265 ------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDR 312
                            VVG   + APE I       K D++SFG+ L E+I        
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--- 221

Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQ----KLAAVANKCLARQAK 368
                         P        TM     + G                +  +C     +
Sbjct: 222 -------------DPDYL---PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPE 265

Query: 369 GRPKMSEVVEVLNKIVDAAETGTPQTPLKNLSLKDDFETSKK 410
            RP   ++   L  +        P  P      +  +ET ++
Sbjct: 266 KRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRR 307

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 2e-60
 Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 57/309 (18%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH----K 144
           F+EL            IG GGFG VYR             ++AVK       +      +
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFWIGD-------EVAVKAARHDPDEDISQTIE 51

Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
               E  +  +++HPN++ L G C ++    +    + E+     +   L+ +    +P 
Sbjct: 52  NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGK---RIPP 104

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE--------QWNAKLSDFGLAR 256
           +  +  A   ARG+ YLH+     II RD KSSNIL+ +            K++DFGLAR
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK 316
                       +  G   + APE I+    +  SD+WS+GV L+EL+TG  P       
Sbjct: 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

Query: 317 --SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS 374
             +    +  +   +           P           +  A +   C       RP  +
Sbjct: 221 AVAYGVAMNKLALPI-----------PS-------TCPEPFAKLMEDCWNPDPHSRPSFT 262

Query: 375 EVVEVLNKI 383
            +++ L  I
Sbjct: 263 NILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 6e-60
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 56/299 (18%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-------KEWVTEVNVLGVV 156
            IG+GGFG V++G +        K  +A+K L     +G        +E+  EV ++  +
Sbjct: 26  QIGKGGFGLVHKGRLVKD-----KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            HPN+VKL G             ++ E++P   +   L  +    + W+ +L++  D A 
Sbjct: 81  NHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIAL 133

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQW-----NAKLSDFGLARLGPSDGLSHVSTAVV 271
           G+ Y+    +  I+ RD +S NI L          AK++DFGL++        H  + ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLL 187

Query: 272 GTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV---- 325
           G   + APE I     +Y  K+D +SF + LY ++TG  P D      + K +  +    
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMIREEG 246

Query: 326 -RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            RP +           P+           +L  V   C +   K RP  S +V+ L+++
Sbjct: 247 LRPTI-----------PE-------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (500), Expect = 7e-60
 Identities = 78/305 (25%), Positives = 132/305 (43%), Gaps = 51/305 (16%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEW 146
             ++    +       IG G FG VY+G            D+AVK L+         + +
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAF 67

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNT 206
             EV VL    H N++  +GY         Q  ++ ++    S+  HL +  +       
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKK 121

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            + IA+  ARG+ YLH      II RD KS+NI L E    K+ DFGLA        SH 
Sbjct: 122 LIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178

Query: 267 STAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
              + G+I + APE I+   +   +++SD+++FG+ LYEL+TG+ P      +   +++E
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIE 236

Query: 324 WV-----RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            V      P L+  +       PK           ++  +  +CL ++   RP    ++ 
Sbjct: 237 MVGRGSLSPDLSKVRSNC----PK-----------RMKRLMAECLKKKRDERPSFPRILA 281

Query: 379 VLNKI 383
            + ++
Sbjct: 282 EIEEL 286

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  196 bits (501), Expect = 2e-59
 Identities = 68/305 (22%), Positives = 116/305 (38%), Gaps = 34/305 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV--LGVVEHPNL 161
            IG+G +G V+ G  R          +AVK            W  E  +    ++ H N+
Sbjct: 44  QIGKGRYGEVWMGKWRGE-------KVAVKVFFT---TEEASWFRETEIYQTVLMRHENI 93

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           +  I    +      Q  LI +Y  N S+ D+L S    TL   + LK+A  +  GL +L
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHL 150

Query: 222 HEGMDFQ-----IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG--LSHVSTAVVGTI 274
           H  +        I  RD KS NIL+ +     ++D GLA    SD   +       VGT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 275 GYAAPE----YIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            Y  PE     +          +D++SFG+ L+E+            + +    + V   
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-GGIVEEYQLPYHDLVPSD 269

Query: 329 LTDAKKFTMILD----PKLEGKYSIKLA-QKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +      ++      P    ++S     +++  +  +C A     R     V + L K+
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 384 VDAAE 388
            ++ +
Sbjct: 330 SESQD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  192 bits (491), Expect = 2e-58
 Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 34/300 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV--LGVVEHPNL 161
            +G+G +G V+RG  +         ++AVK  S R  +    W  E  +    ++ H N+
Sbjct: 15  CVGKGRYGEVWRGSWQGE-------NVAVKIFSSRDEK---SWFRETELYNTVMLRHENI 64

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           +  I           Q  LI  Y    S+ D+L      TL   + L+I    A GLA+L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHL 121

Query: 222 HEGMDFQ-----IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG--LSHVSTAVVGTI 274
           H  +        I  RD KS NIL+ +     ++D GLA +       L   +   VGT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 275 GYAAPE------YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            Y APE       +       + DIW+FG+ L+E+       +      +    + V   
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPND 240

Query: 329 LTDAKKFTMILDPKL-----EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +      ++   +         +S      LA +  +C  +    R     + + L KI
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (493), Expect = 3e-58
 Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 34/300 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV--LGVVEHPNL 161
            IG+G FG V+RG  R         ++AVK  S    +  + W  E  +    ++ H N+
Sbjct: 49  SIGKGRFGEVWRGKWRGE-------EVAVKIFSS---REERSWFREAEIYQTVMLRHENI 98

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           +  I    +D+    Q  L+ +Y  + S+ D+L      T+     +K+A   A GLA+L
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 155

Query: 222 HEGMDFQ-----IIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTI 274
           H  +        I  RD KS NIL+ +     ++D GLA      +D +       VGT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 275 GYAAPE----YIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
            Y APE     I         ++DI++ G+  +E+   R  +       +    + V   
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSD 274

Query: 329 LTDAKKFTMILDPKL-----EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +  +   ++ + KL         S +  + +A +  +C       R     + + L+++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (476), Expect = 4e-56
 Identities = 68/343 (19%), Positives = 126/343 (36%), Gaps = 62/343 (18%)

Query: 58  SQNASDFSSESSSRNTFAVLSQRQSNLRVFT--FSELKTATKNFSRSLMIGEGGFGGVYR 115
             N S  S+ S  R      SQ    L+ +   F +L+           IG+G FG VY 
Sbjct: 3   EMNLSLLSARSFPRKA----SQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYH 51

Query: 116 GVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLVKLIGYCAEDDE 173
           G            ++A++ +          K +  EV       H N+V  +G C     
Sbjct: 52  GRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103

Query: 174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD 233
             I    I      R++   +    +  L  N   +IAQ+  +G+ YLH      I+ +D
Sbjct: 104 LAI----ITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD 155

Query: 234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS---TAVVGTIGYAAPEYIQTGRL--- 287
            KS N+  D      ++DFGL  +                 G + + APE I+       
Sbjct: 156 LKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 288 ------TYKSDIWSFGVFLYELITGRRPLDRNRPKS-EQKLLEWVRPHLTDAKKFTMILD 340
                 +  SD+++ G   YEL     P      ++   ++   ++P             
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-----------NL 263

Query: 341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            ++       + ++++ +   C A + + RP  ++++++L K+
Sbjct: 264 SQIG------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  159 bits (405), Expect = 2e-45
 Identities = 71/294 (24%), Positives = 122/294 (41%), Gaps = 28/294 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V         D+     +AVKQL   G    +++  E+ +L  +    +VK 
Sbjct: 31  LGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G       + ++  L+ EY+P+  ++D L    +A L  +  L  +    +G+ YL   
Sbjct: 90  RGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS- 145

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
                + RD  + NIL++ + + K++DFGLA+L P D               I + APE 
Sbjct: 146 RRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWYAPES 201

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD 340
           +     + +SD+WSFGV LYEL T   +    +         E   P L+   +      
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL----- 256

Query: 341 PKLEGKYSIKLAQ------KLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE 388
             LE     +L        ++  +   C A   + RP  S +   L+ +   + 
Sbjct: 257 --LEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 6e-45
 Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 29/295 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V        +D+     +AVK+L     +  +++  E+ +L  ++H N+VK 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C     R ++  LI EY+P  S++D+L    +  +     L+      +G+ YL   
Sbjct: 108 KGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
             +  I RD  + NIL++ +   K+ DFGL ++ P D   +           I + APE 
Sbjct: 164 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--PGESPIFWYAPES 219

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD- 340
           +   + +  SD+WSFGV LYEL T          +  + +    +  +       ++ + 
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279

Query: 341 ---PKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE 388
              P+ +G     Y I           +C       RP   ++   +++I D   
Sbjct: 280 GRLPRPDGCPDEIYMIMT---------ECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (400), Expect = 7e-45
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 31/299 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG V       T D      +AVK L +  G Q    W  E+++L  + H +++K
Sbjct: 39  LGEGHFGKVSLYCYDPTNDG-TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G C +     +Q  L+ EY+P  S++D+L      ++     L  AQ    G+AYLH 
Sbjct: 98  YKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA 152

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPE 280
              +  I RD  + N+LLD     K+ DFGLA+  P                 + + APE
Sbjct: 153 -QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAPE 207

Query: 281 YIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            ++  +  Y SD+WSFGV LYEL+T             E   +   +  +    +     
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL---- 263

Query: 340 DPKLEGKYSIKLAQ------KLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTP 392
              LE     +L +      ++  +   C   +A  RP    ++ +L  + +  +   P
Sbjct: 264 ---LERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  157 bits (398), Expect = 7e-45
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 29/295 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V        +D+     +AVK+L     +  +++  E+ +L  ++H N+VK 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C     R ++  LI EY+P  S++D+L    +  +     L+      +G+ YL   
Sbjct: 77  KGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
             +  I RD  + NIL++ +   K+ DFGL ++ P D               I + APE 
Sbjct: 133 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKVKEPGESPIFWYAPES 188

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD- 340
           +   + +  SD+WSFGV LYEL T          +  + +    +  +       ++ + 
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248

Query: 341 ---PKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE 388
              P+ +G     Y I           +C       RP   ++   +++I D   
Sbjct: 249 GRLPRPDGCPDEIYMIMT---------ECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  157 bits (398), Expect = 1e-44
 Identities = 66/332 (19%), Positives = 117/332 (35%), Gaps = 45/332 (13%)

Query: 68  SSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK 127
            SS +     S R++    F    +    K++     +GEGGF  V   ++    D H  
Sbjct: 2   GSSHHHHHHSSGRENLY--FQGHMVIIDNKHYLFIQKLGEGGFSYVD--LVEGLHDGHF- 56

Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPN 187
              A+K++     Q  +E   E ++  +  HPN+++L+ YC  +     +  L+  +   
Sbjct: 57  --YALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114

Query: 188 RSVQDHLTSRFQATLPWNTR--LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
            ++ + +               L +     RGL  +H         RD K +NILL ++ 
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEG 171

Query: 246 NAKLSDFGLARLGPSDGLSHVS-------TAVVGTIGYAAPEYIQTGR---LTYKSDIWS 295
              L D G                      A   TI Y APE         +  ++D+WS
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231

Query: 296 FGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSI----KL 351
            G  LY ++ G  P D    K +   L                    ++ + SI    + 
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVAL-------------------AVQNQLSIPQSPRH 272

Query: 352 AQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           +  L  + N  +      RP +  ++  L  +
Sbjct: 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (394), Expect = 4e-44
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 33/293 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG V         D+     +AVK L    G     +   E+ +L  + H N+VK
Sbjct: 29  LGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G C ED   GI+  LI E++P+ S++++L    +  +    +LK A    +G+ YL  
Sbjct: 88  YKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS 144

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPE 280
              +  + RD  + N+L++ +   K+ DFGL +   +D      T        + + APE
Sbjct: 145 -RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDRDSPVFWYAPE 199

Query: 281 YIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
            +   +    SD+WSFGV L+EL+T        +      K++      +T  +    + 
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 340 D----PKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
           +    P         Y +           KC   Q   R     ++E    ++
Sbjct: 258 EGKRLPCPPNCPDEVYQLMR---------KCWEFQPSNRTSFQNLIEGFEALL 301

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (389), Expect = 3e-43
 Identities = 67/233 (28%), Positives = 113/233 (48%), Gaps = 23/233 (9%)

Query: 81  QSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRG 139
           Q+ LR+   +E K           +G G FG VY+G+    E    KI +A+K+L     
Sbjct: 6   QALLRILKETEFKKIKV-------LGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATS 57

Query: 140 LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ 199
            + +KE + E  V+  V++P++ +L+G C           LI + MP   + D++    +
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREH-K 111

Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP 259
             +     L      A+G+ YL E      + RD  + N+L+    + K++DFGLA+L  
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 260 SDGLSHVSTAVVGT--IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           ++       A  G   I + A E I     T++SD+WS+GV ++EL+T G +P
Sbjct: 169 AE--EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  149 bits (378), Expect = 3e-42
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G FG V+ G          K  +A+K + R G    ++++ E  V+  + HP LV+L
Sbjct: 16  IGSGQFGLVHLGYWL------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C E         L+ E+M +  + D+L ++ +      T L +  D   G+AYL E 
Sbjct: 69  YGVCLEQAPI----CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL-EE 122

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
                I RD  + N L+ E    K+SDFG+ R    D      T+  GT   + +A+PE 
Sbjct: 123 ACV--IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEV 176

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
               R + KSD+WSFGV ++E+ + G+ P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  149 bits (378), Expect = 4e-42
 Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 21/211 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLV 162
           +G G FG V +GV R      K+ID+A+K L ++G +    +E + E  ++  +++P +V
Sbjct: 18  LGCGNFGSVRQGVYRM---RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +LIG C  +       +L+ E      +   L  + +  +P +   ++    + G+ YL 
Sbjct: 74  RLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL- 126

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
           E  +F  + RD  + N+LL  +  AK+SDFGL++   +D      TA       + + AP
Sbjct: 127 EEKNF--VHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAP 182

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   + + +SD+WS+GV ++E ++ G++P
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (382), Expect = 1e-41
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           IG G FG V+ G +R+         +AVK            +++ E  +L    HPN+V+
Sbjct: 122 IGRGNFGEVFSGRLRA-----DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           LIG C +         ++ E +        L +   A L   T L++  DAA G+ YL  
Sbjct: 177 LIGVCTQKQPI----YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES 231

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT----IGYAAP 279
                 I RD  + N L+ E+   K+SDFG++R         V  A  G     + + AP
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAP 284

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E +  GR + +SD+WSFG+ L+E  + G  P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASP 315

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  152 bits (385), Expect = 2e-41
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+           K   +AVK + + G    + ++ E NV+  ++H  LVKL
Sbjct: 196 LGAGQFGEVWMATYN------KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                ++        +I E+M   S+ D L S   +  P    +  +   A G+A++ E 
Sbjct: 249 HAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQ 302

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            ++  I RD +++NIL+      K++DFGLAR+   +      TA  G    I + APE 
Sbjct: 303 RNY--IHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKWTAPEA 356

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           I  G  T KSD+WSFG+ L E++T GR P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  147 bits (373), Expect = 2e-41
 Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G             +AVK L ++G      ++ E N++  ++H  LV+L
Sbjct: 21  LGAGQFGEVWMGYYN------GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                ++        +I EYM N S+ D L +     L  N  L +A   A G+A++ E 
Sbjct: 74  YAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EE 127

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            ++  I RD +++NIL+ +  + K++DFGLARL   +      TA  G    I + APE 
Sbjct: 128 RNY--IHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEA 181

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           I  G  T KSD+WSFG+ L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  147 bits (374), Expect = 2e-41
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY GV +        + +AVK L +      +E++ E  V+  ++HPNLV+L
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G C  +        +I E+M   ++ D+L    +  +     L +A   +  + YL E 
Sbjct: 75  LGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EK 129

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            +F  I RD  + N L+ E    K++DFGL+RL   D      TA  G    I + APE 
Sbjct: 130 KNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPES 183

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +   + + KSD+W+FGV L+E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  147 bits (373), Expect = 2e-41
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V  G  R       + D+A+K + + G     E++ E  V+  + H  LV+L
Sbjct: 32  LGTGQFGVVKYGKWR------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C +         +I EYM N  + ++L    +        L++ +D    + YL E 
Sbjct: 85  YGVCTKQRPI----FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL-ES 138

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
             F  + RD  + N L+++Q   K+SDFGL+R    D      T+ VG+   + ++ PE 
Sbjct: 139 KQF--LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEV 192

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +   + + KSDIW+FGV ++E+ + G+ P
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  151 bits (383), Expect = 3e-41
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V  G  R          +AVK + +      + ++ E +V+  + H NLV+L
Sbjct: 201 IGKGEFGDVMLGDYRGN-------KVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQL 251

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G   E+        ++ EYM   S+ D+L SR ++ L  +  LK + D    + YL EG
Sbjct: 252 LGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG 307

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            +F  + RD  + N+L+ E   AK+SDFGL +          S+        + + APE 
Sbjct: 308 NNF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEA 357

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           ++  + + KSD+WSFG+ L+E+ + GR P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (371), Expect = 5e-41
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL---SRRGLQGHKEWVTEVNVLGVVEHPNL 161
           +G+G FG V RG   +   S K + +AVK L        +   +++ EVN +  ++H NL
Sbjct: 26  LGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           ++L G             ++ E  P  S+ D L    Q      T  + A   A G+ YL
Sbjct: 84  IRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYL 137

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAA 278
            E   F  I RD  + N+LL  +   K+ DFGL R  P +                 + A
Sbjct: 138 -ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCA 192

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           PE ++T   ++ SD W FGV L+E+ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 5e-41
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V  G  +       + D+AVK + + G     E+  E   +  + HP LVK 
Sbjct: 16  LGSGQFGVVKLGKWK------GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C+++        ++ EY+ N  + ++L S     L  +  L++  D   G+A+L E 
Sbjct: 69  YGVCSKEY----PIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFL-ES 122

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
             F  I RD  + N L+D     K+SDFG+ R    D       + VGT   + ++APE 
Sbjct: 123 HQF--IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEV 176

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
               + + KSD+W+FG+ ++E+ + G+ P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (372), Expect = 7e-41
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 12/207 (5%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G FG V++GV    E    KI + +K +  + G Q  +     +  +G ++H ++V+
Sbjct: 21  LGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L+G C           L+ +Y+P  S+ DH+    +  L     L      A+G+ YL E
Sbjct: 80  LLGLCPGS-----SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL-E 132

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ 283
                 + R+  + N+LL      +++DFG+A L P D    + +     I + A E I 
Sbjct: 133 EHGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 284 TGRLTYKSDIWSFGVFLYELIT-GRRP 309
            G+ T++SD+WS+GV ++EL+T G  P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (370), Expect = 8e-41
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNL 161
           +G G FG V +G  +          +AVK L +          E + E NV+  +++P +
Sbjct: 25  LGSGNFGTVKKGYYQM---KKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           V++IG C  +       +L+ E      +  +L  +    +     +++    + G+ YL
Sbjct: 81  VRMIGICEAE-----SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 133

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAA 278
            E  +F  + RD  + N+LL  Q  AK+SDFGL++   +D   +   A       + + A
Sbjct: 134 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYA 188

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           PE I   + + KSD+WSFGV ++E  + G++P
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (379), Expect = 9e-41
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V+ G             +A+K L + G    + ++ E  V+  + H  LV+L
Sbjct: 192 LGQGCFGEVWMGTWN------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ EYM   S+ D L       L     + +A   A G+AY+ E 
Sbjct: 245 YAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ER 298

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
           M++  + RD +++NIL+ E    K++DFGLARL   +      TA  G    I + APE 
Sbjct: 299 MNY--VHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWTAPEA 352

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              GR T KSD+WSFG+ L EL T GR P
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (372), Expect = 1e-40
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           ++G G FG VY+G+    E    KI +A+K+L      + +KE + E  V+  V++P++ 
Sbjct: 22  VLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L+G C           LI + MP   + D++    +  +     L      A+G+ YL 
Sbjct: 81  RLLGICLTS-----TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL- 133

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           E      + RD  + N+L+    + K++DFGLA+L  ++   + +      I + A E I
Sbjct: 134 EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                T++SD+WS+GV ++EL+T G +P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  144 bits (366), Expect = 2e-40
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V  G  R          +AVK + +      + ++ E +V+  + H NLV+L
Sbjct: 29  IGKGEFGDVMLGDYRGN-------KVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQL 79

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G   E+        ++ EYM   S+ D+L SR ++ L  +  LK + D    + YL EG
Sbjct: 80  LGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG 135

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPEY 281
            +F  + RD  + N+L+ E   AK+SDFGL +          S+        + + APE 
Sbjct: 136 NNF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEA 185

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           ++  + + KSD+WSFG+ L+E+ + GR P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (377), Expect = 4e-40
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY GV +        + +AVK L +      +E++ E  V+  ++HPNLV+L
Sbjct: 228 LGGGQYGEVYEGVWK-----KYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G C  +        +I E+M   ++ D+L    +  +     L +A   +  + YL E 
Sbjct: 282 LGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EK 336

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
            +F  I R+  + N L+ E    K++DFGL+RL   D  +  + A    I + APE +  
Sbjct: 337 KNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
            + + KSD+W+FGV L+E+ T G  P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP 419

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  145 bits (368), Expect = 6e-40
 Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 41/305 (13%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSH----KKIDIAVK 133
               S + + T +    + + + R   IGEG FG       +STED      K+I+I+  
Sbjct: 5   HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILV--KSTEDGRQYVIKEINIS-- 60

Query: 134 QLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQD 192
           ++S +  +   E   EV VL  ++HPN+V+      E+       L I  +Y     +  
Sbjct: 61  RMSSKERE---ESRREVAVLANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFK 112

Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
            + ++       +  L         L ++H+    +I+ RD KS NI L +    +L DF
Sbjct: 113 RINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF 169

Query: 253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD- 311
           G+AR+  S     ++ A +GT  Y +PE  +      KSDIW+ G  LYEL T +   + 
Sbjct: 170 GIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
            +      K++            F     P +   YS      L ++ ++   R  + RP
Sbjct: 228 GSMKNLVLKIIS---------GSF-----PPVSLHYS----YDLRSLVSQLFKRNPRDRP 269

Query: 372 KMSEV 376
            ++ +
Sbjct: 270 SVNSI 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  144 bits (364), Expect = 8e-40
 Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 28/246 (11%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVN 151
            T+   +  S ++G+G    V+RG  + T         A+K  +        +  + E  
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKT-----GDLFAIKVFNNISFLRPVDVQMREFE 59

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-FQATLPWNTRLKI 210
           VL  + H N+VKL  +  E++     ++LI E+ P  S+   L        LP +  L +
Sbjct: 60  VLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLARLGPSDGLSHV 266
            +D   G+ +L E     I+ R+ K  NI+     D Q   KL+DFG AR    D     
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-- 172

Query: 267 STAVVGTIGYAAPEYIQTGRL--------TYKSDIWSFGVFLYELITGRRP-LDRNRPKS 317
             ++ GT  Y  P+  +   L            D+WS GV  Y   TG  P      P+ 
Sbjct: 173 -VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

Query: 318 EQKLLE 323
            ++++ 
Sbjct: 232 NKEVMY 237

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (376), Expect = 9e-40
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V+ G             +A+K L + G    + ++ E  V+  + H  LV+L
Sbjct: 275 LGQGCFGEVWMGTWN------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ EYM   S+ D L       L     + +A   A G+AY+ E 
Sbjct: 328 YAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ER 381

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
           M++  + RD +++NIL+ E    K++DFGLARL   +  +    A    I + APE    
Sbjct: 382 MNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 438

Query: 285 GRLTYKSDIWSFGVFLYELIT-GRRP 309
           GR T KSD+WSFG+ L EL T GR P
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVP 464

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  148 bits (375), Expect = 2e-39
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G FG V +GV R      K+ID+A+K L         +E + E  ++  +++P +V+
Sbjct: 344 LGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           LIG C  +       +L+ E      +   L  + +  +P +   ++    + G+ YL E
Sbjct: 401 LIGVCQAE-----ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL-E 453

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAPE 280
             +F  + R+  + N+LL  +  AK+SDFGL++   +D      TA       + + APE
Sbjct: 454 EKNF--VHRNLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPE 509

Query: 281 YIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            I   + + +SD+WS+GV ++E ++ G++P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (361), Expect = 3e-39
 Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 35/286 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPN 160
            IG G F  VYR       D      +A+K++    L   K     + E+++L  + HPN
Sbjct: 39  KIGRGQFSEVYRA--ACLLDGVP---VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 161 LVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARG 217
           ++K      ED+E     L I  E      +   +    + +  +P  T  K        
Sbjct: 94  VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L ++H     +++ RD K +N+ +      KL D GL R   S   +   + +VGT  Y 
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHS-LVGTPYYM 203

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM 337
           +PE I      +KSDIWS G  LYE+   + P   +   +   L +         K    
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQC 253

Query: 338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
              P     YS    ++L  + N C+    + RP ++ V +V  ++
Sbjct: 254 DYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (358), Expect = 3e-39
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 22/211 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLV 162
           +GEG FG VY GV  + +   +KI++AVK   ++   L   +++++E  ++  ++HP++V
Sbjct: 20  LGEGFFGEVYEGVYTNHKG--EKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KLIG   E+        +I E  P   +  +L    + +L   T +  +    + +AYL 
Sbjct: 77  KLIGIIEEE-----PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL- 129

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
           E ++   + RD    NIL+      KL DFGL+R    +           T   I + +P
Sbjct: 130 ESINC--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWMSP 183

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   R T  SD+W F V ++E+++ G++P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  141 bits (357), Expect = 4e-39
 Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 57/296 (19%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNV 152
            +F    +IG GGFG V++   +   D      K++    ++  R           EV  
Sbjct: 11  MDFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRVKYNNEKAER-----------EVKA 57

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRL------------LIYEYMPNRSVQDHLTSRFQA 200
           L  ++H N+V   G     D                   +  E+    +++  +  R   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
            L     L++ +   +G+ Y+H     ++I RD K SNI L +    K+ DFGL     +
Sbjct: 118 KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK 320
           DG     T   GT+ Y +PE I +     + D+++ G+ L EL+               K
Sbjct: 175 DGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSK 226

Query: 321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
                         FT + D  +   +     +K   +  K L+++ + RP  SE+
Sbjct: 227 F-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (355), Expect = 9e-39
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G F  VY+G+     D+   +++A  +L  R L     + +  E  +L  ++HPN+V
Sbjct: 34  IGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 163 KLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           +      E   +G + +++  E M + +++ +L  RF+  +         +   +GL +L
Sbjct: 89  RFYDSW-ESTVKGKKCIVLVTELMTSGTLKTYLK-RFK-VMKIKVLRSWCRQILKGLQFL 145

Query: 222 HEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           H      II RD K  NI +     + K+ D GLA L      +  + AV+GT  + APE
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPE 200

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRP 309
             +        D+++FG+ + E+ T   P
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP 228

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  141 bits (357), Expect = 1e-38
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 18/211 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G FG VY+G+++++    K++ +A+K L + G   +   +++ E  ++G   H N++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGK-KEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L G  ++        ++I EYM N ++   L  +          + + +  A G+ YL 
Sbjct: 110 RLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYL- 163

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
             M++  + RD  + NIL++     K+SDFGL+R+   D  +  +T+  G    I + AP
Sbjct: 164 ANMNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAP 219

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   + T  SD+WSFG+ ++E++T G RP
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (357), Expect = 1e-38
 Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G  G V  G +R      + + +A+K L + G   +  +++++E +++G  +HPN++
Sbjct: 57  IGSGDSGEVCYGRLRV--PGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L G            +++ EYM N S+   L +           + + +    G+ YL 
Sbjct: 114 RLEGVVTRGR----LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYL- 167

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
             + +  + RD  + N+L+D     K+SDFGL+R+   D  +  +T   G    I + AP
Sbjct: 168 SDLGY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAP 223

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I     +  SD+WSFGV ++E++  G RP
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  142 bits (360), Expect = 2e-38
 Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 28/246 (11%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVN 151
            T+   +  S ++G+G    V+RG  + T D       A+K  +        +  + E  
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDL-----FAIKVFNNISFLRPVDVQMREFE 59

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-FQATLPWNTRLKI 210
           VL  + H N+VKL  +  E++     ++LI E+ P  S+   L        LP +  L +
Sbjct: 60  VLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLARLGPSDGLSHV 266
            +D   G+ +L E     I+ R+ K  NI+     D Q   KL+DFG AR    D     
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-- 172

Query: 267 STAVVGTIGYAAPEYIQTGRLTY--------KSDIWSFGVFLYELITGRRP-LDRNRPKS 317
             ++ GT  Y  P+  +   L            D+WS GV  Y   TG  P      P+ 
Sbjct: 173 -VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

Query: 318 EQKLLE 323
            ++++ 
Sbjct: 232 NKEVMY 237

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (353), Expect = 2e-38
 Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 44/287 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP 159
            IG G +G   +  IR   D      K++D     ++    Q     V+EVN+L  ++HP
Sbjct: 13  TIGTGSYGRCQK--IRRKSDGKILVWKELDYG--SMTEAEKQ---MLVSEVNLLRELKHP 65

Query: 160 NLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAAR 216
           N+V+   Y     +R    L I  EY     +   +T  ++ +  L     L++      
Sbjct: 66  NIVR---YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 217 GLAYLHE--GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
            L   H        ++ RD K +N+ LD + N KL DFGLAR+   D  +  +   VGT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTP 180

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            Y +PE +       KSDIWS G  LYEL     P       S+++L             
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL------------- 224

Query: 335 FTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              I +    ++  +YS     +L  +  + L  +   RP + E++E
Sbjct: 225 AGKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (358), Expect = 2e-38
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 22/288 (7%)

Query: 35  RSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKT 94
           R+S +   +         G     + ++    ++ S N +   +            EL  
Sbjct: 18  RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQ 77

Query: 95  ATKNFSRSL---------MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHK 144
           A ++              +IG G FG VY G +   +   KKI  AVK L+R   +    
Sbjct: 78  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVS 135

Query: 145 EWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
           +++TE  ++    HPN++ L+G C   +      L++  YM +  +++ + +        
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNE-THNPTV 191

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
              +      A+G+ +L     F  + RD  + N +LDE++  K++DFGLAR        
Sbjct: 192 KDLIGFGLQVAKGMKFL-ASKKF--VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

Query: 265 HVSTAVVGT--IGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            V         + + A E +QT + T KSD+WSFGV L+EL+T G  P
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (354), Expect = 2e-38
 Identities = 75/353 (21%), Positives = 116/353 (32%), Gaps = 59/353 (16%)

Query: 30  KSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTF 89
            S  V     N    +   ++     F  + +    S     +      Q+        F
Sbjct: 7   HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------F 59

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWV 147
             L            +G G +G V++   RS ED       AVK+     RG +     +
Sbjct: 60  QRLS----------RLGHGSYGEVFKV--RSKEDGRL---YAVKRSMSPFRGPKDRARKL 104

Query: 148 TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWN 205
            EV     V +HP  V+L     E        L +  E     S+Q H    + A+LP  
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGG-----ILYLQTELC-GPSLQQHC-EAWGASLPEA 157

Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
                 +D    LA+LH      ++  D K +NI L  +   KL DFGL     + G   
Sbjct: 158 QVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214

Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV 325
           V     G   Y APE +Q       +D++S G+ + E+            +  Q+L    
Sbjct: 215 V---QEGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELPHGG--EGWQQL---- 264

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                        L P+     S     +L +V    L    K R     ++ 
Sbjct: 265 ---------RQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (350), Expect = 4e-38
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IGEG FG V++G+  S E+    + +A+K   +        ++++ E   +   +HP++V
Sbjct: 23  IGEGQFGDVHQGIYMSPEN--PALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KLIG   E+        +I E      ++  L  R + +L   + +  A   +  LAYL 
Sbjct: 80  KLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYL- 132

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
           E   F  + RD  + N+L+      KL DFGL+R                    I + AP
Sbjct: 133 ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAP 186

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   R T  SD+W FGV ++E++  G +P
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (350), Expect = 6e-38
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 21/214 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLV 162
           +IG G FG VY G +   +   KKI  AVK L+R   +    +++TE  ++    HPN++
Sbjct: 32  VIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            L+G C   +      L++  YM +  +++ + +           +      A+G+ YL 
Sbjct: 90  SLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL- 144

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA----- 277
               F  + RD  + N +LDE++  K++DFGLAR    D       +V    G       
Sbjct: 145 ASKKF--VHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198

Query: 278 -APEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            A E +QT + T KSD+WSFGV L+EL+T G  P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (349), Expect = 8e-38
 Identities = 58/305 (19%), Positives = 112/305 (36%), Gaps = 69/305 (22%)

Query: 105 IGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G+G F  +++GV R   D     + ++ +K L +      + +    +++  + H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
              G C   DE     +L+ E++   S+  +L    +  +    +L++A+  A  + +L 
Sbjct: 76  LNYGVCVCGDE----NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFL- 129

Query: 223 EGMDFQIIFRDFKSSNILLDEQWN--------AKLSDFGLARLGPSDGLSHVSTAVVGTI 274
           E      I  +  + NILL  + +         KLSD G++              V+   
Sbjct: 130 EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175

Query: 275 GY------AAPEYIQTGRL-TYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVR 326
                     PE I+  +     +D WSFG  L+E+ + G +PL                
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL---------------- 219

Query: 327 PHLTDAKKFTMILD----PKLEGK--YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
             L   +K     D    P  +     ++            C+  +   RP    ++  L
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAAELANLIN---------NCMDYEPDHRPSFRAIIRDL 270

Query: 381 NKIVD 385
           N +  
Sbjct: 271 NSLFT 275

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (349), Expect = 9e-38
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 13/210 (6%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLV 162
           +IG+G FG VY G          +I  A+K LSR   +Q  + ++ E  ++  + HPN++
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQ--NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            LIG     +       ++  YM +  +   + S  Q        +      ARG+ YL 
Sbjct: 86  ALIGIMLPPEGL---PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYL- 140

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT--IGYAAPE 280
               F  + RD  + N +LDE +  K++DFGLAR         V         + + A E
Sbjct: 141 AEQKF--VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 281 YIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            +QT R T KSD+WSFGV L+EL+T G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (350), Expect = 9e-38
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLV 162
           +GEG FG V  G ++  +     + +AVK +       +  +E+++E   +    HPN++
Sbjct: 42  LGEGEFGSVMEGNLKQEDG--TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 163 KLIGYCAEDDERGIQRLL-IYEYMPNRSVQDHLTSR----FQATLPWNTRLKIAQDAARG 217
           +L+G C E   +GI + + I  +M    +  +L           +P  T LK   D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG-- 275
           + YL    +F  + RD  + N +L +     ++DFGL++      +        G I   
Sbjct: 160 MEYL-SNRNF--LHRDLAARNCMLRDDMTVCVADFGLSKK-----IYSGDYYRQGRIAKM 211

Query: 276 ---YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              + A E +     T KSD+W+FGV ++E+ T G  P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (351), Expect = 1e-37
 Identities = 71/315 (22%), Positives = 119/315 (37%), Gaps = 45/315 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNLV 162
           ++ EGGF  VY    +      +    A+K+L     + ++  + EV  +  +  HPN+V
Sbjct: 35  VLAEGGFAFVYEA--QDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 163 KLIGYCA---EDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTRLKIAQDAARGL 218
           +     +   E+ + G    L+   +    + + L     +  L  +T LKI     R +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTAVV---- 271
            ++H      II RD K  N+LL  Q   KL DFG A      P    S    A+V    
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 272 ---GTIGYAAPEYIQTGR---LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV 325
               T  Y  PE I       +  K DIW+ G  LY L   + P +     ++ +++   
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN-- 263

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD 385
                   K+++                 +       L    + R  ++EVV  L +I  
Sbjct: 264 -------GKYSIPPHD----TQYTVFHSLIR----AMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 386 AAETGTPQTPLKNLS 400
           A     P++P+  L 
Sbjct: 309 ARNV-NPKSPITELL 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (348), Expect = 3e-37
 Identities = 64/284 (22%), Positives = 102/284 (35%), Gaps = 35/284 (12%)

Query: 31  SISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFS 90
           S SV S  +++  S      K+ S  +++          +         +  +       
Sbjct: 2   SGSVSSGQAHSLASL----AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD------Y 51

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV 150
           E +      +    +G G FG V+R   + T         AVK++    L+  +    E+
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ-----CAVKKVR---LEVFRV--EEL 101

Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRLK 209
                +  P +V L G   E        + I+ E +   S+   +       LP +  L 
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQM--GCLPEDRALY 154

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDFGLARLGPSDGLSHVST 268
               A  GL YLH     +I+  D K+ N+LL      A L DFG A     DGL     
Sbjct: 155 YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211

Query: 269 A---VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
               + GT  + APE +       K DIWS    +  ++ G  P
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (350), Expect = 3e-37
 Identities = 62/211 (29%), Positives = 109/211 (51%), Gaps = 19/211 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLV 162
           +G G FG V  G ++    S K+I +A+K L + G   +  ++++ E +++G  +HPN++
Sbjct: 53  VGAGEFGEVCSGRLKLP--SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L G   +        +++ EYM N S+   L     A       + + +  A G+ YL 
Sbjct: 110 RLEGVVTKSKPV----MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYL- 163

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT---IGYAAP 279
             M +  + RD  + NIL++     K+SDFGL R+   D  +  +T   G    I + +P
Sbjct: 164 SDMGY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIPIRWTSP 219

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           E I   + T  SD+WS+G+ L+E+++ G RP
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (345), Expect = 5e-37
 Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 47/303 (15%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEW 146
           F  +    + +S    IG GG   V++ +     +  K+I  A+K ++           +
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVL-----NEKKQI-YAIKYVNLEEADNQTLDSY 73

Query: 147 VTEVNVLGVVEHPNL--VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPW 204
             E+  L  ++  +   ++L  Y  E  ++ I   ++ E   N  +   L  +   ++  
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDY--EITDQYI--YMVMECG-NIDLNSWLKKK--KSIDP 126

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
             R    ++    +  +H      I+  D K +N L+ +    KL DFG+A     D  S
Sbjct: 127 WERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 182

Query: 265 HVSTAVVGTIGYAAPEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
            V  + VGT+ Y  PE I+             +++ KSD+WS G  LY +  G+ P    
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-Q 241

Query: 314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM 373
                 KL                I+DP  E ++     + L  V   CL R  K R  +
Sbjct: 242 IINQISKLHA--------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

Query: 374 SEV 376
            E+
Sbjct: 288 PEL 290

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (345), Expect = 7e-37
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNL 161
           +G+G FG V    ++  + S   + +AVK L +  +    +    + E   +   +HP++
Sbjct: 31  LGKGEFGSVREAQLKQEDGS--FVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 162 VKLIGYCAEDDERGIQR--LLIYEYMPNRSVQDHL----TSRFQATLPWNTRLKIAQDAA 215
            KL+G       +G     ++I  +M +  +   L           LP  T ++   D A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            G+ YL    +F  I RD  + N +L E     ++DFGL+R      +        G   
Sbjct: 148 CGMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLSRK-----IYSGDYYRQGCAS 199

Query: 276 -----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                + A E +     T  SD+W+FGV ++E++T G+ P
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  141 bits (357), Expect = 1e-36
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 23/230 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLV 162
            +G GGFG V R + + T        +A+KQ  +     ++E W  E+ ++  + HPN+V
Sbjct: 21  RLGTGGFGYVLRWIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 163 KLIGYCAEDDERGIQR----LLIYEYMPNRSVQDHLTSR-FQATLPWNTRLKIAQDAARG 217
                   D  + +      LL  EY     ++ +L        L       +  D +  
Sbjct: 76  SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
           L YLHE     II RD K  NI+L    ++   K+ D G A+      L       VGT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTL 187

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
            Y APE ++  + T   D WSFG   +E ITG RP L   +P      + 
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (339), Expect = 2e-36
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V+     +   +  K+ +AVK L    L   K++  E  +L  ++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRLKI 210
            G C + D      ++++EYM +  +   L +                +  L  +  L I
Sbjct: 83  YGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           A   A G+ YL     F  + RD  + N L+      K+ DFG++R   S     V    
Sbjct: 139 ASQIASGMVYL-ASQHF--VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           +  I +  PE I   + T +SD+WSFGV L+E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (341), Expect = 3e-36
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 21/219 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +GEG FG V+     +      K+ +AVK L        +++  E  +L +++H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR-------------LKIA 211
            G C E        L+++EYM +  +   L S                        L +A
Sbjct: 109 FGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
              A G+ YL  G+ F  + RD  + N L+ +    K+ DFG++R   S     V    +
Sbjct: 165 SQVAAGMVYL-AGLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             I +  PE I   + T +SD+WSFGV L+E+ T G++P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (338), Expect = 3e-36
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           ++G+G +G VY G   S +       IA+K++  R  +  +    E+ +   ++H N+V+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVR-----IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 164 LIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLTSRFQATLPWNTRL--KIAQDAARGLAY 220
            +G  +E+       + I+ E +P  S+   L S++   L  N +      +    GL Y
Sbjct: 84  YLGSFSENG-----FIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKY 137

Query: 221 LHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           LH+    QI+ RD K  N+L++      K+SDFG ++     G++  +    GT+ Y AP
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 192

Query: 280 EYIQTGRLTY--KSDIWSFGVFLYELITGRRP 309
           E I  G   Y   +DIWS G  + E+ TG+ P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  135 bits (342), Expect = 5e-36
 Identities = 71/357 (19%), Positives = 133/357 (37%), Gaps = 59/357 (16%)

Query: 35  RSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKT 94
            SS      S  ++   +  E    ++ D  ++   + + +         R+++  +   
Sbjct: 6   HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ-- 63

Query: 95  ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNV 152
                     IG GG   V++ +     +  K+I  A+K ++      Q    +  E+  
Sbjct: 64  ----------IGSGGSSKVFQVL-----NEKKQI-YAIKYVNLEEADNQTLDSYRNEIAY 107

Query: 153 LGVVEHPNL--VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI 210
           L  ++  +   ++L  Y  E  ++ I   ++ E   N  +   L  +   ++    R   
Sbjct: 108 LNKLQQHSDKIIRLYDY--EITDQYI--YMVMEC-GNIDLNSWLKKK--KSIDPWERKSY 160

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
            ++    +  +H+     I+  D K +N L+ +    KL DFG+A     D  S V  + 
Sbjct: 161 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216

Query: 271 VGTIGYAAPEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
           VG + Y  PE I+             +++ KSD+WS G  LY +  G+ P          
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQIS 275

Query: 320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           KL                I+DP  E ++     + L  V   CL R  K R  + E+
Sbjct: 276 KLHA--------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (338), Expect = 5e-36
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 27/220 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVK 163
           +G+G FG VY GV +       +  +A+K ++    ++   E++ E +V+      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------FQATLPWNTRLKIAQDAA 215
           L+G  ++        L+I E M    ++ +L S           A    +  +++A + A
Sbjct: 93  LLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            G+AYL     F  + RD  + N ++ E +  K+ DFG+ R      +        G  G
Sbjct: 149 DGMAYL-NANKF--VHRDLAARNCMVAEDFTVKIGDFGMTRD-----IYETDYYRKGGKG 200

Query: 276 Y-----AAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                  +PE ++ G  T  SD+WSFGV L+E+ T   +P
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  133 bits (336), Expect = 7e-36
 Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 53/305 (17%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEWVTEVNV 152
            +F     +G GGFG V+    ++  D      K+I +  ++L+R  +        EV  
Sbjct: 5   TDFEPIQCLGRGGFGVVFE--AKNKVDDCNYAIKRIRLPNRELAREKVM------REVKA 56

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQ-----RLLIY---EYMPNRSVQDHLTSRFQATLP- 203
           L  +EHP +V+      E +          ++ +Y   +     +++D +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL------ 257
            +  L I    A  + +LH      ++ RD K SNI        K+ DFGL         
Sbjct: 117 RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 258 ----GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRN 313
                         T  VGT  Y +PE I     ++K DI+S G+ L+EL+    P    
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST- 229

Query: 314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM 373
             + E+         LTD +       P L  +           +    L+     RP+ 
Sbjct: 230 --QMERVRT------LTDVRNLKF---PPLFTQKY----PCEYVMVQDMLSPSPMERPEA 274

Query: 374 SEVVE 378
             ++E
Sbjct: 275 INIIE 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (336), Expect = 1e-35
 Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 47/295 (15%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLG 154
           + +S    IG GG   V++ +     +  K+I  A+K ++           +  E+  L 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL-----NEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 62

Query: 155 VVEHPNL--VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
            ++  +   ++L  Y  E  ++ I   ++ E   N  +   L  +   ++    R    +
Sbjct: 63  KLQQHSDKIIRLYDY--EITDQYI--YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWK 115

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
           +    +  +H      I+  D K +N L+ +    KL DFG+A     D  S V  + VG
Sbjct: 116 NMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 273 TIGYAAPEYIQ-----------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
           T+ Y  PE I+             +++ KSD+WS G  LY +  G+ P          KL
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL 230

Query: 322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
                           I+DP  E ++     + L  V   CL R  K R  + E+
Sbjct: 231 HA--------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  137 bits (346), Expect = 3e-35
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IGEG FG V++G+  S E+    + +A+K   +        ++++ E   +   +HP++V
Sbjct: 398 IGEGQFGDVHQGIYMSPEN--PAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KLIG   E+        +I E      ++  L  R + +L   + +  A   +  LAYL 
Sbjct: 455 KLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYL- 507

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           E   F  + RD  + N+L+      KL DFGL+R          S   +  I + APE I
Sbjct: 508 ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 564

Query: 283 QTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              R T  SD+W FGV ++E++  G +P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  132 bits (334), Expect = 3e-35
 Identities = 47/233 (20%), Positives = 84/233 (36%), Gaps = 44/233 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---------------- 148
           + +G F  +                 A+K+  +  L+  +++                  
Sbjct: 39  LNQGKFNKIILCE-------KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 149 -EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR 207
            E+ ++  +++   +   G     +   +   +IYEYM N S+       F     +   
Sbjct: 92  NELQIITDIKNEYCLTCEGII--TNYDEV--YIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 208 L------KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
           +       I +      +Y+H   +  I  RD K SNIL+D+    KLSDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
            +     +  GT  +  PE+      +Y   K DIWS G+ LY +     P  
Sbjct: 206 KI---KGS-RGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  130 bits (330), Expect = 1e-34
 Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 40/227 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLG-VVEHPNLV 162
           IGEG FG V +  I+       ++D A+K++        H+++  E+ VL  +  HPN++
Sbjct: 33  IGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR-------------L 208
            L+G C           L  EY P+ ++ D L  SR   T P                 L
Sbjct: 90  NLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
             A D ARG+ YL      Q I RD  + NIL+ E + AK++DFGL+R            
Sbjct: 146 HFAADVARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEV 194

Query: 269 AVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            V  T+G     + A E +     T  SD+WS+GV L+E+++ G  P
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  128 bits (325), Expect = 2e-34
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWV 147
           + +    ++F    ++G+G F GVYR     T      +++A+K + ++ +      + V
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHT-----GLEVAIKMIDKKAMYKAGMVQRV 58

Query: 148 T-EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLP 203
             EV +   ++HP++++L  Y  ED         +Y   E   N  +  +L +R +    
Sbjct: 59  QNEVKIHCQLKHPSILELYNY-FEDSNY------VYLVLEMCHNGEMNRYLKNRVKPFSE 111

Query: 204 WNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL 263
              R  + Q    G+ YLH      I+ RD   SN+LL    N K++DFGLA        
Sbjct: 112 NEARHFMHQ-IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            H +    GT  Y +PE         +SD+WS G   Y L+ GR P D
Sbjct: 168 KHYTLC--GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (328), Expect = 2e-34
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 27/220 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G FG VY G +    +    + +AVK L      Q   +++ E  ++    H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-----FQATLPWNTRLKIAQDAARGL 218
            IG   +       R ++ E M    ++  L          ++L     L +A+D A G 
Sbjct: 98  CIGVSLQSL----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            YL E   F  I RD  + N LL        AK+ DFG+AR      +   S    G   
Sbjct: 154 QYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCA 205

Query: 276 Y-----AAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                   PE    G  T K+D WSFGV L+E+ + G  P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (324), Expect = 3e-34
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 35/227 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLV 162
           +GE  FG VY+G +       +   +A+K L +        +E+  E  +   ++HPN+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRL 208
            L+G   +D        +I+ Y  +  + + L  R               ++ L     +
Sbjct: 76  CLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            +    A G+ YL        + +D  + N+L+ ++ N K+SD GL R      +     
Sbjct: 132 HLVAQIAAGMEYL-SSHHV--VHKDLATRNVLVYDKLNVKISDLGLFRE-----VYAADY 183

Query: 269 AVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
             +         + APE I  G+ +  SDIWS+GV L+E+ + G +P
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (323), Expect = 5e-34
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK---EWVTEVNVL 153
           + + R   +G+GGF   +      T     K   A K + +  L       +   E+++ 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADT-----KEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKI 210
             + H ++V   G+  ED++       ++   E    RS+ +    R   T P   R  +
Sbjct: 70  RSLAHQHVVGFHGF-FEDNDF------VFVVLELCRRRSLLELHKRRKALTEP-EARYYL 121

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
            Q    G  YLH      +I RD K  N+ L+E    K+ DFGLA     DG        
Sbjct: 122 RQ-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 176

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 177 -GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (326), Expect = 6e-34
 Identities = 36/304 (11%), Positives = 68/304 (22%), Gaps = 44/304 (14%)

Query: 47  RDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIG 106
           RD+ K   E       +   E ++       +    N      S L    +       + 
Sbjct: 12  RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71

Query: 107 EGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVK 163
            G    V+        +       A+K  +        E             +   +  +
Sbjct: 72  VGDRSVVFLVRDVERLED-----FALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 164 LIGYC----------------------AEDDERGIQRLLIYEYMPNRSVQ----DHLTSR 197
                                       +DD      LL+                    
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 198 FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 257
           F+          +     R  A L       ++   F   N+ +       L D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 258 GPSDGLSHVSTAVVGTIGYAAPEYIQ--TGRLTYKSDIWSFGVFLYELITGRRPLDRNRP 315
                +     A    + YA  E++   T   T+  + W  G+ +Y +     P     P
Sbjct: 244 -----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 316 KSEQ 319
             + 
Sbjct: 299 GIKG 302

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 7e-34
 Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 37/260 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWVT-EVNVLGVVEHPNL 161
           +G+G FG VY    + +     K  +A+K L +  L+       +  EV +   + HPN+
Sbjct: 17  LGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLA 219
           ++L GY    D   +   LI EY P  +V   L    +F       T   I +  A  L+
Sbjct: 72  LRLYGYFH--DATRV--YLILEYAPLGTVYRELQKLSKFD---EQRTATYITE-LANALS 123

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           Y H     ++I RD K  N+LL      K++DFG +   PS       T + GT+ Y  P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPP 176

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLL-------EWVRPHLTD 331
           E I+      K D+WS GV  YE + G+ P       ++ +++        ++V      
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE---G 233

Query: 332 AKKF-TMILDPKLEGKYSIK 350
           A+   + +L      +  ++
Sbjct: 234 ARDLISRLLKHNPSQRPMLR 253

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 1e-33
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 41/262 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVK-----QLSRRGLQGHKEWVTEVNVLGVVEHP 159
           +G+G FG VY    +       K  +A+K     QL + G++       E+ +   + HP
Sbjct: 22  LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHP 74

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARG 217
           N++++  Y    D + I   L+ E+ P   +   L    RF       +   + +  A  
Sbjct: 75  NILRMYNYFH--DRKRI--YLMLEFAPRGELYKELQKHGRFD---EQRSATFMEE-LADA 126

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L Y HE    ++I RD K  N+L+  +   K++DFG +   PS       T   GT+ Y 
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMC-GTLDYL 179

Query: 278 APEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLL-------EWVRPHL 329
            PE I+      K D+W  GV  YE + G  P    +  ++ ++++        ++    
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD-- 237

Query: 330 TDAKKF-TMILDPKLEGKYSIK 350
             +K   + +L      +  +K
Sbjct: 238 -GSKDLISKLLRYHPPQRLPLK 258

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  128 bits (324), Expect = 1e-33
 Identities = 47/324 (14%), Positives = 101/324 (31%), Gaps = 62/324 (19%)

Query: 47  RDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIG 106
            ++     + N +  S++   ++       L       RV   SEL    +   R  ++G
Sbjct: 25  EELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE--SELGERPRTLVRGTVLG 82

Query: 107 EGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-------------------------- 140
           +           + T +S       V                                  
Sbjct: 83  QEDPYAYLEATDQETGES-----FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 141 --QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYM--PNRSVQDHLTS 196
             + H  ++   +++   +   ++++     E D   + R  +Y  M    ++  + L S
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 197 --RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
                 +L  + RL++     R LA LH    + ++    +  +I+LD++    L+ F  
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252

Query: 255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----------GRLTYKSDIWSFGVFLYEL 303
                 DG   VS     + G+  PE                 +T+  D W+ G+ +Y +
Sbjct: 253 LV---RDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 304 ITGRRP-LDRNRPKSEQKLLEWVR 326
                P          + +    +
Sbjct: 307 WCADLPITKDAALGGSEWIFRSCK 330

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (319), Expect = 2e-33
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 26/224 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVL-GVVEHPNLV 162
           +G G FG V          S   + +AVK L     L   +  ++E+ VL  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR----------------FQATLPWNT 206
            L+G C          L+I EY     + + L  +                 +  L    
Sbjct: 91  NLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            L  +   A+G+A+L        I RD  + NILL      K+ DFGLAR   +D    V
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                  + + APE I     T++SD+WS+G+FL+EL + G  P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (319), Expect = 2e-33
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 23/222 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL-GVVEHPNLV 162
           +G G FG V        + +     +AVK L        H+  ++E+ +L  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRL 208
            L+G C +        ++I E+    ++  +L S+              ++  L     +
Sbjct: 95  NLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
             +   A+G+ +L        I RD  + NILL E+   K+ DFGLAR    D       
Sbjct: 152 CYSFQVAKGMEFL-ASRKC--IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                + + APE I     T +SD+WSFGV L+E+ + G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (322), Expect = 3e-33
 Identities = 61/220 (27%), Positives = 90/220 (40%), Gaps = 27/220 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR-GLQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G FG VY G +    +    + +AVK L      Q   +++ E  ++    H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-----FQATLPWNTRLKIAQDAARGL 218
            IG   +       R ++ E M    ++  L          ++L     L +A+D A G 
Sbjct: 139 CIGVSLQSL----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            YL E   F  I RD  + N LL        AK+ DFG+AR      +        G   
Sbjct: 195 QYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCA 246

Query: 276 Y-----AAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                   PE    G  T K+D WSFGV L+E+ + G  P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (318), Expect = 3e-33
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 20/210 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVLGVVEHP 159
           ++G GG G VY       ED+ ++  +A+K +    L     + T    E    G ++ P
Sbjct: 41  LVGRGGMGDVYEA-----EDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           ++V +  +   D     Q  +    +    +   L  +    L     + I +     L 
Sbjct: 95  HVVPIHDFGEIDG----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALD 148

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
             H         RD K  NIL+     A L DFG+A     + L+ +    VGT+ Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAP 204

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           E       TY++DI++    LYE +TG  P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (317), Expect = 3e-33
 Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 34/297 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVLGVVEHPN 160
           +G GG   VY       ED+   I +A+K +     +  +E +     EV+    + H N
Sbjct: 19  LGGGGMSTVYLA-----EDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           +V +I    EDD       L+ EY+   ++ +++ S     L  +T +        G+ +
Sbjct: 73  IVSMIDVDEEDD----CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKH 126

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
            H+    +I+ RD K  NIL+D     K+ DFG+A+      L+  +  V+GT+ Y +PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPE 182

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD 340
             +       +DI+S G+ LYE++ G  P +          +     H+ D+        
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV------- 229

Query: 341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVEVLNKIVDAAETGTPQTPL 396
           P +       + Q L+ V  +   +    R K + E+ + L+ ++           L
Sbjct: 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYEL 286

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (318), Expect = 5e-33
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK---EWVTEVNVL 153
           + + R   +G+GGF   +      T     K   A K + +  L       +   E+++ 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADT-----KEVFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKI 210
             + H ++V   G+  ED++       ++   E    RS+ +    R   T P   R  +
Sbjct: 96  RSLAHQHVVGFHGF-FEDNDF------VFVVLELCRRRSLLELHKRRKALTEP-EARYYL 147

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
            Q    G  YLH      +I RD K  N+ L+E    K+ DFGLA     DG        
Sbjct: 148 RQ-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 202

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
            GT  Y APE +     +++ D+WS G  +Y L+ G+ P +
Sbjct: 203 -GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 7e-33
 Identities = 36/231 (15%), Positives = 69/231 (29%), Gaps = 23/231 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           ++GEG F  VY        D+  K    +K                +  L        +K
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQAT---LPWNTRLKIAQDAARGLAY 220
                   +      +L+ E     ++ + +          +P    +  A      +  
Sbjct: 132 FYSAHLFQNGS----VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 221 LHEGMDFQIIFRDFKSSNILL-----------DEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           +H+    +II  D K  N +L           D      L D G +          + TA
Sbjct: 188 VHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 270 VVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ 319
              T G+   E + + +   Y+ D +     +Y ++ G     +N     +
Sbjct: 245 KCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  125 bits (315), Expect = 8e-33
 Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 41/234 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +GEG FG V +      +       +AVK L         ++ ++E NVL  V HP+++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR----------------------FQAT 201
           L G C++D       LLI EY    S++  L                          +  
Sbjct: 91  LYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
           L     +  A   ++G+ YL   M    + RD  + NIL+ E    K+SDFGL+R    +
Sbjct: 147 LTMGDLISFAWQISQGMQYL-AEMKL--VHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 262 GLSHVSTAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                 + V  + G     + A E +     T +SD+WSFGV L+E++T G  P
Sbjct: 204 -----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (319), Expect = 1e-32
 Identities = 38/274 (13%), Positives = 83/274 (30%), Gaps = 47/274 (17%)

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR------------ 137
           SEL    +   R  ++G+           + T +        V                 
Sbjct: 71  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQM 125

Query: 138 ----------RGLQGHKEWVTEVNVLG---VVEHPNLVKLIGYCAEDDERGIQRLLIYEY 184
                     RG++  K+    +  +    +V+ P   K+I    ++ +  +        
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 185 MPNRSVQDHLTS-----RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
               ++Q              +L  + RL++     R LA LH    + ++    +  +I
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDI 242

Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI-----QTGRLTYKSDIW 294
           +LD++    L+ F       +  +S             A   +         +T+  D W
Sbjct: 243 VLDQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301

Query: 295 SFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
           + G+ +Y +     P   +   +     EW+   
Sbjct: 302 TLGLAIYWIWCADLPNTDD---AALGGSEWIFRS 332

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (315), Expect = 1e-32
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 22/220 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL-GVVEHPNLV 162
           +G G FG V              + +AVK L S       +  ++E+ ++  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL------------TSRFQATLPWNTRLKI 210
            L+G C          L+I EY     + + L             +   +T      L  
Sbjct: 114 NLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV 270
           +   A+G+A+L    +   I RD  + N+LL     AK+ DFGLAR   +D    V    
Sbjct: 170 SSQVAQGMAFL-ASKNC--IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
              + + APE I     T +SD+WS+G+ L+E+ + G  P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (311), Expect = 2e-32
 Identities = 58/295 (19%), Positives = 104/295 (35%), Gaps = 48/295 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           ++G+G FG V +               A+K++     +     ++EV +L  + H  +V+
Sbjct: 13  VLGQGAFGQVVKARNALD-----SRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 164 LIGYCAEDDERGIQRLL------IY---EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
                 E                ++   EY  N ++ D + S        +   ++ +  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQI 125

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS------- 267
              L+Y+H      II RD K  NI +DE  N K+ DFGLA+                  
Sbjct: 126 LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 268 -----TAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
                T+ +GT  Y A E +  TG    K D++S G+  +E+I                +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-----GMERVNI 237

Query: 322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           L+ +R     +        P  +     K+ +K+       +      RP    +
Sbjct: 238 LKKLR-----SVSIE--FPPDFDDNKM-KVEKKI---IRLLIDHDPNKRPGARTL 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 4e-32
 Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 31/298 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVLGVVEHP 159
           ++G GG   V+        D     D+AVK L R  L     +      E      + HP
Sbjct: 19  ILGFGGMSEVHLA-----RDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            +V +      +   G    ++ EY+   +++D + +     +     +++  DA + L 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 130

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST-AVVGTIGYAA 278
           + H+     II RD K +NI++      K+ DFG+AR     G S   T AV+GT  Y +
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI 338
           PE  +   +  +SD++S G  LYE++TG  P   + P      +     H+ +       
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE------- 234

Query: 339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVEVLNKIVDAAETGTPQTP 395
            DP         L+  L AV  K LA+  + R +  +E+   L ++ +      P+  
Sbjct: 235 -DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (310), Expect = 7e-32
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 41/234 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           IGEG FG V++              +AVK L          ++  E  ++   ++PN+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR----------------------FQAT 201
           L+G CA          L++EYM    + + L S                           
Sbjct: 115 LLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 202 LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
           L    +L IA+  A G+AYL     F  + RD  + N L+ E    K++DFGL+R     
Sbjct: 171 LSCAEQLCIARQVAAGMAYL-SERKF--VHRDLATRNCLVGENMVVKIADFGLSR----- 222

Query: 262 GLSHVSTAVVGTIGY-----AAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            +                    PE I   R T +SD+W++GV L+E+ + G +P
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (309), Expect = 1e-31
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL-GVVEHPNLV 162
           +G G FG V          +   I +AVK L  +      +  ++E+ ++  +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL-TSRFQATLPWNTR-------------- 207
            L+G C           LI+EY     + ++L + R + +                    
Sbjct: 113 NLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 208 ------LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD 261
                 L  A   A+G+ +L        + RD  + N+L+      K+ DFGLAR   SD
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
               V       + + APE +  G  T KSD+WS+G+ L+E+ + G  P
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  122 bits (307), Expect = 2e-31
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)

Query: 105 IGEGGFGGVYRGVIR--STEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL-GVVEHPN 160
           +GEG FG V          +   + + +AVK L      +   + V+E+ ++  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNT 206
           ++ L+G C +D        +I EY    +++++L +R               +  + +  
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +      ARG+ YL        I RD  + N+L+ E    K++DFGLAR   +      
Sbjct: 159 LVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDINNID---- 211

Query: 267 STAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                 T G     + APE +     T++SD+WSFGV ++E+ T G  P
Sbjct: 212 -YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 3e-31
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 36/229 (15%)

Query: 105 IGEGGFGGVYRGVIR--STEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL-GVVEHPN 160
           +GEG FG V          +  ++   +AVK L S    +   + ++E+ ++  + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR------------- 207
           ++ L+G C +D        +I EY    +++++L +R    L ++               
Sbjct: 137 IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 208 -LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +  A   ARG+ YL        I RD  + N+L+ E    K++DFGLAR      + H+
Sbjct: 193 LVSCAYQVARGMEYL-ASKKC--IHRDLAARNVLVTEDNVMKIADFGLARD-----IHHI 244

Query: 267 STAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
                 T G     + APE +     T++SD+WSFGV L+E+ T G  P
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  120 bits (303), Expect = 4e-31
 Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 36/274 (13%)

Query: 57  NSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRG 116
           +   A       S ++       R+     F F   K           +GEG F  V   
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKF--GKI----------LGEGSFSTVVLA 49

Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGYCAEDDE 173
              +T   +     A+K L +R +    +      E +V+  ++HP  VKL  Y    D+
Sbjct: 50  RELATSREY-----AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQDD 102

Query: 174 RGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII 230
               +L     Y  N  +  ++     F  T    TR   A+     L YLH      II
Sbjct: 103 E---KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALEYLHG---KGII 152

Query: 231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK 290
            RD K  NILL+E  + +++DFG A++   +     + + VGT  Y +PE +        
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 212

Query: 291 SDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
           SD+W+ G  +Y+L+ G  P    N     QK+++
Sbjct: 213 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (307), Expect = 7e-31
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 28/222 (12%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVV 156
           +F    ++G G  G +               D+AVK++             EV +L    
Sbjct: 25  SFCPKDVLGHGAEGTIVY------RGMFDNRDVAVKRILPECFSFADR---EVQLLRESD 75

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
           EHPN+++   +C E D +     +  E     ++Q+++  +  A L       + Q    
Sbjct: 76  EHPNVIRY--FCTEKDRQFQ--YIAIELCAA-TLQEYVEQKDFAHLGLEPI-TLLQQTTS 129

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWN-----AKLSDFGLAR-LGPSDGLSHVSTAV 270
           GLA+LH      I+ RD K  NIL+          A +SDFGL + L          + V
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 271 VGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRP 309
            GT G+ APE +        TY  DI+S G   Y +I+    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 8e-31
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 21/208 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLV 162
            I  GG G +Y  + R+         + +K L   G    +   + E   L  V HP++V
Sbjct: 87  CIAHGGLGWIYLALDRNVNGR----PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 163 KLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           ++  +    D  G     ++ EY+  +S++     +    LP    +    +    L+YL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      +++ D K  NI+L E+   KL D G      S G       + GT G+ APE 
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPE- 247

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRP 309
           I     T  +DI++ G  L  L      
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (303), Expect = 1e-30
 Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 44/297 (14%)

Query: 45  TDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKN---FSR 101
           T R   +     +++++S  +S +        LS       +   SE +        F R
Sbjct: 21  TKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR 80

Query: 102 SL-----MIGEGGFGGVYRGVIR--STEDSHKKIDIAVKQL-SRRGLQGHKEWVTEVNVL 153
                   +GEG FG V          +   + + +AVK L      +   + V+E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 154 -GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------F 198
             + +H N++ L+G C +D        +I EY    +++++L +R               
Sbjct: 141 KMIGKHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 199 QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
           +  + +   +      ARG+ YL        I RD  + N+L+ E    K++DFGLAR  
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 259 PSDGLSHVSTAVVGTIG-----YAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
            +            T G     + APE +     T++SD+WSFGV ++E+ T G  P
Sbjct: 254 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  118 bits (297), Expect = 2e-30
 Identities = 60/309 (19%), Positives = 103/309 (33%), Gaps = 65/309 (21%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQ--LSRRGLQGHKEWVTEVNVL 153
           T  F     IG G FG V++ V R        I  A+K+      G    +  + EV   
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLD----GCI-YAIKRSKKPLAGSVDEQNALREVYAH 64

Query: 154 GVV-EHPNLVKLIGYCAEDDERGIQRLLIY-EYMPNRSVQDHLT--SRFQATLPWNTRLK 209
            V+ +H ++V+     AEDD      +LI  EY    S+ D ++   R  +         
Sbjct: 65  AVLGQHSHVVRYFSAWAEDD-----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-------------------QWNAKLS 250
           +     RGL Y+H      ++  D K SNI +                     +   K+ 
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGRRP 309
           D G         +S       G   + A E +Q       K+DI++  + +         
Sbjct: 177 DLGHVTR-----ISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

Query: 310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG 369
                P++  +  E  +  L           P++    S    Q+   +    +    + 
Sbjct: 231 -----PRNGDQWHEIRQGRL-----------PRIPQVLS----QEFTELLKVMIHPDPER 270

Query: 370 RPKMSEVVE 378
           RP    +V+
Sbjct: 271 RPSAMALVK 279

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 2e-30
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
            K ++R   IG+G  G VY  +  +T       ++A++Q++ +     +  + E+ V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 156 VEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK----- 209
            ++PN+V  +      DE     L ++ EY+   S+ D +T          T +      
Sbjct: 74  NKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVT---------ETCMDEGQIA 119

Query: 210 -IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVS 267
            + ++  + L +LH     Q+I RD KS NILL    + KL+DFG  A++  +   S  S
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRS 174

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           T +VGT  + APE +       K DIWS G+   E+I G  P 
Sbjct: 175 T-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (301), Expect = 3e-30
 Identities = 50/245 (20%), Positives = 85/245 (34%), Gaps = 25/245 (10%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEG--GFGGVYRGVIRSTEDSHKKIDIAVKQ- 134
                NL     S        +    +IG+G      V     + T +      + V++ 
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEY-----VTVRRI 60

Query: 135 -LSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD 192
            L     +       E++V  +  HPN+V        D+E     L ++  +M   S +D
Sbjct: 61  NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKD 115

Query: 193 HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
            + + F   +       I Q   + L Y+H       + R  K+S+IL+       LS  
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGL 172

Query: 253 G-LARLGPSDG----LSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWSFGVFLYELIT 305
                +         +       V  + + +PE +Q     Y  KSDI+S G+   EL  
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 306 GRRPL 310
           G  P 
Sbjct: 233 GHVPF 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (296), Expect = 3e-30
 Identities = 80/281 (28%), Positives = 120/281 (42%), Gaps = 43/281 (15%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLG 154
            + F++   IG+G FG V++G+   T+       +A+K +     +   E +  E+ VL 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKV-----VAIKIIDLEEAEDEIEDIQQEITVLS 75

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
             + P + K  G   +D +  I    I EY+   S  D L       L       I ++ 
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPG---PLDETQIATILREI 128

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGT 273
            +GL YLH     + I RD K++N+LL E    KL+DFG+  +L  +D     +T  VGT
Sbjct: 129 LKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNT-FVGT 182

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK 333
             + APE I+      K+DIWS G+   EL  G  P     P                 K
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----------------MK 226

Query: 334 KFTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
              +I     P LEG YS  L + +      CL ++   RP
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRP 263

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (299), Expect = 3e-30
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 20/221 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVK 163
           +G G  G V++   + +      + +A K +          + + E+ VL     P +V 
Sbjct: 41  LGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
             G    D E  I      E+M   S+   L  +    +P     K++    +GL YL E
Sbjct: 96  FYGAFYSDGEISI----CMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA-RLGPSDGLSHVSTAVVGTIGYAAPEYI 282
               +I+ RD K SNIL++ +   KL DFG++ +L  S     ++ + VGT  Y +PE +
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERL 202

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
           Q    + +SDIWS G+ L E+  GR P+     K  + +  
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (297), Expect = 4e-30
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 33/223 (14%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
                  + IGEG  G V     + +        +AVK +  R  Q  +    EV ++  
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHS-----GRQVAVKMMDLRKQQRRELLFNEVVIMRD 98

Query: 156 VEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK----- 209
            +H N+V++       +E     L ++ E++   ++ D ++           RL      
Sbjct: 99  YQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVS---------QVRLNEEQIA 144

Query: 210 -IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVS 267
            + +   + LAYLH      +I RD KS +ILL      KLSDFG  A++  S  +    
Sbjct: 145 TVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRK 199

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           + +VGT  + APE I       + DIWS G+ + E++ G  P 
Sbjct: 200 S-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (294), Expect = 6e-30
 Identities = 74/281 (26%), Positives = 113/281 (40%), Gaps = 37/281 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVK 163
           IG G    V             K  +A+K+++    Q   + +  E+  +    HPN+V 
Sbjct: 23  IGSGATAVVQAAYCAPK-----KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK------IAQDAAR 216
                   DE     L L+ + +   SV D +          +  L       I ++   
Sbjct: 78  YYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG----LARLGPSDGLSHVSTAVVG 272
           GL YLH+      I RD K+ NILL E  + +++DFG    LA  G         T  VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVG 188

Query: 273 TIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQKLLEWVRPHLT 330
           T  + APE ++  R   +K+DIWSFG+   EL TG  P  +  P K     L+   P L 
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248

Query: 331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
              +     D ++  KY     + ++     CL +  + RP
Sbjct: 249 TGVQ-----DKEMLKKYGKSFRKMIS----LCLQKDPEKRP 280

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  114 bits (289), Expect = 2e-29
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 48/225 (21%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVEHPNLVK 163
           +GEG +G V   V R TE++     +AVK +  +      E +  E+ +  ++ H N+VK
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 164 LIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR---- 216
             G+  E +         Y   EY     + D +             +   +  A+    
Sbjct: 70  FYGHRREGNI-------QYLFLEYCSGGELFDRIEPD--------IGMP--EPDAQRFFH 112

Query: 217 ----GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTA 269
               G+ YLH      I  RD K  N+LLDE+ N K+SDFGLA   R    + L +    
Sbjct: 113 QLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-- 167

Query: 270 VVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
             GT+ Y APE ++  R  +     D+WS G+ L  ++ G  P D
Sbjct: 168 -CGTLPYVAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 6e-29
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 21/242 (8%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR 137
                +L     S L+     F    ++G G +G VY+G    T         A+K +  
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKT-----GQLAAIKVMDV 59

Query: 138 RGLQGHKEWVTEVNVLG-VVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMPNRSVQDHL 194
            G    +E   E+N+L     H N+    G +  ++      +L L+ E+    SV D +
Sbjct: 60  TG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118

Query: 195 TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 254
            +    TL       I ++  RGL++LH+    ++I RD K  N+LL E    KL DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 255 -ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-----YKSDIWSFGVFLYELITGRR 308
            A+L     +   +T  +GT  + APE I           +KSD+WS G+   E+  G  
Sbjct: 176 SAQL--DRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

Query: 309 PL 310
           PL
Sbjct: 233 PL 234

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  113 bits (286), Expect = 7e-29
 Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 58/243 (23%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---------------- 148
           IG+G +G V      +  D+      A+K LS++ L     +                  
Sbjct: 21  IGKGSYGVVKLA--YNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 149 ----------EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF 198
                     E+ +L  ++HPN+VKL+    + +E  +   +++E +    V +      
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVME------ 127

Query: 199 QATLPWNTRL------KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF 252
              +P    L         QD  +G+ YLH     +II RD K SN+L+ E  + K++DF
Sbjct: 128 ---VPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 253 GLARL-GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRR 308
           G++     SD L   +   VGT  + APE +   R  +     D+W+ GV LY  + G+ 
Sbjct: 182 GVSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 309 PLD 311
           P  
Sbjct: 239 PFM 241

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  114 bits (287), Expect = 8e-29
 Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 61/266 (22%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVEHPNLVK 163
           +GEG +G V   V R TE++     +AVK +  +      E +  E+ +  ++ H N+VK
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 164 LIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR---- 216
             G+  E +         Y   EY     + D +             +   +  A+    
Sbjct: 70  FYGHRREGNI-------QYLFLEYCSGGELFDRIEPD--------IGMP--EPDAQRFFH 112

Query: 217 ----GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA---RLGPSDGLSHVSTA 269
               G+ YLH      I  RD K  N+LLDE+ N K+SDFGLA   R    + L +    
Sbjct: 113 QLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-- 167

Query: 270 VVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD---------RNRPKS 317
             GT+ Y APE ++  R  +     D+WS G+ L  ++ G  P D          +  + 
Sbjct: 168 -CGTLPYVAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224

Query: 318 EQKLLEWVRPHL-TDAKKF-TMILDP 341
           +  L  W    + +        IL  
Sbjct: 225 KTYLNPWK--KIDSAPLALLHKILVE 248

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (286), Expect = 9e-29
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 33/223 (14%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
            + F     +GEG +G VY+ + + T        +A+KQ+        +E + E++++  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQI-----VAIKQVPVE--SDLQEIIKEISIMQQ 80

Query: 156 VEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLK----- 209
            + P++VK  G   ++ +     L ++ EY    SV D +  R       N  L      
Sbjct: 81  CDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLR-------NKTLTEDEIA 128

Query: 210 -IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVS 267
            I Q   +GL YLH     + I RD K+ NILL+ + +AKL+DFG+  +L  +D ++  +
Sbjct: 129 TILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRN 183

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
           T V+GT  + APE IQ       +DIWS G+   E+  G+ P 
Sbjct: 184 T-VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 1e-28
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 47/283 (16%)

Query: 105 IGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNL 161
           +G G  G V++   R T    + K++  +  +   + +        +++V+    + P +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRIL------MDLDVVLKSHDCPYI 86

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           V+  G    + +  I      E M   +  + L  R Q  +P     K+     + L YL
Sbjct: 87  VQCFGTFITNTDVFI----AMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAPE 280
            E     +I RD K SNILLDE+   KL DFG+  RL   D  +       G   Y APE
Sbjct: 141 KE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAK--DRSAGCAAYMAPE 194

Query: 281 YIQTGRL-----TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR---PHLTDA 332
            I            ++D+WS G+ L EL TG+ P    +   E  L + ++   P L   
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQEEPPLLPGH 253

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
             F+       + +  +            CL +  + RPK ++
Sbjct: 254 MGFS------GDFQSFV----------KDCLTKDHRKRPKYNK 280

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  112 bits (282), Expect = 4e-28
 Identities = 60/271 (22%), Positives = 103/271 (38%), Gaps = 33/271 (12%)

Query: 57  NSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRG 116
           +S +    SS    R +           ++    E +     +    ++G GGFG VY G
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 117 VIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT------EVNVLGVVEH--PNLVKLIGYC 168
                 D+     +A+K + +  +    E         EV +L  V      +++L    
Sbjct: 63  --IRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL--LD 115

Query: 169 AEDDERGIQRLLIYEY-MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDF 227
             +       +LI E   P + + D +T R    L               + + H   + 
Sbjct: 116 WFERPDSF--VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NC 168

Query: 228 QIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
            ++ RD K  NIL+D  +   KL DFG   L   D +        GT  Y+ PE+I+  R
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF---DGTRVYSPPEWIRYHR 224

Query: 287 LTY---KSDIWSFGVFLYELITGRRPLDRNR 314
             Y    + +WS G+ LY+++ G  P + + 
Sbjct: 225 --YHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  112 bits (282), Expect = 5e-28
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 41/233 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH--KEWVTEVNVLGVVEHPNLV 162
           IG+G F  V       T       ++A+K + +  L     ++   EV ++ ++ HPN+V
Sbjct: 23  IGKGNFAKVKLARHILT-----GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR------ 216
           KL  +   + E+ +   LI EY     V D+L +          R+K  +  AR      
Sbjct: 78  KL--FEVIETEKTL--YLIMEYASGGEVFDYLVAH--------GRMK--EKEARSKFRQI 123

Query: 217 --GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
              + Y H+     I+ RD K+ N+LLD   N K++DFG +      G         G  
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAP 177

Query: 275 GYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD-RNRPKSEQKLLE 323
            YAAPE  Q G+  Y   + D+WS GV LY L++G  P D +N  +  +++L 
Sbjct: 178 PYAAPELFQ-GKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (280), Expect = 6e-28
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 45/227 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT----EVNVLGVVEHPN 160
           +GEG +G V       +E   +    AVK L ++ L+           E+ +L  + H N
Sbjct: 13  LGEGSYGKVKEV--LDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQ--DHLTSRFQATLPWNTRLKIAQDAAR-- 216
           +++L+     ++++ +   ++ EY      +  D +  +         R  + Q  A   
Sbjct: 68  VIQLVDVLYNEEKQKM--YMVMEYCVCGMQEMLDSVPEK---------RFPVCQ--AHGY 114

Query: 217 ------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL---GPSDGLSHVS 267
                 GL YLH      I+ +D K  N+LL      K+S  G+A       +D     S
Sbjct: 115 FCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 268 TAVVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
               G+  +  PE    G  T+   K DIWS GV LY + TG  P +
Sbjct: 172 Q---GSPAFQPPEIAN-GLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  112 bits (281), Expect = 7e-28
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 33/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---------EVNVLGV 155
           +G G FG V+  V +         ++ VK + +  +     W+          E+ +L  
Sbjct: 32  LGSGAFGFVWTAVDKEK-----NKEVVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAILSR 85

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYE-YMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
           VEH N++K+      +++   Q  L+ E +     +   +       L       I +  
Sbjct: 86  VEHANIIKV--LDIFENQGFFQ--LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQL 139

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
              + YL       II RD K  NI++ E +  KL DFG A       L +      GTI
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTI 193

Query: 275 GYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
            Y APE +  G   Y   + ++WS GV LY L+    P  
Sbjct: 194 EYCAPEVLM-GNP-YRGPELEMWSLGVTLYTLVFEENPFC 231

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (280), Expect = 9e-28
 Identities = 74/283 (26%), Positives = 115/283 (40%), Gaps = 42/283 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR-RGLQGHKEWVTEVNV-LGVVEHPNLV 162
           IG G +G V + V + +        +AVK++      +  K+ + +++V +   + P +V
Sbjct: 30  IGRGAYGSVNKMVHKPS-----GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           +  G    + +  I      E M         ++ S     +P     KI     + L +
Sbjct: 85  QFYGALFREGDCWI----CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAP 279
           L E  + +II RD K SNILLD   N KL DFG+  +L   D ++   T   G   Y AP
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAK--TRDAGCRPYMAP 194

Query: 280 EYIQTGRL----TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           E I           +SD+WS G+ LYEL TGR P  +     +Q                
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------------L 239

Query: 336 TMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
           T ++    P+L      + +       N CL +    RPK  E
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (286), Expect = 1e-27
 Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 40/274 (14%)

Query: 65  SSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDS 124
              SS R         Q+   +F  S+    ++ + R   +G G +G V     + T   
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT--- 61

Query: 125 HKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY 182
              ++ A+K + +  +    + + + EV VL +++HPN++KL  +   +D+R     L+ 
Sbjct: 62  --HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF--EDKRNYY--LVM 115

Query: 183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR-------GLAYLHEGMDFQIIFRDFK 235
           E      + D +  R +             DAA        G+ YLH+     I+ RD K
Sbjct: 116 ECYKGGELFDEIIHRMKFN---------EVDAAVIIKQVLSGVTYLHK---HNIVHRDLK 163

Query: 236 SSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSD 292
             N+LL   ++    K+ DFGL+ +  +          +GT  Y APE ++  +   K D
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCD 219

Query: 293 IWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           +WS GV L+ L+ G  P      +++Q++L  V 
Sbjct: 220 VWSIGVILFILLAGYPPFGG---QTDQEILRKVE 250

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  109 bits (276), Expect = 1e-27
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 41/221 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV---TEVNVLGVVEHPNL 161
           +G G FG V  G  + T        +AVK L+R+ ++          E+  L +  HP++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHK-----VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----- 216
           +KL  Y            ++ EY+    + D++            R++  +  AR     
Sbjct: 74  IKL--YQVISTPTDF--FMVMEYVSGGELFDYICKH--------GRVE--EMEARRLFQQ 119

Query: 217 ---GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
               + Y H      ++ RD K  N+LLD   NAK++DFGL+ +         S    G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 173

Query: 274 IGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
             YAAPE I  GRL Y   + DIWS GV LY L+ G  P D
Sbjct: 174 PNYAAPEVIS-GRL-YAGPEVDIWSCGVILYALLCGTLPFD 212

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  109 bits (275), Expect = 3e-27
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT------EVNVL---- 153
           ++G+GGFG V+ G      D  +   +A+K + R  + G            EV +L    
Sbjct: 38  LLGKGGFGTVFAG--HRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEY-MPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
               HP +++L      + + G   +L+ E  +P + + D++T +    L          
Sbjct: 93  AGGGHPGVIRL--LDWFETQEGF--MLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFG 146

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
                + + H      ++ RD K  NIL+D  +  AKL DFG   L   D          
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF---D 199

Query: 272 GTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLDRNR 314
           GT  Y+ PE+I   +  Y    + +WS G+ LY+++ G  P +R++
Sbjct: 200 GTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPFERDQ 243

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (274), Expect = 3e-27
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 30/225 (13%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNV 152
            + +     +G+G FG VY+   + T         A K +     +  +E    + E+ +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGAL-----AAAKVIE---TKSEEELEDYIVEIEI 69

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           L   +HP +VKL+G    D +     L ++ E+ P  +V   +       L       + 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVC 123

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAV 270
           +     L +LH     +II RD K+ N+L+  + + +L+DFG+ A+      L    +  
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDS-F 177

Query: 271 VGTIGYAAPEYI-----QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           +GT  + APE +     +     YK+DIWS G+ L E+     P 
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 4e-27
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 35/233 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVK 163
           +G G FG V+    RS+      ++  +K +++   Q   E +  E+ VL  ++HPN++K
Sbjct: 30  LGSGAFGDVHLVEERSS-----GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR------- 216
           +      +D   +   ++ E      + + + S        +         A        
Sbjct: 85  IFEVF--EDYHNMY--IVMETCEGGELLERIVSAQARGKALSEG-----YVAELMKQMMN 135

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
            LAY H      ++ +D K  NIL          K+ DFGLA L  SD     ST   GT
Sbjct: 136 ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGT 189

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
             Y APE  +   +T+K DIWS GV +Y L+TG  P       S +++ +   
Sbjct: 190 ALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG---TSLEEVQQKAT 238

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (279), Expect = 7e-27
 Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 41/235 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWV-TEVNVLGVVEHPNL 161
           +G+G FG V     + T       + AVK +S+R ++    KE +  EV +L  ++HPN+
Sbjct: 34  LGKGSFGEVILCKDKIT-----GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----- 216
           +KL  +   +D+      L+ E      + D + SR + +           DAAR     
Sbjct: 89  MKLYEFF--EDKGYFY--LVGEVYTGGELFDEIISRKRFS---------EVDAARIIRQV 135

Query: 217 --GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
             G+ Y+H+    +I+ RD K  N+LL    +  N ++ DFGL+    +          +
Sbjct: 136 LSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKI 189

Query: 272 GTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           GT  Y APE +  G    K D+WS GV LY L++G  P +     +E  +L+ V 
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG---ANEYDILKKVE 240

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (280), Expect = 9e-27
 Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 40/293 (13%)

Query: 87  FTFSELKTATKN-FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE 145
           + + E +   ++ F    ++G GGFG V+   +++T     K+  A K+L+++ L+  K 
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT----GKL-YACKKLNKKRLKKRKG 228

Query: 146 W---VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQAT 201
           +   + E  +L  V    +V L  Y  E        L L+   M    ++ H+ +  +  
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLA-YAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 202 LPWN---TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG 258
             +         AQ    GL +LH+     II+RD K  N+LLD+  N ++SD GLA   
Sbjct: 284 PGFQEPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKS 317
            +      +    GT G+ APE +      +  D ++ GV LYE+I  R P   R     
Sbjct: 340 KAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

Query: 318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR 370
            ++L                +L+  +   Y  K +          L +  + R
Sbjct: 398 NKEL-------------KQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKR 435

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (270), Expect = 9e-27
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 38/232 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G +G V   V + T     +I  A K++ +  ++    +  E+ ++  ++HPN+++L
Sbjct: 17  IGRGSWGEVKIAVQKGT-----RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 165 IGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAARGL 218
                 +D   I   L+ E         R V          A        +I +D    +
Sbjct: 72  YETF--EDNTDIY--LVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAV 119

Query: 219 AYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTI 274
           AY H+     +  RD K  N L          KL DFGLA    P   +       VGT 
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTP 172

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            Y +P+ ++ G    + D WS GV +Y L+ G  P       ++ +++  +R
Sbjct: 173 YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSA---PTDSEVMLKIR 220

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (273), Expect = 1e-26
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 41/275 (14%)

Query: 54  SEFNSQNASDFSSESSSRNTFAVL------SQRQSNLRVFTFSELKTA---TKNFSRSLM 104
           S ++  +  D+   ++    F           R  +L+    +EL       K FS    
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNL 161
           IG G FG VY        +      +A+K++S  G Q +++W   + EV  L  + HPN 
Sbjct: 62  IGHGSFGAVYFARDVRNSEV-----VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA---QDAARGL 218
           ++  G    +    +    + EY    S  D L    +  L     ++IA     A +GL
Sbjct: 117 IQYRGCYLREHTAWL----VMEYCLG-SASDLLEVH-KKPL---QEVEIAAVTHGALQGL 167

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
           AYLH      +I RD K+ NILL E    KL DFG      +  ++  ++  VGT  + A
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS-----ASIMAPANS-FVGTPYWMA 218

Query: 279 PEYI---QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           PE I     G+   K D+WS G+   EL   + PL
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (272), Expect = 1e-26
 Identities = 58/271 (21%), Positives = 96/271 (35%), Gaps = 64/271 (23%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW-----VTEVNVLGVVEHP 159
           IG+G +G V   +   T     +   A+K +++  ++           TEV ++  + HP
Sbjct: 34  IGQGSYGVVRVAIENQT-----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ------- 212
           N+ +L      +DE+ I   L+ E      + D L      +        +         
Sbjct: 89  NIARLYEVY--EDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 213 ------------------------DAAR-------GLAYLHEGMDFQIIFRDFKSSNILL 241
                                     +         L YLH      I  RD K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 242 --DEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY--KSDIWS 295
             ++ +  KL DFGL++     ++G  +  T   GT  + APE + T   +Y  K D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 296 FGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            GV L+ L+ G  P       ++   +  V 
Sbjct: 262 AGVLLHLLLMGAVPFPG---VNDADTISQVL 289

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (277), Expect = 1e-26
 Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 40/261 (15%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR 137
                +          T  + ++   M+G+G FG V +   R T     + + AVK +++
Sbjct: 3   HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRIT-----QQEYAVKVINK 57

Query: 138 RGLQG-HKEWV-TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT 195
              +      +  EV +L  ++HPN++KL      +D       ++ E      + D + 
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEIL--EDSSSFY--IVGELYTGGELFDEII 113

Query: 196 SRFQATLPWNTRLKIAQDAAR-------GLAYLHEGMDFQIIFRDFKSSNILL---DEQW 245
            R + +           DAAR       G+ Y+H+     I+ RD K  NILL   ++  
Sbjct: 114 KRKRFS---------EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDC 161

Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
           + K+ DFGL+     +         +GT  Y APE ++ G    K D+WS GV LY L++
Sbjct: 162 DIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLS 217

Query: 306 GRRPLDRNRPKSEQKLLEWVR 326
           G  P      K+E  +L+ V 
Sbjct: 218 GTPPFYG---KNEYDILKRVE 235

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (268), Expect = 2e-26
 Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 48/284 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNV-LGVVEHPNLV 162
           +G G +G V +     +     +I +AVK++      Q  K  + ++++ +  V+ P  V
Sbjct: 15  LGRGAYGVVEKMRHVPS----GQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAY 220
              G    + +  I      E M + S+            T+P +   KIA    + L +
Sbjct: 70  TFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL-ARLGPSDGLSHVSTAVVGTIGYAAP 279
           LH      +I RD K SN+L++     K+ DFG+   L              G   Y AP
Sbjct: 125 LHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI----DAGCKPYMAP 178

Query: 280 EYIQTGRL----TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           E I         + KSDIWS G+ + EL   R P D      +Q                
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---------------L 223

Query: 336 TMILD---PKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMSE 375
             +++   P+L   K+S +         ++CL + +K RP   E
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFT----SQCLKKNSKERPTYPE 263

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (274), Expect = 5e-26
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 51/245 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL------------QGHKEWV-TEVN 151
           +G G +G V     ++        + A+K + +               +   E +  E++
Sbjct: 44  LGSGAYGEVLLCKEKNG-----HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           +L  ++HPN++KL      +D++     L+ E+     + + + +R +            
Sbjct: 99  LLKSLDHPNIIKLFDVF--EDKKYFY--LVTEFYEGGELFEQIINRHKFD---------E 145

Query: 212 QDAAR-------GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSD 261
            DAA        G+ YLH+     I+ RD K  NILL   +   N K+ DFGL+     D
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 262 GLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL 321
              +     +GT  Y APE ++  +   K D+WS GV +Y L+ G  P      +++Q +
Sbjct: 203 ---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG---QNDQDI 255

Query: 322 LEWVR 326
           ++ V 
Sbjct: 256 IKKVE 260

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (268), Expect = 6e-26
 Identities = 69/329 (20%), Positives = 126/329 (38%), Gaps = 42/329 (12%)

Query: 18  SNKDKNEEQKTAKSIS-VRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAV 76
            NK   E ++  + I  + +       +  R +R   S+  +  A       +       
Sbjct: 12  DNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTEN 71

Query: 77  LSQRQSNLRVFTFSELKTA--TKNFSRSLMIGEGGFGGVYRGVIRSTEDSH--KKIDIAV 132
           L  +                  + +    +IG G    V R V R+T      K +++  
Sbjct: 72  LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 133 KQLSRRGLQGHKEWV-TEVNVL-GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP---- 186
           ++LS   L+  +E    E ++L  V  HP+++ LI     +    +   L+++ M     
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--ESSSFM--FLVFDLMRKGEL 187

Query: 187 -NRSVQ-DHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ 244
            +   +   L+ + +          I +     +++LH      I+ RD K  NILLD+ 
Sbjct: 188 FDYLTEKVALSEK-ETR-------SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236

Query: 245 WNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPE----YIQTGRLTY--KSDIWSFG 297
              +LSDFG +  L P + L      + GT GY APE     +      Y  + D+W+ G
Sbjct: 237 MQIRLSDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292

Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           V L+ L+ G  P      + +  +L  + 
Sbjct: 293 VILFTLLAGSPPFWH---RRQILMLRMIM 318

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  108 bits (271), Expect = 6e-26
 Identities = 63/300 (21%), Positives = 109/300 (36%), Gaps = 57/300 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           +G G  G V        + S +   +AVK++             E+ +L    +HPN+++
Sbjct: 23  LGYGSSGTVVF------QGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73

Query: 164 LIGYCAEDDERGIQRLLIYEYMP----NRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
              YC+E  +R +   +  E       +     +++            + + +  A G+A
Sbjct: 74  Y--YCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 220 YLHEGMDFQIIFRDFKSSNILLD-------------EQWNAKLSDFGLARLGPSDGLSHV 266
           +LH      II RD K  NIL+              E     +SDFGL +   S   S  
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 267 STA--VVGTIGYAAPEYIQ-------TGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK 316
           +      GT G+ APE ++         RLT   DI+S G   Y +++ G+ P      +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
               +             F++     L  +  I  A  L    ++ +      RP   +V
Sbjct: 247 ESNII----------RGIFSLDEMKCLHDRSLIAEATDL---ISQMIDHDPLKRPTAMKV 293

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  108 bits (271), Expect = 8e-26
 Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 41/221 (18%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT---EVNVLGVVEHPNL 161
           +G G FG V  G    T        +AVK L+R+ ++          E+  L +  HP++
Sbjct: 24  LGVGTFGKVKVGKHELTGHK-----VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----- 216
           +KL  Y        I   ++ EY+    + D++            RL   +  +R     
Sbjct: 79  IKL--YQVISTPSDI--FMVMEYVSGGELFDYICKN--------GRLD--EKESRRLFQQ 124

Query: 217 ---GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
              G+ Y H  M   ++ RD K  N+LLD   NAK++DFGL+ +         S    G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178

Query: 274 IGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
             YAAPE I  GRL Y   + DIWS GV LY L+ G  P D
Sbjct: 179 PNYAAPEVIS-GRL-YAGPEVDIWSSGVILYALLCGTLPFD 217

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  107 bits (268), Expect = 1e-25
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 29/229 (12%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPN 160
            IG+G FG V       T    KK+  A+K ++++      E      E+ ++  +EHP 
Sbjct: 22  AIGKGSFGKVCIVQKNDT----KKM-YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 161 LVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARG 217
           LV L  Y  +D+E     + ++ + +    ++ HL     F        +L I +     
Sbjct: 77  LVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQQNVHF--KEET-VKLFICE-LVMA 127

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L YL      +II RD K  NILLDE  +  ++DF +A + P +      T + GT  Y 
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYM 181

Query: 278 APEYIQTGRL---TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
           APE   + +    ++  D WS GV  YEL+ GRRP       S ++++ 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  104 bits (262), Expect = 1e-25
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 40/234 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWV-TEVNVLGVVEHPNLV 162
           +G+G FG V +   R T     + + AVK +++   +      +  EV +L  ++HPN++
Sbjct: 30  LGKGSFGEVLKCKDRIT-----QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 163 KLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAAR 216
           KL      +D       ++ E        +  ++    +    A        +I +    
Sbjct: 85  KLFEIL--EDSSSFY--IVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFS 132

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVG 272
           G+ Y+H      I+ RD K  NILL   ++  + K+ DFGL+     +  +       +G
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----KDRIG 185

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           T  Y APE ++ G    K D+WS GV LY L++G  P      K+E  +L+ V 
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDILKRVE 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  105 bits (265), Expect = 2e-25
 Identities = 59/239 (24%), Positives = 91/239 (38%), Gaps = 50/239 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-EVNVLGVVEHPNLVK 163
           IG G FG       + T++      +AVK + R       E V  E+     + HPN+V+
Sbjct: 28  IGSGNFGVARLMRDKLTKEL-----VAVKYIERGAAI--DENVQREIINHRSLRHPNIVR 80

Query: 164 LIGYCAEDDERGIQRLLIY---EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR---- 216
                            +    EY     + + + +          R    +D AR    
Sbjct: 81  FKEVILTPTH-------LAIIMEYASGGELYERICN--------AGRFS--EDEARFFFQ 123

Query: 217 ----GLAYLHEGMDFQIIFRDFKSSNILLDEQW--NAKLSDFGLARLGPSDGLSHVSTAV 270
               G++Y H     QI  RD K  N LLD       K+ DFG ++          +   
Sbjct: 124 QLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 177

Query: 271 VGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEWV 325
           VGT  Y APE +   +  Y    +D+WS GV LY ++ G  P  D   P+  +K ++ +
Sbjct: 178 VGTPAYIAPEVLL-RQE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (265), Expect = 2e-25
 Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 54/296 (18%)

Query: 37  SASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTAT 96
           S  N+     R       E  S           S+ T A+     +    F    +    
Sbjct: 23  SMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQ 82

Query: 97  KNFS------RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV 150
              +      ++ ++G G FG V++    +T      + +A K +  RG++  +E   E+
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETAT-----GLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQD--HLTSRFQATLP 203
           +V+  ++H NL++L     E     +   L+ EY+      +R + +  +LT        
Sbjct: 138 SVMNQLDHANLIQLYDAF-ESKNDIV---LVMEYVDGGELFDRIIDESYNLTEL------ 187

Query: 204 WNTRLKIAQDAAR-------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGL 254
                    D          G+ ++H+     I+  D K  NIL   +     K+ DFGL
Sbjct: 188 ---------DTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGL 235

Query: 255 AR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           AR   P + L        GT  + APE +    +++ +D+WS GV  Y L++G  P
Sbjct: 236 ARRYKPREKL----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  106 bits (267), Expect = 2e-25
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 27/246 (10%)

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---W 146
            +++   ++F    +IG G FG V    +++ +        A+K L++  +    E   +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVF-----AMKILNKWEMLKRAETACF 121

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWN 205
             E +VL   +   +  L  Y  +DD      L L+ +Y     +   L S+F+  LP  
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNN----LYLVMDYYVGGDLLTLL-SKFEDRLPEE 175

Query: 206 -TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
             R  +A+     +  +H+      + RD K  NIL+D   + +L+DFG       DG  
Sbjct: 176 MARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 265 HVSTAVVGTIGYAAPEYIQT---GRLTY-KS-DIWSFGVFLYELITGRRPL-DRNRPKSE 318
             S A VGT  Y +PE +Q    G+  Y    D WS GV +YE++ G  P    +  ++ 
Sbjct: 232 QSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290

Query: 319 QKLLEW 324
            K++  
Sbjct: 291 GKIMNH 296

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  105 bits (264), Expect = 2e-25
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 42/221 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV---TEVNVLGVVEHPNL 161
           +GEG FG V       T+       +A+K +SR+ L+     +    E++ L ++ HP++
Sbjct: 17  LGEGSFGKVKLATHYKTQQK-----VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----- 216
           +KL  Y        I  +++ EY     + D++  +         R+   +D  R     
Sbjct: 72  IKL--YDVITTPTDI--VMVIEYA-GGELFDYIVEK--------KRMT--EDEGRRFFQQ 116

Query: 217 ---GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
               + Y H     +I+ RD K  N+LLD+  N K++DFGL+ +         S    G+
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS 170

Query: 274 IGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLD 311
             YAAPE I  G+L Y   + D+WS G+ LY ++ GR P D
Sbjct: 171 PNYAAPEVIN-GKL-YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 3e-25
 Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 50/235 (21%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G F  V+    R T         A+K + +           E+ VL  ++H N+V L
Sbjct: 17  LGSGAFSEVFLVKQRLT-----GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 165 IGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAAR-- 216
                 +        L+ + +      +R ++    T +               DA+   
Sbjct: 72  EDIY--ESTTHYY--LVMQLVSGGELFDRILERGVYTEK---------------DASLVI 112

Query: 217 -----GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVST 268
                 + YLH   +  I+ RD K  N+L    +E     ++DFGL+++  +  +    +
Sbjct: 113 QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----S 165

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE 323
              GT GY APE +     +   D WS GV  Y L+ G  P      ++E KL E
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKLFE 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  107 bits (268), Expect = 3e-25
 Identities = 81/385 (21%), Positives = 149/385 (38%), Gaps = 48/385 (12%)

Query: 3   SEAIGFQEDMKC--LYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQN 60
           S  + F + +    +   +K K   +   ++    +          + V           
Sbjct: 78  SRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP 137

Query: 61  ASDFSSESSSRN----TFAVLSQRQSNLRVFTFSELKTATKN------FSRSLMIGEGGF 110
             D   E +       + A  +    ++    F + K   +       F +  ++G+GGF
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197

Query: 111 GGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGY 167
           G V    +R+T     K+  A K+L ++ ++  K     + E  +L  V    +V L  Y
Sbjct: 198 GEVCACQVRAT----GKM-YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-Y 251

Query: 168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWN-TRLKIAQDAARGLAYLHEGMD 226
             E  +      L+   M    ++ H+    QA  P        A+    GL  LH    
Sbjct: 252 AYETKDA---LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR--- 304

Query: 227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
            +I++RD K  NILLD+  + ++SD GLA   P           VGT+GY APE ++  R
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNER 361

Query: 287 LTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEG 345
            T+  D W+ G  LYE+I G+ P   R +    +++               ++ +     
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-------------ERLVKEVPE-- 406

Query: 346 KYSIKLAQKLAAVANKCLARQAKGR 370
           +YS + + +  ++ ++ L +    R
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAER 431

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (259), Expect = 6e-25
 Identities = 58/342 (16%), Positives = 103/342 (30%), Gaps = 82/342 (23%)

Query: 97  KNFSRSLMIGEGGFGGVYRG--------------VIRSTEDSHKKIDIAVKQLSRRG--- 139
            +F     +G GGFG V+                 + + E + +K+   VK L++     
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 140 -LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIY---------------- 182
            ++    W+         E   +                                     
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 183 ---------------EYMPNRSVQDHLTSRFQATLP-WNTRLKIAQDAARGLAYLHEGMD 226
                          +     +++D +  R           L I    A  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG----------LSHVSTAVVGTIGY 276
             ++ RD K SNI        K+ DFGL      D                T  VGT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT 336
            +PE I     ++K DI+S G+ L+EL+           + E+  +      +TD +   
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRI------ITDVRNLK 290

Query: 337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
               P L  +   +    +       L+     RP+ ++++E
Sbjct: 291 F---PLLFTQKYPQEHMMV----QDMLSPSPTERPEATDIIE 325

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  102 bits (257), Expect = 8e-25
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 40/240 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH--KKIDIA-VKQLSRRGLQGHKEWV-TEVNVL-GVVEHP 159
           +G G    V R + + T   +  K ID+      S   +Q  +E    EV++L  V  HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQD 213
           N+++L      +        L+++ M      +   +   L+ + +         KI + 
Sbjct: 85  NIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVTLSEK-ETR-------KIMRA 132

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVG 272
               +  LH+     I+ RD K  NILLD+  N KL+DFG +  L P + L      V G
Sbjct: 133 LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCG 185

Query: 273 TIGYAAPEYIQTGRLTYKS------DIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           T  Y APE I+              D+WS GV +Y L+ G  P      + +  +L  + 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIM 242

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  106 bits (265), Expect = 1e-24
 Identities = 76/389 (19%), Positives = 141/389 (36%), Gaps = 57/389 (14%)

Query: 5   AIGFQEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMS---TDRDVRKSGSEFNSQNA 61
            + F E++K       ++     + +           + S   +   +         +  
Sbjct: 82  LVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQV 141

Query: 62  SDFSSESSSRNTFAVLSQR-----QSNLRVFTFSELKTATKNFSRSL-------MIGEGG 109
                +         L          + +   F + K    N   ++       +IG GG
Sbjct: 142 PPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGG 201

Query: 110 FGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVV---EHPNLVK 163
           FG VY      T     K+  A+K L ++ ++  +     + E  +L +V   + P +V 
Sbjct: 202 FGEVYGCRKADT----GKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +  Y     ++    L  I + M    +  HL+     +     R   A+    GL ++H
Sbjct: 257 MS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAE-IILGLEHMH 309

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 +++RD K +NILLDE  + ++SD GLA             A VGT GY APE +
Sbjct: 310 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVL 362

Query: 283 QTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           Q G      +D +S G  L++L+ G  P  +++ K + ++               M L  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRMTLTM 409

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGR 370
            +  +     + +L ++    L R    R
Sbjct: 410 AV--ELPDSFSPELRSLLEGLLQRDVNRR 436

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (255), Expect = 1e-24
 Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 55/229 (24%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV------TEVNVLGVVEH 158
           +G G F  V +   + T       + A K + +R L   +  V       EVN+L  + H
Sbjct: 13  LGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQD-HLTSRFQATLPWNTRLKIAQ 212
           PN++ L     E+    +   LI E +      +   +   LT                 
Sbjct: 68  PNIITLHDIF-ENKTDVV---LILELVSGGELFDFLAEKESLTED--------------- 108

Query: 213 DAAR-------GLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLAR-LGPS 260
           +A +       G+ YLH     +I   D K  NI+L          KL DFG+A  +   
Sbjct: 109 EATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +        + GT  + APE +    L  ++D+WS GV  Y L++G  P
Sbjct: 166 NEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (259), Expect = 2e-24
 Identities = 55/226 (24%), Positives = 87/226 (38%), Gaps = 46/226 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--------TEVNVLGVV 156
           +G G  G V     R T        +A++ +S+R                 TE+ +L  +
Sbjct: 143 LGSGACGEVKLAFERKT-----CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKI 210
            HP ++K+  +   +D       ++ E M      ++ V    L                
Sbjct: 198 NHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK--------LY 244

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHV 266
                  + YLHE     II RD K  N+LL   +E    K++DFG ++ LG +  +   
Sbjct: 245 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 298

Query: 267 STAVVGTIGYAAPEYI-QTGRLTY--KSDIWSFGVFLYELITGRRP 309
              + GT  Y APE +   G   Y    D WS GV L+  ++G  P
Sbjct: 299 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  103 bits (258), Expect = 3e-24
 Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 28/271 (10%)

Query: 63  DFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTE 122
           DF +   ++N    LS+ +  +      +L+   +++    +IG G FG V     +ST 
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 94

Query: 123 DSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL 179
             +     A+K LS+  +    +   +  E +++     P +V+L  Y  +DD      L
Sbjct: 95  KVY-----AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRY----L 144

Query: 180 -LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN 238
            ++ EYMP   + + + S +     W  R   A+     L  +H       I RD K  N
Sbjct: 145 YMVMEYMPGGDLVNLM-SNYDVPEKW-ARFYTAEVVL-ALDAIHS---MGFIHRDVKPDN 198

Query: 239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--GRLTY-KS-DIW 294
           +LLD+  + KL+DFG       +G+    TA VGT  Y +PE +++  G   Y +  D W
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWW 257

Query: 295 SFGVFLYELITGRRP-LDRNRPKSEQKLLEW 324
           S GVFLYE++ G  P    +   +  K++  
Sbjct: 258 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (258), Expect = 3e-24
 Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 29/248 (11%)

Query: 90  SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---W 146
            E++    +F    +IG G F  V    ++ T   +     A+K +++  +    E   +
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY-----AMKIMNKWDMLKRGEVSCF 108

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWN 205
             E +VL   +   + +L  +  +D+      L L+ EY     +   L S+F   +P  
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENY----LYLVMEYYVGGDLLTLL-SKFGERIPAE 162

Query: 206 -TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS 264
             R  +A+     +  +H       + RD K  NILLD   + +L+DFG      +DG  
Sbjct: 163 MARFYLAEIVM-AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 265 HVSTAVVGTIGYAAPEYIQ-----TGRLTY-KS-DIWSFGVFLYELITGRRP-LDRNRPK 316
               A VGT  Y +PE +Q      G  +Y    D W+ GVF YE+  G+ P    +  +
Sbjct: 219 RSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277

Query: 317 SEQKLLEW 324
           +  K++ +
Sbjct: 278 TYGKIVHY 285

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (253), Expect = 3e-24
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 43/264 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLV 162
           ++GEG    V   +   T       + AVK + ++          EV +L     H N++
Sbjct: 20  VLGEGAHARVQTCINLIT-----SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--F---QATLPWNTRLKIAQDAARG 217
           +LI +  E+++R     L++E M   S+  H+  R  F   +A+        + QD A  
Sbjct: 75  ELIEFF-EEEDR---FYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASA 123

Query: 218 LAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTA---- 269
           L +LH   +  I  RD K  NIL    ++    K+ DF L   +  +   S +ST     
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 270 VVGTIGYAAPEYIQTGRLTYKS-----DIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW 324
             G+  Y APE ++             D+WS GV LY L++G  P    R  S+      
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-GRCGSDCGWDRG 239

Query: 325 VRPHLTDAKKFTMILDPKLEGKYS 348
                     F  I     EGKY 
Sbjct: 240 EACPACQNMLFESI----QEGKYE 259

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (253), Expect = 4e-24
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 43/223 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV------TEVNVLGVVEH 158
           +G G F  V +   +ST      ++ A K + +R  +  +  V       EV++L  V H
Sbjct: 20  LGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR-- 216
            N++ L     E+    +   LI E +    + D L  +   +          ++A    
Sbjct: 75  HNVITLHDVY-ENRTDVV---LILELVSGGELFDFLAQKESLS---------EEEATSFI 121

Query: 217 -----GLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSDGLSHV 266
                G+ YLH     +I   D K  NI+L        + KL DFGLA  +         
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
              + GT  + APE +    L  ++D+WS GV  Y L++G  P
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  101 bits (254), Expect = 4e-24
 Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 32/298 (10%)

Query: 39  SNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKN 98
           ++     + +   SG    +        E        + +   +          K   +N
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTG------HAEKVGIEN 55

Query: 99  FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV----TEVNVLG 154
           F    ++G G +G V+  V + +     K+  A+K L +  +    +      TE  VL 
Sbjct: 56  FELLKVLGTGAYGKVFL-VRKISGHDTGKL-YAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 155 VVEH-PNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
            +   P LV L  Y  + + +    L LI +Y+    +  HL+ R + T     ++ + +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETK----LHLILDYINGGELFTHLSQRERFTEHE-VQIYVGE 167

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
                L +LH+     II+RD K  NILLD   +  L+DFGL++   +D          G
Sbjct: 168 -IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222

Query: 273 TIGYAAPEYIQTGRLTY-KS-DIWSFGVFLYELITGRRP-----LDRNRPKSEQKLLE 323
           TI Y AP+ ++ G   + K+ D WS GV +YEL+TG  P        ++ +  +++L+
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =   99 bits (250), Expect = 5e-24
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 39/234 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLV 162
           +G+G F  V R V ++T      ++ A K ++ + L     ++   E  +   ++HPN+V
Sbjct: 14  LGKGAFSVVRRCVHKTT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 163 KLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAAR 216
           +L       +E      L+++ +         V  +  +    A+          Q    
Sbjct: 69  RLHDSI--QEESFHY--LVFDLVTGGELFEDIVAREFYSEA-DAS-------HCIQQILE 116

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVG 272
            +AY H      I+ R+ K  N+LL    +    KL+DFGLA  +  S+          G
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HGFAG 169

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           T GY +PE ++    +   DIW+ GV LY L+ G  P      + + +L   ++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIK 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  101 bits (254), Expect = 7e-24
 Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 48/222 (21%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+R V ++T           K ++            E++++  + HP L+ L
Sbjct: 59  LGSGAFGVVHRCVEKAT-----GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 165 IGYCAEDDERGIQRLLIYEYMP-----NRSVQD--HLTSRFQATLPWNTRLKIAQDAAR- 216
                ED    +   LI E++      +R   +   ++                 +    
Sbjct: 114 HDAF-EDKYEMV---LILEFLSGGELFDRIAAEDYKMSEA---------------EVINY 154

Query: 217 ------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSDGLSHVS 267
                 GL ++HE     I+  D K  NI+ + +  +  K+ DFGLA  L P + +    
Sbjct: 155 MRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---- 207

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
                T  +AAPE +    + + +D+W+ GV  Y L++G  P
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  103 bits (258), Expect = 7e-24
 Identities = 64/311 (20%), Positives = 109/311 (35%), Gaps = 51/311 (16%)

Query: 14  CLYASNK----DKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESS 69
            + A NK       E                     ++     G    S N  ++  +  
Sbjct: 81  RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140

Query: 70  SRNTFAVLSQRQSNLR-VFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKI 128
            +     +  +  ++   +   E             +G G FG V+R   R+T       
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRVTERAT-----GN 183

Query: 129 DIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-- 186
           + A K +        +    E+  + V+ HP LV L     EDD   +   +IYE+M   
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMV---MIYEFMSGG 239

Query: 187 ---NRSVQD--HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL 241
               +   +   ++             +  +   +GL ++HE      +  D K  NI+ 
Sbjct: 240 ELFEKVADEHNKMSEDEAV--------EYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 288

Query: 242 DEQWNA--KLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGV 298
             + +   KL DFGL   L P   +        GT  +AAPE  +   + Y +D+WS GV
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344

Query: 299 FLYELITGRRP 309
             Y L++G  P
Sbjct: 345 LSYILLSGLSP 355

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (252), Expect = 8e-24
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 34/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----EVNVLGVVEHP 159
           IG+G F  V R + R T         AVK +            T     E ++  +++HP
Sbjct: 32  IGKGPFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR--- 216
           ++V+L+       +  +   +++E+M    +   +  R  A   ++        A+    
Sbjct: 87  HIVELLETY--SSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYMR 137

Query: 217 ----GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTA 269
                L Y H+  +  II RD K   +LL   +     KL  FG+A      G   V+  
Sbjct: 138 QILEALRYCHD-NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGG 192

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            VGT  + APE ++        D+W  GV L+ L++G  P
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (251), Expect = 9e-24
 Identities = 58/272 (21%), Positives = 101/272 (37%), Gaps = 71/272 (26%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLVK 163
           +G G FG V+R V  S+     K     K +  +G    +  V  E+++L +  H N++ 
Sbjct: 13  LGRGEFGIVHRCVETSS-----KKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILH 65

Query: 164 LIGYCAEDDERGIQRLLIYEYMP-----NRSVQD--HLTSRFQATLPWNTRLKIAQDAAR 216
           L     E  E  +   +I+E++       R       L  R               +   
Sbjct: 66  LHESF-ESMEELV---MIFEFISGLDIFERINTSAFELNER---------------EIVS 106

Query: 217 -------GLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSDGLSHV 266
                   L +LH      I   D +  NI+   + ++  K+ +FG AR L P D     
Sbjct: 107 YVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--- 160

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWV 325
              +     Y APE  Q   ++  +D+WS G  +Y L++G  P L        Q+++E +
Sbjct: 161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENI 215

Query: 326 R-----------PHLTD-AKKFT---MILDPK 342
                         ++  A  F    ++ + K
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (250), Expect = 1e-23
 Identities = 54/233 (23%), Positives = 99/233 (42%), Gaps = 37/233 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           IG G +    R + ++T      ++ AVK + +       E   E+ +L    +HPN++ 
Sbjct: 30  IGVGSYSVCKRCIHKAT-----NMEFAVKIIDKSKRDP-TE---EIEILLRYGQHPNIIT 80

Query: 164 LIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAARG 217
           L      DD + +   ++ E M      ++ ++    + R +A+        +     + 
Sbjct: 81  LKDVY--DDGKYV--YVVTELMKGGELLDKILRQKFFSER-EAS-------AVLFTITKT 128

Query: 218 LAYLHEGMDFQIIFRDFKSSNILL-DEQWNA---KLSDFGLARLGPSDGLSHVSTAVVGT 273
           + YLH      ++ RD K SNIL  DE  N    ++ DFG A+   ++    +      T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYT 183

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
             + APE ++        DIWS GV LY ++TG  P       + +++L  + 
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 46/226 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--------TEVNVLGVV 156
           +G G  G V     R T        +A+K +S+R                 TE+ +L  +
Sbjct: 18  LGSGACGEVKLAFERKT-----CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKI 210
            HP ++K+  +   +D       ++ E M      ++ V    L                
Sbjct: 73  NHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK--------LY 119

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHV 266
                  + YLHE     II RD K  N+LL   +E    K++DFG ++ LG +  +   
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 173

Query: 267 STAVVGTIGYAAPEYI-QTGRLTY--KSDIWSFGVFLYELITGRRP 309
              + GT  Y APE +   G   Y    D WS GV L+  ++G  P
Sbjct: 174 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 20/225 (8%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDI-AVKQLSRRGLQGHKEW--VTEVNVLGVVEHPN 160
           ++G+G FG V+     S  D+ +   + A+K L +  L+         E ++L  V HP 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQ---LYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87

Query: 161 LVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           +VKL  Y  + + +    L LI +++    +   L+     T     +  +A+ A   L 
Sbjct: 88  IVKLH-YAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELAL-ALD 140

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +LH      II+RD K  NILLDE+ + KL+DFGL++          + +  GT+ Y AP
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAP 195

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
           E +     T  +D WSFGV ++E++TG  P   ++R ++   +L+
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 43/223 (19%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV------TEVNVLGVVEH 158
           +G G F  V +   +ST      ++ A K + +R  +  +  V       EV++L  V H
Sbjct: 20  LGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR-- 216
           PN++ L     E+    +   LI E +    + D L  +   +          ++A    
Sbjct: 75  PNIITLHDVY-ENRTDVV---LILELVSGGELFDFLAQKESLS---------EEEATSFI 121

Query: 217 -----GLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSDGLSHV 266
                G+ YLH     +I   D K  NI+L        + KL DFGLA  +         
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
              + GT  + APE +    L  ++D+WS GV  Y L++G  P
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 55/229 (24%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV------TEVNVLGVVEH 158
           +G G F  V +   +ST      +  A K + +R  +  +  V       EV++L  ++H
Sbjct: 19  LGSGQFAVVKKCREKST-----GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQD-HLTSRFQATLPWNTRLKIAQ 212
           PN++ L     E+    I   LI E +      +   +   LT                 
Sbjct: 74  PNVITLHEVY-ENKTDVI---LILELVAGGELFDFLAEKESLTEE--------------- 114

Query: 213 DAAR-------GLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKLSDFGLAR-LGPS 260
           +A         G+ YLH     QI   D K  NI+L      +   K+ DFGLA  +   
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +        + GT  + APE +    L  ++D+WS GV  Y L++G  P
Sbjct: 172 NEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.2 bits (245), Expect = 5e-23
 Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 21/223 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLV 162
           ++G G  G V     R T         A+K L             EV+        P++V
Sbjct: 36  VLGLGVNGKVLECFHRRT-----GQKCALKLLYDSPKAR-----QEVDHHWQASGGPHIV 85

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            ++             L+I E M    +   +  R           +I +D    + +LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 223 EGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
                 I  RD K  N+L    ++    KL+DFG A+    + L         T  Y AP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAP 198

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
           E +   +     D+WS GV +Y L+ G  P   N  ++    +
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.0 bits (245), Expect = 6e-23
 Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 20/226 (8%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV----TEVNVLGVVEHP 159
           ++G+GG+G V++ V + T  +  KI  A+K L +  +  + +       E N+L  V+HP
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGANTGKI-FAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            +V LI Y  +   +    L LI EY+    +   L               +A+  +  L
Sbjct: 82  FIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAE-ISMAL 134

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            +LH+     II+RD K  NI+L+ Q + KL+DFGL +    DG   V+    GTI Y A
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMA 189

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
           PE +         D WS G  +Y+++TG  P    NR K+  K+L+
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 69/335 (20%), Positives = 114/335 (34%), Gaps = 69/335 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           +GEG F    + V + +         AVK +S+R     ++   E+  L     HPN+VK
Sbjct: 19  LGEGSFSICRKCVHKKS-----NQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70

Query: 164 LIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAARG 217
           L      D        L+ E +       R  +  H +    +         I +     
Sbjct: 71  LHEVF-HDQLH---TFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSA 118

Query: 218 LAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
           ++++H   D  ++ RD K  N+L    ++    K+ DFG ARL P D           T+
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTL 173

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            YAAPE +         D+WS GV LY +++G+ P                         
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTCTS 220

Query: 335 FTMILDPKLEGKYSI---------KLAQKLAAVANKCLARQAKGRPKMSEVVE---VLNK 382
              I+    +G +S          + A+ L       L      R KMS +     + + 
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDL---IQGLLTVDPNKRLKMSGLRYNEWLQDG 277

Query: 383 IVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRF 417
                 +     PL    +      +    +K  F
Sbjct: 278 ------SQLSSNPLMTPDILGSSGAAVHTCVKATF 306

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY+   +  +D       A+KQ+   G+        E+ +L  ++HPN++ L
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKD---YALKQIEGTGI--SMSACREIALLRELKHPNVISL 83

Query: 165 IGYCAEDDERGIQRLLIYEYMPN------RSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
                   +R +   L+++Y  +      +  +    ++    LP      +      G+
Sbjct: 84  QKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNA----KLSDFGLARL--GPSDGLSHVSTAVVG 272
            YLH      ++ RD K +NIL+  +       K++D G ARL   P   L+ +   VV 
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 273 TIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           T  Y APE +  G   Y    DIW+ G    EL+T   P+
Sbjct: 198 TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 39/234 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLV 162
           +G+G F  V R V ++T      ++ A K ++ + L     ++   E  +   ++HPN+V
Sbjct: 37  LGKGAFSVVRRCVHKTT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 163 KLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAAR 216
           +L       +E      L+++ +         V  +  +    +           Q    
Sbjct: 92  RLHDSI--QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS--------HCIQQILE 139

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVG 272
            +AY H      I+ R+ K  N+LL    +    KL+DFGLA  +  S+          G
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HGFAG 192

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
           T GY +PE ++    +   DIW+ GV LY L+ G  P      + + +L   ++
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIK 243

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.8 bits (242), Expect = 9e-23
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 37/226 (16%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVN 151
           + + +   IGEG +G V++   R T     +I +A+K++    L    E V  +   E+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET----HEI-VALKRVR---LDDDDEGVPSSALREIC 53

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPWNTRL 208
           +L  ++H N+V+L      D     ++L L++E+     +   D          P   + 
Sbjct: 54  LLKELKHKNIVRLH-----DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKS 105

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHV 266
            + Q   +GL + H      ++ RD K  N+L++     KL++FGLAR    P    S  
Sbjct: 106 FLFQ-LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
              VV T+ Y  P+ +  G   Y +  D+WS G    EL    RPL
Sbjct: 162 ---VV-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 37/219 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWV-TEVNVLGVVEH-PNL 161
           +G G F  V + + +ST       + A K L +R   Q  +  +  E+ VL + +  P +
Sbjct: 37  LGRGKFAVVRQCISKST-----GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR----- 216
           + L     E+    I   LI EY     +           +          D  R     
Sbjct: 92  INLHEVY-ENTSEII---LILEYAAGGEIFSLCLPELAEMVS-------ENDVIRLIKQI 140

Query: 217 --GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAV 270
             G+ YLH+     I+  D K  NILL       + K+ DFG++R +G +  L      +
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----REI 193

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +GT  Y APE +    +T  +D+W+ G+  Y L+T   P
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 36/233 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWV-TEVNVLGVVEHPNLV 162
           +G+G F  V R V           + A   ++ + L     + +  E  +  +++HPN+V
Sbjct: 19  LGKGAFSVVRRCVKVLA-----GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 163 KLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTRLKIAQDAAR 216
           +L    +E+        LI++ +         V  ++ +    +           Q    
Sbjct: 74  RLHDSISEEGHH----YLIFDLVTGGELFEDIVAREYYSEADAS--------HCIQQILE 121

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
            + + H+ M   ++ R+ K  N+LL    +    KL+DFGLA     +          GT
Sbjct: 122 AVLHCHQ-MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGT 176

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
            GY +PE ++        D+W+ GV LY L+ G  P      + + +L + ++
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRLYQQIK 226

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 31/305 (10%)

Query: 24  EEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSN 83
           E     ++   R   +    +    ++K  +      +   S  S +      L++ +  
Sbjct: 85  ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH 143
           + +  F  LK          ++G+G FG V     ++T   +     A+K L +  +   
Sbjct: 145 VTMNEFEYLK----------LLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAK 189

Query: 144 KEW---VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQ 199
            E    +TE  VL    HP L  L  Y  +  +R    L  + EY     +  HL SR +
Sbjct: 190 DEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR----LCFVMEYANGGELFFHL-SRER 243

Query: 200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGP 259
                  R   A+     L YLH   +  +++RD K  N++LD+  + K++DFGL + G 
Sbjct: 244 VFSEDRARFYGAE-IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300

Query: 260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSE 318
            DG         GT  Y APE ++        D W  GV +YE++ GR P  +++  K  
Sbjct: 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

Query: 319 QKLLE 323
           + +L 
Sbjct: 359 ELILM 363

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVNVLGVVEHP 159
           IGEG +G V++   R T     +I +A+K+            +      E+ +L  ++HP
Sbjct: 11  IGEGSYGVVFKCRNRDT----GQI-VAIKKF---LESEDDPVIKKIALREIRMLKQLKHP 62

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           NLV L+     +  R  +RL L++EY  + +V   L    +       +    Q   + +
Sbjct: 63  NLVNLL-----EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ-TLQAV 115

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGY 276
            + H+      I RD K  NIL+ +    KL DFG ARL  GPSD         V T  Y
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD----EVATRWY 168

Query: 277 AAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            +PE +  G   Y    D+W+ G    EL++   PL
Sbjct: 169 RSPE-LLVGDTQYGPPVDVWAIGCVFAELLS-GVPL 202

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 32/275 (11%)

Query: 57  NSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTAT-KNFSRSLMIGEGGFGGVYR 115
           N+  A   S + S +   A    ++  L+ +      TA    F R   +G G FG V  
Sbjct: 2   NAAAAKKGSEQESVKEFLA--KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML 59

Query: 116 GVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGYCAEDD 172
              + + + +     A+K L ++ +   K+    + E  +L  V  P LVKL  +  +D+
Sbjct: 60  VKHKESGNHY-----AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDN 113

Query: 173 ERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQI 229
                 L ++ EY+    +  HL    RF        R   AQ       YLH      +
Sbjct: 114 SN----LYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQ-IVLTFEYLHS---LDL 162

Query: 230 IFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY 289
           I+RD K  N+L+D+Q   +++DFG A+          +  + GT    APE I +     
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217

Query: 290 KSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
             D W+ GV +YE+  G  P       +  +K++ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 40/224 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNV-----------L 153
           IG G +G VY+     +        +A+K +    +         + +           L
Sbjct: 17  IGVGAYGTVYKARDPHS----GHF-VALKSVR---VPNGGGGGGGLPISTVREVALLRRL 68

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD---HLTSRFQATLPWNTRLK 209
              EHPN+V+L+  CA        ++ L++E++     QD   +L       LP  T   
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKD 124

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL-GPSDGLSHVST 268
           + +   RGL +LH      I+ RD K  NIL+      KL+DFGLAR+      L+ V  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-- 179

Query: 269 AVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            VV T+ Y APE +     TY +  D+WS G    E+   R+PL
Sbjct: 180 -VV-TLWYRAPE-VLLQS-TYATPVDMWSVGCIFAEMFR-RKPL 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 50/229 (21%), Positives = 84/229 (36%), Gaps = 25/229 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           +G G  G V +   + T     +   A+K L             EV +     + P++V+
Sbjct: 70  LGLGINGKVLQIFNKRT-----QEKFALKMLQDCPKAR-----REVELHWRASQCPHIVR 119

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           ++    E+   G + L ++ E +    +   +  R           +I +     + YLH
Sbjct: 120 IVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 223 EGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAA 278
                 I  RD K  N+L          KL+DFG A+     + L    T    T  Y A
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCYTPYYVA 231

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWVR 326
           PE +   +     D+WS GV +Y L+ G  P    +       +   +R
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 34/216 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVNVLGVVEHP 159
           +GEG +G V +   + T     +I +A+K+          + V      E+ +L  + H 
Sbjct: 33  VGEGSYGMVMKCRNKDT----GRI-VAIKKFL---ESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           NLV L+     +  +  +R  L++E++ + ++ D L            +  + Q    G+
Sbjct: 85  NLVNLL-----EVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ-IINGI 137

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGY 276
            + H      II RD K  NIL+ +    KL DFG AR    P +         V T  Y
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----EVATRWY 190

Query: 277 AAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            APE +  G + Y    D+W+ G  + E+  G  PL
Sbjct: 191 RAPE-LLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 36/230 (15%)

Query: 94  TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T--- 148
           +++  F +   +G G +  VY+G+ ++T        +A+K++        +E    T   
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTT----GVY-VALKEVK----LDSEEGTPSTAIR 52

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQAT-LPW 204
           E++++  ++H N+V+L      ++     +L L++E+M N  +   D  T       L  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDG 262
           N          +GLA+ HE    +I+ RD K  N+L++++   KL DFGLAR    P + 
Sbjct: 108 NLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            S     VV T+ Y AP+ +  G  TY +  DIWS G  L E+IT  +PL
Sbjct: 165 FSSE---VV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMIT-GKPL 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 71/243 (29%), Positives = 102/243 (41%), Gaps = 25/243 (10%)

Query: 78  SQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSH--KKIDIAVKQL 135
           S    N         +     F    M G+G FG V  G  +ST  S   KK+ I   + 
Sbjct: 4   SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRF 62

Query: 136 SRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGY---CAEDDERGIQRLLIYEYMPN--RSV 190
             R LQ        +  L V+ HPN+V+L  Y     E D R I   ++ EY+P+     
Sbjct: 63  RNRELQ-------IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRC 115

Query: 191 QDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKL 249
             +   R  A  P   ++ + Q   R +  LH      +  RD K  N+L++E     KL
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQ-LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL 173

Query: 250 SDFGLAR-LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGR 307
            DFG A+ L PS+     + A + +  Y APE I   +  T   DIWS G    E++ G 
Sbjct: 174 CDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG- 228

Query: 308 RPL 310
            P+
Sbjct: 229 EPI 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.3 bits (227), Expect = 7e-21
 Identities = 38/294 (12%), Positives = 84/294 (28%), Gaps = 60/294 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNL 161
            G       ++ +     D+     +A+  +  +G+      +E ++    L  ++ P +
Sbjct: 39  HGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
            +++         G   L++ E++   S+Q+   +           ++  Q  A      
Sbjct: 94  ARVLDV-VHTRAGG---LVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAA 145

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      +       S + +                   DG       V+          
Sbjct: 146 HR---AGVALSIDHPSRVRVSI-----------------DG-----DVVLAYPATMPDA- 179

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
                   + DI   G  LY L+  R PL     +S    L                  P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPEAGVRS---GLAPAERDTAG--------QP 222

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTP 395
                    +  +++AVA + +      R   S ++ ++ +    A+      P
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGP 275

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 34/229 (14%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVNV 152
            + +   IG+G FG V++   R T     +  +A+K++    ++  KE    T   E+ +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKT----GQK-VALKKVL---MENEKEGFPITALREIKI 69

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRL----LIYEYMPN--RSVQDHLTSRFQATLPWNT 206
           L +++H N+V LI  C        +      L++++  +    +  ++  +F  +     
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE---- 125

Query: 207 RLK-IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGL 263
            +K + Q    GL Y+H     +I+ RD K++N+L+      KL+DFGLAR      +  
Sbjct: 126 -IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 264 SHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            +  T  V T+ Y  PE +  G   Y    D+W  G  + E+ T R P+
Sbjct: 182 PNRYTNRVVTLWYRPPE-LLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 70/293 (23%), Positives = 110/293 (37%), Gaps = 66/293 (22%)

Query: 35  RSSASNTSMSTDRDVRKSGSEFNSQNASDFSSESSSRNTFAVLSQRQSNLR-VFTFSELK 93
              +S   + T+    +S S   S  AS     +S    + +    +  L   F      
Sbjct: 5   HHHSSGVDLGTENLYFQSMS---SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE- 60

Query: 94  TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL 153
                      +G G    VYR   + T+  +     A+K L +      K   TE+ VL
Sbjct: 61  -----------LGRGATSIVYRCKQKGTQKPY-----ALKVLKKT--VDKKIVRTEIGVL 102

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMP-----NRSVQ-DHLTSRFQATLPWNTR 207
             + HPN++KL      +    I   L+ E +      +R V+  + + R          
Sbjct: 103 LRLSHPNIIKLKEIF--ETPTEIS--LVLELVTGGELFDRIVEKGYYSER---------- 148

Query: 208 LKIAQDAAR-------GLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLAR- 256
                DAA         +AYLHE     I+ RD K  N+L          K++DFGL++ 
Sbjct: 149 -----DAADAVKQILEAVAYLHE-NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200

Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +     +      V GT GY APE ++      + D+WS G+  Y L+ G  P
Sbjct: 201 VEHQVLM----KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G FG V++  +  +++      +A+K++    LQ  +    E+ ++ +V+HPN+V L
Sbjct: 48  IGNGSFGVVFQAKLVESDE------VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97

Query: 165 IGYCAEDDERGIQRL--LIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
             +   + ++  +    L+ EY+P        H     Q       +L + Q   R LAY
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAA 278
           +H      I  RD K  N+LLD      KL DFG A+ L   +     + + + +  Y A
Sbjct: 157 IHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRA 209

Query: 279 PEYIQTGRL-TYKSDIWSFGVFLYELITGRRPL 310
           PE I      T   DIWS G  + EL+ G +PL
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 69/230 (30%), Positives = 113/230 (49%), Gaps = 39/230 (16%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T-- 148
           +   + + +   +GEG +G VY+      +DS  +I +A+K++    L    E +  T  
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKA-----KDSQGRI-VALKRIR---LDAEDEGIPSTAI 67

Query: 149 -EVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPW 204
            E+++L  + HPN+V LI     D     + L L++E+M    + V D   +  Q     
Sbjct: 68  REISLLKELHHPNIVSLI-----DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ---DS 119

Query: 205 NTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDG 262
             ++ + Q   RG+A+ H+    +I+ RD K  N+L++     KL+DFGLAR    P   
Sbjct: 120 QIKIYLYQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
            +H    VV T+ Y AP+ +  G   Y +  DIWS G    E+IT  +PL
Sbjct: 176 YTHE---VV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMIT-GKPL 219

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 39/226 (17%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVN 151
           + + +   +GEG +  VY+G  + T      + +A+K++    L+ H+E    T   EV+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLT----DNL-VALKEIR---LE-HEEGAPCTAIREVS 52

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPWNTRL 208
           +L  ++H N+V L      D     + L L++EY+    +   D   +        N +L
Sbjct: 53  LLKDLKHANIVTLH-----DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN---MHNVKL 104

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHV 266
            + Q   RGLAY H     +++ RD K  N+L++E+   KL+DFGLAR    P+    + 
Sbjct: 105 FLFQ-LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
              VV T+ Y  P+ I  G   Y +  D+W  G   YE+ T  RPL
Sbjct: 161 ---VV-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMAT-GRPL 200

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 78/325 (24%), Positives = 134/325 (41%), Gaps = 29/325 (8%)

Query: 9   QEDMKCLYASNKDKNEEQKTAKSISVRSSASNTSMSTDRDVRKSGSEFNSQNASDFSSES 68
                 + + +   +E QK       +  +       +  V   GSE N +    F    
Sbjct: 251 TSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAK 310

Query: 69  SSRNTFAVLSQRQSNLRVFTFSELKTATK--NFSRSLMIGEGGFGGVYRGVIRSTEDSHK 126
             + T A   +  + +  F  +  +   K  +F+  +++G+G FG V     + T++ + 
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELY- 369

Query: 127 KIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHPNLVKLIGYCAEDDERGIQRL-LI 181
               AVK L +  +    +    + E  VL    + P L +L   C +  +R    L  +
Sbjct: 370 ----AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR----LYFV 420

Query: 182 YEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI 239
            EY+    +  H+    RF    P       A+  A GL +L       II+RD K  N+
Sbjct: 421 MEYVNGGDLMYHIQQVGRF--KEPH-AVFYAAE-IAIGLFFLQS---KGIIYRDLKLDNV 473

Query: 240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVF 299
           +LD + + K++DFG+ +    DG     T   GT  Y APE I         D W+FGV 
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDG-VTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531

Query: 300 LYELITGRRPLD-RNRPKSEQKLLE 323
           LYE++ G+ P +  +  +  Q ++E
Sbjct: 532 LYEMLAGQAPFEGEDEDELFQSIME 556

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 39/226 (17%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVN 151
           + +     IGEG +G VY+      ++++ +   A+K++    L+   E +  T   E++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-----QNNYGET-FALKKIR---LEKEDEGIPSTTIREIS 52

Query: 152 VLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPWNTRL 208
           +L  ++H N+VKL             RL L++E++    + + D      +       + 
Sbjct: 53  ILKELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKS 104

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHV 266
            + Q    G+AY H+    +++ RD K  N+L++ +   K++DFGLAR    P    +H 
Sbjct: 105 FLLQ-LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
              +V T+ Y AP+ +  G   Y +  DIWS G    E++    PL
Sbjct: 161 ---IV-TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVN-GTPL 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 34/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--T---EVNVL---GVV 156
           IGEG +G V++   R  ++  + +  A+K++    +Q  +E +  +   EV VL      
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFV--ALKRVR---VQTGEEGMPLSTIREVAVLRHLETF 71

Query: 157 EHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQD 213
           EHPN+V+L   C         +L L++E++     +  D +       +P  T   +   
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQ 128

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL-GPSDGLSHVSTAVVG 272
             RGL +LH     +++ RD K  NIL+      KL+DFGLAR+      L+ V   VV 
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VV- 181

Query: 273 TIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           T+ Y APE +     +Y +  D+WS G    E+   R+PL
Sbjct: 182 TLWYRAPE-VLLQS-SYATPVDLWSVGCIFAEMFR-RKPL 218

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G FG VY+  +  + +      +A+K++    LQ  +    E+ ++  ++H N+V+L
Sbjct: 62  IGNGSFGVVYQAKLCDSGE-----LVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112

Query: 165 IGY-CAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
             +  +  +++    L L+ +Y+P     V  H +   Q       +L + Q   R LAY
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAY 171

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNA-KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +H    F I  RD K  N+LLD      KL DFG A+          + + + +  Y AP
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRYYRAP 225

Query: 280 EYIQTGRL-TYKSDIWSFGVFLYELITGRRPL 310
           E I      T   D+WS G  L EL+ G +P+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.1 bits (222), Expect = 6e-20
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 31/239 (12%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV----T 148
           K + ++F     +G G FG V+    R     +     A+K L +  +   K+ V     
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYY-----AMKVLKKEIVVRLKQ-VEHTND 55

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWN 205
           E  +L +V HP ++++     +D ++    + +I +Y+    +   L  + RF   +   
Sbjct: 56  ERLMLSIVTHPFIIRMW-GTFQDAQQ----IFMIMDYIEGGELFSLLRKSQRFPNPV--- 107

Query: 206 TRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH 265
            +   A+     L YLH      II+RD K  NILLD+  + K++DFG A+  P      
Sbjct: 108 AKFYAAE-VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158

Query: 266 VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
           V+  + GT  Y APE + T       D WSFG+ +YE++ G  P  D N  K+ +K+L 
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 21/210 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPN 160
           ++G+G FG V     ++T     +   A+K L +  +    E    VTE  VL    HP 
Sbjct: 12  LLGKGTFGKVILVREKAT----GRY-YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 161 LVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           L  L  Y  +  +R    L  + EY     +  HL+     T     R   A+     L 
Sbjct: 67  LTALK-YAFQTHDR----LCFVMEYANGGELFFHLSRERVFTEER-ARFYGAE-IVSALE 119

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           YLH      +++RD K  N++LD+  + K++DFGL + G SDG         GT  Y AP
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAP 174

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           E ++        D W  GV +YE++ GR P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 63/266 (23%), Positives = 107/266 (40%), Gaps = 50/266 (18%)

Query: 65  SSESSSRNTFAVLSQRQSNLRVFTFSELKTATK--NFSRSLMIGEGGFGGVYRGVIRSTE 122
           +           L  +       + S   +AT    + R   +GEG +G VY+ +   T 
Sbjct: 2   AHHHHHHMGT--LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVT- 58

Query: 123 DSHKKIDIAVKQLSRRGLQGHKEWV--T---EVNVLGVVEHPNLVKLIGYCAEDDERGIQ 177
               +  +A+K++    L+  +E V  T   EV++L  ++H N+++L      +      
Sbjct: 59  ---NET-VAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH----- 106

Query: 178 RL-LIYEYMPNRSVQDH-LTSRFQATLPWNTRL--KIAQDAARGLAYLHEGMDFQIIFRD 233
           RL LI+EY       ++ L          + R+          G+ + H     + + RD
Sbjct: 107 RLHLIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRD 157

Query: 234 FKSSNILLDEQWNA-----KLSDFGLARL--GPSDGLSHVSTAVVGTIGYAAPEYIQTGR 286
            K  N+LL     +     K+ DFGLAR    P    +H    ++ T+ Y  PE I  G 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---II-TLWYRPPE-ILLGS 212

Query: 287 LTYKS--DIWSFGVFLYELITGRRPL 310
             Y +  DIWS      E++  + PL
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM-KTPL 237

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 39/234 (16%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSH----KKIDIAVKQLSRRGLQGHKEW 146
           ++K+  K + +   +GEG F  VY+   R    +     KKI +  +  ++ G+      
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGIN----- 56

Query: 147 VT---EVNVLGVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN--RSVQDHLTSRFQA 200
            T   E+ +L  + HPN++ L+             + L++++M      +    +     
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKS-----NISLVFDFMETDLEVIIKDNSLVL-- 109

Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL--G 258
             P + +  +     +GL YLH+     I+ RD K +N+LLDE    KL+DFGLA+    
Sbjct: 110 -TPSHIKAYMLM-TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

Query: 259 PSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS--DIWSFGVFLYELITGRRPL 310
           P+   +H    VV T  Y APE +  G   Y    D+W+ G  L EL+  R P 
Sbjct: 165 PNRAYTHQ---VV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAELLL-RVPF 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVL 153
            K +     IG G  G V      +  D+  + ++A+K+LSR  +     K    E+ ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVC-----AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78

Query: 154 GVVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMP---NRSVQDHLTSRFQATLPWNTRL 208
             V H N++ L+  +  +      Q + ++ E M     + +Q  L     + L      
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL------ 132

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
            + Q    G+ +LH      II RD K SNI++      K+ DFGLAR   + G S + T
Sbjct: 133 -LYQ-MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 184

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
             V T  Y APE I         DIWS G  + E+I G   L
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 23/226 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHP 159
           +IG+G FG V     ++     +    AVK L ++ +   KE    ++E NVL   V+HP
Sbjct: 45  VIGKGSFGKVLLARHKAE----EVF-YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            LV L  +  +  ++    L  + +Y+    +  HL        P   R   A+  A  L
Sbjct: 100 FLVGLH-FSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAE-IASAL 152

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            YLH      I++RD K  NILLD Q +  L+DFGL +          ++   GT  Y A
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLA 207

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
           PE +         D W  G  LYE++ G  P   RN  +    +L 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.0 bits (218), Expect = 6e-19
 Identities = 70/294 (23%), Positives = 110/294 (37%), Gaps = 49/294 (16%)

Query: 27  KTAKSISVRSSASNTSMSTDRDVRKSGSEFN---SQNASDFSSESSSRNTFAVLSQRQSN 83
             ++       A         DV      +N   S+  + F S     +TF V  +R  N
Sbjct: 8   YCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTV-LKRYQN 66

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQ 141
           L+                   IG G  G V      +  D+    ++A+K+LSR  +   
Sbjct: 67  LKP------------------IGSGAQGIVC-----AAYDAVLDRNVAIKKLSRPFQNQT 103

Query: 142 GHKEWVTEVNVLGVVEHPNLVKLIG-YCAEDDERGIQRL-LIYEYMP---NRSVQDHLTS 196
             K    E+ ++  V H N++ L+  +  +      Q + L+ E M     + +Q  L  
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              + L +            G+ +LH      II RD K SNI++      K+ DFGLAR
Sbjct: 164 ERMSYLLYQM--------LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

Query: 257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
              +     + T  V T  Y APE I         DIWS G  + E++   + L
Sbjct: 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHP 159
           M+G+G FG V+    + T     +   A+K L +  +    +    + E  VL    EHP
Sbjct: 24  MLGKGSFGKVFLAEFKKT----NQF-FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            L  +     +  E     L  + EY+    +  H+ S  +  L        A+    GL
Sbjct: 79  FLTHMF-CTFQTKEN----LFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAAE-IILGL 131

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            +LH      I++RD K  NILLD+  + K++DFG+ +          +    GT  Y A
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIA 186

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           PE +   +  +  D WSFGV LYE++ G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 27/228 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHP 159
           ++G+G FG V    ++ T      +  AVK L +  +    +    +TE  +L     HP
Sbjct: 30  VLGKGSFGKVMLARVKET----GDL-YAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAAR 216
            L +L   C +  +R    L  + E++    +  H+  + RF        R   A+    
Sbjct: 85  FLTQLF-CCFQTPDR----LFFVMEFVNGGDLMFHIQKSRRF--DEAR-ARFYAAE-IIS 135

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            L +LH+     II+RD K  N+LLD + + KL+DFG+ + G  +G    +    GT  Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDY 190

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLE 323
            APE +Q        D W+ GV LYE++ G  P    N     + +L 
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 27/228 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHP 159
           ++G+G FG V     + T     ++  AVK L +  +    +    + E  VL    + P
Sbjct: 27  VLGKGSFGKVMLSERKGT----DEL-YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHL--TSRFQATLPWNTRLKIAQDAAR 216
            L +L   C +  +R    L  + EY+    +  H+    RF    P       A+  A 
Sbjct: 82  FLTQLH-SCFQTMDR----LYFVMEYVNGGDLMYHIQQVGRF--KEPH-AVFYAAE-IAI 132

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
           GL +L       II+RD K  N++LD + + K++DFG+ +    DG    +    GT  Y
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDY 187

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD-RNRPKSEQKLLE 323
            APE I         D W+FGV LYE++ G+ P +  +  +  Q ++E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 22/211 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWV-TEVNVLG-VVEHP 159
           +IG G +  V    ++ T+  +     A+K + +  +   +  +WV TE +V      HP
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIY-----AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 160 NLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            LV L   C + + R    L  + EY+    +  H+  + +       R   A+  +  L
Sbjct: 71  FLVGLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLAL 123

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            YLHE     II+RD K  N+LLD + + KL+D+G+ + G   G    ++   GT  Y A
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIA 178

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           PE ++     +  D W+ GV ++E++ GR P
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 29/268 (10%)

Query: 54  SEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSL-------MIG 106
           S ++  +  D+   ++    F               +  ++   + S  L       +IG
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61

Query: 107 EGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK--EWV-TEVNVLG-VVEHPNLV 162
            G +  V    ++ T+  +     A++ + +  +   +  +WV TE +V      HP LV
Sbjct: 62  RGSYAKVLLVRLKKTDRIY-----AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 163 KLIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
            L   C + + R    L  + EY+    +  H+  + +       R   A+  +  L YL
Sbjct: 117 GLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNYL 169

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           HE     II+RD K  N+LLD + + KL+D+G+ + G   G    ++   GT  Y APE 
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEI 224

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRP 309
           ++     +  D W+ GV ++E++ GR P
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 53/269 (19%), Positives = 87/269 (32%), Gaps = 67/269 (24%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL-SRRGLQGHKEWVTE-------------V 150
           +G G FG V        + +     +AVK L        H+  ++E             V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 151 NVLGVV--------------EHPNLVKLI------------------------------- 165
           N+LG                +  NL   +                               
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 166 ----GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
                             +  + + +   ++     ++  L     +  +   A+G+ +L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
                 + I RD  + NILL E+   K+ DFGLAR    D            + + APE 
Sbjct: 210 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRP 309
           I     T +SD+WSFGV L+E+ + G  P
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 46/219 (21%), Positives = 83/219 (37%), Gaps = 44/219 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNLVK 163
           +G G +  V+  +  +  +      + VK L        K+   E+ +L  +   PN++ 
Sbjct: 44  LGRGKYSEVFEAINITNNEK-----VVVKILK---PVKKKKIKREIKILENLRGGPNIIT 95

Query: 164 LIGYCAEDDERGIQRLLIYEYMPN---RSVQDHLTSR------FQATLPWNTRLKIAQDA 214
           L       D       L++E++ N   + +   LT        ++  L            
Sbjct: 96  L--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE-IL------------ 140

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLG-PSDGLSHVSTAVVG 272
            + L Y H      I+ RD K  N+++D E    +L D+GLA    P    +      V 
Sbjct: 141 -KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVA 192

Query: 273 TIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPL 310
           +  +  PE +   ++  Y  D+WS G  L  +I  + P 
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 40/225 (17%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT-----------EVNVL 153
           I  G +G V  GV            +A+K++      G    +            E+ +L
Sbjct: 30  ISSGSYGAVCAGVDSEGIP------VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN------RSVQDHLTSRFQATLPWNT 206
               HPN++ L       +E  + +L L+ E M           +  ++ +         
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH-------I 136

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
           +  +      GL  LHE     ++ RD    NILL +  +  + DF LAR   +D     
Sbjct: 137 QYFMYH-ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---N 189

Query: 267 STAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T  V    Y APE + Q    T   D+WS G  + E+   R+ L
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 61/260 (23%)

Query: 92  LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVK---QLSRRGLQGHKEWVT 148
           L+T++K +S    +G G FG V       +         A+K   Q  R   +       
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKR-----FALKKVLQDPRYKNR------- 49

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRL----------------------------- 179
           E++++ V++H N++KL+ Y     +   +                               
Sbjct: 50  ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109

Query: 180 -----LIYEYMPN--RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR 232
                +I EY+P+    V        ++       + I Q   R + ++H      I  R
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHR 165

Query: 233 DFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYK 290
           D K  N+L++ +    KL DFG A+          S A + +  Y APE +      T  
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 291 SDIWSFGVFLYELITGRRPL 310
            D+WS G    ELI G +PL
Sbjct: 223 IDLWSIGCVFGELILG-KPL 241

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 30/214 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V      S  D      +A+K+LSR  +     K    E+ +L  ++H N++
Sbjct: 32  VGSGAYGSVC-----SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86

Query: 163 KLIG-YCAEDDERGIQRL-LIYEYMP---NRSVQDHLTSRFQATLPWNTRLKIAQDAARG 217
            L+  +      R      L+  +M     + +    +           +  + Q   +G
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS-------EEKIQYLVYQ-MLKG 138

Query: 218 LAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYA 277
           L Y+H      ++ RD K  N+ ++E    K+ DFGLAR           T  V T  Y 
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYR 190

Query: 278 APEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           APE I          DIWS G  + E++TG + L
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 25/212 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V      S  D      +A+K+L R  +     K    E+ +L  + H N++
Sbjct: 33  VGSGAYGAVC-----SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87

Query: 163 KLIG-YCAEDDERGIQRL-LIYEYMPNRSVQD-HLTSRFQATLPWNTRLKIAQDAARGLA 219
            L+  +  ++         L+  +M      D     + +       +  + Q   +GL 
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQ-MLKGLR 142

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           Y+H      II RD K  N+ ++E    K+ DFGLAR           T  V T  Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAP 194

Query: 280 EYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
           E I    R T   DIWS G  + E+ITG + L
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 45/230 (19%), Positives = 77/230 (33%), Gaps = 48/230 (20%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           +G G  G V +   + T     +   A+K L             EV +     + P++V+
Sbjct: 26  LGLGINGKVLQIFNKRT-----QEKFALKMLQDCPKAR-----REVELHWRASQCPHIVR 75

Query: 164 LIGYCAEDDERGIQRL-LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           ++    E+   G + L ++ E +    +   +  R           +I +     + YLH
Sbjct: 76  IVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 223 EGMDFQIIFRDFKSSNILL---DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
             ++  I  RD K  N+L          KL+DFG A                        
Sbjct: 135 S-IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------K 168

Query: 280 EYIQTGRLTY--KSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWVR 326
           E        Y    D+WS GV +Y L+ G  P    +       +   +R
Sbjct: 169 ETTGEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 67/260 (25%), Positives = 106/260 (40%), Gaps = 44/260 (16%)

Query: 57  NSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRG 116
           +SQ    F  +  ++  + V  +R  NL                    +G G +G     
Sbjct: 8   HSQERPTFYRQELNKTIWEV-PERYQNLSP------------------VGSGAYG----- 43

Query: 117 VIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLVKLIG-YCAEDDE 173
            + +  D+   + +AVK+LSR  + +   K    E+ +L  ++H N++ L+  +      
Sbjct: 44  SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103

Query: 174 RGIQRL-LIYEYMPNRSVQD-HLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF 231
                + L+   M      D +   + Q     + +  I Q   RGL Y+H      II 
Sbjct: 104 EEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIH 155

Query: 232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI-QTGRLTYK 290
           RD K SN+ ++E    K+ DFGLAR       +   T  V T  Y APE +         
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210

Query: 291 SDIWSFGVFLYELITGRRPL 310
            DIWS G  + EL+TG R L
Sbjct: 211 VDIWSVGCIMAELLTG-RTL 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 28/220 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G GG G V+     S  D+     +A+K++     Q  K  + E+ ++  ++H N+VK+
Sbjct: 19  LGCGGNGLVF-----SAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73

Query: 165 I------GYCAEDDERGIQRL----LIYEYMPNRSVQD-HLTSRFQATLPWNTRLKIAQD 213
                  G    DD   +  L    ++ EYM      D          L  + RL + Q 
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARLFMYQ- 128

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLAR-LGPSDGLSHVSTAVV 271
             RGL Y+H      ++ RD K +N+ ++ E    K+ DFGLAR + P        +  +
Sbjct: 129 LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 272 GTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
            T  Y +P  +      T   D+W+ G    E++TG + L
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--------RRGLQGHKEWVTEVNVLGVV 156
           IGEG +G V      S  D+  K+ +A+K++S        +R L+       E+ +L   
Sbjct: 35  IGEGAYGMVC-----SAYDNLNKVRVAIKKISPFEHQTYCQRTLR-------EIKILLRF 82

Query: 157 EHPNLVKLIGYCAEDDERGIQRL-LIYEYMPNRSVQD-HLTSRFQATLPWNTRLKIAQDA 214
            H N++ +           ++ + ++ + M      D +   + Q     +    + Q  
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQ-I 137

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGT 273
            RGL Y+H      ++ RD K SN+LL+   + K+ DFGLAR   P    +   T  V T
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 274 IGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
             Y APE +  +   T   DIWS G  L E+++  RP+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 56/253 (22%), Positives = 96/253 (37%), Gaps = 71/253 (28%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR---------RGLQGHKEWVTEVNVLGV 155
           IG G +G VY        D + + ++A+K+++R         R L+       E+ +L  
Sbjct: 34  IGRGSYGYVYLAY-----DKNTEKNVAIKKVNRMFEDLIDCKRILR-------EITILNR 81

Query: 156 VEHPNLVKLIGYCAEDDERGIQRL-LIYEYMPN------RSVQDHLTSRFQATLPWNTRL 208
           ++   +++L      DD      L ++ E   +      ++    LT     T+ +N  L
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNL-L 139

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
                   G  ++HE     II RD K +N LL++  + K+ DFGLAR   S+  +++  
Sbjct: 140 -------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 269 AVVGTIGYAAPEYIQTGRLT-------YKS--------------DIWSFGVFLYELITG- 306
            +               +LT       Y++              DIWS G    EL+   
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 307 ---------RRPL 310
                    R PL
Sbjct: 250 QSHINDPTNRFPL 262

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 57/237 (24%), Positives = 85/237 (35%), Gaps = 64/237 (27%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--------RRGLQGHKEWVTEVNVLGVV 156
           +GEG +G V      S         +A+K++          R L+       E+ +L   
Sbjct: 19  LGEGAYGVVC-----SATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKILKHF 66

Query: 157 EHPNLVKLIGYCAEDDERGIQRL-LIYEYM---------PNRSVQDHLTSRFQATLPWNT 206
           +H N++ +      D       + +I E M               DH+      TL    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL---- 122

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
                    R +  LH      +I RD K SN+L++   + K+ DFGLAR+       + 
Sbjct: 123 ---------RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 267 S--------TAVVGTIGYAAPEYIQTGRLTYKS-----DIWSFGVFLYELITGRRPL 310
                       V T  Y APE +    LT        D+WS G  L EL   RRP+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVM----LTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 64/316 (20%), Positives = 108/316 (34%), Gaps = 87/316 (27%)

Query: 54  SEFNSQNASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTA---TKNFSRSLMIGEGGF 110
           +     N+    + S S+       Q  S+    +     +       +    +IG G +
Sbjct: 7   AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSY 66

Query: 111 GGVYRGVIRSTEDSHKKIDIAVKQLSR---------RGLQGHKEWVTEVNVLGVVEHPNL 161
           G V         D  +K  +A+K++ R         R L+       E+ +L  + H ++
Sbjct: 67  GHVCEAY-----DKLEKRVVAIKKILRVFEDLIDCKRILR-------EIAILNRLNHDHV 114

Query: 162 VKLIGYCAEDDERGIQRL-LIYEYMPN------RSVQDHLTSRFQATLPWNTRLKIAQDA 214
           VK++      D      L ++ E   +      R+   +LT     TL +N         
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV-YLTELHIKTLLYNL-------- 165

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV---- 270
             G+ Y+H      I+ RD K +N L+++  + K+ DFGLAR        +    +    
Sbjct: 166 LVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 271 ---------------------VGTIGYAAPEYIQTGRLTYKS-----DIWSFGVFLYELI 304
                                V T  Y APE I    L  ++     D+WS G    EL+
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI----LLQENYTEAIDVWSIGCIFAELL 278

Query: 305 T----------GRRPL 310
                       R PL
Sbjct: 279 NMIKENVAYHADRGPL 294

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 32/115 (27%), Positives = 53/115 (46%), Gaps = 24/115 (20%)

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAV----- 270
           + + YLH G    ++ RD K SNILL+ + + K++DFGL+R   +      +  +     
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 271 --------------VGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL 310
                         V T  Y APE +  + + T   D+WS G  L E++   +P+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 44/221 (19%), Positives = 83/221 (37%), Gaps = 31/221 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL---------- 153
            +G G F  V+        D      +A+K + R      +    E+ +L          
Sbjct: 26  KLGWGHFSTVWLAK-----DMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 154 -GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
              +   +++KL+ +       G+  ++++E +   ++   +       +P     +I++
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDE------QWNAKLSDFGLARLGPSDGLSHV 266
               GL Y+H      II  D K  N+L++           K++D G A           
Sbjct: 139 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEH 191

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
            T  + T  Y +PE +        +DIWS    ++ELITG 
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 73/343 (21%), Positives = 130/343 (37%), Gaps = 67/343 (19%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +IG+G FG V +       D      +A+K + R   + H++   E+ +L         +
Sbjct: 104 VIGKGSFGQVVKAY-----DHKVHQHVALKMV-RNEKRFHRQAAEEIRIL---------E 148

Query: 164 LIGYCAEDDERGIQRL-----------LIYEYMPNRSVQDHL-TSRFQATLPWNTRL--K 209
            +    +D+   +  +           + +E + + ++ + +  ++FQ    ++  L  K
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQ---GFSLPLVRK 204

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGLARLGPSDGLSHVS 267
            A    + L  LH     +II  D K  NILL +Q  +  K+ DFG +          V 
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVY 257

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP 327
           T +  +  Y APE I   R     D+WS G  L EL+TG  PL     + +Q        
Sbjct: 258 TYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQ-------- 307

Query: 328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA 387
                     +++  L G  S KL               +KG P+   V  + +  V   
Sbjct: 308 -------LACMIE--LLGMPSQKLLDA---SKRAKNFVSSKGYPRYCTVTTLSDGSVVLN 355

Query: 388 ETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEKGCLAW 430
              + +  L+      ++  + K      F+D ++    CL W
Sbjct: 356 GGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK---QCLEW 395

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.5 bits (143), Expect = 5e-10
 Identities = 34/208 (16%), Positives = 56/208 (26%), Gaps = 42/208 (20%)

Query: 85  RVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH- 143
               FS     T+   R   IGEG FG V++ +   T  + K I I    L     Q   
Sbjct: 9   GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 144 KEWVTEVNVL---------GVVEHPNLVKLIG--------------------------YC 168
           +E + E+ +                  + L                              
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ 228
             D  +  Q  ++ E+       + + ++        T   I       LA        +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKL---SSLATAKSILHQLTASLAVAEA--SLR 182

Query: 229 IIFRDFKSSNILLDEQWNAKLSDFGLAR 256
              RD    N+LL +    KL      +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 35/172 (20%), Positives = 48/172 (27%), Gaps = 56/172 (32%)

Query: 189 SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL------- 241
            +   +       LP     KI Q   +GL YLH     +II  D K  NILL       
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYI 187

Query: 242 ------------------------------------------DEQWNAKLSDFGLARLGP 259
                                                      E+   K++D G A    
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV- 246

Query: 260 SDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD 311
                   T  + T  Y + E +        +DIWS     +EL TG    +
Sbjct: 247 ----HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 47/227 (20%), Positives = 81/227 (35%), Gaps = 31/227 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-----------GHKEWVTEVNVL 153
           IG+GGFG +Y   + S+E         VK                      E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
             +++  + K  G    D      R +I +      +Q    +  +      T L+++  
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-RFSRKTVLQLSLR 160

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK--LSDFGLA-RLGPSDGLSHVS--- 267
               L Y+HE    + +  D K+SN+LL+ +   +  L D+GLA R  P       +   
Sbjct: 161 ILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 268 -TAVVGTIGYA---APEYIQTGRLTYKSDIWSFG-VFLYELITGRRP 309
                GTI +    A   +   R   + D+   G   +   +TG  P
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQ-WLTGHLP 260

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 50/220 (22%), Positives = 85/220 (38%), Gaps = 36/220 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
           +IG+G FG V +       D  ++  +A+K + +       +   EV +L         +
Sbjct: 61  LIGKGSFGQVVKAY-----DRVEQEWVAIKII-KNKKAFLNQAQIEVRLL---------E 105

Query: 164 LIGYCAEDDERGIQRL-----------LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L+     + +  I  L           L++E + + ++ D L +     +  N   K AQ
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA--KLSDFGLARLGPSDGLSHVSTAV 270
                L +L    +  II  D K  NILL     +  K+ DFG +          +   +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYI 219

Query: 271 VGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL 310
             +  Y +PE +         D+WS G  L E+ TG  PL
Sbjct: 220 Q-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL 257

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 31/217 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH-PNLVK 163
           IG G FG +Y G      D     ++A+K    +    H +   E  +  +++    +  
Sbjct: 17  IGSGSFGDIYLG-----TDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPT 69

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           +    AE D      +++ E +   S++D      +      T L +A      + Y+H 
Sbjct: 70  IRWCGAEGD----YNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHS 123

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAK---LSDFGLARL-GPSDGLSHV----STAVVGTIG 275
                 I RD K  N L+          + DFGLA+    +    H+    +  + GT  
Sbjct: 124 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 276 YA---APEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           YA       I+  R   + D+ S G  L     G  P
Sbjct: 181 YASINTHLGIEQSR---RDDLESLGYVLMYFNLGSLP 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 39/220 (17%), Positives = 74/220 (33%), Gaps = 35/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH-PNLVK 163
           IGEG FG ++ G      +      +A+K   RR      +   E     ++     +  
Sbjct: 18  IGEGSFGVIFEG-----TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPN 70

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           +  +  E        +L+ + +   S++D L    +      T    A+     +  +HE
Sbjct: 71  VYYFGQEGL----HNVLVIDLLG-PSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHE 124

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAK-----LSDFGLAR--LGPSDGLSHV----STAVVG 272
                 ++RD K  N L+    +       + DFG+ +    P     H+       + G
Sbjct: 125 -KSL--VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK-QHIPYREKKNLSG 180

Query: 273 TIGYA---APEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           T  Y         +  R   + D+ + G      + G  P
Sbjct: 181 TARYMSINTHLGREQSR---RDDLEALGHVFMYFLRGSLP 217

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 40/231 (17%), Positives = 77/231 (33%), Gaps = 39/231 (16%)

Query: 105 IGEGGFGGVYRGVIRSTEDSH---KKIDIAVKQLSRRG-----------LQGHKEWVTEV 150
                 G +Y     ST       +K   ++K  ++ G                +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKI 210
            +        +   +G+    D+    R L+   +  RS+Q  L    +  L   + L++
Sbjct: 110 KLYS-TPLLAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164

Query: 211 AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK--LSDFGLARLGPSDGLSHV-- 266
           A      L +LHE    + +  +  + NI +D +  ++  L+ +G A      G  HV  
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG-KHVAY 220

Query: 267 ----STAVVGTIGYA---APEYIQTGRLTYKSDIWSFG-VFLYELITGRRP 309
                +   G + +      +     R   +SD+ S G   L   + G  P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLK-WLYGFLP 267

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 1e-06
 Identities = 45/293 (15%), Positives = 87/293 (29%), Gaps = 103/293 (35%)

Query: 8   FQEDMKCLYASN---------------KDKNEEQKTAKSI-SVRSSASNTSMSTDRDVRK 51
           F ++  C    +                 K+    T +   ++ S            V+K
Sbjct: 29  FVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM-------VQK 81

Query: 52  SGSEFNSQN----ASDFSSES--SSRNTFAVLSQR---QSNLRVFT---------FSELK 93
              E    N     S   +E    S  T   + QR    ++ +VF          + +L+
Sbjct: 82  FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141

Query: 94  TATKNFSRSLMI---GEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE----W 146
            A      +  +   G  G G               K  +A+       +Q   +    W
Sbjct: 142 QALLELRPAKNVLIDGVLGSG---------------KTWVALDVCLSYKVQCKMDFKIFW 186

Query: 147 VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL--LIYEYMPNRSVQDHLTSRFQATLPW 204
           +                 +  C   +   ++ L  L+Y+  PN + +   +S        
Sbjct: 187 LN----------------LKNCNSPETV-LEMLQKLLYQIDPNWTSRSDHSS-------- 221

Query: 205 NTRLKI--AQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK-LSDFGL 254
           N +L+I   Q   R L          +  + +++  ++L    NAK  + F L
Sbjct: 222 NIKLRIHSIQAELRRL----------LKSKPYENCLLVLLNVQNAKAWNAFNL 264

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 7e-05
 Identities = 46/279 (16%), Positives = 85/279 (30%), Gaps = 81/279 (29%)

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV-STAVVGTIGYAAPE 280
           H  MDF+     ++  +IL   + +A + +F    +   D    + S   +  I  +   
Sbjct: 4   HHHMDFETGEHQYQYKDILSVFE-DAFVDNFDCKDV--QDMPKSILSKEEIDHIIMSKDA 60

Query: 281 YIQTGRLTYKSDIWSF--------GVFL-------YELITGRRPLDRNRPKSEQKLLEWV 325
              T RL      W+           F+       Y+ +      ++ +P    ++    
Sbjct: 61  VSGTLRL-----FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115

Query: 326 RPHL-TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCL--ARQAK--------GRPKMS 374
           R  L  D + F          KY++   Q    +  + L   R AK        G  K  
Sbjct: 116 RDRLYNDNQVFA---------KYNVSRLQPYLKL-RQALLELRPAKNVLIDGVLGSGKTW 165

Query: 375 EVVEVL----------NKI--VDAAETGTPQTPLKNL-------------------SLKD 403
             ++V            KI  ++     +P+T L+ L                   ++K 
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 404 DFETSKKERLKRRFVDPIRGEKGCLAWL--TWRPKLVKT 440
               S +  L+R      +  + CL  L      K    
Sbjct: 226 RIH-SIQAELRRLLKS--KPYENCLLVLLNVQNAKAWNA 261

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 45/217 (20%), Positives = 84/217 (38%), Gaps = 31/217 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVK 163
           IG G FG +Y G      +     ++A+K  + +    H + + E  +  +++    +  
Sbjct: 15  IGSGSFGEIYLG-----TNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPN 67

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           +  +  E D      +L+ + +   S++D      +  L   T L +A      + ++H 
Sbjct: 68  VRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS 121

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAK---LSDFGLARL-GPSDGLSHV----STAVVGTIG 275
                 + RD K  N L+     A    + DFGLA+    +    H+    +  + GT  
Sbjct: 122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 276 YA---APEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           YA       I+  R   + D+ S G  L   + G  P
Sbjct: 179 YASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 40/220 (18%), Positives = 73/220 (33%), Gaps = 35/220 (15%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH-PNLVK 163
           IG G FG +  G      + +    +A+K    +          E      +     + +
Sbjct: 17  IGCGNFGELRLGK-----NLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQ 69

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           +  +            ++ E +   S++D      + T    T L IA      + Y+H 
Sbjct: 70  VYYFGPCGK----YNAMVLELL-GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHS 123

Query: 224 GMDFQIIFRDFKSSNILLDEQWNAK-----LSDFGLAR--LGPSDGLSHV----STAVVG 272
                +I+RD K  N L+    N       + DF LA+  + P     H+      ++ G
Sbjct: 124 ---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK-KHIPYREHKSLTG 179

Query: 273 TIGYA---APEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           T  Y         +  R   + D+ + G      + G  P
Sbjct: 180 TARYMSINTHLGKEQSR---RDDLEALGHMFMYFLRGSLP 216

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 30/121 (24%), Positives = 42/121 (34%), Gaps = 28/121 (23%)

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-------------------KL 249
            +A      L +LH   + Q+   D K  NIL                          ++
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
           +DFG A    +    H +T +V T  Y  PE I         D+WS G  L+E   G   
Sbjct: 184 ADFGSA----TFDHEHHTT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FT 237

Query: 310 L 310
           L
Sbjct: 238 L 238

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 43/226 (19%), Positives = 88/226 (38%), Gaps = 32/226 (14%)

Query: 105 IGEGGFGGVYRG--VIRSTEDSHKKIDIAVK---QLSR-----RGLQGHKEWVTEVNVLG 154
           IG GGFG +Y      +  +D+   + +  +    L       + +   K+ + +     
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKWIERK 103

Query: 155 VVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDA 214
            +++  +    G    + +    R ++ E +    +Q         T   +T L++    
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRM 160

Query: 215 ARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK--LSDFGLA-RLGPSDGLSHVS---- 267
              L Y+HE    + +  D K++N+LL  +   +  L+D+GL+ R  P+           
Sbjct: 161 LDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 268 TAVVGTIGYAAPEYIQT--GR-LTYKSDIWSFG-VFLYELITGRRP 309
               GTI + +   +    G  L+ +SD+   G   L   + G+ P
Sbjct: 218 KGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLR-WLCGKLP 259

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 31/121 (25%), Positives = 44/121 (36%), Gaps = 28/121 (23%)

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA-------------------KL 249
           K+A    + + +LH     ++   D K  NIL  +                       K+
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP 309
            DFG A    +    H ST +V T  Y APE I     +   D+WS G  L E   G   
Sbjct: 179 VDFGSA----TYDDEHHST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FT 232

Query: 310 L 310
           +
Sbjct: 233 V 233

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 29/123 (23%), Positives = 39/123 (31%), Gaps = 26/123 (21%)

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS---- 264
               +  + L YL       +   D K  NILLD+ +  K                    
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 265 -----------------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR 307
                            +  + ++ T  Y APE I        SD+WSFG  L EL TG 
Sbjct: 198 STGIKLIDFGCATFKSDYHGS-IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG- 255

Query: 308 RPL 310
             L
Sbjct: 256 SLL 258

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	441
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.52
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.56
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.07
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.99
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.18
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.66
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.67
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.46
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.17
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.31

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-60  Score=455.16  Aligned_cols=266  Identities=27%  Similarity=0.440  Sum_probs=218.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||+||+|.+........+..||||++........++|.+|+.+|++++|||||+++|+|.+.+.   
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~---   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP---   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE---
Confidence            57889999999999999999987654444556799999987666667789999999999999999999999987664   


Q ss_pred             eEEEEEeccCCCChHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSR-----------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                       .|||||||++|+|.++|...           ....+++..++.|+.||+.||.|||++   +||||||||+||||+.++
T Consensus        90 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           90 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             -EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence             49999999999999999753           235799999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~  324 (441)
                      .+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.......   +...
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~  242 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC  242 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999986544333333445689999999999999999999999999999999999 899997654332   2222


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      +....              ....+..+++++.+|+.+||+.||++|||+.+|+++|+++.+.
T Consensus       243 i~~~~--------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQGR--------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCC--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            21110              0112335677899999999999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-59  Score=455.38  Aligned_cols=266  Identities=25%  Similarity=0.448  Sum_probs=212.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||+||+|+++..........||||++........++|.+|+.+|++++|||||+++|+|.+...   
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~---  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP---  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE---
Confidence            56788889999999999999987644444456799999987766667889999999999999999999999987654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRF-------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                       .|||||||++|+|.++|....             ..++++.+++.|+.||+.||.|||++   +||||||||+||||++
T Consensus       118 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          118 -LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             -EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             -EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence             499999999999999997532             24699999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~  322 (441)
                      ++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.......   ++
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~  270 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI  270 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999997655443444556789999999999999999999999999999999999 899997654332   22


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ..+...    .          ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       271 ~~i~~g----~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQG----R----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHT----C----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcC----C----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            222111    0          0112335677899999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-59  Score=443.73  Aligned_cols=260  Identities=28%  Similarity=0.491  Sum_probs=205.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||+||+|++.+        .||||+++....  ...+.|.+|+.+|++++|||||+++|++..+   
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---  104 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---  104 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---
Confidence            578888999999999999998653        289999875432  3356799999999999999999999998643   


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        .+|||||||+||+|.++|... ...+++..++.|+.||+.||.|||++   +||||||||+||||++++.+||+|||+
T Consensus       105 --~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          105 --NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             --SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             --eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence              249999999999999999754 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |+..............+||+.|||||++.+   +.|+.++|||||||++|||+||+.||..........  ..+....  
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~~~~--  254 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVGRGY--  254 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHTTC--
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCC--
Confidence            987654433334556789999999999864   468999999999999999999999997654332211  1111110  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                             ..|.+ ...+.++++.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       255 -------~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 -------ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             -------CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             -------CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                   11111 12334567889999999999999999999999999987754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-59  Score=449.21  Aligned_cols=263  Identities=24%  Similarity=0.403  Sum_probs=212.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++++.+.||+|+||+||+|.+.+.........||||.+..... ...++|.+|+.+|++++|||||+++|+|.+.+.. 
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~-  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE-
Confidence            35677889999999999999987654444556799999976443 2347899999999999999999999999876644 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                         +||||||++|+|.++|..+.              ...+++..++.|+.||+.||.|||++   +||||||||+||||
T Consensus       105 ---~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          105 ---SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             ---EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             ---EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence               99999999999999996432              24689999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQK  320 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~  320 (441)
                      ++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |..||.......   
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987544333334456789999999999999999999999999999999998 899997655332   


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      +...+...              .....+.+++..+.+|+.+||+.||++||++.+|++.|+..
T Consensus       256 ~~~~i~~~--------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVEMIRNR--------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHcC--------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22222111              01122345678899999999999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.7e-58  Score=447.20  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=212.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.|+..+.||+|+||+||+|+++.++..     ||||++........+.+.+|+.+|+.++|||||+++++|.+.+    
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~-----vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKL-----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCE-----EEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            5699999999999999999999887654     9999998766556677889999999999999999999998876    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      .+|||||||+||+|.+++..   ..+++..+..|+.||+.||.|||++   +||||||||+||||+.+|.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            45999999999999999975   4699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.........   ..+....       
T Consensus       219 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~~~-------  286 (346)
T 4fih_A          219 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDNL-------  286 (346)
T ss_dssp             ECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSS-------
T ss_pred             ecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHcCC-------
Confidence            764432  2345689999999999999999999999999999999999999999765433222   2221111       


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .+.  ......+++++.+||.+||+.||++|||+.|+++
T Consensus       287 ---~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          287 ---PPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---CCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               011  1122346678999999999999999999999887

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.1e-59  Score=449.74  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++++.||+|+||+||+|++..++..     ||||++.....  ...+.+.+|+.+|++++|||||++++++.+.+  
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--   96 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ-----YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG--   96 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCE-----EEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCE-----EEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--
Confidence            6899999999999999999999877654     99999976543  23467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|||||||+||+|.++|..+....+++..++.|+.||+.||.|||++   +||||||||+||||+.++.+||+|||+
T Consensus        97 --~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           97 --SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             --EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence              459999999999999999876567789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      |+.....  .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......   +...+....     
T Consensus       172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~-----  241 (350)
T 4b9d_A          172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIISGS-----  241 (350)
T ss_dssp             ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTC-----
T ss_pred             ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCC-----
Confidence            9975432  122345789999999999999999999999999999999999999997654322   221111100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          . +    ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       242 ----~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          242 ----F-P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----C-C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----C-C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0 0    122345678999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-58  Score=441.88  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=211.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|++..++..     ||||++.+...   ...+.+.+|+.+|++++|||||++++++.+.+ 
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~-----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCE-----EEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence            5799999999999999999999887654     99999976432   23467889999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|||||||+||+|.+++...  +.+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       106 ---~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          106 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ---EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence               459999999999999999763  6899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+............+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.......   +...+...     
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~-----  249 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIKL-----  249 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT-----
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC-----
Confidence            9997655444444567899999999999999999999999999999999999999997654322   22211110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +    ..++..+++++.+||.+||..||++|||++|++.
T Consensus       250 ------~----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          250 ------E----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ------C----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ------C----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                  0    0122345678899999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.3e-58  Score=441.88  Aligned_cols=258  Identities=24%  Similarity=0.283  Sum_probs=210.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+.|.+.+.||+|+||+||+|+++.++..     ||||++......     .+|+.+|+.++|||||++++++.+.+   
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~-----vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~---  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQ-----CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP---  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT---
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCE-----EEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            35688889999999999999999887654     999999764322     47999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGl  254 (441)
                       .+|||||||+||+|.++|...  +.+++..+..|+.||+.||.|||++   +||||||||+||||+.+| .+||+|||+
T Consensus       124 -~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          124 -WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             -EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             -EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence             459999999999999999763  6799999999999999999999998   999999999999999987 599999999


Q ss_pred             CCCCCCCCCc---ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          255 ARLGPSDGLS---HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |+........   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+...      
T Consensus       198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------  271 (336)
T 4g3f_A          198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------  271 (336)
T ss_dssp             CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------
T ss_pred             CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------
Confidence            9876543221   1233468999999999999999999999999999999999999999765443222111100      


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                               +......+..+++.+.++|.+||+.||++|||+.|+++.|..++...
T Consensus       272 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          272 ---------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             ---------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                     00001233456788999999999999999999999999999887654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.5e-58  Score=446.57  Aligned_cols=270  Identities=25%  Similarity=0.377  Sum_probs=224.4

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCC-CCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEH-PNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~  172 (441)
                      ..++|++.+.||+|+||+||+|.+...+.....+.||||.+...... ..+.+.+|+.+|.+++| ||||+++|+|...+
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            34789999999999999999999998877777888999999765443 34678999999999965 99999999997653


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                      .   .++||||||++|+|.++|....              ...+++..++.|+.||+.||.|||++   +||||||||+|
T Consensus       142 ~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N  215 (353)
T 4ase_A          142 G---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  215 (353)
T ss_dssp             S---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             C---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence            2   2489999999999999997532              24589999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchh
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS  317 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~  317 (441)
                      |||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.......
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997665544445567889999999999999999999999999999999998 999997654322


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      .  +...+...              .....+..+++++.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus       296 ~--~~~~i~~g--------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 E--FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             H--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            1  11111110              01122334567899999999999999999999999999999865

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-57  Score=430.52  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      ++.+.||+|+||+||+|.+..++..     ||+|++.....  ...+.+.+|+.+|++++|||||+++++|.........
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVE-----VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeE-----EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            5666899999999999999877654     99999875433  2346789999999999999999999999765433345


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeecCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLAR  256 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~  256 (441)
                      .|||||||+||+|.+++..  ...+++..+..|+.||+.||.|||++ .++||||||||+||||+ .++.+||+|||+|+
T Consensus       104 ~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            7999999999999999976  36899999999999999999999987 12399999999999997 48999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      .....    ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......  .+...+....       
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~~~~-------  246 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGV-------  246 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTC-------
T ss_pred             eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHHcCC-------
Confidence            64332    3456799999999999865 69999999999999999999999996543221  1222111110       


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .....+..+++++.+||.+||+.||++|||+.++++
T Consensus       247 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  011122234567899999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-57  Score=449.95  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.|++.+.||+|+||.||+|.++.++..     ||||++........+.+.+|+.+|+.++|||||+++++|.+.+    
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~-----vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKL-----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCE-----EEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----
Confidence            5699999999999999999999887754     9999998766666677899999999999999999999998776    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      .+|||||||+||+|.+++..   ..+++..+..|+.||+.||.|||++   +||||||||+||||+.+|.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            45999999999999999975   4699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||..........   .+.....      
T Consensus       296 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~~------  364 (423)
T 4fie_A          296 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNLP------  364 (423)
T ss_dssp             ECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCC------
T ss_pred             ECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCCC------
Confidence            764432  23456899999999999999999999999999999999999999997654333222   2211110      


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          +.+  .....+++.+.+||.+||..||++|||+.|+++
T Consensus       365 ----~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          365 ----PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                111  112245678999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-56  Score=420.77  Aligned_cols=246  Identities=25%  Similarity=0.428  Sum_probs=192.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|.+..++.     .||||++.+....   ....+.+|+.+|+.++|||||++++++.+.+ 
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQ-----KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCC-----EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence            589999999999999999999877665     4999999764332   2457889999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..||||||| +|+|.+++..  .+.+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        87 ---~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           87 ---EIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             ---EEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ---EEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence               459999999 7899999976  46899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +|+......   ...+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||.......   +...+....   
T Consensus       158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~~~~---  228 (275)
T 3hyh_A          158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNISNGV---  228 (275)
T ss_dssp             CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTC---
T ss_pred             CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCC---
Confidence            998654322   3345799999999999998876 578999999999999999999997644322   222111110   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                  ..++..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       229 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        0122235678899999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-56  Score=426.61  Aligned_cols=246  Identities=26%  Similarity=0.382  Sum_probs=196.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||+||+|++..+..  ....||||++.+....  ....+.+|+.+|++++|||||++++++.+.+  
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSD--ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTT--TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCC--CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence            579999999999999999998754322  2345999999764322  2346788999999999999999999998766  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|||||||+||+|.+++..  .+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       100 --~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          100 --KLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             --EEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             --EEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccc
Confidence              45999999999999999976  36899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      |+......  ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||........   ...+...      
T Consensus       173 a~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~~------  241 (304)
T 3ubd_A          173 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMILKA------  241 (304)
T ss_dssp             EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC------
T ss_pred             ceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHHHcC------
Confidence            98643322  234467899999999999999999999999999999999999999976543322   2211110      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                               ...++..+++++.+||.+||+.||++||++
T Consensus       242 ---------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          242 ---------KLGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                     001223456789999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.2e-56  Score=425.08  Aligned_cols=270  Identities=24%  Similarity=0.317  Sum_probs=204.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||+||+|++.+       ..||||++...... ...+..|+..+.+++|||||+++++|...+....
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g-------~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT-------EEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            467888999999999999998753       24999999754322 1223356667778999999999999988765555


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG-----MDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .+|||||||++|+|.++|..   ..+++..++.++.|++.||.|||++     ..++||||||||+||||+.++.+||+|
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            67999999999999999976   4699999999999999999999975     234899999999999999999999999


Q ss_pred             cCCCCCCCCCCCc--ceeeceecccCcCCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCchh------
Q 013504          252 FGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTG------RLTYKSDIWSFGVFLYELITGRRPLDRNRPKS------  317 (441)
Q Consensus       252 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltG~~P~~~~~~~~------  317 (441)
                      ||+|+........  ......+||+.|||||++.+.      .++.++|||||||++|||+||..||.......      
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            9999865433221  123346899999999998764      36779999999999999999988774322110      


Q ss_pred             ------HHHHHHhhhhhcccccchhhhcCCCCCCc-chHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          318 ------EQKLLEWVRPHLTDAKKFTMILDPKLEGK-YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       318 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                            ...+...+         ....++|.+... ...+++..+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       232 ~~~~~~~~~~~~~~---------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          232 VPSDPSVEEMRKVV---------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCSSCCHHHHHHHH---------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccccchHHHHHHHH---------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                  00111000         001112222221 1235677899999999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-54  Score=412.55  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=191.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++++.||+|+||+||+|+++.++..     ||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCN-----YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCE-----EEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCE-----EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            35799999999999999999999877654     999998765433 346788999999999999999999999765431


Q ss_pred             --------CeeEEEEEeccCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          175 --------GIQRLLIYEYMPNRSVQDHLTSRFQ-ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       175 --------~~~~~lv~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                              ...+|||||||+||+|.+++..+.. ...++..++.|+.||+.||.|||++   +||||||||+||||+.++
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCC
Confidence                    2246899999999999999976422 2345667899999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCc----------ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCc
Q 013504          246 NAKLSDFGLARLGPSDGLS----------HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP  315 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~  315 (441)
                      .+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||.... 
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-  231 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-  231 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-
Confidence            9999999999876443211          12245689999999999999999999999999999999996   775311 


Q ss_pred             hhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       .....+..+.             +... .......++.+.+|+.+||+.||++|||+.++++
T Consensus       232 -~~~~~~~~~~-------------~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 -ERVRTLTDVR-------------NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHHHHH-------------TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHh-------------cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111111111             0011 1122344566788999999999999999999886

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-53  Score=419.34  Aligned_cols=276  Identities=22%  Similarity=0.291  Sum_probs=209.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      ++|++++.||+|+||+||+|.++.++..     ||||++.....  ...+.+.+|+.+|+.++|||||++++++..... 
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~-----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQ-----VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCE-----EEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence            5799999999999999999999887654     99999976432  234678899999999999999999999875432 


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                       ....+|||||||+ |+|.+++..  .+.+++..+..|+.||+.||.|||++   +||||||||+|||++.++.+||+||
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence             1235699999995 689999976  46899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCC--CcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          253 GLARLGPSDG--LSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |+|+......  ......+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.........+.......
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998654321  12234567999999999998775 56999999999999999999999998765443333222111100


Q ss_pred             cccc-------c---hhhhcCCCCCCc---chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          330 TDAK-------K---FTMILDPKLEGK---YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       330 ~~~~-------~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      ....       .   ....+.+.....   ....+++++.+||.+||..||++|||+.++++  ++.+.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            0000       0   000000000000   01124567899999999999999999999987  45443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-51  Score=423.55  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHH---HHHHHhccCCCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWV---TEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~---~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      .++|+++++||+|+||+||+|+++.++..     ||||++.+....   ....+.   .++.+++.++|||||+++++|.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~-----~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKM-----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCE-----EEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            36899999999999999999999887764     999999754321   112233   3467778889999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      +.+    .+|||||||+||+|.++|..  .+.+++..+..|+.||+.||.|||++   +||||||||+||||+.+|.+||
T Consensus       263 ~~~----~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          263 TPD----KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ECC----EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence            876    45999999999999999986  36899999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      +|||+|+.....    ...+.+||+.|||||++.. ..|+.++|||||||++|||++|..||..........+...+...
T Consensus       334 ~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~  409 (689)
T 3v5w_A          334 SDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM  409 (689)
T ss_dssp             CCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC
T ss_pred             cccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Confidence            999999875443    2345799999999999964 57999999999999999999999999754333322222221110


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                                     ...++..+++++.+||.+||+.||.+|++     +++|++
T Consensus       410 ---------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ---------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                           01223346678999999999999999998     688876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.4e-51  Score=423.71  Aligned_cols=253  Identities=23%  Similarity=0.390  Sum_probs=212.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.++.++..     ||+|++........+.+.+|+.+|+.++|||||+++++|.+..   
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~-----~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  227 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNN-----FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN---  227 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS---
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCE-----EEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence            36899999999999999999999887764     9999998776666678889999999999999999999998766   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC--CcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ--WNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFG  253 (441)
                       .+|||||||+||+|.++|..+ ...+++..+..++.||+.||.|||++   +|+||||||+||||+.+  +.+||+|||
T Consensus       228 -~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          228 -EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             -EEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             -EEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence             459999999999999999653 45799999999999999999999998   99999999999999854  889999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+.....   ......+||+.|||||++.+..|+.++|||||||++|||++|..||...........+...        
T Consensus       303 ~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~--------  371 (573)
T 3uto_A          303 LTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--------  371 (573)
T ss_dssp             SCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--------
T ss_pred             ceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC--------
Confidence            99976543   2345678999999999999999999999999999999999999999765443222221110        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +..+.......+++.+.+||.+||+.||.+||++.|+++
T Consensus       372 ------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          372 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  011111222345678899999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.2e-51  Score=400.05  Aligned_cols=204  Identities=26%  Similarity=0.383  Sum_probs=169.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      ..+.|++.+.||+|+||+||+|+++...  .....||||.+....  ...++.+|+.+|..+ +||||+++++++.+.+ 
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~-   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQV--GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND-   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTT--SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT-
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccC--CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC-
Confidence            4578999999999999999999875321  123469999987653  345678999999998 7999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEeec
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSDF  252 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DF  252 (441)
                         +.|||||||+||+|.+++.     .+++..+..++.||+.||.|||++   ||+||||||+||||+.+ +.+||+||
T Consensus        94 ---~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           94 ---HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             ---EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ---EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence               4599999999999999983     489999999999999999999998   99999999999999876 79999999


Q ss_pred             CCCCCCCCCCC--------------------------cceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHh
Q 013504          253 GLARLGPSDGL--------------------------SHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELIT  305 (441)
Q Consensus       253 Gla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt  305 (441)
                      |+|+.......                          .......+||+.|||||++.+. .|+.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99985433211                          0112346899999999998775 58999999999999999999


Q ss_pred             CCCCCCCCC
Q 013504          306 GRRPLDRNR  314 (441)
Q Consensus       306 G~~P~~~~~  314 (441)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999996544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.7e-50  Score=387.63  Aligned_cols=285  Identities=40%  Similarity=0.709  Sum_probs=235.1

Q ss_pred             hHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           89 FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        89 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      +.++...+++|.+.+.||+|+||.||+|.+.. +     ..||||++........+.+.+|+.+++.++||||+++++++
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-G-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-C-----CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECC-C-----CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            33445567899999999999999999998643 2     24999998876666677899999999999999999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ...+.    .++||||+++|+|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       105 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          105 DERNE----MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             CCTTC----CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred             cCCCe----EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence            87654    499999999999999996532  23589999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|..
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            99999999986543332333445679999999999999999999999999999999999999997665544433444432


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ... ........+++.+.......++..+.+++.+||+.||++||++.++++.|+.+++..
T Consensus       258 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          258 ESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            221 122334455666666777889999999999999999999999999999999987643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-48  Score=374.85  Aligned_cols=289  Identities=44%  Similarity=0.739  Sum_probs=234.7

Q ss_pred             CCccccchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCC
Q 013504           82 SNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPN  160 (441)
Q Consensus        82 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpn  160 (441)
                      ..++.+++.++....++|.+.+.||+|+||.||+|.+.. +     ..||||++...... ....+.+|+.+++.++|||
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-G-----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN   88 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-S-----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-C-----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence            446678999999999999999999999999999997543 2     24999998765432 2346889999999999999


Q ss_pred             eeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       161 Iv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                      |+++++++......    ++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+++..+|+||||||+|
T Consensus        89 iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           89 LLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             BCCCCEEECCSSCC----EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             ccceEEEEecCCce----EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            99999999876644    99999999999999997643  3359999999999999999999998755689999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC--ch
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNR--PK  316 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~--~~  316 (441)
                      ||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....  ..
T Consensus       165 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          165 ILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             EEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             EEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            999999999999999998754332 223445679999999999999899999999999999999999999995211  01


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                      .......|...... ........+..+........+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          244 DDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             cchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            11122333333222 334455566666777888899999999999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-48  Score=382.94  Aligned_cols=268  Identities=25%  Similarity=0.429  Sum_probs=217.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCC--CcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTE--DSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||+|.+....  .......||||.+..... .....+.+|+.+|+.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            368999999999999999999986432  223455799999976543 2346788999999999 899999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      +.    .|+||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       160 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  232 (370)
T 2psq_A          160 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  232 (370)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             CC----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence            64    499999999999999997642              23588999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999986544332223344567899999999999999999999999999999999 99999765433


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .....+.   ..              .....+..++..+.+++.+||+.||++||++.++++.|+.++...
T Consensus       313 ~~~~~~~---~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          313 ELFKLLK---EG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             GHHHHHH---TT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHh---cC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            2222111   10              011122345678999999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=376.70  Aligned_cols=268  Identities=28%  Similarity=0.437  Sum_probs=216.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||+|.+........+.+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~-----va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----   80 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEV-----MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK----   80 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCE-----EEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcE-----EEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC----
Confidence            6799999999999999999998876653     9999987766666778999999999999999999999998765    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             eeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccce
Confidence            359999999999999999764 46799999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcc------------eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          257 LGPSDGLSH------------VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       257 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      .........            ......||+.|+|||++.+..++.++|||||||++|||++|..||...........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---  233 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---  233 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---
Confidence            654332111            11246899999999999999999999999999999999999999865432211000   


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccCCC
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTP  392 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p  392 (441)
                              .......+.    ..+..+++.+.+++.+||+.||++||++.++++.|+.+........|
T Consensus       234 --------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~  289 (310)
T 3s95_A          234 --------LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP  289 (310)
T ss_dssp             --------BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             --------hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCccc
Confidence                    000000000    11123456788999999999999999999999999999877655443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.3e-48  Score=376.73  Aligned_cols=280  Identities=25%  Similarity=0.308  Sum_probs=211.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.+.+       ..||||++..... ......+|+.++++++||||+++++++.......
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT-------EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             hhhchhhheecccCceEEEEEEECC-------CEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            3689999999999999999998763       3499999975432 2345567999999999999999999998876555


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEecccCCCcEEEcCCCcEE
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM-------DFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                      ...++||||+++|+|.+++..   ..+++..++.++.|++.||.|||+..       ..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            567999999999999999976   46999999999999999999999741       22899999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      |+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.............
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999999765443333334456899999999998763     45567899999999999999999997543221111000


Q ss_pred             hhhhhcccccch----hhhcCCCCCCc-chHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          324 WVRPHLTDAKKF----TMILDPKLEGK-YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       324 ~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ............    .....+.+... .....+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            000000000000    00011111111 1224667899999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.8e-48  Score=371.82  Aligned_cols=260  Identities=29%  Similarity=0.486  Sum_probs=203.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+.+.       .||||++......  ..+.+.+|+.++++++||||+++++++.....
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWHGS-------DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTE-------EEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             hhHceeeeEeecCCCeEEEEEEECCC-------cEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            46899999999999999999987432       3999998765432  34678899999999999999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEcCCCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~~~~~~kl~  250 (441)
                          .++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++   +  |+||||||+|||++.++.+||+
T Consensus       109 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          109 ----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             ----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence                399999999999999997532 12389999999999999999999998   7  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....    
T Consensus       182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~----  255 (309)
T 3p86_A          182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----  255 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC----
T ss_pred             CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----
Confidence            999998643321  22345689999999999999999999999999999999999999997654432222111100    


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                  .....+..+++.+.+++.+||+.||.+||++.++++.|+.+++..
T Consensus       256 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 ------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                        011222345678999999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-47  Score=367.67  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=209.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++........+.+.+|+.+++.++||||+++++++...+.  
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--   91 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE--   91 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCC-----EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE--
Confidence            4689999999999999999999776654     499999876665566778899999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++..   ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        92 --~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           92 --LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             --EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             --EEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence              5999999999999999976   3699999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...............  .       
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~-------  232 (297)
T 3fxz_A          164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--G-------  232 (297)
T ss_dssp             EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--C-------
T ss_pred             eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C-------
Confidence            86544322  234568999999999999999999999999999999999999999765433222111100  0       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ......+..++..+.+++.+||+.||++||++.++++
T Consensus       233 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 ------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  0011123345678999999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=371.45  Aligned_cols=266  Identities=25%  Similarity=0.461  Sum_probs=214.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+..++.  ....||||.+..... ...+.+.+|+.+++.++||||+++++++.....  
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  124 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQ--RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL--  124 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTS--CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC--
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCC--CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc--
Confidence            679999999999999999999876543  234599999976532 334678899999999999999999999987664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       125 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          125 --AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             --CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             --cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence              49999999999999999653 45799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.   ..     
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~-----  270 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE---EG-----  270 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TT-----
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cC-----
Confidence            87544321 122334466889999999999999999999999999999999 999997654332222111   10     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhcc
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAET  389 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  389 (441)
                               .....+..++..+.+++.+||..||++||++.+|++.|+.+++....
T Consensus       271 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          271 ---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             ---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                     01112234567899999999999999999999999999999876443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.8e-48  Score=379.62  Aligned_cols=276  Identities=25%  Similarity=0.366  Sum_probs=222.5

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeE
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGY  167 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~  167 (441)
                      .+.....++|.+.+.||+|+||.||+|.+...........||||++...... ..+.+.+|+.++.++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            3344456889999999999999999999877665666778999999765432 346789999999999 89999999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCC------------------------------------------------
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ------------------------------------------------  199 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------  199 (441)
                      +...+.   ..++||||+++|+|.+++.....                                                
T Consensus        95 ~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           95 CTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             ECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            987543   24899999999999999976422                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCC
Q 013504          200 ----------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGL  263 (441)
Q Consensus       200 ----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  263 (441)
                                      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            1289999999999999999999998   999999999999999999999999999987654443


Q ss_pred             cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCC
Q 013504          264 SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK  342 (441)
Q Consensus       264 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (441)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.........  .......              
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~--------------  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEG--------------  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHT--------------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcC--------------
Confidence            444556789999999999999999999999999999999998 99999765432211  1111100              


Q ss_pred             CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       343 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .....+..+++.+.+++.+||+.||.+||++.++++.|+.++++.
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            001112234567999999999999999999999999999998653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=381.97  Aligned_cols=269  Identities=25%  Similarity=0.413  Sum_probs=213.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+...........||||++..... .....+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367999999999999999999987654444566799999975432 3345788999999999999999999999876644


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC---c
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF-----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---N  246 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~---~  246 (441)
                          ++||||+++|+|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++   .
T Consensus       150 ----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          150 ----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ----EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             ----EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence                99999999999999997642     24589999999999999999999998   999999999999999555   4


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........   +
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~---i  299 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---V  299 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---H
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H
Confidence            99999999974322222223345678999999999999999999999999999999998 9999976543322221   1


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      ....              ....+..++..+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus       300 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          300 TSGG--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HcCC--------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            1110              011122455678999999999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-47  Score=367.54  Aligned_cols=268  Identities=27%  Similarity=0.415  Sum_probs=219.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|.+.+.||+|+||.||+|.+...........||||.+..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            3478999999999999999999986554444456799999976432 334678899999999999999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQ----------------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF  231 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  231 (441)
                          .++||||+++|+|.+++.....                      ..+++..++.++.||+.||.|||++   +|+|
T Consensus       101 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A          101 ----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence                3999999999999999976422                      3488999999999999999999998   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL  310 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~  310 (441)
                      |||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986654433333344567899999999999899999999999999999999 99999


Q ss_pred             CCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ...........+...                 .....+..++..+.+++.+||+.||++||++.++++.|++++..
T Consensus       254 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          254 PGIPPERLFNLLKTG-----------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TTCCGGGHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHhhcC-----------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            765543322222110                 01112234567899999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-47  Score=370.74  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||||++.....  ...+.+.+|+.+|+.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGRE-----VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCE-----EEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence            46899999999999999999998776654     99999876532  33467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           88 ---TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             ---EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ---EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence               459999999999999999763  6799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++......   .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+.   ...   
T Consensus       160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~---  230 (328)
T 3fe3_A          160 FSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---RGK---  230 (328)
T ss_dssp             CCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCC---
T ss_pred             CceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC---
Confidence            998654322   23457899999999999888875 78999999999999999999997654332222111   100   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                  ...+..++..+.+++.+||..||.+|||+.++++
T Consensus       231 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 ------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                        0112234567889999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-47  Score=370.54  Aligned_cols=263  Identities=27%  Similarity=0.446  Sum_probs=209.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+..++... ...||+|.+..... ...+.+.+|+.++++++||||+++++++....   
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----C-CEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS---
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceE-EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence            67999999999999999999987765543 33479998865432 34567899999999999999999999998643   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        91 --~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             --EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             --eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence              38999999999999999764 46799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+....        
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------  236 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------  236 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--------
Confidence            86544433333445677889999999999999999999999999999999 999997665443332222110        


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               ....+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                     1112223556789999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-46  Score=366.91  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||+|++....   ......+.+|+.+|+.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCE-----EEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            36899999999999999999998876654     9999987542   223456889999999999999999999998766


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        79 ----~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 ----RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence                45999999999999999976  35799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||........   ...+..   ..
T Consensus       150 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~---~~  221 (337)
T 1o6l_A          150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILM---EE  221 (337)
T ss_dssp             TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH---CC
T ss_pred             cchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HHHHHc---CC
Confidence            9998643322  234567899999999999999999999999999999999999999975443221   111110   00


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                  ..++..+++.+.++|.+||+.||++||     ++.+|++
T Consensus       222 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                        012234567899999999999999999     8999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-46  Score=359.32  Aligned_cols=283  Identities=38%  Similarity=0.633  Sum_probs=226.4

Q ss_pred             CccccchHHHHHHhcCCccc------ceeecccceeEEEEEEcCCCCcccceeEEEEEccccC----chhhHHHHHHHHH
Q 013504           83 NLRVFTFSELKTATKNFSRS------LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG----LQGHKEWVTEVNV  152 (441)
Q Consensus        83 ~~~~~~~~~~~~~~~~f~~~------~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~i  152 (441)
                      ....|++.++..++++|...      +.||+|+||.||+|.+.+       ..||||++....    ....+.+.+|+.+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~   83 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAMVDITTEELKQQFDQEIKV   83 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS-------CEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC-------ceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence            45678999999999998887      899999999999998632       249999986532    2234678899999


Q ss_pred             hccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 013504          153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR-FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF  231 (441)
Q Consensus       153 l~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  231 (441)
                      ++.++||||+++++++...+.    .++||||+++|+|.+++... ....+++..++.++.|++.||.|||++   +|+|
T Consensus        84 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H  156 (307)
T 2nru_A           84 MAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIH  156 (307)
T ss_dssp             HHHCCCTTBCCEEEEECSSSS----CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHhcCCCCeEEEEEEEecCCc----eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceec
Confidence            999999999999999987664    39999999999999999743 245799999999999999999999998   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD  311 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~  311 (441)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus       157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  235 (307)
T 2nru_A          157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD  235 (307)
T ss_dssp             SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence            99999999999999999999999986554333333445689999999998864 58899999999999999999999997


Q ss_pred             CCCchhH-HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          312 RNRPKSE-QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       312 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ....... .......   ......+...+++.+ ...+...+..+.+++.+||+.||.+||++.+|++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          236 EHREPQLLLDIKEEI---EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTBSSSBTTHHHHHH---HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cCcchHHHHHHHHHh---hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            6443221 1111111   111122233333333 2345678889999999999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=373.35  Aligned_cols=268  Identities=25%  Similarity=0.412  Sum_probs=219.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||+|.+.....  ......||||++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            3689999999999999999999875432  23445699999976543 2346788999999999 999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      +..    ++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       148 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          148 GPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             SSC----EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             Cce----EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            644    99999999999999998643              24599999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      ||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654433333445678999999999999999999999999999999999 99999765433


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ...   ..+....              ....+..++..+.+++.+||+.||++||++.+|++.|+.++...
T Consensus       301 ~~~---~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          301 ELF---KLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHH---HHHHTTC--------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHH---HHHHcCC--------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            222   2111110              01112235678999999999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-46  Score=364.25  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=214.3

Q ss_pred             ccchHHHHHHhcC----------CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc
Q 013504           86 VFTFSELKTATKN----------FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV  155 (441)
Q Consensus        86 ~~~~~~~~~~~~~----------f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~  155 (441)
                      .+++++++.+++.          |...+.||+|+||.||+|.+..++.     .||||++........+.+.+|+.+++.
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR-----QVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCc-----EEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            4677777777654          7778899999999999999876554     499999987665666788999999999


Q ss_pred             CCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 013504          156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK  235 (441)
Q Consensus       156 l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK  235 (441)
                      ++||||+++++++...+    ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +|+|||||
T Consensus        99 l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlk  168 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK  168 (321)
T ss_dssp             CCCTTBCCEEEEEEETT----EEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             CCCCCcceEEEEEEECC----EEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCC
Confidence            99999999999998765    35999999999999999864   4799999999999999999999998   99999999


Q ss_pred             CCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCc
Q 013504          236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP  315 (441)
Q Consensus       236 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~  315 (441)
                      |+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       169 p~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          169 SDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             HHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999998654332  123456899999999999999999999999999999999999999976543


Q ss_pred             hhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          316 KSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....   ..+....          .+.+  .....++..+.+++.+||+.||++||++.++++
T Consensus       247 ~~~~---~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 VQAM---KRLRDSP----------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHH---HHHHHSS----------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHH---HHHhcCC----------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2221   1111110          0111  112235577899999999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-47  Score=370.42  Aligned_cols=270  Identities=27%  Similarity=0.433  Sum_probs=216.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|.+.+.||+|+||.||+|.+...........||||.+...... ....+.+|+.+++.++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45789999999999999999999876544444567999999865433 34678899999999999999999999987654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF----------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF  231 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  231 (441)
                          .++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||++   +|+|
T Consensus       125 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          125 ----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             ----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence                499999999999999997632                      15789999999999999999999998   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL  310 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~  310 (441)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999975433222223345678999999999999999999999999999999999 99999


Q ss_pred             CCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      ........   ...+...    .          ....+..++..+.+++.+||+.||++||++.++++.|+++.+...
T Consensus       278 ~~~~~~~~---~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          278 YGMAHEEV---IYYVRDG----N----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTSCHHHH---HHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCChHHH---HHHHhCC----C----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            76543222   1111110    0          011223456789999999999999999999999999999876543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-47  Score=378.86  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+...... ....+.+|+.+|+.++||||+++++++...+. 
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNT-----LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCe-----EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC-
Confidence            4689999999999999999999876554     4999998754322 23567899999999999999999999987654 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++|+|.+++... +..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       187 ---~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          187 ---IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ---cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence               39999999999999999754 35689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.   ..     
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~---~~-----  331 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---KG-----  331 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH---TT-----
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC-----
Confidence            986433211111122346788999999999999999999999999999998 999997654332222211   10     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               .....+..++..+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus       332 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 ---------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                     01112234567899999999999999999999999999998653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=370.74  Aligned_cols=269  Identities=24%  Similarity=0.409  Sum_probs=215.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+...........||||.+..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            478999999999999999999986655555566799999975432 2346788999999999 99999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQ---------------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR  232 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  232 (441)
                          .++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||++   +|+||
T Consensus       124 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          124 ----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             ----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             ----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence                4999999999999999976432                     2479999999999999999999998   99999


Q ss_pred             ccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 013504          233 DFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLD  311 (441)
Q Consensus       233 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~  311 (441)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986544433334456778999999999999999999999999999999998 999997


Q ss_pred             CCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ........  .......              .....+..++..+.+++.+||+.||.+||++.++++.|+.++...
T Consensus       277 ~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          277 GIPVDANF--YKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TCCCSHHH--HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCCcHHHH--HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            65432211  1111110              111122235678999999999999999999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-46  Score=370.22  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=207.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      ..+.|.+.+.||+|+||.||+|.+..++..     ||+|.+......      ..+.+.+|+.+|+.++||||+++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-----~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLE-----YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCE-----EEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence            346799999999999999999998876654     999998765432      246788999999999999999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC---
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---  245 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~---  245 (441)
                      .+..    ..++||||++||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++   
T Consensus        85 ~~~~----~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           85 ENRT----DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred             EeCC----EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCc
Confidence            8765    45999999999999999976  46799999999999999999999998   999999999999998877   


Q ss_pred             -cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          246 -NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                       .+||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........   
T Consensus       156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~---  229 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---  229 (361)
T ss_dssp             CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---
T ss_pred             cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence             79999999998754432   23456899999999999999999999999999999999999999976543222111   


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +....           ..+.......++..+.+||.+||..||++||++.++++
T Consensus       230 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          230 ITAVS-----------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHTTC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhcC-----------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11100           00011112234577899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9e-47  Score=371.78  Aligned_cols=281  Identities=18%  Similarity=0.236  Sum_probs=215.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhh-----------HHHHHHHHHhccCCCCCeeeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-----------KEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~hpnIv~l  164 (441)
                      .++|.+.+.||+|+||.||+|.+..+........||||++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            468999999999999999999998776555556799999876542211           234456777888899999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--  242 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--  242 (441)
                      ++++..........||||||+ +++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            999987654444579999999 99999999763 46799999999999999999999998   999999999999998  


Q ss_pred             CCCcEEEeecCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          243 EQWNAKLSDFGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999765432111     11234569999999999999999999999999999999999999997532221


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      ..  .........  .....++++.+.   ...++..+.+++..||+.+|.+||++.+|++.|+++++...
T Consensus       269 ~~--~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          269 KY--VRDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HH--HHHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH--HHHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            11  111110000  011111111111   01345789999999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-47  Score=365.84  Aligned_cols=280  Identities=24%  Similarity=0.402  Sum_probs=212.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.+..... .....||||++........+.+.+|+.++++++||||+++++++...+.. 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-   86 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-   86 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCS-SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT-
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccC-CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence            3689999999999999999998643221 23446999999876656667889999999999999999999999765432 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        87 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           87 -NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             -ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence             348999999999999999764 34699999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc--
Q 013504          256 RLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA--  332 (441)
Q Consensus       256 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--  332 (441)
                      +........ .......+|+.|+|||++.+..++.++||||||+++|+|++|..|+......    ............  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI  237 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence            875433211 1223456788899999999999999999999999999999999998642111    000000000000  


Q ss_pred             -cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          333 -KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       333 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                       ......+........+..++..+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence             000000111111223345678899999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.3e-47  Score=367.62  Aligned_cols=263  Identities=26%  Similarity=0.444  Sum_probs=211.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+..++... ...|++|.+.... ......+.+|+.++..++||||+++++++...    
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESI-KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS----   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSC-CEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS----
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceE-EEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence            57999999999999999999988765543 3448888875443 22335667899999999999999999998633    


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        88 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           88 -SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             -SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             -ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence             248999999999999999754 35789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  235 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------  235 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------
Confidence            97655444444456778899999999999999999999999999999999 9999986654433333221110       


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                ...+..++..+.+++.+||..||.+||++.++++.|+.+...
T Consensus       236 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 ----------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                      011112344678999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7e-47  Score=361.63  Aligned_cols=264  Identities=23%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||+|.+.....   ...+.+.+|+.++..++||||+++++++...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNI-----KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCS-----EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCC-----eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence            4679999999999999999999876654     399999864332   23467889999999999999999999997665


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        85 ----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           85 ----CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence                459999999999999999763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ........   
T Consensus       156 g~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~~---  229 (294)
T 4eqm_A          156 GIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQDSV---  229 (294)
T ss_dssp             SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHSSCC---
T ss_pred             CCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhhccC---
Confidence            9998654332 12234467999999999999999999999999999999999999999765432211  11111000   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-CHHHHHHHHHHHHhhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-KMSEVVEVLNKIVDAA  387 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  387 (441)
                              +.........+++.+.+++.+||+.||++|| +++++.+.|+.++...
T Consensus       230 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          230 --------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             --------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             --------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                    0001112234567899999999999999998 8999999998876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.8e-47  Score=363.33  Aligned_cols=269  Identities=26%  Similarity=0.420  Sum_probs=219.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+...........||||.+..... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            368999999999999999999976544445566799999976543 2346788999999999 99999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQ----------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      .    ++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       102 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A          102 T----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             C----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             c----EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            4    999999999999999976432                2589999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987655443334445678899999999999999999999999999999999 99999765432


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ...  ........              ....+..++..+.+++.+||+.||.+||++.++++.|++++...
T Consensus       255 ~~~--~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 SKF--YKMIKEGF--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHH--HHHHHHTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHH--HHHhccCC--------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            211  11111100              01112235578999999999999999999999999999988653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-46  Score=371.17  Aligned_cols=264  Identities=26%  Similarity=0.482  Sum_probs=201.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+.....  ....||||.+..... ...+.+.+|+.++++++||||+++++++.....  
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  120 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSK--KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP--  120 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTS--CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS--
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCC--CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc--
Confidence            589999999999999999998763221  233599999976432 334678999999999999999999999987654  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       121 --~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          121 --VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             --CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             --eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence              49999999999999999753 45799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........   ...+....    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~~~~----  267 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGY----  267 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHHTTE----
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC----
Confidence            875433211 11223356788999999999999999999999999999998 9999976543322   22111110    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                ....+..++..+.+++.+||+.||++||++.+|++.|+.++...
T Consensus       268 ----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          268 ----------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ----------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ----------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                      01112245678999999999999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=363.67  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=209.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+..++... ...|++|.+.... ......+.+|+.+++.++||||+++++++....  
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSC-CEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceE-EEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence            367999999999999999999988776543 3347888876543 234577889999999999999999999998654  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        91 ---~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           91 ---VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             ---EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             ---ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence               48999999999999999764 45799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+...        
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--------  235 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------  235 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------
Confidence            987654433333445567889999999999999999999999999999999 99999766544333222211        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               .....+..++..+.+++.+||..||.+||++.++++.|+.+...
T Consensus       236 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          236 ---------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                     01112223556789999999999999999999999999999854

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-46  Score=357.57  Aligned_cols=276  Identities=25%  Similarity=0.318  Sum_probs=215.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.++||+|+||.||+|.+..++.     .||||++..... ...+.+.+|+.+|++++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD-----LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCc-----EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            3679999999999999999999887655     499999876442 3346778999999999999999999999866533


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE----cCCCcEEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl----~~~~~~kl  249 (441)
                        ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++   +|+||||||+|||+    +.++.+||
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           83 --HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             --CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             --eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence              4589999999999999997642 23499999999999999999999998   99999999999999    78888999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCch-hHHH
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ--------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK-SEQK  320 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~-~~~~  320 (441)
                      +|||+++......   ......||+.|+|||++.        +..++.++|||||||++|||++|..||...... ....
T Consensus       158 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  234 (319)
T 4euu_A          158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (319)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred             ccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence            9999998754432   233467999999999886        577899999999999999999999999644322 2222


Q ss_pred             HHHhhhhhcccc----------cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDA----------KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       321 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ....+.......          ..+...-+..........++..+.+++.+||+.||++||++.++++...+..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222221111100          0000000111223456788899999999999999999999999999887653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.6e-46  Score=357.97  Aligned_cols=264  Identities=27%  Similarity=0.413  Sum_probs=204.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc--CCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+.+       ..||||++...   ....+.+|.+++..  ++||||+++++++....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQG-------ENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETT-------EEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECC-------EEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            35789999999999999999998742       24999998654   23455567666665  79999999999987765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecccCCCcEEEcCC
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH--------EGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ......++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred             CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence            544567999999999999999964   57999999999999999999999        76   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcc--eeeceecccCcCCccccccC------CCCccccchhHHHHHHHHHhC----------
Q 013504          245 WNAKLSDFGLARLGPSDGLSH--VSTAVVGTIGYAAPEYIQTG------RLTYKSDIWSFGVFLYELITG----------  306 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltG----------  306 (441)
                      +.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999997543322111  12345899999999999876      445789999999999999999          


Q ss_pred             CCCCCCCCchhH--HHHHHhhhhhcccccchhhhcCCCCC-CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          307 RRPLDRNRPKSE--QKLLEWVRPHLTDAKKFTMILDPKLE-GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       307 ~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ..||........  ..........         ...+.+. ......++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVD---------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhcc---------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            888854322111  1111111000         0011111 123346788999999999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-46  Score=354.16  Aligned_cols=257  Identities=27%  Similarity=0.486  Sum_probs=210.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+..+.      .||+|++..... ..+.+.+|+.++++++||||+++++++.+...   
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   79 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP---   79 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             hhceeeheecCCCccEEEEEEecCCC------eEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc---
Confidence            67999999999999999999976432      499999976543 34678899999999999999999999987654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           80 -ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             -EEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             -eEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence             49999999999999999754 45799999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........   +....      
T Consensus       155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~---~~~~~------  224 (269)
T 4hcu_A          155 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGF------  224 (269)
T ss_dssp             GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHTTC------
T ss_pred             cccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HhcCc------
Confidence            643321 112233467888999999999999999999999999999999 9999976543322111   11100      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              ....+..++..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus       225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 --------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                    0111223456789999999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=361.78  Aligned_cols=252  Identities=24%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      .+.|.+.+.||+|+||.||+|.+..++..     ||+|.+......      ....+.+|+.+|+.++||||+++++++.
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQ-----YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCE-----EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcE-----EEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            46799999999999999999998876653     999998764432      2467889999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC----
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW----  245 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~----  245 (441)
                      ...    ..++||||+++|+|.+++..  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    
T Consensus        85 ~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           85 NKT----DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred             eCC----EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence            755    45999999999999999975  46799999999999999999999998   999999999999999887    


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus       156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  232 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV  232 (326)
T ss_dssp             CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred             CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence            79999999998754322   233467999999999999999999999999999999999999999765432222111110


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .              ..........++..+.+++.+||..||++||++.++++
T Consensus       233 ~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 N--------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C--------------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C--------------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0              00111112234577899999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-46  Score=354.04  Aligned_cols=263  Identities=26%  Similarity=0.413  Sum_probs=202.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.  ....||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.   
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCC--CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC---
Confidence            3689999999999999999999875432  234589999876433 2346788999999999999999999998532   


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++..+ ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        89 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           89 --PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             --SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             --ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence              248999999999999999764 35799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.   ..     
T Consensus       163 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~---~~-----  233 (281)
T 1mp8_A          163 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NG-----  233 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TT-----
T ss_pred             ccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH---cC-----
Confidence            98754332 112334567889999999999999999999999999999997 999997654433222111   00     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                               .....+..++..+.+++.+||+.||++||++.++++.|+++++..
T Consensus       234 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          234 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                     001122345678999999999999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.6e-46  Score=376.31  Aligned_cols=254  Identities=29%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+.+.       .||||.+....  ..+.+.+|+.+|++++||||+++++++.....  
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~-------~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  260 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--  260 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTE-------EEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS--
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCC-------eEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC--
Confidence            46789999999999999999987532       49999997654  45788999999999999999999999876542  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       261 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          261 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             -ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence             259999999999999999876555689999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.....     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.   ..      
T Consensus       337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~------  402 (450)
T 1k9a_A          337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG------  402 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH---TT------
T ss_pred             cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC------
Confidence            854322     223467899999999999999999999999999999998 999997654433222111   10      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              .....+..+++.+.+++.+||..||++||++.++++.|+.+...
T Consensus       403 --------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 --------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                    01122335668899999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-46  Score=362.59  Aligned_cols=271  Identities=24%  Similarity=0.387  Sum_probs=199.7

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+..++..  ...||||.+....  ....+.+.+|+.+++.++||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGS--FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCc--ceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            357899999999999999999987765431  1248999987653  234577899999999999999999999998755


Q ss_pred             cCCe--eEEEEEeccCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          173 ERGI--QRLLIYEYMPNRSVQDHLTSRF----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       173 ~~~~--~~~lv~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ..+.  ..++||||+++|+|.+++....    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            3211  2389999999999999986432    22689999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999987654433333445567889999999999999999999999999999999 99999765543322211100


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .                 ....+..++..+.+++.+||+.||++||++.++++.|++++...
T Consensus       256 ~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          256 N-----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             C-----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             C-----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            0                 01122345578999999999999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=370.51  Aligned_cols=249  Identities=26%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||||++.....   .....+.+|..+|..+ +||||+++++++...
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-----~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDL-----YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCE-----EEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            47899999999999999999998876654     99999875422   2345678899999988 799999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        97 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~D  167 (353)
T 3txo_A           97 D----RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLAD  167 (353)
T ss_dssp             S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcc
Confidence            6    459999999999999999763  6799999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........   ..+...   
T Consensus       168 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i~~~---  239 (353)
T 3txo_A          168 FGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EAILND---  239 (353)
T ss_dssp             CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHC---
T ss_pred             ccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---HHHHcC---
Confidence            99998643322  2345678999999999999989999999999999999999999999765433221   111110   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH------HHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM------SEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  378 (441)
                                  ...++..++..+.+++.+||+.||++||++      .++++
T Consensus       240 ------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 ------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                        001222355778999999999999999998      77776

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.8e-46  Score=353.99  Aligned_cols=253  Identities=28%  Similarity=0.496  Sum_probs=205.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-------hHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-------HKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|.+.......       .+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKS-----VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCC-----EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             ccceehhccccCCceeEEEEEEcCCce-----EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            679999999999999999999876655     39999986543321       167889999999999999999999986


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEcCCCc-
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLDEQWN-  246 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~~~~~-  246 (441)
                      ...      ++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +  |+||||||+|||++.++. 
T Consensus        94 ~~~------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           94 NPP------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             TTT------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred             CCC------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence            543      7999999999999998754 46799999999999999999999998   7  999999999999988776 


Q ss_pred             ----EEEeecCCCCCCCCCCCcceeeceecccCcCCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          247 ----AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ--TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       247 ----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                          +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|..||..........
T Consensus       164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  238 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF  238 (287)
T ss_dssp             CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred             CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence                99999999985432     244568999999999983  4567889999999999999999999997654433221


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                      ......              .......+..+++.+.+++.+||+.||++||++.++++.|+++
T Consensus       239 ~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 INMIRE--------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHH--------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHhc--------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111110              1111122334567899999999999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-46  Score=365.45  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||||++...... ..+.+.+|+.+++.++||||+++++++...+  
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcE-----EEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            46899999999999999999998876654     999998654332 2356789999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+||||+++|+|.+++..  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        79 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           79 --IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             --EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             --eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence              35999999999999999965  45799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+....     
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~-----  225 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-----  225 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC-----
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc-----
Confidence            986543332233445789999999999987775 7789999999999999999999975443221 111111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               ........++..+.+|+.+||+.||++||++.++++
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 ---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                     000111235577889999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-46  Score=363.06  Aligned_cols=265  Identities=16%  Similarity=0.218  Sum_probs=212.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+.....  ...+.+|+.+++.+ +||||+++++++....  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--   78 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNE-----YVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--   78 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTE-----EEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCc-----EEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--
Confidence            4689999999999999999999876654     499999875432  34578999999999 9999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-----EEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-----AKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-----~kl  249 (441)
                        ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.     +||
T Consensus        79 --~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           79 --YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             --ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence              359999999 99999999764 46899999999999999999999998   9999999999999999887     999


Q ss_pred             eecCCCCCCCCCCCcc-----eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          250 SDFGLARLGPSDGLSH-----VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            9999998654332111     12457899999999999999999999999999999999999999987654443333322


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      +....... ...         .....++ .+.+++..||+.||.+||++.+|++.|+++.+..
T Consensus       232 i~~~~~~~-~~~---------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          232 IGDTKRAT-PIE---------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHS-CHH---------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhhccC-CHH---------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            21110000 000         0011234 8999999999999999999999999999988654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.6e-47  Score=367.01  Aligned_cols=268  Identities=24%  Similarity=0.395  Sum_probs=218.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.......||+|.+..... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            468999999999999999999998877666666799999976543 2346788999999999 89999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                          .++||||+++|+|.+++....            ...+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus       125 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          125 ----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             ----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             ----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence                499999999999999997532            34689999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQK  320 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~  320 (441)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......... 
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-  276 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-  276 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence            9999999999999986544333333445678899999999999999999999999999999999 99999765432211 


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                       ........              ....+..++..+.+++.+||+.||.+||++.+|++.|+++...
T Consensus       277 -~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 -YKLVKDGY--------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -HHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHhcCC--------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence             11111100              0111123456789999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=361.63  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=206.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+   
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKK-----TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME---   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT---
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCc-----EEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC---
Confidence            4689999999999999999999877654     49999987543 33456789999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC--CCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE--QWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~--~~~~kl~DFG  253 (441)
                       ..++||||++||+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.  ++.+||+|||
T Consensus        75 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           75 -ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             -EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             -EEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence             359999999999999999753 35799999999999999999999998   9999999999999987  7899999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+.....   
T Consensus       150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~---  220 (321)
T 1tki_A          150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIMNAEY---  220 (321)
T ss_dssp             TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHHTCC---
T ss_pred             CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHcCCC---
Confidence            998764432   344578999999999999888999999999999999999999999765432221   11111000   


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              .........++..+.+++.+||..||.+|||+.++++
T Consensus       221 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          221 --------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    0000111234678999999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=368.76  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=207.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+|+.++||||+++++++.+.. 
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~-----~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-   88 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKM-----YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-   88 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence            6799999999999999999998877654     99999875432   23467889999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        89 ---~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           89 ---DMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ---EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence               35999999999999999976  46799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +++......   .....+||+.|+|||++.+   ..++.++|||||||++|||++|..||................... 
T Consensus       161 ~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-  236 (384)
T 4fr4_A          161 IAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-  236 (384)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-
T ss_pred             eeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-
Confidence            998654332   3456789999999999864   458999999999999999999999997654444333333221111 


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-HHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  378 (441)
                                    ..++..++..+.+||.+||+.||.+||+ +++|+.
T Consensus       237 --------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                          1122345678999999999999999998 777765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.8e-46  Score=354.06  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=218.7

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|.+.... ...+.+.+|+.+++.++||||+++++++..... 
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTE-----EEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCE-----EEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-
Confidence            45789999999999999999999887654     49999987543 345778899999999999999999999977654 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++++|.+++.......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        84 ---~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           84 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence               49999999999999999876667799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...        
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------  228 (288)
T 3kfa_A          158 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------  228 (288)
T ss_dssp             GGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------
T ss_pred             ceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc--------
Confidence            98765432 223445678899999999999999999999999999999999 99999765543332222110        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               .....+..+++.+.+++.+||..||.+||++.++++.|+.+...
T Consensus       229 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          229 ---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                     11112234567899999999999999999999999999998865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=373.49  Aligned_cols=255  Identities=21%  Similarity=0.324  Sum_probs=206.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .+|+|++......  ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~-----~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQ-----EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTE-----EEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCc-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence            346789999999999999999999877664     4999998765432  345688999999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc---CCCcEE
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAK  248 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~---~~~~~k  248 (441)
                      +    ..|+|||||+||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+|
T Consensus        83 ~----~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           83 G----HHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             S----EEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             C----EEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            5    35999999999999999987  36799999999999999999999998   999999999999998   567899


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      |+|||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+...
T Consensus       154 L~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~---~~i~~~  228 (444)
T 3soa_A          154 LADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY---QQIKAG  228 (444)
T ss_dssp             ECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHT
T ss_pred             EccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHhC
Confidence            99999998654432  2234568999999999999999999999999999999999999999765432222   111111


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..           .........+++.+.+|+.+||+.||++||++.++++
T Consensus       229 ~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 AY-----------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CC-----------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-----------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00           0011111245678999999999999999999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.1e-46  Score=351.73  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=210.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..+.      .||+|.+..... ...++.+|+.++.+++||||+++++++.....  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   77 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQY------DVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--   77 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTE------EEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             hhheeeeeeeccCCCceEEEEEecCce------eEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc--
Confidence            468999999999999999999876432      399999976543 34678899999999999999999999976653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           78 --IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             --eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence              49999999999999999764 34699999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+....        
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  222 (268)
T 3sxs_A          152 RYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--------  222 (268)
T ss_dssp             EECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------
T ss_pred             eecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC--------
Confidence            8654432 222334566788999999999899999999999999999999 999997654332222111100        


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               ....+..+++.+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus       223 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 ---------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                     0011122456789999999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-46  Score=359.12  Aligned_cols=246  Identities=25%  Similarity=0.420  Sum_probs=205.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||.||+|....++.     .||+|++.....   ...+.+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGR-----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            3679999999999999999999887665     499999875432   23456788999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        80 ----~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 ----QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence                45999999999999999976  46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........   ..+..   . 
T Consensus       151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~---~-  218 (318)
T 1fot_A          151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---EKILN---A-  218 (318)
T ss_dssp             SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHH---C-
T ss_pred             CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---C-
Confidence            999865432     34568999999999999999999999999999999999999999764432211   11110   0 


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                               .  ..++..++..+.+++.+||..||++||     +++++++
T Consensus       219 ---------~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 ---------E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---------C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                     0  012223557889999999999999999     8888886

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-45  Score=366.92  Aligned_cols=251  Identities=25%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      ++|.+.++||+|+||.||+|++..++.     .||+|++.+....   ....+.+|..+|.++ +||||+++++++.+..
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            679999999999999999999887664     4999998765322   234577899999886 8999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||++||+|..++...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus       127 ----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          127 ----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeec
Confidence                459999999999999999763  6799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh------HHHHHHhhh
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS------EQKLLEWVR  326 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~------~~~~~~~~~  326 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...+...+.
T Consensus       198 Gla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          198 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             TTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             ceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            9998643322  23456789999999999999999999999999999999999999996432111      111111110


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH------HHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM------SEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  378 (441)
                      .             ..  ..++..++..+.+||.+||+.||++||++      .+|++
T Consensus       276 ~-------------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          276 E-------------KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             H-------------CC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             c-------------cc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            0             00  11233456789999999999999999985      56665

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-46  Score=383.12  Aligned_cols=260  Identities=26%  Similarity=0.456  Sum_probs=215.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||.+.... ...+.+.+|+.+|++++||||++++++|..... 
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-  290 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-  290 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTE-----EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCe-----EEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-
Confidence            34678999999999999999999876543     49999997654 345789999999999999999999999987664 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .+|||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       291 ---~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          291 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             ---EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence               39999999999999999876566799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.   .      
T Consensus       365 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---~------  434 (495)
T 1opk_A          365 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K------  434 (495)
T ss_dssp             EECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---T------
T ss_pred             ceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c------
Confidence            98754332 122234456789999999999999999999999999999999 999997655433222211   1      


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                              ......+..++..+.+|+.+||+.||++||++.+|++.|+.++.
T Consensus       435 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 --------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                    11112233466789999999999999999999999999988753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.2e-46  Score=361.00  Aligned_cols=272  Identities=25%  Similarity=0.372  Sum_probs=220.4

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+...........||||.+...... ..+.+.+|+.++.++ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            345789999999999999999999876555556677999999765432 346788999999999 799999999998765


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQ--------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      +.   ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||++   +|+||||||+
T Consensus       104 ~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~  177 (316)
T 2xir_A          104 GG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  177 (316)
T ss_dssp             TS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             CC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccc
Confidence            43   24899999999999999976432              1288999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999987655443344556788999999999999999999999999999999998 99999765432


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ..  ....+....              ....+..+++.+.+++.+||+.||.+||++.++++.|+.++++.
T Consensus       258 ~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          258 EE--FCRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HH--HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HH--HHHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            21  111111100              00111234567899999999999999999999999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.7e-46  Score=364.81  Aligned_cols=254  Identities=22%  Similarity=0.365  Sum_probs=207.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGL-----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCC-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            45789999999999999999999877665     499999876543  23467889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC---cEEE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---NAKL  249 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~---~~kl  249 (441)
                          ..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++   .+||
T Consensus       102 ----~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          102 ----FHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             ----EEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             ----EEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence                35999999999999999976  46799999999999999999999998   999999999999998654   5999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+....
T Consensus       173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~~~  246 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKAGA  246 (362)
T ss_dssp             CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTC
T ss_pred             eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCC
Confidence            9999998755332   2334689999999999999999999999999999999999999997644322   221111110


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .           .........+++.+.+|+.+||..||++||++.++++.
T Consensus       247 ~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 Y-----------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             C-----------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             C-----------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0           00111112456789999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-45  Score=352.99  Aligned_cols=266  Identities=15%  Similarity=0.245  Sum_probs=213.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++....  ....+.+|+.++..+ +|+||+++++++....  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--   79 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQ-----QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--   79 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTE-----EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCc-----EEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--
Confidence            4679999999999999999999866554     49999986543  334677899999999 8999999999987655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-----EEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-----AKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-----~kl  249 (441)
                        ..++||||+ +++|.+++... +..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.     +||
T Consensus        80 --~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           80 --HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             --eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence              359999999 99999999764 45699999999999999999999998   9999999999999987776     999


Q ss_pred             eecCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          250 SDFGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       250 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            999999865443211     123456899999999999999999999999999999999999999987554333333222


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      +....... ..         ......+++.+.+++.+||+.||++||++.+|++.|+++++..
T Consensus       233 ~~~~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          233 IGEKKQST-PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHS-CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhccCc-cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            21110000 00         0011134678999999999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.1e-46  Score=359.02  Aligned_cols=266  Identities=25%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++......   ....+.+|+.++..++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHR-----DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCc-----eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            3689999999999999999999876654     4999999765332   2356889999999999999999999998776


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      ..+...|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            6555669999999999999999763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  ........ 
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~~~-  237 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVREDPI-  237 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHCCCC-
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCCCC-
Confidence            999865433211 22334679999999999999999999999999999999999999997654322211  11110000 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHH-HHHHHHHh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV-EVLNKIVD  385 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~~  385 (441)
                                 ........++..+.+++.+||+.||++||++.+++ ..|..+..
T Consensus       238 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 -----------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             -----------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             -----------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                       00001123567899999999999999999766555 45555443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-46  Score=365.53  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=204.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-----hhhHHHHHHHHHhccCCCCCeeeEEeEEec
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAE  170 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  170 (441)
                      .+.|++.+.||+|+||.||+|.+..++..     ||||++.....     ...+.+.+|+.+++.++||||+++++++..
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQ-----FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCE-----EEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            46799999999999999999998876654     99999864321     135678899999999999999999999987


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc--
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--  246 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~--  246 (441)
                      .+    ..|+|||||++|+|.+++..+  .+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.  
T Consensus        98 ~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           98 DG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             TT----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTC
T ss_pred             CC----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCC
Confidence            65    359999999999999888643  234689999999999999999999998   9999999999999987655  


Q ss_pred             -EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          247 -AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                       +||+|||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....    .....+
T Consensus       171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i  244 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI  244 (351)
T ss_dssp             CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH
T ss_pred             cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH
Confidence             9999999998755432  223456899999999999999999999999999999999999999975321    111111


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....           .........++..+.+|+.+||..||++||++.++++
T Consensus       245 ~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKY-----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCC-----------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11000           0000111234578999999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-46  Score=355.32  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.  ......||+|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3679999999999999999999887653  22345699999977665666789999999999999999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-------
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-------  246 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-------  246 (441)
                      .    ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.       
T Consensus        87 ~----~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           87 N----ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             C----EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             C----EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            4    9999999999999999764 34599999999999999999999998   9999999999999988887       


Q ss_pred             -EEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCC-CCCCCCchhHHHHHH
Q 013504          247 -AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRR-PLDRNRPKSEQKLLE  323 (441)
Q Consensus       247 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~-P~~~~~~~~~~~~~~  323 (441)
                       +||+|||++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|.. ||.............
T Consensus       159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence             99999999875432      234578999999999987 678999999999999999999654 454332221111111


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      . .              ..    .+...+..+.+++.+||+.||++||++.++++.|+.++...
T Consensus       233 ~-~--------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          233 D-R--------------HQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             T-T--------------CC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             c-c--------------CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0 0              00    01112346889999999999999999999999999987643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-46  Score=362.47  Aligned_cols=270  Identities=23%  Similarity=0.402  Sum_probs=215.8

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ....++|.+.+.||+|+||.||+|.+...........||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345578999999999999999999987533333455699999976543 2345688999999999999999999999776


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE  243 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~  243 (441)
                      ..    .++||||+++|+|.+++....        ...+++..++.++.||+.||.|||++   +|+||||||+|||++.
T Consensus       101 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~  173 (322)
T 1p4o_A          101 QP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             Cc----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence            54    399999999999999987531        14678999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~  322 (441)
                      ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........... 
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-  252 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-  252 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH-
Confidence            99999999999986543322222334577899999999999999999999999999999999 8999976543222111 


Q ss_pred             HhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                        +...    .          ....+..++..+.+++.+||+.||.+||++.++++.|++++..
T Consensus       253 --~~~~----~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          253 --VMEG----G----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             --HHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --HHcC----C----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence              1100    0          0011224567799999999999999999999999999887643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=354.43  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=197.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------------------------hhHHHHHHH
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------------------------GHKEWVTEV  150 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~  150 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++......                          ..+.+.+|+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNT-----YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTE-----EEEEEEEECC-------------------------------CHHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCc-----EEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            679999999999999999999877654     4999998754321                          125678999


Q ss_pred             HHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 013504          151 NVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQII  230 (441)
Q Consensus       151 ~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  230 (441)
                      .+|+.++||||+++++++......  ..++||||+++++|.+++..   ..+++..++.++.||+.||.|||++   +|+
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iv  159 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDPNED--HLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KII  159 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECSSSS--EEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHhCCCCCCCeEEEEEEcCCCC--EEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence            999999999999999999864332  56999999999999887643   5799999999999999999999998   999


Q ss_pred             ecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC---CCccccchhHHHHHHHHHhCC
Q 013504          231 FRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR---LTYKSDIWSFGVFLYELITGR  307 (441)
Q Consensus       231 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltG~  307 (441)
                      ||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|.
T Consensus       160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            99999999999999999999999998654332  2234568999999999987765   377899999999999999999


Q ss_pred             CCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          308 RPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       308 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .||........   ...+....             ........++..+.+++.+||+.||++||++.++++
T Consensus       238 ~pf~~~~~~~~---~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          238 CPFMDERIMCL---HSKIKSQA-------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSSCCSSHHHH---HHHHHHCC-------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCccHHHH---HHHHhccc-------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99975433221   11111100             000011234567899999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.1e-46  Score=353.56  Aligned_cols=261  Identities=30%  Similarity=0.533  Sum_probs=196.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..        .+|+|++.....  ...+.+.+|+.+++.++||||+++++++.... 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCc-
Confidence            4689999999999999999997543        289999875432  33467889999999999999999999764332 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 ----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           94 ----LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             ----CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             ----cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence                48999999999999999654 46799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +++...............||+.|+|||++.   +..++.++||||||+++|+|++|..||........  ......... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-  242 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGS-  242 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTS-
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccc-
Confidence            998654332233344568999999999986   56788899999999999999999999976543322  111111110 


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                              ..+. .......++..+.+++.+||+.||.+||++.++++.|+++.+
T Consensus       243 --------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 --------LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --------CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --------cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                    0011 011223456789999999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.5e-46  Score=353.48  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=207.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+....      .||+|++..... ..+++.+|+.++..++||||+++++++.....  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   93 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--   93 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTE------EEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCC------eEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC--
Confidence            468999999999999999999876432      499999976543 34678899999999999999999999976653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        94 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           94 --IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             --EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             --eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence              49999999999999999753 35699999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.   ...     
T Consensus       168 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~~-----  238 (283)
T 3gen_A          168 RYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGL-----  238 (283)
T ss_dssp             GGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTC-----
T ss_pred             ccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---ccc-----
Confidence            8653321 111223456788999999999999999999999999999998 999997654332222211   100     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               ....+..+++.+.+++.+||+.||.+||++.++++.|+++++.
T Consensus       239 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 ---------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                     0111123356789999999999999999999999999998864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=366.63  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+..........+.+|+.+|+.++||||+++++++.+..   
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---  121 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGR-----VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY---  121 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCC-----EEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC---
Confidence            4689999999999999999999887665     39999987765555567889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC--CCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE--QWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~--~~~~kl~DFG  253 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.  ++.+||+|||
T Consensus       122 -~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          122 -EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             -EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             -EEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence             459999999999999999753 35799999999999999999999998   9999999999999974  5779999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+....    
T Consensus       197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~~~----  266 (387)
T 1kob_A          197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKRCD----  266 (387)
T ss_dssp             TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHCC----
T ss_pred             cceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHhCC----
Confidence            998764432   234468999999999999999999999999999999999999999765432221   1111100    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ..........++..+.++|.+||..||++||++.++++
T Consensus       267 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 -------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                   00111122245678999999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.7e-46  Score=349.83  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=206.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+.+.       .||||++.....  ...+.+.+|+.++++++||||+++++++......
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGN-------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTE-------EEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCe-------eEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            6799999999999999999998532       499999876542  3346788999999999999999999999876322


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEcCCCcEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                        ..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.++|+||
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           83 --HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             --SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             --CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEec
Confidence              359999999999999999876555799999999999999999999987   7  999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTY---KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |++.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|..||.............  .   
T Consensus       158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~---  225 (271)
T 3kmu_A          158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA--L---  225 (271)
T ss_dssp             GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH--H---
T ss_pred             cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH--h---
Confidence            88764222       2357899999999998765554   7999999999999999999997654322211110  0   


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                                 .......+..++..+.+++.+||+.||++||++.++++.|+.+.+
T Consensus       226 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 -----------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                       001112223456789999999999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.9e-46  Score=358.24  Aligned_cols=283  Identities=27%  Similarity=0.431  Sum_probs=214.9

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      |.+.+.||+|+||.||++.+..... .....||||++..... .....+.+|+.+|+.++||||+++++++...+..  .
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--S  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT--E
T ss_pred             HhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc--e
Confidence            4899999999999999998754332 2445699999986543 3346788999999999999999999999875433  4


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      .++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            6899999999999999976   3599999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          258 GPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       258 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....+..... ......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~  261 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRLT  261 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHHH
Confidence            6543221 22344578889999999999899999999999999999999999996421110 00000000000 000011


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccCCC
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTP  392 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p  392 (441)
                      ..+........+..++..+.+++.+||+.||++||++.++++.|+.+.+......|
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            11111222223345678899999999999999999999999999999887665444

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-46  Score=362.96  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++.....   .....+.+|+.+|+.++||||+++++++.+.. 
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGN-----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCC-----EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-
Confidence            689999999999999999999887665     399999875432   23467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       115 ---~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          115 ---NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ---EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence               459999999999999999763  5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||........   ...+...     
T Consensus       187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~-----  253 (350)
T 1rdq_E          187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSG-----  253 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC-----
T ss_pred             cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HHHHHcC-----
Confidence            99865432     3456899999999999999999999999999999999999999976543222   1111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                              .  ..++..++..+.++|.+||+.||.+||+     +++|++
T Consensus       254 --------~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          254 --------K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------C--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                    0  0122245678999999999999999998     888876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2e-46  Score=366.29  Aligned_cols=251  Identities=26%  Similarity=0.457  Sum_probs=205.3

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEe
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCA  169 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  169 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||++.....   .....+..|..++..+ +||||+++++++.
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            345789999999999999999999887654     499999976431   2345677899999876 9999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      +.+    ..|+||||++||+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        89 ~~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           89 TKE----NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             CSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence            765    459999999999999999763  5799999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   +...+... 
T Consensus       160 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~-  233 (345)
T 1xjd_A          160 ADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMD-  233 (345)
T ss_dssp             CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC-
T ss_pred             eEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHhC-
Confidence            9999998643322  12456789999999999999999999999999999999999999997654322   22211110 


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH-HHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS-EVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  378 (441)
                                .+    .++..++..+.+++.+||..||++||++. +|++
T Consensus       234 ----------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 ----------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                      01    11223567889999999999999999997 6664

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-46  Score=379.78  Aligned_cols=260  Identities=26%  Similarity=0.437  Sum_probs=212.0

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ...++|.+.+.||+|+||.||+|.+...      ..||||.+.... ...+.+.+|+.+|+.++||||+++++++.. + 
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~-  255 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-  255 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTT------EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCc------cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C-
Confidence            3457899999999999999999998643      249999997654 346789999999999999999999999863 2 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       256 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          256 ---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             ---SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             ---ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence               249999999999999999764445789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++...... ........+|+.|+|||++....++.++|||||||++|||++ |..||.........   ..+....   
T Consensus       330 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~~~---  402 (454)
T 1qcf_A          330 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALERGY---  402 (454)
T ss_dssp             GGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHHTC---
T ss_pred             CceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCC---
Confidence            998654321 111223456789999999999999999999999999999999 99999765433222   1111110   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                 ....+..+++.+.+++.+||..||++||++.+|++.|+++...
T Consensus       403 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 -----------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                       0111234567899999999999999999999999999988654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4e-46  Score=366.29  Aligned_cols=278  Identities=23%  Similarity=0.295  Sum_probs=213.8

Q ss_pred             CCccccchHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC----
Q 013504           82 SNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE----  157 (441)
Q Consensus        82 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~----  157 (441)
                      .....+++.+.....++|.+.+.||+|+||.||+|.+..++.     .||||++.... .....+..|+.+++.+.    
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~   93 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK-----YYAVKVVRNIK-KYTRSAKIEADILKKIQNDDI   93 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECSCH-HHHHHHHHHHHHHHHTCCCST
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe-----EEEEEEeccch-hhhhhhHHHHHHHHHhcccCC
Confidence            344455666666677899999999999999999999877654     49999986432 33456778999999886    


Q ss_pred             -CCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 013504          158 -HPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKS  236 (441)
Q Consensus       158 -hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp  236 (441)
                       ||||+++++++...+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||
T Consensus        94 ~h~~iv~~~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  165 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKP  165 (360)
T ss_dssp             TGGGBCCEEEEEEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CCCCeecccceeeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCc
Confidence             999999999998765    359999999 99999999876556799999999999999999999998   999999999


Q ss_pred             CcEEEcC-------------------------CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccc
Q 013504          237 SNILLDE-------------------------QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKS  291 (441)
Q Consensus       237 ~NILl~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  291 (441)
                      +|||++.                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++
T Consensus       166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~  240 (360)
T 3llt_A          166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSS  240 (360)
T ss_dssp             GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred             ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCcc
Confidence            9999975                         788999999999864332     2356899999999999999999999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch-------hhhc-C-------CCCC------------
Q 013504          292 DIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF-------TMIL-D-------PKLE------------  344 (441)
Q Consensus       292 DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~-------~~~~------------  344 (441)
                      |||||||++|+|++|+.||...........+.............       ...+ .       +...            
T Consensus       241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  320 (360)
T 3llt_A          241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC  320 (360)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred             chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence            99999999999999999997655443333222221111100000       0000 0       0000            


Q ss_pred             -CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          345 -GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       345 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ........+.+.+|+.+||+.||++|||+.++++
T Consensus       321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0001112267889999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-45  Score=358.24  Aligned_cols=268  Identities=25%  Similarity=0.429  Sum_probs=215.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||+|.+.....  ......||||++..... .....+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            3689999999999999999999864322  23345699999976543 3346788999999999 999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQ--------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS  237 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~  237 (441)
                      +.    .++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       114 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          114 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             SC----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             Cc----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence            64    4999999999999999976421              2489999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCch
Q 013504          238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPK  316 (441)
Q Consensus       238 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~  316 (441)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999987654432223344567899999999998899999999999999999999 99999765432


Q ss_pred             hHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          317 SEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      .....   +....              ....+..++..+.+++.+||+.||.+||++.++++.|+.++...
T Consensus       267 ~~~~~---~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          267 ELFKL---LKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHH---HHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHH---HhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            22111   11100              01112245678999999999999999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-46  Score=372.88  Aligned_cols=258  Identities=23%  Similarity=0.350  Sum_probs=207.4

Q ss_pred             HHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeE
Q 013504           91 ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGY  167 (441)
Q Consensus        91 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~  167 (441)
                      +++...++|.+.+.||+|+||.||+|.+..++..     ||+|++.+...   .....+.+|+.++..++||||++++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~-----~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcE-----EEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3444568999999999999999999999877654     99999865322   122457789999999999999999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      +.+..    ..|||||||+||+|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+
T Consensus       138 ~~~~~----~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          138 FQDDR----YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             EECSS----EEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEECC----EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCE
Confidence            98765    45999999999999999975   4689999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR----LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      ||+|||+++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|..||...........+.
T Consensus       208 kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          208 KLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             EECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            999999998654432 22334678999999999998765    7889999999999999999999997654332222111


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHH
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVE  378 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  378 (441)
                      .....+              .......++..+.+||.+||..+|.+  ||++++|++
T Consensus       287 ~~~~~~--------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          287 NHKNSL--------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             THHHHC--------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hccccc--------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            100000              00001134578899999999999988  999999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-46  Score=374.89  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=209.0

Q ss_pred             hHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEE
Q 013504           89 FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLI  165 (441)
Q Consensus        89 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~  165 (441)
                      +.+++...++|++.++||+|+||+||+|.+..++.     .||+|++.+....   ....+.+|+.++..++||||++++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  140 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH  140 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCc-----EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            33445566899999999999999999999887654     4999998753221   123478899999999999999999


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      ++|.+..    ..|||||||+||+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+||||+.++
T Consensus       141 ~~~~~~~----~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          141 YAFQDDN----NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             EEEECSS----EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             EEEeeCC----EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence            9998766    459999999999999999753 46799999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      .+||+|||+++...... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||..........
T Consensus       213 ~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~  291 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  291 (437)
T ss_dssp             CEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             CEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence            99999999998654432 22334578999999999987     4678999999999999999999999997654332222


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCC--CCCHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKG--RPKMSEVVE  378 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  378 (441)
                      .+......+.         -|.    ....+++.+.+||.+||+.+|++  ||+++++++
T Consensus       292 ~i~~~~~~~~---------~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          292 KIMNHKERFQ---------FPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHTHHHHCC---------CCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhhhcccccc---------CCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1110000000         010    01124577899999999888888  999999988

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.2e-46  Score=360.78  Aligned_cols=282  Identities=24%  Similarity=0.370  Sum_probs=215.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|.+..... .....||||++........+.+.+|+.++++++||||+++++++...+..  
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ--   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSS-SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC--
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCC-CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc--
Confidence            689999999999999999998643222 23456999999877666667789999999999999999999998754433  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             eEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence            468999999999999999764 24699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ... ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~  253 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMG-CERDVPALSRL  253 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC-----CCHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcc-cccccccHHHH
Confidence            76443321 1223456888999999999999999999999999999999999998542211000 000 00000000011


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ...+........+..+++.+.+++.+||+.||++||++.++++.|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1111112222334456788999999999999999999999999999987644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.6e-46  Score=362.87  Aligned_cols=250  Identities=25%  Similarity=0.429  Sum_probs=204.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEec
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAE  170 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  170 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|++.....   .....+..|..+|..+ +||||+++++++..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            34789999999999999999999876654     499999876432   2345678899999988 89999999999987


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .+    ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        93 ~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           93 MD----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence            65    459999999999999999763  5799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   +...+...  
T Consensus       164 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~--  236 (353)
T 2i0e_A          164 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH--  236 (353)
T ss_dssp             CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC--
T ss_pred             eCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHhC--
Confidence            999998643322  23455789999999999999999999999999999999999999997644322   22111110  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                                 .  ..++..++..+.+|+.+||..||.+||+     +.+|++
T Consensus       237 -----------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          237 -----------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----------C--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----------C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                       0  0122345678999999999999999995     577765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.1e-46  Score=350.19  Aligned_cols=253  Identities=28%  Similarity=0.479  Sum_probs=194.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch----hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ----GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ++|++.+.||+|+||.||+|.+.+.       .||||++......    ..+.+.+|+.+++.++||||+++++++....
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGD-------EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP   79 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTE-------EEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCC-------eEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            6799999999999999999997532       4999998754322    2467889999999999999999999998766


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC--------C
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE--------Q  244 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~--------~  244 (441)
                      .    .++||||+++++|.+++..   ..+++..++.++.|++.||.|||++...+|+||||||+|||++.        +
T Consensus        80 ~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           80 N----LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             -----CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             c----eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            4    4999999999999999864   57999999999999999999999981112999999999999986        7


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +.+||+|||+++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............. 
T Consensus       153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  227 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-  227 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-
T ss_pred             cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-
Confidence            789999999998654322    234679999999999999999999999999999999999999997644322111110 


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                     ........+..+++.+.+++.+||+.||.+||++.++++.|+.+
T Consensus       228 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 ---------------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                           01111122334567899999999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=366.45  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEE
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      ...+.||+|+||.||+|.+..++.     .||+|++........+.+.+|+.+|++++||||+++++++...+    ..+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~  162 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGL-----KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIV  162 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCc-----EEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEE
Confidence            335689999999999999877654     39999998776666778999999999999999999999998765    359


Q ss_pred             EEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE--cCCCcEEEeecCCCCC
Q 013504          180 LIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL--DEQWNAKLSDFGLARL  257 (441)
Q Consensus       180 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl--~~~~~~kl~DFGla~~  257 (441)
                      |||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.
T Consensus       163 lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            999999999999998753 35689999999999999999999998   99999999999999  6778899999999987


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhh
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM  337 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (441)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+  .....        
T Consensus       239 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~~~~--------  305 (373)
T 2x4f_A          239 YKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--LACRW--------  305 (373)
T ss_dssp             CCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCC--------
T ss_pred             cCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC--------
Confidence            54432   233457999999999999889999999999999999999999999765432221111  11000        


Q ss_pred             hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       338 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                          .+.......+++.+.+|+.+||+.||.+||++.++++  ++.+
T Consensus       306 ----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          306 ----DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             ----CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             ----CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence                0011111245678999999999999999999999998  5544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.3e-46  Score=360.74  Aligned_cols=276  Identities=25%  Similarity=0.411  Sum_probs=210.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+...........||||.+..... .....+.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            368999999999999999999865433333445699999975432 3346788999999999999999999999876644


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQ-----ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWN  246 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~  246 (441)
                          ++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||++   +|+||||||+|||++.   +..
T Consensus       109 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          109 ----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ----EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             ----EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence                999999999999999976432     4589999999999999999999998   9999999999999984   446


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........   ...+
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~  258 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFV  258 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHH
Confidence            99999999875433222223345678999999999999999999999999999999998 9999976543222   2211


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccCCCCCC
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTP  395 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p~~~  395 (441)
                      ....              ....+..++..+.+++.+||+.||.+||++.++++.|+.+........+..+
T Consensus       259 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~  314 (327)
T 2yfx_A          259 TSGG--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP  314 (327)
T ss_dssp             HTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCC
T ss_pred             hcCC--------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhccccc
Confidence            1100              0111224557789999999999999999999999999998876544333333

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.5e-45  Score=350.20  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=201.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+..++..     ||+|++......  ....+.+|+.++++++||||+++++++....  
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEI-----VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCce-----EEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--
Confidence            5799999999999999999998876653     999998754432  2467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++ +|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        75 --~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           75 --KLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             --EEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             --EEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              45999999975 666666543 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHH-HHhhhhhccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKL-LEWVRPHLTD  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~-~~~~~~~~~~  331 (441)
                      ++......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ... ..........
T Consensus       148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~  225 (292)
T 3o0g_A          148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            98654322  2234568899999999997765 79999999999999999999888643332221 111 1111000000


Q ss_pred             c-cchhhhcC---------CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 A-KKFTMILD---------PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~-~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      . .......+         ..........++..+.+|+.+||+.||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0 00000000         00001122245678899999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-45  Score=354.15  Aligned_cols=277  Identities=24%  Similarity=0.378  Sum_probs=209.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.|++.+.||+|+||.||+|.+.... ......||+|.+..... .....+.+|+.+++.++||||+++++++...+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN-   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C-
T ss_pred             hhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc-
Confidence            56899999999999999999864332 22345699999875432 2346788999999999999999999999876433 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        99 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 -GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             -eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence             358999999999999999654 35799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--c
Q 013504          256 RLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--A  332 (441)
Q Consensus       256 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~  332 (441)
                      +........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+.....    .......+....  .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTV  249 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCH
Confidence            876543321 223346788899999999999999999999999999999999998642210    000000000000  0


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ......+........+..+++.+.+++.+||+.||.+||++.++++.|+.++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000111111112233456678999999999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-45  Score=349.33  Aligned_cols=259  Identities=28%  Similarity=0.467  Sum_probs=211.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+...      ..||+|.+.... ...+.+.+|+.+++.++||||+++++++....   
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   81 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---   81 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCC------cEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCC---
Confidence            46899999999999999999987542      249999987644 23567889999999999999999999986432   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++.......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        82 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           82 --IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             --CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             --cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence              48999999999999999754334799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+....     
T Consensus       157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~-----  227 (279)
T 1qpc_A          157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLERGY-----  227 (279)
T ss_dssp             EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTC-----
T ss_pred             ccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHhccc-----
Confidence            8754332 112234567889999999998899999999999999999999 9999976543221   11111110     


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                               ....+..++..+.+++.+||..||++||++.++++.|+++....
T Consensus       228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 ---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                     01112245678999999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-45  Score=352.20  Aligned_cols=271  Identities=24%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+.....  ....||+|.+.....  ...+.+.+|+.++++++||||+++++++....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDG--TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTS--CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCC--ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            44789999999999999999998765432  234699999875432  23467889999999999999999999998755


Q ss_pred             cCC-eeEEEEEeccCCCChHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          173 ERG-IQRLLIYEYMPNRSVQDHLTS----RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       173 ~~~-~~~~lv~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      ..+ ...++||||+++|+|.+++..    .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            322 135899999999999999853    2246799999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~  326 (441)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............   
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL---  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---
Confidence            9999999986544332233345577889999999999999999999999999999999 899997654433222111   


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ..              .....+..++..+.+++.+||..||.+||++.++++.|+++++..
T Consensus       264 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          264 HG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             TT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            00              001122345678999999999999999999999999999998653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-45  Score=348.03  Aligned_cols=262  Identities=26%  Similarity=0.424  Sum_probs=210.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+.....  ....||+|.+..... ...+.+.+|+.+++.++||||+++++++....  
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKG--EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP--   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTC--CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCC--CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence            4689999999999999999999765432  244699999876532 34567889999999999999999999986432  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        87 ---~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           87 ---TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             ---CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence               38999999999999999764 45689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+....       
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-------  231 (281)
T 3cc6_A          160 SRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------  231 (281)
T ss_dssp             GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-------
T ss_pred             Ccccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-------
Confidence            986543321 12334567889999999999999999999999999999998 999997554433222221100       


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                ....+..+++.+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus       232 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          232 ----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                      0011123457799999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.2e-46  Score=375.29  Aligned_cols=259  Identities=27%  Similarity=0.443  Sum_probs=207.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..+      ..||||.+.... ...+.+.+|+.+|++++||||+++++++.. .. 
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~-  252 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-  252 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS-
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCC------ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc-
Confidence            346799999999999999999998653      249999997654 335678999999999999999999999865 22 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++|+|.+++....+..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       253 ---~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          253 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             ---CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             ---eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence               48999999999999999764456799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.........   ..+...     
T Consensus       327 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~~-----  397 (452)
T 1fmk_A          327 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVERG-----  397 (452)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTT-----
T ss_pred             ceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcC-----
Confidence            98754322 112234567889999999999999999999999999999999 99999765433222   111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               .....+..++..+.+++.+||+.||++||++.+|++.|+++...
T Consensus       398 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 ---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                     01112234667899999999999999999999999999988754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-45  Score=360.04  Aligned_cols=251  Identities=26%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++.....   .....+.+|+.++.++ +||||+++++++....
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCC-----EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            679999999999999999999887654     499999976532   2345678899999987 8999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        84 ----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           84 ----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             ----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence                459999999999999999763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh------HHHHHHhhh
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS------EQKLLEWVR  326 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~------~~~~~~~~~  326 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ...+...+.
T Consensus       155 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          155 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             GGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             cccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            9998643322  23455789999999999999999999999999999999999999996432111      111111110


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH------HHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM------SEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  378 (441)
                                   ...  ..++..++..+.+++.+||..||++||++      .++++
T Consensus       233 -------------~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          233 -------------EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -------------HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -------------cCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                         000  11223456789999999999999999995      56665

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=351.61  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=199.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|.+.+       ..||||.+...  ...+.+.+|+.++++++||||+++++++.+.     
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   73 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP-----   73 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred             hHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            578999999999999999998753       24999998654  3456788999999999999999999988632     


Q ss_pred             eEEEEEeccCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc-EEEeecCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQ-ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN-AKLSDFGL  254 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~-~kl~DFGl  254 (441)
                       .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|||+
T Consensus        74 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           74 -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             -TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             -cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence             3899999999999999975422 24788999999999999999999832238999999999999998886 79999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........      
T Consensus       153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~------  220 (307)
T 2eva_A          153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNG------  220 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTT------
T ss_pred             ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcC------
Confidence            9754322     23357999999999999999999999999999999999999999754332211 11111000      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                              ........++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus       221 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          221 --------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             --------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             --------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence                    001122245677899999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-45  Score=373.21  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||||++....   ......+.+|+.+++.++||||+++++++...+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRY-----YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCE-----EEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            46899999999999999999998877654     9999987542   223456778999999999999999999998766


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .    .+|||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ .   +|+||||||+||||+.++.+||+|
T Consensus       222 ~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 R----LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             E----EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             E----EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            3    59999999999999999763  579999999999999999999997 7   899999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ..   
T Consensus       293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~~---  364 (446)
T 4ejn_A          293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---ME---  364 (446)
T ss_dssp             CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HC---
T ss_pred             CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---hC---
Confidence            99998643322  22445789999999999999999999999999999999999999997654322221111   00   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                      .            ..++..+++.+.+||.+||+.||.+||     ++.++++
T Consensus       365 ~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          365 E------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            0            012223567889999999999999999     9999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-45  Score=353.54  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+.. +     ..||+|++......  ....+.+|+.+++.++||||+++++++.....
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-G-----RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-S-----CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-C-----CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            4789999999999999999999754 2     24999998754322  23678899999999999999999999986653


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||++ |+|.+++... ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 ----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 ----LTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             ----EEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ----EEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence                599999997 5888888754 45699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~  331 (441)
                      +++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ .........
T Consensus       165 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          165 LARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             TCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             CceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            998654322  12344678999999999876 56899999999999999999999999765544332222 111100000


Q ss_pred             c----cchhh-------hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 A----KKFTM-------ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~----~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .    .....       .............+++++.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0    00000       00000000111234567899999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=355.02  Aligned_cols=266  Identities=25%  Similarity=0.491  Sum_probs=206.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|...+.||+|+||.||+|.+..++. .....||||.+..... .....+.+|+.+++.++||||+++++++.....  
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  120 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP--  120 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCC-CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC--
Confidence            578888999999999999999876532 2345699999876433 234568899999999999999999999976553  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       121 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          121 --MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             --EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             --cEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence              49999999999999999764 46799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||........   ...+....    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~~~~~----  267 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDGF----  267 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTC----
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHCCC----
Confidence            86543221 111223456889999999999999999999999999999999 9999975543222   11111100    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                                ....+..++..+.+++.+||+.||++||++.++++.|++++....
T Consensus       268 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          268 ----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                      011122456789999999999999999999999999999986543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=374.46  Aligned_cols=277  Identities=21%  Similarity=0.291  Sum_probs=191.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc-
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD-  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++....  ....+.+.+|+.+|+.++||||+++++++.... 
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKR-----VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--C-----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCc-----EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            3689999999999999999999887665     49999986532  234567889999999999999999999986543 


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      ......|+||||+ +++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence            2223569999998 6799999975  46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCc-------------------------ceeeceecccCcCCcccc-ccCCCCccccchhHHHHHHHHHh-
Q 013504          253 GLARLGPSDGLS-------------------------HVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELIT-  305 (441)
Q Consensus       253 Gla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt-  305 (441)
                      |+++........                         ......+||+.|+|||++ .+..++.++|||||||++|||++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999875432110                         123456899999999976 56679999999999999999999 


Q ss_pred             ----------CCCCCCCCCchh-----------------HHHHHHhhhhhcccc-------------cchhhhcCCCCC-
Q 013504          306 ----------GRRPLDRNRPKS-----------------EQKLLEWVRPHLTDA-------------KKFTMILDPKLE-  344 (441)
Q Consensus       306 ----------G~~P~~~~~~~~-----------------~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~-  344 (441)
                                |+++|.+.....                 ....+..+...+...             ..+...+..... 
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      566664432100                 000000000000000             000000000000 


Q ss_pred             --CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          345 --GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       345 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                        .......+..+.+|+.+||..||++|||++++++  +++.+
T Consensus       361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence              0111234678899999999999999999999998  45554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=370.50  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=207.9

Q ss_pred             chHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeE
Q 013504           88 TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        88 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l  164 (441)
                      .+.+.....++|++.+.||+|+||.||+|.+..++..     ||+|++.+...   .....+.+|..++..++||||+++
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~-----vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV-----YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            3444555678999999999999999999999876654     99999875322   123457789999999999999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++++.+.+    ..||||||++||+|.+++... +..+++..+..++.||+.||.|||++   +|+||||||+||||+.+
T Consensus       127 ~~~~~~~~----~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~  198 (412)
T 2vd5_A          127 HFAFQDEN----YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC  198 (412)
T ss_dssp             EEEEECSS----EEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             EEEEeeCC----EEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence            99998765    459999999999999999764 35799999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                      +.+||+|||+++...... .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.......
T Consensus       199 g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             SCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            999999999998754432 12234568999999999987       3568999999999999999999999997654332


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCC---CCHHHHHH
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR---PKMSEVVE  378 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  378 (441)
                      ....+......+.         -+    .....++..+.+||.+||+ +|.+|   |++++|++
T Consensus       278 ~~~~i~~~~~~~~---------~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          278 TYGKIVHYKEHLS---------LP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHTHHHHCC---------CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHhcccCcC---------CC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            2211111000000         01    1122456789999999999 99998   58998877

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.2e-45  Score=354.99  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=200.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .||||++..... ...+.+.+|+.+|++++||||+++++++.+...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDC-----NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCC-----EEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCc-----EEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            34689999999999999999999886655     499999875443 235678999999999999999999999866432


Q ss_pred             C-----------------------------------------------------CeeEEEEEeccCCCChHHHHhhcCC-
Q 013504          174 R-----------------------------------------------------GIQRLLIYEYMPNRSVQDHLTSRFQ-  199 (441)
Q Consensus       174 ~-----------------------------------------------------~~~~~lv~E~~~~gsL~~~l~~~~~-  199 (441)
                      .                                                     ....++|||||++|+|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence            1                                                     1136999999999999999976422 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCc----------ceeec
Q 013504          200 ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS----------HVSTA  269 (441)
Q Consensus       200 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~  269 (441)
                      ...++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........          .....
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            2355667899999999999999998   9999999999999999999999999999876543211          12234


Q ss_pred             eecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchH
Q 013504          270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSI  349 (441)
Q Consensus       270 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (441)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..|+.     ...........             . .......
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~-------------~-~~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRN-------------L-KFPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHT-------------T-CCCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhc-------------c-CCCcccc
Confidence            679999999999999999999999999999999999877652     11111111110             0 0112233


Q ss_pred             HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          350 KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       350 ~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..++.+.+++.+||+.||++||++.++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            55677899999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-45  Score=354.11  Aligned_cols=268  Identities=23%  Similarity=0.357  Sum_probs=190.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||+|.+...... ....+.+|+.+++.++||||+++++++...+  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGV-----YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN--   76 (317)
T ss_dssp             ---------------CEEEEEECSSSCC-----EEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCc-----EEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--
Confidence            4679999999999999999999876654     4999998754432 3467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF----QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                        ..++||||++ |+|.+++....    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence              4599999997 69999986532    24689999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus       151 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          151 DFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             CCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999998654321  12334678999999999876 468999999999999999999999997655433322221110000


Q ss_pred             cc--------ccchhhhcCCCC--------CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TD--------AKKFTMILDPKL--------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~--------~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..        ...+...+....        .......++..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00        000000000000        00011134568999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-45  Score=348.55  Aligned_cols=265  Identities=29%  Similarity=0.447  Sum_probs=207.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|.+.+.||+|+||.||+|.+.....  ....+|+|.+..... ...+.+.+|+.++++++||||+++++++...+.  
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS--
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC--ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC--
Confidence            568899999999999999999765432  234589999876433 334678899999999999999999999765443  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       101 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          101 -SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             -CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             -ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence             348999999999999999753 46789999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCC--cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGL--SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +.......  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||................      
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------  249 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------  249 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC------
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC------
Confidence            86543221  112344578889999999999999999999999999999999 566665544332222111100      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                 ....+..++..+.+++.+||+.||++||++.++++.|+.++...
T Consensus       250 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                       00112234567999999999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-45  Score=360.42  Aligned_cols=266  Identities=29%  Similarity=0.442  Sum_probs=202.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ..|.+.+.||+|+||.||+|.+.....  ....||+|.+..... ...+.+.+|+.++++++||||+++++++...+.  
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTT--EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS--
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCC--cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC--
Confidence            357788899999999999999865432  344689999875432 345778999999999999999999999865432  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       165 -~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          165 -SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             -CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             -CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccc
Confidence             248999999999999999753 45788999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc--ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          256 RLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       256 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +........  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+....      
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~------  313 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------  313 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC------
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC------
Confidence            865432211  12234567889999999999999999999999999999999 678886554333222111000      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                                 ....+..++..+.+++.+||+.||++||++.++++.|+.++....
T Consensus       314 -----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                       001122355779999999999999999999999999999987643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.1e-45  Score=348.07  Aligned_cols=265  Identities=22%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+. ++.     .||+|++......  ....+.+|+.+++.++||||+++++++...+. 
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~-----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGE-----TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSC-----EEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCC-----EEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-
Confidence            57999999999999999999873 232     4999998654432  23678899999999999999999999987653 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++||||+++ +|.+++... ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        75 ---~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           75 ---LVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             ---EEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             ---EEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence               5999999975 999988753 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhcccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~  332 (441)
                      ++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ..........
T Consensus       147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (288)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence            87543221  123345789999999998764 5899999999999999999999999765433222111 1110000000


Q ss_pred             -cchh--hhcCCCCC-------CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 -KKFT--MILDPKLE-------GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 -~~~~--~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ....  ...++...       ......++..+.+++.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000  00011000       1111235678899999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-45  Score=365.10  Aligned_cols=257  Identities=20%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             hcCCccc-ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc-CCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRS-LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV-VEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+. ++||+|+||.||+|.+..++..     ||||++...     ..+.+|+.++.+ .+||||+++++++.....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~-----vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK-----FALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCE-----EEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            3567776 6899999999999998877654     999998532     456788888754 589999999999876333


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~  250 (441)
                      .....|||||||+||+|.+++..+....+++..+..|+.||+.||.|||+.   +|+||||||+|||++.   ++.+||+
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            233569999999999999999875556799999999999999999999998   9999999999999987   7889999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHH-HHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ-KLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~-~~~~~~~~~~  329 (441)
                      |||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+....
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~  283 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  283 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence            999998654321   234578999999999999999999999999999999999999999754432110 0111110000


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                 ..+.......++..+.+||.+||..||++||++.++++.
T Consensus       284 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          284 -----------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -----------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                       000011112456789999999999999999999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-46  Score=363.29  Aligned_cols=246  Identities=24%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+++.++||||+++++++.... 
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-   82 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQK-----VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-   82 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCE-----EEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence            6799999999999999999998777654     99999875422   12357889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+ +|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        83 ---~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           83 ---DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             ---EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             ---EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence               359999999 78999998763  5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........             
T Consensus       154 ~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------  217 (336)
T 3h4j_B          154 LSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------  217 (336)
T ss_dssp             CTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------
T ss_pred             cceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            998654332   2345689999999999988776 68999999999999999999999654321100             


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         ..+..  .....+..+++.+.+++.+||..||.+|||+.++++
T Consensus       218 ---~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 ---KKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               00000  011123345678899999999999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=361.23  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=190.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||++....  ..+.+.+|+.+|++++||||+++++++....  
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  121 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQK-----PYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--  121 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCc-----EEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--
Confidence            45789999999999999999999887654     39999987643  3456778999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~D  251 (441)
                        ..++||||+++|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.   ++.+||+|
T Consensus       122 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          122 --EISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             --EEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             --eEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence              35999999999999999976  46799999999999999999999998   9999999999999975   88999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ....+...   
T Consensus       195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~---  266 (349)
T 2w4o_A          195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNC---  266 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTT---
T ss_pred             CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhC---
Confidence            99998654321   23456899999999999999999999999999999999999999975443221  11111100   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .        ..........++..+.+|+.+||+.||++||++.++++
T Consensus       267 ~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          267 E--------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C--------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0        00011112245678899999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=351.86  Aligned_cols=271  Identities=25%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-----hhhHHHHHHHHHhccCC---CCCeeeEEe
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-----QGHKEWVTEVNVLGVVE---HPNLVKLIG  166 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~---hpnIv~l~~  166 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .||||++.....     .....+.+|+.+++.++   ||||+++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGH-----FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCC-----EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            46789999999999999999999776654     499999874331     11345667888877764   999999999


Q ss_pred             EEeccccC-CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          167 YCAEDDER-GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       167 ~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      ++...... ....++||||++ |+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            99775432 234689999996 6999999876555699999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus       158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  234 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  234 (308)
T ss_dssp             CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred             CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999998654332   234568999999999999999999999999999999999999999765543332221111


Q ss_pred             hhhcccccchh-------hhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFT-------MILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...... ..+.       ..+.+...   ......++..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000000 0000       00000000   0011235578899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=355.88  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=207.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|....++.     .||||++........+.+.+|+.+++.++||||+++++++.......
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH-----FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCC-----EEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCc-----EEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            3689999999999999999999876654     49999987665556678899999999999999999999997544434


Q ss_pred             eeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      ...++||||+++|+|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            4679999999999999998753  346799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-------eeeceecccCcCCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          254 LARLGPSDGLSH-------VSTAVVGTIGYAAPEYIQTGR---LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       254 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      ++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||........ ....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH
Confidence            987543211000       012346799999999987654   68899999999999999999999942110000 0000


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ...              ..........++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       259 ~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          259 AVQ--------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHH--------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             Hhh--------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            000              00111112245678999999999999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-45  Score=344.98  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=209.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++..     +|+|.+........+.+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   79 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIR-----RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--   79 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcE-----EEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence            356899999999999999999998876543     8999988766566778999999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl~D  251 (441)
                        ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|
T Consensus        80 --~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           80 --DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             --eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence              359999999999999999763  5799999999999999999999998   99999999999999   7889999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.   .... 
T Consensus       153 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~-  224 (277)
T 3f3z_A          153 FGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR---EGTF-  224 (277)
T ss_dssp             CTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCC-
T ss_pred             cccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---hCCC-
Confidence            99998654332   2345679999999999865 48999999999999999999999997654322211111   1000 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                                .........+++.+.+++.+||+.||++||++.++++  ++++..
T Consensus       225 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          225 ----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                      0000011134678999999999999999999999997  555543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-45  Score=364.10  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=193.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHH-hccCCCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNV-LGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  172 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .||+|++.+....   ....+.+|..+ ++.++||||+++++++...+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCC-----EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCC-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            679999999999999999999887665     3999999765432   23456677777 56789999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       113 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          113 ----KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence                459999999999999999763  5789999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+..     
T Consensus       184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~-----  253 (373)
T 2r5t_A          184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN-----  253 (373)
T ss_dssp             CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHHHH-----
T ss_pred             ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHh-----
Confidence            9998533221  23456789999999999999999999999999999999999999997543322   1111110     


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE  375 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  375 (441)
                              ..  ..++..++..+.+||.+||+.||.+||++.+
T Consensus       254 --------~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 --------KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --------SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --------cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                    00  0112235577899999999999999999853

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-45  Score=344.00  Aligned_cols=256  Identities=27%  Similarity=0.475  Sum_probs=209.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|.+.+.||+|+||.||+|.+...      ..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+.   
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   77 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP---   77 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             hheeeeeEecCCCceeEEEEEecCC------CeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---
Confidence            6799999999999999999998643      2499999976543 34678899999999999999999999987654   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        78 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           78 -ICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             -CEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             -eEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccc
Confidence             49999999999999999764 35789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+....      
T Consensus       153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i~~~~------  222 (267)
T 3t9t_A          153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGF------  222 (267)
T ss_dssp             GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTC------
T ss_pred             cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHHhcCC------
Confidence            643321 111223467889999999998999999999999999999999 8999976543222   11111110      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                              ....+..++..+.+++.+||+.||++||++.++++.|+++.+
T Consensus       223 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          223 --------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    001112345678999999999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.7e-45  Score=360.77  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||||++.... .....+.+|+.+++.++||||+++++++....   
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---   89 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKEL-----VAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPT---   89 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCE-----EEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcE-----EEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC---
Confidence            36799999999999999999998877654     9999987543 23466889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc--EEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--AKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFG  253 (441)
                       ..++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.  +||+|||
T Consensus        90 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           90 -HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             -EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence             359999999999999999763  5799999999999999999999998   9999999999999987766  9999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCch-hHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYK-SDIWSFGVFLYELITGRRPLDRNRPK-SEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~  331 (441)
                      +++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ........+..    
T Consensus       164 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----  236 (361)
T 3uc3_A          164 YSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS----  236 (361)
T ss_dssp             CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----
T ss_pred             cccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----
Confidence            99853322   12345689999999999988888765 89999999999999999999754332 11222221111    


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                               ..........+++.+.+|+.+||..||++|||+.++++.
T Consensus       237 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 ---------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                     000111111245778999999999999999999999983

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4e-45  Score=354.78  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=194.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .++|++.+.||+|+||.||+|......  .....||+|++.....    .....+.+|+.+|+.++||||+++++++...
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGA--NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSST--TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccC--CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            367999999999999999999875321  1233599999876532    2335577899999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +.    .|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        94 ~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           94 GK----LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             SC----EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred             CE----EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence            53    59999999999999999763  5789999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+....  
T Consensus       165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~--  237 (327)
T 3a62_A          165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILKCK--  237 (327)
T ss_dssp             CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHTC--
T ss_pred             CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHhCC--
Confidence            99998543221  1234568999999999999999999999999999999999999999765432211   1111100  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                   ...+..++..+.+++.+||..||++||     ++.++++
T Consensus       238 -------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                         011223567889999999999999999     7778876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=345.12  Aligned_cols=265  Identities=29%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      .|...++||+|+||.||+|.+..+..  ....+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..  
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ--NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL--   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS--CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC--
T ss_pred             EEccCceeccCCCceEEEEEEecCCC--ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC--
Confidence            56677899999999999999865543  234599999876443 3346788999999999999999999999765432  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        98 -~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           98 -PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             -CEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             -cEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence             38999999999999999753 46789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCC--cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCC-CCCCCchhHHHHHHhhhhhccccc
Q 013504          257 LGPSDGL--SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP-LDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       257 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      .......  ........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |...........+....       
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------  245 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------  245 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-------
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-------
Confidence            6543221  1122345788999999999999999999999999999999996555 54433322222211110       


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                                ....+..++..+.+++.+||+.||.+||++.++++.|++++....
T Consensus       246 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 ----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                      011122345779999999999999999999999999999987653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=364.37  Aligned_cols=279  Identities=24%  Similarity=0.318  Sum_probs=217.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.++||+|+||.||+|.+..++.     .||||++..... .....+.+|+.++++++||||+++++++......
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD-----LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCc-----EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            3679999999999999999999987665     499999876442 2346778999999999999999999999876533


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE----cCCCcEEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DEQWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl----~~~~~~kl  249 (441)
                        ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++   +|+||||||+|||+    +.++.+||
T Consensus        83 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           83 --HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             --CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             --eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence              4599999999999999997542 23499999999999999999999998   99999999999999    77888999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCc-hhHHH
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--------GRLTYKSDIWSFGVFLYELITGRRPLDRNRP-KSEQK  320 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~elltG~~P~~~~~~-~~~~~  320 (441)
                      +|||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||..... .....
T Consensus       158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~  234 (396)
T 4eut_A          158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (396)
T ss_dssp             CCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred             ecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence            9999998654322   2334679999999999865        5677899999999999999999999964332 11122


Q ss_pred             HHHhhhhhcccc----------cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          321 LLEWVRPHLTDA----------KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       321 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ....+.......          ..+....+..........++..+.+++.+||+.||++||++.++++.++++++..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            222111111000          0000000111223455788899999999999999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-45  Score=362.72  Aligned_cols=271  Identities=22%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCC-CCCeeeEEeEEec
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAE  170 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  170 (441)
                      ...++|.+.+.||+|+||.||+|.+..++..     ||||++....  ......+.+|+.+|..+. ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~   80 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEV-----VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA   80 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCE-----EEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCE-----EEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence            4567899999999999999999998877654     9999986532  234467789999999997 9999999999986


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .+..  ..|+|||||+ ++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        81 ~~~~--~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           81 DNDR--DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             TTSS--CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCCC--EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            5432  4699999996 699999876   4799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCC-------------------CcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 013504          251 DFGLARLGPSDG-------------------LSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       251 DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                      |||+++......                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999998643211                   1112345689999999999876 67899999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhhhhcccccchhhhc------------------CCCCCCcch------------HHHHHHHHHHHH
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAKKFTMIL------------------DPKLEGKYS------------IKLAQKLAAVAN  360 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~------------~~~~~~l~~li~  360 (441)
                      ...........+..... .+.......+.                  .......++            ..+++.+.+|+.
T Consensus       232 ~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            76554332222111100 00000000000                  000000000            023567899999


Q ss_pred             HhhcccCCCCCCHHHHHHH
Q 013504          361 KCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       361 ~cl~~dP~~RPs~~evl~~  379 (441)
                      +||..||++|||+.++++.
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-45  Score=345.45  Aligned_cols=248  Identities=28%  Similarity=0.470  Sum_probs=202.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||+|++......   ....+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFI-----LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcE-----EEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            46899999999999999999998876653     999998654321   2456889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 ----~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           83 ----RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             ----EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred             ----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence                359999999999999999763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....      
T Consensus       154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------  223 (279)
T 3fdn_A          154 GWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------  223 (279)
T ss_dssp             CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------
T ss_pred             cccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------
Confidence            998754332    2345689999999999999999999999999999999999999997654332222211110      


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                  ...+..++..+.+++.+||+.||++||++.++++.
T Consensus       224 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 ------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        11122345678899999999999999999999983

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-45  Score=345.20  Aligned_cols=265  Identities=24%  Similarity=0.446  Sum_probs=212.1

Q ss_pred             cCCcccc-eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSL-MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.. .||+|+||.||+|.+.....   ...||||.+..... ...+.+.+|+.+++.++||||+++++++...   
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---C---CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCC---cceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC---
Confidence            5677766 89999999999998754322   34599999986533 3456788999999999999999999999432   


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           83 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             --SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             --CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence              259999999999999999753 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.   ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~---~~----  229 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QG----  229 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---TT----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh---cC----
Confidence            9876433211 11233467899999999998899999999999999999998 999997654432222111   10    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccC
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETG  390 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  390 (441)
                                .....+..++..+.+++.+||..||++||++.++++.|+.+.......
T Consensus       230 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          230 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                      011122345678999999999999999999999999999998766543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-45  Score=362.62  Aligned_cols=271  Identities=21%  Similarity=0.289  Sum_probs=204.9

Q ss_pred             hcCCcccceeecc--cceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEG--GFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .++|++.+.||+|  +||.||+|.+..++..     ||||++.....  .....+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEY-----VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCE-----EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCE-----EEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            3689999999999  9999999999876654     99999876542  2345678899999999999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +    ..++||||+++|+|.+++.......+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        99 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d  171 (389)
T 3gni_B           99 N----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG  171 (389)
T ss_dssp             T----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             C----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence            6    359999999999999999876567899999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCC-----cceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HH
Q 013504          252 FGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LE  323 (441)
Q Consensus       252 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~  323 (441)
                      ||++........     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........... ..
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            998864322111     111223578999999999987  5789999999999999999999999976443322110 00


Q ss_pred             hhhhhcccc-----cchh-------------hhc---------CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHH
Q 013504          324 WVRPHLTDA-----KKFT-------------MIL---------DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV  376 (441)
Q Consensus       324 ~~~~~~~~~-----~~~~-------------~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  376 (441)
                      ...+.+.+.     ....             ...         ...........+++.+.+|+.+||+.||++|||+.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            000000000     0000             000         0000011233456789999999999999999999999


Q ss_pred             HH
Q 013504          377 VE  378 (441)
Q Consensus       377 l~  378 (441)
                      ++
T Consensus       332 l~  333 (389)
T 3gni_B          332 LN  333 (389)
T ss_dssp             TT
T ss_pred             hc
Confidence            97

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-45  Score=351.26  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=201.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|++......   ..+.+.+|+.++..++||||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRER-----IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCe-----EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            4789999999999999999999876654     4999998765332   2367889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       108 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          108 ----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             ----EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSC
T ss_pred             ----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecC
Confidence                459999999999999999763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||......   .....+...... 
T Consensus       179 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-  253 (309)
T 2h34_A          179 GIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIPR-  253 (309)
T ss_dssp             CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCCC-
T ss_pred             ccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCCC-
Confidence            99986543321 1233567999999999999999999999999999999999999999754322   111111111000 


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-CHHHHHHHHHHHHhhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-KMSEVVEVLNKIVDAA  387 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  387 (441)
                                 .......++..+.+++.+||..||++|| +++++++.|+.++...
T Consensus       254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                       0112234566799999999999999999 9999999999887554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=380.77  Aligned_cols=265  Identities=24%  Similarity=0.443  Sum_probs=209.5

Q ss_pred             cCCcccc-eeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSL-MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +++.+.. .||+|+||.||+|.++....   ...||||++..... ...+.+.+|+.+|+.++||||+++++++...   
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSC---EEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCC---cEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---
Confidence            3444444 79999999999998865432   34599999976533 3457899999999999999999999999753   


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus       409 --~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          409 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             --SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             --CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence              259999999999999999754 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.   ..    
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~~----  555 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QG----  555 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH---TT----
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cC----
Confidence            9875433211 11223456789999999999999999999999999999998 999997665433222211   10    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhccC
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETG  390 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  390 (441)
                                .....+..++..+.+|+.+||..||++||++.+|++.|+.+.......
T Consensus       556 ----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          556 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence                      011223356688999999999999999999999999999988765443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.4e-45  Score=346.69  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=201.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+.+       ..||||.+....  ..+.+.+|+.+++.++||||+++++++.....  
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC----
T ss_pred             hhhceEEeEEecCCCceEEEEEEcC-------CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC--
Confidence            3679999999999999999998753       249999987543  45678899999999999999999999765432  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++.......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           89 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             -ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence             349999999999999999764333488999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      ......     .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........   +...      
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~~~~------  230 (278)
T 1byg_A          165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKG------  230 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---HTTT------
T ss_pred             cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhcC------
Confidence            854332     223467899999999999999999999999999999998 9999976543322111   1100      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              .....+..+++.+.+++.+||+.||++||++.++++.|+.+...
T Consensus       231 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 --------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                    01112234567899999999999999999999999999998754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=357.56  Aligned_cols=270  Identities=18%  Similarity=0.209  Sum_probs=201.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-----------hHHHHHHHHHhccCCCCCeeeEE
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-----------HKEWVTEVNVLGVVEHPNLVKLI  165 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~hpnIv~l~  165 (441)
                      ++|.+.+.||+|+||.||+|.+..++.  ....+|||.+.......           ...+.+|+.++..++||||++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPE--KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCG--GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCC--ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            679999999999999999999876321  22348999987653221           13466788999999999999999


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      +++..........|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            99987543344679999999 99999999764  3899999999999999999999998   999999999999998887


Q ss_pred             --cEEEeecCCCCCCCCCCC-----cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          246 --NAKLSDFGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       246 --~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                        .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999976532211     1112456899999999999999999999999999999999999999954222111


Q ss_pred             --HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          319 --QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       319 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                        ..........+..  .......       ...++..+.+++.+||..||++||++.+|++.|+.+
T Consensus       269 ~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDELPQ--SVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHTTTH--HHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHhhcccccH--HHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence              1111111111110  0000000       013456899999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.2e-45  Score=347.93  Aligned_cols=270  Identities=18%  Similarity=0.285  Sum_probs=207.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||++.....  ...+.+|+.+++.++|++++..+.++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGE-----EVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCc-----eEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            345789999999999999999999876654     499998655432  2457789999999999888888777755433


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl~  250 (441)
                         ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+
T Consensus        79 ---~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           79 ---YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ---EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             ---ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEe
Confidence               458999999 99999999743 45799999999999999999999998   99999999999999   788999999


Q ss_pred             ecCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          251 DFGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       251 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      |||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            99999865443221     1233568999999999999999999999999999999999999999764433222221111


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      ....... .         .......+++.+.+++.+||+.||++||++.+|++.|+++++...
T Consensus       231 ~~~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          231 SEKKMST-P---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHS-C---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hcccccc-h---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            1000000 0         000111245789999999999999999999999999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.9e-45  Score=376.74  Aligned_cols=253  Identities=29%  Similarity=0.487  Sum_probs=208.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+|..++||||+++++++.+.+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~-----vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKM-----YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCE-----EEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            46799999999999999999999876654     99999875432   23456789999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..|+||||++||+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus       258 ----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence                459999999999999999875555699999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~  331 (441)
                      |+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+...+...   
T Consensus       331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---  404 (576)
T 2acx_A          331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---  404 (576)
T ss_dssp             TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---
T ss_pred             ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---
Confidence            9998754432   23456899999999999998999999999999999999999999976543211 1121111110   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                  ...++..++..+.+||.+||+.||.+||     ++.+|++
T Consensus       405 ------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                        0112234567899999999999999999     7888886

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-44  Score=350.90  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=206.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+......      ..+.+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGL-----EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCe-----EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4679999999999999999999887654     3999998764432      2467889999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC----
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW----  245 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~----  245 (441)
                      ...    ..++||||+++++|.+++..  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++    
T Consensus        86 ~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           86 NRT----DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             cCC----EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence            765    35999999999999999976  46789999999999999999999998   999999999999999888    


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.  
T Consensus       157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--  231 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--  231 (321)
T ss_dssp             CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred             CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--
Confidence            79999999998654432   2344679999999999999999999999999999999999999997654322211111  


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ...           ..........++..+.+++.+||+.||++||++.++++
T Consensus       232 -~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 -SVS-----------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -TTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -hcc-----------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             100           00011111234567899999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=350.98  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||+||+|.+..++.     .||||++.....  ........|+..+..+ +||||+++++++.+..
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGR-----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSC-----EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCe-----EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            4689999999999999999999886654     399998765432  2233455666666555 9999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+ +++|.+++... +..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       131 ----~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          131 ----ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             ----EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence                459999999 77999998765 46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....  .    ...+       
T Consensus       202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--~----~~~~-------  264 (311)
T 3p1a_A          202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--G----WQQL-------  264 (311)
T ss_dssp             TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--H----HHHH-------
T ss_pred             eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--H----HHHH-------
Confidence            9998654322   2344679999999999875 79999999999999999999977664211  0    0101       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .........+..++..+.+++.+||+.||++||++.++++
T Consensus       265 ------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          265 ------RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                  0111111222345678999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-44  Score=366.15  Aligned_cols=267  Identities=22%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||||++....  ....+++.+|+.+|+.++||||+++++++.....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTE-----EEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCC-----EEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            4689999999999999999999877654     49999997642  2335678899999999999999999999976542


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                        .....||||||+++ +|.+.+..    .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|
T Consensus       136 ~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             cccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence              22356999999965 57777643    589999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhc-
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHL-  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~-  329 (441)
                      ||+++.....   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......... +....... 
T Consensus       208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9999865432   224457899999999999999999999999999999999999999976543322211 11110000 


Q ss_pred             --------------cc-----ccchhhhcCCC---CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 --------------TD-----AKKFTMILDPK---LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 --------------~~-----~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                    ..     ...+.......   .........+..+.+|+.+||..||++|||+.++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                          00     00000000000   001112234678999999999999999999999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-45  Score=356.18  Aligned_cols=261  Identities=23%  Similarity=0.260  Sum_probs=201.5

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-----chhhHHHHHHHHHhccCCCCCeeeEEe
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-----LQGHKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      +....++|.+.+.||+|+||.||+|.+..++.     .||+|++....     ....+.+.+|+.+++.++||||+++++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRA-----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCc-----eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            45567899999999999999999999877655     39999986542     234567889999999999999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcC--------------------------------------CCCCCHHHHH
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF--------------------------------------QATLPWNTRL  208 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~  208 (441)
                      ++.+..    ..++||||+++|+|.+++....                                      ...+++..++
T Consensus        96 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           96 VYEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             EEECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             hhccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            998765    4599999999999999985210                                      1123567788


Q ss_pred             HHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC--cEEEeecCCCCCCCCCC--CcceeeceecccCcCCcccccc
Q 013504          209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW--NAKLSDFGLARLGPSDG--LSHVSTAVVGTIGYAAPEYIQT  284 (441)
Q Consensus       209 ~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~  284 (441)
                      .++.||+.||.|||++   +|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+
T Consensus       172 ~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence            9999999999999998   999999999999998776  89999999998543211  1112345689999999999875


Q ss_pred             --CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHh
Q 013504          285 --GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKC  362 (441)
Q Consensus       285 --~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  362 (441)
                        ..++.++|||||||++|||++|..||...........+.  ...            ..........+++.+.+++.+|
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~~~li~~~  314 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL--NKK------------LCFENPNYNVLSPLARDLLSNL  314 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCC------------CCTTSGGGGGSCHHHHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH--hcc------------cccCCcccccCCHHHHHHHHHH
Confidence              678999999999999999999999997654332221111  000            0001111123567899999999


Q ss_pred             hcccCCCCCCHHHHHH
Q 013504          363 LARQAKGRPKMSEVVE  378 (441)
Q Consensus       363 l~~dP~~RPs~~evl~  378 (441)
                      |+.||.+||++.++++
T Consensus       315 l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          315 LNRNVDERFDAMRALQ  330 (345)
T ss_dssp             SCSCTTTSCCHHHHHH
T ss_pred             cCCChhHCCCHHHHhc
Confidence            9999999999999988

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-45  Score=357.68  Aligned_cols=253  Identities=22%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||++.....    ...+|+.++.++ +||||+++++++.+.. 
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNM-----EFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK-   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-
Confidence            45789999999999999999999887654     499999976542    234688888887 7999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC----CcEEE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ----WNAKL  249 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~----~~~kl  249 (441)
                         ..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||+.++    +.+||
T Consensus        90 ---~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           90 ---YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             ---EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence               45999999999999999976  46799999999999999999999998   99999999999998543    35999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...+....
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  239 (342)
T 2qr7_A          162 CDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK  239 (342)
T ss_dssp             CCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred             EECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence            9999998654332  12345689999999999988889999999999999999999999997543333333333222110


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 ..+.......++..+.+|+.+||..||++||++.++++
T Consensus       240 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          240 -----------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       01111222345678999999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=348.87  Aligned_cols=266  Identities=23%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++......  ..+.+.+|+.++++++||||+++++++....  
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQ-----IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--
Confidence            679999999999999999999887655     3999988665432  2456789999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        76 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           76 --RLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             --EEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             --eEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence              35999999999999998865  46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  331 (441)
                      ++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........  
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            98654322  12345689999999999876 66899999999999999999999999776544333222211110000  


Q ss_pred             ------ccchhh--hcCCCCCCcc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ------AKKFTM--ILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ------~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ......  ..++......   ...++..+.+++.+||+.||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                  000000  0000000000   0235667899999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.9e-45  Score=355.50  Aligned_cols=247  Identities=25%  Similarity=0.422  Sum_probs=180.0

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeEEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      .+.||+|+||.||+|.+..++.     .||||++...   ....+.+|+.++..+. ||||+++++++.+..    ..|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQ-----AFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCC-----EEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEE
T ss_pred             CCccccCCCeEEEEEEECCCCC-----EEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEE
Confidence            3789999999999999987665     3999998653   3456778999999996 999999999998765    3599


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC---cEEEeecCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW---NAKLSDFGLARL  257 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~  257 (441)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++   .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999999999999987  46799999999999999999999998   999999999999997665   799999999986


Q ss_pred             CCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCch----hHHHHHHhhhhhccccc
Q 013504          258 GPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK----SEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       258 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~----~~~~~~~~~~~~~~~~~  333 (441)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......    ........+...     
T Consensus       159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          159 KPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             cCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence            54332  2234567899999999999999999999999999999999999999754321    111111111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ...........+++.+.+|+.+||+.||.+||++.++++
T Consensus       232 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          232 ------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                  011111222346778999999999999999999999885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-44  Score=346.63  Aligned_cols=263  Identities=24%  Similarity=0.403  Sum_probs=199.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++....   ......+.+|+.+++.++||||+++++++...+ 
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-  105 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGV-----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-  105 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCC-----EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCc-----eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence            579999999999999999999876654     49999987533   233467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                         ..++||||+++++|.+++..  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       106 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          106 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             ---cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence               35999999999999999864  2346789999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....+...   
T Consensus       180 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---  253 (310)
T 2wqm_A          180 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIEQC---  253 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHHTT---
T ss_pred             ccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhhcc---
Confidence            99998654322  123346799999999999999999999999999999999999999965432211 111111100   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                .........++..+.+++.+||..||++||++.+|++.|+++....
T Consensus       254 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 ----------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             ----------CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence                      0000111235678999999999999999999999999999997654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=355.60  Aligned_cols=261  Identities=16%  Similarity=0.179  Sum_probs=206.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC---CCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE---HPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  171 (441)
                      ..++|.+.+.||+|+||.||+|.+...........||||++....   ..++.+|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            357899999999999999999975443333444569999997653   446677888877776   99999999999877


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-----
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSR---FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-----  243 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-----  243 (441)
                      +.    .||||||+++|+|.+++...   ....+++..++.|+.||+.||.|||++   +|+||||||+||||+.     
T Consensus       140 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          140 NG----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             SC----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             CC----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            64    49999999999999999742   246799999999999999999999998   9999999999999998     


Q ss_pred             ------CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh
Q 013504          244 ------QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS  317 (441)
Q Consensus       244 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~  317 (441)
                            ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999975432222334556789999999999999999999999999999999999999995321100


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCC-CCHHHHHHHHHHHHhhh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGR-PKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~~  387 (441)
                                     ..    ....+...   ..++.+.+++..||..+|.+| |++.++.+.|++++...
T Consensus       293 ---------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ---------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                           00    01111111   124567789999999999999 78899999999988763

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=349.37  Aligned_cols=273  Identities=27%  Similarity=0.376  Sum_probs=205.4

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc--CCCCCeeeEEeEEec
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCAE  170 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~  170 (441)
                      ....++|++.+.||+|+||.||+|.+.+       ..||||++....   ...+.+|.+++..  ++||||+++++++..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWRG-------EKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEECC-------ceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            3455789999999999999999998752       349999986432   3344556666555  499999999999987


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecccCCCcEEEcCCC
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM-----DFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDlKp~NILl~~~~  245 (441)
                      ........++||||+++|+|.+++..   ..+++..++.++.|++.||.|||++.     ..+|+||||||+|||++.++
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence            65433467999999999999999975   46999999999999999999999741     23899999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCc--ceeeceecccCcCCccccccCCCCcc------ccchhHHHHHHHHHhC----------C
Q 013504          246 NAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGRLTYK------SDIWSFGVFLYELITG----------R  307 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~il~elltG----------~  307 (441)
                      .+||+|||+++........  .......||+.|+|||++.+..++..      +|||||||++|||++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999999999765433211  11234689999999999988776665      9999999999999999          6


Q ss_pred             CCCCCCCchhH--HHHHHhhhhhcccccchhhhcCCCCCC-cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          308 RPLDRNRPKSE--QKLLEWVRPHLTDAKKFTMILDPKLEG-KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       308 ~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      .||........  .........         ....+.+.. .....++..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCI---------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhh---------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            66643322111  111111000         001111111 112378889999999999999999999999999999998


Q ss_pred             hhh
Q 013504          385 DAA  387 (441)
Q Consensus       385 ~~~  387 (441)
                      +..
T Consensus       331 ~~~  333 (337)
T 3mdy_A          331 ESQ  333 (337)
T ss_dssp             HTT
T ss_pred             hhc
Confidence            754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-44  Score=344.86  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=198.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .+|+|.+..... ...+.+.+|+.+|+.++||||+++++++....  
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   93 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGL-----ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--   93 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCc-----eEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC--
Confidence            4679999999999999999999877654     389999876542 23577889999999999999999999998655  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl  249 (441)
                        ..++||||+++|+|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||
T Consensus        94 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           94 --NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             --EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             --eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEE
Confidence              359999999999999998642  246799999999999999999999998   99999999999999   45678999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||...................
T Consensus       169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            9999998654322   234567999999999885 578999999999999999999999997654333222221111000


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                    . .....+++.+.+++.+||+.||++||++.++++
T Consensus       245 --------------~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 --------------A-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --------------C-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --------------c-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          0 000113567889999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=357.90  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=194.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCC--CCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEH--PNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~  171 (441)
                      .++|++.+.||+|+||.||+|.+.. +     ..||||++.....  .....+.+|+.+|..++|  |||+++++++...
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-S-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-C-----CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            4679999999999999999998643 2     2499999875433  234678899999999976  9999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .    ..++||| +.+++|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+|
T Consensus        82 ~----~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           82 Q----YIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             S----EEEEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             C----EEEEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence            5    4599999 558899999987  46899999999999999999999998   999999999999997 57899999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      ||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........ .
T Consensus       151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~  229 (343)
T 3dbq_A          151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K  229 (343)
T ss_dssp             CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H
T ss_pred             cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-H
Confidence            999987654433333456789999999999865           6788999999999999999999999975432211 1


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ...              .+++.....++...+..+.+++.+||+.||.+||++.++++.
T Consensus       230 ~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 LHA--------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHH--------------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH--------------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111              111111222222334678899999999999999999999984

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.1e-45  Score=368.49  Aligned_cols=247  Identities=26%  Similarity=0.412  Sum_probs=205.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||||++.....   .....+.+|+.+|+.++||||+++++++...+ 
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-   89 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHK-----VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-   89 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCE-----EEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            6799999999999999999998876653     99999875432   22457889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||+++|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        90 ---~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           90 ---DIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ---EEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             ---EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence               35999999999999999975  46799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........   +....   
T Consensus       162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~~---  232 (476)
T 2y94_A          162 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK---ICDGI---  232 (476)
T ss_dssp             SCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH---HHTTC---
T ss_pred             chhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH---HhcCC---
Confidence            998754432   2345689999999999988765 6899999999999999999999976543322111   11100   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .  ..+..+++.+.+|+.+||..||.+||++.++++
T Consensus       233 ----------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 ----------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                      0  111234567899999999999999999999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.6e-45  Score=347.61  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=207.9

Q ss_pred             hcCCcccc-eeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSL-MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+ .||+|+||.||+|.+....   ....||||++......  ..+.+.+|+.+++.++||||+++++++.. +
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S
T ss_pred             chhhhhccCccccccCeeeEeeeecCCC---ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C
Confidence            36788888 9999999999999765332   2345999998765322  24678899999999999999999999943 2


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        91 ----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           91 ----SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             ----SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ----CcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence                35899999999999999976  45799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          253 GLARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       253 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |+++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.   ..  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~--  236 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KG--  236 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TT--
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cC--
Confidence            999875443321 11223456789999999998889999999999999999999 999997654432222111   10  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                                  .....+..++..+.+++.+||+.||++||++.++++.|+++....
T Consensus       237 ------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          237 ------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                        001122345678999999999999999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-44  Score=344.92  Aligned_cols=267  Identities=18%  Similarity=0.294  Sum_probs=210.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.....  ...+.+|+.+++.++|++++..+.++.....  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGE-----EVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD--   78 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT--
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCc-----EEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC--
Confidence            4689999999999999999999876654     499999865432  3568899999999999887777777655433  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEEeec
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSDF  252 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl~DF  252 (441)
                       ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+||
T Consensus        79 -~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           79 -YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             -EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             -ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence             458999999 99999999743 46799999999999999999999998   99999999999999   48889999999


Q ss_pred             CCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          253 GLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       253 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+..
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            999865443221     112456899999999999999999999999999999999999999976443222111111110


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ..... ..         ......+++.+.+++.+||+.||++||++.+|++.|+++....
T Consensus       233 ~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          233 KKMST-PI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHS-CH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccCC-ch---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            00000 00         0011234577999999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-44  Score=342.64  Aligned_cols=252  Identities=22%  Similarity=0.396  Sum_probs=202.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..|.+.+.||+|+||.||+|.+..++..     ||+|.+.....  ...+.+.+|+.+++.++||||+++++++......
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-----va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVE-----VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceE-----EEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            3578888999999999999998776543     89998875432  2346788999999999999999999999875544


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEc-CCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLD-EQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~-~~~~~kl~D  251 (441)
                      ....++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.   +  |+||||||+|||++ .++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence            45679999999999999999763  6799999999999999999999998   7  99999999999997 889999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|..||........  .........  
T Consensus       176 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~--  246 (290)
T 1t4h_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGV--  246 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTC--
T ss_pred             CCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHhccC--
Confidence            9999764432    234467999999999886 4699999999999999999999999975433221  111111100  


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                 .....+...++.+.+++.+||+.||.+||++.++++
T Consensus       247 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 -----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                       011112233467899999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-44  Score=351.64  Aligned_cols=262  Identities=28%  Similarity=0.482  Sum_probs=208.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++..   ..+++|.+.... ....+.+.+|+.+++++ +||||+++++++...+  
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcc---cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--
Confidence            6799999999999999999998766532   236888886532 22346788999999999 9999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                        ..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus       100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl  174 (327)
T 1fvr_A          100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL  174 (327)
T ss_dssp             --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEE
Confidence              3599999999999999997532              24799999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~  319 (441)
                      ++.++.+||+|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       175 ~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--  249 (327)
T 1fvr_A          175 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--  249 (327)
T ss_dssp             ECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred             EcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--
Confidence            999999999999998743221   12234567889999999998889999999999999999998 999997654322  


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                       ....+...              .....+..++..+.+++.+||..||.+||++.++++.|+.+++...
T Consensus       250 -~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          250 -LYEKLPQG--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             -HHHHGGGT--------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -HHHHhhcC--------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence             11111110              0111222456789999999999999999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=343.62  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=203.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|++.....    .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLC-----RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCC-----EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCc-----EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            4689999999999999999999776654     499999875432    2346788999999999999999999998644


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +..  ..++||||++++ |.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        79 ~~~--~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           79 EKQ--KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             -----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCC--eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence            322  459999999876 88888766567899999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCC--CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL--TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      ||++................||+.|+|||++.+...  +.++||||||+++|+|++|..||.........   ..+....
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~i~~~~  229 (305)
T 2wtk_C          153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF---ENIGKGS  229 (305)
T ss_dssp             CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHCC
T ss_pred             cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHHhcCC
Confidence            999987654333334455679999999999876443  77999999999999999999999765432211   1111100


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                 .    ..+..++..+.+++.+||..||.+||++.++++.
T Consensus       230 -----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----------Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----------C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----------C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       0    1112345678899999999999999999999973

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.2e-45  Score=346.47  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccc-
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD-  172 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  172 (441)
                      ....+|++.+.||+|+||.||+|.+..++.     .||+|.+....    ..+.+|+.+++.++||||+++++++.... 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGK-----TYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCC-----EEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCe-----EEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            355789999999999999999999876554     49999987543    35668999999999999999999886521 


Q ss_pred             -----------cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          173 -----------ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       173 -----------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                                 ......++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  155 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL  155 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence                       1122468999999999999999876567899999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      +.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..|+..     ....
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~  227 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKF  227 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHH
T ss_pred             cCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHH
Confidence            999999999999998654432   22345799999999999999999999999999999999999988731     1111


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ....             ....+    +..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       228 ~~~~-------------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          228 FTDL-------------RDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHH-------------HTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHh-------------hcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            1111             01111    122456788999999999999999999999999988654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-44  Score=341.52  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+..++..     ||+|++.....  ...+.+.+|+.++++++||||+++++++.... 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLE-----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCce-----EEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-
Confidence            47899999999999999999998876553     99999875443  23467889999999999999999999997665 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc---EEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~---~kl~  250 (441)
                         ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+
T Consensus        79 ---~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           79 ---FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             ---EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence               349999999999999998764  5799999999999999999999998   9999999999999986665   9999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...   ..
T Consensus       151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~  224 (284)
T 3kk8_A          151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---AY  224 (284)
T ss_dssp             CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---CC
T ss_pred             eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc---cc
Confidence            999997654332   233467999999999999999999999999999999999999999765433222211110   00


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .           ........+++.+.+++.+||+.||++||++.++++
T Consensus       225 ~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 D-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             C-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0           001111234577899999999999999999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=378.95  Aligned_cols=259  Identities=27%  Similarity=0.451  Sum_probs=211.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..+.      .||||++.... ...+.+.+|+.+|++++||||+++++++.. .  
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~--  334 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--  334 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTE------EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCc------eEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c--
Confidence            3467888999999999999999986532      49999997654 335678999999999999999999999865 2  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..+|||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus       335 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          335 --PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             --SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             --cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence              249999999999999999764446799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++...... ........+|..|+|||++.+..++.++|||||||++|||++ |..||........   ...+...     
T Consensus       410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i~~~-----  480 (535)
T 2h8h_A          410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERG-----  480 (535)
T ss_dssp             TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHHHTT-----
T ss_pred             ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC-----
Confidence            98654321 111223456789999999999999999999999999999999 9999976543322   2111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                               .....+..++..+.+||.+||+.||++||++.+|++.|+.++..
T Consensus       481 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 ---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                     01112234567899999999999999999999999999987643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-45  Score=361.62  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCC--CCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVE--HPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~  172 (441)
                      ++|.+.+.||+|+||.||+|.+.. +     ..||||++.....  .....+.+|+.+|..++  ||||+++++++...+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-C-----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            569999999999999999998654 2     2499999875432  33467889999999996  599999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    .|+||| +.+++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++ ++.+||+||
T Consensus       130 ~----~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          130 Y----IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             E----EEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             E----EEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            3    599999 5689999999873  5789999999999999999999998   999999999999996 578999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      |+++..............+||+.|+|||++.+           ..++.++|||||||++|||++|..||....... ..+
T Consensus       199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~  277 (390)
T 2zmd_A          199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKL  277 (390)
T ss_dssp             SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHH
T ss_pred             CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHH
Confidence            99987654332333445689999999999865           468899999999999999999999997543221 111


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      ..              ++++.....++...+..+.+|+.+||..||++||++.++++.
T Consensus       278 ~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HA--------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HH--------------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH--------------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11              111111111222235678999999999999999999999974

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=352.74  Aligned_cols=281  Identities=25%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHH--HhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVN--VLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+.+       ..||||++....   ...+..|.+  .+..++||||+++++++.....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDE-------RPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETT-------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             hHHhheeeecccCCCeEEEEEEECC-------eEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            3689999999999999999997633       349999986543   233444444  4556899999999987654322


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEecccCCCcEEEcCCCc
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM------DFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~iiHrDlKp~NILl~~~~~  246 (441)
                       .....++||||+++|+|.+++..   ...++..++.++.||+.||.|||+.+      ..+|+||||||+|||++.++.
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             CCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence             22346899999999999999976   34589999999999999999999752      228999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCC------cceeeceecccCcCCcccccc-------CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013504          247 AKLSDFGLARLGPSDGL------SHVSTAVVGTIGYAAPEYIQT-------GRLTYKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      +||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999986543211      112234579999999999876       35667899999999999999997776432


Q ss_pred             CchhH-HHHHHhhhhhcccccchh-----hhcCCCCCC--cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          314 RPKSE-QKLLEWVRPHLTDAKKFT-----MILDPKLEG--KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       314 ~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      ..... ..................     ....+.+..  .....+++.+.+++.+||+.||++|||+.++++.|++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            21111 000000000000000000     000111111  1123477789999999999999999999999999999997


Q ss_pred             hhcc
Q 013504          386 AAET  389 (441)
Q Consensus       386 ~~~~  389 (441)
                      ....
T Consensus       319 ~~~~  322 (336)
T 3g2f_A          319 IWER  322 (336)
T ss_dssp             CCCC
T ss_pred             HHHh
Confidence            6544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-44  Score=340.59  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=205.2

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .||+|.+..... ...+.+.+|+.+++.++||||+++++++.... 
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE-----AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCc-----EEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-
Confidence            45789999999999999999999876655     399999875433 33467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++++|.+++..  ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           79 ---IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             ---EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ---EEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence               35999999999999999965  45799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+....    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----  225 (276)
T 2yex_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK----  225 (276)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC----
T ss_pred             CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc----
Confidence            9986533222222345689999999999987665 6789999999999999999999976443211 111111100    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ........++..+.+++.+||+.||++||++.++++
T Consensus       226 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 ----------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                      000111235677889999999999999999999886

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-44  Score=348.43  Aligned_cols=257  Identities=26%  Similarity=0.366  Sum_probs=197.7

Q ss_pred             cCCccc-ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRS-LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      +.|.+. +.||+|+||.||+|.+..++.     .||||++..........+.+|+.++.++ +||||+++++++...+  
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--   84 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQ-----EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--   84 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCC-----EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCc-----EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--
Confidence            568774 789999999999999776554     4999999776555567889999999985 7999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc---EEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~---~kl~D  251 (441)
                        ..++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.   +||+|
T Consensus        85 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           85 --RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             --EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence              459999999999999999764  5799999999999999999999998   9999999999999998776   99999


Q ss_pred             cCCCCCCCCCCC-----cceeeceecccCcCCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCchh----
Q 013504          252 FGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQT-----GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS----  317 (441)
Q Consensus       252 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~----  317 (441)
                      ||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.......    
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            999986432211     111234569999999999875     558899999999999999999999997654321    


Q ss_pred             --------HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          318 --------EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       318 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ...+...+....           ..+.......++..+.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGK-----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhHHHHHHHHHhccC-----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                    011111111000           00000011134578999999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=352.73  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeEEe
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKLIG  166 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~  166 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||.+......        ....+.+|+.+|+.++||||+++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~   96 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNK-----EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD   96 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTE-----EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCc-----EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            45789999999999999999999877654     4999998765321        2235668999999999999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          167 YCAEDDERGIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      ++....    ..++||||+.+| +|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        97 ~~~~~~----~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           97 IFENQG----FFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             EEECSS----EEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred             EEeeCC----EEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence            998765    359999999776 99999976  46799999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......        
T Consensus       168 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------  236 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------  236 (335)
T ss_dssp             CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred             cEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence            99999999998754432   2344689999999999988776 78899999999999999999999642110        


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                .....      ..+..++..+.+++.+||+.||++||++.++++.
T Consensus       237 ----------~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----------VEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------TTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------Hhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000      0111245678999999999999999999999983

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.5e-44  Score=366.00  Aligned_cols=259  Identities=22%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .+.|.+.+.||+|+||.||+|.+..++..     ||+|++.....  .....+.+|+.+|+.++||||+++++++.... 
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-  109 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVE-----RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-  109 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCE-----EEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcE-----EEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence            46799999999999999999998876653     99999876532  23567889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC---CcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~---~~~kl~  250 (441)
                         ..|+|||||++|+|.+++..+  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+   +.+||+
T Consensus       110 ---~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          110 ---NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence               359999999999999998764  5799999999999999999999998   99999999999999764   459999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....   .
T Consensus       182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~  254 (494)
T 3lij_A          182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---Y  254 (494)
T ss_dssp             CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---C
T ss_pred             ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---C
Confidence            999998654322   234568999999999886 579999999999999999999999997654432222211110   0


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHhh
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVDA  386 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~  386 (441)
                                 .........++..+.+++.+||+.||.+|||+.++++  ++......
T Consensus       255 -----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  301 (494)
T 3lij_A          255 -----------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK  301 (494)
T ss_dssp             -----------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred             -----------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence                       0011111245678999999999999999999999997  56665544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=351.09  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=192.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccc--
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDD--  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--  172 (441)
                      ..+|.+.+.||+|+||.||+|.+..++.     .||||.+..........+.+|+.++.++. ||||+++++++....  
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGR-----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCC-----EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCc-----EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            3579999999999999999999877655     39999987666556678899999999995 999999999985321  


Q ss_pred             --cCCeeEEEEEeccCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecccCCCcEEEcCCCcE
Q 013504          173 --ERGIQRLLIYEYMPNRSVQDHLTS-RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ--IIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       173 --~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlKp~NILl~~~~~~  247 (441)
                        ......++||||++ |+|.+++.. .....+++..++.++.||+.||.|||++   +  |+||||||+|||++.++.+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence              22335689999995 799998864 2345799999999999999999999998   7  9999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcc----------eeeceecccCcCCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013504          248 KLSDFGLARLGPSDGLSH----------VSTAVVGTIGYAAPEYI---QTGRLTYKSDIWSFGVFLYELITGRRPLDRNR  314 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltG~~P~~~~~  314 (441)
                      ||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998754432110          11245699999999998   56678899999999999999999999996432


Q ss_pred             chhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          315 PKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      ...   ....                 ..........+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus       258 ~~~---~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          258 KLR---IVNG-----------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHH---hhcC-----------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            211   1000                 0000011122345789999999999999999999999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-44  Score=344.87  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|.+..........+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   79 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--   79 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCC-----EEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC--
Confidence            34689999999999999999999876654     49999998655444567889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl~D  251 (441)
                        ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|
T Consensus        80 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           80 --HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             --EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence              459999999999999999763  5799999999999999999999998   99999999999999   7889999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+++.....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..... 
T Consensus       153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~-  224 (304)
T 2jam_A          153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIKEGYY-  224 (304)
T ss_dssp             CSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHCCC-
T ss_pred             CCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCC-
Confidence            9999864332    2234579999999999999999999999999999999999999997654322   1111111100 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .........++..+.+++.+||..||++||++.++++
T Consensus       225 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 ----------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ----------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ----------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      0011122345678999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=352.82  Aligned_cols=279  Identities=24%  Similarity=0.400  Sum_probs=212.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|.+.... ......||||++........+.+.+|+.+++.++||||+++++++...+..  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR--  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC--
Confidence            57999999999999999999864321 123456999999876656667899999999999999999999998765432  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            348999999999999999764 35699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc---c
Q 013504          257 LGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD---A  332 (441)
Q Consensus       257 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~  332 (441)
                      ........ .......+|..|+|||++.+..++.++|||||||++|+|++|..||.....    ............   .
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhH
Confidence            76543221 112335678889999999988899999999999999999999999853210    000000000000   0


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ......+........+..++..+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            000001111111122334667899999999999999999999999999998765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=353.29  Aligned_cols=272  Identities=23%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++....... ...+.+|+.+++.++||||+++++++.....  
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS--   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC--
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCc-----EEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE--
Confidence            579999999999999999999887665     39999987543221 1234579999999999999999999987654  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||++ |+|.+++... +..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        75 --~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           75 --LTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             --EEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             --EEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence              499999996 5999998764 45799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc---
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD---  331 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---  331 (441)
                      +......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........   
T Consensus       148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (324)
T 3mtl_A          148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW  225 (324)
T ss_dssp             ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence            8644321  22344678999999999876 56899999999999999999999999776544332222111100000   


Q ss_pred             -----ccchhhhcCCCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          332 -----AKKFTMILDPKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       332 -----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                           ...+.....+....    .....++..+.+|+.+||+.||++|||+.++++  ++..+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                 00000000000000    011134567899999999999999999999998  555543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.1e-44  Score=348.48  Aligned_cols=271  Identities=26%  Similarity=0.393  Sum_probs=210.7

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc--CCCCCeeeEEeEEe
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV--VEHPNLVKLIGYCA  169 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~  169 (441)
                      .....++|.+.+.||+|+||.||+|.+.+       ..||||.+...   ....+.+|++++..  ++||||+++++++.
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEcC-------ccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            34566889999999999999999998742       34999998654   34567788888877  79999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecccCCCcEEE
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH--------EGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHrDlKp~NILl  241 (441)
                      .........++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.   +|+||||||+|||+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            776433356999999999999999976   46899999999999999999999        66   99999999999999


Q ss_pred             cCCCcEEEeecCCCCCCCCCCCcc--eeeceecccCcCCccccccCC------CCccccchhHHHHHHHHHhC-------
Q 013504          242 DEQWNAKLSDFGLARLGPSDGLSH--VSTAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITG-------  306 (441)
Q Consensus       242 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltG-------  306 (441)
                      +.++.+||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999997654332111  224467999999999987653      33689999999999999999       


Q ss_pred             ---CCCCCCCCchh--HHHHHHhhhhhcccccchhhhcCCCCCCc-chHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHH
Q 013504          307 ---RRPLDRNRPKS--EQKLLEWVRPHLTDAKKFTMILDPKLEGK-YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL  380 (441)
Q Consensus       307 ---~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  380 (441)
                         ..||.......  .......+..         ....+.+... ....++..+.+|+.+||+.||++||++.+|++.|
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccCccccCcCcccHHHHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence               77886543211  1111111100         0011111111 1236778899999999999999999999999999


Q ss_pred             HHHHhhh
Q 013504          381 NKIVDAA  387 (441)
Q Consensus       381 ~~~~~~~  387 (441)
                      +.+.++.
T Consensus       332 ~~i~~~~  338 (342)
T 1b6c_B          332 SQLSQQE  338 (342)
T ss_dssp             HHHHHTT
T ss_pred             HHHHHHh
Confidence            9998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.8e-45  Score=355.03  Aligned_cols=248  Identities=30%  Similarity=0.437  Sum_probs=200.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .+.|...+.||+|+||.||+|.+..++.     .||||++......   ..+.+.+|+.+++.++||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCe-----EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3569999999999999999999876654     4999998754322   2356889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||++ |+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       128 ----~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          128 ----TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             ----EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ----eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeec
Confidence                3599999996 6888888643 46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |+++....      .....||+.|+|||++.   ...++.++|||||||++|||++|..||..........  ...... 
T Consensus       199 G~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~~-  269 (348)
T 1u5q_A          199 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNE-  269 (348)
T ss_dssp             TTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSC-
T ss_pred             cCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhcC-
Confidence            99986533      23468999999999984   5678999999999999999999999997554322111  111000 


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                .+.   .....++..+.+++.+||+.||++||++.++++.
T Consensus       270 ----------~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 ----------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ----------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----------CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      000   1112345678899999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-44  Score=370.50  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.++||+|+||.||+|.+..++..     ||+|++.....   .....+.+|+.+|+.++||||+++++++....
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~-----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKL-----YACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcE-----EEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            36899999999999999999998876654     99999875432   22456889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                          ..|+||||++||+|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+||||+.+|.+||+
T Consensus       259 ----~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          259 ----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             ----EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEe
Confidence                4599999999999999997543  35799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchh-HHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKS-EQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~-~~~~~~~~~~~~  329 (441)
                      |||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+...+... 
T Consensus       332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-  408 (543)
T 3c4z_A          332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-  408 (543)
T ss_dssp             CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-
T ss_pred             ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-
Confidence            9999987544321  2344689999999999999999999999999999999999999997643221 11222111110 


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH-----HHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM-----SEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  378 (441)
                                    ...++..++..+.++|.+||..||++||++     .+|++
T Consensus       409 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 --------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                          011223456789999999999999999975     56665

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.8e-44  Score=340.09  Aligned_cols=259  Identities=24%  Similarity=0.388  Sum_probs=206.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+......      ..+.+.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGK-----EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCC-----eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence            3679999999999999999999887654     3999998764322      2567889999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC----
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW----  245 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~----  245 (441)
                      ...    ..++||||+++++|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+||+++.++    
T Consensus        79 ~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           79 NKT----DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred             CCC----eEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence            765    35999999999999999976  35799999999999999999999998   999999999999998877    


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...
T Consensus       150 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  226 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV  226 (283)
T ss_dssp             CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             ceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence            79999999998654322   233467999999999999999999999999999999999999999765432221111110


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      .              ..........++..+.+++.+||..||++||++.++++  +++.+..
T Consensus       227 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          227 N--------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             C--------------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             c--------------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            0              00011111234567899999999999999999999998  5666543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=355.55  Aligned_cols=273  Identities=17%  Similarity=0.257  Sum_probs=208.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcc---cceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeee----------
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSH---KKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK----------  163 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~----------  163 (441)
                      ++|.+.+.||+|+||.||+|.+..+....   ....||+|.+...     ..+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            68999999999999999999987642111   1345999998654     45778999999999999988          


Q ss_pred             -----EEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          164 -----LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       164 -----l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                           +++++...+.   ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus       117 ~~i~~~~~~~~~~~~---~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          117 LAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             CSCCCCCEEEEETTT---EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             cCccchhhccccCCc---EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                 5666665322   469999999 99999999875447899999999999999999999998   99999999999


Q ss_pred             EEEcCCC--cEEEeecCCCCCCCCCCC-----cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 013504          239 ILLDEQW--NAKLSDFGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLD  311 (441)
Q Consensus       239 ILl~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~  311 (441)
                      ||++.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  899999999986543211     111234589999999999999999999999999999999999999997


Q ss_pred             CCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          312 RNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      ....... ..............   ...+..   .....++..+.+++.+||+.||++||++.+|++.|+++++...
T Consensus       270 ~~~~~~~-~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          270 NCLPNTE-DIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGTTCHH-HHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCCcCHH-HHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            5432211 11111111100000   000000   0011245789999999999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=342.13  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=183.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+.....   .....+.+|+.+++.++||||+++++++...+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGL-----EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCc-----eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            3679999999999999999999876554     499999865432   12367889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        85 ----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           85 ----YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             ----EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred             ----eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence                459999999999999999764 36799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........           
T Consensus       157 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------  223 (278)
T 3cok_A          157 GLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-----------  223 (278)
T ss_dssp             TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred             cceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-----------
Confidence            99986543221  22346799999999999988999999999999999999999999975432211100           


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           .....  ...+..++..+.+++.+||+.||++||++.++++
T Consensus       224 -----~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 -----VVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -----CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----Hhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                 00000  0112235577899999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-44  Score=350.83  Aligned_cols=265  Identities=20%  Similarity=0.294  Sum_probs=193.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh--hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.......  ...+.+|+.+++.++||||+++++++.... 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  106 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNE-----TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-  106 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCc-----eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence            4689999999999999999999877654     49999997554322  356779999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE-----cCCCcEE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL-----DEQWNAK  248 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl-----~~~~~~k  248 (441)
                         ..++||||++ |+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||+     +.++.+|
T Consensus       107 ---~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          107 ---RLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             ---EEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             ---EEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEE
Confidence               3599999997 599999976  35799999999999999999999998   99999999999999     4555699


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus       178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999997643221  123446789999999999874 489999999999999999999999976544322221111100


Q ss_pred             hcccccch---------hhhc----CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKF---------TMIL----DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~---------~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ......+         ....    ...+.......++..+.+|+.+||+.||++|||+.++++
T Consensus       256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 -LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             -CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             0000000         0000    000000111124578899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-44  Score=341.25  Aligned_cols=246  Identities=25%  Similarity=0.429  Sum_probs=204.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||+|++.....   .....+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   87 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-   87 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCc-----EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-
Confidence            679999999999999999999876654     499999865432   22357889999999999999999999998755 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++...  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           88 ---RIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ---EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence               459999999999999999764  5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      ++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...        
T Consensus       160 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------  227 (284)
T 2vgo_A          160 WSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--------  227 (284)
T ss_dssp             TCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred             ccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--------
Confidence            98754432    233467999999999999999999999999999999999999999765432221111100        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +    ..++..++..+.+++.+||+.||.+||++.++++
T Consensus       228 ------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ------D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                  0    0122235577899999999999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-44  Score=349.23  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=205.9

Q ss_pred             HHHHHhcCCccc-ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccC-CCCCeeeEEe
Q 013504           91 ELKTATKNFSRS-LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVV-EHPNLVKLIG  166 (441)
Q Consensus        91 ~~~~~~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~  166 (441)
                      ......+.|.+. +.||+|+||.||+|.+..++.     .||+|++.....  .....+.+|+.++..+ +||||+++++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQ-----EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCC-----EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            344566778887 899999999999999887665     399999876432  2356788999999999 5799999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---  243 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---  243 (441)
                      ++....    ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.   
T Consensus        97 ~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A           97 VYENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             EEECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred             EEEeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence            998665    359999999999999999765567899999999999999999999998   9999999999999987   


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE  323 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~  323 (441)
                      ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus       170 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  246 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS  246 (327)
T ss_dssp             BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            7899999999998654322   2344689999999999999999999999999999999999999997654332221111


Q ss_pred             hhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          324 WVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...              ..........++..+.+++.+||+.||++||++.++++
T Consensus       247 ~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          247 QVN--------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HTC--------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcc--------------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            110              00111112245677899999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-44  Score=361.43  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeE
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKL  164 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l  164 (441)
                      ....++|.+.+.||+|+||.||+|.+..++..     ||||++......        ....+.+|+.+|++++||||+++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKK-----VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcE-----EEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            34568999999999999999999998877654     999998754321        12347799999999999999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++++...     ..++||||+++|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+
T Consensus       206 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~  275 (419)
T 3i6u_A          206 KNFFDAE-----DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ  275 (419)
T ss_dssp             CEEEESS-----EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSS
T ss_pred             EEEEecC-----ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecC
Confidence            9998543     24899999999999999875  46799999999999999999999998   99999999999999755


Q ss_pred             C---cEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          245 W---NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       245 ~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                      +   .+||+|||+++.....   .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||........
T Consensus       276 ~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  352 (419)
T 3i6u_A          276 EEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  352 (419)
T ss_dssp             SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred             CCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence            4   4999999999875432   23345789999999999853   6688899999999999999999999975432211


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  ...+.....           .........++..+.+++.+||+.||++||++.++++
T Consensus       353 ~--~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 L--KDQITSGKY-----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             H--HHHHHTTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H--HHHHhcCCC-----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1  111100000           0000111234678999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-44  Score=355.44  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||+|++..... ...+.+.+|+.+++.++||||+++++++...+  
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  104 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--  104 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcE-----EEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--
Confidence            36899999999999999999998866543     99999876532 23467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+
T Consensus       105 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          105 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             --EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             --EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCC
Confidence              359999999999999999763  5799999999999999999999973  1799999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh-cc---
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH-LT---  330 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~-~~---  330 (441)
                      +.....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.................. ..   
T Consensus       179 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          179 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             CHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             Cccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence            864321    1233468999999999999999999999999999999999999999765433322111000000 00   


Q ss_pred             ------------------cc----cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 ------------------DA----KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ------------------~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                        ..    .....+............++..+.+|+.+||..||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                              00    0000000000111111234667999999999999999999999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.9e-44  Score=376.63  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=202.6

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      +.||+|+||.||+|.+....   ....||||++.....  ...+++.+|+.+|.+++|||||++++++....     .+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSS---CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----EEE
T ss_pred             CEeccCCCEEEEEEEEcCCC---cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEE
Confidence            47999999999999775432   234599999976433  23477899999999999999999999996432     489


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      ||||+++|+|.+++..  ...+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....
T Consensus       447 v~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            9999999999999976  46799999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          261 DGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       261 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+...             
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------------  588 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------------  588 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence            321 122334567889999999999999999999999999999998 99999765543322222110             


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                          .....+..++..+.+|+.+||+.||++||++.+|++.|+++...
T Consensus       589 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          589 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                01122334668899999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-44  Score=349.57  Aligned_cols=249  Identities=24%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||++.+..++..     +|+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEV-----FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            36799999999999999999998876653     89999875432   23466889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          115 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence                459999999999999998763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...       
T Consensus       186 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------  256 (335)
T 2owb_A          186 GLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------  256 (335)
T ss_dssp             TTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------
T ss_pred             cCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------
Confidence            9998654322  1234467999999999999999999999999999999999999999765432221111100       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ..    ..+..++..+.+++.+||+.||++||++.++++
T Consensus       257 -------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          257 -------EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -------CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00    111234567889999999999999999999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.2e-44  Score=364.89  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ..++|.+.+.||+|+||.||+|.+..++..     ||||++....  ......+.+|+.+|++++||||+++++++....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQE-----YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCE-----EEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCE-----EEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            346899999999999999999998876553     9999986432  223567889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc---CCCcEEE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKL  249 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~---~~~~~kl  249 (441)
                          ..|+|||||++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||
T Consensus        95 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           95 ----SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             ----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence                459999999999999999764  5799999999999999999999998   999999999999995   4567999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++......   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.   ...
T Consensus       166 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~  238 (486)
T 3mwu_A          166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---TGK  238 (486)
T ss_dssp             CSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTC
T ss_pred             EECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC
Confidence            9999998654322   2345689999999999875 69999999999999999999999997654332222111   100


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .           .........+++.+.++|.+||..||.+|||+.++++
T Consensus       239 ~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          239 Y-----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             C-----------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C-----------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0           0011112345678999999999999999999999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4e-44  Score=342.05  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=205.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     +|+|.+.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEV-----FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCce-----EEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            36799999999999999999998876653     89999865432   23466889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        89 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence                359999999999999998763  5799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.   ..    
T Consensus       160 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~----  230 (294)
T 2rku_A          160 GLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---KN----  230 (294)
T ss_dssp             TTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TT----
T ss_pred             cCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---hc----
Confidence            9998654322  12344679999999999998889999999999999999999999997654322111111   00    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                 ....+..++..+.+++.+||+.||++||++.++++.
T Consensus       231 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          231 -----------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                       001122345678899999999999999999999983

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.6e-43  Score=347.97  Aligned_cols=273  Identities=23%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.....  .....+.+|+.+++.++||||+++++++.....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILER-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCc-----eEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence            3689999999999999999999876654     499999875432  234678899999999999999999999976542


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                        .....|+||||++ |+|.+++.    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           99 LEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             TTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence              1235699999996 57888885    3589999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhh---
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRP---  327 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~---  327 (441)
                      ||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .....   
T Consensus       171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999865432   1234568999999999999999999999999999999999999999765432221111 00000   


Q ss_pred             ------------hcccc-----cchhhhcCC---CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          328 ------------HLTDA-----KKFTMILDP---KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       328 ------------~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                                  .....     ..+......   ..........+..+.+|+.+||..||++|||+.++++  +++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                        00000     000000000   0011122345778999999999999999999999998  555443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-44  Score=352.35  Aligned_cols=271  Identities=25%  Similarity=0.316  Sum_probs=201.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++..     ||||++.....  ...+.+.+|+.+|+.++||||+++++++.....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAK-----VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCE-----EEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCE-----EEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            46899999999999999999998776654     99999865432  234678899999999999999999999976532


Q ss_pred             C--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 R--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .  ....|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence            1  12359999999 8899999976   4799999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999875432     344688999999999877 6799999999999999999999999976554322221111100000


Q ss_pred             c--------c--cchhhhcCC---CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          331 D--------A--KKFTMILDP---KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       331 ~--------~--~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      .        .  ..+...+..   ..........++.+.+|+.+||..||++|||+.++++  +++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            0        0  000000000   0001112244678999999999999999999999998  45443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-44  Score=342.27  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=204.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||+|.+.....  ...+.+.+|+.++++++||||+++++++.....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK-----ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   79 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCc-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence            3689999999999999999999876654     499999875432  234678899999999999999999998865433


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEecccCCCcEEEcCCCc
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGMDFQ-----IIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----iiHrDlKp~NILl~~~~~  246 (441)
                      .  ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||++   +     |+||||||+|||++.++.
T Consensus        80 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~  154 (279)
T 2w5a_A           80 T--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQN  154 (279)
T ss_dssp             T--EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSC
T ss_pred             c--eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCC
Confidence            2  469999999999999999753  234599999999999999999999998   6     999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      +||+|||+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...+.
T Consensus       155 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~  229 (279)
T 2w5a_A          155 VKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKIR  229 (279)
T ss_dssp             EEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred             EEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHHh
Confidence            9999999998654321  122346789999999999999999999999999999999999999976543221   11111


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHH
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN  381 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  381 (441)
                      ....              ...+..++..+.+++.+||+.||++||++.+|++.+.
T Consensus       230 ~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          230 EGKF--------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             hccc--------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            1000              0112245678999999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-44  Score=350.26  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||||++......  ..+.+.+|+.+++.++||||+++++++....  
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   97 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRI-----VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--   97 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCE-----EEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCce-----EEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--
Confidence            6799999999999999999998876553     999998654432  2355779999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        98 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A           98 --RWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             --EEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             --EEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence              35999999999999888754  46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh-hhhc---
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV-RPHL---  329 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~-~~~~---  329 (441)
                      ++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... ....   
T Consensus       171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            98654322  123446799999999998775 7899999999999999999999999765543322111110 0000   


Q ss_pred             ----ccccchhhhcCCCCCC-----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 ----TDAKKFTMILDPKLEG-----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ----~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          ...........+....     .....+++.+.+|+.+||+.||++||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                0000000011111111     111235678999999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.4e-44  Score=366.69  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=208.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.....   .....+.+|+.++++++||||+++++++....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQ-----ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCC-----EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4689999999999999999999887665     399999865432   34567889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEE
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKL  249 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl  249 (441)
                          ..++||||+.+|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||
T Consensus       100 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 ----YFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             ----EEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence                45999999999999999976  46799999999999999999999998   99999999999999   56788999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.   ...
T Consensus       171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~  243 (484)
T 3nyv_A          171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---KGK  243 (484)
T ss_dssp             CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCC
T ss_pred             EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCC
Confidence            9999998654332   2344679999999999875 79999999999999999999999997654332222211   100


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      .           .........+++.+.+++.+||..||.+|||+.++++  ++...
T Consensus       244 ~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          244 Y-----------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             C-----------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             C-----------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            0           0011122345678999999999999999999999998  45543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.7e-44  Score=365.40  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=202.1

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-------------hhhHHHHHHHHHhccCCCCCe
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-------------QGHKEWVTEVNVLGVVEHPNL  161 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~hpnI  161 (441)
                      ..++|.+.+.||+|+||.||+|.+..++..     ||+|++.....             ...+.+.+|+.+|+.++||||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  108 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSE-----KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI  108 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCE-----EEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcE-----EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence            357899999999999999999998876654     99999876432             224678899999999999999


Q ss_pred             eeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       162 v~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                      +++++++....    ..++|||||++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus       109 v~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          109 IKLFDVFEDKK----YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL  179 (504)
T ss_dssp             CCEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CeEEEEEEcCC----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence            99999998765    459999999999999999764  5799999999999999999999998   99999999999999


Q ss_pred             cCCC---cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          242 DEQW---NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       242 ~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                      +.++   .+||+|||+++......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||........
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8776   69999999998754432   234568999999999986 5699999999999999999999999976544322


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...+....   .           .........+++.+.+|+.+||..||.+|||+.++++
T Consensus       256 ~~~i~~~~---~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 IKKVEKGK---Y-----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHCC---C-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCC---C-----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            22211100   0           0000111234678999999999999999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-43  Score=361.30  Aligned_cols=265  Identities=18%  Similarity=0.298  Sum_probs=208.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCC-CeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP-NLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~  174 (441)
                      .++|.+.++||+|+||.||+|.+..++.     .||||++.....  ...+.+|+.+++.++|+ +|..+..++...+  
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~--   76 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD--   76 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCC-----EEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT--
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCc-----EEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC--
Confidence            4689999999999999999999876655     499998765432  34577899999999775 5555544444333  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE---cCCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL---DEQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl---~~~~~~kl~D  251 (441)
                        ..+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++   +|+||||||+||||   +.++.+||+|
T Consensus        77 --~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           77 --YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             --EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence              359999999 99999999753 46799999999999999999999998   99999999999999   6889999999


Q ss_pred             cCCCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh
Q 013504          252 FGLARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR  326 (441)
Q Consensus       252 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~  326 (441)
                      ||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            9999865443221     12235789999999999999999999999999999999999999998765544333332221


Q ss_pred             hhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      ...... ..         ......++.++.+++..||+.+|++||++.+|++.|++++..
T Consensus       230 ~~~~~~-~~---------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          230 EKKVAT-SI---------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHHHS-CH---------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hccccc-cH---------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            111000 00         011123457899999999999999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-44  Score=348.42  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=198.2

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-----hHHHHHHHHHhccCCCCCeeeEEeEE
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-----HKEWVTEVNVLGVVEHPNLVKLIGYC  168 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~  168 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||++.......     ...+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQ-----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF   81 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCS-----EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCc-----EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            345789999999999999999999876654     39999987543221     24678999999999999999999999


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                      .....    .++||||+++ +|.+++... ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~----~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           82 GHKSN----ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             CCTTC----CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             eeCCc----eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence            87654    4999999975 898888753 35789999999999999999999998   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVR  326 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~  326 (441)
                      |+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+ ....
T Consensus       153 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~  230 (346)
T 1ua2_A          153 LADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG  230 (346)
T ss_dssp             ECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999998754332  223456899999999998764 5889999999999999999999999765433222211 1110


Q ss_pred             hhccc----ccchhhhcCCCCCCc-----chHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          327 PHLTD----AKKFTMILDPKLEGK-----YSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       327 ~~~~~----~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                      .....    ...............     ....++..+.+|+.+||..||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000    000000000000000     112345789999999999999999999999883

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.2e-44  Score=351.03  Aligned_cols=278  Identities=22%  Similarity=0.303  Sum_probs=208.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++...... ....+.+|+.+|.+++||||+++++++..... 
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKV-----RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCe-----EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            4689999999999999999999876654     4999998754332 34678899999999999999999999976542 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .....|+||||++ |+|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            2224699999996 599999975   4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLS-HVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99865432211 11244689999999998654 45899999999999999999999999766544333222111000000


Q ss_pred             c----------cchhhhcCCCCC---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHHh
Q 013504          332 A----------KKFTMILDPKLE---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       332 ~----------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      .          ............   ......++..+.+|+.+||+.||++||++.++++  +++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            0          000000000000   0011234567899999999999999999999998  4554433

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-44  Score=342.43  Aligned_cols=262  Identities=26%  Similarity=0.395  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||.||+|.+.....  ....||||.+....   ....+.+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSG--KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS--CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCC--ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            679999999999999999998754322  23458999987543   233567889999999999999999999997654 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        95 ----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           95 ----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             ----ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence                38999999999999999764 35689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+...   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~---  240 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKIDKE---  240 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTS---
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HHHHHcc---
Confidence            99876443221 12234567889999999998889999999999999999999 9999976543221   1111110   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                                ......+..++..+.+++.+||..||++||++.++++.|+++..
T Consensus       241 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 ----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                      00011122456789999999999999999999999999998753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-44  Score=353.95  Aligned_cols=277  Identities=21%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      ....++|.+.+.||+|+||.||+|.+..++.     .||||++.....    ...+|+.+|+.++||||+++++++....
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~   73 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGK-----RFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTG   73 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCC-----EEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCC-----EEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecC
Confidence            3456789999999999999999999877665     499998865432    2237999999999999999999986543


Q ss_pred             c----------------------------------CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHH
Q 013504          173 E----------------------------------RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAAR  216 (441)
Q Consensus       173 ~----------------------------------~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~  216 (441)
                      .                                  .....++||||++ |+|.+.+..  ..+..+++..+..++.||+.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            2                                  2224689999997 588887753  23578999999999999999


Q ss_pred             HHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccch
Q 013504          217 GLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIW  294 (441)
Q Consensus       217 ~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  294 (441)
                      ||.|||+.   +|+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||
T Consensus       153 aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          153 AVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            99999998   999999999999997 68899999999998654332   23456789999999998765 489999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhccc-----ccchhhh-----cCCCCCCcchHHHHHHHHHHHHHhh
Q 013504          295 SFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLTD-----AKKFTMI-----LDPKLEGKYSIKLAQKLAAVANKCL  363 (441)
Q Consensus       295 SlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl  363 (441)
                      ||||++|||++|+.||...........+ .........     .......     .........+..++..+.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            9999999999999999765443322211 111000000     0000000     0000111122335677999999999


Q ss_pred             cccCCCCCCHHHHHH--HHHHHHh
Q 013504          364 ARQAKGRPKMSEVVE--VLNKIVD  385 (441)
Q Consensus       364 ~~dP~~RPs~~evl~--~L~~~~~  385 (441)
                      ..||++|||+.++++  +++.+.+
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             cCChhhCCCHHHHhcCHHHHHHHh
Confidence            999999999999997  5655543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-44  Score=378.82  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=206.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC---chhhHHHHHHHHHhccC-CCCCeeeEEeEEec
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAE  170 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  170 (441)
                      ..++|.+.+.||+|+||.||+|.+..++..     ||||++....   ......+..|..+|..+ +||||+++++++.+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~-----vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDEL-----YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCE-----EEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcE-----EEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence            346899999999999999999999877654     9999987542   22345678899999987 79999999999877


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .+    .+||||||++||+|.+++...  ..+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+
T Consensus       414 ~~----~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          414 MD----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred             CC----EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence            65    459999999999999999864  5799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.......   +...+..   
T Consensus       485 DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~---  556 (674)
T 3pfq_A          485 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME---  556 (674)
T ss_dssp             CCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHS---
T ss_pred             ecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHHh---
Confidence            999998643332  23456789999999999999999999999999999999999999997654322   2221111   


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH-----HHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM-----SEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  378 (441)
                                ..  ..++..++.++.+||.+||..||++||++     ++|++
T Consensus       557 ----------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          557 ----------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----------SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----------CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                      00  11233466789999999999999999997     66665

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.8e-44  Score=341.17  Aligned_cols=249  Identities=29%  Similarity=0.449  Sum_probs=205.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.|.+.+.||+|+||.||+|.+..++.     .||||.+..... ...+.+.+|+.+++.++||||+++++++....   
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   93 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT---   93 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCc-----EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence            569999999999999999999876654     499999876543 33577889999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        94 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           94 -KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             -EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence             35999999999999999964   5799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........   +...       
T Consensus       167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-------  234 (303)
T 3a7i_A          167 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IPKN-------  234 (303)
T ss_dssp             EECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-------
T ss_pred             eecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hhcC-------
Confidence            7654322  123456899999999999999999999999999999999999999976543222111   1110       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                         ..+.    ....++..+.+++.+||+.||++||++.++++.
T Consensus       235 ---~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          235 ---NPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---CCCC----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---CCCC----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               0011    112345678999999999999999999999984

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-43  Score=349.18  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             hHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccC-CCC
Q 013504           89 FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVV-EHP  159 (441)
Q Consensus        89 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l-~hp  159 (441)
                      +.......++|.+.+.||+|+||.||+|.+..++.     .||||++......        ..+.+.+|+.++.++ +||
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH-----EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCc-----EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34445667889999999999999999999876654     3999998654311        134577899999998 899


Q ss_pred             CeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcE
Q 013504          160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNI  239 (441)
Q Consensus       160 nIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NI  239 (441)
                      ||+++++++....    ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus       161 ~iv~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI  231 (365)
T 2y7j_A          161 HIITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI  231 (365)
T ss_dssp             TBCCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CEeEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999999997655    459999999999999999763  5799999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013504          240 LLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT------GRLTYKSDIWSFGVFLYELITGRRPLDRN  313 (441)
Q Consensus       240 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltG~~P~~~~  313 (441)
                      |++.++.+||+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||...
T Consensus       232 l~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          232 LLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             EECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            99999999999999998654432   2345689999999999864      35788999999999999999999999754


Q ss_pred             CchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          314 RPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ......   ..+......           ........++..+.+++.+||+.||++||++.++++
T Consensus       309 ~~~~~~---~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          309 RQILML---RMIMEGQYQ-----------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SHHHHH---HHHHHTCCC-----------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHH---HHHHhCCCC-----------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            332211   111110000           000000123567899999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-43  Score=342.26  Aligned_cols=261  Identities=20%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|.+..++.     .||||++....   .+.+.+|+.+++.++ ||||+++++++...... 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~-  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNE-----KVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSR-  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCc-----EEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC-
Confidence            689999999999999999999877655     49999987533   467889999999996 99999999999874332 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGl  254 (441)
                       ..++||||+++++|.+++.     .+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus       107 -~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          107 -TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             -CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             -ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence             4599999999999999884     388999999999999999999998   999999999999999776 899999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH--HHH--------
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK--LLE--------  323 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~--~~~--------  323 (441)
                      ++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........  ...        
T Consensus       178 a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~  254 (330)
T 3nsz_A          178 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  254 (330)
T ss_dssp             CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             ceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence            98654332   2344689999999999877 678999999999999999999999995443322110  000        


Q ss_pred             -hhhhhc-ccccchhhhcC--------CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          324 -WVRPHL-TDAKKFTMILD--------PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       324 -~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       +..... .....+.....        ..........++..+.+|+.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000000 00000000000        00111112235678999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=346.99  Aligned_cols=262  Identities=28%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEE
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYC  168 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  168 (441)
                      .++....++|.+.+.||+|+||.||+|.+..++.     .||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCC-----eEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3344456889999999999999999999876654     49999986543 3356788999999998 899999999999


Q ss_pred             eccccC--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          169 AEDDER--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       169 ~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ......  ....++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence            874321  23569999999999999999875556899999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      +||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........
T Consensus       168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            9999999998654321  1234467999999999986     56789999999999999999999999975543222111


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +.  ...           .+.   .....++..+.+++.+||..||.+||++.++++
T Consensus       246 ~~--~~~-----------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IP--RNP-----------APR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HH--HSC-----------CCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hh--cCc-----------ccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            10  000           000   011234567899999999999999999999988

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-43  Score=346.59  Aligned_cols=272  Identities=21%  Similarity=0.318  Sum_probs=204.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++......  ....+.+|+.+++.++||||+++++++......
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQ-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCC-----EEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCC-----EEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            689999999999999999999877665     3999998655432  245778999999999999999999999875321


Q ss_pred             ----CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 ----GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                          ....++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence                2246999999964 788877653 35799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCC--CcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          251 DFGLARLGPSDG--LSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       251 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999998654222  1122345688999999998876 4589999999999999999999999987654433333222211


Q ss_pred             hcccc--------cchhhhc-CCCCCCcchHH-----HHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDA--------KKFTMIL-DPKLEGKYSIK-----LAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~--------~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....        ....... ...........     .++.+.+|+.+||+.||++||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11100        0000000 00000111111     1456889999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.1e-44  Score=360.09  Aligned_cols=204  Identities=28%  Similarity=0.378  Sum_probs=167.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++....  ....+.+.+|+.+|+.++||||+++++++.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEK-----NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCc-----EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            4689999999999999999999887654     49999997542  2334678899999999999999999999976532


Q ss_pred             C-CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 R-GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 ~-~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      . ....|+||||++ |+|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence            1 124699999995 699999976  46799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCc--------------------ceeeceecccCcCCcccc-ccCCCCccccchhHHHHHHHHHhCCCCC
Q 013504          253 GLARLGPSDGLS--------------------HVSTAVVGTIGYAAPEYI-QTGRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       253 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                      |+++........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999875433211                    123567899999999986 5667999999999999999999854444

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.2e-44  Score=339.24  Aligned_cols=246  Identities=21%  Similarity=0.283  Sum_probs=197.6

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|.+.....  .....+.+|+.++..+ +||||+++++++...
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGC-----IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCc-----eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            45789999999999999999999876654     499999876432  3346788999999998 999999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-----
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRF--QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-----  244 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-----  244 (441)
                      +    ..++||||+++++|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+     
T Consensus        84 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~  156 (289)
T 1x8b_A           84 D----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNA  156 (289)
T ss_dssp             T----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------
T ss_pred             C----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcc
Confidence            5    4599999999999999997532  26799999999999999999999998   99999999999999844     


Q ss_pred             --------------CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCC
Q 013504          245 --------------WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRP  309 (441)
Q Consensus       245 --------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P  309 (441)
                                    ..+||+|||++......      ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             -------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                          47999999999865432      224699999999999765 566899999999999999999887


Q ss_pred             CCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          310 LDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +....  .......   ..               ....+..++..+.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~--~~~~~~~---~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          231 PRNGD--QWHEIRQ---GR---------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CSSSH--HHHHHHT---TC---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Ccchh--HHHHHHc---CC---------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            64321  1111100   00               01122235578899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=337.62  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=198.6

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCee
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~  177 (441)
                      +|....+||+|+||.||+|.+..++.     .||||.+........+.+.+|+.+++.++||||+++++++...+    .
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~   93 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQV-----RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG----F   93 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCC-----EEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----E
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCe-----EEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----c
Confidence            45556689999999999999877654     49999998766555678899999999999999999999998765    3


Q ss_pred             EEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CCcEEEeecCCC
Q 013504          178 RLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QWNAKLSDFGLA  255 (441)
Q Consensus       178 ~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla  255 (441)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||++   +|+||||||+|||++. ++.+||+|||++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccc
Confidence            599999999999999997643 23567889999999999999999998   9999999999999987 899999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR--LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +......  .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||......... ......  .    
T Consensus       171 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~--~----  241 (295)
T 2clq_A          171 KRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFKVGM--F----  241 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHHHHH--H----
T ss_pred             cccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHhhcc--c----
Confidence            8654321  1234567999999999987654  889999999999999999999999643322111 110000  0    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          ...+    ..+..++..+.+++.+||+.||++||++.++++
T Consensus       242 ----~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 ----KVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                0011    122345678899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-43  Score=373.30  Aligned_cols=263  Identities=25%  Similarity=0.411  Sum_probs=210.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.  ....||||.+...... ..+.+.+|+.+++.++||||+++++++.+.  
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence            34789999999999999999999876543  2345899998764332 346788999999999999999999998532  


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..++||||+++|+|.+++..+ ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       464 ---~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          464 ---PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             ---ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence               248999999999999999754 45799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      +++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.........   ..+....   
T Consensus       537 ~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~~~---  609 (656)
T 2j0j_A          537 LSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE---  609 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHHTC---
T ss_pred             CCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC---
Confidence            998764432 122334567889999999999999999999999999999997 99999765433221   1111100   


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                 ....+..++..+.+++.+||..||++||++.+|++.|+.+++.
T Consensus       610 -----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 -----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                       0112234567899999999999999999999999999999765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=339.90  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|.+....  ....+.+|+.++..++||||+++++++....  
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   97 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQ-----IVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--   97 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCC-----EEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCC-----EEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--
Confidence            45789999999999999999999876654     49999987643  3467889999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        98 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           98 --DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence              359999999999999999743 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.............   ..      
T Consensus       172 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~------  240 (314)
T 3com_A          172 AGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP---TN------  240 (314)
T ss_dssp             CEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HS------
T ss_pred             chhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---cC------
Confidence            97654321  12344679999999999999999999999999999999999999997544322111110   00      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            .......+..++..+.+++.+||..||.+||++.++++
T Consensus       241 ------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          241 ------PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  00011122335678999999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-44  Score=343.05  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||+|.+..........+.+|+.+++.++||||+++++++...+.  
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   90 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK--   90 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCC-----EEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C--
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCc-----EEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe--
Confidence            4689999999999999999999877654     499999877665667788999999999999999999999987653  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++||||+++++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        91 --~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           91 --LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             --EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             --EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence              49999999999999998753 45799999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYI-----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ......  ........||+.|+|||++     .+..++.++||||||+++|+|++|..||.........  ........ 
T Consensus       165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-  239 (302)
T 2j7t_A          165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKSDP-  239 (302)
T ss_dssp             HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSCC-
T ss_pred             cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHhccCC-
Confidence            532110  1112345799999999988     3667899999999999999999999999765432211  11110000 


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                +  ....+..++..+.+++.+||+.||++||++.++++
T Consensus       240 ----------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 ----------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                      0  01122345678999999999999999999999876

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-43  Score=350.40  Aligned_cols=269  Identities=20%  Similarity=0.244  Sum_probs=206.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC--------CCCeeeEEeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE--------HPNLVKLIGY  167 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l~~~  167 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.... .....+.+|+.+|+.++        ||||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKK-----FVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCe-----EEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            4689999999999999999999876654     49999997542 33467889999999885        7889999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC--
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW--  245 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~--  245 (441)
                      +......+...++||||+ +++|.+++.......+++..++.++.||+.||.|||+++  +|+||||||+||||+.++  
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence            985543444679999999 777777776654567999999999999999999999852  799999999999999775  


Q ss_pred             -----------------------------------------------cEEEeecCCCCCCCCCCCcceeeceecccCcCC
Q 013504          246 -----------------------------------------------NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA  278 (441)
Q Consensus       246 -----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  278 (441)
                                                                     .+||+|||+++.....     .....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence                                                           7999999999865432     334579999999


Q ss_pred             ccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH---HHHHHhhhhhccc------------------ccchhh
Q 013504          279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE---QKLLEWVRPHLTD------------------AKKFTM  337 (441)
Q Consensus       279 PE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~---~~~~~~~~~~~~~------------------~~~~~~  337 (441)
                      ||++.+..++.++|||||||++|||++|..||........   ......+...+..                  ......
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            9999999999999999999999999999999975543221   1111111000000                  000000


Q ss_pred             hcCCCC---------CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          338 ILDPKL---------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       338 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      +.+...         ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000         01234677889999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-43  Score=355.35  Aligned_cols=271  Identities=23%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--C
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--R  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~  174 (441)
                      .+|.+.+.||+|+||.||+|.+..++.     .||||++....    ....+|+.+|+.++||||+++++++.....  .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGE-----LVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCc-----EEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            469999999999999999999987655     39999986532    223479999999999999999999865432  2


Q ss_pred             CeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC-CcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ-WNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~-~~~kl~D  251 (441)
                      ....++||||+++ +|.+.+..  .....+++..++.++.||+.||.|||++   +|+||||||+||||+.+ +.+||+|
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence            2345799999975 67666542  2356899999999999999999999998   99999999999999955 5689999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHL  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~  329 (441)
                      ||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ++.......
T Consensus       201 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          201 FGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             CTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             chhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998654322   23346899999999998764 78999999999999999999999997654332221 111110000


Q ss_pred             cc-----ccchhhhcCCCCCC-----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          330 TD-----AKKFTMILDPKLEG-----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       330 ~~-----~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      .+     ...+....-+.+..     .++...+..+.+|+.+||..||.+||++.++++  +++.+
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            00     00000000011110     112234678999999999999999999999997  45444

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-43  Score=334.66  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=195.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+.....   .....+.+|+.+++.++||||+++++++...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGH-----KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCc-----eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3689999999999999999999876554     499999865432   23457889999999999999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        85 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 ----DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence                459999999999999999763  5789999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |++.......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......   ....+..... 
T Consensus       156 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-  228 (276)
T 2h6d_A          156 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGVF-  228 (276)
T ss_dssp             CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC-
T ss_pred             ccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCcc-
Confidence            9998654322   2334678999999999987765 589999999999999999999997643322   1111111100 


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                    ..+..++..+.+++.+||+.||++||++.++++
T Consensus       229 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 --------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                          011234567889999999999999999999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-43  Score=340.82  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=198.7

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--------hhhHHHHHHHHHhccCCCCCeeeEE
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--------QGHKEWVTEVNVLGVVEHPNLVKLI  165 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~  165 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||.+.....        .....+.+|+.+|+.++||||++++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   81 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCK-----KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK   81 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCc-----EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence            345789999999999999999999877654     499999875432        1123577999999999999999999


Q ss_pred             eEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          166 GYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       166 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      +++....     .++||||+++++|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        82 ~~~~~~~-----~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  151 (322)
T 2ycf_A           82 NFFDAED-----YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  151 (322)
T ss_dssp             EEEESSS-----EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred             eEEcCCc-----eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence            9986543     4999999999999999975  46899999999999999999999998   999999999999998766


Q ss_pred             c---EEEeecCCCCCCCCCCCcceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-
Q 013504          246 N---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-  318 (441)
Q Consensus       246 ~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-  318 (441)
                      .   +||+|||+++.....   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||........ 
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          152 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             CCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence            5   999999999865432   1233467999999999874   46788999999999999999999999975433211 


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...+.   ....           .........++..+.+++.+||..||++||++.++++
T Consensus       229 ~~~~~---~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 KDQIT---SGKY-----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHH---HTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHH---hCcc-----------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11111   0000           0000111234578899999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-45  Score=360.78  Aligned_cols=253  Identities=17%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEcccc---CchhhHHHHHHHH---HhccCCCCCeeeEE----
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR---GLQGHKEWVTEVN---VLGVVEHPNLVKLI----  165 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---il~~l~hpnIv~l~----  165 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++...   .....+.+.+|+.   +|+.++||||++++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCC-----EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCc-----EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            4679999999999999999999866554     4999998743   2234567889994   55556899999998    


Q ss_pred             ---eEEecccc----------CC---eeEEEEEeccCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhC
Q 013504          166 ---GYCAEDDE----------RG---IQRLLIYEYMPNRSVQDHLTSRFQ-----ATLPWNTRLKIAQDAARGLAYLHEG  224 (441)
Q Consensus       166 ---~~~~~~~~----------~~---~~~~lv~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~  224 (441)
                         +++...+.          ..   ...||||||+ +|+|.+++.....     ..+++..++.|+.||+.||.|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               66554421          00   0258999999 6899999975311     1233488889999999999999998


Q ss_pred             CCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-----------CCCccccc
Q 013504          225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-----------RLTYKSDI  293 (441)
Q Consensus       225 ~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv  293 (441)
                         +|+||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             ---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence               999999999999999999999999999985322     3445678 999999999887           89999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCH
Q 013504          294 WSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM  373 (441)
Q Consensus       294 wSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  373 (441)
                      |||||++|||++|+.||........                ...+...      ...+++.+.+++.+||+.||++||++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999999999999964332110                0001110      01345778999999999999999999


Q ss_pred             HHHHH--HHHHHHh
Q 013504          374 SEVVE--VLNKIVD  385 (441)
Q Consensus       374 ~evl~--~L~~~~~  385 (441)
                      .++++  +++.+.+
T Consensus       355 ~e~l~hp~f~~~~~  368 (377)
T 3byv_A          355 LQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHTSHHHHHHHH
T ss_pred             HHHhhChHHHHHHH
Confidence            99997  5665543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-43  Score=348.80  Aligned_cols=282  Identities=20%  Similarity=0.263  Sum_probs=203.7

Q ss_pred             chHHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-----------hhHHHHHHHHHhccC
Q 013504           88 TFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-----------GHKEWVTEVNVLGVV  156 (441)
Q Consensus        88 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l  156 (441)
                      .+.++....++|.+.+.||+|+||.||+|.+.. +     ..||||++......           ..+.+.+|+.+++.+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   86 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-G-----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF   86 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-S-----CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-C-----CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence            356778888999999999999999999998654 2     34999998653321           126788999999999


Q ss_pred             CCCCeeeEEeEEeccc-cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 013504          157 EHPNLVKLIGYCAEDD-ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK  235 (441)
Q Consensus       157 ~hpnIv~l~~~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK  235 (441)
                      +||||+++++++...+ ......|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++   +|+|||||
T Consensus        87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  161 (362)
T 3pg1_A           87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH  161 (362)
T ss_dssp             CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred             CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence            9999999999986543 22335699999997 6888888753 45799999999999999999999998   99999999


Q ss_pred             CCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013504          236 SSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNR  314 (441)
Q Consensus       236 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~  314 (441)
                      |+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998543322   2345689999999999877 678999999999999999999999997654


Q ss_pred             chhHHHHH-Hhhhhhccc------ccchhhhcCC---CCC----CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--
Q 013504          315 PKSEQKLL-EWVRPHLTD------AKKFTMILDP---KLE----GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--  378 (441)
Q Consensus       315 ~~~~~~~~-~~~~~~~~~------~~~~~~~~~~---~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--  378 (441)
                      .......+ .........      ..........   ...    .......++.+.+|+.+||+.||++|||+.++++  
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence            33222211 111000000      0000000000   000    0111234567899999999999999999999997  


Q ss_pred             HHHHH
Q 013504          379 VLNKI  383 (441)
Q Consensus       379 ~L~~~  383 (441)
                      +++.+
T Consensus       319 ~f~~~  323 (362)
T 3pg1_A          319 YFESL  323 (362)
T ss_dssp             GGTTT
T ss_pred             hhhhc
Confidence            34444

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-43  Score=356.14  Aligned_cols=264  Identities=20%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC------CCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV------EHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~  169 (441)
                      ..+|++.+.||+|+||.||+|.+..++.     .||||++.... .....+.+|+.+++.+      +|+||+++++++.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQ-----HVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTE-----EEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCc-----EEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            4579999999999999999999877654     49999997542 3345667788887776      5789999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc--E
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN--A  247 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~--~  247 (441)
                      ...    ..++||||+. ++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.  +
T Consensus       170 ~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          170 FRN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             ETT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             cCC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence            765    3599999995 6999999876556799999999999999999999998   9999999999999999887  9


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999999764332     3346899999999999999999999999999999999999999976654332221111100


Q ss_pred             hcc-----cccchhhhcC--------------------------------CCCCCcc----hHHHHHHHHHHHHHhhccc
Q 013504          328 HLT-----DAKKFTMILD--------------------------------PKLEGKY----SIKLAQKLAAVANKCLARQ  366 (441)
Q Consensus       328 ~~~-----~~~~~~~~~~--------------------------------~~~~~~~----~~~~~~~l~~li~~cl~~d  366 (441)
                      ...     ........++                                +.....+    ....++.+.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            000     0000000000                                0000000    0112467899999999999


Q ss_pred             CCCCCCHHHHHH
Q 013504          367 AKGRPKMSEVVE  378 (441)
Q Consensus       367 P~~RPs~~evl~  378 (441)
                      |++|||+.++++
T Consensus       397 P~~Rpta~e~L~  408 (429)
T 3kvw_A          397 PAVRMTPGQALR  408 (429)
T ss_dssp             TTTSCCHHHHHT
T ss_pred             hhhCCCHHHHhC
Confidence            999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-44  Score=352.36  Aligned_cols=263  Identities=13%  Similarity=0.112  Sum_probs=187.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHH---HhccCCCCCeeeEE-----
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVN---VLGVVEHPNLVKLI-----  165 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---il~~l~hpnIv~l~-----  165 (441)
                      .+|.+.+.||+|+||.||+|.+..++.     .||||++.....   .....+.+|+.   +|+. +||||++++     
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~  135 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLE-----DFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLL  135 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCc-----eeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence            468999999999999999999876654     499999987653   22355677854   5555 799988865     


Q ss_pred             --eEEeccccC-------------CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHhhC
Q 013504          166 --GYCAEDDER-------------GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTR------LKIAQDAARGLAYLHEG  224 (441)
Q Consensus       166 --~~~~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~  224 (441)
                        +++......             ....||||||++ |+|.+++... +..+++..+      +.++.||+.||.|||++
T Consensus       136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence              444333210             134699999998 8999999764 234566666      78889999999999998


Q ss_pred             CCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc--CCCCccccchhHHHHHHH
Q 013504          225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYE  302 (441)
Q Consensus       225 ~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~e  302 (441)
                         +|+||||||+||||+.++.+||+|||+++....     ......||+.|+|||++.+  ..++.++|||||||++||
T Consensus       214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             ---CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence               999999999999999999999999999986532     2224577899999999987  679999999999999999


Q ss_pred             HHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HH
Q 013504          303 LITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VL  380 (441)
Q Consensus       303 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L  380 (441)
                      |++|+.||....+.....   +     . ...................+++.+.+|+.+||+.||++||++.++++  ++
T Consensus       286 lltg~~Pf~~~~~~~~~~---~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGS---W-----K-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTC---C-----C-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             HHhCCCCCCCcCcccccc---h-----h-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            999999997653321100   0     0 00000001111111112345678999999999999999999999987  45


Q ss_pred             HHHH
Q 013504          381 NKIV  384 (441)
Q Consensus       381 ~~~~  384 (441)
                      +++.
T Consensus       357 ~~~~  360 (371)
T 3q60_A          357 LQLQ  360 (371)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-44  Score=342.40  Aligned_cols=263  Identities=26%  Similarity=0.419  Sum_probs=185.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+..... .....+.+|+.+++.++||||+++++++...+. 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   87 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKE-----KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE-   87 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----C-----EEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCc-----EEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-
Confidence            4789999999999999999998765544     499999875432 234668899999999999999999999987664 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAK  248 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~k  248 (441)
                         .++||||+++++|.+++...      ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        88 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           88 ---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             ---cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence               49999999999999998641      245689999999999999999999998   999999999999999999999


Q ss_pred             EeecCCCCCCCCCCC---cceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          249 LSDFGLARLGPSDGL---SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       249 l~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      |+|||++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............  
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--  239 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--  239 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--
Confidence            999999876543211   112334679999999999876 56899999999999999999999999765443222111  


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .......  ......++.    ....++..+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~--~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQNDPPS--LETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSSCCC--TTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCCCc--cccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1000000  000000111    11234567899999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-44  Score=350.65  Aligned_cols=256  Identities=27%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccC-CCCCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  171 (441)
                      ++|.+.+.||+|+||.||+|.+....  .....||||++.....    .....+.+|+.+|..+ +||||+++++++...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccC--CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            67999999999999999999985321  1234599999875432    2335567899999999 699999999999876


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .    ..++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus       132 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          132 T----KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             T----EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred             c----eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEee
Confidence            5    359999999999999999764  5799999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPH  328 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~  328 (441)
                      ||+++...... ........||+.|+|||++.+  ..++.++|||||||++|||++|..||........ ..+.......
T Consensus       203 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          203 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             CCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence            99998653322 122345689999999999986  3478899999999999999999999965432221 1111111100


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVEV  379 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  379 (441)
                                     ...++..++..+.+|+.+||..||++||     ++.++++.
T Consensus       282 ---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                           0112234567789999999999999999     89998873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.6e-43  Score=334.51  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---------hhhHHHHHHHHHhccCC-CCCeeeE
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---------QGHKEWVTEVNVLGVVE-HPNLVKL  164 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-hpnIv~l  164 (441)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||||++.....         ...+.+.+|+.+++++. ||||+++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCK-----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCc-----eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            34789999999999999999999877654     499999875431         12356789999999995 9999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ  244 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~  244 (441)
                      ++++....    ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        90 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           90 KDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  160 (298)
T ss_dssp             EEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             eeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence            99997655    459999999999999999763  5799999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          245 WNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ------TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                      +.+||+|||++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|..||........
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  237 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  237 (298)
T ss_dssp             CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence            999999999998654332   234467999999999885      45688999999999999999999999975443222


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...+.   ...           ..........++..+.+++.+||+.||++||++.++++
T Consensus       238 ~~~~~---~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 LRMIM---SGN-----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHH---HTC-----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHh---cCC-----------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111   100           00011111245678999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-43  Score=351.23  Aligned_cols=271  Identities=21%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--C
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--R  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~  174 (441)
                      .+|.+.+.||+|+||.||+|.+..++.      +|+|++.....    ...+|+.+|+.++||||+++++++.....  .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~------~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE------VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE------EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe------EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            579999999999999999999876542      78887754322    12369999999999999999999976543  2


Q ss_pred             CeeEEEEEeccCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeec
Q 013504          175 GIQRLLIYEYMPNRSVQDHLT-SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDF  252 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DF  252 (441)
                      ....++||||++++.+..... ......+++..++.++.||+.||.|||++   +|+||||||+||||+ .++.+||+||
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence            234689999997654433322 22356899999999999999999999998   999999999999999 7999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhhcc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPHLT  330 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~~~  330 (441)
                      |+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ........
T Consensus       187 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          187 GSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             TTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9998654332   23356889999999998765 5899999999999999999999999765533222111 11100000


Q ss_pred             c-----ccch-----hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          331 D-----AKKF-----TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       331 ~-----~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                      .     ...+     .......+...++..+++.+.+|+.+||+.||.+||++.++++  +++.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            0     0000     0000000001112235678999999999999999999999997  35444

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.9e-43  Score=339.37  Aligned_cols=265  Identities=20%  Similarity=0.284  Sum_probs=204.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCC------CeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP------NLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~~  169 (441)
                      .++|.+.+.||+|+||.||+|.+....    ...||||++.... .....+.+|+.+++.++|+      +|+++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAG----GRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCC----CcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            468999999999999999999874321    2359999986542 3346678899999888665      4999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC------
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE------  243 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~------  243 (441)
                      ..+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.      
T Consensus        88 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           88 HHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred             cCC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence            765    459999999 89999999876556799999999999999999999998   9999999999999987      


Q ss_pred             -------------CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 013504          244 -------------QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       244 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                                   ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                         668999999999864332     23468999999999999999999999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhhhhccccc-----c--------------------hhhhcCCCC-CCcchHHHHHHHHHHHHHhhc
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAK-----K--------------------FTMILDPKL-EGKYSIKLAQKLAAVANKCLA  364 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  364 (441)
                      ...........+...........     .                    ......+.. ........++.+.+|+.+||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            86654433333222211110000     0                    000000000 011123567889999999999


Q ss_pred             ccCCCCCCHHHHHH
Q 013504          365 RQAKGRPKMSEVVE  378 (441)
Q Consensus       365 ~dP~~RPs~~evl~  378 (441)
                      .||++||++.++++
T Consensus       315 ~dP~~Rpt~~ell~  328 (339)
T 1z57_A          315 YDPAKRITLREALK  328 (339)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             cCcccccCHHHHhc
Confidence            99999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=339.52  Aligned_cols=271  Identities=20%  Similarity=0.313  Sum_probs=198.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccc---
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD---  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  172 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|.+........+.+.+|+.+++.++||||+++++++....   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDK-----RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTE-----EEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCe-----EEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            4689999999999999999999876654     49999988766556678899999999999999999999985432   


Q ss_pred             -------cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CC
Q 013504          173 -------ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQ  244 (441)
Q Consensus       173 -------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~  244 (441)
                             ......++||||++ |+|.+++..   ..+++..++.++.|++.||.|||++   +|+||||||+|||++ .+
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence                   11235699999997 699999964   5789999999999999999999998   999999999999997 56


Q ss_pred             CcEEEeecCCCCCCCCCCC-cceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          245 WNAKLSDFGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       245 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      +.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7999999999986543211 112234567999999998865 67899999999999999999999999765543222211


Q ss_pred             Hhhhhhccccc--c--------hhh-hcCCCC-CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          323 EWVRPHLTDAK--K--------FTM-ILDPKL-EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       323 ~~~~~~~~~~~--~--------~~~-~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ....+......  .        ... ...+.. .......++..+.+++.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            11100000000  0        000 000000 00111235678999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.1e-43  Score=346.81  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=186.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++....  ....+.+.+|+.+|+.++||||+++++++.....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGL-----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTE-----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCC-----EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            4689999999999999999999876654     49999987543  2334678899999999999999999999975421


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                        .....|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence              112359999999 7899998865   5799999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc-
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL-  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~-  329 (441)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....... 
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864332     345689999999999877 678999999999999999999999997655433222211110000 


Q ss_pred             -------ccc--cchhhhcCCCCCCcc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 -------TDA--KKFTMILDPKLEGKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 -------~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ...  ..+...+.......+   ....++.+.+|+.+||..||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                   000  000000000000000   1123567899999999999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-43  Score=345.74  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=203.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-----------------hHHHHHHHHHhccCCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-----------------HKEWVTEVNVLGVVEH  158 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~~l~h  158 (441)
                      .++|.+.+.||+|+||.||+|.+  ++     ..||||.+.......                 ...+.+|+.+++.++|
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DN-----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TT-----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CC-----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            46899999999999999999998  22     359999987543221                 1778999999999999


Q ss_pred             CCeeeEEeEEeccccCCeeEEEEEeccCCCChHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEe
Q 013504          159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDH------LTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIF  231 (441)
Q Consensus       159 pnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH  231 (441)
                      |||+++++++...+    ..++||||+++|+|.++      +.......+++..++.++.||+.||.|||+ +   +|+|
T Consensus       103 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          103 EYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             TTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             CCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            99999999998765    45999999999999999      655446789999999999999999999998 7   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCc-cccchhHHHHHHHHHhCCCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTY-KSDIWSFGVFLYELITGRRP  309 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~il~elltG~~P  309 (441)
                      |||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865332    34456899999999999877 6666 89999999999999999999


Q ss_pred             CCCCCchhHHHHHHhhhhhccccc-chhhhcCC---CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          310 LDRNRPKSEQKLLEWVRPHLTDAK-KFTMILDP---KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      |......  ......+........ .......+   .........++..+.+++.+||+.||.+||++.++++
T Consensus       252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9765442  112221111100000 00000000   0000111345678999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.5e-43  Score=341.63  Aligned_cols=255  Identities=21%  Similarity=0.275  Sum_probs=177.1

Q ss_pred             hcCCcccc-eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHH-HHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSL-MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEV-NVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+ +||+|+||.||+|.+..++..     ||||++....     ...+|+ ..++.++||||+++++++.....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~-----vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQK-----CALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCE-----EEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            46888854 699999999999999876553     9999986532     222333 34566799999999999987544


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~  250 (441)
                      .....++||||+++|+|.+++..+....+++..++.++.||+.||.|||++   +|+||||||+|||++.   ++.+||+
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            444579999999999999999876556899999999999999999999998   9999999999999976   4459999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~~~~  329 (441)
                      |||+++.....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ......  
T Consensus       174 Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  247 (336)
T 3fhr_A          174 DFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL--  247 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc--
Confidence            99999865432    23456789999999999888899999999999999999999999965432211100 000000  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               ............++..+.+|+.+||+.||.+||++.++++
T Consensus       248 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 ---------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     0000111111245678999999999999999999999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2e-42  Score=341.65  Aligned_cols=271  Identities=22%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++......  ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGE-----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCC-----EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            4689999999999999999999877654     4999999764322  24678899999999999999999999987653


Q ss_pred             CC--eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RG--IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      ..  ...++||||+. ++|.+++.    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred             cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence            21  12389999996 68888874    4599999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus       188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9999864332     344678999999999877 6789999999999999999999999976543322211111000000


Q ss_pred             c----------ccchhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          331 D----------AKKFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       331 ~----------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                      .          .......+......   .....+++.+.+|+.+||+.||++||++.++++  +++.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            0          00000000000000   011234678999999999999999999999998  454443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-42  Score=331.99  Aligned_cols=258  Identities=22%  Similarity=0.359  Sum_probs=196.0

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      ..++|++.+.||+|+||.||+|.+..++.     .||||.+... ......+.+|+.+++.++||||+++++++.+... 
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSR-----YYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCe-----EEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            45689999999999999999999876654     4999998643 2345678899999999999999999999876421 


Q ss_pred             --------CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          174 --------RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       174 --------~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                              .....++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence                    123569999999999999999753 45678899999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCCCCCCCCC------------CcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCC
Q 013504          246 NAKLSDFGLARLGPSDG------------LSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDR  312 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~  312 (441)
                      .+||+|||+++......            .........||+.|+|||++.+. .++.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            99999999998654221            01123456799999999998764 68999999999999999998   5532


Q ss_pred             CCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  .........+..           ....+...++...+..+.+++.+||+.||.+||++.++++
T Consensus       231 ~--~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 G--MERVNILKKLRS-----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H--HHHHHHHHHHHS-----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c--hhHHHHHHhccc-----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1  111112111111           0111122233455677899999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=347.51  Aligned_cols=270  Identities=23%  Similarity=0.349  Sum_probs=183.7

Q ss_pred             hcCCcc-cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSR-SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~-~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .+.|.+ +++||+|+||.||+|.+..+..   ...||||++.....  ...+.+|+.+|+.++||||+++++++......
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKD---DKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSC---CCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCC---CeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            355776 5589999999999999764321   23499999976542  35678999999999999999999999754433


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE----cC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR-------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL----DE  243 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl----~~  243 (441)
                        ..++||||++ |+|.+++...       ....+++..++.++.||+.||.|||++   +|+||||||+||||    +.
T Consensus        94 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           94 --KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             --EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTT
T ss_pred             --eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCC
Confidence              5699999995 5888887532       123599999999999999999999998   99999999999999    77


Q ss_pred             CCcEEEeecCCCCCCCCCCC-cceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchh----
Q 013504          244 QWNAKLSDFGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKS----  317 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~----  317 (441)
                      ++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......    
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            88999999999987543211 1223457899999999998874 58999999999999999999999996543311    


Q ss_pred             ------HHHHHHhhhhhcccccchhhh------------c-CCCCCCcc--------hHHHHHHHHHHHHHhhcccCCCC
Q 013504          318 ------EQKLLEWVRPHLTDAKKFTMI------------L-DPKLEGKY--------SIKLAQKLAAVANKCLARQAKGR  370 (441)
Q Consensus       318 ------~~~~~~~~~~~~~~~~~~~~~------------~-~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~R  370 (441)
                            ...+......  .....+..+            + ........        ....+..+.+||.+||..||.+|
T Consensus       248 ~~~~~~l~~i~~~~g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGF--PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             CCCHHHHHHHHHHHCC--CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cchHHHHHHHHHhhCC--CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  0111111100  000000000            0 00000000        00114578899999999999999


Q ss_pred             CCHHHHHH
Q 013504          371 PKMSEVVE  378 (441)
Q Consensus       371 Ps~~evl~  378 (441)
                      ||+.++++
T Consensus       326 ~ta~e~L~  333 (405)
T 3rgf_A          326 ITSEQAMQ  333 (405)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.7e-43  Score=342.67  Aligned_cols=271  Identities=21%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||.+...... ....+.+|+.+++.++||||+++++++..... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGE-----IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCc-----EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            4689999999999999999999876654     4999998654332 34567899999999999999999998875421 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      .....++||||+. |+|.+++..   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence            1224699999996 699999876   4799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcc--------eeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          254 LARLGPSDGLSH--------VSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       254 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +++.........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            998654321110        1223578999999998765 6789999999999999999999999976553322221111


Q ss_pred             hhhhcccccc--------hhhhcC--CCC-C---CcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKK--------FTMILD--PKL-E---GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~--------~~~~~~--~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..........        ......  +.. .   ......++..+.+++.+||..||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1000000000        000000  000 0   0011245678899999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-42  Score=335.54  Aligned_cols=270  Identities=24%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEc-CCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC---CCCCeeeEEeEE
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIR-STEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV---EHPNLVKLIGYC  168 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~  168 (441)
                      ..++|.+.+.||+|+||.||+|.+. .++     ..||+|++......  ....+.+|+.+++.+   +||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCC-----EEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            4578999999999999999999985 333     34899988654321  123566788777766   899999999998


Q ss_pred             eccc-cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcE
Q 013504          169 AEDD-ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNA  247 (441)
Q Consensus       169 ~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~  247 (441)
                      .... ......++||||++ |+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence            7321 12235699999997 6999999876556799999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH-HHhhh
Q 013504          248 KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL-LEWVR  326 (441)
Q Consensus       248 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~-~~~~~  326 (441)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .....
T Consensus       160 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          160 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             EECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999999865432   123456899999999999999999999999999999999999999976554322211 11110


Q ss_pred             hhcccccchh-------hhcC---CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          327 PHLTDAKKFT-------MILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       327 ~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .  .....+.       ....   ..........++..+.+|+.+||+.||++||++.++++
T Consensus       237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 L--PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             C--CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0  0000000       0000   00001122345678899999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=341.27  Aligned_cols=258  Identities=23%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+...        +|+|.+.....  ...+.+.+|+.+++.++||||+++++++.....
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~~--------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHGE--------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESSS--------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcCe--------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            46899999999999999999987542        89999875432  223556789999999999999999999987653


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||+++++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||
T Consensus       104 ----~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          104 ----LAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             ----EEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             ----eEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence                49999999999999999753 35799999999999999999999998   999999999999998 6799999999


Q ss_pred             CCCCCCCCC---CcceeeceecccCcCCcccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          254 LARLGPSDG---LSHVSTAVVGTIGYAAPEYIQT---------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       254 la~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      +++......   .........||+.|+|||++.+         ..++.++|||||||++|+|++|..||...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  254 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ  254 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            987543211   1112234569999999999864         4578899999999999999999999976543322111


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                         +....          .+..   ....++..+.+++.+||..||++||++.++++.|+.+.+.
T Consensus       255 ---~~~~~----------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          255 ---MGTGM----------KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ---HHTTC----------CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ---hccCC----------CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence               11100          0100   0112345688999999999999999999999999988754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-42  Score=330.39  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=188.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-h-HHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-H-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||+|++....... . ..+.++...++.++||||+++++++...+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQ-----IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCe-----EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            4689999999999999999999876654     49999987653222 2 234455556888899999999999987654


Q ss_pred             CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                          .++||||++ |+|.+++..  .....+++..++.++.|++.||.|||++  .+|+||||||+|||++.++.+||+|
T Consensus        81 ----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           81 ----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             ----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred             ----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEee
Confidence                499999996 588888753  2356899999999999999999999984  2899999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYI----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||....... .........
T Consensus       154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~  229 (290)
T 3fme_A          154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQVVEE  229 (290)
T ss_dssp             C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHHHHS
T ss_pred             cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHHhcc
Confidence            99998654322   23345799999999996    55678999999999999999999999997533221 111111111


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                      .              ........++..+.+++.+||+.||++||++.++++  +++.
T Consensus       230 ~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          230 P--------------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             C--------------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             C--------------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            0              001111235677899999999999999999999998  4544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.6e-43  Score=345.20  Aligned_cols=269  Identities=19%  Similarity=0.290  Sum_probs=204.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-----------CCCeeeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-----------HPNLVKL  164 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l  164 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++.... .....+.+|+.++++++           ||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNT-----HVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCc-----EEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            3689999999999999999999876654     49999987532 33466788999998876           8999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--  242 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--  242 (441)
                      ++++...+..+...++||||+ +++|.+++.......+++..++.++.||+.||.|||++  .+|+||||||+|||++  
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEecc
Confidence            999987665555679999999 99999999876566799999999999999999999984  2899999999999994  


Q ss_pred             ----CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          243 ----EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       243 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                          ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                4457999999999865432     2345799999999999999999999999999999999999999975432211


Q ss_pred             ----HH---HHHhhhhh--------------cccccchhhhcCC---------CCCCcchHHHHHHHHHHHHHhhcccCC
Q 013504          319 ----QK---LLEWVRPH--------------LTDAKKFTMILDP---------KLEGKYSIKLAQKLAAVANKCLARQAK  368 (441)
Q Consensus       319 ----~~---~~~~~~~~--------------~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~  368 (441)
                          ..   +.......              .........+...         .....++..++..+.+||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence                11   11111000              0000000000000         001124567888999999999999999


Q ss_pred             CCCCHHHHHH
Q 013504          369 GRPKMSEVVE  378 (441)
Q Consensus       369 ~RPs~~evl~  378 (441)
                      +||++.++++
T Consensus       324 ~Rpt~~ell~  333 (373)
T 1q8y_A          324 KRADAGGLVN  333 (373)
T ss_dssp             TCBCHHHHHT
T ss_pred             ccCCHHHHhh
Confidence            9999999988

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-42  Score=338.83  Aligned_cols=278  Identities=24%  Similarity=0.312  Sum_probs=195.4

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      .....++|.+.+.||+|+||.||+|.+..++.     .||||++.... .......+|+..+..++||||+++++++...
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM-----SVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCC-----EEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            44566899999999999999999999887655     39999886543 2234566788888999999999999999764


Q ss_pred             cc---CCeeEEEEEeccCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEecccCCCcEEEcC-
Q 013504          172 DE---RGIQRLLIYEYMPNRSVQDHLTS--RFQATLPWNTRLKIAQDAARGLAYLH--EGMDFQIIFRDFKSSNILLDE-  243 (441)
Q Consensus       172 ~~---~~~~~~lv~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~iiHrDlKp~NILl~~-  243 (441)
                      ..   .....++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +.   +|+||||||+|||++. 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence            33   22336899999976 55554432  23567899999999999999999999  76   9999999999999996 


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 013504          244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL  322 (441)
Q Consensus       244 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~  322 (441)
                      ++.+||+|||+++......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            8999999999998755432   233467899999999986654 899999999999999999999999765543322211


Q ss_pred             HhhhhhcccccchhhhcCCCC----------------CCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          323 EWVRPHLTDAKKFTMILDPKL----------------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                      ...  ...........+++..                ........+..+.+|+.+||+.||.+||++.++++  +++++.
T Consensus       245 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          245 VRV--LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHH--HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHH--cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            110  0000000000000000                00111125678999999999999999999999998  455543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-42  Score=328.67  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||+|++.....  .....+.+|+.++++++||||+++++++...
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQ-----EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCc-----EEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence            456789999999999999999999876554     499999865432  3456788999999999999999999999875


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC---CcEE
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ---WNAK  248 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~---~~~k  248 (441)
                      .    ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+   +.+|
T Consensus        94 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           94 S----SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             C----eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            5    359999999999999998763  5799999999999999999999998   99999999999999764   4699


Q ss_pred             EeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhh
Q 013504          249 LSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH  328 (441)
Q Consensus       249 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~  328 (441)
                      |+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.   ..
T Consensus       165 L~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~  237 (287)
T 2wei_A          165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---TG  237 (287)
T ss_dssp             ECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HC
T ss_pred             EeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---cC
Confidence            99999998654322   1234568999999998865 58999999999999999999999997654332211111   10


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                      ..           .........++..+.+++.+||..||++||++.++++  ++++
T Consensus       238 ~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          238 KY-----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             CC-----------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             CC-----------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            00           0000111234678999999999999999999999998  4444

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.1e-43  Score=335.77  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCC--CCCeeeEEeEEe
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVE--HPNLVKLIGYCA  169 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~--hpnIv~l~~~~~  169 (441)
                      ...++|.+.+.||+|+||.||+|.+.. +     ..||||++.....  .....+.+|+.++.+++  ||||+++++++.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCC-C-----cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            345789999999999999999998753 2     2499999875432  33467889999999996  599999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ...    ..++||| +.+++|.+++..  ...+++..++.++.|++.||.|||++   +|+||||||+|||+++ +.+||
T Consensus        99 ~~~----~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           99 TDQ----YIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             CSS----EEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred             cCC----EEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence            765    3599999 568999999986  35789999999999999999999998   9999999999999965 79999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCchhH
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-----------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE  318 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~  318 (441)
                      +|||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  247 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence            99999987654332223345679999999999875           4688899999999999999999999975432211


Q ss_pred             HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          319 QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                       .....              .++......+...+..+.+++.+||+.||++||++.++++.
T Consensus       248 -~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 -KLHAI--------------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHHH--------------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHH--------------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             11111              11111111222235678999999999999999999999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.4e-42  Score=338.88  Aligned_cols=206  Identities=23%  Similarity=0.312  Sum_probs=172.9

Q ss_pred             HHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CC-----CeeeEEeE
Q 013504           94 TATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HP-----NLVKLIGY  167 (441)
Q Consensus        94 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~~  167 (441)
                      ...++|.+.+.||+|+||.||+|.+..++.     .||||++.... .....+.+|+.++..++ |+     +|++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQE-----WVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCc-----EEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            345789999999999999999999876654     49999997542 33456778888888874 55     49999999


Q ss_pred             EeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--CCC
Q 013504          168 CAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--EQW  245 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--~~~  245 (441)
                      +...+    ..++||||++ |+|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+||||+  .++
T Consensus       125 ~~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          125 FMFRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             eccCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence            98765    4599999995 5999999876556799999999999999999999952 23899999999999994  578


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCch
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPK  316 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~  316 (441)
                      .+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            8999999999865432     23468999999999999999999999999999999999999999865543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.8e-42  Score=336.49  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=203.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC------eeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN------LVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~~~~~  169 (441)
                      .++|.+.+.||+|+||.||+|.+..++.    ..||+|++.... .....+.+|+.+++.++|++      ++.+++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCc----eEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            4689999999999999999999876542    359999987542 33466788999999887665      999999887


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE--------
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL--------  241 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl--------  241 (441)
                      ...    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||+        
T Consensus        93 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           93 FHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred             eCC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence            765    459999999 77888888765556799999999999999999999998   99999999999999        


Q ss_pred             -----------cCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 013504          242 -----------DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       242 -----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                                 +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence                       56789999999999864332     23468999999999999999999999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhhhhccccc-----c--------------------hhhhcCC-CCCCcchHHHHHHHHHHHHHhhc
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAK-----K--------------------FTMILDP-KLEGKYSIKLAQKLAAVANKCLA  364 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~  364 (441)
                      ...........+.......+...     .                    ......+ ..........+..+.+|+.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            86554333222222111110000     0                    0000000 00001122456789999999999


Q ss_pred             ccCCCCCCHHHHHH
Q 013504          365 RQAKGRPKMSEVVE  378 (441)
Q Consensus       365 ~dP~~RPs~~evl~  378 (441)
                      .||++|||+.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=336.53  Aligned_cols=264  Identities=22%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++......  ..+.+.+|+.+++.++||||+++++++.....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE-----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCC-----EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            3679999999999999999999876654     4999998764322  24678899999999999999999999986543


Q ss_pred             C--CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 R--GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      .  ....|+||||++ ++|.+++.    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred             cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence            2  123489999996 68888774    3599999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc-
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL-  329 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~-  329 (441)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... 
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864332     334688999999999877 678999999999999999999999997654332221111000000 


Q ss_pred             -------ccc--cchhhhc----CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 -------TDA--KKFTMIL----DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 -------~~~--~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .+.  ......+    .+.+ ......++..+.+++.+||+.||++||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   000  0000000    0000 1112345678999999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.7e-42  Score=332.26  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=178.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHH-HhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVN-VLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++..... ....++..|+. +++.++||||+++++++...+  
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~--   94 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQ-----IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--   94 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTE-----EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCC-----EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--
Confidence            689999999999999999999876654     499999876533 23345566666 777789999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTS---RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                        ..++||||+++ +|.+++..   .....+++..+..++.|++.||.|||++  .+|+||||||+|||++.++.+||+|
T Consensus        95 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           95 --DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             --EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECC
T ss_pred             --ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEcc
Confidence              35999999975 88887752   2356899999999999999999999984  2799999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYI----QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      ||+++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.......  .   ....
T Consensus       170 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~  241 (327)
T 3aln_A          170 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--D---QLTQ  241 (327)
T ss_dssp             CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC
T ss_pred             CCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--H---HHHH
Confidence            99998654321   22334799999999998    45678999999999999999999999997532210  0   0000


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...       ...+.+.......++..+.+++.+||..||++||++.++++
T Consensus       242 ~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          242 VVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             Hhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000       00111111112235678999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=333.49  Aligned_cols=244  Identities=26%  Similarity=0.490  Sum_probs=192.1

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccC----CCCCee
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVV----EHPNLV  162 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~hpnIv  162 (441)
                      ....++|.+.+.||+|+||.||+|.+..++.     .||||++......      ....+.+|+.++.++    +||||+
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~  101 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL-----QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI  101 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCC-----EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCe-----EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence            3456789999999999999999998766554     4999999765432      123345789988888    899999


Q ss_pred             eEEeEEeccccCCeeEEEEEec-cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEE
Q 013504          163 KLIGYCAEDDERGIQRLLIYEY-MPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILL  241 (441)
Q Consensus       163 ~l~~~~~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl  241 (441)
                      ++++++...+.    .++|||| +.+++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus       102 ~~~~~~~~~~~----~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          102 RLLDWFETQEG----FMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI  172 (312)
T ss_dssp             CEEEEC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred             eEEEEEecCCe----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence            99999877654    3899999 7899999999763  5799999999999999999999998   99999999999999


Q ss_pred             c-CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCchhHH
Q 013504          242 D-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLT-YKSDIWSFGVFLYELITGRRPLDRNRPKSEQ  319 (441)
Q Consensus       242 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltG~~P~~~~~~~~~~  319 (441)
                      + .++.+||+|||+++......    .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||....     
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence            9 88999999999998754432    3446799999999998877764 58999999999999999999996421     


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .....                   ....+..++..+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 EILEA-------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHT-------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHhhh-------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100                   00112234567899999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.5e-42  Score=335.55  Aligned_cols=244  Identities=25%  Similarity=0.453  Sum_probs=198.6

Q ss_pred             HHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCC--CCCeeeE
Q 013504           93 KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVE--HPNLVKL  164 (441)
Q Consensus        93 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--hpnIv~l  164 (441)
                      ....++|.+.+.||+|+||.||+|.+..++.     .||||.+......      ....+.+|+.++++++  ||||+++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTE-----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCc-----EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            3445789999999999999999999876654     4999998765322      1244668999999996  5999999


Q ss_pred             EeEEeccccCCeeEEEEEeccCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-
Q 013504          165 IGYCAEDDERGIQRLLIYEYMPN-RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-  242 (441)
Q Consensus       165 ~~~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-  242 (441)
                      ++++...+    ..++||||+.+ ++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++ 
T Consensus       114 ~~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          114 LDWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL  184 (320)
T ss_dssp             EEEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred             EEEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC
Confidence            99998765    35999999976 8999999763  6799999999999999999999998   999999999999999 


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHH
Q 013504          243 EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKL  321 (441)
Q Consensus       243 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~  321 (441)
                      .++.+||+|||+++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|..||....     ..
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~  255 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI  255 (320)
T ss_dssp             TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred             CCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh
Confidence            7889999999999865432    2334679999999999987766 678999999999999999999996421     11


Q ss_pred             HHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          322 LEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..   ..            .    ..+..++..+.+++.+||+.||++||++.++++
T Consensus       256 ~~---~~------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IR---GQ------------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HH---CC------------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hc---cc------------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10   00            0    011234567899999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=324.40  Aligned_cols=252  Identities=28%  Similarity=0.426  Sum_probs=179.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-h-HHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-H-KEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||.||+|.+..++.     .||||++....... . +.+.++..+++.++||||+++++++...+ 
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGH-----VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCC-----EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred             hccccccceeeecCCeeEEEEEEecCCe-----EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Confidence            3679999999999999999999876654     49999997654322 2 23344556788889999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                         ..++||||+ ++.+..+... ....+++..++.++.|++.||.|||+ .   +|+||||||+|||++.++.+||+||
T Consensus        98 ---~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           98 ---DVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             ---EEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ---cEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence               459999999 5555555443 35689999999999999999999997 4   8999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |++.......   ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.......  ........
T Consensus       170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~  244 (318)
T 2dyl_A          170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKVLQ  244 (318)
T ss_dssp             TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHH
T ss_pred             CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHHhc
Confidence            9997654322   233457999999999984     4568899999999999999999999997543221  11111111


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ...          +.+.  ....++..+.+++.+||+.||.+||++.++++
T Consensus       245 ~~~----------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          245 EEP----------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             SCC----------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCC----------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            000          0000  01134567899999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6e-41  Score=337.82  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=183.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.|...++||+|+||+||.+... ++     ..||||++....   ...+.+|+.+|..+ +||||+++++++....   
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~-~g-----~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~---   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF-QG-----RPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR---   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES-SS-----SEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS---
T ss_pred             heeeccCeEeeCCCeEEEEEEEE-CC-----eEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence            34556788999999999865432 22     359999986532   35677899999876 8999999999987655   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC------
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQAT-----LPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ------  244 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~------  244 (441)
                       ..|||||||+ |+|.+++.......     .++..++.++.||+.||.|||++   +|+||||||+|||++.+      
T Consensus        83 -~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           83 -FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             -EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSC
T ss_pred             -eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccc
Confidence             4599999995 69999997642111     13335678999999999999998   99999999999999754      


Q ss_pred             -------CcEEEeecCCCCCCCCCCCc--ceeeceecccCcCCcccccc-------CCCCccccchhHHHHHHHHHh-CC
Q 013504          245 -------WNAKLSDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQT-------GRLTYKSDIWSFGVFLYELIT-GR  307 (441)
Q Consensus       245 -------~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-G~  307 (441)
                             +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   47999999999876543211  12235689999999999875       568999999999999999999 99


Q ss_pred             CCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          308 RPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       308 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .||....... .......   ..         .+.........++..+.+++.+||+.||.+||++.+|++
T Consensus       238 ~Pf~~~~~~~-~~i~~~~---~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSRE-SNIIRGI---FS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTHH-HHHHHTC---CC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhhH-HHHhcCC---CC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            9997543322 1111110   00         011112234567889999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=337.22  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=183.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|.+.++||+|+||+||..... ++     ..||||++......   .+.+|+.+|+.+ +||||+++++++.+..   
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-~~-----~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~---   91 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-DN-----RDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQ---   91 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-SS-----SEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETT---
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-CC-----eEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence            56899999999999996543322 22     24999998764432   345899999999 8999999999987665   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-----CCcEEEe
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-----QWNAKLS  250 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-----~~~~kl~  250 (441)
                       ..|||||||+ |+|.+++... ...+.+..++.++.||+.||.|||++   +|+||||||+|||++.     ...+||+
T Consensus        92 -~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           92 -FQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             -EEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             -EEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence             3599999995 6999999764 33455667789999999999999998   9999999999999953     2358899


Q ss_pred             ecCCCCCCCCCCC-cceeeceecccCcCCccccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhh
Q 013504          251 DFGLARLGPSDGL-SHVSTAVVGTIGYAAPEYIQ---TGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       251 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~  325 (441)
                      |||+++....... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||.............  
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~--  243 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--  243 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT--
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc--
Confidence            9999987543321 12234568999999999997   4567889999999999999999 999996543222111100  


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ....     .  ........+..+.+|+.+||+.||.+||++.+|++
T Consensus       244 ------~~~~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ------ACSL-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------CCCC-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCCc-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  0000     0  00112245667889999999999999999999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4e-41  Score=350.47  Aligned_cols=275  Identities=26%  Similarity=0.364  Sum_probs=206.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++..     ||||++..... .....+.+|+.++++++||||+++++++.....  
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~-----VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQ-----VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCC-----EEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcE-----EEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            6899999999999999999988766554     99999876432 334678899999999999999999998765211  


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc---EEE
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF-QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN---AKL  249 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~---~kl  249 (441)
                      .+...++||||++||+|.+++.... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.   +||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence            1224589999999999999997632 23689999999999999999999998   9999999999999987765   999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ..|.....
T Consensus       166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~  237 (676)
T 3qa8_A          166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVR  237 (676)
T ss_dssp             CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC
T ss_pred             ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhh
Confidence            9999998764432   234568999999999999999999999999999999999999999654211     11111100


Q ss_pred             ccc-----------cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHH-----HHHHHHHHHhhh
Q 013504          330 TDA-----------KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSE-----VVEVLNKIVDAA  387 (441)
Q Consensus       330 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~  387 (441)
                      ...           ..................++..+.+++.+||..||++||++.+     .++.+++++...
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            000           0000000001112344567889999999999999999999988     556777776543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-40  Score=315.38  Aligned_cols=234  Identities=14%  Similarity=0.176  Sum_probs=183.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|.+.+.||+|+||.||+|.+..++.     .||||++......   ..+.+.+|+.++..++||||+++++++...+ 
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-  104 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDR-----QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-  104 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTE-----EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCc-----eEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-
Confidence            579999999999999999999876554     4999999865432   2367889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+||||++|++|.+++..   + .....+..++.||+.||.|||++   +|+||||||+|||++.++.+||+++|
T Consensus       105 ---~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          105 ---GGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             ---EEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             ---cEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence               35999999999999999954   2 35567889999999999999998   99999999999999999999998443


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                                            |++       .++.++|||||||++|||++|+.||...........   .......  
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~--  220 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAG--  220 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTS--
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhcc--
Confidence                                  333       368899999999999999999999976443210000   0000000  


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                            .+.........+++.+.+++.+||+.||++| |+.++++.|+.+....
T Consensus       221 ------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          221 ------QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             ------CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             ------CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence                  0000001122456789999999999999999 9999999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-40  Score=350.88  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||.||+|.+....    ...||||++..... .....+.+|+.++.+++||||+++++++...+..
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVN----GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGT----TEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCC----CcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            478999999999999999999986521    23599999875433 3345688999999999999999999999876653


Q ss_pred             Ce-eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          175 GI-QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       175 ~~-~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                      +. ..||||||++|++|.+++..    .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            22 25999999999999987743    799999999999999999999998   99999999999999986 89999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||......           .+    
T Consensus       227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~----  284 (681)
T 2pzi_A          227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GL----  284 (681)
T ss_dssp             TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SC----
T ss_pred             cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------cc----
Confidence            99865432      346799999999998765 488999999999999999999888531100           00    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-HHHHHHHHHHHHh
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVEVLNKIVD  385 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~~  385 (441)
                               .........++.+.++|.+||+.||++||+ ++++...|..++.
T Consensus       285 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          285 ---------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ---------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ---------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                     011112234577899999999999999995 6667777776653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.4e-40  Score=314.45  Aligned_cols=234  Identities=20%  Similarity=0.303  Sum_probs=181.6

Q ss_pred             hcCCccc-ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHh-ccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRS-LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVL-GVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+. ++||+|+||.||+|.+..++.     .||+|.+..     ...+.+|+.++ +.++||||+++++++.....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-----KFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCc-----EEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            3567776 789999999999999876654     499999854     24567889888 55699999999999876333


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~  250 (441)
                      .....++||||+++|+|.+++.......+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            233569999999999999999876556899999999999999999999998   9999999999999998   7889999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||++....                        +..++.++|||||||++|+|++|..||.........   .    ...
T Consensus       163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~----~~~  211 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P----GMK  211 (299)
T ss_dssp             CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------C----CSC
T ss_pred             ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---H----HHH
Confidence            999986422                        245678899999999999999999999654321100   0    000


Q ss_pred             cccchhhhcCCC--CCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPK--LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           .......  ........++..+.+++.+||+.||++||++.++++
T Consensus       212 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 -----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -----CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0000000  000111235678999999999999999999999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-39  Score=326.21  Aligned_cols=246  Identities=18%  Similarity=0.239  Sum_probs=182.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCC-CCee---------
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEH-PNLV---------  162 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h-pnIv---------  162 (441)
                      +.+|...++||+|+||.||+|.+..++.     .||||++......   ..+.+.+|+.+++.++| +|+.         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCC-----ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            3568888999999999999999887665     4999998743332   25678899999999977 2211         


Q ss_pred             -e-----------EEeEEeccc-cCCeeEEEEEeccCCCChHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 013504          163 -K-----------LIGYCAEDD-ERGIQRLLIYEYMPNRSVQDHLT-----SRFQATLPWNTRLKIAQDAARGLAYLHEG  224 (441)
Q Consensus       163 -~-----------l~~~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  224 (441)
                       .           ++.++.... ......+++|+++ +++|.+++.     ......+++..++.++.||+.||.|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence             1           111111111 0112346777766 789999985     22245678889999999999999999998


Q ss_pred             CCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccc----------ccCCCCccccch
Q 013504          225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI----------QTGRLTYKSDIW  294 (441)
Q Consensus       225 ~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvw  294 (441)
                         +|+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++          .+..++.++|||
T Consensus       231 ---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          231 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             ---CcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence               999999999999999999999999999886432     2445678 999999999          555688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH
Q 013504          295 SFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS  374 (441)
Q Consensus       295 SlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  374 (441)
                      ||||++|||++|+.||........                ...++...      ..+++.+.+|+.+||+.||++||++.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999999999999999965432110                01111100      12357799999999999999999988


Q ss_pred             HHHH
Q 013504          375 EVVE  378 (441)
Q Consensus       375 evl~  378 (441)
                      ++++
T Consensus       360 ~~l~  363 (413)
T 3dzo_A          360 QAME  363 (413)
T ss_dssp             HHTT
T ss_pred             HHHh
Confidence            8765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.8e-39  Score=311.93  Aligned_cols=246  Identities=17%  Similarity=0.194  Sum_probs=185.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--------hhhHHHHHHHHHhccCC---------C
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--------QGHKEWVTEVNVLGVVE---------H  158 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~---------h  158 (441)
                      .++|.+.+.||+|+||+||+|++.+       ..||||++.....        ...+.+.+|+.+|+.++         |
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETT-------EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEeCC-------ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            4679999999999999999998732       3599999986532        12367888999988875         8


Q ss_pred             CCeeeEEeEEecccc--------------------------CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHH
Q 013504          159 PNLVKLIGYCAEDDE--------------------------RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ  212 (441)
Q Consensus       159 pnIv~l~~~~~~~~~--------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  212 (441)
                      |||+++.+.+.....                          .....|||||||++|++.+.+..   ..+++..++.++.
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~  168 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILH  168 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHH
Confidence            888888877542210                          02356999999999987777743   5789999999999


Q ss_pred             HHHHHHHHHh-hCCCCCeEecccCCCcEEEcCCC--------------------cEEEeecCCCCCCCCCCCcceeecee
Q 013504          213 DAARGLAYLH-EGMDFQIIFRDFKSSNILLDEQW--------------------NAKLSDFGLARLGPSDGLSHVSTAVV  271 (441)
Q Consensus       213 qi~~~L~~LH-~~~~~~iiHrDlKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~  271 (441)
                      ||+.||.||| +.   +|+||||||+||||+.++                    .+||+|||+|+....       ...+
T Consensus       169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~  238 (336)
T 2vuw_A          169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVV  238 (336)
T ss_dssp             HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEE
T ss_pred             HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEE
Confidence            9999999999 88   999999999999999887                    899999999986432       2358


Q ss_pred             cccCcCCccccccCCCCccccchhHHHH-HHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHH
Q 013504          272 GTIGYAAPEYIQTGRLTYKSDIWSFGVF-LYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIK  350 (441)
Q Consensus       272 gt~~y~aPE~~~~~~~~~~~DvwSlG~i-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (441)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||....  ........+...        ..............
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~--------~~~~~~~~~~~~~~  307 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQ--------MTFKTKCNTPAMKQ  307 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHT--------CCCSSCCCSHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhh--------hccCcccchhhhhh
Confidence            999999999998766 889999998777 777888999983210  000011111000        00111122234557


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCHHHHH
Q 013504          351 LAQKLAAVANKCLARQAKGRPKMSEVV  377 (441)
Q Consensus       351 ~~~~l~~li~~cl~~dP~~RPs~~evl  377 (441)
                      +++.+.+||.+||+.|     |+.+++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            8899999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.2e-33  Score=292.80  Aligned_cols=185  Identities=18%  Similarity=0.142  Sum_probs=128.4

Q ss_pred             eecccceeEEEEEEcCCCCcccceeEEEEEccccCc----------hhhHHHHHHHHHhccC-CCCCeeeEEeEEecccc
Q 013504          105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----------QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDE  173 (441)
Q Consensus       105 LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  173 (441)
                      ++.|++|.+..+.....++.     +++|.+.....          ...++|.+|+++|+++ .|+||+++++++.++..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~-----~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGED-----YVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSS-----EEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred             cccCCcccccccccccccce-----eEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence            56667776665554444443     89999875421          2235689999999999 79999999999987764


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .||||||++|++|.++|..  +++++..   .|+.||+.||.|||++   |||||||||+||||+.+|.+||+|||
T Consensus       317 ----~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          317 ----GWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             ----EEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ----EEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence                5999999999999999976  4667654   5889999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP  309 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P  309 (441)
                      +|+......  ....+.+||+.|||||++.+ .+..++|+||+|++++++.+|..+
T Consensus       385 lAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          385 SIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            998765432  23456789999999999875 567789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1e-29  Score=262.04  Aligned_cols=185  Identities=19%  Similarity=0.290  Sum_probs=140.7

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------hhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------GHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      ...++||+|+||.||+|...+.       .+++|........        ..+++.+|+.+|++++||||+++..++...
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~-------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDF-------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEEECSSC-------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEEEECCC-------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence            4456899999999999954432       3778775443221        124578999999999999999555555544


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      +..    ||||||++|++|.+++..          +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|
T Consensus       412 ~~~----~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          412 DNK----RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             TTT----EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             Ccc----EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence            433    999999999999999964          468999999999999998   9999999999999999  999999


Q ss_pred             cCCCCCCCCCCCcc-----eeeceecccCcCCcccccc--CCCCccccchhHHHHHHHHHhCCCCC
Q 013504          252 FGLARLGPSDGLSH-----VSTAVVGTIGYAAPEYIQT--GRLTYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       252 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltG~~P~  310 (441)
                      ||+++.........     ......||+.|||||++..  ..|+..+|+|+..+-.++.+.++.+|
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999765432111     1246789999999999987  66888899999999999888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.3e-25  Score=212.64  Aligned_cols=152  Identities=13%  Similarity=0.091  Sum_probs=117.8

Q ss_pred             HHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc------------------hhhHHHHHHHHH
Q 013504           91 ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL------------------QGHKEWVTEVNV  152 (441)
Q Consensus        91 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~i  152 (441)
                      .+......|.+.+.||+|+||.||+|.+ .++.     .||+|.+.....                  .....+.+|+.+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~-----~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~  157 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFG-----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA  157 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTE-----EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCC-----EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence            3344455677889999999999999998 4333     499999864321                  123567899999


Q ss_pred             hccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 013504          153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFR  232 (441)
Q Consensus       153 l~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  232 (441)
                      |++++  | +++++++.. +.    .|+||||++||+|.+ +..        .....++.|++.||.|||+.   +|+||
T Consensus       158 l~~l~--~-~~v~~~~~~-~~----~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHr  217 (282)
T 1zar_A          158 LQKLQ--G-LAVPKVYAW-EG----NAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHG  217 (282)
T ss_dssp             HHHTT--T-SSSCCEEEE-ET----TEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHhcc--C-CCcCeEEec-cc----eEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeC
Confidence            99998  4 555555433 22    399999999999988 421        23557999999999999998   99999


Q ss_pred             ccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc
Q 013504          233 DFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT  284 (441)
Q Consensus       233 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  284 (441)
                      ||||+|||++ ++.+||+|||+++.               +..|+|||++..
T Consensus       218 Dlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          218 DLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             CCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9999999999 99999999999863               456789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=2.9e-21  Score=180.45  Aligned_cols=138  Identities=16%  Similarity=0.094  Sum_probs=103.9

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCccccee--EEEEEccccCch------------------------hhHHHHHHHH
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKID--IAVKQLSRRGLQ------------------------GHKEWVTEVN  151 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  151 (441)
                      -|.+.+.||+|+||.||+|.+..++     ..  ||||++......                        ....+.+|+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDG-----KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETT-----EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCC-----cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            3678889999999999999874333     35  899986543111                        0125778999


Q ss_pred             HhccCCCCCe--eeEEeEEeccccCCeeEEEEEeccCC-C----ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh-h
Q 013504          152 VLGVVEHPNL--VKLIGYCAEDDERGIQRLLIYEYMPN-R----SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH-E  223 (441)
Q Consensus       152 il~~l~hpnI--v~l~~~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~  223 (441)
                      +|.++.|++|  ..++++    ..    .+|||||+.+ |    +|.++...     .++..+..++.|++.||.||| +
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~----~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MK----NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ET----TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCeEEEc----CC----CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH
Confidence            9999988754  344432    12    2899999942 4    67666432     235577899999999999999 8


Q ss_pred             CCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          224 GMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       224 ~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      .   +|+||||||+|||++.  .++|+|||+|...
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            7   9999999999999998  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=3.5e-18  Score=166.55  Aligned_cols=137  Identities=12%  Similarity=0.066  Sum_probs=97.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--------------hhHH--------HHHHHHHhcc
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--------------GHKE--------WVTEVNVLGV  155 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~il~~  155 (441)
                      -|++.+.||.|+||.||+|....+      ..||||+++.....              ....        ..+|...|.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G------~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKG------KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTC------CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECCCC------CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            399999999999999999986432      35999987532110              0011        2356777777


Q ss_pred             CCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 013504          156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFK  235 (441)
Q Consensus       156 l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlK  235 (441)
                      +.+.++....-+...  ..    +|||||++|++|.++..        ......++.||+.+|.|||+.   ||||||||
T Consensus       170 L~~~gv~vp~p~~~~--~~----~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLK  232 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQS--RH----TIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFN  232 (397)
T ss_dssp             HHHTTCSCCCEEEEE--TT----EEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             HHhcCCCCCeeeecc--Cc----eEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence            755443222111111  11    89999999988865532        123467889999999999998   99999999


Q ss_pred             CCcEEEcCCC----------cEEEeecCCCCC
Q 013504          236 SSNILLDEQW----------NAKLSDFGLARL  257 (441)
Q Consensus       236 p~NILl~~~~----------~~kl~DFGla~~  257 (441)
                      |.|||+++++          .+.|+||+.+..
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999998876          389999997764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=6.8e-13  Score=123.51  Aligned_cols=147  Identities=14%  Similarity=0.091  Sum_probs=110.3

Q ss_pred             HHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCCeeeEEeEEec
Q 013504           92 LKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPNLVKLIGYCAE  170 (441)
Q Consensus        92 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  170 (441)
                      +......|.+...+|.|+.+.||++...+       ..+++|............+.+|+.+|+.+ .+.++.++++++..
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~-------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECCC-------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            34455679888889999999999986432       23899998653222234577899999988 46778889988875


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG--------------------------  224 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------  224 (441)
                      .+    ..|+||||++|.+|.+.+..       ......++.+++.+|..||+.                          
T Consensus        82 ~~----~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T 3tm0_A           82 DG----WSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             TT----EEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             CC----ceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence            44    34999999999999876321       123457888999999999981                          


Q ss_pred             ------------------------------CCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          225 ------------------------------MDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       225 ------------------------------~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                                                    ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                          01358999999999999876666799999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1e-11  Score=114.91  Aligned_cols=137  Identities=15%  Similarity=0.108  Sum_probs=94.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC--eeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN--LVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~  174 (441)
                      .++.+..+.+.|..+.||++.... +.     .+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+. 
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~-g~-----~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-   89 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQG-RP-----VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-   89 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTT-SC-----CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-
T ss_pred             CCCceEecccCCCCceEEEEecCC-CC-----eEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-
Confidence            345554444466679999986432 22     3888987543   2245678999998885444  5568887765432 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM-----------------------------  225 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------  225 (441)
                         .++||||++|.+|.  ...     ..   ...++.+++..|..||+..                             
T Consensus        90 ---~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           90 ---DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             ---EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             ---CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence               49999999998884  211     11   2356777888888888641                             


Q ss_pred             --------------------------CCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          226 --------------------------DFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       226 --------------------------~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                                                ...++|+|++|.|||+++++.+.|+|||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                      1139999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=8.9e-11  Score=114.41  Aligned_cols=147  Identities=16%  Similarity=0.253  Sum_probs=105.3

Q ss_pred             cccceeecccceeEEEEEEcCCCCcccceeEEEEEcc--ccC-chhhHHHHHHHHHhccCC--CCCeeeEEeEEeccccC
Q 013504          100 SRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS--RRG-LQGHKEWVTEVNVLGVVE--HPNLVKLIGYCAEDDER  174 (441)
Q Consensus       100 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~  174 (441)
                      ..++.|+.|.++.||+....+.       .+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+....
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~~-------~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPGQ-------TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSSC-------EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             ceEEEcCCcccceEEEEEECCc-------eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            3456789999999999875431       37788765  322 122346778999999886  45688888888765321


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM-----------------------------  225 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------  225 (441)
                      + ..|+||||++|..+.+..    -..++......++.+++..|..||+..                             
T Consensus       114 g-~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          114 G-RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             S-SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             C-CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence            2 248999999998875422    134677888899999999999999720                             


Q ss_pred             --------------------------CCCeEecccCCCcEEEcCCCc--EEEeecCCCCCC
Q 013504          226 --------------------------DFQIIFRDFKSSNILLDEQWN--AKLSDFGLARLG  258 (441)
Q Consensus       226 --------------------------~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~  258 (441)
                                                ...++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                      247999999999999987753  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=1.2e-10  Score=110.72  Aligned_cols=186  Identities=22%  Similarity=0.246  Sum_probs=120.4

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccC-CCCC--eeeEEeEEeccccCCeeE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV-EHPN--LVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpn--Iv~l~~~~~~~~~~~~~~  178 (441)
                      ++.++.|....||+..    .      .+++|.....  .....+.+|+.+|+.+ .+..  +.+++.+....... ...
T Consensus        25 i~~~~~G~~n~v~~v~----~------~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~-~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----R------DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY-QMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST----T------SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC-SCS
T ss_pred             eEecCCCCcceEEEEC----C------EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC-Ccc
Confidence            4568999999999853    1      2788875432  2346678999999887 3332  34444443222211 123


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG----------------------------------  224 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------  224 (441)
                      |+||++++|.+|.+...    ..++..+...++.+++..|..||+.                                  
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            88999999988875433    2466777788888888888888861                                  


Q ss_pred             ---------------------CCCCeEecccCCCcEEEcC--CCcEEEeecCCCCCCCCCCCcceeeceecccCc---CC
Q 013504          225 ---------------------MDFQIIFRDFKSSNILLDE--QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY---AA  278 (441)
Q Consensus       225 ---------------------~~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~a  278 (441)
                                           ....++|+|++|.||++++  +..+.|+||+.+........      ......+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccC
Confidence                                 0135899999999999998  55678999998875432110      0001111   22


Q ss_pred             cccccc-----CCC---------CccccchhHHHHHHHHHhCCCCC
Q 013504          279 PEYIQT-----GRL---------TYKSDIWSFGVFLYELITGRRPL  310 (441)
Q Consensus       279 PE~~~~-----~~~---------~~~~DvwSlG~il~elltG~~P~  310 (441)
                      |+....     +..         ....+.|++|.++|.+.+|..+|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            332110     111         12258999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.52  E-value=8.1e-07  Score=84.30  Aligned_cols=137  Identities=18%  Similarity=0.174  Sum_probs=90.0

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCC---CeeeEEeEEeccccCCeeE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP---NLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~~~~~~~~  178 (441)
                      ++.++.|....||+.   + +      .+++|+-..  ......+.+|+.+|+.+.+.   .+.+++.+......   ..
T Consensus        24 v~~l~~G~~n~v~~v---g-~------~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g---~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---N-G------DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG---NP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE---T-T------TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS---CE
T ss_pred             eeecCCCcceeEEEE---C-C------EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC---ce
Confidence            456888988999987   2 1      278887432  22345778999999998642   35666666642221   24


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 013504          179 LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG----------------------------------  224 (441)
Q Consensus       179 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------  224 (441)
                      ++||||++|.+|.+....    .++......++.+++..|..||+.                                  
T Consensus        89 ~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           89 FVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            899999999888763211    233444445555555555555532                                  


Q ss_pred             -----------------------CCCCeEecccCCCcEEEcC---CCc-EEEeecCCCCC
Q 013504          225 -----------------------MDFQIIFRDFKSSNILLDE---QWN-AKLSDFGLARL  257 (441)
Q Consensus       225 -----------------------~~~~iiHrDlKp~NILl~~---~~~-~kl~DFGla~~  257 (441)
                                             ....++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   1235799999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=2.4e-06  Score=79.16  Aligned_cols=135  Identities=19%  Similarity=0.172  Sum_probs=91.5

Q ss_pred             eecccce-eEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeEEEEE
Q 013504          105 IGEGGFG-GVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRLLIY  182 (441)
Q Consensus       105 LG~G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~lv~  182 (441)
                      +..|..| .||+......+.     .+.+|.-...   ....+.+|..+|+.+. +--+.++++++.+.+.    .++||
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~-----~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~----~~lvm   99 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAP-----ELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD----AWLLT   99 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCC-----CEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE----EEEEE
T ss_pred             ccCCCcCCeEEEEEecCCCe-----EEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe----EEEEE
Confidence            4445554 689876543332     2778875432   3456778999988773 3346777888776543    49999


Q ss_pred             eccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 013504          183 EYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGM-------------------------------------  225 (441)
Q Consensus       183 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  225 (441)
                      |+++|.++.+.....      ......+..+++..|.-||...                                     
T Consensus       100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            999998887765321      1233456666677777777520                                     


Q ss_pred             ------------------CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          226 ------------------DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       226 ------------------~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                                        ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              12379999999999999887778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=1.1e-06  Score=85.05  Aligned_cols=89  Identities=9%  Similarity=0.042  Sum_probs=53.1

Q ss_pred             ccee-ecccceeEEEEEEcCCCC-cccceeEEEEEccccC---chhhHHHHHHHHHhccCC-C--CCeeeEEeEEecccc
Q 013504          102 SLMI-GEGGFGGVYRGVIRSTED-SHKKIDIAVKQLSRRG---LQGHKEWVTEVNVLGVVE-H--PNLVKLIGYCAEDDE  173 (441)
Q Consensus       102 ~~~L-G~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~  173 (441)
                      .+.| +.|..+.+|+........ ......+.+|......   ......+.+|+.+|+.+. +  -.+.+++.++.+...
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 888889999876531000 0002247788765422   111245678888888873 3  356778777755432


Q ss_pred             CCeeEEEEEeccCCCChH
Q 013504          174 RGIQRLLIYEYMPNRSVQ  191 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~  191 (441)
                      .+ ..|+||||++|.++.
T Consensus       105 ~g-~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LG-TPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TS-SCEEEEECCCCBCCC
T ss_pred             cC-CceEEEEecCCCChh
Confidence            11 238999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=4.1e-06  Score=82.40  Aligned_cols=76  Identities=13%  Similarity=0.087  Sum_probs=46.5

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-------hhhHHHHHHHHHhccCCC--C-CeeeEEeEEecc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-------QGHKEWVTEVNVLGVVEH--P-NLVKLIGYCAED  171 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--p-nIv~l~~~~~~~  171 (441)
                      .+.||.|.++.||++.....+.     .++||.......       ....++..|..+|..+..  | .+.+++.+.  .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~-----~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDR-----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----C-----EEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T
T ss_pred             EEECCCCceEEEEEEEECCCCc-----EEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C
Confidence            4579999999999996543222     388887543211       123456789988887732  3 344555442  2


Q ss_pred             ccCCeeEEEEEeccCCC
Q 013504          172 DERGIQRLLIYEYMPNR  188 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~g  188 (441)
                      +..    ++||||+++.
T Consensus       108 ~~~----~lvmE~l~g~  120 (397)
T 2olc_A          108 EMA----VTVMEDLSHL  120 (397)
T ss_dssp             TTT----EEEECCCTTS
T ss_pred             Ccc----EEEEEeCCCc
Confidence            222    8999999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=1.9e-05  Score=75.47  Aligned_cols=32  Identities=19%  Similarity=0.275  Sum_probs=28.1

Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            34899999999999998888999999997753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=8.8e-05  Score=70.29  Aligned_cols=76  Identities=13%  Similarity=0.119  Sum_probs=54.3

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC---CCCeeeEEeEEeccccCCee
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE---HPNLVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~  177 (441)
                      ..+.|+.|....+|+....  +     ..+.+|.....   ....+..|...|+.|.   ...+.+++++....+    .
T Consensus        40 ~~~~l~gG~~n~~y~v~~~--~-----~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g----~  105 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE--V-----QTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG----H  105 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS--S-----CEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----E
T ss_pred             eeEEeCCccceeeeEEEEC--C-----CeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----c
Confidence            3457899999999998632  1     13788876542   2456778999888873   356788888776543    3


Q ss_pred             EEEEEeccCCCCh
Q 013504          178 RLLIYEYMPNRSV  190 (441)
Q Consensus       178 ~~lv~E~~~~gsL  190 (441)
                      .++||||++|..+
T Consensus       106 ~~lvme~l~G~~~  118 (312)
T 3jr1_A          106 SFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEECCCCCCC
T ss_pred             eEEEEEeccCCCC
Confidence            4999999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.70  E-value=0.00022  Score=66.63  Aligned_cols=80  Identities=18%  Similarity=0.176  Sum_probs=54.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC---CCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH---PNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~  173 (441)
                      .....+..+|.|..+.||+....+..      .+.+|+-..........+..|+..|+.|.-   -.+.+++++.  .  
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~------~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--   84 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGT------PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--   84 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSC------EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCC------EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--
Confidence            34556778999999999999875432      388898665443334567789998887732   1344454432  2  


Q ss_pred             CCeeEEEEEeccCCCCh
Q 013504          174 RGIQRLLIYEYMPNRSV  190 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL  190 (441)
                      .    ++||||++++..
T Consensus        85 ~----~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 R----TLAMEWVDERPP   97 (288)
T ss_dssp             T----EEEEECCCCCCC
T ss_pred             c----eEEEEeecccCC
Confidence            2    899999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.60  E-value=0.00034  Score=69.12  Aligned_cols=31  Identities=13%  Similarity=0.310  Sum_probs=27.5

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARLG  258 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  258 (441)
                      ..++|+|++|.|||++.++ ++|+||+.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            4899999999999998876 999999988753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.59  E-value=0.00024  Score=62.74  Aligned_cols=99  Identities=13%  Similarity=0.060  Sum_probs=65.5

Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCccee
Q 013504          188 RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS  267 (441)
Q Consensus       188 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  267 (441)
                      -+|.+.|..+ +.+++++++|.++.|.+.+|.-+-.+.  .-..+=+-|..|+|..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            3789999865 689999999999999999987762110  111334457999999999988763 2111           


Q ss_pred             eceecccCcCCccccccCCCCccccchhHHHHHHHHHh
Q 013504          268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT  305 (441)
Q Consensus       268 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt  305 (441)
                         .....+.|||... ...+.+.=|||||+++|..+-
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence               1123456888753 344567789999999999885

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.56  E-value=0.00034  Score=65.72  Aligned_cols=30  Identities=17%  Similarity=0.148  Sum_probs=25.4

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            35899999999999 5666789999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.36  E-value=0.0017  Score=61.43  Aligned_cols=160  Identities=12%  Similarity=0.132  Sum_probs=82.6

Q ss_pred             cchHHHHHHhcCCcc-----cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC-
Q 013504           87 FTFSELKTATKNFSR-----SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN-  160 (441)
Q Consensus        87 ~~~~~~~~~~~~f~~-----~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-  160 (441)
                      ++.+++......|..     .+.|+.|....+|+....+.       .+.+|......  ....+..|+.++..+...+ 
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-------~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~   77 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGL   77 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC-----CCHHHHHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-------cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCC
Confidence            445566666666654     23466788889999875432       27888876521  2234556777776663212 


Q ss_pred             -eeeEEeEEecccc---CCeeEEEEEeccCCCChHH--------------HHhhc---CCCC----C---CHHHHHH---
Q 013504          161 -LVKLIGYCAEDDE---RGIQRLLIYEYMPNRSVQD--------------HLTSR---FQAT----L---PWNTRLK---  209 (441)
Q Consensus       161 -Iv~l~~~~~~~~~---~~~~~~lv~E~~~~gsL~~--------------~l~~~---~~~~----l---~~~~~~~---  209 (441)
                       +.+++... +...   .....++||+|++|..+..              .++..   ...+    .   .|.....   
T Consensus        78 ~vP~~~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~  156 (322)
T 2ppq_A           78 SCPLPLPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  156 (322)
T ss_dssp             CCCCBCCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             CCCcccCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence             22222110 0000   0013488999999865421              01111   0011    0   1111000   


Q ss_pred             ---------HHHHHHHHHHHHhhC----CCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          210 ---------IAQDAARGLAYLHEG----MDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       210 ---------i~~qi~~~L~~LH~~----~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                               +...+...+..+...    ...+++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                     001133444555421    13479999999999999987666899999765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.22  E-value=0.0012  Score=65.47  Aligned_cols=79  Identities=14%  Similarity=0.153  Sum_probs=47.7

Q ss_pred             cceeecccceeEEEEEEcCCCCc--ccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC-eeeEEeEEeccccCCeeE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDS--HKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN-LVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~~~~  178 (441)
                      ++.|+.|....||++........  .....+.+|+.....  ....+.+|..++..+...+ ..++++.+.  +      
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------
Confidence            45678888899999876532100  011247788774321  1145568999888874333 356666543  1      


Q ss_pred             EEEEeccCCCCh
Q 013504          179 LLIYEYMPNRSV  190 (441)
Q Consensus       179 ~lv~E~~~~gsL  190 (441)
                      .+||||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            479999987444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0023  Score=63.81  Aligned_cols=75  Identities=12%  Similarity=0.082  Sum_probs=44.6

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCe-eeEEeEEeccccCCeeEEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL-VKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~l  180 (441)
                      ++.|+.|-...+|++.....+     ..+.+|+..... ...-...+|..++..|...++ .++++++.  +      .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~-----~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~------G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQ-----AKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N------GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTT-----EEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T------EE
T ss_pred             EEEcCCCeEeEEEEEEECCCC-----ceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C------eE
Confidence            456888888999998765411     237777764322 111112478888888854444 56666652  1      35


Q ss_pred             EEeccCCCCh
Q 013504          181 IYEYMPNRSV  190 (441)
Q Consensus       181 v~E~~~~gsL  190 (441)
                      ||||++|.+|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999988544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.15  E-value=0.0032  Score=59.80  Aligned_cols=32  Identities=31%  Similarity=0.497  Sum_probs=27.9

Q ss_pred             CCeEecccCCCcEEEcCC----CcEEEeecCCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQ----WNAKLSDFGLARLG  258 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~----~~~kl~DFGla~~~  258 (441)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999874    67999999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.07  E-value=0.0019  Score=62.81  Aligned_cols=145  Identities=17%  Similarity=0.226  Sum_probs=79.6

Q ss_pred             ceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQRL  179 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~  179 (441)
                      +.|..|-...+|++.......  ......+.+++.... ......+.+|..+++.+. +.-..++++++.+        -
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------c
Confidence            457778888999987642100  011234777775332 223455668999988773 3333566665532        2


Q ss_pred             EEEeccCCCChHHH--------------H---hhc---CCCCCC--HHHHHHHHHHHHH-------------------HH
Q 013504          180 LIYEYMPNRSVQDH--------------L---TSR---FQATLP--WNTRLKIAQDAAR-------------------GL  218 (441)
Q Consensus       180 lv~E~~~~gsL~~~--------------l---~~~---~~~~l~--~~~~~~i~~qi~~-------------------~L  218 (441)
                      +||||++|.+|..-              |   +..   ......  +.++.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            79999998655311              1   110   111222  3455555544321                   12


Q ss_pred             HHHh----hC-CCCCeEecccCCCcEEEcCC----CcEEEeecCCCC
Q 013504          219 AYLH----EG-MDFQIIFRDFKSSNILLDEQ----WNAKLSDFGLAR  256 (441)
Q Consensus       219 ~~LH----~~-~~~~iiHrDlKp~NILl~~~----~~~kl~DFGla~  256 (441)
                      ..|.    .. ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2222    11 12368999999999999876    789999998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.99  E-value=0.01  Score=56.12  Aligned_cols=29  Identities=24%  Similarity=0.263  Sum_probs=25.4

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4689999999999999 4 899999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.87  E-value=0.0034  Score=60.68  Aligned_cols=80  Identities=9%  Similarity=0.079  Sum_probs=42.2

Q ss_pred             cceeecccceeEEEEEEcCCCC---cccceeEEEEEccccCchhhHHHHHHHHHhccCCCCC-eeeEEeEEeccccCCee
Q 013504          102 SLMIGEGGFGGVYRGVIRSTED---SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPN-LVKLIGYCAEDDERGIQ  177 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~~~  177 (441)
                      ...|+.|....+|+........   ......+.+|+..... ........|..+++.+...+ +.++++..  .  .   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--C---
Confidence            3467888888999987643100   0001237777764422 11112357888888774323 44666543  1  1   


Q ss_pred             EEEEEeccCCCCh
Q 013504          178 RLLIYEYMPNRSV  190 (441)
Q Consensus       178 ~~lv~E~~~~gsL  190 (441)
                       ++||||++|.++
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             689999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.18  E-value=0.0059  Score=58.31  Aligned_cols=31  Identities=16%  Similarity=0.336  Sum_probs=27.7

Q ss_pred             CCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          227 FQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       227 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.66  E-value=0.026  Score=55.48  Aligned_cols=80  Identities=14%  Similarity=0.054  Sum_probs=45.3

Q ss_pred             cceeecccceeEEEEEEcCCCCc--ccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDS--HKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++.|..|-...+|+.........  .....+.+++..... ...-...+|..+++.+. +.-..++++.+  .+      
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~------  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE------  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC------
Confidence            44577788889999886531110  002247777754322 11112247888888773 33345555533  11      


Q ss_pred             EEEEeccCCCCh
Q 013504          179 LLIYEYMPNRSV  190 (441)
Q Consensus       179 ~lv~E~~~~gsL  190 (441)
                      ++||||++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            789999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.67  E-value=0.36  Score=46.92  Aligned_cols=30  Identities=30%  Similarity=0.396  Sum_probs=24.8

Q ss_pred             CeEecccCCCcEEE------cCCCcEEEeecCCCCC
Q 013504          228 QIIFRDFKSSNILL------DEQWNAKLSDFGLARL  257 (441)
Q Consensus       228 ~iiHrDlKp~NILl------~~~~~~kl~DFGla~~  257 (441)
                      .++|+|+.+.|||+      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.46  E-value=1  Score=39.47  Aligned_cols=123  Identities=9%  Similarity=0.051  Sum_probs=78.7

Q ss_pred             HHHHhccCCCCCeeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 013504          149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQ  228 (441)
Q Consensus       149 E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  228 (441)
                      |+.+|. ..||+.+.. .+-...+      -++..|-...+...|-.-   ..++....++++.+|+....+++.     
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----   99 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----   99 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----
T ss_pred             HHHHHh-ccCCcccce-EEEEccc------EEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----
Confidence            343433 368888876 3444444      233444333333333221   346778899999999887766664     


Q ss_pred             eEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCC
Q 013504          229 IIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRR  308 (441)
Q Consensus       229 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~  308 (441)
                      -+|--|.|+||+++.++.+++.-.|+-..+                   +|.     ..+...=+-.+=|++..+++++.
T Consensus       100 r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~  155 (215)
T 4ann_A          100 RYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQ  155 (215)
T ss_dssp             SEECCCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTC
T ss_pred             ceEEEEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCC
Confidence            478899999999999999999877754322                   221     11111123467888999999998


Q ss_pred             CCC
Q 013504          309 PLD  311 (441)
Q Consensus       309 P~~  311 (441)
                      .|+
T Consensus       156 ~Fe  158 (215)
T 4ann_A          156 SFD  158 (215)
T ss_dssp             CHH
T ss_pred             CHH
Confidence            884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.17  E-value=3.5  Score=36.17  Aligned_cols=82  Identities=10%  Similarity=0.107  Sum_probs=58.5

Q ss_pred             CCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCc
Q 013504          201 TLPWNTRLKIAQDAARGLA-YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP  279 (441)
Q Consensus       201 ~l~~~~~~~i~~qi~~~L~-~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  279 (441)
                      .++...+++++.+|+.... +++     .-+|--|.|+||+++.++.++|.-.|+-..                   ++|
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP  136 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPP  136 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSS
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCC
Confidence            4677889999998887666 555     357888999999999999999987776432                   222


Q ss_pred             cccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 013504          280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLD  311 (441)
Q Consensus       280 E~~~~~~~~~~~DvwSlG~il~elltG~~P~~  311 (441)
                      .-+     +..-=+-.+=|++..++.++..|+
T Consensus       137 ~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          137 DEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            211     111113367788888998888774

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.31  E-value=0.15  Score=50.73  Aligned_cols=63  Identities=10%  Similarity=0.141  Sum_probs=17.5

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEE------EEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecc
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAV------KQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAED  171 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  171 (441)
                      +.+.||   ||.||+|.+....     .+|||      |.......  .....+.+|..++..++|||+++.+++....
T Consensus       146 l~~~lG---fG~v~~g~~~~~~-----~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~~  216 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKH-----MPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVHT  216 (463)
T ss_dssp             STTTSS---BCCC--------------CCBGGGC-----------------------------------CBCCCEEEEC
T ss_pred             ccccCC---chhhhcccccccC-----CchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEee
Confidence            345666   9999999986532     23666      55543221  2234677889999999999999998876543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	441
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-71
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-65
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-64
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 6e-71
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 34/284 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G FG VY+G            D+AVK L+      Q  + +  EV VL    H N++
Sbjct: 16  IGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
             +GY         Q  ++ ++    S+  HL    +        + IA+  A+G+ YLH
Sbjct: 68  LFMGYSTAP-----QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH 121

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 II RD KS+NI L E    K+ DFGLA +      SH    + G+I + APE I
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 283 QT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
           +       +++SD+++FG+ LYEL+TG+ P      + +   +                L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG-----------YL 227

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            P L  K      + +  +  +CL ++   RP   +++  +  +
Sbjct: 228 SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-67
 Identities = 78/286 (27%), Positives = 119/286 (41%), Gaps = 36/286 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+ G             +AVK L ++G      ++ E N++  ++H  LV+L
Sbjct: 21  LGAGQFGEVWMGYYNGHTK------VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                ++        +I EYM N S+ D L +     L  N  L +A   A G+A++ E 
Sbjct: 74  YAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD +++NIL+ +  + K++DFGLARL   +            I + APE I  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINY 184

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEWVRPHLTDAKKFTMILDPK 342
           G  T KSD+WSFG+ L E++T  R         E  Q L    R    D           
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD----------- 233

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE 388
                     ++L  +   C   + + RP    +  VL     A E
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (543), Expect = 1e-66
 Identities = 76/312 (24%), Positives = 141/312 (45%), Gaps = 41/312 (13%)

Query: 87  FTFSELKTATKNFSRSL---------MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR 137
           FTF +   A + F++ +         +IG G FG V  G ++      ++I +A+K L  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLP--GKREIFVAIKTLKS 64

Query: 138 RGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTS 196
               +  +++++E +++G  +HPN++ L G   +        ++I E+M N S+ D    
Sbjct: 65  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSL-DSFLR 119

Query: 197 RFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR 256
           +          + + +  A G+ YL    D   + RD  + NIL++     K+SDFGL+R
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 257 LGPSDGLSHVSTAVVG---TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR 312
               D      T+ +G    I + APE IQ  + T  SD+WS+G+ ++E+++ G RP   
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK 372
               + Q ++  +              D +L     +     L  +   C  +    RPK
Sbjct: 237 ---MTNQDVINAIEQ------------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPK 279

Query: 373 MSEVVEVLNKIV 384
             ++V  L+K++
Sbjct: 280 FGQIVNTLDKMI 291

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 8e-65
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 35/286 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG G FG V+ G   + +       +A+K + R G    ++++ E  V+  + HP LV+L
Sbjct: 13  IGSGQFGLVHLGYWLNKDK------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
            G C E         L++E+M +  + D+L ++        T L +  D   G+AYL E 
Sbjct: 66  YGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEA 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
               +I RD  + N L+ E    K+SDFG+ R    D     ST     + +A+PE    
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSF 176

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLE 344
            R + KSD+WSFGV ++E+ +  +    NR  SE  ++E +            +  P+L 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRL- 226

Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETG 390
                  +  +  + N C   + + RP  S ++  L +I   AE+G
Sbjct: 227 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI---AESG 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 2e-64
 Identities = 68/298 (22%), Positives = 132/298 (44%), Gaps = 35/298 (11%)

Query: 91  ELKTATKNFS-RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVT 148
           +L     N     + +G G FG V +GV R  +   K+ID+A+K L +   +   +E + 
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMR 58

Query: 149 EVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRL 208
           E  ++  +++P +V+LIG C     +    +L+ E      +   L  + +  +P +   
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVA 112

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVS 267
           ++    + G+ YL    +   + RD  + N+LL  +  AK+SDFGL++ LG  D      
Sbjct: 113 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPL-DRNRPKSEQKLLEWV 325
           +A    + + APE I   + + +SD+WS+GV ++E ++ G++P      P+    + +  
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
           R                       +   +L A+ + C   + + RP    V + +   
Sbjct: 230 RMECPP------------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 3e-64
 Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 30/299 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V+RG  R  E       +AVK  S R  +       E+    ++ H N++  
Sbjct: 11  IGKGRFGEVWRGKWRGEE-------VAVKIFSSREERSWFREA-EIYQTVMLRHENILGF 62

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           I    +D+    Q  L+ +Y  + S+ D+L      T+     +K+A   A GLA+LH  
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHME 119

Query: 225 MDFQ-----IIFRDFKSSNILLDEQWNAKLSDFGLARL--GPSDGLSHVSTAVVGTIGYA 277
           +        I  RD KS NIL+ +     ++D GLA      +D +       VGT  Y 
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 278 APEYIQT------GRLTYKSDIWSFGVFLYELITGRRPL----DRNRPKSEQKLLEWVRP 327
           APE +             ++DI++ G+  +E+           D   P  +    +    
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 328 HLTDAKKFTMILDPKLEGKY-SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD 385
            +         L P +  ++ S +  + +A +  +C       R     + + L+++  
Sbjct: 240 EMRKVVCEQ-KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 7e-64
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 30/289 (10%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVV 156
           +F+   +IG G FG VY G +   ++  KKI  AVK L+R    G   +++TE  ++   
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLL--DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            HPN++ L+G C   +      L++  YM +  +++ + +           +      A+
Sbjct: 86  SHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAK 141

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLS--HVSTAVVGTI 274
           G+ +L      + + RD  + N +LDE++  K++DFGLAR          H  T     +
Sbjct: 142 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            + A E +QT + T KSD+WSFGV L+EL+T   P     P  +    +     L   + 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR- 252

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
              +L P+            L  V  KC   +A+ RP  SE+V  ++ I
Sbjct: 253 ---LLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 9e-64
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 40/281 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IG+G FG V  G  R  +       +AVK +        + ++ E +V+  + H NLV+L
Sbjct: 15  IGKGEFGDVMLGDYRGNK-------VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G   E+        ++ EYM   S+ D+L SR ++ L  +  LK + D    + YL   
Sbjct: 66  LGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG- 121

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                + RD  + N+L+ E   AK+SDFGL +   S             + + APE ++ 
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE 174

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEWVRPHLTDAKKFTMILDPK 342
            + + KSD+WSFG+ L+E+ +  R      P  +   ++ +  +    D           
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD----------- 223

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                       +  V   C    A  RP   ++ E L  I
Sbjct: 224 -------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 5e-63
 Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 36/289 (12%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVV 156
           K+ +    +G G FG V  G  R   D      +A+K + + G     E++ E  V+  +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMI-KEGSMSEDEFIEEAKVMMNL 56

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            H  LV+L G C +         +I EYM N  + ++L    +        L++ +D   
Sbjct: 57  SHEKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCE 111

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGY 276
            + YL      Q + RD  + N L+++Q   K+SDFGL+R    D     S      + +
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRW 167

Query: 277 AAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEWVRPHLTDAKK 334
           + PE +   + + KSDIW+FGV ++E+ +  +        SE  + + + +R +      
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------ 221

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                 P L        ++K+  +   C   +A  RP    ++  +  +
Sbjct: 222 -----RPHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 7e-63
 Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 45/301 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLG-VVEHPNL 161
           ++G G FG V          +   I +AVK L  +     +E  ++E+ ++  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQ---------------------A 200
           V L+G C           LI+EY     + ++L S+ +                      
Sbjct: 104 VNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159

Query: 201 TLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS 260
            L +   L  A   A+G+ +L        + RD  + N+L+      K+ DFGLAR   S
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

Query: 261 DGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK 320
           D    V       + + APE +  G  T KSD+WS+G+ L+E+ +         P     
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN- 275

Query: 321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVL 380
                         F  ++    +        +++  +   C A  ++ RP    +   L
Sbjct: 276 --------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 381 N 381
            
Sbjct: 322 G 322

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 7e-63
 Identities = 65/294 (22%), Positives = 138/294 (46%), Gaps = 27/294 (9%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHK-EWVTEVNVLGVV 156
             +R  +IG G FG VY+G+++++    K++ +A+K L     +  + +++ E  ++G  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 157 EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAAR 216
            H N+++L G  ++        ++I EYM N ++   L  +          + + +  A 
Sbjct: 67  SHHNIIRLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAA 121

Query: 217 GLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG-LSHVSTAVVGTIG 275
           G+ YL        + RD  + NIL++     K+SDFGL+R+   D   ++ ++     I 
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           + APE I   + T  SD+WSFG+ ++E++T           S  ++++ +          
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAI---------- 226

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAET 389
               +        +     +  +  +C  ++   RPK +++V +L+K++ A ++
Sbjct: 227 ----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-62
 Identities = 54/277 (19%), Positives = 109/277 (39%), Gaps = 31/277 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G F  VY+G+   T      +++A  +L  R L     + +  E  +L  ++HPN+V
Sbjct: 17  IGRGSFKTVYKGLDTET-----TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +         +     +L+ E M + +++ +L       +         +   +GL +LH
Sbjct: 72  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH 129

Query: 223 EGMDFQIIFRDFKSSNILL-DEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
                 II RD K  NI +     + K+ D GLA L      +  + AV+GT  + APE 
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM 184

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
            +  +     D+++FG+ + E+ T   P    +  ++                +  +   
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSG 228

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                +      ++  +   C+ +    R  + +++ 
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 5e-62
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 34/295 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG V+ G    T        +A+K L + G    + ++ E  V+  + H  LV+L
Sbjct: 25  LGQGCFGEVWMGTWNGTTR------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
               +E+        ++ EYM   S+ D L       L     + +A   A G+AY+   
Sbjct: 78  YAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                + RD +++NIL+ E    K++DFGLARL   +            I + APE    
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY 188

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLE 344
           GR T KSD+WSFG+ L EL T  R          +++L+ V       + + M   P   
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVE------RGYRMPCPP--- 237

Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAETGTPQTPLKNL 399
                +  + L  +  +C  ++ + RP    +   L     + E      P +NL
Sbjct: 238 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE--PQYQPGENL 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 5e-62
 Identities = 68/298 (22%), Positives = 111/298 (37%), Gaps = 40/298 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLG-VVEHPNLV 162
           +G G FG V          S   + +AVK L        +E + +E+ VL  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR----------------FQATLPWNT 206
            L+G C          L+I EY     + + L  +                 +  L    
Sbjct: 91  NLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            L  +   A+G+A+L        I RD  + NILL      K+ DFGLAR   +D    V
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR 326
                  + + APE I     T++SD+WS+G+FL+EL +         P   +       
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------- 256

Query: 327 PHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
                   F  ++              ++  +   C       RP   ++V+++ K +
Sbjct: 257 --------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 9e-62
 Identities = 70/318 (22%), Positives = 114/318 (35%), Gaps = 46/318 (14%)

Query: 89  FSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWV 147
              L+    N      IGEG FG V++              +AVK L          ++ 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 148 TEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR---------- 197
            E  ++   ++PN+VKL+G CA          L++EYM    + + L S           
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 198 ------------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW 245
                           L    +L IA+  A G+AYL E    + + RD  + N L+ E  
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT 305
             K++DFGL+R   S             I +  PE I   R T +SD+W++GV L+E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 306 GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLAR 365
                       E                   + D  +          +L  +   C ++
Sbjct: 238 YGLQPYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281

Query: 366 QAKGRPKMSEVVEVLNKI 383
               RP    +  +L ++
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 1e-61
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 46/315 (14%)

Query: 91  ELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTE 149
           ELK    +F +   +G G  G V++   + +      + +A K +          + + E
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQIIRE 54

Query: 150 VNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
           + VL     P +V   G    D E      +  E+M   S+   L       +P     K
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKA--GRIPEQILGK 108

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
           ++    +GL YL E     I+ RD K SNIL++ +   KL DFG++          ++ +
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV---- 325
            VGT  Y +PE +Q    + +SDIWS G+ L E+  GR P+     K  + +        
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

Query: 326 ----------------------RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCL 363
                                 RP +   +    I++       S   + +     NKCL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282

Query: 364 ARQAKGRPKMSEVVE 378
            +    R  + +++ 
Sbjct: 283 IKNPAERADLKQLMV 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 36/284 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLV 162
           +G G FG V +G  +  +       +AVK L           E + E NV+  +++P +V
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKT---VAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           ++IG C  +       +L+ E      +  +L       +     +++    + G+ YL 
Sbjct: 72  RMIGICEAES-----WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE 124

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSD-GLSHVSTAVVGTIGYAAPEY 281
              +   + RD  + N+LL  Q  AK+SDFGL++   +D       T     + + APE 
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 282 IQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS-EQKLLEWVRPHLTDAKKFTMIL 339
           I   + + KSD+WSFGV ++E  + G++P    +       L +  R             
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-------- 233

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                        +++  + N C     + RP  + V   L   
Sbjct: 234 ----------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (498), Expect = 3e-60
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 30/279 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G +G VY GV +        + +AVK L    ++  +E++ E  V+  ++HPNLV+L
Sbjct: 25  LGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +G C  +    I      E+M   ++ D+L    +  +     L +A   +  + YL + 
Sbjct: 79  LGVCTREPPFYII----TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 133

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
                I RD  + N L+ E    K++DFGL+RL   D            I + APE +  
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY 190

Query: 285 GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLE 344
            + + KSD+W+FGV L+E+ T                         D  +   +L+    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKDYR 234

Query: 345 GKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +      +K+  +   C       RP  +E+ +    +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-60
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 30/291 (10%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVL 153
           K+      +G+G FG V RG   +   S K + +AVK L    L   +   +++ EVN +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
             ++H NL++L G       +     ++ E  P  S+ D L    Q      T  + A  
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQ 119

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV-STAVVG 272
            A G+ YL      + I RD  + N+LL  +   K+ DFGL R  P +   +V       
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA 332
              + APE ++T   ++ SD W FGV L+E+ T  +        S+              
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------------- 223

Query: 333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                I              Q +  V  +C A + + RP    + + L + 
Sbjct: 224 --LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 6e-60
 Identities = 79/343 (23%), Positives = 142/343 (41%), Gaps = 42/343 (12%)

Query: 84  LRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQG 142
           LR+   +E       F +  ++G G FG VY+G+         KI +A+K+L      + 
Sbjct: 3   LRILKETE-------FKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKA 54

Query: 143 HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATL 202
           +KE + E  V+  V++P++ +L+G C     +     LI + MP   + D++        
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNI- 108

Query: 203 PWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDG 262
                L      A+G+ YL    D +++ RD  + N+L+    + K++DFGLA+L  ++ 
Sbjct: 109 GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

Query: 263 LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL 322
             + +      I + A E I     T++SD+WS+GV ++EL+T         P SE    
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---- 221

Query: 323 EWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK 382
                        + IL+              +  +  KC    A  RPK  E++   +K
Sbjct: 222 ------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

Query: 383 IVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIRGEK 425
           +         + P + L ++ D            F   +  E+
Sbjct: 270 MA--------RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 304

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 32/280 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G +G   +   +S         +  K+L    +     +  V+EVN+L  ++HPN+V
Sbjct: 12  IGTGSYGRCQKIRRKSD-----GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLT--SRFQATLPWNTRLKIAQDAARGLAY 220
           +      +     +   ++ EY     +   +T  ++ +  L     L++       L  
Sbjct: 67  RYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 221 LHEGMD--FQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            H   D    ++ RD K +N+ LD + N KL DFGLAR+   D  +  + A VGT  Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMS 182

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI 338
           PE +       KSDIWS G  LYEL     P                    +  +    I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----------------TAFSQKELAGKI 226

Query: 339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            + K   +   + + +L  +  + L  +   RP + E++E
Sbjct: 227 REGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-58
 Identities = 74/315 (23%), Positives = 132/315 (41%), Gaps = 49/315 (15%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLG-VVEHPNL 161
           +IGEG FG V +  I+       ++D A+K++        H+++  E+ VL  +  HPN+
Sbjct: 17  VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTR 207
           + L+G C           L  EY P+ ++ D L                   +TL     
Sbjct: 74  INLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           L  A D ARG+ YL +    Q I RD  + NIL+ E + AK++DFGL+R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKK 183

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRP--LDRNRPKSEQKLLEWV 325
           T     + + A E +     T  SD+WS+GV L+E+++            +  +KL +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD 385
           R                   +  +    ++  +  +C   +   RP  ++++  LN++++
Sbjct: 244 RL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 386 AAETGTPQTPLKNLS 400
             +T    T  +  +
Sbjct: 286 ERKTYVNTTLYEKFT 300

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-58
 Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 31/284 (10%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLS-RRGLQGHKEWVTEVNVLGV 155
           +++     +GEG +G V   V R TE+      +AVK +  +R +   +    E+ +  +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEE-----AVAVKIVDMKRAVDCPENIKKEICINKM 59

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + H N+VK  G+  E + +     L  EY     + D +       +P     +      
Sbjct: 60  LNHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLM 113

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
            G+ YLH      I  RD K  N+LLDE+ N K+SDFGLA +   +    +   + GT+ 
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

Query: 276 YAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
           Y APE ++         D+WS G+ L  ++ G  P D+     ++               
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------- 215

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
           ++   + K       K+     A+ +K L      R  + ++ +
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-57
 Identities = 60/280 (21%), Positives = 116/280 (41%), Gaps = 37/280 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G+G FG VY+   + T      +  A K +  +  +  ++++ E+++L   +HPN+VKL
Sbjct: 20  LGDGAFGKVYKAQNKET-----SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           +     ++       ++ E+    +V   +    +  L  +    + +     L YLH+ 
Sbjct: 75  LDAFYYENNL----WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD- 128

Query: 225 MDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT 284
              +II RD K+ NIL     + KL+DFG++             + +GT  + APE +  
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMC 184

Query: 285 -----GRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEWVRPHLTDAKKFTMI 338
                    YK+D+WS G+ L E+     P  + N  +   K+ +   P L    +++  
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS-- 242

Query: 339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                                 KCL +    R   S++++
Sbjct: 243 --------------SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-57
 Identities = 69/298 (23%), Positives = 117/298 (39%), Gaps = 37/298 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLG-VVEHPNLV 162
           +G G FG V        + +     +AVK L        H+  ++E+ +L  +  H N+V
Sbjct: 21  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRL 208
            L+G C +        ++I E+    ++  +L S+              ++  L     +
Sbjct: 81  NLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 209 KIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVST 268
             +   A+G+ +L      + I RD  + NILL E+   K+ DFGLAR    D       
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 269 AVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPH 328
                + + APE I     T +SD+WSFGV L+E+ +         P    K+ E     
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRR 249

Query: 329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA 386
           L +  +           +       ++      C   +   RP  SE+VE L  ++ A
Sbjct: 250 LKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-57
 Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 39/277 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNL 161
           +G+G FG VY    + +     K  +A+K L +  L       +   EV +   + HPN+
Sbjct: 14  LGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 162 VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
           ++L GY  +     +    I EY P  +V   L  +  +            + A  L+Y 
Sbjct: 69  LRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYC 122

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H     ++I RD K  N+LL      K++DFG +   PS   + +     GT+ Y  PE 
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEM 175

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDP 341
           I+      K D+WS GV  YE + G+ P + N  +   K +  V     D          
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------- 225

Query: 342 KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                    + +    + ++ L      RP + EV+E
Sbjct: 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 6e-57
 Identities = 77/327 (23%), Positives = 122/327 (37%), Gaps = 45/327 (13%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNV 152
            K FS    IG G FG VY               +A+K++S  G Q +++W   + EV  
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 153 LGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQ 212
           L  + HPN ++  G    +        L+ EY    +       +    L       +  
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTH 122

Query: 213 DAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
            A +GLAYLH      +I RD K+ NILL E    KL DFG A +         + + VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173

Query: 273 TIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL 329
           T  + APE I     G+   K D+WS G+   EL   + PL                 ++
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL----------------FNM 217

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE---VLNKIVDA 386
                   I   +     S   ++      + CL +  + RP    +++   VL +    
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

Query: 387 AETGTPQTPLKNLSLKDDFETSKKERL 413
                 Q     +   D+ +  K +++
Sbjct: 278 VIMDLIQRTKDAVRELDNLQYRKMKKI 304

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 8e-56
 Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 33/285 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE-WVTEVNVLGVVEHPNLV 162
            IGEG FG V++G+  S E+    +  A+K          +E ++ E   +   +HP++V
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAV--AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KLIG   E+        +I E      ++  L  R   +L   + +  A   +  LAYL 
Sbjct: 72  KLIGVITEN-----PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE 125

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                + + RD  + N+L+      KL DFGL+R        + ++     I + APE I
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESI 181

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEWVRPHLTDAKKFTMILD 340
              R T  SD+W FGV ++E++       +    ++   ++    R  +           
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP--------- 232

Query: 341 PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD 385
                         L ++  KC A     RP+ +E+   L+ I++
Sbjct: 233 ---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-54
 Identities = 62/298 (20%), Positives = 125/298 (41%), Gaps = 32/298 (10%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGV 155
           +  + S  +G+G FG VY GV +       +  +A+K ++    ++   E++ E +V+  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSR--------FQATLPWNTR 207
               ++V+L+G  ++        L+I E M    ++ +L S           A    +  
Sbjct: 80  FNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 208 LKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS 267
           +++A + A G+AYL+     + + RD  + N ++ E +  K+ DFG+ R           
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 268 TAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP 327
              +  + + +PE ++ G  T  SD+WSFGV L+E+ T                      
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------Q 237

Query: 328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD 385
            L++ +    +++  L  K        L  +   C     K RP   E++  + + ++
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 2e-54
 Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 32/283 (11%)

Query: 96  TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV 155
            K ++R   IG+G  G VY  +  +T       ++A++Q++ +     +  + E+ V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
            ++PN+V  +      DE      ++ EY+   S+ D +T              + ++  
Sbjct: 74  NKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECL 126

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           + L +LH     Q+I RD KS NILL    + KL+DFG       +      + +VGT  
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPY 181

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           + APE +       K DIWS G+   E+I G  P     P     L              
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------------- 227

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            +  +   E +   KL+       N+CL    + R    E+++
Sbjct: 228 -IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  176 bits (447), Expect = 7e-53
 Identities = 64/285 (22%), Positives = 118/285 (41%), Gaps = 29/285 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG---HKEWVTEVNVLGVVEHPN 160
           ++G GG   V+              D+AVK L     +    +  +  E      + HP 
Sbjct: 14  ILGFGGMSEVHLARDLRL-----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
           +V +      +   G    ++ EY+   +++D +    +  +     +++  DA + L +
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAAP 279
            H+     II RD K +NI++      K+ DFG+AR +  S      + AV+GT  Y +P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
           E  +   +  +SD++S G  LYE++TG  P   + P      +     H+ +        
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSAR 237

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-MSEVVEVLNKI 383
                      L+  L AV  K LA+  + R +  +E+   L ++
Sbjct: 238 HE--------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 8e-52
 Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 45/300 (15%)

Query: 105 IGEGGFGGVYRGVIRST--EDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLG-VVEHPN 160
           +GEG FG V          +  ++   +AVK L     +    + ++E+ ++  + +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHL--------------TSRFQATLPWNT 206
           ++ L+G C +D        +I EY    +++++L              +   +  L    
Sbjct: 81  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 207 RLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHV 266
            +  A   ARG+ YL      + I RD  + N+L+ E    K++DFGLAR          
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 267 STAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE--QKLLEW 324
           +T     + + APE +     T++SD+WSFGV L+E+ T         P  E  + L E 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253

Query: 325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV 384
            R                           +L  +   C       RP   ++VE L++IV
Sbjct: 254 HRMDKPS------------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 9e-52
 Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 35/287 (12%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTE 149
           K   ++F    ++GEG F  V      +T       + A+K L +R +           E
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELAT-----SREYAIKILEKRHIIKENKVPYVTRE 58

Query: 150 VNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
            +V+  ++HP  VKL     +D++          Y  N  +  ++      +        
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRK--IGSFDETCTRF 112

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
              +    L YLH      II RD K  NILL+E  + +++DFG A++   +     + +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL 329
            VGT  Y +PE +        SD+W+ G  +Y+L+ G  P    R  +E  + + +    
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKII--- 223

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
                       KLE  +  K   K   +  K L   A  R    E+
Sbjct: 224 ------------KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (434), Expect = 5e-50
 Identities = 61/276 (22%), Positives = 110/276 (39%), Gaps = 32/276 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+R   R+T       + A K +        +    E+  + V+ HP LV L
Sbjct: 34  LGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                +D+E     ++IYE+M    + + +       +  +  ++  +   +GL ++HE 
Sbjct: 89  HDAFEDDNEM----VMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 225 MDFQIIFRDFKSSNILLDEQWN--AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                +  D K  NI+   + +   KL DFGL           V     GT  +AAPE  
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVA 197

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
           +   + Y +D+WS GV  Y L++G  P      +++ + L  V+             D  
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKS-----------CDWN 243

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
           ++      +++       K L      R  + + +E
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (421), Expect = 3e-48
 Identities = 56/276 (20%), Positives = 111/276 (40%), Gaps = 32/276 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+R V ++T           K ++            E++++  + HP L+ L
Sbjct: 37  LGSGAFGVVHRCVEKATGR-----VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                +  E     +LI E++    + D + +     +     +   + A  GL ++HE 
Sbjct: 92  HDAFEDKYEM----VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 225 MDFQIIFRDFKSSNILLDEQWNA--KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
               I+  D K  NI+ + +  +  K+ DFGLA     D +  V      T  +AAPE +
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIV 200

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
               + + +D+W+ GV  Y L++G  P      + + + L+ V              D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNV-----------KRCDWE 246

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            +      ++ +        L ++ + R  + + +E
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-47
 Identities = 67/337 (19%), Positives = 124/337 (36%), Gaps = 32/337 (9%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGH-KEWVTEVNVLGVVEHPNLV 162
            IGEG +G V             K+ +A+K++S    Q + +  + E+ +L    H N++
Sbjct: 15  YIGEGAYGMVCSAYDNVN-----KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            +           ++ + +  ++    +   L ++    L  +          RGL Y+H
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH 126

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSH-VSTAVVGTIGYAAPEY 281
                 ++ RD K SN+LL+   + K+ DFGLAR+   D       T  V T  Y APE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 282 IQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILD 340
           +   +  T   DIWS G  L E+++ R          +   +  +    +      +I  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 341 PKLEGKYSI-------------KLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVD 385
                  S+                 K   + +K L      R ++ + +    L +  D
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303

Query: 386 AAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPIR 422
            ++    + P K      + +   KE+LK    +   
Sbjct: 304 PSDEPIAEAPFK---FDMELDDLPKEKLKELIFEETA 337

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 7e-47
 Identities = 53/276 (19%), Positives = 104/276 (37%), Gaps = 29/276 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-TEVNVLGVVEHPNLV 162
           ++G G F  V     + T     +  +A+K ++++ L+G +  +  E+ VL  ++HPN+V
Sbjct: 16  VLGTGAFSEVILAEDKRT-----QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
            L               LI + +    + D +  +           ++       + YLH
Sbjct: 71  ALDDIYESGGHL----YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH 124

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           +        +        LDE     +SDFGL+++        V +   GT GY APE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVL 181

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
                +   D WS GV  Y L+ G  P      +++ KL E +           +  + +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQI-----------LKAEYE 227

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            +  Y   ++          + +  + R    + ++
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 3e-46
 Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 26/289 (8%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNV---LGVVEHP 159
           IGEG +G V++              +A+K++  +  +       + EV V   L   EHP
Sbjct: 15  IGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
           N+V+L   C         +L +     ++ +  +L    +  +P  T   +     RGL 
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +LH     +++ RD K  NIL+      KL+DFGLAR+          T+VV T+ Y AP
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAP 184

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL----------EWVRPHL 329
           E +         D+WS G    E+   +     +    +   +          +W R   
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
              + F       +E K+   + +    +  KCL      R      + 
Sbjct: 245 LPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 1e-44
 Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 47/291 (16%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---------QGHKEWVTEVNVLG 154
           ++G G    V R + + T       + AVK +   G          +  +  + EV++L 
Sbjct: 10  ILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 155 VV-EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
            V  HPN+++L        E      L+++ M    + D+LT +   TL      KI + 
Sbjct: 65  KVSGHPNIIQLKDTY----ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRA 118

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
               +  LH+     I+ RD K  NILLD+  N KL+DFG +              V GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGT 172

Query: 274 IGYAAPEYIQTGRL------TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP 327
             Y APE I+            + D+WS GV +Y L+ G  P      + +  +L  +  
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMS 229

Query: 328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                       + +         +  +  + ++ L  Q + R    E + 
Sbjct: 230 G-----------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 41/289 (14%), Positives = 88/289 (30%), Gaps = 35/289 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           IGEG FG ++ G             +A+K   RR      +   E     ++     +  
Sbjct: 13  IGEGSFGVIFEGTNLLN-----NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
           + Y  ++    +   L+ + +      + L           T    A+     +  +HE 
Sbjct: 66  VYYFGQEGLHNV---LVIDLLGPS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 225 MDFQIIFRDFKSSNILLDEQWN-----AKLSDFGLARLGPSDGLS-----HVSTAVVGTI 274
               +++RD K  N L+    +       + DFG+ +                  + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            Y +         + + D+ + G      + G  P    +  + ++  E +       KK
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-----KK 232

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
            +  L     G       ++     +          P    +  + +K+
Sbjct: 233 QSTPLRELCAG-----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-44
 Identities = 53/276 (19%), Positives = 110/276 (39%), Gaps = 33/276 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKL 164
           +G G FG V+R V  S+     K     K +  +G         E+++L +  H N++ L
Sbjct: 13  LGRGEFGIVHRCVETSS-----KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66

Query: 165 IGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG 224
                  +E     ++I+E++    + + + +     L     +         L +LH  
Sbjct: 67  HESFESMEEL----VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS- 120

Query: 225 MDFQIIFRDFKSSNILLDEQWNA--KLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
               I   D +  NI+   + ++  K+ +FG AR             +     Y APE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH 175

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMILDPK 342
           Q   ++  +D+WS G  +Y L++G  P      ++ Q+++E +           M  +  
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENI-----------MNAEYT 221

Query: 343 LEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
            + +   +++ +     ++ L ++ K R   SE ++
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 33/288 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVK 163
            IG G FG +Y G   +        ++A+K    +    H +   E  +  +++    + 
Sbjct: 14  KIGSGSFGDIYLGTDIAA-----GEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
            I +C  + +     +++ E +      + L +         T L +A      + Y+H 
Sbjct: 67  TIRWCGAEGDY---NVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 224 GMDFQIIFRDFKSSNIL---LDEQWNAKLSDFGLARLGPSDGLS-----HVSTAVVGTIG 275
                 I RD K  N L     +     + DFGLA+               +  + GT  
Sbjct: 122 K---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
           YA+         + + D+ S G  L     G  P    +  ++++  E +       +K 
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------EKK 232

Query: 336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI 383
                  L   Y      + A   N C + +   +P  S + ++   +
Sbjct: 233 MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-44
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 40/282 (14%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLG-VVEHP 159
           M+G+G FG V+    + T         A+K L +  +    +    + E  VL    EHP
Sbjct: 9   MLGKGSFGKVFLAEFKKT-----NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            L  +       +          EY+    +  H+ S  +     +     A +   GL 
Sbjct: 64  FLTHMFCTFQTKENLFFV----MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQ 117

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
           +LH      I++RD K  NILLD+  + K++DFG+ +               GT  Y AP
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
           E +   +  +  D WSFGV LYE++ G+ P      + E++L   +R             
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMD----------- 218

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLN 381
           +P           ++   +  K   R+ + R  +    ++  
Sbjct: 219 NPFYPRWLE----KEAKDLLVKLFVREPEKRLGVRG--DIRQ 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 75/330 (22%), Positives = 124/330 (37%), Gaps = 52/330 (15%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLG 154
           +FS   +IG GGFG VY      T         A+K L ++ +   QG    + E  +L 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADT-----GKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 155 VV---EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIA 211
           +V   + P +V +       D+       I + M    +  HL+               A
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVF--SEADMRFYA 113

Query: 212 QDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVV 271
            +   GL ++H      +++RD K +NILLDE  + ++SD GLA               V
Sbjct: 114 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166

Query: 272 GTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT 330
           GT GY APE +Q G      +D +S G  L++L+ G  P  +++ K + ++         
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 224

Query: 331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVV--EVLN------- 381
                      +L   +S     +L ++    L R    R         EV         
Sbjct: 225 ---------AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

Query: 382 --KIVDAAETGTPQTP-LKNLSLKDDFETS 408
             ++V   +   P  P    ++  D F+  
Sbjct: 272 DWQMVFLQKYPPPLIPPRGEVNAADAFDIG 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-43
 Identities = 59/291 (20%), Positives = 104/291 (35%), Gaps = 32/291 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV-----TEVNVLGVVEH 158
            +GEG F  VY+   ++T        +A+K++        K+ +      E+ +L  + H
Sbjct: 5   FLGEGQFATVYKARDKNT-----NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           PN++ L+              L++++M          +     L  +          +GL
Sbjct: 60  PNIIGLLDAFGHKSNI----SLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGL 113

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA 278
            YLH+     I+ RD K +N+LLDE    KL+DFGLA+   S   ++  T  V T  Y A
Sbjct: 114 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168

Query: 279 PEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL----------EWVRP 327
           PE +   R+     D+W+ G  L EL+     L  +    +   +          +W   
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228

Query: 328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                                      L  +           R   ++ ++
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 51/279 (18%), Positives = 97/279 (34%), Gaps = 30/279 (10%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLV 162
           ++G G  G V +   + T     +   A+K L         +   EV +     + P++V
Sbjct: 19  VLGLGINGKVLQIFNKRT-----QEKFALKMLQDC-----PKARREVELHWRASQCPHIV 68

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +++             L++ E +    +   +  R           +I +     + YLH
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 223 EGMDFQIIFRDFKSSNILLDEQWN---AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
                 I  RD K  N+L   +      KL+DFG A+   S            T  Y AP
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 182

Query: 280 EYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMIL 339
           E +   +     D+WS GV +Y L+ G  P   N   +    +          K    + 
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KTRIRMG 232

Query: 340 DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
             +       ++++++  +    L  +   R  ++E + 
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 62/257 (24%), Positives = 103/257 (40%), Gaps = 30/257 (11%)

Query: 97  KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE---WVTEVNVL 153
           ++F     +G G FG V+    R           A+K L +  +   K+      E  +L
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHN-----GRYYAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 154 GVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
            +V HP ++++ G   +      Q  +I +Y+    +   L    +   P       A +
Sbjct: 59  SIVTHPFIIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAE 112

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGT 273
               L YLH      II+RD K  NILLD+  + K++DFG A+      +  V+  + GT
Sbjct: 113 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGT 164

Query: 274 IGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRP--------KSEQKLLEWV 325
             Y APE + T       D WSFG+ +YE++ G  P   +           +E +   + 
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224

Query: 326 RPHLTDAKKFTMILDPK 342
              + D     +  D  
Sbjct: 225 NEDVKDLLSRLITRDLS 241

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-42
 Identities = 73/370 (19%), Positives = 124/370 (33%), Gaps = 41/370 (11%)

Query: 68  SSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKK 127
           S      A   Q     +  ++++ K          +IG G FG VY+  +  +      
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDS-----G 45

Query: 128 IDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG--IQRLLIYEYM 185
             +A+K++    LQ  +    E+ ++  ++H N+V+L  +     E+   +   L+ +Y+
Sbjct: 46  ELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101

Query: 186 PNRSVQDHLT-SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-E 243
           P    +     SR + TLP            R LAY+H      I  RD K  N+LLD +
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPD 158

Query: 244 QWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYEL 303
               KL DFG A+           + +      A          T   D+WS G  L EL
Sbjct: 159 TAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

Query: 304 ITGRRPLDRNRPKSEQKLLEWVRPHLTDA-----------KKFTMILDPKLEGKYSIKLA 352
           + G+     +    +   +  V    T              KF  I        +  +  
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 276

Query: 353 QKLAAVANKCLARQAKGRPKMSEVVE--VLNKIVDAAETGTPQTPLKNLSLKDDFETSKK 410
            +  A+ ++ L      R    E       +++ D             L      E S  
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336

Query: 411 ERLKRRFVDP 420
             L    + P
Sbjct: 337 PPLATILIPP 346

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-42
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 41/284 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVT------EVNVLGVVEH 158
           +G G F  V +   +ST      +  A K + +R  +  +  V+      EV++L  ++H
Sbjct: 18  LGSGQFAVVKKCREKST-----GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 159 PNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
           PN++ L        +     +LI E +    + D L  +   +L      +  +    G+
Sbjct: 73  PNVITLHEVYENKTDV----ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGV 126

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQW----NAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
            YLH     QI   D K  NI+L ++       K+ DFGLA         +    + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 180

Query: 275 GYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK 334
            + APE +    L  ++D+WS GV  Y L++G  P   +     Q+ L  V         
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANV--------- 228

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
               ++ + E +Y    +        + L +  K R  + + ++
Sbjct: 229 --SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 55/294 (18%), Positives = 106/294 (36%), Gaps = 27/294 (9%)

Query: 98  NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGV 155
           NF +   IGEG +G VY+   + T        +A+K++             + E+++L  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-----GEVVALKKIRLDTETEGVPSTAIREISLLKE 57

Query: 156 VEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
           + HPN+VKL+     ++     +L +     ++ ++  + +     +P            
Sbjct: 58  LNHPNIVKLLDVIHTEN-----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIG 275
           +GLA+ H      ++ RD K  N+L++ +   KL+DFGLAR          +  VV    
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWY 168

Query: 276 YAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF 335
            A    +     +   DIWS G    E++T R     +    +   +        +    
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228

Query: 336 TMILDPKLEGKYSIKLAQKLAAVA-----------NKCLARQAKGRPKMSEVVE 378
            +   P  +  +     Q  + V            ++ L      R      + 
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 5e-40
 Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 51/285 (17%)

Query: 104 MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKE------WVTEVNVLGVV- 156
           ++G GGFG VY G+  S       + +A+K + +  +    E         EV +L  V 
Sbjct: 11  LLGSGGFGSVYSGIRVSD-----NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 157 -EHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAA 215
                +++L+ +    D      +LI E            +  +  L             
Sbjct: 66  SGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVL 120

Query: 216 RGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTI 274
             + + H      ++ RD K  NIL+D  +   KL DFG   L        V T   GT 
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTR 173

Query: 275 GYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK 333
            Y+ PE+I+  R     + +WS G+ LY+++ G  P + +      ++    R  ++   
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--FRQRVSSE- 230

Query: 334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
                                   +   CLA +   RP   E+  
Sbjct: 231 ---------------------CQHLIRWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 8e-40
 Identities = 59/297 (19%), Positives = 114/297 (38%), Gaps = 33/297 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG--HKEWVTEVNVLGVVEHPNLV 162
           IG+G FG V++   R T        +A+K++     +       + E+ +L +++H N+V
Sbjct: 18  IGQGTFGEVFKARHRKT-----GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 163 KLIGYCAEDDERGIQR----LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGL 218
            LI  C        +      L++++  +           +     +   ++ Q    GL
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGL 130

Query: 219 AYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVS--TAVVGTIGY 276
            Y+H     +I+ RD K++N+L+      KL+DFGLAR       S  +  T  V T+ Y
Sbjct: 131 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 277 AAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL--------EWVRP 327
             PE +   R      D+W  G  + E+ T    +  N  + +  L+          V P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVA------NKCLARQAKGRPKMSEVVE 378
           ++ + + +  +   K + +      +            +K L      R    + + 
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 55/287 (19%), Positives = 108/287 (37%), Gaps = 29/287 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQL--SRRGLQGHKEWVTEVNVLGVVEHPNLV 162
           IGEG +G VY+      E        A+K++   +         + E+++L  ++H N+V
Sbjct: 10  IGEGTYGVVYKAQNNYGET------FALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           KL              +L++E++     +          L   T          G+AY H
Sbjct: 64  KLYDVIHTKKRL----VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH 117

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
           +    +++ RD K  N+L++ +   K++DFGLAR          +  +V     A    +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLM 173

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV--------RPHLTDAKK 334
            + + +   DIWS G    E++ G           +   +  +         P++T+  K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 335 FTM---ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
           +     + +P     +   L +    + +K L      R    + +E
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-37
 Identities = 75/326 (23%), Positives = 120/326 (36%), Gaps = 38/326 (11%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V   V   T        +A+K+L R        K    E+ +L  + H N++
Sbjct: 26  VGSGAYGAVCSAVDGRT-----GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 163 KLIGYCAEDDERGIQR--LLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
            L+     D+         L+  +M      D         L  +    +     +GL Y
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           +H      II RD K  N+ ++E    K+ DFGLAR   S     ++  VV     A   
Sbjct: 137 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEV 189

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL---------EWVRPHLTD 331
            +   R T   DIWS G  + E+ITG+     +    + K +         E+V+   +D
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 332 AKKFTMILDPKLEGKYSIKLAQKLAAVA----NKCLARQAKGRPKMSEVVE--VLNKIVD 385
             K  M   P+LE K    +    + +A     K L   A+ R    E +       + D
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 386 AAETGTPQTPLKNLSLKDDFETSKKE 411
             +    Q    +    DD + +  E
Sbjct: 310 TEDEPQVQKYDDSF---DDVDRTLDE 332

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 67/284 (23%), Positives = 105/284 (36%), Gaps = 37/284 (13%)

Query: 93  KTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEW---VTE 149
           K    +F    ++G+G FG V     ++T         A+K L +  +    E    VTE
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKAT-----GRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 150 VNVLGVVEHPNLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLK 209
             VL    HP L  L       D          EY     +  HL+              
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHLSRERV--FTEERARF 109

Query: 210 IAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTA 269
              +    L YLH      +++RD K  N++LD+  + K++DFGL + G SDG       
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 164

Query: 270 VVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL 329
             GT  Y APE ++        D W  GV +YE++ GR P                  + 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----------------YNQ 208

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKM 373
              + F +IL  ++   +   L+ +  ++    L +  K R   
Sbjct: 209 DHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 3e-36
 Identities = 56/288 (19%), Positives = 95/288 (32%), Gaps = 29/288 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IGEG +G V++   R T        +A+K++             + E+ +L  ++H N+V
Sbjct: 10  IGEGTYGTVFKAKNRET-----HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 163 KLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH 222
           +L      D +  +    ++E+      +          L             +GL + H
Sbjct: 65  RLHDVLHSDKKLTL----VFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 223 EGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                 ++ RD K  N+L++     KL++FGLAR          S  VV           
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLF 174

Query: 283 QTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQ--KLLEWVRP----------HLT 330
                +   D+WS G    EL    RPL       +Q  ++   +             L 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE 378
           D K + M            KL      +    L      R    E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 4e-34
 Identities = 55/297 (18%), Positives = 102/297 (34%), Gaps = 44/297 (14%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLG-VVEHPNLVK 163
           +G G +  V+  +  +  +      + VK L        K+   E+ +L  +   PN++ 
Sbjct: 43  LGRGKYSEVFEAINITNNE-----KVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94

Query: 164 LIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE 223
           L     +   R     L++E++ N   +         TL          +  + L Y H 
Sbjct: 95  LADIVKDPVSRTPA--LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS 147

Query: 224 GMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYI 282
                I+ RD K  N+++D E    +L D+GLA               V +  +  PE +
Sbjct: 148 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELL 201

Query: 283 QTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-------EWVRPHLTDAKK 334
              ++  Y  D+WS G  L  +I  + P        +Q +        E +  ++     
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 335 FTMILDPKLEGKYSIKLAQKLAAVAN-------------KCLARQAKGRPKMSEVVE 378
                   + G++S K  ++     N             K L    + R    E +E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 5e-32
 Identities = 61/274 (22%), Positives = 102/274 (37%), Gaps = 22/274 (8%)

Query: 61  ASDFSSESSSRNTFAVLSQRQSNLRVFTFSELKTATKNFSRSLMIGEGGFGGVYRGVIRS 120
           A+   SE  S   F   ++     +  T S+       F R   +G G FG V     + 
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 121 TEDSHKKIDIAVKQLSRRGLQGHKEW---VTEVNVLGVVEHPNLVKLIGYCAEDDERGIQ 177
           +         A+K L ++ +   K+    + E  +L  V  P LVKL     ++    + 
Sbjct: 65  S-----GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM- 118

Query: 178 RLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSS 237
              + EY+    +  HL                A        YLH      +I+RD K  
Sbjct: 119 ---VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170

Query: 238 NILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFG 297
           N+L+D+Q   +++DFG A+          +  + GT    APE I +       D W+ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 298 VFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD 331
           V +YE+  G  P   ++P    + +   +     
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 33/274 (12%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEH-P 159
           +G G +G V+     S  D+ K    A+K L +  +    +  +   TE  VL  +   P
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLY--AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            LV L      + +  +      +Y+    +  HL+ R + T        +       + 
Sbjct: 90  FLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVL 140

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAP 279
            L       II+RD K  NILLD   +  L+DFGL++   +D  +  +    GTI Y AP
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAP 199

Query: 280 EYIQTGRLTY--KSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTM 337
           + ++ G   +    D WS GV +YEL+TG  P   +  K+ Q  +               
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------SRR 247

Query: 338 ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP 371
           IL  +    Y  +++     +  + L +  K R 
Sbjct: 248 ILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 78/347 (22%), Positives = 124/347 (35%), Gaps = 48/347 (13%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLV 162
           IG G  G V               ++A+K+LSR        K    E+ ++  V H N++
Sbjct: 25  IGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 163 KLIGYCAEDD--ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAY 220
            L+         E      L+ E M     Q                  +      G+ +
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKH 134

Query: 221 LHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPE 280
           LH      II RD K SNI++      K+ DFGLAR   + G S + T  V T  Y APE
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188

Query: 281 YIQTGRLTYKSDIWSFGVFLYELITGRRP----------------LDRNRPKSEQKLLEW 324
            I         DIWS G  + E++  +                  L    P+  +KL   
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 325 VRPHLTDAKKFTMILDPKL--------EGKYSIKLAQKLAAVANKCLARQAKGRPKMSEV 376
           VR ++ +  K+  +  PKL        + +++   A +   + +K L      R  + + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 377 VE--VLNKIVDAAETGTPQTPLKNLSLKDDFETSKKERLKRRFVDPI 421
           ++   +N   D AE   P   + +  L +   T   E  K      +
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHT--IEEWKELIYKEV 353

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 31/288 (10%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSR--RGLQGHKEWVTEVNVLGVVEHPNLV 162
           +G G +G V       T      + +AVK+LSR  + +   K    E+ +L  ++H N++
Sbjct: 26  VGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 163 KLIGYCAEDDE-RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYL 221
            L+              + +  ++    + + +  +    L  +    +     RGL Y+
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYI 137

Query: 222 HEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEY 281
           H      II RD K SN+ ++E    K+ DFGLAR    +   +V+T        A    
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIM 190

Query: 282 IQTGRLTYKSDIWSFGVFLYELITGRRPLD------------RNRPKSEQKLLEWVRPHL 329
           +         DIWS G  + EL+TGR                R       +LL+ +    
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 330 TDAKKFTMILDPKLEGKYSIKLAQKLAA-VANKCLARQAKGRPKMSEV 376
                 ++   PK+        A  LA  +  K L   +  R   ++ 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 7e-29
 Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 21/233 (9%)

Query: 105 IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNL--- 161
           +G G F  V+               +A+K +    +   +    E+ +L  V   +    
Sbjct: 21  LGWGHFSTVWLAKDMVN-----NTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKE 74

Query: 162 --------VKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQD 213
                   +KL+ +       G+  ++++E +    +        +   P     +I++ 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQ 133

Query: 214 AARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLARLGPSDGLSHVSTAVVG 272
              GL Y+H      II  D K  N+L++       L    +A LG +       T  + 
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 273 TIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV 325
           T  Y +PE +        +DIWS    ++ELITG    + +   S  K  + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 31/204 (15%), Positives = 62/204 (30%), Gaps = 24/204 (11%)

Query: 104 MIGEGGFGGVYRGVIRSTED----SHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHP 159
           ++GEG    V+        +     HK    + K++  +   G   +          E  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 160 NLVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLA 219
            L KL G               Y +  N  + + + ++    +      ++       +A
Sbjct: 67  ALQKLQGLAVPKV---------YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVA 117

Query: 220 YLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR-LGPSDGLSHVSTAVVGTIGYAA 278
             +      I+  D    N+L+ E     + DF  +  +G       +   V   I Y +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 279 PEYIQTGRLTYKSDIWSFGVFLYE 302
             Y        + DI S    + +
Sbjct: 174 RTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	441
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.99
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-57  Score=424.45  Aligned_cols=262  Identities=29%  Similarity=0.506  Sum_probs=206.5

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC--chhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG--LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.+.||+|+||+||+|+++.        .||||++....  ....+.|.+|+.+|++++|||||++++++...  
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--   76 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--   76 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--
Confidence            3679999999999999999997543        29999987543  23457889999999999999999999987543  


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||++   +||||||||+||||+.++.+||+|||
T Consensus        77 ---~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          77 ---QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             ---SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             ---EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence               248999999999999999754 45799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +|+...............||+.|||||++.+   ..|+.++|||||||++|||+||+.||...........  .+.... 
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~--~~~~~~-  226 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF--MVGRGY-  226 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHHTS-
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH--HHhcCC-
Confidence            9987654443344556789999999999864   3588999999999999999999999976544332211  111110 


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              ..+. ....+.++++.+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       227 --------~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         227 --------LSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             --------CCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                    0011 1122335667899999999999999999999999999988753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-57  Score=424.10  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=206.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||+||+|+++.++..     ||||++...... ..+.+.+|+.+|++++|||||++++++.+.+  
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-----VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCE-----EEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--
Confidence            36899999999999999999999877654     999998765432 3456889999999999999999999998766  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        77 --~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          77 --IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             --EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             --eeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence              45999999999999999965  46899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      |+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||........... ....       
T Consensus       150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~-------  221 (271)
T d1nvra_         150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKE-------  221 (271)
T ss_dssp             CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHT-------
T ss_pred             heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhc-------
Confidence            987654433334456789999999999988876 5789999999999999999999975543222111 1110       


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ..........+++.+.+|+.+||+.||++|||++++++
T Consensus       222 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         222 -------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   00011112245677889999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-56  Score=422.49  Aligned_cols=263  Identities=25%  Similarity=0.465  Sum_probs=203.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.++||+|+||+||+|.++.++..  ...||||.+..... ...++|.+|+.+|++++|||||+++|++...+.. 
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~-  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---C--CEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC-
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCE--EEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE-
Confidence            4567788999999999999998765432  23589998876443 3346799999999999999999999999876644 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         ++|||||++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||++
T Consensus       103 ---~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         103 ---MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             ---EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             ---EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence               9999999999999988753 45799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcc---eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          256 RLGPSDGLSH---VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       256 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +.........   ......||+.|||||++.++.++.++|||||||++|||+| |..||.......   +...+...   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~~---  249 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQD---  249 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT---
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---
Confidence            8764432211   1223568999999999999999999999999999999998 899997654332   22222111   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                 .....+.+++..+.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus       250 -----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         250 -----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                       01122335677899999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=416.49  Aligned_cols=246  Identities=28%  Similarity=0.483  Sum_probs=207.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|+++.++..     ||+|++.+...   .....+.+|+.+|+.++|||||++++++.+.+ 
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFI-----LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcE-----EEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-
Confidence            5799999999999999999999877654     99999875432   23467889999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+|||||++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        80 ---~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          80 ---RVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ---EEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence               35999999999999999976  36799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+......    .....||+.|||||++.+..++.++|||||||++|||++|+.||...........+...        
T Consensus       152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------  219 (263)
T d2j4za1         152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------  219 (263)
T ss_dssp             SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred             eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence            998755432    34568999999999999999999999999999999999999999765433222211110        


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ....+..+++++.+|+.+||+.||++|||++++++
T Consensus       220 ----------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ----------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                      01122345678999999999999999999999987

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=420.25  Aligned_cols=250  Identities=27%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||+||+|.+..++.     .||||++........+.+.+|+.+|++++|||||++++++.+.+.   
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~-----~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---   91 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE---   91 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCC-----EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE---
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCC-----EEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE---
Confidence            479999999999999999999877665     499999987665566789999999999999999999999987763   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .|||||||+||+|.+++..   ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|+
T Consensus        92 -~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          92 -LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             -EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             -EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence             5999999999999998865   4699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........  .....        
T Consensus       165 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~--------  232 (293)
T d1yhwa1         165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNG--------  232 (293)
T ss_dssp             ECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHC--------
T ss_pred             eecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH--HHhCC--------
Confidence            764432  234457899999999999999999999999999999999999999976543322111  11100        


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           ......+..++..+.+||.+||+.||++|||+.|+++
T Consensus       233 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 -----TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0011223456778999999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-56  Score=423.09  Aligned_cols=260  Identities=25%  Similarity=0.430  Sum_probs=216.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||+||+|.+..++.     .||||++.... ...+++.+|+.+|++++|||||+++++|.+.+.. 
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-   88 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-   88 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTE-----EEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCe-----EEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee-
Confidence            3678999999999999999999987654     49999987654 3457899999999999999999999999876644 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         +||||||++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+|
T Consensus        89 ---~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          89 ---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             ---EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             ---EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence               9999999999999999876677899999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      +...... ........||+.|+|||++.+..|+.++|||||||++|||++|..||......  ..+...+..        
T Consensus       163 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~--------  231 (287)
T d1opja_         163 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEK--------  231 (287)
T ss_dssp             TTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHT--------
T ss_pred             eecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhc--------
Confidence            9765433 22344567899999999999999999999999999999999977665433221  112221111        


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                            ......+..+++.+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       232 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  11122333566789999999999999999999999999988754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=428.04  Aligned_cols=263  Identities=24%  Similarity=0.417  Sum_probs=216.0

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||+||+|++...........||+|.+..... .....+.+|+.+|.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57999999999999999999998877766777899999875432 3346788999999998 899999999999877654


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQ---------------------ATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRD  233 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  233 (441)
                          |+|||||++|+|.++|..+..                     ..+++..++.|+.||+.||.|||++   +|||||
T Consensus       117 ----~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         117 ----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             ----EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             ----EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence                999999999999999975422                     3589999999999999999999998   999999


Q ss_pred             cCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 013504          234 FKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDR  312 (441)
Q Consensus       234 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~  312 (441)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |..||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987655444444556789999999999999999999999999999999998 8999976


Q ss_pred             CCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          313 NRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                      .......  ...+..              ......+..+++.+.+||.+||+.||++|||+++|++.|..
T Consensus       270 ~~~~~~~--~~~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPVDANF--YKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCCSHHH--HHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHH--HHHHhc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            5432211  111111              11112233466789999999999999999999999999863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=413.47  Aligned_cols=256  Identities=27%  Similarity=0.487  Sum_probs=200.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||+||+|.+.++.      .||||++.... ...+++.+|+.++++++|||||+++|+|...+..  
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~------~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~--   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI--   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTE------EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCC------EEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCce--
Confidence            57899999999999999999986432      49999997644 3457899999999999999999999999877654  


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                        ++|||||++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        76 --~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          76 --CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             --EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             --EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence              9999999999999998754 46789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG-RRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....   ..+...+....      
T Consensus       150 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~------  219 (263)
T d1sm2a_         150 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF------  219 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHHTC------
T ss_pred             eccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHhcC------
Confidence            7654332 223346799999999999999999999999999999999995 555544332   22222221110      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                              ....+..+++.+.+|+.+||+.||++|||+++|++.|+++.+
T Consensus       220 --------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 --------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                    011122345788999999999999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=417.09  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||+||+|.++.++..     ||||.+......  ..+.+.+|+.+|++++|||||++++++.+....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKI-----LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCE-----EEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence            6799999999999999999999877654     999998765432  345688999999999999999999998764432


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCcEEEcCCCcEEEe
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR--FQATLPWNTRLKIAQDAARGLAYLHEGM--DFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                        ..|||||||++|+|.+++...  ....+++..++.++.||+.||.|||++.  ..+|+||||||+||||+.++.+||+
T Consensus        79 --~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          79 --TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             --EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence              458999999999999998642  3568999999999999999999999861  1249999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      |||+|+......  .......||+.|||||++.+..|+.++|||||||++|||+||+.||.......   +...+...  
T Consensus       157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~~~--  229 (269)
T d2java1         157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIREG--  229 (269)
T ss_dssp             CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHT--
T ss_pred             eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHHHcC--
Confidence            999998764432  23445789999999999999999999999999999999999999997654322   22211110  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .        . ...+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ---~--------~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 ---K--------F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---C--------C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C--------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               0        0 0122345678999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-56  Score=415.71  Aligned_cols=258  Identities=28%  Similarity=0.450  Sum_probs=210.6

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|++.+.||+|+||.||+|.+++.      ..||||++.... ...+.+.+|+.+|++++|||||+++|++.+..   
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCC------CEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCC---
Confidence            36789999999999999999997643      249999997644 34577999999999999999999999885432   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++|||||++|+|.+++.......+++..++.|+.||+.||.|||++   +|+||||||+||||++++.+||+|||+|
T Consensus        82 --~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          82 --IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             --CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             --eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence              38999999999999988765455799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCC-CCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPL-DRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...... ........||+.|||||++.++.++.++|||||||++|||+||..|+ ......   .....+...      
T Consensus       157 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~~~------  226 (272)
T d1qpca_         157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERG------  226 (272)
T ss_dssp             EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT------
T ss_pred             EEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhc------
Confidence            9765432 22334568999999999999999999999999999999999965554 433222   222222111      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              .....+..+++.+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       227 --------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 --------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                    01112234567899999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=417.82  Aligned_cols=252  Identities=23%  Similarity=0.401  Sum_probs=208.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      +.|++.+.||+|+||+||+|.+..++..     ||||++........+.+.+|+.+|++++|||||++++++.+.+    
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVL-----AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeE-----EEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence            4689999999999999999999877654     9999998776666788999999999999999999999998766    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..+||||||++|+|.+++.+. ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence            359999999999999998654 46799999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcceeeceecccCcCCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQ-----TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      .....  .......+||+.|+|||++.     +..|+.++|||||||++|||++|+.||...........+.  ...   
T Consensus       159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~--~~~---  231 (288)
T d2jfla1         159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA--KSE---  231 (288)
T ss_dssp             ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH--HSC---
T ss_pred             ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCC---
Confidence            54321  11234578999999999984     4568999999999999999999999997655433221111  000   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ......+..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       232 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 ----------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      0011223356778999999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-55  Score=408.98  Aligned_cols=252  Identities=22%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      |+..+.||+|+||+||+|.+..++..     ||+|.+.....  ...+.+.+|+++|++++|||||++++++........
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~-----va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVE-----VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeE-----EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            35666899999999999999877653     99999876432  234678899999999999999999999977554445


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc-CCCcEEEeecCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD-EQWNAKLSDFGLA  255 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla  255 (441)
                      ..|+|||||++|+|.+++...  ..+++..++.++.||+.||.|||++ ..+|+||||||+||||+ +++.+||+|||+|
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            679999999999999999763  6799999999999999999999987 12399999999999996 5789999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      +.....    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.......  .+...+....      
T Consensus       163 ~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~~~------  229 (270)
T d1t4ha_         163 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGV------  229 (270)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTC------
T ss_pred             eeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHcCC------
Confidence            864332    2345789999999999865 69999999999999999999999997543322  1222111110      


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             .....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       230 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 -------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                   011122234567899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=417.14  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|.+..++..     ||||++.....   ...+.+.+|+.+|++++||||+++++++.+.+ 
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCE-----EEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-
Confidence            6799999999999999999999877654     99999875432   23467889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+|||||+||+|.+++...  +.+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+|||
T Consensus        82 ---~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          82 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ---EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence               359999999999999998763  6899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||........   ...+...     
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~~~-----  225 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKL-----  225 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHTT-----
T ss_pred             cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHHHcC-----
Confidence            99976554434445567899999999999999999999999999999999999999976543222   1111110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEV  379 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  379 (441)
                                ...++..+++.+.+||.+||+.||++|||++|++..
T Consensus       226 ----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 ----------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                      011223456788999999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=410.37  Aligned_cols=261  Identities=24%  Similarity=0.458  Sum_probs=211.2

Q ss_pred             cCCcccce-eecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLM-IGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~-LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|.+... ||+|+||+||+|.++.++.   ...||||++...... ..++|.+|+.+|++++|||||+++|++..+.  
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---C---CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCC---cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe--
Confidence            46677774 9999999999998865432   245999999765433 3577999999999999999999999986432  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .|||||||++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        83 ---~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          83 ---LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             ---EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             ---EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence               48999999999999998653 46799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLS-HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...........   +...    
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---i~~~----  228 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQG----  228 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---HHTT----
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HHcC----
Confidence            9876543322 22334678999999999999999999999999999999998 9999976554322222   1110    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                                .....+..+++++.+|+.+||+.||++||++.+|++.|+.....
T Consensus       229 ----------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         229 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                      01122345668899999999999999999999999999887643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=410.36  Aligned_cols=265  Identities=24%  Similarity=0.468  Sum_probs=205.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      +.|+..++||+|+||.||+|.++.++. .....||||++...... ...+|.+|+.+|++++|||||+++|++.+.+.  
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~--   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP--   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc--
Confidence            568889999999999999999886543 23456999998754433 34578899999999999999999999987664  


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .++|||||.+|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        84 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          84 --MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             --EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             --eEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence              49999999999999988754 46799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCC-cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGL-SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +....... ........||+.|||||++.++.++.++|||||||++|||++|..|+......  ..+...+..       
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~-------  228 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIND-------  228 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT-------
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhc-------
Confidence            87544321 22233457899999999999999999999999999999999976655432221  222222211       


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                             ......+.+++..+.+|+.+||+.||++||++.+|++.|+++++.
T Consensus       229 -------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         229 -------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                   111223334667899999999999999999999999999998864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=423.32  Aligned_cols=269  Identities=24%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||+||+|.+..++.     .||+|++...... ....+.+|+.+|+.++|||||+++++|.+.+  
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   77 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGL-----VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--   77 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTE-----EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            5789999999999999999999887664     4999998765332 3467889999999999999999999998766  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHE-GMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                        +.|||||||+||+|.+++.+.  +.+++..+..++.|++.||.|||+ +   +|+||||||+||||+.++.+||+|||
T Consensus        78 --~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          78 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             --EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence              459999999999999999763  579999999999999999999996 4   79999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh-hhhhccc-
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW-VRPHLTD-  331 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~-  331 (441)
                      +|+.....    ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||........+..... ....... 
T Consensus       151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            99864321    23457999999999999999999999999999999999999999976543322111000 0000000 


Q ss_pred             ------------------------ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHH
Q 013504          332 ------------------------AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNK  382 (441)
Q Consensus       332 ------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  382 (441)
                                              ...................++.++.+|+.+||+.||++|||++|+++  +++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                                    00000000000000111124567899999999999999999999998  5554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=406.57  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             ceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          103 LMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       103 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      +.||+|+||+||+|.++...   ....||||++.....  ...+++.+|+.+|++++|||||+++++|..+.     .+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-----~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----EEE
T ss_pred             CCcccCCCeEEEEEEEccCC---cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----EEE
Confidence            46999999999999986543   234699999875432  23467899999999999999999999986432     489


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      |||||++|+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....
T Consensus        85 vmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence            9999999999999976  46799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          261 DGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       261 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ..... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.........   ..+...          
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~~i~~~----------  226 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEKG----------  226 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTT----------
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---HHHHcC----------
Confidence            43222 2334679999999999999999999999999999999998 89999765433222   211110          


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                          .....+..+++.+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       227 ----~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         227 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                0112233566789999999999999999999999999887653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-54  Score=413.98  Aligned_cols=252  Identities=21%  Similarity=0.366  Sum_probs=192.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .+.|++.+.||+|+||+||+|.++.++..     ||||++...... ....+.+|+.+|+.++|||||++++++.+.+  
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKL-----VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCE-----EEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCE-----EEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            46799999999999999999999877654     999998765433 2356778999999999999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc---CCCcEEEee
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD---EQWNAKLSD  251 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~---~~~~~kl~D  251 (441)
                        ..|||||||+||+|.+++..  .+.+++..+..++.||+.||.|||++   +|+||||||+|||+.   +++.+||+|
T Consensus        81 --~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          81 --HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             --EEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             --EEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence              45999999999999999976  46899999999999999999999998   999999999999994   578899999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      ||+|+......   .....+||+.|||||++.+..|+.++|||||||++|||++|..||.........   ..+...   
T Consensus       154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~~---  224 (307)
T d1a06a_         154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQILKA---  224 (307)
T ss_dssp             C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHTT---
T ss_pred             cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHhcc---
Confidence            99998654332   234578999999999999999999999999999999999999999765432221   111110   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                              ...........+++.+.+|+.+||+.||++|||+.|+++
T Consensus       225 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         225 --------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                    011111223356678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.7e-54  Score=417.64  Aligned_cols=253  Identities=23%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .++|.+.+.||+|+||.||+|.++.++.     .||||++........+.+.+|+.+|++++|||||++++++.+.+   
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~-----~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---   96 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGN-----NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN---   96 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT---
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            3589999999999999999999887764     49999998776666678899999999999999999999998765   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--CCCcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--EQWNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFG  253 (441)
                       ..|||||||+||+|.+++... .+.+++..+..|+.||+.||.|||++   +||||||||+||||+  .++.+||+|||
T Consensus        97 -~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          97 -EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             -EEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             -EEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence             459999999999999999653 45799999999999999999999998   999999999999995  46789999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+......   ......||+.|||||++.+..++.++|||||||++|||++|+.||...........   +...     
T Consensus       172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~-----  240 (350)
T d1koaa2         172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VKSC-----  240 (350)
T ss_dssp             TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT-----
T ss_pred             hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHhC-----
Confidence            998765432   34567899999999999999999999999999999999999999976543322211   1110     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            +..........+++.+.+||.+||+.||++|||+.++++
T Consensus       241 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         241 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ------CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  001111222345678999999999999999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=401.07  Aligned_cols=253  Identities=26%  Similarity=0.458  Sum_probs=210.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||+||+|++++.      ..||||.++.... ..+++.+|+.++++++||||++++|+|.+++.   
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~---   73 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP---   73 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTT------EEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS---
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCC------CEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc---
Confidence            6899999999999999999998633      2499999986543 35689999999999999999999999987653   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        74 -~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          74 -IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             -EEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             -eEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence             49999999999999997654 35789999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...........   +...       
T Consensus       149 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i~~~-------  217 (258)
T d1k2pa_         149 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQG-------  217 (258)
T ss_dssp             BCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HHTT-------
T ss_pred             eccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---HHhC-------
Confidence            7654332 23344679999999999999999999999999999999998 8999976654332221   1110       


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHH
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNK  382 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  382 (441)
                             .....+..++..+.+|+.+||+.||++|||+++|++.|.+
T Consensus       218 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                   0111223455789999999999999999999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.9e-54  Score=416.36  Aligned_cols=252  Identities=21%  Similarity=0.357  Sum_probs=210.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||.||+|.+..++..     ||||++..........+.+|+.+|++++|||||++++++.+.+    
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~-----vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRV-----FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY----   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS----
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCE-----EEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            5799999999999999999998877654     9999998766555677889999999999999999999998765    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEc--CCCcEEEeecCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLD--EQWNAKLSDFGL  254 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFGl  254 (441)
                      ..|||||||+||+|.+++... +..+++..++.|+.||+.||.|||++   ||+||||||+||||+  .++.+||+|||+
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence            459999999999999987653 45799999999999999999999998   999999999999997  678999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      |+......   ......||+.|+|||++.+..|+.++|||||||++|||+||..||...........+.   ..      
T Consensus       176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~~------  243 (352)
T d1koba_         176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---RC------  243 (352)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---HC------
T ss_pred             ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hC------
Confidence            98765432   3456789999999999999999999999999999999999999997654332221111   10      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                           +..........+++.+.+||.+||+.||.+|||+.++++
T Consensus       244 -----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         244 -----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 011112222346678999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=410.97  Aligned_cols=268  Identities=25%  Similarity=0.367  Sum_probs=209.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|.+.........+.||||++..... ...+.+.+|+.++.++ +||||+.+++++...+. 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC-
Confidence            67999999999999999999998877777778899999975443 3346678888888776 78999999999876543 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                        ..++|||||++|+|.+++..+.              ...+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus        92 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL  166 (299)
T d1ywna1          92 --PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  166 (299)
T ss_dssp             --CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             --eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence              3589999999999999997532              24588999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITG-RRPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG-~~P~~~~~~~~~~  319 (441)
                      |+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| ..||........ 
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-  245 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-  245 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            999999999999999876554444444567899999999999999999999999999999999997 467765433221 


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                       +...+...              .....+..+++++.+++.+||+.||++|||+.+|++.|++++++
T Consensus       246 -~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         246 -FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             -HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHhcC--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence             11111110              01112234567899999999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-54  Score=412.06  Aligned_cols=263  Identities=27%  Similarity=0.445  Sum_probs=210.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+|+++++||+|+||+||+|.+..++... ...||+|.+.... ....+++.+|+.+|++++|||||+++|+|.+..   
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----C-CEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEE-EEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            46999999999999999999988766533 3358999986543 234578999999999999999999999998653   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                        .+++|||+.+|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+|
T Consensus        85 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             --eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence              37899999999999988764 56899999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...............||+.|+|||++.++.++.++|||||||++|||+| |..||...........+..   .      
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---~------  229 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---G------  229 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---T------
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---C------
Confidence            97655444444455679999999999999999999999999999999998 7899976554333222211   0      


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                              .....+..+++.+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       230 --------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         230 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             --------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                    01112234567899999999999999999999999999988653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=401.49  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=203.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++.+.||+|+||.||+|++..++.  ....||||.+....... .+.+.+|+.+|++++|||||++++++.+.    
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN----   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCc--eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            579999999999999999999876543  23458999987544333 46789999999999999999999998542    


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                       ..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        81 -~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          81 -PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             -eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence             249999999999999987654 46799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccc
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKK  334 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  334 (441)
                      +...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+.   ..    . 
T Consensus       156 ~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~---~~----~-  226 (273)
T d1mp8a_         156 RYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NG----E-  226 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TT----C-
T ss_pred             eeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH---cC----C-
Confidence            8754332 223445678999999999999999999999999999999998 899997665443222211   10    0 


Q ss_pred             hhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          335 FTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                               ....+..+++.+.+||.+||+.||++|||+.+|++.|+.++++.
T Consensus       227 ---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         227 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                     11223356788999999999999999999999999999988654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-54  Score=409.60  Aligned_cols=266  Identities=26%  Similarity=0.417  Sum_probs=216.8

Q ss_pred             HhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-hHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           95 ATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        95 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ..++|++++.||+|+||+||+|++++.........||||++....... .+++.+|+.+|++++||||++++++|.....
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            457899999999999999999999876555566679999997654433 4678999999999999999999999987664


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRF----------------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIF  231 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  231 (441)
                      .    ++||||+++|+|.+++....                      ...+++..++.|+.||+.||.|||++   +|||
T Consensus        91 ~----~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          91 M----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             C----EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             e----EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            4    99999999999999996431                      23588999999999999999999998   9999


Q ss_pred             cccCCCcEEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCC-CCC
Q 013504          232 RDFKSSNILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR-RPL  310 (441)
Q Consensus       232 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~-~P~  310 (441)
                      |||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998654443333445678999999999999999999999999999999999985 577


Q ss_pred             CCCCchhHHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHH
Q 013504          311 DRNRPKSEQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIV  384 (441)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  384 (441)
                      ........   ...+....              ....+..+++++.+|+.+||+.||++|||+.+|+++|+++.
T Consensus       244 ~~~~~~e~---~~~v~~~~--------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEV---IYYVRDGN--------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHH---HHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHH---HHHHHcCC--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            65543322   22221110              01123345678999999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-54  Score=411.57  Aligned_cols=246  Identities=29%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      +.|+..+.||+|+||+||+|++..++.     .||||++......   ..+.+.+|+.+|++++|||||++++++.+.+ 
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCc-----EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-
Confidence            459999999999999999999887764     4999998765433   2356889999999999999999999998765 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+|||||++|+|..++..  ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        89 ---~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          89 ---TAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             ---EEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ---EEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence               35999999999999877765  46899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT---GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      +|+....      .....||+.|||||++.+   +.|+.++|||||||++|||++|..||...........  .....  
T Consensus       161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~--i~~~~--  230 (309)
T d1u5ra_         161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNE--  230 (309)
T ss_dssp             TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSC--
T ss_pred             cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHhCC--
Confidence            9986433      234689999999999864   4689999999999999999999999976543221111  11000  


Q ss_pred             cccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          331 DAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                               .+.   ..+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       231 ---------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 ---------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                     011   112235678999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=405.72  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=205.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||+||+|.++++.      .||||++.... ...+.|.+|+.+|++++|||||++++++.+. .   
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~------~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~---   85 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P---   85 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S---
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCC------EEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC-C---
Confidence            57999999999999999999987653      39999997554 3457899999999999999999999998543 2   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                       .++|||||++|+|..++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus        86 -~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             -eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhh
Confidence             38999999999999998765556799999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchh
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFT  336 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (441)
                      ...... ........||+.|+|||++..+.++.++|||||||++|||++|..|+......  ......+...        
T Consensus       162 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~--------  230 (285)
T d1fmka3         162 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG--------  230 (285)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT--------
T ss_pred             hccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhc--------
Confidence            754332 22334467999999999999999999999999999999999976665433221  2222222111        


Q ss_pred             hhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          337 MILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                            .....+..+++.+.++|.+||+.||++||++++|+++|++.+..
T Consensus       231 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         231 ------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                  01122334667899999999999999999999999999987644

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=403.72  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=207.9

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCCCCCeeeEEeEEe
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVEHPNLVKLIGYCA  169 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~  169 (441)
                      .+.|++++.||+|+||+||+|.++.++..     ||||++.+....      ..+.+.+|+.+|++++|||||++++++.
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~-----~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQ-----YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCE-----EEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            36799999999999999999999877654     999998754322      2467889999999999999999999998


Q ss_pred             ccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC----
Q 013504          170 EDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW----  245 (441)
Q Consensus       170 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~----  245 (441)
                      +.+    ..|||||||+||+|.+++...  +.+++..++.++.||+.||.|||++   +|+||||||+|||++.++    
T Consensus        84 ~~~----~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          84 NKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred             ECC----EEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence            766    459999999999999999764  5799999999999999999999998   999999999999998776    


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~  325 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus       155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~  231 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV  231 (293)
T ss_dssp             CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred             ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence            49999999998764432   234568999999999999999999999999999999999999999765433222111110


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                    ...........++..+.+||.+||+.||++|||++++++
T Consensus       232 --------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 --------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          001111122345678899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=409.20  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=209.3

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++++.||+|+||.||+|++..++..     ||||++.+...   ...+.+.+|+.+|++++||||+++++++.+.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~-----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCE-----EEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            36799999999999999999998877654     99999976432   23467889999999999999999999998876


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                          .+|+|||||+||+|.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+||
T Consensus        79 ----~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 ----RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ----ccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence                45999999999999999976  46899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+|+......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........   ...+...    
T Consensus       150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i~~~----  220 (337)
T d1o6la_         150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILME----  220 (337)
T ss_dssp             TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC----
T ss_pred             ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHHHhcC----
Confidence            9998754432  234567999999999999999999999999999999999999999976553322   2211110    


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                                 ...++..+++++.+||.+||+.||.+||+     ++++++
T Consensus       221 -----------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                       01123345678899999999999999995     788877

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.6e-53  Score=398.76  Aligned_cols=265  Identities=25%  Similarity=0.394  Sum_probs=209.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHHHHHHHhccCCCCCeeeEEeEEeccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  172 (441)
                      .++|++.+.||+|+||.||+|.+..++.     .||||++......   ....+.+|+.+|+.++||||+++++++...+
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~   80 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHR-----DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCC-----EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence            3679999999999999999999887654     4999999765432   2356889999999999999999999998877


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      ..+...|||||||+||+|.+++..  .+.+++..++.++.||+.||.|||++   +|+||||||+||||+.++.++|+||
T Consensus        81 ~~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          81 PAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             SSSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred             CCCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence            665567999999999999999876  36899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCC-CcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDG-LSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |.+....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||..........  ..+.    .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~~~~----~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVR----E  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH----C
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH--HHHh----c
Confidence            9987543322 2223455789999999999999999999999999999999999999997654332211  1111    1


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-CHHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-KMSEVVEVLNKIV  384 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  384 (441)
                      .        +.........+++.+.++|.+||+.||++|| +++++++.|.++.
T Consensus       230 ~--------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         230 D--------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             C--------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C--------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0        0011112224567899999999999999999 8999999888764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=398.05  Aligned_cols=253  Identities=29%  Similarity=0.461  Sum_probs=202.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++++.||+|+||.||+|.+.++       .||||+++...  ..+.+.+|+.++++++||||++++|+|.+...   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~-------~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---   74 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---   74 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTE-------EEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCe-------EEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---
Confidence            5788999999999999999998543       39999997643  34678999999999999999999999965432   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||||+++|+|.++|..+....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence            248999999999999999765445699999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhcccccch
Q 013504          257 LGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTDAKKF  335 (441)
Q Consensus       257 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (441)
                      .....     .....+|+.|+|||++.++.++.++|||||||++|||+| |++||........   ..++..        
T Consensus       152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i~~--------  215 (262)
T d1byga_         152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK--------  215 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTT--------
T ss_pred             ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc--------
Confidence            64332     334578999999999999999999999999999999998 7888876544332   222211        


Q ss_pred             hhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          336 TMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                            ......+..+++.+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus       216 ------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         216 ------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                  011123334567899999999999999999999999999998653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.8e-53  Score=403.40  Aligned_cols=245  Identities=25%  Similarity=0.425  Sum_probs=206.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++++.||+|+||+||+|+++.++..     ||||++.+...   ...+.+.+|+.+|+.++|||||++++++.+.+ 
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~-----vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCE-----EEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-
Confidence            5799999999999999999999877654     99999875432   23467889999999999999999999998766 


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                         ..|+|||||+||+|..++..  ...+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||
T Consensus        78 ---~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          78 ---QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             ---eeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence               45999999999999999976  46789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+.....     ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.   ..     
T Consensus       150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~~-----  216 (316)
T d1fota_         150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---NA-----  216 (316)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HC-----
T ss_pred             cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH---cC-----
Confidence            99875432     345789999999999999999999999999999999999999997654332221111   10     


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                ...++..+++.+.+++.+||..||.+|+     +++++++
T Consensus       217 ----------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         217 ----------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                      0112234567789999999999999996     8999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=401.82  Aligned_cols=266  Identities=26%  Similarity=0.424  Sum_probs=219.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||.||+|++....+....+.||||++...... ....+.+|+.+++++ +|||||+++++|.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            688999999999999999999987655566778999999765433 345788999999998 799999999999877644


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRF----------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                          ++|||||++|+|.+++....                ...+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus       103 ----~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_         103 ----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             ----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ----EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence                99999999999999997532                23689999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchh
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS  317 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~  317 (441)
                      ||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999998765544455566799999999999999999999999999999999999 555555443322


Q ss_pred             H-HHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          318 E-QKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       318 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      . ...+..                 ......+..++..+.+||.+||+.||++|||+.+|+++|++++..
T Consensus       256 ~~~~~i~~-----------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 KFYKMIKE-----------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHH-----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhc-----------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2 122111                 011112234567899999999999999999999999999988765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=397.77  Aligned_cols=266  Identities=26%  Similarity=0.429  Sum_probs=213.1

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCC--cccceeEEEEEccccCch-hhHHHHHHHHHhccC-CCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTED--SHKKIDIAVKQLSRRGLQ-GHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  172 (441)
                      ++|.+++.||+|+||.||+|++..+..  ......||||++...... ...++.+|+..+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            679999999999999999999876643  234567999999765543 346788899999888 8999999999998765


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCc
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRF--------------QATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSN  238 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~N  238 (441)
                      .    .++|||||++|+|.++|..+.              ...+++.+++.++.||+.||.|||++   +||||||||+|
T Consensus        93 ~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          93 P----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             S----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             e----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            4    499999999999999997543              24689999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchh
Q 013504          239 ILLDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKS  317 (441)
Q Consensus       239 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~  317 (441)
                      ||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.......
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999997655444444556789999999999999999999999999999999998 788887554332


Q ss_pred             HHHHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          318 EQKLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                         +...+...              .....+..+++.+.+|+.+||+.||++|||+.+|++.|+.++..
T Consensus       246 ---~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 ---LFKLLKEG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ---HHHHHHTT--------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHcC--------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence               22221110              11122234567899999999999999999999999999998653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=396.24  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++.+.||+|+||+||+|.+.....  ....||||++.....   ...++|.+|+.+|++++||||++++|+|.+. .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~--~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSG--KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS--CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCC--cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            679999999999999999999865432  344699999876432   3346789999999999999999999999653 2


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++|||||++|+|.+++..+ ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        85 ----~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          85 ----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             ----hheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence                38999999999999988754 35799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-eeeceecccCcCCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          254 LARLGPSDGLSH-VSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELIT-GRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       254 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      +++......... ......||..|+|||++.+..++.++|||||||++|||+| |..||.......   ...++...   
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~---  230 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKE---  230 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTS---
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhC---
Confidence            999765443222 2334568889999999999999999999999999999998 899997554332   22222111   


Q ss_pred             ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHH
Q 013504          332 AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKI  383 (441)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  383 (441)
                                ......+..++..+.+|+.+||..||++|||+.+|++.|.++
T Consensus       231 ----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 ----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      111122335567899999999999999999999999998864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-52  Score=403.80  Aligned_cols=245  Identities=23%  Similarity=0.367  Sum_probs=206.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      ++|++++.||+|+||.||+|.++.++..     ||||++.....   ...+.+.+|+.+|+.++|||||++++++.....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~-----~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCE-----EEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence            5799999999999999999999877654     99999875432   234678899999999999999999999987663


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecC
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFG  253 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG  253 (441)
                          .++||||+.+|+|.+++...  +.+++..++.++.||+.||.|||++   +||||||||+||||+.++.+||+|||
T Consensus       116 ----~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 ----LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ----cccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence                59999999999999999764  5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +|+.....     .....||+.|||||++.+..++.++|||||||++|||+||+.||........   ...+....    
T Consensus       187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~----  254 (350)
T d1rdqe_         187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSGK----  254 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC----
T ss_pred             eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHHHhcCC----
Confidence            99875432     3457899999999999999999999999999999999999999976543222   11111100    


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCC-----CHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRP-----KMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  378 (441)
                                 ...+..+++++.++|.+||..||.+|+     +++++++
T Consensus       255 -----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                       011224567899999999999999994     8999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=402.92  Aligned_cols=256  Identities=20%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             hcCCcccc-eeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhcc-CCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSL-MIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGV-VEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|.+.. +||+|+||.||+|.+..++..     ||||++..     ...+.+|+.++.+ ++|||||+++++|.+...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~-----vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK-----FALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCE-----EEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            46798874 699999999999998877654     99999864     2456789998765 589999999999976443


Q ss_pred             CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEe
Q 013504          174 RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLS  250 (441)
Q Consensus       174 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~  250 (441)
                      .....|||||||+||+|.++|..+....+++..++.|+.||+.||.|||++   +|+||||||+|||++.   ++.+||+
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            344679999999999999999876556899999999999999999999998   9999999999999975   4569999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-HHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-LLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-~~~~~~~~~  329 (441)
                      |||+|+......   .....+||+.|||||++.+..|+.++|||||||++|+|+||+.||.......... +...+    
T Consensus       157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i----  229 (335)
T d2ozaa1         157 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----  229 (335)
T ss_dssp             CCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC----
T ss_pred             ccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH----
Confidence            999998754432   2345789999999999999999999999999999999999999996543322111 11000    


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .       .....+.......+++++.+||.+||+.||++|||+.++++
T Consensus       230 ~-------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 R-------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             C-------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             h-------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0       00011122233467788999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=398.86  Aligned_cols=262  Identities=27%  Similarity=0.469  Sum_probs=209.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccC-CCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVV-EHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++.+.||+|+||+||+|+++.++..   ..||||.+..... ...+.+.+|+.+|.++ +|||||++++++.+.+  
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeE---EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence            6788999999999999999999876532   3478888764432 3456789999999998 7999999999998765  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR--------------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                        .+++||||+++|+|.++|..+              ....+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus        85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL  159 (309)
T d1fvra_          85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL  159 (309)
T ss_dssp             --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence              459999999999999999653              246799999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCchhHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR-RPLDRNRPKSEQ  319 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~-~P~~~~~~~~~~  319 (441)
                      ++.++.+||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|. +||.....   .
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~  233 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A  233 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H
T ss_pred             EcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---H
Confidence            9999999999999998644322   223457899999999999999999999999999999999975 56754432   2


Q ss_pred             HHHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhhc
Q 013504          320 KLLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAAE  388 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  388 (441)
                      .+...+...              .....+..+++.+.+||.+||+.||++||++++|++.|+++++...
T Consensus       234 ~~~~~i~~~--------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         234 ELYEKLPQG--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHHHHGGGT--------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHhc--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            222222111              0112233466789999999999999999999999999999987543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-51  Score=403.18  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=202.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---hhHHHH---HHHHHhccCCCCCeeeEEeEEec
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---GHKEWV---TEVNVLGVVEHPNLVKLIGYCAE  170 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~---~E~~il~~l~hpnIv~l~~~~~~  170 (441)
                      ++|++.++||+|+||.||+|++..++..     ||||++.+....   ....+.   .|+.+++.++|||||++++++.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~-----vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKM-----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCE-----EEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCE-----EEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence            6799999999999999999999877654     999998653321   122233   44777888899999999999987


Q ss_pred             cccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          171 DDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       171 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                      .+    ..|||||||+||+|.++|..  ...+++..++.++.||+.||.|||++   +||||||||+||||+.++.+||+
T Consensus        79 ~~----~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          79 PD----KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred             CC----EEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence            66    35999999999999999976  36789999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          251 DFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       251 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      |||+|+.....    .....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||..........+......  
T Consensus       150 DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--  223 (364)
T d1omwa3         150 DLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--  223 (364)
T ss_dssp             CCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--
T ss_pred             eeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--
Confidence            99999865443    2345689999999999865 5689999999999999999999999976554433332221110  


Q ss_pred             ccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          330 TDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                                   .....+..+++.+.+||.+||+.||++||+     ++++++
T Consensus       224 -------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                         011122345678999999999999999999     688876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=396.31  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      -++|++.+.||+|+||+||+|.+..++.     .||||++..... ....+.+|+.+|+.++|||||++++++.+.+   
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~-----~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~---   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKK-----TYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME---   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT---
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence            3679999999999999999999887765     499999976543 3456789999999999999999999998766   


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCC--CcEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQ--WNAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFG  253 (441)
                       ..|||||||+||+|.+++... +..+++.+++.|+.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||
T Consensus        75 -~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          75 -ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             -EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             -EEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence             459999999999999999753 35799999999999999999999998   99999999999999854  579999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccccc
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAK  333 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  333 (441)
                      +++.....   .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+.   ..   . 
T Consensus       150 ~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~---~~---~-  219 (321)
T d1tkia_         150 QARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM---NA---E-  219 (321)
T ss_dssp             TCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HT---C-
T ss_pred             hhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hC---C-
Confidence            99875433   23455789999999999999999999999999999999999999997654332221111   10   0 


Q ss_pred             chhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          334 KFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                             ..+.......+++++.+|+.+||..||++|||+.|+++
T Consensus       220 -------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 -------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00011111235677899999999999999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-51  Score=386.99  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=205.6

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch---------hhHHHHHHHHHhccCC-CCCeeeEEe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ---------GHKEWVTEVNVLGVVE-HPNLVKLIG  166 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~-hpnIv~l~~  166 (441)
                      ++|++.+.||+|+||+||+|++..++.     .||||++......         ..+.+.+|+.+|++++ ||||+++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~-----~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~   77 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCK-----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   77 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCC-----EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence            689999999999999999999876654     4999998765322         1235789999999996 999999999


Q ss_pred             EEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          167 YCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                      ++.+.+    ..|||||||++|+|.++|..+  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        78 ~~~~~~----~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          78 TYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             EEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             ecccCc----ceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence            998766    459999999999999999763  6899999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQT------GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK  320 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~  320 (441)
                      +||+|||+++......   .....+||+.|+|||++.+      ..++.++||||+||++|||++|+.||..........
T Consensus       149 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~  225 (277)
T d1phka_         149 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  225 (277)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence            9999999998765432   2345789999999998863      346889999999999999999999998655333222


Q ss_pred             HHHhhhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          321 LLEWVRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      .+....              ..........+++++.+|+.+||+.||++||++.+|++
T Consensus       226 ~i~~~~--------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         226 MIMSGN--------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHTC--------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhCC--------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111100              01111223356788999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=395.46  Aligned_cols=266  Identities=23%  Similarity=0.413  Sum_probs=216.0

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      .++|.+.+.||+|+||+||+|.+...........||||++..... .....+.+|+.++++++|||||++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            368899999999999999999987655545556799999976433 3345688999999999999999999999876654


Q ss_pred             CeeEEEEEeccCCCChHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCc
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSR--------FQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWN  246 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~  246 (441)
                          ++|||||++|+|.+++...        ....+++..+..++.|++.||.|||++   +|+||||||+||||+.++.
T Consensus        99 ----~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          99 ----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ----EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             ----eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence                9999999999999998642        124578999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCchhHHHHHHhh
Q 013504          247 AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGR-RPLDRNRPKSEQKLLEWV  325 (441)
Q Consensus       247 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~-~P~~~~~~~~~~~~~~~~  325 (441)
                      +||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. .||.......   ....+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~i  248 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFV  248 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            9999999998765444333445568999999999999999999999999999999999984 7776543322   22211


Q ss_pred             hhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHh
Q 013504          326 RPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVD  385 (441)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  385 (441)
                      ..    .         . ....+..++..+.+++.+||+.+|++|||+.+|++.|++.++
T Consensus       249 ~~----~---------~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 ME----G---------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HT----T---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             Hh----C---------C-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11    0         0 011223456789999999999999999999999999987654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=398.35  Aligned_cols=248  Identities=25%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc---hhhHHHHHHHHHhc-cCCCCCeeeEEeEEeccc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL---QGHKEWVTEVNVLG-VVEHPNLVKLIGYCAEDD  172 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~  172 (441)
                      ++|.+.+.||+|+||+||+|++..++.     .||||++.+...   ...+.+..|..++. .++|||||++++++.+.+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~-----~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCC-----EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence            579999999999999999999987765     499999975321   23356677777765 689999999999998876


Q ss_pred             cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          173 ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       173 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      .    .|||||||++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        77 ~----~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 N----LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             E----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             c----eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            4    59999999999999999763  6789999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      |+++......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+...       
T Consensus       148 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------  218 (320)
T d1xjda_         148 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------  218 (320)
T ss_dssp             TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred             chhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------
Confidence            9998654432  2344578999999999999999999999999999999999999999765443322221110       


Q ss_pred             cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHH-HHHH
Q 013504          333 KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMS-EVVE  378 (441)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  378 (441)
                             .+    .++..+++.+.+|+.+||+.||++||++. ++++
T Consensus       219 -------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 -------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                   01    12234567899999999999999999996 6765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=392.28  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=205.7

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEccccC-chhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCeeEEE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRG-LQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLL  180 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~l  180 (441)
                      .++||+|+||+||+|.+..++.  ....||||.+.... ....++|.+|+.+|++++||||++++|++...+.   ..++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC--EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEE
Confidence            4689999999999999876532  23458999987533 3345789999999999999999999999876432   3589


Q ss_pred             EEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCCCCCCC
Q 013504          181 IYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLARLGPS  260 (441)
Q Consensus       181 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  260 (441)
                      |||||++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+++....
T Consensus       107 v~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            99999999999998754 45788899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc--ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccccchhhh
Q 013504          261 DGLS--HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDAKKFTMI  338 (441)
Q Consensus       261 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      ....  .......||+.|+|||.+..+.++.++||||||+++|||+||..||......  .+...++...    .     
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g----~-----  251 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG----R-----  251 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT----C-----
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcC----C-----
Confidence            3221  2233467899999999999999999999999999999999988887543211  1111111110    0     


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          339 LDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       339 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                           ....+..+++.+.+|+.+||+.||++||++.||++.|+.+++.
T Consensus       252 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 0112234567899999999999999999999999999999764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=390.82  Aligned_cols=273  Identities=25%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHH--HHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWV--TEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|...+.||+|+||.||+|++.+       ..||||++....   .+.+.  .|+..+..++||||+++++++.+.+..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g-------~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            467788899999999999998743       249999986543   23333  455566678999999999999987766


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecccCCCcEEEcCCCcEEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG-----MDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      ....++|||||++|+|.++|..   ..+++..++.++.|++.||.|||+.     .+.+|+||||||+||||+.++.+||
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            5677999999999999999976   4699999999999999999999962     1248999999999999999999999


Q ss_pred             eecCCCCCCCCCCCc--ceeeceecccCcCCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCchhHHH-
Q 013504          250 SDFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTGR------LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK-  320 (441)
Q Consensus       250 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~-  320 (441)
                      +|||+++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||.......... 
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            999999875443221  1234578999999999987643      5678999999999999999998875332111000 


Q ss_pred             -------HHHhhhhhcccccchhhhcCCCCCCcc-hHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          321 -------LLEWVRPHLTDAKKFTMILDPKLEGKY-SIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       321 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                             .........     .....+|.+.... ..+....+.+|+.+||+.||++|||+.+|++.|+++.++.
T Consensus       230 ~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             TTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence                   000000000     0011122222221 3356678999999999999999999999999999987653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=386.77  Aligned_cols=267  Identities=22%  Similarity=0.331  Sum_probs=201.9

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++++.||+|+||+||+|++..++..     ||||++......  ....+.+|+.+|++++|||||++++++.+.+  
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-----VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCE-----EEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--
Confidence            5899999999999999999999877654     999998654322  2467889999999999999999999998766  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                        ..|+||||+.+ ++.+++.......+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+
T Consensus        75 --~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          75 --KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             --EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             --ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence              45999999964 566666555567899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc--
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD--  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  331 (441)
                      |+......  .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...........+........+  
T Consensus       149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            98654332  2334568999999999877665 578999999999999999999999765433222111100000000  


Q ss_pred             ------ccchhhhcCCCCCCc---chHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ------AKKFTMILDPKLEGK---YSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                            ...............   ....++..+.+|+.+||..||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                  000000000000000   11134567899999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=387.18  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             ccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchh-----hHHHHHHHHHhccCCCCCeeeEEeEEeccccCC
Q 013504          101 RSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQG-----HKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERG  175 (441)
Q Consensus       101 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  175 (441)
                      .+++||+|+||+||+|.+..++..     ||||++.......     .+.+.+|+.+|+.++|||||++++++...+.. 
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~-   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQI-----VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI-   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSE-----EEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC-
T ss_pred             cceEeccCcCeEEEEEEECCCCcE-----EEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce-
Confidence            356899999999999998776654     9999987543322     24688999999999999999999999887654 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGLA  255 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla  255 (441)
                         ||||||+.++++...+..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        76 ---~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          76 ---SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             ---EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ---eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence               999999988877766543  46799999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc-----
Q 013504          256 RLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL-----  329 (441)
Q Consensus       256 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~-----  329 (441)
                      +......  ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||......+....+.......     
T Consensus       148 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~  225 (299)
T d1ua2a_         148 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  225 (299)
T ss_dssp             STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            8654432  22345689999999998865 457999999999999999999999997655433222211110000     


Q ss_pred             ccccchhhhcC-CCCCC----cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TDAKKFTMILD-PKLEG----KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~~~~~~~~~~-~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ........... .....    ......++.+.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000000 00000    011134578999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=380.59  Aligned_cols=272  Identities=23%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccC---CCCCeeeEEeEEec
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVV---EHPNLVKLIGYCAE  170 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~  170 (441)
                      .++|++++.||+|+||+||+|.+..++.    ..||||++......  ....+.+|+.+|+.+   +||||++++++|..
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCC----EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            4789999999999999999999865432    34899998654322  233566788877765   89999999999865


Q ss_pred             cc-cCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEE
Q 013504          171 DD-ERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKL  249 (441)
Q Consensus       171 ~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl  249 (441)
                      .. ......+++|||++++.+..... .....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence            43 22345799999998877654443 3457899999999999999999999998   9999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc
Q 013504          250 SDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL  329 (441)
Q Consensus       250 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~  329 (441)
                      +|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.......
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999999864332   23456789999999999999999999999999999999999999997665433322221111000


Q ss_pred             cc-----ccc-hhhhc---CCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 TD-----AKK-FTMIL---DPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 ~~-----~~~-~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ..     ... .....   ...........+++.+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00     000 00000   000011222345678899999999999999999999886

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=383.47  Aligned_cols=241  Identities=24%  Similarity=0.446  Sum_probs=196.8

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------hhHHHHHHHHHhccCC--CCCeeeEEeE
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------GHKEWVTEVNVLGVVE--HPNLVKLIGY  167 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--hpnIv~l~~~  167 (441)
                      .++|++.++||+|+||+||+|++..++.     .||||++......      ...++.+|+.+|++++  |||||+++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL-----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCC-----EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            3579999999999999999999987765     4999998754321      1234668999999986  8999999999


Q ss_pred             EeccccCCeeEEEEEeccCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-CC
Q 013504          168 CAEDDERGIQRLLIYEYMPN-RSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-QW  245 (441)
Q Consensus       168 ~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-~~  245 (441)
                      +.+.+.    .++||||+.+ +++.+++..  ...+++..++.++.||+.||.|||++   +|+||||||+|||++. ++
T Consensus        78 ~~~~~~----~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          78 FERPDS----FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             EECSSE----EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             EeeCCe----EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence            987664    5999999976 688888876  36899999999999999999999998   9999999999999985 47


Q ss_pred             cEEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          246 NAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRL-TYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       246 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      .+||+|||+|+.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     .....
T Consensus       149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~  219 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRG  219 (273)
T ss_dssp             EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHC
T ss_pred             eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhhc
Confidence            8999999999865433    2345789999999999987765 567899999999999999999996421     11110


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                         .            .    .++..+++++.+|+.+||..||++|||++|+++
T Consensus       220 ---~------------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 ---Q------------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---C------------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---c------------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               0            0    111234578899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-49  Score=372.98  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch--hhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ--GHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++++.||+|+||+||+|.+..+      ..||||++......  ..+.+.+|+.+|++++||||+++++++...+. 
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred             CCceeccEEecCCCcEEEEEEeCCC------CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-
Confidence            5799999999999999999987532      24999999765432  24678999999999999999999999988764 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .+++|||+.++.+..+...  .+.+++..+..++.||+.||.|||+.   +||||||||+|||++.++.+||+|||+
T Consensus        75 ---~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          75 ---LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             ---EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             ---eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence               4999999987766666544  47899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhc----
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHL----  329 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~----  329 (441)
                      +.......  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.......    
T Consensus       147 a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (286)
T d1ob3a_         147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (286)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence            98654332  223445799999999998754 56899999999999999999999997654333222111110000    


Q ss_pred             -ccccch---hh---hcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          330 -TDAKKF---TM---ILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       330 -~~~~~~---~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       ......   ..   ...+.........+++.+.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000   00   00010011122235678899999999999999999999984

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=380.27  Aligned_cols=272  Identities=21%  Similarity=0.294  Sum_probs=202.2

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc-hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL-QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      +.+|++++.||+|+||+||+|++..++..     ||||++..... ...+.+.+|+.+|+.++||||+++++++......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVR-----VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSE-----EEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcE-----EEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            45799999999999999999998877654     99999976543 2346788999999999999999999999776543


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                      ....+++|+|+.+|+|.+++..   ..+++..++.++.||+.||.|||++   +||||||||+||||+.++.+||+|||+
T Consensus        82 ~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          82 QMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence            3333556667779999999975   4699999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeceecccCcCCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcccc
Q 013504          255 ARLGPSDGLS-HVSTAVVGTIGYAAPEYIQ-TGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTDA  332 (441)
Q Consensus       255 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  332 (441)
                      ++........ ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......................
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            9865433211 1234568999999999984 4567889999999999999999999997655433322211111000000


Q ss_pred             ----------cchhhhcCCCCCC---cchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          333 ----------KKFTMILDPKLEG---KYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       333 ----------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                .............   ......+.++.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      0000000000000   011123467899999999999999999999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=378.22  Aligned_cols=272  Identities=24%  Similarity=0.300  Sum_probs=200.2

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEecccc--CC
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE--RG  175 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~  175 (441)
                      +|...++||+|+||+||+|++..++..     ||||++.....    ...+|+.+|++++||||++++++|.....  ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~-----vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCE-----EEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCE-----EEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            688889999999999999999877654     99999876432    22379999999999999999999865432  23


Q ss_pred             eeEEEEEeccCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEeecC
Q 013504          176 IQRLLIYEYMPNRSVQDHLT-SRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFG  253 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFG  253 (441)
                      ...+||||||+++.+..... ......+++..+..++.||+.||.|||++   +|+||||||+||||+.++ .+||+|||
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence            35689999997664443332 22356899999999999999999999998   999999999999999775 89999999


Q ss_pred             CCCCCCCCCCcceeeceecccCcCCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhh------
Q 013504          254 LARLGPSDGLSHVSTAVVGTIGYAAPEYIQT-GRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVR------  326 (441)
Q Consensus       254 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~------  326 (441)
                      +++......   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....      
T Consensus       169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            998654432   2345689999999998765 568999999999999999999999997654332221111100      


Q ss_pred             ---hhcccc--cchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          327 ---PHLTDA--KKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       327 ---~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                         ......  ..+................++.+.+|+.+||..||++|||+.|+++  +++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence               000000  0000000000011112245677899999999999999999999997  465554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.9e-48  Score=366.44  Aligned_cols=266  Identities=15%  Similarity=0.240  Sum_probs=210.7

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCC-CCeeeEEeEEeccccC
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEH-PNLVKLIGYCAEDDER  174 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~  174 (441)
                      .++|++.+.||+|+||+||+|++..++.     .||||++....  ....+.+|++++..+.| +||+.+++++....  
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--   74 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQ-----QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--   74 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTE-----EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--
Confidence            3689999999999999999999887654     49999886543  23456789999999865 89999999987665  


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC-----CCcEEE
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE-----QWNAKL  249 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~-----~~~~kl  249 (441)
                        ..++||||+ +++|.+++... +..+++..+..++.|++.||.|||++   +|+||||||+|||++.     ++.+||
T Consensus        75 --~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          75 --HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             --ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence              349999999 78999988654 46799999999999999999999998   9999999999999964     577999


Q ss_pred             eecCCCCCCCCCCC-----cceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHh
Q 013504          250 SDFGLARLGPSDGL-----SHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEW  324 (441)
Q Consensus       250 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~  324 (441)
                      +|||+|+.......     .......+||+.|||||++.+..++.++|||||||++|||++|..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            99999987543221     1123457899999999999999999999999999999999999999976554433332222


Q ss_pred             hhhhcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhhh
Q 013504          325 VRPHLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDAA  387 (441)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  387 (441)
                      +...... ....         .....+++++.+++..|+..+|++||+++.+.+.|+++++..
T Consensus       228 i~~~~~~-~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         228 IGEKKQS-TPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHH-SCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCC-CChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1111000 0000         111234577999999999999999999999999999988654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-48  Score=368.62  Aligned_cols=264  Identities=18%  Similarity=0.293  Sum_probs=201.5

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCCCCCeeeEEeEEeccccCCe
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGI  176 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~  176 (441)
                      ++|++.+.||+|+||+||+|.+..++.     .||||++....  ...++.+|+++++.++|+|++.++..+.....   
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~---   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGE-----EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCC-----EEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCC---
Confidence            579999999999999999999877654     49999877643  23467889999999987776666555544332   


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcC---CCcEEEeecC
Q 013504          177 QRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDE---QWNAKLSDFG  253 (441)
Q Consensus       177 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFG  253 (441)
                      ..++||||+ +++|.+.+... ...+++..+..++.|++.||.|||++   +|+||||||+|||++.   +..+||+|||
T Consensus        77 ~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            358999999 66777766543 46899999999999999999999998   9999999999999854   5569999999


Q ss_pred             CCCCCCCCCCc-----ceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHH-hhhh
Q 013504          254 LARLGPSDGLS-----HVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLE-WVRP  327 (441)
Q Consensus       254 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~-~~~~  327 (441)
                      +|+........     .......||+.|||||++.+..++.++|||||||++|||++|..||............. ....
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            99876433211     22345789999999999999999999999999999999999999997654433222211 1111


Q ss_pred             hcccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHHHHHHHHhh
Q 013504          328 HLTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVEVLNKIVDA  386 (441)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  386 (441)
                      .....           .......+++++.+++..||+.+|++||++.++.+.|+++...
T Consensus       232 ~~~~~-----------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         232 KMSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHSC-----------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCC-----------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            00000           0011123567899999999999999999999999999988754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=375.83  Aligned_cols=272  Identities=25%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++++.||+|+||+||+|.+..++..     ||||++.....  ...+.+.+|+.+|+.++|||||+++++|...+.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~-----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAK-----VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCE-----EEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCE-----EEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            46899999999999999999998877654     99999975432  234678899999999999999999999987653


Q ss_pred             --CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          174 --RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       174 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                        .....|+||||| +++|..++..   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence              223459999999 6778877754   5799999999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhcc
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLT  330 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~  330 (441)
                      ||+|+.....     .+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||....................
T Consensus       165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            9999875432     3457899999999998764 568999999999999999999999976644332222111110000


Q ss_pred             c----------ccchhhhcCC---CCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHHH
Q 013504          331 D----------AKKFTMILDP---KLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKIV  384 (441)
Q Consensus       331 ~----------~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  384 (441)
                      .          ..........   ..........++.+.+||.+||..||++|||+.++++  +|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0          0000000000   0001111234567889999999999999999999998  465543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=366.70  Aligned_cols=272  Identities=21%  Similarity=0.283  Sum_probs=199.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      ++|++++.||+|+||+||+|++..++..     ||||++.....  .....+.+|+.+|++++||||+++++++..... 
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQK-----VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCE-----EEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            6899999999999999999998876653     99999865433  234678899999999999999999999866432 


Q ss_pred             ---CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEe
Q 013504          174 ---RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLS  250 (441)
Q Consensus       174 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~  250 (441)
                         .....++||||+.++.+..+...  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             ccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence               12246899999987776655443  56789999999999999999999998   99999999999999999999999


Q ss_pred             ecCCCCCCCCCCCc--ceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhh
Q 013504          251 DFGLARLGPSDGLS--HVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRP  327 (441)
Q Consensus       251 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~  327 (441)
                      |||+++........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999765432211  123346799999999998765 689999999999999999999999976554443333222211


Q ss_pred             hccccc--------chhhhcC-CCCCCcchH-----HHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 HLTDAK--------KFTMILD-PKLEGKYSI-----KLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ~~~~~~--------~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                      ......        ....... .........     ...+.+.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            111000        0000000 000011111     12456789999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-47  Score=367.86  Aligned_cols=261  Identities=20%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERG  175 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  175 (441)
                      ++|++++.||+|+||+||+|++..++.     .||||++....   .+++.+|+.+|+.++ ||||+++++++...... 
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~-  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNE-----KVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSR-  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC-
Confidence            579999999999999999999877665     49999987543   467889999999995 99999999999865433 


Q ss_pred             eeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC-cEEEeecCC
Q 013504          176 IQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW-NAKLSDFGL  254 (441)
Q Consensus       176 ~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGl  254 (441)
                       ..++|||||++++|..+.     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus       106 -~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         106 -TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             -SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             -ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence             469999999999997654     4689999999999999999999998   999999999999998654 699999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHH--HHH--------
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQK--LLE--------  323 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~--~~~--------  323 (441)
                      |+......   ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........+.  ...        
T Consensus       177 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         177 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             ceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            98754432   23456899999999998765 47999999999999999999999997654332211  110        


Q ss_pred             -hhhh-hcccccchhhhcC--------CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          324 -WVRP-HLTDAKKFTMILD--------PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       324 -~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                       +... .......+.....        ..........+++++.+||.+||..||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000 0000001111110        00111122345678899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-47  Score=358.72  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEeccccC
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER  174 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  174 (441)
                      ++|++++.||+|+||+||+|++..++..     ||||+++....  ....++.+|+.+|+.++||||+++++++..... 
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~-----vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEI-----VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCE-----EEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcE-----EEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-
Confidence            5799999999999999999999877654     99999865432  235678899999999999999999999988764 


Q ss_pred             CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeecCC
Q 013504          175 GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDFGL  254 (441)
Q Consensus       175 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl  254 (441)
                         .++|||++.+++|..++..  .+.+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||.
T Consensus        76 ---~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          76 ---LTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             ---EEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ---eeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence               4899999999998888765  57889999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeceecccCcCCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCchhH-HHHHHhhhhhccc-
Q 013504          255 ARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGR-LTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-QKLLEWVRPHLTD-  331 (441)
Q Consensus       255 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~-  331 (441)
                      ++.......  ......+++.|+|||++.... ++.++|||||||++|||++|+.||........ ...+......... 
T Consensus       148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (292)
T d1unla_         148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence            987654322  233456788999999887655 68999999999999999999999754333222 1111111100000 


Q ss_pred             ----------ccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          332 ----------AKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       332 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                                ....................++.+.+|+.+||+.||.+|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00000000000011122345677899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=365.97  Aligned_cols=266  Identities=22%  Similarity=0.274  Sum_probs=194.4

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc-
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE-  173 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  173 (441)
                      ++|++++.||+|+||+||+|.+..++.     .||||++.....  ....++.+|+.+|++++||||++++++|...+. 
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTE-----EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCC-----EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence            679999999999999999999887665     499999976433  234568899999999999999999999976532 


Q ss_pred             -CCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 -RGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                       .....|+|||||.++ +.+.+.    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++||
T Consensus        92 ~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          92 EEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             TTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence             234679999999655 445553    4689999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhh----
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRP----  327 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~----  327 (441)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++++|++|+.||...........+ .....    
T Consensus       164 ~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            998865432   2345578999999999999999999999999999999999999999755432221111 00000    


Q ss_pred             ----h-------ccc-----ccchhhhcC---CCCCCcchHHHHHHHHHHHHHhhcccCCCCCCHHHHHH
Q 013504          328 ----H-------LTD-----AKKFTMILD---PKLEGKYSIKLAQKLAAVANKCLARQAKGRPKMSEVVE  378 (441)
Q Consensus       328 ----~-------~~~-----~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  378 (441)
                          .       ...     .........   ...........+..+.+|+.+||..||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                0       000     000000000   01112233456788999999999999999999999997

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=367.02  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=201.3

Q ss_pred             cCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc----hhhHHHHHHHHHhccCCC-CCeeeEEeEEecc
Q 013504           97 KNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL----QGHKEWVTEVNVLGVVEH-PNLVKLIGYCAED  171 (441)
Q Consensus        97 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  171 (441)
                      ++|++++.||+|+||+||+|.......  .+..||||.+.+...    ...+.+.+|+.+|++++| |||+++++++.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHD--TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTT--TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCC--CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            679999999999999999998754321  233599999875432    234567789999999966 8999999999877


Q ss_pred             ccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEee
Q 013504          172 DERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSD  251 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~D  251 (441)
                      ..    .++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus       102 ~~----~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         102 TK----LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             TE----EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred             Cc----eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEee
Confidence            63    59999999999999999763  5778899999999999999999998   999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeeceecccCcCCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHH-Hhhhhh
Q 013504          252 FGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG--RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLL-EWVRPH  328 (441)
Q Consensus       252 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~-~~~~~~  328 (441)
                      ||+++...... ........||+.|++||.+.+.  .++.++|||||||+||||++|+.||...........+ ......
T Consensus       173 FG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         173 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             ccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99998654432 2234457899999999998764  4678999999999999999999999765433222211 111000


Q ss_pred             cccccchhhhcCCCCCCcchHHHHHHHHHHHHHhhcccCCCCCC-----HHHHHH
Q 013504          329 LTDAKKFTMILDPKLEGKYSIKLAQKLAAVANKCLARQAKGRPK-----MSEVVE  378 (441)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  378 (441)
                                     ....+..+++++.+|+.+||+.||++||+     ++|+++
T Consensus       252 ---------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                           01122346788999999999999999995     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-46  Score=360.43  Aligned_cols=272  Identities=22%  Similarity=0.307  Sum_probs=201.4

Q ss_pred             hcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCc--hhhHHHHHHHHHhccCCCCCeeeEEeEEecccc
Q 013504           96 TKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGL--QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDE  173 (441)
Q Consensus        96 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  173 (441)
                      .++|++++.||+|+||+||+|++..++.     .||||++.....  ...+++.+|+.+|+.++|||||++++++.....
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGL-----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTE-----EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            4689999999999999999999887664     499999976543  234578899999999999999999999875432


Q ss_pred             C-CeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCCcEEEeec
Q 013504          174 R-GIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQWNAKLSDF  252 (441)
Q Consensus       174 ~-~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF  252 (441)
                      . ....+++|+|+.+|+|.+++..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++||
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence            1 1123667778889999999964   4799999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeeceecccCcCCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCchhHHHHHHhhhhhccc
Q 013504          253 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTG-RLTYKSDIWSFGVFLYELITGRRPLDRNRPKSEQKLLEWVRPHLTD  331 (441)
Q Consensus       253 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  331 (441)
                      |++.....     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.........
T Consensus       166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            99976432     23457899999999987665 4688999999999999999999999765443332222111000000


Q ss_pred             -------ccchhhhcC--CCCC-Ccc---hHHHHHHHHHHHHHhhcccCCCCCCHHHHHH--HHHHH
Q 013504          332 -------AKKFTMILD--PKLE-GKY---SIKLAQKLAAVANKCLARQAKGRPKMSEVVE--VLNKI  383 (441)
Q Consensus       332 -------~~~~~~~~~--~~~~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  383 (441)
                             .........  +... ..+   ....++.+.+||.+||+.||++|||+.|+++  ++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                   000000000  0000 000   1134567889999999999999999999998  45543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-42  Score=336.00  Aligned_cols=272  Identities=19%  Similarity=0.252  Sum_probs=195.3

Q ss_pred             CCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-----------CCCeeeEEe
Q 013504           98 NFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-----------HPNLVKLIG  166 (441)
Q Consensus        98 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~  166 (441)
                      +|++++.||+|+||+||+|++..++.     .||||+++.... ..+.+.+|+.+++.++           |+||+++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~-----~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNT-----HVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            59999999999999999999887665     499999976532 2456778998888775           578999999


Q ss_pred             EEeccccCCeeEEEEEeccCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEEEcCCC
Q 013504          167 YCAEDDERGIQRLLIYEYMPNR-SVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNILLDEQW  245 (441)
Q Consensus       167 ~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NILl~~~~  245 (441)
                      ++......  ..+++|+++..+ .............+++..+..++.||+.||.|||+.  .+|+||||||+||||+.++
T Consensus        88 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          88 HFNHKGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             EEEEEETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred             Eeeecccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccC
Confidence            98765544  235566655443 344444445567899999999999999999999973  2899999999999998665


Q ss_pred             c------EEEeecCCCCCCCCCCCcceeeceecccCcCCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCchhH-
Q 013504          246 N------AKLSDFGLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTYKSDIWSFGVFLYELITGRRPLDRNRPKSE-  318 (441)
Q Consensus       246 ~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltG~~P~~~~~~~~~-  318 (441)
                      .      ++|+|||.+......     ....+||+.|+|||++.+..++.++||||+||++++|++|+.||........ 
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            3      999999999864332     3456899999999999999999999999999999999999999965432211 


Q ss_pred             ---HHHHHhhhh--hccc-----ccchhhhc---------CC----------CCCCcchHHHHHHHHHHHHHhhcccCCC
Q 013504          319 ---QKLLEWVRP--HLTD-----AKKFTMIL---------DP----------KLEGKYSIKLAQKLAAVANKCLARQAKG  369 (441)
Q Consensus       319 ---~~~~~~~~~--~~~~-----~~~~~~~~---------~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~  369 (441)
                         ..+......  ....     ........         ..          ..........++.+.+|+.+||..||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence               111111000  0000     00000000         00          0012234567889999999999999999


Q ss_pred             CCCHHHHHH--HHHHHH
Q 013504          370 RPKMSEVVE--VLNKIV  384 (441)
Q Consensus       370 RPs~~evl~--~L~~~~  384 (441)
                      |||++|+|+  ++++..
T Consensus       319 Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CBCHHHHHTCGGGTTCT
T ss_pred             CcCHHHHhcCcccCCCC
Confidence            999999987  355443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.8e-25  Score=196.04  Aligned_cols=164  Identities=14%  Similarity=0.102  Sum_probs=118.1

Q ss_pred             CcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCch------------------hhHHHHHHHHHhccCCCCC
Q 013504           99 FSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQ------------------GHKEWVTEVNVLGVVEHPN  160 (441)
Q Consensus        99 f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~il~~l~hpn  160 (441)
                      +.+++.||+|+||+||+|.+.. +     ..||||+++.....                  ......+|+..+.++.|++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-g-----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-F-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-T-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             chhCCEeeeCcceEEEEEECCC-C-----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            3567899999999999998753 2     34999986532110                  0123456888999999999


Q ss_pred             eeeEEeEEeccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCcEE
Q 013504          161 LVKLIGYCAEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEGMDFQIIFRDFKSSNIL  240 (441)
Q Consensus       161 Iv~l~~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlKp~NIL  240 (441)
                      ++..+++..    .    +++|||++++.+.+         ++...+..++.|++.+|.|||++   +|+||||||+|||
T Consensus        76 v~~~~~~~~----~----~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL  135 (191)
T d1zara2          76 VPKVYAWEG----N----AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  135 (191)
T ss_dssp             SCCEEEEET----T----EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             cceEEEecC----C----EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence            999876531    1    79999998765432         34455678999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCCCCCCCCCCcceeeceecccCcCC------ccccccCCCCccccchhHHHHH
Q 013504          241 LDEQWNAKLSDFGLARLGPSDGLSHVSTAVVGTIGYAA------PEYIQTGRLTYKSDIWSFGVFL  300 (441)
Q Consensus       241 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlG~il  300 (441)
                      ++++ .++|+|||+|+........          .|..      .+. ....|+.++|+||+.--+
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            9965 5899999999764332210          1111      111 235678899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=6e-08  Score=87.46  Aligned_cols=149  Identities=15%  Similarity=0.125  Sum_probs=97.6

Q ss_pred             HHHHHHhcCCcccceeecccceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEE
Q 013504           90 SELKTATKNFSRSLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYC  168 (441)
Q Consensus        90 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  168 (441)
                      .+++.....|+..+..+.++.+.||+....+.       .+.+|............+.+|..++..+. +--+.+++.+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-------~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-------NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSC-------EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-------eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            35667777888777665555678998753222       27788876554334445678888877663 33356666666


Q ss_pred             eccccCCeeEEEEEeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------
Q 013504          169 AEDDERGIQRLLIYEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLHEG------------------------  224 (441)
Q Consensus       169 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------  224 (441)
                      ...+    ..++||++++|.++.+.....       .....++.+++..|..||+.                        
T Consensus        80 ~~~~----~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          80 RHDG----WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EETT----EEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             ecCC----ceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence            5544    348999999998886544210       11223445555555556542                        


Q ss_pred             --------------------------------CCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          225 --------------------------------MDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       225 --------------------------------~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                                                      ....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                            02247999999999999987667799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=1.9e-05  Score=70.08  Aligned_cols=129  Identities=16%  Similarity=0.121  Sum_probs=76.0

Q ss_pred             eeccc-ceeEEEEEEcCCCCcccceeEEEEEccccCchhhHHHHHHHHHhccCC--CCCeeeEEeEEeccccCCeeEEEE
Q 013504          105 IGEGG-FGGVYRGVIRSTEDSHKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE--HPNLVKLIGYCAEDDERGIQRLLI  181 (441)
Q Consensus       105 LG~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~~~lv  181 (441)
                      +..|. -+.||+....+..      .+.+|......   ...+..|...|+.+.  .-.+.+++++..+.+    ..++|
T Consensus        18 ~~~G~s~~~v~r~~~~~~~------~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~~~v   84 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRP------VLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAG----RDWLL   84 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSC------CEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEEEE
T ss_pred             cCCcccCCeEEEEEeCCCC------EEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccccc----ceEEE
Confidence            34444 3678987654332      26777755432   234567888777663  233566777665544    24899


Q ss_pred             EeccCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 013504          182 YEYMPNRSVQDHLTSRFQATLPWNTRLKIAQDAARGLAYLH---------------------------------------  222 (441)
Q Consensus       182 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---------------------------------------  222 (441)
                      |++++|.++.+..       ...   ..++.++...|.-||                                       
T Consensus        85 ~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (255)
T d1nd4a_          85 LGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  154 (255)
T ss_dssp             EECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence            9999886653310       000   011122222222222                                       


Q ss_pred             ------------hC----CCCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          223 ------------EG----MDFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       223 ------------~~----~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                                  ..    ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                        21    12248999999999999987767899999765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=2.4e-05  Score=74.50  Aligned_cols=78  Identities=14%  Similarity=0.112  Sum_probs=46.2

Q ss_pred             cceeecccceeEEEEEEcCCCCcccceeEEEEEcccc------Cc-hhhHHHHHHHHHhccC-CC--CCeeeEEeEEecc
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDSHKKIDIAVKQLSRR------GL-QGHKEWVTEVNVLGVV-EH--PNLVKLIGYCAED  171 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~-~~~~~~~~E~~il~~l-~h--pnIv~l~~~~~~~  171 (441)
                      .+.||.|....||+.....++.     .+.||.-...      .. ....+...|..+|+.+ .+  ..+.+++.+..  
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~-----svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDR-----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----C-----EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--
T ss_pred             EEEeCCCceEeEEEEEeCCCCe-----EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--
Confidence            3468999999999987554433     3777764321      11 1234556788888766 22  34566665532  


Q ss_pred             ccCCeeEEEEEeccCCCCh
Q 013504          172 DERGIQRLLIYEYMPNRSV  190 (441)
Q Consensus       172 ~~~~~~~~lv~E~~~~gsL  190 (441)
                      +..    ++|||++++..+
T Consensus       104 ~~~----~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMA----VTVMEDLSHLKI  118 (392)
T ss_dssp             TTT----EEEECCCTTSEE
T ss_pred             CCC----EEEEeccCCccc
Confidence            222    899999977543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.99  E-value=0.0013  Score=61.90  Aligned_cols=79  Identities=14%  Similarity=0.135  Sum_probs=48.9

Q ss_pred             cceeecccceeEEEEEEcCCCCc--ccceeEEEEEccccCchhhHHHHHHHHHhccCC-CCCeeeEEeEEeccccCCeeE
Q 013504          102 SLMIGEGGFGGVYRGVIRSTEDS--HKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVE-HPNLVKLIGYCAEDDERGIQR  178 (441)
Q Consensus       102 ~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~  178 (441)
                      ++.|+.|-.-.+|++........  .....|.+++.....  ......+|..+++.+. +.-..++++++.  +      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C------
Confidence            34688888899999887654221  112235566654322  2234457898888874 444457777763  2      


Q ss_pred             EEEEeccCCCCh
Q 013504          179 LLIYEYMPNRSV  190 (441)
Q Consensus       179 ~lv~E~~~~gsL  190 (441)
                      .+||||++|.+|
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.74  E-value=0.0027  Score=57.54  Aligned_cols=31  Identities=23%  Similarity=0.199  Sum_probs=27.4

Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLAR  256 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  256 (441)
                      ..++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999988777899999775

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.21  E-value=0.0059  Score=55.62  Aligned_cols=30  Identities=23%  Similarity=0.258  Sum_probs=24.6

Q ss_pred             CCCeEecccCCCcEEEcCCCcEEEeecCCCCC
Q 013504          226 DFQIIFRDFKSSNILLDEQWNAKLSDFGLARL  257 (441)
Q Consensus       226 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  257 (441)
                      ..++||+|+.+.|||++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4579999999999999743  45899998764